<SEC-DOCUMENT>0000275053-22-000023.txt : 20221103
<SEC-HEADER>0000275053-22-000023.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221103171142
ACCESSION NUMBER:		0000275053-22-000023
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		59
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NATURES SUNSHINE PRODUCTS INC
		CENTRAL INDEX KEY:			0000275053
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870327982
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34483
		FILM NUMBER:		221359089

	BUSINESS ADDRESS:	
		STREET 1:		2901 WEST BLUEGRASS BLVD.
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		(801) 341-7900

	MAIL ADDRESS:	
		STREET 1:		2901 WEST BLUEGRASS BLVD.
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMTEC INDUSTRIES INC
		DATE OF NAME CHANGE:	19821108
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>natr-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:0c0039ed-9423-4265-b7e9-653c93e0671e,g:99a2bdfa-c370-4e73-96ea-a47009d21b4e,d:6eb6669461dd48148c47c5e30947a7a4--><html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:natr="http://naturessunshine.com/20220930" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>natr-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGFibGU6NWNiYWRmN2U0NTBmNDYyZTlhNmEzMGI4MTFlZGFjZjAvdGFibGVyYW5nZTo1Y2JhZGY3ZTQ1MGY0NjJlOWE2YTMwYjgxMWVkYWNmMF8xLTEtMS0xLTM2NTE3_e9a8870e-8ec2-4bf5-9ef6-9f1b1323dec9">0000275053</ix:nonNumeric><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGFibGU6NWNiYWRmN2U0NTBmNDYyZTlhNmEzMGI4MTFlZGFjZjAvdGFibGVyYW5nZTo1Y2JhZGY3ZTQ1MGY0NjJlOWE2YTMwYjgxMWVkYWNmMF80LTEtMS0xLTM2NTE3_9aa127dd-2d10-4f87-9b8b-f445af84c8b1">false</ix:nonNumeric><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGFibGU6NWNiYWRmN2U0NTBmNDYyZTlhNmEzMGI4MTFlZGFjZjAvdGFibGVyYW5nZTo1Y2JhZGY3ZTQ1MGY0NjJlOWE2YTMwYjgxMWVkYWNmMF8xMi0xLTEtMS0zNjUxNw_51eba60f-6d4e-481c-83af-d43cae2ca344">2022</ix:nonNumeric><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGFibGU6NWNiYWRmN2U0NTBmNDYyZTlhNmEzMGI4MTFlZGFjZjAvdGFibGVyYW5nZTo1Y2JhZGY3ZTQ1MGY0NjJlOWE2YTMwYjgxMWVkYWNmMF8xMy0xLTEtMS0zNjUxNw_3d6b8603-e162-463f-8b59-ce09404db84b">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGV4dHJlZ2lvbjoyMmEyMmVlYWJhOTY0MjUzODViM2IwOGVmZTg1YzY4Nl8xOQ_fae11ef0-c77e-4e52-8562-a01051bb92c6">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i5d187ffc6a1e4ec4a033a6d10d3b0da6_D20220101-20220930" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81NS9mcmFnOjgwMmMxN2JlMWM2ZTRjODg5ZDY5OTk4Njg5YWQ0ZTFlL3RhYmxlOjc4OGIxNGE1ZTM3NDRmNjZhMDBiM2Y5YTIxMGNhNzVhL3RhYmxlcmFuZ2U6Nzg4YjE0YTVlMzc0NGY2NmEwMGIzZjlhMjEwY2E3NWFfMS0xLTEtMS0zNjUxNw_111bfa51-7ab7-4b9f-ae65-55d536936b65">1</ix:nonNumeric><ix:nonNumeric contextRef="ic6759b4d6bdc4c09915380281d2e0a8d_D20220101-20220930" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81NS9mcmFnOjgwMmMxN2JlMWM2ZTRjODg5ZDY5OTk4Njg5YWQ0ZTFlL3RhYmxlOjc4OGIxNGE1ZTM3NDRmNjZhMDBiM2Y5YTIxMGNhNzVhL3RhYmxlcmFuZ2U6Nzg4YjE0YTVlMzc0NGY2NmEwMGIzZjlhMjEwY2E3NWFfMS0yLTEtMS0zNjUxNw_21ece1ac-a5b7-41bd-8aa7-9b678bd3299e">1.25</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="natr-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ce7aad2623047ba8addd0803daa97b8_I20221021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="id5fbf276129e47918eed3c1199ae0b7f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if49e9f1a5ba44e46b40fa8219c379488_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5b7f325a374195a547054c530354da_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21726f161d9144c981677c9a99d24247_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a03d0e2e0f4675968fee999d70cd9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03abfe1166e94acca8a49677b13b5cf0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1933b6d048a44bf8cfbb6b1cd3cd3d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f1bb76039d144b9aa58a21c14728060_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f4d3acbe9b44659a91f7fd1c3d496a6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15218d9f24de436b834e94ec6b7a0b0a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9297f3eeb3c94b419740d6866d8f7fa3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d091b18a034cff89766812998da336_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69e160aafda54f33bc08d1b8e1e4a739_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i806380af81994042ab6c34e36fc9e4e4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8fc16447ae46a9b23c72b39b9594ee_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94264228c295486ba38b41b36c269fb7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba67555887c94157b7a8aa02815a129c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i150dc190a6c548f8964429c219799683_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1faefa48e67d4f9bbfe8e3424767234d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1d99554b99d48c89c6d05c03b41c591_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie041b2243726491bbcd617dcdbd9ee67_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23da71b505a4aed8729342c64157a41_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b247ac9dad4b0d9c915a260843ac3a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a3f5bcc65a84d81b343742fa3687210_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d93b30a1dd64266b09ca1dbe8a45ce9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i266bc0c70d8240a68e7030d4a3572f2a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67def2bf001441ce8b5360fb751d05c8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i896cdfbdeb6844b7919d0c99a82986ba_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5368041dc04d7a876079103b591a82_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bf72498d14409e8704c249bbf5dff4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4633088b44c14861af62ac14bfa848b0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82edb931ed8744efb0bb55d80302158e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3eefe80682a456688d647d706338b94_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584cc6cef84645d9aced1d159fb33e8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcdea242da894c9096e6edc3b69c848c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45b62ba4a6054191ab5a2cfa2177eb37_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i567421871cb84ff3947a1c4f0439f49e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b678cf1500d473b98980c984f33d848_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if699539c6d8d44db865d338e2352f43f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id292b6800f4b4953a4a8fc8f19b5c00f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6c47cc5bdab45b9a83e045e422ae9d1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2daecb1c459472faf935c58f3d99556_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed2af8ce51a451dad2b3584762627b2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05f25ce1bda74c48805771205ffcbbf8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i261b16c64967417fb69e183d714d9071_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a44095252141c78d08c366bb1f2bce_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a7eaf75c524a39958b86619197e5f9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf26778247cf45e487700b6f55866416_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3478de1ed17e4979a47bd4d3d1f5d7d0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd19a9c61024bdcbe7a41dbec049830_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dd64c1df3f04a6ea9ed4b040fb9c417_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7debe8761cc44795a69514ea9d87827b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide03d0a470604be19addddae37f14109_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56b974fe0214d9691e4d03c981d7efb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i428520a8a69e426a8fe5926e9ce42e43_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie441a8e4124a4d1b8054036ab19f5a25_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6b8c3d3276a40a8b5cf97b7662f1789_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id81a97f8651b47b3a684dd5ff1e10415_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d49ac7e33054ec294ea97a34ce760b0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb9057781307454eaa3ab969709f5839_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaca5bb1e0ec4e8fac38bd64a9792a66_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i742edf6aff37488aa80e713e9a672a7a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f10af2594854b9fb57ee7ef9b152993_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib41f685a036d4f58a4e05731f4478dfc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a51afc7549405b92c990bdb852d8cb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">natr:AccruedSeveranceandRentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004662f9de7b4fdfbabc81b8850a070f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">natr:AccruedSeveranceandRentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia06b2ea113604f608cfe139f6473b4f8_I20170711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-07-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia088a5fe1c0d4659856719b55cc649b5_I20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="borrowing"><xbrli:measure>natr:borrowing</xbrli:measure></xbrli:unit><xbrli:context id="i22efa19eb0344c72ad687994862269e2_D20220623-20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-23</xbrli:startDate><xbrli:endDate>2022-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iddc8134658ca4954b354f15805380b94_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f0cbc126bdd4b63949c4345575e09e6_D20220623-20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-23</xbrli:startDate><xbrli:endDate>2022-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if06d201ef25c4642849a07427e18a4e2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c79105659ed47199844f29f16ee8732_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e03c2f550744858bfdef123a1e103dc_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42bf1f4955d14fd785dd3122c680d83b_I20201119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03715efd129a44a1865caa1ea43fa333_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">natr:IndicativeIndexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8562a44c05df4b34a7f6a8878e388882_D20201119-20201119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-19</xbrli:startDate><xbrli:endDate>2020-11-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="payment"><xbrli:measure>natr:payment</xbrli:measure></xbrli:unit><xbrli:context id="id7b42e335b02463ea1d3019cd2f3474b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e5bb1cef6c4becb6ebf74bc1b7e3eb_D20210405-20210405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-05</xbrli:startDate><xbrli:endDate>2021-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee350a313d8f4cd4b7964c9818ca55c8_I20210310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38f58e1adc7e4bd4adbdfed111f9df0b_I20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c0ddf3d82324bcb905a643d93542091_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae0afd2c25447bc920e0df4c8c9b207_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9593f0319dc4fe48d712b42fc7be268_D20210505-20210505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-05</xbrli:startDate><xbrli:endDate>2021-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb44a2c98f1740dbb00c82b0e332d00e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50cfb2216c6e4898a183ccf77630d5ae_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb5874cb29674dc6a3388b35641bbd9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1121eb8e41764e2f885ce89e9efd6fca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i070b06d98cf645ae85a6b3eff5f58702_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3925d99f6de43c5afbf93f61d4d675d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie46e49fee8fd42a2aab87f77ac2f490e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23b536a276514486b763bbc7d3034568_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef0509b465a4ac38cc9efafd19b9daf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dc49deb25cc408796443b55a640d385_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20e20adf95940ca8fd836f859de3b03_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa9bd7370039495491ec25c69d400f48_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic152af38654942a3a96dcd69544a74da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0055094229274cb5af4f7333a237c4ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ae4407db5044cd68a2c86c97449360f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9f3b5b7f4ad40a29dec40525ebba7de_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedRestrictedStockUnitsRSUs1YearVestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vestinginstallment"><xbrli:measure>natr:vestingInstallment</xbrli:measure></xbrli:unit><xbrli:context id="i9901ca354f7443948673dbff989dd14d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedRestrictedStockUnitsRSUs3YearVestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05187ed32f1a4459918c007aceb10282_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a19d8970b2543048df69222e0305ed8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">natr:NetSalesandOperatingIncomeTargetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04dd1d0e30dd4749869d484b28d4c2f3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1aa6de8d3384bec8195c0705cf1e5ee_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10c14c6b81e84c7b8f58f51625726416_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761305687fcc410da48c9004616a56eb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabe8b4b0a68d4a079325eda61ea70e86_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dff8e40d0d240aa9a88877fdfd05209_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i523fb664c6924406a1e7680eb6501b9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic317fd5637e24133b38464894a02a48a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8b227faac114cf89d93aacc27030ee3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa5248e41f6f4304969ef1dca24c02cb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if495bbb4e2364ea1b89e3ce85fd3847d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7532a655100648398d64a5c418cefbd7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d187ffc6a1e4ec4a033a6d10d3b0da6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6759b4d6bdc4c09915380281d2e0a8d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>natr:segment</xbrli:measure></xbrli:unit><xbrli:context id="iaffce26a8c8b429fb3267aa0f04b6886_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d3acc32b97542e5a94dd4a3bb1b4cd7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6de094914c5f46db86d9dc44c155ea51_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9597cde95214777a01076967abb5bfd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01f17fd5fec04cceb20a25018feb023a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee2afc6d0574fa68adf6928f3f7ca2e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35fb57db9af244869c886dfc1addaba9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7f268d552ed4fd791df8fd022fc4127_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ca94f66cae0472e950944808843bf52_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0c54aef4fc24df184a67d7a6e8a4686_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8bbc89738474e36a998144b3ab76005_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if64ed51372db4414b6b3e91b38ec9b38_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i989dadafa5b04aa6983e589a0e3400b1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f83106d3c64004a59b18515c555b70_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icefc13a45af1427495b1821d0c2f7f72_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9d15fce936b4a1393ca7b8ca3173e02_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9789e91bbdb4bb3981bfa676460e65f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad4ac3adcab842aa92dac9e2832e0d49_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c2ceb81578b43c2a003d38ceeea837f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f7fca25b7e64744a88843d142be5e47_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43ce284ec08d45a8b2f4eaf1d21af325_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f7edfa74c3a4facaef4c6ce7195e3a1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7890d7b2c60340b3922736cdbf24446a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac3dd237480d4bb2a35fab25b753dc3b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c0a4dbff9664147803b502780897f38_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b416cf57d384a54804362b64dbbf5ea_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ecb353578384ec8a536a7a833c0fc5c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14a40364c7f64f5b80d862226b34ff6a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic001fa920873448dbc6ef54932a229ce_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9960683c96654f1ebd545850683426af_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7057434687ff46f199ae8cac13391907_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i746ecd7e625c4144b3062ca451baff75_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34383a427ad9404f8336487647135d64_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i031ea41430044721be426b9e153f6d4e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb7cc106017f4bf790288d1410c6604f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7aa79c6bd1146a299f812340a1c9843_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice4ea04852d949b7b25b5dff1ff385c0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b447bb6325c4a93813bee7f6470e956_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a38b38d33164e7f8b12740fd234f511_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6afa9b57d0c8439a97666baea62606a5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1422bc583463406ab563aaeac2967f11_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i271947650c0641aa8199e5d38ec3dc01_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia86d933ddea04f8fb10973d2824e48fa_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f271afb02914124b483854f23bca344_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae9278b469d041fc8fff0e48fbaf4ca2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e611910bb3b4d8ab7ed214bddf977b3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6db6b432f4df49c1b4c2fca343cba1bf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if69d793ea3634ef3bc0a0ae9b4bcb442_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d5784c20ae64613902d57eaa1241f9a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idecec013f09941a7ae837474c48050ec_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if691899efd02473bbc07a3634d9602b9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a1a086a005d481397a9ec0c504d08f3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07a9c9b9a5d64082b24c3ce6b7f77d2a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if666c3e591d34e419fe5cea9d63c76d0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id82dd7fc19f2499ab5018e7a7327d0f2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3fc9b884d79481ba64714a98c37701b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i455e487fd71d4e1f9f70e1f7708b649d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2febb6991fd410a9e2bb3ad36bfa7b0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i766f81ea59e3447c8731e8067d14378c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b388a0ba69473fb479c83bba1002bc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0d2a86b74014923a32749b21e57e32b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id811e29bb810469fb1c0ff8a40d5baca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i110b96df81934c4a895b7332653dfdfa_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb2292964ed74f2c93618691aed0bf17_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e9fedb6d37e44a48ae4c2c1a283eced_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8027c00bfbb440189c17c3cef6fd9b0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92940ae0daed421bbc0a168e8b5e7afd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida2f5eb698ef4d4497ce138f3923d2a9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8871c124bfc4ab59b69f58aa8ac2306_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8f1af7974d3467f8810ee1a2c00cef0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i229bd20fdbd341b1a80e3c4e77eccf82_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i705c1e9af35d4a6e8814be31f200cad7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91e4ef35e1824ccd882bf7fff758fffa_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2403109edfcf49318ed206f1f7e61b38_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b7f893932fe4cdfa20944e08ccd08b2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15464f06de2947f184afb9420f0a1d8f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d33ddcece9a4459a1d275467de416cc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f841c8711ef4ed49fbf8d826bc99285_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2489b6c3524e4e7b9c1a4e326997805c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic089f06dc3df44b08a41d0888be18ae8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i422653a3b8d4475789d80957e8caed9d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31f4302be1d4bfba2a29bd5573f373f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e4d19f07f584072a8e2b404743234e4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e8031c49d064ec995642d0179e0484b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16eb866672624d548d5ec50e5c190e14_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc90dbbf82d04aea8f8e7d67a1c1b202_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i601e923be0e041b98944eb6ce61046a8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88024d56c5604272b98bf435e9880a43_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9795542b5d774f05aa511f90de376487_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e26d0a6ff7f45ada98e9349e001bbcb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25551ab7ec84b1bb4cba21a91fe3ed1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16954cbf01f143ceb864705c2fa0aa79_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c51dace4af44a7ca2837c323c420d65_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81d52a6ed02545c9901d63a06dde0c2d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f7036575f84653b7c99e0bfb760ad9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id685627d492845129ed93f47b2600c71_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8828b4bb2ca4a78bc626f16aaba9fb6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd76854b160450aaf7d25c1de52f345_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973e94e3c4404183a5aafd47340dac63_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326578d04941458389bc907b4ad873c0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e200f708ff842429882977de66a40cb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6450b3e52c24654b5a6cc4658015a1b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5664bf6fe1c74422abdd683652227653_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f174cab779147c29b714f2811393f87_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d25faa8b14c4291be6d757f80e48839_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i328dfba4c23f4457928a6cdb96fc8f77_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee902b6bcd8140a6bcd5753dea705623_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0380da3a0fc43dabab9b5d91973518b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7763e9ad44b443bf8f1343ad714748ad_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09258a1dafea4f46913ce7064e9df669_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if881a438f54d41fdbca0d3ae23ae6f96_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8ceb2715c3147c3a1acd033f373b6f7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5641230f75e947e3b420ea68cb7362a5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d3e4239b05749efb73231210fcd5b18_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ff533dd32af4803adfde1b7642cb050_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22b7264ca2e0467e95df7299dce5077d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54595879e3a144e9984de9671b792908_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f54d1d04d5442bfbd655e919fea5146_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66719a00cb6a489eba77f2f4f2fad567_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia834fba69cf84a55bcbbac80c88e2afe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c1f33dd8d78416888f9868e6b210ee4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic071da5568ec49dba654382b69827d3a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia26db1a48ab045ff967ff61767510615_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40a63ab18aa54729a20e2ec4a9991db1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37724458b90a4f009836dd15510c28d2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18896a1ab1614d4fbd39660918fa2ea5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82fb728c64d94cd9a7821fd5b723bcbc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3712db2c199b49b3b7c8d62c7dea3e2c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5143d898f89c4757b88ba36166facb40_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if34568f0ea034fd888a5237c3a1cb09b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a28ef0b4677478f8f5027325b718a83_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b008c611ecb4419800960c8e592d0ad_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba0114f77e84101866720c25f0493b7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b314b15d654ad785f11accf7d8aded_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a4aaaf217b48c082080afab03641e6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icebd38c2c3754ea4936025826c0e61e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5479a522979746c0beefbf88acbfc76c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d33f22f45f044fdb3c35e22eacd0d4d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief2efe54ca2e4f2dbc51a62ceca74009_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62f9fe04c4724f8d8703c8915a244329_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia728a540cb63450d8fe3503583cad26d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie641fbd2f6974546af07155f94734fbc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98381a37664e48548eeae68619c1ae03_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c16e0b053f4d47b09be402979af494_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if876afffb2454b8f9813b911a0c89bd2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>natr:claim</xbrli:measure></xbrli:unit><xbrli:context id="i388c52769b8c403aae9816b6a35b9616_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c2c500c91547a2b8ce14a47ea99029_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a40bfae9b044ad7af9bf711c7647199_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95aa0b7acd74228b82c668e2ce7b986_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d6179a221754815aa24768673e73000_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i712f9d7d51b845a1b2668f6d2775c79d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a4cd2649ad43e1af381be20efb83db_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5da800ec6cf0494cbcc64545e0f23b44_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b0e83c4abf344a5b8794db175c95e39_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib64da197a61a4a098d6c97001abfa251_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c616686bc27495f86f33cccfd0ba207_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f558ae5860a4d0aaca0786b80ce2b37_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:FosunPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ebaa3f43bee42c18c5ed0c1bf61f4b4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:FosunPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ee5eda554ad4659907fd5cb08273632_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia764c839880b4c7e9899c96c4ea22bfb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5236b078ac4a6daebf4680b5be165b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i455120a077da4df088d0bd54ec5106fa_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e093e27ec0a4b8ba600829b8e48847e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad3dfe96a539486182ac2875e73b964a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b4a4f5139a945ab966207cbdb52726a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:CompanysJointVenturePartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd095404eb1749d5b8208d23f0b59607_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:CompanysJointVenturePartnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a632e9166b44345976a990799025881_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4162cfa26b14df99488a4f76a09b41f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01f3880d0019417fb3e190f74f5f8a25_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id147596397c04e229b6d434f653bc101_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e406e3dd789497cb667823793e51f2d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b5f131172d44dbab10213532398fcf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id750b81e065841b08fc01573faa37105_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4b170f280e46a2b3047bb6edd5bf27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id976048dc79248cdb7a4f9d5569849ac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="product_category"><xbrli:measure>natr:product_category</xbrli:measure></xbrli:unit><xbrli:context id="i12e083e1f3414241b1bb88a79fea2b88_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6eb6669461dd48148c47c5e30947a7a4_1"></div><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8xNTM_f06e7715-7726-4cb5-97dd-5ec2d327506a">10-Q</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8xNzA_1e9acc28-99bb-4c3a-8539-2458afcfb48c">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160; QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8yOTc_a7c59df4-16df-4afc-8c8e-0c76b3012d1d">September&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8zMDg_6e9d0c08-a8de-47d7-8752-7295c5bf21d3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160; TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF80OTI_90f0573f-fa9c-4e5b-93fb-5eac4f605076">001-34483</ix:nonNumeric></span></div><div style="text-align:center"><img src="natr-20220930_g1.jpg" alt="natr-20220930_g1.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF80OTg_071d9d9d-d83a-4cd0-b8ef-05311f92a97b">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6MTNiZmU4ODE0NjEzNGZlZThhNjRhYmY4MzM3MTU3NGMvdGFibGVyYW5nZToxM2JmZTg4MTQ2MTM0ZmVlOGE2NGFiZjgzMzcxNTc0Y18wLTAtMS0xLTM2NTE3_97b3e6b4-c5db-416a-8fb2-0918b4ebc8ae">Utah</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6MTNiZmU4ODE0NjEzNGZlZThhNjRhYmY4MzM3MTU3NGMvdGFibGVyYW5nZToxM2JmZTg4MTQ2MTM0ZmVlOGE2NGFiZjgzMzcxNTc0Y18wLTItMS0xLTM2NTE3_8e1344ad-35eb-4c76-9c51-819c6b36a035">87-0327982</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81NjA_7919d302-98a9-41ce-a33c-c063921715cd">2901 Bluegrass Boulevard</ix:nonNumeric>, <ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81NjQ_e9d9c280-82fb-4bf8-bfd2-4b871345c566">Suite&#160;100</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81Njc_e28579b1-3c97-4569-a8fb-d4d5335fccff">Lehi</ix:nonNumeric>, <ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81NzE_3d226bfb-8a8f-47c0-ab2e-d8d212c3b888">Utah</ix:nonNumeric> <ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81NzQ_263302da-ac47-4e7a-85a6-ce2d9813ec03">84043</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF82MzQ_c1047269-3c6e-4169-942f-20e370112e2b">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF82Mzg_cb616819-9338-425b-8fe0-08640a859f8b">341-7900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6N2VhZjQwZmMyMTBkNGQ3ODk3NTEzZTY5YjI0MGJhNjcvdGFibGVyYW5nZTo3ZWFmNDBmYzIxMGQ0ZDc4OTc1MTNlNjliMjQwYmE2N18xLTAtMS0xLTM2NTE3_94e479bb-0eb7-4fe1-8df3-ae1fa08bb36c">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6N2VhZjQwZmMyMTBkNGQ3ODk3NTEzZTY5YjI0MGJhNjcvdGFibGVyYW5nZTo3ZWFmNDBmYzIxMGQ0ZDc4OTc1MTNlNjliMjQwYmE2N18xLTEtMS0xLTM2NTE3_f83255e0-7c96-44fe-952f-9580e09dae47">NATR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6N2VhZjQwZmMyMTBkNGQ3ODk3NTEzZTY5YjI0MGJhNjcvdGFibGVyYW5nZTo3ZWFmNDBmYzIxMGQ0ZDc4OTc1MTNlNjliMjQwYmE2N18xLTItMS0xLTM2NTE3L3RleHRyZWdpb246NWYyYTYzZjQxOWQ1NGNlMWIyMWFmOWU3Y2VkYWMwN2ZfNA_49158ce3-cb17-4860-aee4-34167340e683">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant; (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160; <ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8xMTMy_0587c7cb-fc4f-46ea-a32a-d0542134e007">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8xNDU4_a36c7d3e-7a2a-4075-9f4e-1d2b06bdfb0e">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and an &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Large accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6YzUxMDM1NjZjZTBhNGRmNjkzMmFhNDYzNDkxM2JiNmIvdGFibGVyYW5nZTpjNTEwMzU2NmNlMGE0ZGY2OTMyYWE0NjM0OTEzYmI2Yl8wLTItMS0xLTM2NTE3L3RleHRyZWdpb246YmExNGIzOTQ5NGRlNDVkZGE0NWE5NzBhYWYxZTU3MTNfNQ_27b4de87-1090-4eb0-9547-54afd223a109">Accelerated filer</ix:nonNumeric>&#160;&#160;&#9746;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6YzUxMDM1NjZjZTBhNGRmNjkzMmFhNDYzNDkxM2JiNmIvdGFibGVyYW5nZTpjNTEwMzU2NmNlMGE0ZGY2OTMyYWE0NjM0OTEzYmI2Yl8yLTItMS0xLTM2NTE3L3RleHRyZWdpb246MWRjZDVhZjhjYTY1NGQwZjljZDk0M2UxNzhiZTlmZjZfMzE_fb2edd05-1a6b-4c3b-b8e6-d81b12c4977f">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6YzUxMDM1NjZjZTBhNGRmNjkzMmFhNDYzNDkxM2JiNmIvdGFibGVyYW5nZTpjNTEwMzU2NmNlMGE0ZGY2OTMyYWE0NjM0OTEzYmI2Yl80LTItMS0xLTM2NTE3L3RleHRyZWdpb246NjNmOGI0YWU2MDg4NGE2YmI3ZjYwMzc5ZWM2NzVjYjJfMzA_01bfb5db-f229-448a-8294-eeb4b10928f1">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8yMjk5_fa03dda2-9f27-4cf3-b235-0b3015ce1878">&#253;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of Common Stock, no par value, outstanding on October 21, 2022, was <ix:nonFraction unitRef="shares" contextRef="i7ce7aad2623047ba8addd0803daa97b8_I20221021" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8yMjg4_a654e9a2-3336-4f4a-a929-6d4728651585">19,166,635</ix:nonFraction> shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarter Ended September&#160;30, 2022 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_13">Part&#160;I.&#160;Financial&#160;Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_19">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_22">Condensed Consolidated Statements of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_22">Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_25">Condensed Consolidated Statements of Comprehensive Incom</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_25">e (loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_28">Condensed Consolidated Statement</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_28">s</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_28"> of Changes in Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_31">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_31">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_34">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_34">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_76">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_76">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_79">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_79">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_79">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_82">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_82">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_82">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_85">Part&#160;II. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_85">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_88">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_88">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_88">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_91">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_91">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_91">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_94">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_94">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_94">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_97">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_97">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_97">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_100">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_100">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_100">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_103">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_103">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_103">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_106">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_106">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_106">35</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information included or incorporated herein by reference in this report may be deemed to be &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans, strategies and financial results, including expected improvement in gross profit and gross margin. All statements (other than statements of historical fact) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as &#8220;believe,&#8221; &#8220;hope,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;positioned,&#8221; &#8220;strategy&#8221; and similar expressions, and are based on assumptions and assessments made in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. For example, information appearing under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; includes forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are more fully described in this report, including the risks set forth under &#8220;Risk Factors&#8221; in Item 1A, and in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021, but include the following:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">extensive government regulations to which the Company&#8217;s products, business practices and manufacturing activities are subject;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">legal challenges to the Company&#8217;s direct selling program or to the classification of its independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">liabilities and obligations arising from improper activity by the Company&#8217;s independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">product liability claims;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the Company&#8217;s ability to attract and retain independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the loss of one or more key independent consultants who have a significant sales network;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the Company&#8217;s joint venture for operations in China with Fosun Industrial Co., Ltd.;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the effect of fluctuating foreign exchange rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">failure of the Company&#8217;s independent consultants to comply with advertising laws;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">changes to the Company&#8217;s independent consultants compensation plans;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">geopolitical issues and conflicts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">adverse effects caused by the ongoing coronavirus pandemic;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company&#8217;s customers to purchase products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">risks associated with the manufacturing of the Company&#8217;s products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">supply chain disruptions, manufacturing interruptions or delays, or the failure to accurately forecast customer demand;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">failure to timely and effectively obtain shipments of products from our manufacturers and deliver products to our independent consultants and customers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">world-wide slowdowns and delays related to supply chain, ingredient shortages and logistical challenges;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">uncertainties relating to the application of transfer pricing, duties, value-added taxes, and other tax regulations, and changes thereto;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">changes in tax laws, treaties or regulations, or their interpretation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">cybersecurity threats and exposure to data loss;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the storage, processing, and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">reliance on information technology infrastructure; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the sufficiency of trademarks and other intellectual property rights.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements speak only as of the date of this report and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this report. Except as is required by law, we expressly disclaim any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this report.&#160;Throughout this report, we refer to Nature&#8217;s Sunshine Products,&#160;Inc., together with our subsidiaries, as "we," "us," "our," "our Company" or &#8220;the Company.&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FINANCIAL STATEMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMy0xLTEtMS0zNjUxNw_1ecf74f0-d288-416c-9b0c-aaea6aff78ef">56,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMy0zLTEtMS0zNjUxNw_f4311b01-5085-4f97-8790-ac5c61887a37">86,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNC0wLTEtMS0zNjUxNy90ZXh0cmVnaW9uOjRlNDdhYTgwYmYwNDQ5N2NhMGIzOGQ3YmIyZWY3Njg3XzY3_245edf1e-e625-4e27-b929-792ac081067a">673</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNC0wLTEtMS0zNjUxNy90ZXh0cmVnaW9uOjRlNDdhYTgwYmYwNDQ5N2NhMGIzOGQ3YmIyZWY3Njg3Xzc0_ebe9d7f3-9a3d-4f93-95f2-588db4937a57">143</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNC0xLTEtMS0zNjUxNw_d13ea105-3dde-4011-bf17-739861091f6a">9,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNC0zLTEtMS0zNjUxNw_f0475a0c-165f-4fa5-95c0-4de350d4b2f5">8,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNy0xLTEtMS0zNjUxNw_b0c59645-1db6-49a1-9c8b-860238ee97e8">67,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNy0zLTEtMS0zNjUxNw_ee31bb8d-78ba-4f1a-b715-c037c89a409f">60,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfOC0xLTEtMS0zNjUxNw_37ce70a5-88d5-4a78-9f24-b47ef22eac3d">8,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfOC0zLTEtMS0zNjUxNw_61f74bfe-01ce-4a46-8821-4ea12e230568">8,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfOS0xLTEtMS0zNjUxNw_fce10190-ae01-4a04-a5a6-1d6717c5a917">142,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfOS0zLTEtMS0zNjUxNw_acc58918-dbe9-4982-9dc2-323647382e75">164,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTEtMS0xLTEtMzY1MTc_edc2f259-6032-46f9-953b-349b7ccbf02e">47,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTEtMy0xLTEtMzY1MTc_e33e411b-057b-422e-a4ca-88d071637df6">50,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTItMS0xLTEtMzY1MTc_1a84483d-896a-4557-98f9-f4957f507ca0">16,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTItMy0xLTEtMzY1MTc_7508e0eb-a0f4-4816-9cc9-2df830541229">18,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesTradingRestricted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTMtMS0xLTEtMzY1MTc_1cc64f85-6025-4228-881f-0ef78e94e72f">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesTradingRestricted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTMtMy0xLTEtMzY1MTc_48ad19ef-4a97-4e47-93ab-23ad0dc33d58">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTUtMS0xLTEtMzY1MTc_8fd0be89-e773-4e81-a558-e16bc38ad575">7,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTUtMy0xLTEtMzY1MTc_8c3710a0-7b62-463c-81ab-80b27636b919">13,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTYtMS0xLTEtMzY1MTc_4d4a4eab-3238-4959-9a57-e5dfe33f1728">9,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTYtMy0xLTEtMzY1MTc_9bee82af-5fa4-4c27-9a9e-a03d5343b043">10,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTctMS0xLTEtMzY1MTc_ac7cab8f-7aa2-4995-8af0-090c85a25875">223,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTctMy0xLTEtMzY1MTc_794875dc-6248-4f36-bbab-3f5ab426eba4">258,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjEtMS0xLTEtMzY1MTc_454a93b5-af91-44e7-bd46-e2356513fd31">7,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjEtMy0xLTEtMzY1MTc_c814d1d4-364b-4c25-a790-79d12168e69a">9,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued volume incentives and service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="natr:AccruedVolumeIncentiveandServiceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjItMS0xLTEtMzY1MTc_df404c05-189f-499e-a354-ff19d9ffa1f6">21,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="natr:AccruedVolumeIncentiveandServiceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjItMy0xLTEtMzY1MTc_8c2d3f30-28df-4aab-80af-1ae4fddac76a">23,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjMtMS0xLTEtMzY1MTc_e10a066a-ec8f-4a3a-99ec-4a7657517b19">24,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjMtMy0xLTEtMzY1MTc_1d65b5c8-c256-4b21-9753-1841fa99e96c">31,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjQtMS0xLTEtMzY1MTc_725b14c1-4c03-4039-8bf7-1bbe552f44c6">1,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjQtMy0xLTEtMzY1MTc_e66cb509-00d5-4e9e-b14a-d73d9d34cde3">3,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related party notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjYtMS0xLTEtMzY1MTc_1a0f47b7-7d6b-4f46-9dfd-350b82ee99eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjYtMy0xLTEtMzY1MTc_1a76289d-43fa-4f6b-97f7-2fe4421da3bb">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjctMS0xLTEtMzY1MTc_330c7a54-0858-4098-a164-8b2d78cf47ee">3,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjctMy0xLTEtMzY1MTc_3140cba4-7ca7-4f50-8089-2c37f6ce1a6f">2,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjgtMS0xLTEtMzY1MTc_d6230b6e-2b6d-4cc7-979a-1f7c7a88da1e">4,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjgtMy0xLTEtMzY1MTc_df4e50d1-9214-452f-96a5-2c8c9de43e65">4,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjktMS0xLTEtMzY1MTc_ff9004cb-3dc2-4d87-b759-19029b049ed1">1,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjktMy0xLTEtMzY1MTc_6b43777c-7710-4fd4-bc69-17a7bd9e837f">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzAtMS0xLTEtMzY1MTc_70a06065-d5fe-4e01-95bf-c7501bddade1">63,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzAtMy0xLTEtMzY1MTc_7d002d1d-4d02-4d16-bb54-891696f5e748">76,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzItMS0xLTEtMzY1MTc_cb1d44be-8f53-439c-8882-0816e45059d9">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzItMy0xLTEtMzY1MTc_b510eb83-c448-4304-a8db-79b8e3d0a8ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzMtMS0xLTEtMzY1MTc_5d0fde10-4940-4d89-bde1-0b44081d5e2f">14,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzMtMy0xLTEtMzY1MTc_08903563-fe3e-47ce-826f-69bd295956d7">15,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzUtMS0xLTEtMzY1MTc_9ecaf703-07fa-46e8-9bd6-ffb01d731012">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzUtMy0xLTEtMzY1MTc_70ca4754-4878-43cf-a577-472f86ac631b">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzYtMS0xLTEtMzY1MTc_f352b476-679b-4e07-9ffa-f32633b0f7b4">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzYtMy0xLTEtMzY1MTc_a05809e2-d599-40c4-9fb2-22bd4f7c876d">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzctMS0xLTEtMzY1MTc_02a47504-dc72-4bf0-a652-928d68026c1d">1,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzctMy0xLTEtMzY1MTc_19423a4e-2862-4fb9-a9c4-cddc72ec0c89">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzgtMS0xLTEtMzY1MTc_966feadf-3b43-44a9-b4e9-58715b250714">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzgtMy0xLTEtMzY1MTc_30b0704d-b93c-4b8b-b756-6e163f6aca08">1,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzktMS0xLTEtMzY1MTc_3f1c52d4-2acf-4732-8273-128c979632e2">81,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzktMy0xLTEtMzY1MTc_87b25be5-4932-4785-98f7-ec9f8526783d">97,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, <ix:nonFraction unitRef="usdPerShare" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="INF" name="us-gaap:CommonStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl8xOA_14a70fa6-950c-473d-9528-e6716dd70db7"><ix:nonFraction unitRef="usdPerShare" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="INF" name="us-gaap:CommonStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl8xOA_5990384f-0117-401d-8692-0d8ba9cab7b6">no</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl8zMg_dd33b74c-3f68-444a-b58d-e613c9623f4e"><ix:nonFraction unitRef="shares" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl8zMg_fd3f6ef4-ac2d-4696-92bf-2c94331f4873">50,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl81NA_dbc94ac7-2b13-4b9b-9b8a-de0166ea207f"><ix:nonFraction unitRef="shares" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl81NA_fbd6ec15-864b-426f-81b2-fed8182afcda">19,166</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl82MQ_3c397812-b8ca-462e-a035-5e99739089b1"><ix:nonFraction unitRef="shares" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl82MQ_b6a768a4-8943-44b3-b964-baa8198eaea8">19,724</ix:nonFraction></ix:nonFraction> shares issued&#160;and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMS0xLTEtMzY1MTc_344a61c5-491d-4857-807f-0062f27e6dc1">121,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMy0xLTEtMzY1MTc_eb081d18-9b4f-46d9-9964-107229d7dc40">133,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDUtMS0xLTEtMzY1MTc_d054a1c3-3e78-4324-ba9d-12ac475122c1">32,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDUtMy0xLTEtMzY1MTc_e8ae22ff-7b9c-470d-a16c-36d44f7966f6">35,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDYtMS0xLTEtMzY1MTc_49379e42-8253-424a-8e76-ed7eb708b107">4,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDYtMy0xLTEtMzY1MTc_0bdf4174-24be-40d2-b75b-444d55bc6cb4">3,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDctMS0xLTEtMzY1MTc_a628b169-6071-4eea-b3d9-fb66f8339b98">16,181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDctMy0xLTEtMzY1MTc_0863c1fb-c3d1-41d5-9c68-f1cf85b9060b">10,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDgtMS0xLTEtMzY1MTc_ce972365-9b78-4846-9088-cc8e5d2e4c9f">141,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDgtMy0xLTEtMzY1MTc_cd746cd0-f4b1-4c23-9bd6-f066b1531999">161,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDktMS0xLTEtMzY1MTc_878888d9-ab55-4ff3-b127-1b65a1b7b58b">223,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDktMy0xLTEtMzY1MTc_b3b63515-abc3-46bd-94fe-449003e60e42">258,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands, except per share information)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMi0xLTEtMS0zNjUxNw_9c406a20-9335-4157-b64c-2877dad8d66d">104,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMi0zLTEtMS0zNjUxNw_78f2e7bb-171f-4dc6-ab38-5b99b9926a05">114,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMy0xLTEtMS0zNjUxNw_f9565993-eb61-4e39-9921-cf201c5e18c1">29,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMy0zLTEtMS0zNjUxNw_f1021a89-319a-4d32-b99a-19ecb07aaf23">29,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfNC0xLTEtMS0zNjUxNw_e1846a10-6ca8-46ec-bb44-0c1dd09bdbe8">74,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfNC0zLTEtMS0zNjUxNw_01223cb1-e953-4029-a8c0-6934c1b092e0">85,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="natr:VolumeIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfNy0xLTEtMS0zNjUxNw_73403400-8e51-4301-b2ae-277aadc65544">33,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="natr:VolumeIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfNy0zLTEtMS0zNjUxNw_439642d5-b1f8-4b51-b68e-bfb4efbb9221">35,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfOC0xLTEtMS0zNjUxNw_383fbebf-435c-4f22-8e1f-c20106c870de">36,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfOC0zLTEtMS0zNjUxNw_51542882-5a83-4bab-b48c-b0c99c9a7187">39,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfOS0xLTEtMS0zNjUxNw_8ac114ab-de6c-4fdb-9d57-26d152553996">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfOS0zLTEtMS0zNjUxNw_0dbf3dc7-01f7-4bd4-9900-d8e933c66394">10,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTAtMS0xLTEtMzY1MTc_a1886982-fe50-4df1-9e3f-3b5988a57c9b">2,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTAtMy0xLTEtMzY1MTc_ba972f92-425a-45dc-9e3c-8a883324f1b2">886</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTEtMS0xLTEtMzY1MTc_3a4f098e-62a9-4faf-aade-43853e9ccd62">2,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTEtMy0xLTEtMzY1MTc_43dfe894-866f-4b2e-a6bc-b2b28e22f893">9,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTItMS0xLTEtMzY1MTc_14f551bd-1172-4fd9-95a4-6628450058a7">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTItMy0xLTEtMzY1MTc_e16d3f61-c746-469e-a05e-eb9c0d191f51">3,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTMtMS0xLTEtMzY1MTc_21e5dd39-d8f2-4a74-8b13-570865358216">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTMtMy0xLTEtMzY1MTc_fcc08471-e0a4-42d4-9cba-a8afd556df39">5,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTQtMS0xLTEtMzY1MTc_9c5acbcf-2983-4aa9-af2c-325a046c0627">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTQtMy0xLTEtMzY1MTc_f771647a-6cfc-4bdf-8b39-0f4a7c93e69f">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTUtMS0xLTEtMzY1MTc_9c337eec-2db1-421b-9922-94a3ceff4f0a">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTUtMy0xLTEtMzY1MTc_c2a9e832-0da7-4ed2-b97f-daa97996b3e1">4,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjItMS0xLTEtMzY1MTc_9b65d910-f30f-4d02-8e1f-520678e5ac37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjItMy0xLTEtMzY1MTc_99737db6-3611-4049-a355-4f0ab51b0af1">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjctMS0xLTEtMzY1MTc_1dcee3ad-a0a3-47c8-a3fe-a636a77b21c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjctMy0xLTEtMzY1MTc_7dbcafc3-2225-4113-bbc0-773dad226131">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average basic common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjktMS0xLTEtMzY1MTc_7cb4f59b-7354-4cef-a535-3847e62c5489">19,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjktMy0xLTEtMzY1MTc_e740a5b6-2156-4982-b27f-3888691395d4">19,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMzAtMS0xLTEtMzY1MTc_742e25a3-7c71-4b27-a9e8-ed0f07d287ce">19,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMzAtMy0xLTEtMzY1MTc_8d7b70b5-4415-495f-8a62-dfe6ae047027">20,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands, except per share information)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:73.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMi0xLTEtMS0zNjUxNw_1ac77a74-01be-4e61-a5e5-fb707700d54f">319,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMi0zLTEtMS0zNjUxNw_691a66db-0eb7-4b20-8e57-ad86419558d0">326,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMy0xLTEtMS0zNjUxNw_14596211-300e-48a4-b2b9-82b61ae8c352">93,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMy0zLTEtMS0zNjUxNw_6a44c743-8abe-446c-adcf-ff90c40396ed">84,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfNC0xLTEtMS0zNjUxNw_f8fa11fd-d304-42a5-ab35-34465709802e">225,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfNC0zLTEtMS0zNjUxNw_745dc519-9137-42d9-adb1-11be1718b203">241,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="natr:VolumeIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfNy0xLTEtMS0zNjUxNw_6fdffe02-937d-4af6-8862-80904fce36a0">99,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="natr:VolumeIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfNy0zLTEtMS0zNjUxNw_56bb4c12-a1aa-4345-86cf-a20349e484ea">105,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfOC0xLTEtMS0zNjUxNw_bd1aa2f8-6f74-4002-b017-58911d779a1a">114,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfOC0zLTEtMS0zNjUxNw_30b90d3e-2620-40ab-8e35-65fc59390914">108,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfOS0xLTEtMS0zNjUxNw_2c94366c-a4d3-41f9-94e7-a12373c3c85e">12,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfOS0zLTEtMS0zNjUxNw_6da18141-ca54-4677-ab54-536af4b29a7e">27,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTAtMS0xLTEtMzY1MTc_e30ec685-eaed-4512-96eb-bd67b329373a">3,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTAtMy0xLTEtMzY1MTc_30424319-afbd-4376-871b-c429ea82f3ac">2,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTEtMS0xLTEtMzY1MTc_d198fe20-323b-416e-bef3-e23a200ccc28">9,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTEtMy0xLTEtMzY1MTc_276fb3ac-7ef1-4ab1-9ac6-96216089d86c">24,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTItMS0xLTEtMzY1MTc_4e6b0999-7e82-4cf5-8ffc-5827d189bda1">10,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTItMy0xLTEtMzY1MTc_3ac43123-a93c-43d9-a723-a8c103b7e805">8,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTMtMS0xLTEtMzY1MTc_c36b6571-36f3-4287-a89b-0576d7002a1e">1,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTMtMy0xLTEtMzY1MTc_46aaf8a9-583e-4711-a704-764abf6f7636">16,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTQtMS0xLTEtMzY1MTc_52825766-3325-41d6-b189-e49127f808de">810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTQtMy0xLTEtMzY1MTc_c3f5a3f9-99b3-463c-b50f-2e49c366a0eb">990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTUtMS0xLTEtMzY1MTc_8b36631b-6389-41c3-95fb-8c034155cb01">2,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTUtMy0xLTEtMzY1MTc_30da4c72-bf59-4e85-bda7-d30de15b166e">15,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjItMS0xLTEtMzY1MTc_955a5c54-1ace-4007-8404-e40f35c7d273">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjItMy0xLTEtMzY1MTc_ce2d6496-9334-4ff8-a7f3-b08ee01eea2b">0.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjctMS0xLTEtMzY1MTc_1161f2ba-9fed-42b1-9334-7ee6f36a76e1">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjctMy0xLTEtMzY1MTc_0d4def3f-6199-41c0-8639-0061cb219b27">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average basic common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjktMS0xLTEtMzY1MTc_c3137284-cf6f-42e4-8bbf-88fad27f23d7">19,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjktMy0xLTEtMzY1MTc_6e3f997f-39c9-4c68-b8a7-7a55c3d0dc18">19,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMzAtMS0xLTEtMzY1MTc_805f8bd5-dcb1-44a3-82fb-2eaa5ee78b80">19,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMzAtMy0xLTEtMzY1MTc_2b1b169e-acc1-4b09-ac07-963e68582baa">20,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMzItMS0xLTEtMzY1MTc_5a39b8c6-158c-440b-833e-cc6cd16893c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMzItMy0xLTEtMzY1MTc_3096c59d-a257-463c-aec4-059e7e6b8afa">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfMi0xLTEtMS0zNjUxNw_c9b95d24-1e8b-49bc-8244-56924b6c5535">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfMi0zLTEtMS0zNjUxNw_b5f5cdc3-f95c-4244-9ae4-a87dba41436c">5,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation loss (net of tax)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfMy0xLTEtMS0zNjUxNw_31c45d46-93a8-4755-a83d-f5956f6b2d97">2,544</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfMy0zLTEtMS0zNjUxNw_6e2c972b-8358-4cb5-8812-f640bc6d0528">925</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfNy0xLTEtMS0zNjUxNw_243d2418-813c-446a-ab29-8191f1c45cb7">2,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfNy0zLTEtMS0zNjUxNw_a9160e8b-4ffe-4de4-ba68-ef9e05316c51">4,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfMi0xLTEtMS0zNjUxNw_bdea92fe-c4a4-4edd-b36d-4316abce412b">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfMi0zLTEtMS0zNjUxNw_2127a808-d7d3-475f-9628-89536637919c">16,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation loss (net of tax)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfMy0xLTEtMS0zNjUxNw_1508b644-db3f-4d34-86a9-5bbed1442f25">5,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfMy0zLTEtMS0zNjUxNw_504f7274-fce4-42f2-bf03-f961910adcb5">1,091</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfNi0xLTEtMS0zNjUxNw_e5a5b853-2b6e-485f-b1fb-5bd86c082b55">7,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfNi0zLTEtMS0zNjUxNw_bbd4abcd-05c2-4e3a-92d0-2a7c088740e7">15,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.875%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21726f161d9144c981677c9a99d24247_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi0xLTEtMS0zNjUxNw_34bd8a52-e611-4b81-b65c-334d6d24965f">19,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21726f161d9144c981677c9a99d24247_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi0zLTEtMS0zNjUxNw_663ddbf8-932a-4bfb-8f9d-5653aaa1e5e5">133,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a03d0e2e0f4675968fee999d70cd9b_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi01LTEtMS0zNjUxNw_7949e3a1-827d-4409-98a5-6c2efaaecb77">35,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03abfe1166e94acca8a49677b13b5cf0_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi03LTEtMS0zNjUxNw_18daea20-5182-4319-9451-958e4a7b6c15">3,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1933b6d048a44bf8cfbb6b1cd3cd3d5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi05LTEtMS0zNjUxNw_e60ab6bc-dae2-48a5-96ab-0eb4f83cf47b">10,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi0xMS0xLTEtMzY1MTc_4d0f9c48-b6ee-4d9a-afae-ec19db829aa2">161,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMy0zLTEtMS0zNjUxNw_cf2069d1-1c0b-4832-9d32-7158833a115c">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMy0xMS0xLTEtMzY1MTc_b83b59d4-0e06-46df-8394-4898ff3e24ec">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331" decimals="-3" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNC0xLTEtMS0zNjUxNw_72507661-c7c6-475e-a68d-f61946bcd923">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNC0zLTEtMS0zNjUxNw_ebe0d779-3b9c-47a3-8801-dd70a66f8ef0">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNC0xMS0xLTEtMzY1MTc_250b03ae-6acf-4ac5-b2ff-70c5522fe94c">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNS0xLTEtMS0zNjUxNw_62387724-456c-4a84-a98a-978b49156c1a">451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNS0zLTEtMS0zNjUxNw_9a48b589-5044-46f7-a69a-b0d9d5edbd85">7,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNS0xMS0xLTEtMzY1MTc_0fe55510-090b-4109-9da4-ce1804bf95d5">7,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f1bb76039d144b9aa58a21c14728060_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNi01LTEtMS0zNjUxNw_9e779b02-448a-47e9-ab56-f4cbce099866">2,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4d3acbe9b44659a91f7fd1c3d496a6_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNi03LTEtMS0zNjUxNw_443d9ae4-78aa-4b44-9f29-cd1b6a1e99fd">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNi0xMS0xLTEtMzY1MTc_4d8fc23f-2652-473b-8012-ee9864a14272">2,686</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15218d9f24de436b834e94ec6b7a0b0a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNy05LTEtMS0zNjUxNw_dbd86020-3781-4a52-b4fd-31bab9f44715">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNy0xMS0xLTEtMzY1MTc_78c99d8d-e72e-494c-a70d-34c0f461f0a0">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9297f3eeb3c94b419740d6866d8f7fa3_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC0xLTEtMS0zNjUxNw_8d792d24-d538-4078-989e-4d791cd0c9b7">19,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9297f3eeb3c94b419740d6866d8f7fa3_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC0zLTEtMS0zNjUxNw_c2cb1aab-0a44-4654-b2fb-e6bc71afdfae">125,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d091b18a034cff89766812998da336_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC01LTEtMS0zNjUxNw_94cec152-8cc8-4c5a-b26c-4c8fbf2a1855">32,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69e160aafda54f33bc08d1b8e1e4a739_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC03LTEtMS0zNjUxNw_efcf21fb-77a4-498b-84ec-90d514e13538">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i806380af81994042ab6c34e36fc9e4e4_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC05LTEtMS0zNjUxNw_9d81779c-36aa-4c56-acbd-59651a44e7ad">11,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8fc16447ae46a9b23c72b39b9594ee_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC0xMS0xLTEtMzY1MTc_2ce595a1-126c-46de-b340-e93fa98ae6bc">149,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOS0zLTEtMS0zNjUxNw_da989593-709e-4a84-ad96-5ab58099655b">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOS0xMS0xLTEtMzY1MTc_a675ca73-f5b8-4e7b-9e3d-3b626ae74eb0">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630" decimals="-3" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTAtMS0xLTEtMzY1MTc_ae7ae831-d328-4511-bbc1-b3f7ad24ce6c">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTAtMy0xLTEtMzY1MTc_ae7eee58-7632-40e3-9773-e3f412d59cbc">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTAtMTEtMS0xLTM2NTE3_f1e389a6-99f4-4905-b391-8657806929b3">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTEtMS0xLTEtMzY1MTc_5d187266-5ad8-45df-9b01-f37d45a199db">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTEtMy0xLTEtMzY1MTc_1b413150-978b-4906-a29f-273b1ec9dfe6">4,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTEtMTEtMS0xLTM2NTE3_2b3209c5-4bec-454e-9761-d75a6aa96976">4,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150dc190a6c548f8964429c219799683_D20220401-20220630" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTItNS0xLTEtMzY1MTc_269ae304-f73b-4967-9b87-54e0bb36f767">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1faefa48e67d4f9bbfe8e3424767234d_D20220401-20220630" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTItNy0xLTEtMzY1MTc_2c23fcba-9212-46ef-9351-fb9d530ce8e3">436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTItMTEtMS0xLTM2NTE3_909ef5be-fbba-49c1-9723-824a76dbbf0a">952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1d99554b99d48c89c6d05c03b41c591_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTMtOS0xLTEtMzY1MTc_2ff74b53-a9ff-44d3-aac7-5bd527284390">2,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTMtMTEtMS0xLTM2NTE3_d1b27b4b-aeea-41a0-9418-4aaed273237c">2,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie041b2243726491bbcd617dcdbd9ee67_I20220630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtMS0xLTEtMzY1MTc_de85293a-7272-43db-bf05-a8499f6dfd46">19,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie041b2243726491bbcd617dcdbd9ee67_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtMy0xLTEtMzY1MTc_4bca9850-f5a5-4846-98e2-02ca43e896eb">121,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23da71b505a4aed8729342c64157a41_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtNS0xLTEtMzY1MTc_af9da5e5-f1c3-4e8c-9c8a-f3b608414531">32,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b247ac9dad4b0d9c915a260843ac3a_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtNy0xLTEtMzY1MTc_b6d194a1-5b44-47f8-9e4a-33d79ed36891">3,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a3f5bcc65a84d81b343742fa3687210_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtOS0xLTEtMzY1MTc_67e842c7-fb58-400d-ba53-65fbc0c6abe3">13,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d93b30a1dd64266b09ca1dbe8a45ce9_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtMTEtMS0xLTM2NTE3_f4b4815b-e21f-4dd6-954d-fc46d48aa4f9">144,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i266bc0c70d8240a68e7030d4a3572f2a_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTUtMy0xLTEtMzY1MTc_46d2494c-55d0-47d1-9974-3a73fcdef790">593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTUtMTEtMS0xLTM2NTE3_644b4b23-7a4a-4635-a00d-81c634fe1d93">593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i266bc0c70d8240a68e7030d4a3572f2a_D20220701-20220930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTctMS0xLTEtMzY1MTc_53ac6b2a-7448-4b72-9b7d-a254c587b9da">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i266bc0c70d8240a68e7030d4a3572f2a_D20220701-20220930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTctMy0xLTEtMzY1MTc_a556516f-58a4-4733-be22-4bc67d68ad90">974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTctMTEtMS0xLTM2NTE3_c4580475-680c-45f4-8ce8-dd3cfd5f07e4">974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67def2bf001441ce8b5360fb751d05c8_D20220701-20220930" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTgtNS0xLTEtMzY1MTc_48b76b8f-7923-42eb-b6f7-b06101a99484">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896cdfbdeb6844b7919d0c99a82986ba_D20220701-20220930" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTgtNy0xLTEtMzY1MTc_998db57c-57a0-4dce-a1bc-a4f8a507bc30">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTgtMTEtMS0xLTM2NTE3_a87d1561-3705-466f-a703-98eb1003ff6d">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f5368041dc04d7a876079103b591a82_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTktOS0xLTEtMzY1MTc_84837d5c-cdbe-4fea-a290-949ff3f3c8c8">2,544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTktMTEtMS0xLTM2NTE3_3bfb0a7c-74c1-4e5b-9acb-f083b5d0e5a9">2,544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22bf72498d14409e8704c249bbf5dff4_I20220930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtMS0xLTEtMzY1MTc_afe64c02-d38b-4b18-bae0-b53192ad7ee0">19,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bf72498d14409e8704c249bbf5dff4_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtMy0xLTEtMzY1MTc_3dc65279-dbca-46d3-b3cd-cea8d7c2b4b5">121,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4633088b44c14861af62ac14bfa848b0_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtNS0xLTEtMzY1MTc_f5d061e6-10f0-401d-8a32-1226f755bdca">32,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82edb931ed8744efb0bb55d80302158e_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtNy0xLTEtMzY1MTc_d68506d4-7bee-4366-afef-df9e9cd42881">4,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3eefe80682a456688d647d706338b94_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtOS0xLTEtMzY1MTc_21f262e7-57dc-40fd-b953-4b7650e9502c">16,181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtMTEtMS0xLTM2NTE3_c5caa964-70fb-4f7e-b7df-2295ada906c9">141,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.875%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i584cc6cef84645d9aced1d159fb33e8f_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi0xLTEtMS0zNjUxNw_32471aa6-4abc-4590-b4fe-828bd9a05b87">19,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584cc6cef84645d9aced1d159fb33e8f_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi0zLTEtMS0zNjUxNw_ad3e4fe3-b2df-4acd-b7a5-b9dedc96abd0">139,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcdea242da894c9096e6edc3b69c848c_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi01LTEtMS0zNjUxNw_e481c68f-2eaa-4ce2-bcd0-e8504e3333bc">26,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b62ba4a6054191ab5a2cfa2177eb37_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi03LTEtMS0zNjUxNw_37855efd-3f2c-45c7-9e45-969e0a89e8b0">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i567421871cb84ff3947a1c4f0439f49e_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi05LTEtMS0zNjUxNw_ad6cdf37-9b48-4bc7-8c66-be1230171cdf">9,955</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b678cf1500d473b98980c984f33d848_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi0xMS0xLTEtMzY1MTc_df302ac3-7c6a-4702-9fc8-2a59e453d053">157,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if699539c6d8d44db865d338e2352f43f_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMy0zLTEtMS0zNjUxNw_6629a2e9-b8db-4691-ac1b-9565b5e3fda7">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMy0xMS0xLTEtMzY1MTc_e36d0c88-b8a9-4d9b-9ea7-2f96a7c8608a">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if699539c6d8d44db865d338e2352f43f_D20210101-20210331" decimals="-3" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNC0xLTEtMS0zNjUxNw_d0badf26-2803-423c-8c79-0fa5d0b291fe">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if699539c6d8d44db865d338e2352f43f_D20210101-20210331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNC0zLTEtMS0zNjUxNw_0a69693b-9b1f-429d-80a2-470f1654dbd9">914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNC0xMS0xLTEtMzY1MTc_747150a0-ce67-479e-884b-11e105c2b5b3">914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNS0wLTEtMS0zNjUxNy90ZXh0cmVnaW9uOmFmMTQ4ZTBjMDg0YzQzYjVhOGIwMzE3NTlhODExNzkxXzIw_f205440a-3d54-4be4-b7ee-b9229e731d66">1.00</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id292b6800f4b4953a4a8fc8f19b5c00f_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNS01LTEtMS0zNjUxNw_f7a838dc-f8c5-4b07-a1b2-d82bec43443e">19,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNS0xMS0xLTEtMzY1MTc_5221f776-a9e6-4685-9444-53f7f5e2058e">19,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id292b6800f4b4953a4a8fc8f19b5c00f_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNi01LTEtMS0zNjUxNw_6da3f4e7-2074-436a-805f-a2d7f3bd5d9c">4,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6c47cc5bdab45b9a83e045e422ae9d1_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNi03LTEtMS0zNjUxNw_b4dddf77-f7a3-432d-80cf-f1583de3fef0">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNi0xMS0xLTEtMzY1MTc_44462da1-2991-45cf-8077-1da20b4bd1a0">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2daecb1c459472faf935c58f3d99556_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNy05LTEtMS0zNjUxNw_56bc86fb-24d7-4e40-8e21-b3d50e7c0928">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNy0xMS0xLTEtMzY1MTc_d6ce59e3-a044-421f-8c52-a40ce669da55">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ed2af8ce51a451dad2b3584762627b2_I20210331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC0xLTEtMS0zNjUxNw_6d11c887-98f1-4d7d-adc5-52993588afde">19,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed2af8ce51a451dad2b3584762627b2_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC0zLTEtMS0zNjUxNw_c49b9079-ecbd-4549-ae02-3db3940edfd6">139,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f25ce1bda74c48805771205ffcbbf8_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC01LTEtMS0zNjUxNw_6b58437e-459d-4f1c-9376-49485c8ca8b6">10,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i261b16c64967417fb69e183d714d9071_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC03LTEtMS0zNjUxNw_0f7d1944-7ddd-4923-9aa1-aaccb507221c">1,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5a44095252141c78d08c366bb1f2bce_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC05LTEtMS0zNjUxNw_59f8c228-7d86-484d-b3be-08b81e2f2d02">10,076</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a7eaf75c524a39958b86619197e5f9_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC0xMS0xLTEtMzY1MTc_ffc37db1-cfed-4cf9-9409-d0cfe2b164b9">141,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOS0zLTEtMS0zNjUxNw_265d32e2-24f0-4e6d-a7c0-ee4dac473f46">1,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOS0xMS0xLTEtMzY1MTc_246c9fef-5c84-41d9-bf5a-fc560bdc2d92">1,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630" decimals="-3" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTAtMS0xLTEtMzY1MTc_cef7426d-4cc5-4a66-9793-3303a03a4608">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTAtMy0xLTEtMzY1MTc_df08601b-1a85-49de-bb8b-e51b01422b06">660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTAtMTEtMS0xLTM2NTE3_cb80b62a-096d-4baf-bbb7-0bf7b6c7a023">660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTEtMS0xLTEtMzY1MTc_7790bbab-2deb-4d83-95e6-04d93145020a">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTEtMy0xLTEtMzY1MTc_8824e273-dc13-4944-a390-05cfab300196">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTEtMTEtMS0xLTM2NTE3_7a3b6889-fc16-48f8-a094-62c64bb2cf30">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3478de1ed17e4979a47bd4d3d1f5d7d0_D20210401-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTItNS0xLTEtMzY1MTc_363170af-a29f-401d-92e6-2c0b39284a3f">6,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd19a9c61024bdcbe7a41dbec049830_D20210401-20210630" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTItNy0xLTEtMzY1MTc_dab8679e-e6ac-4831-bc1b-4e4b1bf2d9f9">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTItMTEtMS0xLTM2NTE3_d040186b-8fee-434c-828f-9085c33e2b14">6,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dd64c1df3f04a6ea9ed4b040fb9c417_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTMtOS0xLTEtMzY1MTc_d2d530ee-b53c-40b1-a24f-ba56d5278c5e">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTMtMTEtMS0xLTM2NTE3_074c8085-7cf8-4a65-a0af-f987092a3f3d">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7debe8761cc44795a69514ea9d87827b_I20210630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtMS0xLTEtMzY1MTc_6ce6fc60-ca68-42c7-a478-44a077dee894">19,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7debe8761cc44795a69514ea9d87827b_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtMy0xLTEtMzY1MTc_57dd08b7-d1c9-482f-9cba-0de8be851491">138,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03d0a470604be19addddae37f14109_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtNS0xLTEtMzY1MTc_be7c284a-c4c6-4db4-a117-6183687c273f">16,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if56b974fe0214d9691e4d03c981d7efb_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtNy0xLTEtMzY1MTc_c68b449f-7264-4512-877f-3207c3e8e673">2,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i428520a8a69e426a8fe5926e9ce42e43_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtOS0xLTEtMzY1MTc_be863e88-7c08-4dc1-bab1-aab487756977">10,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie441a8e4124a4d1b8054036ab19f5a25_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtMTEtMS0xLTM2NTE3_9d5be73f-98ce-474f-b9cd-836692ff0a29">147,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTUtMy0xLTEtMzY1MTc_fb6cdabc-a28c-4d10-b1e5-8eedaa470eb1">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTUtMTEtMS0xLTM2NTE3_69a9b2e7-dd3b-4d97-8d12-43460e734ed0">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930" decimals="-3" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTYtMS0xLTEtMzY1MTc_4630d978-de5f-44bc-bb98-7e5b94334643">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTYtMy0xLTEtMzY1MTc_ca42cceb-e433-4029-8d85-a1a1568be37a">442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTYtMTEtMS0xLTM2NTE3_1924239f-33ec-45e2-9b28-c9a821f3e813">442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctMS0xLTEtMzY2Nzg_dbb0327c-8b3b-4035-9e87-bd5cb9ace0b4">273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctMy0xLTEtMzY2Nzg_016cd111-1b70-4090-aa21-01661bab0553">4,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctMTEtMS0xLTM2Njc4_8b6bcad5-a5a3-4351-9cb6-625f52238512">4,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6b8c3d3276a40a8b5cf97b7662f1789_D20210701-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctNS0xLTEtMzY1MTc_00013dae-12b3-413f-8e66-ce33f6a6a211">4,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81a97f8651b47b3a684dd5ff1e10415_D20210701-20210930" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctNy0xLTEtMzY1MTc_4ae89cb8-d4c4-4d6e-b1a0-3a1d3d21f494">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctMTEtMS0xLTM2NTE3_223802ba-b31a-45bc-8bce-28581c88ae7f">5,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d49ac7e33054ec294ea97a34ce760b0_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTgtOS0xLTEtMzY1MTc_83e6da3a-ca30-4be6-9bce-50d31f65e6f5">925</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTgtMTEtMS0xLTM2NTE3_fc2ad587-185d-422f-b34e-686dfc94b16e">925</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb9057781307454eaa3ab969709f5839_I20210930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktMS0xLTEtMzY1MTc_550fbc29-8e4f-4571-822e-44b7a78c2c44">19,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9057781307454eaa3ab969709f5839_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktMy0xLTEtMzY1MTc_0f9f7bb7-c7ea-40a2-9fe3-e9029a239dc8">134,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaca5bb1e0ec4e8fac38bd64a9792a66_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktNS0xLTEtMzY1MTc_7bb1855f-cf42-4c1a-9745-874162b29da8">21,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i742edf6aff37488aa80e713e9a672a7a_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktNy0xLTEtMzY1MTc_5702ec19-f89a-4204-a5a3-788757de7bf9">2,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f10af2594854b9fb57ee7ef9b152993_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktOS0xLTEtMzY1MTc_8f9fedd9-0363-4e95-99b5-8d6a22a1db75">11,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41f685a036d4f58a4e05731f4478dfc_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktMTEtMS0xLTM2NTE3_0b250a23-3db8-4d28-b925-fcf71b4c76ad">147,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMy0xLTEtMS0zNjUxNw_bc4b8208-e03c-4161-9399-9b7918a78ed7">1,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMy0zLTEtMS0zNjUxNw_a6b95476-a132-4a80-a1cc-703574d22754">16,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNS0xLTEtMS0zNjUxNw_f21aee53-1610-4f8c-9346-7971229790f5">1,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNS0zLTEtMS0zNjUxNw_412d458a-dd2c-42ea-b3c7-791e15edc2b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNi0xLTEtMS0zNjUxNw_b8858f82-d9aa-403b-bf1b-5b1216a6f6d4">8,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNi0zLTEtMS0zNjUxNw_2dbaa5a7-6807-49d0-9eb0-65956e70f46b">8,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="natr:OperatingLeaseNonCashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNy0xLTEtMS0zNjUxNw_17515ad3-70d6-4fad-a123-0739661e30e5">3,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="natr:OperatingLeaseNonCashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNy0zLTEtMS0zNjUxNw_a7287b7c-2162-4007-8ef5-4321f6027028">4,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfOC0xLTEtMS0zNjUxNw_1faa1f80-f6c7-44da-b134-85bb0335505b">1,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfOC0zLTEtMS0zNjUxNw_86284def-73b9-4d9f-a828-433d3439e08a">2,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss on sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfOS0xLTEtMS0zNjUxNw_40e370c3-fcb4-41a9-a40b-b9a93ecf48ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfOS0zLTEtMS0zNjUxNw_8f0b4838-d89b-4724-b7de-019bd7bc0494">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTAtMS0xLTEtMzY1MTc_7ab7bcb8-6439-40ac-895e-3d383391ede0">5,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTAtMy0xLTEtMzY1MTc_22baa91a-11fd-4ac9-ad41-2f75623949a5">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase of trading investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTEtMS0xLTEtMzY1MTc_43d50fda-270b-4c56-9a17-85e85d12c9f1">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTEtMy0xLTEtMzY1MTc_86a4d177-04ae-4031-92f1-df142dd77623">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from sale of trading investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTItMS0xLTEtMzY1MTc_5989182f-68b3-4ed9-88f4-09bf64343b30">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTItMy0xLTEtMzY1MTc_07e556ec-c32f-4613-aed4-564832491c1b">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Realized and unrealized gains (losses) on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTMtMS0xLTEtMzY1MTc_385d181d-c0f7-4937-9e6f-648a904413e4">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTMtMy0xLTEtMzY1MTc_0a952e5c-6673-4eb0-9207-5cb18555d5ad">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign exchange losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTQtMS0xLTEtMzY1MTc_d2bf3559-3153-4129-9587-d11885c80d07">2,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTQtMy0xLTEtMzY1MTc_5c106efe-07d4-4441-a8ad-a16e53a100cf">2,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTYtMS0xLTEtMzY1MTc_59d1a6a1-7b1e-4fc5-9cce-4630c6b7ab11">3,233</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTYtMy0xLTEtMzY1MTc_cd84b293-9a90-4453-a583-d9ef90447e87">2,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTctMS0xLTEtMzY1MTc_eeeb3b3e-a744-4da3-8daf-6b73361d46b8">10,809</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTctMy0xLTEtMzY1MTc_649ca882-a4b0-43a2-982f-863cfafe4594">10,771</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTgtMS0xLTEtMzY1MTc_a5111ca7-ddb0-474b-a1b3-1af529b3c8a2">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTgtMy0xLTEtMzY1MTc_3f59e729-24a4-4b82-be86-585b0f92ab95">1,787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTktMS0xLTEtMzY1MTc_65dea15c-88c5-4ae1-aa24-2a2543a3f60f">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTktMy0xLTEtMzY1MTc_208cb40e-ae0b-4ff7-bd05-1860788e3aac">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjAtMS0xLTEtMzY1MTc_7f805026-4732-4cac-bcc0-e8a704bef43e">1,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjAtMy0xLTEtMzY1MTc_c896f6b1-7870-404d-985a-c3db8367c0aa">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued volume incentives and service fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjEtMS0xLTEtMzY1MTc_7990caec-d587-45f1-a887-2882caa8cde2">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjEtMy0xLTEtMzY1MTc_c1dd33da-b552-494b-b9a9-fdae40885716">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjItMS0xLTEtMzY1MTc_fce8e8fa-e518-4a36-b063-e2772d2580e4">5,172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjItMy0xLTEtMzY1MTc_e19c2db5-1a49-4925-abc1-aa15d97afff3">1,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjMtMS0xLTEtMzY1MTc_1a232888-6f4c-484f-9d9f-e2b948bf98f0">2,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjMtMy0xLTEtMzY1MTc_2c13c5cf-fb06-421d-b372-e781ed6acec2">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="natr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjQtMS0xLTEtMzY1MTc_879a1457-1dcf-4124-b19b-c08150dbed79">3,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="natr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjQtMy0xLTEtMzY1MTc_af5ae95f-0c2b-41df-bb48-f9c20f05423f">4,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjUtMS0xLTEtMzY1MTc_f7caf1fb-5d69-4d00-a518-4ab303cfc1d2">1,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjUtMy0xLTEtMzY1MTc_0974f7e4-ce39-4115-9449-f1ecf55ce33e">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Liability related to unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjYtMS0xLTEtMzY1MTc_ef4efc89-f3da-4963-98c2-0db7bae1253a">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjYtMy0xLTEtMzY1MTc_5fdb9260-e562-4eb3-9cca-3f417c878308">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred compensation payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjctMS0xLTEtMzY1MTc_d53dcb2c-533d-43a6-9674-246a32c76fd9">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjctMy0xLTEtMzY1MTc_27667aeb-ef5f-4504-b840-55a01284766d">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjgtMS0xLTEtMzY1MTc_e4b4e9de-738b-4b52-b16d-d9858d6f366d">2,866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjgtMy0xLTEtMzY1MTc_809ef553-ff6b-42ff-930d-15ff9a27aae0">20,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzAtMS0xLTEtMzY1MTc_322a0251-8b39-48c3-9505-dbc753c2b623">4,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzAtMy0xLTEtMzY1MTc_cd55c673-315d-4690-80db-ee332ea9de91">4,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzQtMS0xLTEtMzY1MTc_c35afdd3-4c61-4fe7-913e-1aba1135eda7">4,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzQtMy0xLTEtMzY1MTc_b9c3b2c7-ce26-4606-846d-3c9d02e2a09c">4,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments of cash dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzYtMS0xLTEtMzY1MTc_f85924d7-6a5e-457e-b3e0-2789d0e0dd96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzYtMy0xLTEtMzY1MTc_eac7a639-be71-4dd9-9284-8a0fb628750f">19,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal payments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzctMS0xLTEtMzY1MTc_d7872be3-62ad-42c1-a4bc-a89763057d13">931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzctMy0xLTEtMzY1MTc_25b43b3d-dae4-4647-b5f7-6da0ce2a78ea">1,001</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzgtMS0xLTEtMzY1MTc_1429f523-8ebd-4c0e-a5b9-1c9b7b58c494">31,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzgtMy0xLTEtMzY1MTc_736c9bc0-cc67-4550-b02a-01c47589bd25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal payments of revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzktMS0xLTEtMzY1MTc_90ea5edd-7423-45c5-a312-45bcb4107a2f">31,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzktMy0xLTEtMzY1MTc_553ef585-f0c9-4ecf-a3c8-4ab8e09f06d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal payments of related party borrowing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDEtMS0xLTEtMzY1MTc_0fc5e0e9-8f0d-4b3e-9a76-4cbdd90a9f26">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDEtMy0xLTEtMzY1MTc_e92d79ce-5c10-4706-b20e-76b94a6e00d1">600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments related to tax withholding for net-share settled equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDMtMS0xLTEtMzY1MTc_90226264-3bc3-4b9c-a6ae-e1891d4f439e">1,129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDMtMy0xLTEtMzY1MTc_0ff8ef8b-58a3-4483-972d-b6e56c6208ee">2,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDUtMS0xLTEtMzY1MTc_c6ebc6d1-6927-4253-9362-a6806a461ee8">12,945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDUtMy0xLTEtMzY1MTc_92da41e4-64e7-408b-9880-8bf9b427321c">6,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDYtMS0xLTEtMzY1MTc_5c0dec08-883d-4417-85a2-5318be9f2d7f">15,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDYtMy0xLTEtMzY1MTc_b8eaaad2-81d0-4984-9636-32132cf6e2f6">29,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDctMS0xLTEtMzY1MTc_8680fefa-c625-4e4b-b51e-e801c9116b1c">6,299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDctMy0xLTEtMzY1MTc_70ddba2a-263a-4425-9518-824d402c8b55">2,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDgtMS0xLTEtMzY1MTc_4b7bb4b5-6576-4117-b7e0-dd6ba17293de">29,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDgtMy0xLTEtMzY1MTc_42153839-4c74-4dde-95ed-aefe96542ee6">16,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDktMS0xLTEtMzY1MTc_0e30f1da-b137-4f37-8e11-9d24b09df9cd">86,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b678cf1500d473b98980c984f33d848_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDktMy0xLTEtMzY1MTc_f2c889ca-d624-4592-9c33-e307ca880c9e">92,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at the end of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTAtMS0xLTEtMzY1MTc_5794878e-8469-46a2-a891-eb3011fd3056">56,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41f685a036d4f58a4e05731f4478dfc_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTAtMy0xLTEtMzY1MTc_e31a81db-6857-4a3a-ad19-2c91c6e86bb4">75,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash paid for income taxes, net of refunds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTItMS0xLTEtMzY1MTc_d7af7009-9862-431e-a47c-4face9925e47">3,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTItMy0xLTEtMzY1MTc_239d5196-7693-4a37-a035-9ae60d820c2a">4,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTMtMS0xLTEtMzY1MTc_8e0e0e7e-f038-4625-9b3a-548651313c60">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTMtMy0xLTEtMzY1MTc_ffd1f8db-f521-49f5-813b-146deb7d34dc">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY2NA_ed3c6df8-987f-4c18-bb03-dad03edbe8f0" continuedAt="i9c71768d419e4afe89fe211b7f1ef01b" escape="true"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY4NQ_8546777e-e136-48ad-bed6-bb7ef06dc632" continuedAt="i0156df36b8be4fe18a7c822279aea43c" escape="true">Basis of Presentation</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i0156df36b8be4fe18a7c822279aea43c" continuedAt="i20db309b4974435182da6476f35ef6b6"><ix:continuation id="i9c71768d419e4afe89fe211b7f1ef01b"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY3NQ_9fde5306-c04e-4680-bdf2-7ae29bff65ac" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY3OA_8fb3a1f5-fde5-4886-842d-d7c90db2230f" continuedAt="i605a1e2262134103815c66b13a4ed32a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i605a1e2262134103815c66b13a4ed32a">The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.</ix:continuation> </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzEyMQ_9ec5f04e-c374-4cab-9214-3036254bbe66">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzEyOA_d3bb259f-453c-49e9-a285-af58b76c11a4">0.8</ix:nonFraction> million for the three and nine months ended September&#160;30, 2022, respectively. Net income attributable to the noncontrolling interests was $<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzI0Mw_4698ec08-af7a-4e5e-bb30-92e6e6c562dd">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzI1MA_37bd79c0-0bba-405d-90cc-354490ae7c9b">1.0</ix:nonFraction> million for the three and nine months ended September&#160;30, 2021, respectively. As of September&#160;30, 2022 and December&#160;31, 2021, noncontrolling interests were $<ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-5" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzM1Mg_e1102072-fb62-4e6b-89a3-9ad250cd8bdf">4.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-5" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzM1OQ_097bfc4a-59f2-4a87-9d9b-2772fe99e4f8">3.2</ix:nonFraction> million, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Related Accruals and Expenses</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded $<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzQzNg_19aaeff9-ce05-484a-8091-d23a21ca6848">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzQ0Mw_38b36b3d-1afc-429c-91a2-910d530a1291">0.4</ix:nonFraction> million of restructuring related expenses during the three and nine months ended September&#160;30, 2022, respectively. We recorded $<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-5" name="us-gaap:RestructuringCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzUzNw_b91f7869-d195-48da-925b-8809e21817ac">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzU0NA_63c8a78f-bbf6-4e43-8b85-40540259f2d2">48,000</ix:nonFraction> of restructuring related expenses during the three and nine months ended September&#160;30, 2021, respectively. Accrued severance and restructuring related costs were $<ix:nonFraction unitRef="usd" contextRef="ie1a51afc7549405b92c990bdb852d8cb_I20220930" decimals="-3" name="us-gaap:RestructuringReserve" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzY4MQ_b9f3e13f-b18b-4402-b7f6-37a6ee1e9e65">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i004662f9de7b4fdfbabc81b8850a070f_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzY4OA_03be44ce-cbb9-4ee5-8e32-7438da026621">0.2</ix:nonFraction> million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY3NA_80e46036-557c-4c41-a5c6-e255bae27a76" continuedAt="ie169017427c84753aef2803a9637d129" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i20db309b4974435182da6476f35ef6b6"><ix:continuation id="ie169017427c84753aef2803a9637d129">potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.</ix:continuation></ix:continuation></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RleHRyZWdpb246MzEwNzQyMWQ5NzVmNDQ1Mzk3OGE0OTQ2Yzc4ZjNkNDdfMTA2_077d7238-f218-408b-bcf3-c6212f9c2419" continuedAt="i87198cbfb3434abdb7630594a444491d" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="i87198cbfb3434abdb7630594a444491d"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RleHRyZWdpb246MzEwNzQyMWQ5NzVmNDQ1Mzk3OGE0OTQ2Yzc4ZjNkNDdfMTA5_44816d38-fe51-406a-a56f-bedf183166dd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMS0xLTEtMS0zNjUxNw_8983a366-1ad5-4869-a104-f660c46e133a">26,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMS0zLTEtMS0zNjUxNw_4df00991-65b0-404e-ae76-0f56852a2f9f">22,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMi0xLTEtMS0zNjUxNw_07a9e971-4d10-47b7-a67e-be1275b868c9">1,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMi0zLTEtMS0zNjUxNw_78ecf4ff-7919-4080-bbf4-33df014e0f6c">1,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMy0xLTEtMS0zNjUxNw_df123aae-2390-4f40-87ee-5ec6ac8b3397">39,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMy0zLTEtMS0zNjUxNw_ae062c29-8af1-4bbf-87a6-6e3c96f79103">36,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfNC0xLTEtMS0zNjUxNw_791d22d2-c957-4e3b-bdd0-236cad3dc952">67,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfNC0zLTEtMS0zNjUxNw_8c217180-a23b-4972-84bc-bfbd05dfa57e">60,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMjg5_ab6c4efe-b58a-4a53-94e2-4de2166e2d31" continuedAt="i1d951aae9e8f426ab8f1eea56fef6284" escape="true">Investment Securities - Trading</ix:nonNumeric></span></div><ix:continuation id="i1d951aae9e8f426ab8f1eea56fef6284"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trading securities portfolio totaled $<ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-5" name="us-gaap:DebtSecuritiesTradingRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfODQ_46ef5c0a-5a08-42ee-9a14-6017f5feb19e">0.7</ix:nonFraction> million at September&#160;30, 2022, and $<ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-5" name="us-gaap:DebtSecuritiesTradingRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfOTg_865282f6-9741-4007-befb-5640a42ad405">1.0</ix:nonFraction> million at December&#160;31, 2021, and generated losses of $<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesTradingRealizedGainLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMTMy_31c5307c-f939-40ad-a86c-f3a141f3f630">25,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:DebtSecuritiesTradingRealizedGainLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMTQ4_dc21528e-6fac-4f80-87ac-e5aa8eadb545">4,000</ix:nonFraction> for the three months ended September&#160;30, 2022 and 2021, respectively, and losses of $<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMjE3_eded4f1f-3bc5-4c43-8e65-bc8d46401177">0.2</ix:nonFraction> million and gains of $<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-5" name="us-gaap:DebtSecuritiesTradingRealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMjMz_b339401e-838d-4bc9-a457-efa628e18cd3">0.1</ix:nonFraction> million for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMjA1OQ_2d12ce02-92dd-4603-a22d-9f51cb9421b7" continuedAt="icf026bec1b9546c1a53017f666b09c1a" escape="true">Revolving Credit Facility and Other Obligations</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icf026bec1b9546c1a53017f666b09c1a"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$<ix:nonFraction unitRef="usd" contextRef="ia06b2ea113604f608cfe139f6473b4f8_I20170711" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTc1_c770afe6-09f9-427a-b17d-d250bdabbb63">25.0</ix:nonFraction> million (the &#8220;Credit Agreement&#8221;).&#160;On June 23, 2022 the credit agreement was amended to extend the term to mature on July 1, 2027 and allows for additional borrowings of $<ix:nonFraction unitRef="usd" contextRef="ia088a5fe1c0d4659856719b55cc649b5_I20220623" decimals="-5" name="natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMzM5_8e50ea72-6693-4ef7-b00f-48ce49b1112c">25.0</ix:nonFraction>&#160;million or up to <ix:nonFraction unitRef="borrowing" contextRef="ia088a5fe1c0d4659856719b55cc649b5_I20220623" decimals="INF" name="natr:LineOfCreditFacilityNumberOfSeparateIncreases" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMzUx_430cb35a-02a2-4620-a980-59fa94d54b4c">three</ix:nonFraction> separate increases of no less than $<ix:nonFraction unitRef="usd" contextRef="ia088a5fe1c0d4659856719b55cc649b5_I20220623" decimals="-5" name="natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMzg5_915cfe3c-c018-42db-b7d4-257892a4c44a">5.0</ix:nonFraction>&#160;million each, subject to the lender's due diligence. The amendment to the credit agreement also modified the calculation of interest. Interest under the amended Credit Agreement is the greater of BSBY Daily Floating Rate or the Index Floor, plus&#160;<ix:nonFraction unitRef="number" contextRef="i22efa19eb0344c72ad687994862269e2_D20220623-20220623" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNTkx_e278cbfa-882e-4775-93ee-01486ced341f">1.50</ix:nonFraction> percent&#160;(<ix:nonFraction unitRef="number" contextRef="iddc8134658ca4954b354f15805380b94_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNTk1_f88e303b-a401-4d7d-a8b2-7ca890cd749c">4.62</ix:nonFraction> percent as of September&#160;30, 2022), and an annual commitment fee of&#160;<ix:nonFraction unitRef="number" contextRef="i8f0cbc126bdd4b63949c4345575e09e6_D20220623-20220623" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNjQx_7544bfe0-a398-4709-9a9e-d9082048b0b0">0.25</ix:nonFraction> percent&#160;on the unused portion of the commitment. At September&#160;30, 2022 and December 31, 2021, there was <ix:nonFraction unitRef="usd" contextRef="if06d201ef25c4642849a07427e18a4e2_I20220930" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNzI0_98402646-851c-435a-af6a-8095e5425e09"><ix:nonFraction unitRef="usd" contextRef="i3c79105659ed47199844f29f16ee8732_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNzI0_9988d23f-b4a7-4f20-8771-280f2b4043d1">no</ix:nonFraction></ix:nonFraction> outstanding balance under the Credit Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of September&#160;30, 2022, we were in compliance with the debt covenants set forth in the Credit Agreement.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $<ix:nonFraction unitRef="usd" contextRef="i0e03c2f550744858bfdef123a1e103dc_I20200421" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTUxNA_b61b8ee5-3f4d-49fd-b6c6-28a6d9bf6e14">6.0</ix:nonFraction>&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $<ix:nonFraction unitRef="usd" contextRef="i42bf1f4955d14fd785dd3122c680d83b_I20201119" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTYzMA_292675d3-e829-4c3e-9415-399bfa0fb929">3.7</ix:nonFraction>&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of <ix:nonFraction unitRef="number" contextRef="i03715efd129a44a1865caa1ea43fa333_I20220930" decimals="2" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTcyMg_94fd01d1-26f2-4510-aa57-c833f4c93dbc">3.00</ix:nonFraction> percent and are required to settle our borrowings under the Capital Credit Agreement in <ix:nonFraction unitRef="payment" contextRef="i8562a44c05df4b34a7f6a8878e388882_D20201119-20201119" decimals="INF" name="natr:DebtInstrumentNumberOfMonthlyPayments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTgxMw_51287cec-e618-4c58-8067-12ceb0c578c6">36</ix:nonFraction> monthly payments of $<ix:nonFraction unitRef="usd" contextRef="i8562a44c05df4b34a7f6a8878e388882_D20201119-20201119" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTgzNw_98ca1474-96f2-4bf1-983a-b5c2a84abaf9">0.1</ix:nonFraction>&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of September&#160;30, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="id7b42e335b02463ea1d3019cd2f3474b_I20220930" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTk2MA_3e9a71b3-80c1-426f-9a3b-d5ad689d75d6">1.5</ix:nonFraction>&#160;million outstanding balance under the Capital Credit Agreement, of which $<ix:nonFraction unitRef="usd" contextRef="id7b42e335b02463ea1d3019cd2f3474b_I20220930" decimals="-5" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMjAyOA_a33e5d39-622b-4b08-8f46-8a173a22a619">1.3</ix:nonFraction>&#160;million was classified as current.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RleHRyZWdpb246MzFjZWQxNTlhMzdlNDEyYWFmNDk5NmE0OTNjOWU0MzlfMTc1Mw_bb0357f2-5295-4249-b11d-575c189fcab7" continuedAt="i62d37aa82e4e4a14be525e31b6af36a1" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="i62d37aa82e4e4a14be525e31b6af36a1" continuedAt="i94da9fb86eed4b608a162cf791794d7c"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per common share (&#8220;Basic EPS&#8221;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#8220;Diluted EPS&#8221;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="i94da9fb86eed4b608a162cf791794d7c"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RleHRyZWdpb246MzFjZWQxNTlhMzdlNDEyYWFmNDk5NmE0OTNjOWU0MzlfMTc1MA_55213184-5d80-4bf0-9ef6-013425ae3ec7" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three and nine months ended September&#160;30, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNS0xLTEtMS0zNjUxNw_f2468410-1e8b-4926-8694-39bbb4d79f76">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNS0zLTEtMS0zNjUxNw_6838423a-468c-4031-8e2f-346b606f280d">4,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNS01LTEtMS0zNjUxNw_7a22b530-1985-4711-8c26-8028cefbaa36">2,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNS03LTEtMS0zNjUxNw_ad75da6a-006f-4b08-bdf8-bfb3c2400df0">15,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNy0xLTEtMS0zNjUxNw_12470454-975a-41e1-ae21-4e67c1a24061">19,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNy0zLTEtMS0zNjUxNw_020fbc0b-481c-4e18-a461-ed8132a994eb">19,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNy01LTEtMS0zNjUxNw_80494e38-8056-44c9-aa99-c613233547b1">19,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNy03LTEtMS0zNjUxNw_fd7dabac-e43d-47c8-b0e4-9723ca1fb2cd">19,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTItMS0xLTEtMzY1MTc_ec98db73-6a1f-4d8a-b8f4-bb65f48d549b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTItMy0xLTEtMzY1MTc_8bd44c64-4559-402e-9d09-570e8a975892">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTItNS0xLTEtMzY1MTc_fcb403c1-7fb0-4922-ba88-fd943336fa42">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTItNy0xLTEtMzY1MTc_098d9357-cdd0-464d-95c5-0dc7e30c371a">0.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTUtMS0xLTEtMzY1MTc_746027d7-e9c5-4ae5-b81f-2cd937757f13">19,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTUtMy0xLTEtMzY1MTc_57d0576b-e2fd-4458-9ed6-f4653407b18c">19,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTUtNS0xLTEtMzY1MTc_ae26c545-ff9b-414e-a26e-e25151853cf4">19,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTUtNy0xLTEtMzY1MTc_17645fbe-b8d0-4f74-9eb1-f206b8948d3a">19,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTYtMS0xLTEtMzY1MTc_033b2a50-2411-4ece-a6d9-6489a91f2c0e">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTYtMy0xLTEtMzY1MTc_e843b2a7-b4ea-450b-936b-177e3d63204c">481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTYtNS0xLTEtMzY1MTc_2bfb1939-59b9-46a6-88dd-9b455934c3c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTYtNy0xLTEtMzY1MTc_d410fee4-2d39-478e-ac4f-bd7dd44fe1e3">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTctMS0xLTEtMzY1MTc_ac3463aa-af97-47ca-ac22-dc6f504b7bd4">19,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTctMy0xLTEtMzY1MTc_6f71a90b-fd77-4d54-a40e-1977c79a1898">20,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTctNS0xLTEtMzY1MTc_df9562c0-76a1-48ac-b107-720cc416ebda">19,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTctNy0xLTEtMzY1MTc_f6695051-3f7d-45cc-9922-0342eeac4c13">20,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjItMS0xLTEtMzY1MTc_73ae1342-56b2-406c-92bd-46d673f8d519">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjItMy0xLTEtMzY1MTc_e6dc4099-1528-4ffc-b215-68099a48cbaf">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjItNS0xLTEtMzY1MTc_e88cbf55-8ac7-4e57-af8a-85873a7810b3">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjItNy0xLTEtMzY1MTc_5a583b40-04ce-436a-8256-379e6cd139eb">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="natr:DilutiveSecuritiesExcludedfromComputationofEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjUtMS0xLTEtMzY1MTc_8234dbd6-b88f-4f67-9866-1534f0cd031a">576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="natr:DilutiveSecuritiesExcludedfromComputationofEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjUtMy0xLTEtMzY1MTc_a70ff575-fb57-4dda-afda-48536f1eb510">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="natr:DilutiveSecuritiesExcludedfromComputationofEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjUtNS0xLTEtMzY1MTc_bfbf2f75-ec44-4eb9-a616-92c6ad754051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="natr:DilutiveSecuritiesExcludedfromComputationofEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjUtNy0xLTEtMzY1MTc_249fcc63-3846-492e-a4a7-6074a2d3f017">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjgtMS0xLTEtMzY1MTc_7e3e8e00-a9e5-438e-9fd4-d754e06b7f93">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjgtMy0xLTEtMzY1MTc_d77f7e69-e720-438b-91f6-273158d47a3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjgtNS0xLTEtMzY1MTc_f4aaea34-2686-4c81-bf72-f2f7749b4cc9">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjgtNy0xLTEtMzY1MTc_f993d554-482b-4805-bbeb-fab894033f97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the nine months ended September 30, 2022, <ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RleHRyZWdpb246MzFjZWQxNTlhMzdlNDEyYWFmNDk5NmE0OTNjOWU0MzlfOTA4_51bf0d64-a141-467d-8673-50027aab9203">no</ix:nonFraction> potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the nine months ended September 30, 2022 include <ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RleHRyZWdpb246MzFjZWQxNTlhMzdlNDEyYWFmNDk5NmE0OTNjOWU0MzlfMTEyNA_3dfa16ee-a24f-4a45-9964-017c279acf81">576</ix:nonFraction> restricted stock units.</span></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted- average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYzMQ_6f4ef5ba-e9f5-4512-8304-366890f78587" continuedAt="i680987eb3efc482bb98a133769db4ea2" escape="true">Capital Transactions</ix:nonNumeric></span></div><ix:continuation id="i680987eb3efc482bb98a133769db4ea2" continuedAt="ie998106e1e9648128bc8b884d830e1c3"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a special non-recurring cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i98e5bb1cef6c4becb6ebf74bc1b7e3eb_D20210405-20210405" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTE2_92745478-7f6a-46d6-8104-bfdb3b03052b">1.00</ix:nonFraction> per common share in an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i98e5bb1cef6c4becb6ebf74bc1b7e3eb_D20210405-20210405" decimals="-5" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTYy_b85317f8-6d35-43de-a323-85a360a9c8c1">19.9</ix:nonFraction>&#160;million that was paid on April 5, 2021, to shareholders of record on March 29, 2021. In accordance with the provisions of our 2012 Stock Incentive Plan (the "2012 Incentive Plan"), as a result of the special dividend we are required to make the participant's original grant whole by preventing either dilution or enlargement of the benefits or potential benefits intended by the original grant. The 2012 Incentive Plan provides our Compensation Committee with the discretion to meet this requirement. See further discussion in the Share-Based Compensation section of this Note.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="ie998106e1e9648128bc8b884d830e1c3" continuedAt="idcc19d19702244d3b9af2bd6b68bd2fd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a $<ix:nonFraction unitRef="usd" contextRef="iee350a313d8f4cd4b7964c9818ca55c8_I20210310" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTEzNA_0f667d06-a155-40fe-a5e8-1e1194b2e24e">15.0</ix:nonFraction>&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $<ix:nonFraction unitRef="usd" contextRef="i38f58e1adc7e4bd4adbdfed111f9df0b_I20220308" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTI4Ng_bcee1eb0-5976-4a94-923d-738bce1fedca">30.0</ix:nonFraction>&#160;million in common shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the nine months ended September&#160;30, 2022 and 2021, we repurchased <ix:nonFraction unitRef="shares" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTQ3OA_2b5d04b0-e2ad-4809-a1e9-5ac91684ef26">834,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTQ4NQ_a53cfecd-7286-4e01-a73b-984b5271786b">350,000</ix:nonFraction> shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTUxOQ_76241e93-0ec2-4c6f-ad6a-cb5859e81216">12.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTUyNg_551ad0ec-4114-4299-9986-47edfbdecdb2">6.0</ix:nonFraction>&#160;million, respectively. At September&#160;30, 2022, the remaining balance available for repurchases under the program was $<ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTYyMQ_4addcf23-1126-476a-a3ea-53962ae8f6d9">24.6</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#8217;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of <ix:nonFraction unitRef="shares" contextRef="i6c0ddf3d82324bcb905a643d93542091_I20121231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMjMyOQ_f921035c-ba58-40a1-9b54-e698a22b9f8b">1,500,000</ix:nonFraction> shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by <ix:nonFraction unitRef="shares" contextRef="ibae0afd2c25447bc920e0df4c8c9b207_D20150101-20151231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMjU5NA_ae9a30af-f364-482e-b57b-5e7c5e6ca40e">1,500,000</ix:nonFraction> shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by <ix:nonFraction unitRef="shares" contextRef="if9593f0319dc4fe48d712b42fc7be268_D20210505-20210505" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMjgwMQ_f92c1fda-999a-4089-a68f-1512ba8bd9b4">2,000,000</ix:nonFraction> shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to <ix:nonNumeric contextRef="icb44a2c98f1740dbb00c82b0e332d00e_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzIzMQ_2faa2895-57dd-4457-acb8-77d119c145c3">48</ix:nonNumeric> months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of <ix:nonFraction unitRef="number" contextRef="i50cfb2216c6e4898a183ccf77630d5ae_D20220101-20220930" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzM2OA_7c30c9ab-d084-4139-8a57-08690035a25c">six</ix:nonFraction>, <ix:nonFraction unitRef="number" contextRef="i50cfb2216c6e4898a183ccf77630d5ae_D20220101-20220930" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzM3Mg_744a66e5-8614-4caa-a546-247d77503b17">eight</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i50cfb2216c6e4898a183ccf77630d5ae_D20220101-20220930" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzM3OQ_cc73fa8a-2b92-4daf-9ddd-53d1ed517bf8">ten</ix:nonFraction> percent as reported in four of five consecutive quarters over the term of the options.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYyNw_f015f99e-61b6-44dc-94c0-a9ea9097ea77" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMS0xLTEtMS0zNjUxNw_31768f75-7a53-401f-a622-db7eb95243ef">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMS0zLTEtMS0zNjUxNw_ae2a8b8e-8d2b-454f-aac6-b439ab763944">12.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMS01LTEtMS0zNjUxNw_e54f9d3a-94ea-4c80-b748-ed16b506eb46">5.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMi0xLTEtMS0zNjUxNw_56fa26a7-5531-4201-a5e5-d50fae574a97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMi0zLTEtMS0zNjUxNw_ec8c76c3-797e-418f-94ab-eb1b5c36e4c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMi01LTEtMS0zNjUxNw_bffd1d09-753e-438f-904d-6a75ec14e0a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMy0xLTEtMS0zNjUxNw_1d82dce3-d748-4dba-87a2-b94cfe30f2b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMy0zLTEtMS0zNjUxNw_3584e75c-8b42-4a01-8e2b-8671de54fd7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMy01LTEtMS0zNjUxNw_426de929-36a3-475e-acc0-a92106b3e9ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNC0xLTEtMS0zNjUxNw_50b0cecf-cf6e-4968-86b3-7a60401f772b">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNC0zLTEtMS0zNjUxNw_005bf32c-5b10-4465-a96a-2daf041769ca">9.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNC01LTEtMS0zNjUxNw_dc3a568d-a4ea-4a87-b7e3-a528ce009e37">3.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNS0xLTEtMS0zNjUxNw_66796395-6b61-4218-ba42-204ff17aef11">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNS0zLTEtMS0zNjUxNw_d2e7cc80-f574-491a-bc9a-addcad7a5ae7">12.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNS01LTEtMS0zNjUxNw_32c78f3b-1482-4c34-ad4f-1e3676ffd4c7">5.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="i070b06d98cf645ae85a6b3eff5f58702_D20210701-20210930" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzYwNw_0dcfb16e-1308-49f7-9d5b-839531b4456a"><ix:nonFraction unitRef="usd" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzYwNw_1625cd4b-e613-4d8c-b709-7fc924f35f55"><ix:nonFraction unitRef="usd" contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzYwNw_3b1b3d13-6682-440d-b195-a4998fc46730"><ix:nonFraction unitRef="usd" contextRef="ic3925d99f6de43c5afbf93f61d4d675d_D20220701-20220930" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzYwNw_402b13c9-3fd8-4d0a-97af-76e2a87d72ac">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> share-based compensation expense for the three- and nine-month periods ended September&#160;30, 2022 and 2021. As of September&#160;30, 2022 and December&#160;31, 2021, there was <ix:nonFraction unitRef="usd" contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzcyMw_252a5c86-1cf1-469a-9961-8e317ebe9af4"><ix:nonFraction unitRef="usd" contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzcyMw_ba1205bb-d68b-494b-a816-d6a2232107b6">no</ix:nonFraction></ix:nonFraction> unrecognized share-based compensation expense related to the grants described above.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the aggregate intrinsic value of outstanding and exercisable stock options to purchase <ix:nonFraction unitRef="shares" contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzkwNg_7393720b-0d6f-4d8a-9281-6b8ad03f0aec">143,000</ix:nonFraction> shares of common stock was $<ix:nonFraction unitRef="usd" contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzkzNg_f1d89fed-041a-44b0-8861-b2ce058024ab">0</ix:nonFraction>. At December&#160;31, 2021, the aggregate intrinsic value of outstanding and exercisable options to purchase <ix:nonFraction unitRef="shares" contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDAyOA_e9a74818-8cf6-401b-a7a3-916461755496">172,000</ix:nonFraction> shares of common stock was $<ix:nonFraction unitRef="usd" contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDA1OA_16cff105-a00c-4e76-a56f-8c9d0c561f66">1.1</ix:nonFraction> million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine-month periods ended September&#160;30, 2022 and 2021, we issued <ix:nonFraction unitRef="shares" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDExNQ_36c2cdc2-4a96-461d-85ae-6f546f513683">29,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDEyMg_74764809-4179-40ab-ab93-d9e303a492ee">53,000</ix:nonFraction> shares of common stock upon the exercise of stock options at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDIxNQ_7a7474e2-07cb-448d-8a9c-25d8705d9645">9.17</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDIyMg_64beba90-48a7-45f4-8245-8d166d86bc59">12.00</ix:nonFraction> per share, respectively. The aggregate intrinsic value of options exercised during the nine-month periods ended September&#160;30, 2022 and 2021, was $<ix:nonFraction unitRef="usd" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDM1MA_118078ad-0350-4805-b4da-29d0b8460ad1">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDM1Nw_8ce8f226-2017-42c2-b66b-235c90de6434">0.4</ix:nonFraction> million, respectively. For the nine-month periods ended September&#160;30, 2022 and 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDQ0MA_7693342e-a91a-4e15-bd30-3592258a54ae">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDQ0Nw_106a1b6e-5b0c-4c45-8a81-010c8b6e6542">0.2</ix:nonFraction> million of tax benefits from the exercise of stock options, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, we did <ix:nonFraction unitRef="shares" contextRef="ie46e49fee8fd42a2aab87f77ac2f490e_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDU0MQ_2d94655b-0821-4b37-9844-309ab2465f9f"><ix:nonFraction unitRef="shares" contextRef="i23b536a276514486b763bbc7d3034568_I20220930" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDU0MQ_da3704bf-af65-451c-8cf6-f35ce92eedc9">no</ix:nonFraction></ix:nonFraction>t have any unvested stock options outstanding.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="idcc19d19702244d3b9af2bd6b68bd2fd" continuedAt="i08cfbdb889a84d0daf78e2993d4467d0"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding restricted stock units (&#8220;RSUs&#8221;), include time-based RSUs, which vest over differing periods of time ranging from <ix:nonNumeric contextRef="i9ef0509b465a4ac38cc9efafd19b9daf_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDc2NA_de51bbb4-a0a9-41b8-9fab-76079cc6b3eb">12</ix:nonNumeric> months to up to <ix:nonNumeric contextRef="i2dc49deb25cc408796443b55a640d385_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDc3Ng_aa71af41-2103-408d-9d84-af4a907f29e1">36</ix:nonNumeric> months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating adjusted EBITDA growth, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until <ix:nonNumeric contextRef="ic20e20adf95940ca8fd836f859de3b03_D20220101-20220930" name="natr:RestrictionPeriodForIssuanceOfShares" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTA4MQ_9eece792-fdf4-47e4-a244-d6119646e86f">two years</ix:nonNumeric> after vesting. At September&#160;30, 2022 and December&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="ifa9bd7370039495491ec25c69d400f48_I20220930" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTEyNA_39213b8b-7dd8-46f7-838d-8ad71a5b6aa4">81,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic152af38654942a3a96dcd69544a74da_I20211231" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTEzMQ_fcc7b3c4-e57d-4cf3-b998-271c26589a37">88,000</ix:nonFraction> vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYyMQ_1703b996-1aa9-4d34-8cb5-a0d581141fa8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0055094229274cb5af4f7333a237c4ea_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMS0xLTEtMS0zNjUxNw_9a27d020-da9f-4a61-b82b-48d1394c402d">830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0055094229274cb5af4f7333a237c4ea_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMS0zLTEtMS0zNjUxNw_34cdd2e0-a398-4ee3-9ca0-4ec3cecfc509">9.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMi0xLTEtMS0zNjUxNw_599d95f4-dc42-4419-af85-b40cc3add8fa">796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMi0zLTEtMS0zNjUxNw_2f559de8-2d97-45e4-ab27-ca3ea8c24054">10.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMy0xLTEtMS0zNjUxNw_cd3f8d10-fc5b-4973-8587-fcc4ad3e003e">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMy0zLTEtMS0zNjUxNw_975b69d0-2e12-4d51-ab8c-f7f86f05d932">9.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfNC0xLTEtMS0zNjUxNw_80e89d32-f80c-46e6-a376-d4128a40b668">329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfNC0zLTEtMS0zNjUxNw_c6c6904f-7ccb-4848-b7ca-72c67e4f16dc">7.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ae4407db5044cd68a2c86c97449360f_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfNS0xLTEtMS0zNjUxNw_a9d230c1-ebca-4078-9a83-fb985862a379">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ae4407db5044cd68a2c86c97449360f_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfNS0zLTEtMS0zNjUxNw_2ae83093-56ab-4a94-ad8a-d91558fbcf39">11.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine-month period ended September&#160;30, 2022, we granted <ix:nonFraction unitRef="shares" contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTQyMQ_510b9a2f-4444-41cd-af96-6adcf96edca5">796,000</ix:nonFraction> RSUs under the 2012 Incentive Plan to the Board of Directors, executive officers and other employees, which were comprised of time-based RSUs, and share-priced and adjusted EBITDA performance-based RSUs. The time-based RSUs were issued with a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie9f3b5b7f4ad40a29dec40525ebba7de_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTY5Mw_3ead21c4-35cd-4206-ae20-1cf87751c18d">11.44</ix:nonFraction> per share and vest in <ix:nonFraction unitRef="vestinginstallment" contextRef="ie9f3b5b7f4ad40a29dec40525ebba7de_D20220101-20220930" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTA5OTUxMTY0Njc2Mw_41362700-fae0-47f9-aac8-f75f8267f5df">12</ix:nonFraction> monthly installments over a <ix:nonNumeric contextRef="ie9f3b5b7f4ad40a29dec40525ebba7de_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTA5OTUxMTY0Njc2Ng_4377272a-b579-483c-828d-c35a6495c234">one year</ix:nonNumeric> period from the grant date or in annual installments over a <ix:nonNumeric contextRef="i9901ca354f7443948673dbff989dd14d_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYyOQ_81b70dc4-d80f-4f05-a4dc-a833a8016b91">three-year</ix:nonNumeric> period from the grant date. The share-priced performance-based RSUs were issued with a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i05187ed32f1a4459918c007aceb10282_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTg4Mg_48327aab-e0c7-4728-a5a0-0b370af7516a">6.01</ix:nonFraction> per share and vest upon achieving share-priced targets over a <ix:nonNumeric contextRef="i1a19d8970b2543048df69222e0305ed8_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYyNA_87162f05-7836-4063-a795-0ba507aa1ca9">three-year</ix:nonNumeric> period from the grant date. The adjusted EBITDA performance-based RSUs were issued with a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i04dd1d0e30dd4749869d484b28d4c2f3_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTA5OTUxMTY0Njc4MQ_a98ac090-23e2-4b73-955a-239845f58063">11.00</ix:nonFraction> per share and vest upon achieving adjusted EBITDA targets over a <ix:nonNumeric contextRef="i04dd1d0e30dd4749869d484b28d4c2f3_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTA5OTUxMTY0Njc5OQ_c402568c-8da2-4ed5-93a1-2c3e95d94ce1">four-year</ix:nonNumeric> period from the grant date.</span></div><div style="padding-left:36pt;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for share-priced performance RSUs, RSUs are valued at market value on the date of grant, which is the grant date share price discounted for expected dividend payments during the vesting period. For RSUs with post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. Using assumptions previously determined for the application of the option pricing model at the valuation date, the Finnerty Model discount for lack of marketability is approximately <ix:nonFraction unitRef="number" contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930" decimals="3" name="natr:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNjYzNQ_5d7b16d7-5e9c-4ea1-bd92-586103d05eaf">12.9</ix:nonFraction> percent for a common share.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-price performance-based RSUs were estimated using the Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved. Our assumptions include a performance period of <ix:nonNumeric contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNjkzMw_4416b93f-04db-4bc2-86aa-a25066ab96c0">three years</ix:nonNumeric>, expected volatility of <ix:nonFraction unitRef="number" contextRef="if1aa6de8d3384bec8195c0705cf1e5ee_D20220101-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNjk2MA_67d0fa2c-5634-4d3b-96f6-df5131d6cf48">50.1</ix:nonFraction> percent, and a risk-free rate of <ix:nonFraction unitRef="number" contextRef="if1aa6de8d3384bec8195c0705cf1e5ee_D20220101-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNjk4OA_6a3e08b4-83bb-4136-8023-45ea23557fc6">3.3</ix:nonFraction> percent.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to time-based RSUs for the three-month periods ended September&#160;30, 2022 and 2021, was approximately $<ix:nonFraction unitRef="usd" contextRef="i10c14c6b81e84c7b8f58f51625726416_D20220701-20220930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzExNg_a60abcde-8502-47ff-ab83-87c7d855b55d">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i761305687fcc410da48c9004616a56eb_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzEyMw_4af53477-d180-4ed1-8931-87341b778dbd">0.6</ix:nonFraction> million, respectively. Share-based compensation expense related to time-based RSUs for the nine-month periods ended September&#160;30, 2022 and 2021, was approximately $<ix:nonFraction unitRef="usd" contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzI2MQ_1764938f-37ad-4d30-b52d-f5ea781d6881">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iabe8b4b0a68d4a079325eda61ea70e86_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzI2OA_4b28cf0f-7588-4fad-8ce0-31efd8e6d32c">1.6</ix:nonFraction> million, respectively. As of September&#160;30, 2022 and December&#160;31, 2021, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $<ix:nonFraction unitRef="usd" contextRef="i8dff8e40d0d240aa9a88877fdfd05209_I20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzQ0MA_68f0124c-3fe1-4f18-bfa7-2c37444fc617">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i523fb664c6924406a1e7680eb6501b9a_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzQ0Nw_7394c437-7ced-49cc-b7ac-f19ea1b08207">1.6</ix:nonFraction> million, respectively. The remaining compensation expense is expected to be recognized over the weighted average period of approximately <ix:nonNumeric contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzU3OQ_64c410e7-8711-4706-9d03-96608d48a9b6">0.8</ix:nonNumeric> years.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to performance-based RSUs for the three-month periods ended September&#160;30, 2022 and 2021, was $<ix:nonFraction unitRef="usd" contextRef="ic317fd5637e24133b38464894a02a48a_D20220701-20220930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzcwMQ_3e02505a-3d1b-4242-9754-9051ba40898f">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id8b227faac114cf89d93aacc27030ee3_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzcwOA_ee16b53f-ace7-4218-91aa-a6af5db70da8">0.3</ix:nonFraction> million, respectively. Share-based compensation expense related to performance-based RSUs for the nine-month periods ended September&#160;30, 2022 and 2021, was $<ix:nonFraction unitRef="usd" contextRef="iaa5248e41f6f4304969ef1dca24c02cb_D20220101-20220930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzgzOQ_d7def513-e1a0-47e4-8bae-11b0ac07c9f9">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if495bbb4e2364ea1b89e3ce85fd3847d_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzg0Ng_189cc84a-5427-458d-b3a9-edebd7fbaa4f">1.2</ix:nonFraction> million, respectively.&#160;Should we attain all of the metrics related to performance-based RSU grants, we would recognize up to $<ix:nonFraction unitRef="usd" contextRef="i7532a655100648398d64a5c418cefbd7_I20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzk4Mg_191e574d-e65a-4b47-8575-ecc696e2cf1e">1.8</ix:nonFraction> million of potential share-based compensation expense. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was <ix:nonFraction unitRef="shares" contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODI0NQ_216364ee-9ba7-4ea6-869f-1edb65648b9e">80,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iabe8b4b0a68d4a079325eda61ea70e86_D20210101-20210930" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODI1Mg_1bb51b27-83b2-4669-98f6-5521d4cb3334">150,000</ix:nonFraction> shares for the nine-month periods ended September&#160;30, 2022 and 2021, respectively. Although shares withheld are not issued, they are </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i08cfbdb889a84d0daf78e2993d4467d0">treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.</ix:continuation>&#160;</span></div><div><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk4Nw_4d6235db-3b1c-4d15-8e25-d8ddf38f7b93" continuedAt="i790e65f4dca044eaa7f488372b58b4a4" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="i790e65f4dca044eaa7f488372b58b4a4" continuedAt="iad8db3e8f81d4881bd92de9f336a5fc0"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="segment" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMzk_48244272-4d4d-421b-b64a-c5e523f7c32a">four</ix:nonFraction> business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. The geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy WorldWide&#174; brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.</span></div><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk4MA_c9b22425-465d-41ae-91cb-dd528ea20ba0" continuedAt="i0fc7ab5c068f4fe2a246fb8a69e7e668" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaffce26a8c8b429fb3267aa0f04b6886_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMy0xLTEtMS0zNjUxNw_e3bd4992-09ae-45d3-9a94-801cf8e2fff9">47,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3acc32b97542e5a94dd4a3bb1b4cd7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMy0zLTEtMS0zNjUxNw_26c0aff6-9065-47c9-bb87-41be793795bf">48,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de094914c5f46db86d9dc44c155ea51_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMy01LTEtMS0zNjUxNw_05c66962-8936-438b-a1ce-d2b3524778a1">141,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9597cde95214777a01076967abb5bfd_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMy03LTEtMS0zNjUxNw_f9491e91-03c9-4e5a-ad5f-d51648f8da1a">127,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f17fd5fec04cceb20a25018feb023a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNC0xLTEtMS0zNjUxNw_bf1aca6c-3ed2-4c47-8bc7-7d55cad3a504">19,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee2afc6d0574fa68adf6928f3f7ca2e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNC0zLTEtMS0zNjUxNw_8bfb9688-da74-4b64-b079-0044a48bd00b">21,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fb57db9af244869c886dfc1addaba9_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNC01LTEtMS0zNjUxNw_222be6bb-5edd-4219-a994-6ba056128a40">58,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f268d552ed4fd791df8fd022fc4127_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNC03LTEtMS0zNjUxNw_2140c635-9df4-4250-aa91-af95144a948d">65,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca94f66cae0472e950944808843bf52_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNS0xLTEtMS0zNjUxNw_8ce5f869-01c9-4b89-8fc1-22ccb1545b02">31,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c54aef4fc24df184a67d7a6e8a4686_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNS0zLTEtMS0zNjUxNw_c6ebac35-2730-4a2d-968c-6799d77ee502">37,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8bbc89738474e36a998144b3ab76005_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNS01LTEtMS0zNjUxNw_d017a763-73fb-41f7-bc2b-4b1a70d31537">101,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64ed51372db4414b6b3e91b38ec9b38_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNS03LTEtMS0zNjUxNw_8c2cc130-e89a-4b06-b1c6-7486db4805e4">112,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i989dadafa5b04aa6983e589a0e3400b1_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNi0xLTEtMS0zNjUxNw_d27d0a93-e6a9-4396-87e7-6cd8cb722ee5">5,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66f83106d3c64004a59b18515c555b70_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNi0zLTEtMS0zNjUxNw_e33d6755-0385-4b93-bb59-1bb522e20a4e">6,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icefc13a45af1427495b1821d0c2f7f72_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNi01LTEtMS0zNjUxNw_3394beba-d9a5-48df-a0ec-87a0cbac42c3">18,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d15fce936b4a1393ca7b8ca3173e02_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNi03LTEtMS0zNjUxNw_f4d6b90c-f471-4b69-a8e7-abf419216d16">20,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNy0xLTEtMS0zNjUxNw_f84f6b68-fa85-4bc8-82a4-5af0d64ccf1c">104,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNy0zLTEtMS0zNjUxNw_a1d08674-5e5b-469f-aa03-b98600f1b40e">114,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNy01LTEtMS0zNjUxNw_742516e2-d89d-44f2-b128-ae4fb81f1aeb">319,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNy03LTEtMS0zNjUxNw_79c3d2cc-63d8-4b53-8a03-d6a582d03cab">326,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaffce26a8c8b429fb3267aa0f04b6886_D20220701-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTAtMS0xLTEtMzY1MTc_f18e3aea-3155-4fb4-9df9-b48d01e62b9c">21,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3acc32b97542e5a94dd4a3bb1b4cd7_D20210701-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTAtMy0xLTEtMzY1MTc_9c42d82f-f7e8-4e03-b9e0-01d693dbcac4">21,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de094914c5f46db86d9dc44c155ea51_D20220101-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTAtNS0xLTEtMzY1MTc_d2a194b2-9d01-4f2b-b95d-d30aba299dc8">64,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9597cde95214777a01076967abb5bfd_D20210101-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTAtNy0xLTEtMzY1MTc_6aa5be9e-7f03-4f8d-b3aa-ade123d49a74">55,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f17fd5fec04cceb20a25018feb023a_D20220701-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTEtMS0xLTEtMzY1MTc_4353ecf3-0244-4e7d-b03e-3ddd2faf9880">7,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee2afc6d0574fa68adf6928f3f7ca2e_D20210701-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTEtMy0xLTEtMzY1MTc_cc9015ed-ee78-45e8-9e3e-b77eeb1504e9">6,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fb57db9af244869c886dfc1addaba9_D20220101-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTEtNS0xLTEtMzY1MTc_0b24af82-97e6-4936-891d-7350946b86a4">18,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f268d552ed4fd791df8fd022fc4127_D20210101-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTEtNy0xLTEtMzY1MTc_09718ff3-2282-4408-a154-21b0267700ff">20,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca94f66cae0472e950944808843bf52_D20220701-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTItMS0xLTEtMzY1MTc_a8a06f5e-2929-41ce-a29c-65e0cbe3479d">10,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c54aef4fc24df184a67d7a6e8a4686_D20210701-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTItMy0xLTEtMzY1MTc_de886a14-0efd-408e-a204-c9e609f813ec">17,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8bbc89738474e36a998144b3ab76005_D20220101-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTItNS0xLTEtMzY1MTc_c33f5764-aa0c-4dbd-9371-18eb059e19a0">35,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64ed51372db4414b6b3e91b38ec9b38_D20210101-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTItNy0xLTEtMzY1MTc_e1ac049a-9f58-4aaa-a691-7a428f6f0571">48,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i989dadafa5b04aa6983e589a0e3400b1_D20220701-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTMtMS0xLTEtMzY1MTc_8449cae3-d620-4537-9924-47e3bfeb295e">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66f83106d3c64004a59b18515c555b70_D20210701-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTMtMy0xLTEtMzY1MTc_895cfda9-5d31-423f-88d6-42dea828e7ff">3,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icefc13a45af1427495b1821d0c2f7f72_D20220101-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTMtNS0xLTEtMzY1MTc_ebbc1429-8bee-4cc7-bb8b-82b0b845bb8c">7,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d15fce936b4a1393ca7b8ca3173e02_D20210101-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTMtNy0xLTEtMzY1MTc_d6fb93ad-d841-40bf-b641-96885a43d9a3">11,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTQtMS0xLTEtMzY1MTc_4d432713-d416-48f1-8ccc-da2b1cb0e87d">41,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTQtMy0xLTEtMzY1MTc_d3e81e6b-8494-48a2-8141-a7c9ab0b4372">49,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTQtNS0xLTEtMzY1MTc_35fe2fd8-1926-4456-977a-723a15e9fec0">126,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTQtNy0xLTEtMzY1MTc_ba698cdd-90e1-45f1-9dde-086ab5fa765c">135,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTYtMS0xLTEtMzY1MTc_a101e584-f248-4fa1-8be5-5e01594760ec">36,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTYtMy0xLTEtMzY1MTc_757c77b1-122d-4ff5-9dcc-39016fc2222e">39,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTYtNS0xLTEtMzY1MTc_417b1cd1-df1a-41f4-96c8-200adec8f8b1">114,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTYtNy0xLTEtMzY1MTc_2b642fb1-78ca-442c-873c-c7100b1e0398">108,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTctMS0xLTEtMzY1MTc_273bf534-7060-4baf-a386-78793ae187ee">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTctMy0xLTEtMzY1MTc_022b3109-9dc0-4a3d-a65f-a5f230bf0b82">10,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTctNS0xLTEtMzY1MTc_dff2c70e-f40f-45c6-a054-bbe14cdbacca">12,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTctNy0xLTEtMzY1MTc_34c8f528-df70-400a-b2fc-43d814e55a1e">27,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTktMS0xLTEtMzY1MTc_65588d1c-3d51-4b61-8843-94a58cb8df52">2,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTktMy0xLTEtMzY1MTc_4e92920c-08c1-4f9a-b87a-240919cb3200">886</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTktNS0xLTEtMzY1MTc_7d929894-8fad-4392-b33d-71232a17be79">3,037</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTktNy0xLTEtMzY1MTc_a2421a40-c19e-4c8f-80ae-3c5b0f5f3f6b">2,290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMjAtMS0xLTEtMzY1MTc_74d26927-fd4a-48a4-bd1b-6cda78a5a4bb">2,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMjAtMy0xLTEtMzY1MTc_a7eb8410-d357-48a7-a20a-01eed4dfc40f">9,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMjAtNS0xLTEtMzY1MTc_245c116c-584f-4628-b069-03fe6214ea3c">9,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMjAtNy0xLTEtMzY1MTc_2664c2d4-9b07-484a-9f65-0901a6d26a70">24,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div></ix:nonNumeric><div style="text-indent:29.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0fc7ab5c068f4fe2a246fb8a69e7e668">(2)&#160;&#160;&#160;&#160;Service fees in China totaled $<ix:nonFraction unitRef="usd" contextRef="id9789e91bbdb4bb3981bfa676460e65f_D20220701-20220930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTE3NQ_d2817c61-bc52-4dc6-9787-58494add2474">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iad4ac3adcab842aa92dac9e2832e0d49_D20220101-20220930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTE4Mg_f302bf72-42c8-4e79-a36b-0d7ca34a85cb">11.3</ix:nonFraction> million for the three and nine-month periods ended September&#160;30, 2022, respectively, compared to $<ix:nonFraction unitRef="usd" contextRef="i5c2ceb81578b43c2a003d38ceeea837f_D20210701-20210930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTI0Ng_4f8af7dc-c2c7-486c-bb21-a48580938b15">5.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2f7fca25b7e64744a88843d142be5e47_D20210101-20210930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTI1Mw_4bffb37b-99ec-41cd-bc9a-fee393d1a0ee">11.7</ix:nonFraction> million for the three and nine-month periods ended September&#160;30, 2021. These service fees are included in selling, general and administrative expenses.</ix:continuation> </span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="iad8db3e8f81d4881bd92de9f336a5fc0" continuedAt="ide98f5c42f9a4467a546f6393a1ece17"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk4OQ_d09233c2-fcc6-40e7-9cd8-2b0497e0b9d7" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September&#160;30, 2022 and 2021, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ce284ec08d45a8b2f4eaf1d21af325_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfMy0xLTEtMS0zNjUxNw_8203899e-28d4-4bc5-aa6a-082704cb59e5">29,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7edfa74c3a4facaef4c6ce7195e3a1_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfMy0zLTEtMS0zNjUxNw_cbc1f28d-ac0e-4555-a068-5a461999424b">34,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7890d7b2c60340b3922736cdbf24446a_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfMy01LTEtMS0zNjUxNw_76e5a462-cdf1-46b5-9dbb-ca6d11908317">93,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac3dd237480d4bb2a35fab25b753dc3b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfMy03LTEtMS0zNjUxNw_0081cf38-1661-42a7-9a0d-3ed355ab3a11">104,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c0a4dbff9664147803b502780897f38_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNC0xLTEtMS0zNjUxNw_1545420b-a9ba-4f74-9eaa-58f12e6e6ecc">14,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b416cf57d384a54804362b64dbbf5ea_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNC0zLTEtMS0zNjUxNw_9702c009-2e91-49f8-ae34-9cc5e81ed8f2">15,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecb353578384ec8a536a7a833c0fc5c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNC01LTEtMS0zNjUxNw_d8d3b01a-67df-4b39-a0c5-fdf593e98e9f">43,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14a40364c7f64f5b80d862226b34ff6a_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNC03LTEtMS0zNjUxNw_abba4f0a-466a-405d-a433-93906cf6ea2d">48,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic001fa920873448dbc6ef54932a229ce_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNS0xLTEtMS0zNjUxNw_8ec36ef1-5689-4bed-b7c6-a782c07ff747">13,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9960683c96654f1ebd545850683426af_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNS0zLTEtMS0zNjUxNw_003a6bd7-5848-467a-b352-fffd18b7cb5c">7,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7057434687ff46f199ae8cac13391907_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNS01LTEtMS0zNjUxNw_0afa5b85-498b-4cfd-8bf5-3f476394d493">35,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746ecd7e625c4144b3062ca451baff75_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNS03LTEtMS0zNjUxNw_7f3b373f-c063-4934-ac45-bbef0f86f5be">14,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34383a427ad9404f8336487647135d64_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNi0xLTEtMS0zNjUxNw_724dbfbd-a0a1-4357-bae2-9ae79fc825e3">46,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i031ea41430044721be426b9e153f6d4e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNi0zLTEtMS0zNjUxNw_69d66972-f5ea-41ec-9506-ca71253b5a3b">56,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7cc106017f4bf790288d1410c6604f_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNi01LTEtMS0zNjUxNw_407920a1-a4d5-4275-acf1-dc79f3363845">147,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7aa79c6bd1146a299f812340a1c9843_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNi03LTEtMS0zNjUxNw_fbc8ce2a-c903-4a41-9a22-dd70e143e4ea">158,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNy0xLTEtMS0zNjUxNw_d86abe5f-f75b-4fa6-8655-6149a09aa579">104,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNy0zLTEtMS0zNjUxNw_42fd839d-dcf6-4d4c-b419-7e759f3166d4">114,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNy01LTEtMS0zNjUxNw_1f55796f-97b2-4ca9-8da6-cf61c3676a33">319,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNy03LTEtMS0zNjUxNw_09ea6b49-aa5a-43dd-a3d4-5602f117c7ce">326,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="ide98f5c42f9a4467a546f6393a1ece17" continuedAt="i259d35c9b39a480e9902ee2b6e317895"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk5Ng_cb461b7b-0ecd-4ae0-a2e4-cb5c49f7114f" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4ea04852d949b7b25b5dff1ff385c0_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMy0xLTEtMS0zNjUxNw_de810dd6-e6c3-4228-bc7c-5957c3829827">14,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b447bb6325c4a93813bee7f6470e956_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMy0zLTEtMS0zNjUxNw_41ff2f10-199c-4a24-8076-6bcdf8c3ccdc">13,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a38b38d33164e7f8b12740fd234f511_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMy01LTEtMS0zNjUxNw_92f8e684-cd45-4e41-b4e9-8732cbfc787e">40,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6afa9b57d0c8439a97666baea62606a5_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMy03LTEtMS0zNjUxNw_e74f1a0e-e3d2-4b9c-bedc-95946b0bb23c">37,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1422bc583463406ab563aaeac2967f11_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNC0xLTEtMS0zNjUxNw_cf7971b0-7887-44d4-a078-83bec79f3564">654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271947650c0641aa8199e5d38ec3dc01_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNC0zLTEtMS0zNjUxNw_e5eb58c0-81f2-4d54-910b-5d6411bf79ae">463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86d933ddea04f8fb10973d2824e48fa_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNC01LTEtMS0zNjUxNw_c3a3a386-abd3-4101-bbc5-4103f435be82">2,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f271afb02914124b483854f23bca344_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNC03LTEtMS0zNjUxNw_7cb774fe-a24e-4f1a-ad9b-185250974341">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9278b469d041fc8fff0e48fbaf4ca2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNS0xLTEtMS0zNjUxNw_abffd892-d443-4c6f-9e59-dd88d24966bb">14,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e611910bb3b4d8ab7ed214bddf977b3_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNS0zLTEtMS0zNjUxNw_e06bd56a-d314-465e-9039-e44042f142f4">13,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db6b432f4df49c1b4c2fca343cba1bf_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNS01LTEtMS0zNjUxNw_11ab8712-5226-4f4b-8181-b4ae7f56543c">41,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if69d793ea3634ef3bc0a0ae9b4bcb442_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNS03LTEtMS0zNjUxNw_ae63295e-fe51-4438-a825-d7ccdca3fd03">35,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5784c20ae64613902d57eaa1241f9a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNi0xLTEtMS0zNjUxNw_eb71ed0f-ae70-4164-a7f3-3c94b89a6e45">8,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idecec013f09941a7ae837474c48050ec_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNi0zLTEtMS0zNjUxNw_d4c91fa7-72f7-4f85-af82-4925922a6f3f">10,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if691899efd02473bbc07a3634d9602b9_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNi01LTEtMS0zNjUxNw_b1eebd94-ed3b-46b4-bec1-54befb568ec7">28,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a1a086a005d481397a9ec0c504d08f3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNi03LTEtMS0zNjUxNw_6f8809dc-70bc-4624-8df4-54d1a74c81e8">25,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a9c9b9a5d64082b24c3ce6b7f77d2a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNy0xLTEtMS0zNjUxNw_be436b56-1f2e-46ef-9387-aeca1e663589">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if666c3e591d34e419fe5cea9d63c76d0_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNy0zLTEtMS0zNjUxNw_543faba4-ed11-49fc-b190-afaace81faeb">4,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id82dd7fc19f2499ab5018e7a7327d0f2_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNy01LTEtMS0zNjUxNw_8f94825b-7661-4b85-8267-a9391ee0fd13">7,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3fc9b884d79481ba64714a98c37701b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNy03LTEtMS0zNjUxNw_16c82f35-e447-4f55-893a-4b699f21d8be">12,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455e487fd71d4e1f9f70e1f7708b649d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOC0xLTEtMS0zNjUxNw_837aa635-4ec8-4175-9450-9b718c403933">6,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2febb6991fd410a9e2bb3ad36bfa7b0_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOC0zLTEtMS0zNjUxNw_7b7efe01-d90e-4146-840e-5ae9de1a2e76">7,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766f81ea59e3447c8731e8067d14378c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOC01LTEtMS0zNjUxNw_5151b92e-687d-4505-ab33-54ef86f49c66">21,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b388a0ba69473fb479c83bba1002bc_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOC03LTEtMS0zNjUxNw_cfdbe453-c957-40a9-9eba-95a406b7c447">17,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaffce26a8c8b429fb3267aa0f04b6886_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOS0xLTEtMS0zNjUxNw_83871208-c723-479b-9c01-0f917ae44387">47,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3acc32b97542e5a94dd4a3bb1b4cd7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOS0zLTEtMS0zNjUxNw_86175285-571e-466c-9a95-3449024d7acf">48,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de094914c5f46db86d9dc44c155ea51_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOS01LTEtMS0zNjUxNw_202150f0-0de8-4b5f-9446-a7b83a244853">141,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9597cde95214777a01076967abb5bfd_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOS03LTEtMS0zNjUxNw_d2504bab-7594-4832-8d97-d3fea46b7e08">127,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d2a86b74014923a32749b21e57e32b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTEtMS0xLTEtMzY1MTc_f9c6aa7a-8d34-400b-8912-57f18e144fb4">8,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id811e29bb810469fb1c0ff8a40d5baca_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTEtMy0xLTEtMzY1MTc_e33652db-ce33-46d5-b9e1-c3d5b5bfb34d">9,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110b96df81934c4a895b7332653dfdfa_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTEtNS0xLTEtMzY1MTc_0b29e964-ae2a-4084-a327-a18e84b60296">25,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb2292964ed74f2c93618691aed0bf17_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTEtNy0xLTEtMzY1MTc_113cdf42-12d7-4aa9-ac58-d691f7ab62f9">28,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9fedb6d37e44a48ae4c2c1a283eced_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTItMS0xLTEtMzY1MTc_033ed2a2-8627-43bf-846b-a7f190cfe517">1,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8027c00bfbb440189c17c3cef6fd9b0_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTItMy0xLTEtMzY1MTc_328cfd2b-4b18-43be-92c5-f1385533b9fc">2,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92940ae0daed421bbc0a168e8b5e7afd_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTItNS0xLTEtMzY1MTc_530e2dd4-cb3c-4820-87af-54dc04a02f56">5,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2f5eb698ef4d4497ce138f3923d2a9_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTItNy0xLTEtMzY1MTc_cec3966f-66f7-4c57-b502-8f71ffd5f9a0">6,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8871c124bfc4ab59b69f58aa8ac2306_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTMtMS0xLTEtMzY1MTc_80ccc27b-da65-41f8-810c-25c5861c7949">2,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f1af7974d3467f8810ee1a2c00cef0_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTMtMy0xLTEtMzY1MTc_d4f44aba-e114-4981-8a04-be8f8379f0ee">2,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229bd20fdbd341b1a80e3c4e77eccf82_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTMtNS0xLTEtMzY1MTc_46d113a8-def2-4676-97cb-db1cac7d601a">7,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705c1e9af35d4a6e8814be31f200cad7_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTMtNy0xLTEtMzY1MTc_7ffa3689-cb54-4442-a59d-185f8f7a760e">8,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e4ef35e1824ccd882bf7fff758fffa_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTQtMS0xLTEtMzY1MTc_461e42c5-048e-4dc0-9004-0c6f2c957dc7">4,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2403109edfcf49318ed206f1f7e61b38_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTQtMy0xLTEtMzY1MTc_842fbe7f-42c3-47f7-83be-8a94c3945e04">5,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7f893932fe4cdfa20944e08ccd08b2_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTQtNS0xLTEtMzY1MTc_170a0517-ae01-4c69-9e93-1f5ed9ab5282">14,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15464f06de2947f184afb9420f0a1d8f_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTQtNy0xLTEtMzY1MTc_7a2977eb-1620-4ab6-9fa5-3730087a7b2f">16,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d33ddcece9a4459a1d275467de416cc_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTUtMS0xLTEtMzY1MTc_8f9f4397-d40f-4fe4-ba36-d57e4bd0ccd8">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f841c8711ef4ed49fbf8d826bc99285_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTUtMy0xLTEtMzY1MTc_2df61b20-9251-432a-9871-d1563fd787ca">1,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2489b6c3524e4e7b9c1a4e326997805c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTUtNS0xLTEtMzY1MTc_49cddcca-1e91-4869-bd64-9b482186cec7">3,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic089f06dc3df44b08a41d0888be18ae8_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTUtNy0xLTEtMzY1MTc_225b9da3-189b-4813-978c-84b4f009fff8">3,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422653a3b8d4475789d80957e8caed9d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTYtMS0xLTEtMzY1MTc_320664a4-e9f1-41e1-a9af-65378e27bcf1">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31f4302be1d4bfba2a29bd5573f373f_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTYtMy0xLTEtMzY1MTc_411f1864-c4a9-4a49-acec-2db7d91c6586">579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e4d19f07f584072a8e2b404743234e4_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTYtNS0xLTEtMzY1MTc_ba35effa-e78b-44d2-8e48-a24ae0c8fbae">1,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e8031c49d064ec995642d0179e0484b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTYtNy0xLTEtMzY1MTc_5017d0af-89a0-4a76-a7f9-413115fe6145">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f17fd5fec04cceb20a25018feb023a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTctMS0xLTEtMzY1MTc_23bd185e-987e-49d1-8895-58256e5dc70a">19,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee2afc6d0574fa68adf6928f3f7ca2e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTctMy0xLTEtMzY1MTc_598e6d2c-9afc-4cb6-8d7e-2c3026c89847">21,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fb57db9af244869c886dfc1addaba9_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTctNS0xLTEtMzY1MTc_6cc40417-f62f-4a34-9892-5896c45f5cc9">58,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f268d552ed4fd791df8fd022fc4127_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTctNy0xLTEtMzY1MTc_c88ce5b0-f75e-4790-ae5c-b6f3f505f45f">65,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16eb866672624d548d5ec50e5c190e14_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTktMS0xLTEtMzY1MTc_949e06e2-abd9-4dac-bfcc-5639607b16fd">14,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc90dbbf82d04aea8f8e7d67a1c1b202_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTktMy0xLTEtMzY1MTc_679eb7ce-511e-44d1-bb58-e5072789ad53">16,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i601e923be0e041b98944eb6ce61046a8_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTktNS0xLTEtMzY1MTc_457d2830-ba5c-49eb-9065-114415439307">44,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88024d56c5604272b98bf435e9880a43_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTktNy0xLTEtMzY1MTc_54db5350-a551-4416-8ff4-8f455c38bee0">49,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9795542b5d774f05aa511f90de376487_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjAtMS0xLTEtMzY1MTc_9ca71e4b-1183-429a-8f3f-54418e55382f">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e26d0a6ff7f45ada98e9349e001bbcb_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjAtMy0xLTEtMzY1MTc_bbda2f79-49eb-4175-bcde-a83283ff95cf">5,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25551ab7ec84b1bb4cba21a91fe3ed1_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjAtNS0xLTEtMzY1MTc_9079f2a7-b344-4fb6-a0da-7f12e3c3948c">12,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16954cbf01f143ceb864705c2fa0aa79_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjAtNy0xLTEtMzY1MTc_fc36561f-1e87-4a7b-9a88-3a22873419cc">14,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c51dace4af44a7ca2837c323c420d65_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjEtMS0xLTEtMzY1MTc_ba9f165e-89bb-4bdb-bd57-1efa56ad9cce">3,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81d52a6ed02545c9901d63a06dde0c2d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjEtMy0xLTEtMzY1MTc_ca94f61f-f6f3-4104-ad4c-253d0e9ac209">4,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f7036575f84653b7c99e0bfb760ad9_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjEtNS0xLTEtMzY1MTc_a534bc96-3834-4396-ac3f-9c3330289d3a">11,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id685627d492845129ed93f47b2600c71_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjEtNy0xLTEtMzY1MTc_acaa39f0-96e2-49ed-a3d1-88e4bd3bff55">12,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8828b4bb2ca4a78bc626f16aaba9fb6_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjItMS0xLTEtMzY1MTc_2b6bb986-d60e-41e7-b008-23f84c015810">8,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccd76854b160450aaf7d25c1de52f345_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjItMy0xLTEtMzY1MTc_a74973ab-3f63-446b-8a1a-8f7f8e898e0e">9,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973e94e3c4404183a5aafd47340dac63_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjItNS0xLTEtMzY1MTc_cee14714-80e9-4e31-a842-d6dbb62ad089">25,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326578d04941458389bc907b4ad873c0_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjItNy0xLTEtMzY1MTc_26458404-e308-48e0-bc00-afc2f8f454a5">28,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e200f708ff842429882977de66a40cb_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjMtMS0xLTEtMzY1MTc_3483d100-f59f-4452-bba8-de9954498cdb">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6450b3e52c24654b5a6cc4658015a1b_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjMtMy0xLTEtMzY1MTc_9bda2067-0031-476e-b3ef-53c8c28551d9">1,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5664bf6fe1c74422abdd683652227653_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjMtNS0xLTEtMzY1MTc_76c569bf-b530-4b62-9a50-f141ef6cb24f">4,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f174cab779147c29b714f2811393f87_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjMtNy0xLTEtMzY1MTc_e70a741e-e501-4924-9e1a-ea413ebe5d4e">5,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d25faa8b14c4291be6d757f80e48839_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjQtMS0xLTEtMzY1MTc_b1054874-e5b9-4b84-86e5-e4f507a2e0f3">797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i328dfba4c23f4457928a6cdb96fc8f77_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjQtMy0xLTEtMzY1MTc_16918aa0-7df4-4c99-b0f3-fea768d50e01">881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee902b6bcd8140a6bcd5753dea705623_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjQtNS0xLTEtMzY1MTc_25955dfe-e0b1-4ef3-9b9f-e181253385f6">2,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0380da3a0fc43dabab9b5d91973518b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjQtNy0xLTEtMzY1MTc_df015fab-f854-4b80-8427-55e7a46cff1e">3,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca94f66cae0472e950944808843bf52_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjUtMS0xLTEtMzY1MTc_2ccd9dd7-a1ff-435b-b3bf-0f28928a8c87">31,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c54aef4fc24df184a67d7a6e8a4686_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjUtMy0xLTEtMzY1MTc_9307e60a-5da6-4629-8b7d-a60612d48dae">37,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8bbc89738474e36a998144b3ab76005_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjUtNS0xLTEtMzY1MTc_32ae4280-7a54-431b-beb7-1c942242baab">101,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64ed51372db4414b6b3e91b38ec9b38_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjUtNy0xLTEtMzY1MTc_34d08d4e-e5a7-49af-916f-4c525945f1a6">112,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7763e9ad44b443bf8f1343ad714748ad_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjctMS0xLTEtMzY1MTc_3f667ccf-1040-44d2-b3c1-4dfd3bbb6253">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09258a1dafea4f46913ce7064e9df669_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjctMy0xLTEtMzY1MTc_3b353c0f-cce4-4fbe-8fb1-ca014c0b0b5f">1,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if881a438f54d41fdbca0d3ae23ae6f96_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjctNS0xLTEtMzY1MTc_d0c23d6d-a590-454c-95d4-93351bb52a86">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ceb2715c3147c3a1acd033f373b6f7_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjctNy0xLTEtMzY1MTc_8672bcef-ca4b-4512-ab0f-79e1e293b0f6">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5641230f75e947e3b420ea68cb7362a5_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjgtMS0xLTEtMzY1MTc_c06f5e9d-ccda-4444-9563-50c85cc1eb57">709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3e4239b05749efb73231210fcd5b18_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjgtMy0xLTEtMzY1MTc_5bab8022-9f5b-4a95-bb1c-d8f24e2a611a">806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff533dd32af4803adfde1b7642cb050_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjgtNS0xLTEtMzY1MTc_25ed87da-8a90-466b-8ab9-85a752f2db45">2,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b7264ca2e0467e95df7299dce5077d_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjgtNy0xLTEtMzY1MTc_a7019506-f4fa-4ca2-b3a9-008d42511d3c">2,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54595879e3a144e9984de9671b792908_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjktMS0xLTEtMzY1MTc_ff76d294-47b1-4c16-bc1e-2976a64a3267">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f54d1d04d5442bfbd655e919fea5146_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjktMy0xLTEtMzY1MTc_1d1f5834-ab12-4ba8-9cd6-0392c2951b6c">448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66719a00cb6a489eba77f2f4f2fad567_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjktNS0xLTEtMzY1MTc_3f17d745-9a66-4d19-9ab2-ea012ce7260b">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia834fba69cf84a55bcbbac80c88e2afe_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjktNy0xLTEtMzY1MTc_9d5070ae-ebdb-4f7e-aa98-bd3b477847c5">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1f33dd8d78416888f9868e6b210ee4_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzAtMS0xLTEtMzY1MTc_9c557331-94ba-466e-a45b-4a48dd1aa87e">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic071da5568ec49dba654382b69827d3a_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzAtMy0xLTEtMzY1MTc_b943eea7-a4ea-42b0-ba34-ed500b25c3a9">2,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia26db1a48ab045ff967ff61767510615_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzAtNS0xLTEtMzY1MTc_fa94dae8-7f10-4a78-a9a1-a8757e5eaf07">7,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40a63ab18aa54729a20e2ec4a9991db1_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzAtNy0xLTEtMzY1MTc_df870aff-1198-41c3-bf15-d0ac351fc3d7">8,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37724458b90a4f009836dd15510c28d2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzEtMS0xLTEtMzY1MTc_30ca2e7a-7fe7-4af8-8dd5-b8520f413809">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18896a1ab1614d4fbd39660918fa2ea5_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzEtMy0xLTEtMzY1MTc_2dadf52e-a1f7-4fe3-b174-b3d944bf8699">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fb728c64d94cd9a7821fd5b723bcbc_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzEtNS0xLTEtMzY1MTc_5ddb88cd-e4cf-4603-84f0-eb84f7802d7d">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3712db2c199b49b3b7c8d62c7dea3e2c_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzEtNy0xLTEtMzY1MTc_92503570-36b2-430e-bb37-7eba3e77351e">1,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5143d898f89c4757b88ba36166facb40_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzItMS0xLTEtMzY1MTc_e0b98662-5689-4d3d-ad3d-f22eb7df789c">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34568f0ea034fd888a5237c3a1cb09b_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzItMy0xLTEtMzY1MTc_ee387540-9288-409d-a237-a1f641b1365b">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a28ef0b4677478f8f5027325b718a83_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzItNS0xLTEtMzY1MTc_be01481b-2919-4e25-b6d5-57702f2a3e48">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b008c611ecb4419800960c8e592d0ad_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzItNy0xLTEtMzY1MTc_7cc671c0-e9f4-47e1-80da-cfbb6fb143f0">663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i989dadafa5b04aa6983e589a0e3400b1_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzMtMS0xLTEtMzY1MTc_8e3f8508-6b2b-4188-95a1-36e6997267ae">5,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66f83106d3c64004a59b18515c555b70_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzMtMy0xLTEtMzY1MTc_935ef977-71fd-47f0-84dc-430476dd6ca5">6,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icefc13a45af1427495b1821d0c2f7f72_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzMtNS0xLTEtMzY1MTc_66c1c196-842d-41f6-bd0c-149065362587">18,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d15fce936b4a1393ca7b8ca3173e02_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzMtNy0xLTEtMzY1MTc_bb4c5db7-2f12-4f0b-860e-b481d24cbb5e">20,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzQtMS0xLTEtMzY1MTc_5d107929-542f-432d-b69b-88b2ac0537d3">104,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzQtMy0xLTEtMzY1MTc_2a2ebc40-e418-4363-b60d-e994439e2898">114,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzQtNS0xLTEtMzY1MTc_d6517a73-ce39-4cd8-816f-3589ae201022">319,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzQtNy0xLTEtMzY1MTc_2b70f284-6fb5-491c-8f42-d0fc479a06be">326,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk4Mg_a73bc511-3ad4-4f18-8bfb-62dc899bac12" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba0114f77e84101866720c25f0493b7_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfMi0xLTEtMS0zNjUxNw_59250543-7409-422f-8859-05eb703f63a2">43,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b314b15d654ad785f11accf7d8aded_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfMi0zLTEtMS0zNjUxNw_40dfb142-4edc-4264-97db-6ca277f8bc3e">46,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a4aaaf217b48c082080afab03641e6_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfMy0xLTEtMS0zNjUxNw_9f297dbd-3171-4d8b-8420-3b90ce6d0bcb">3,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebd38c2c3754ea4936025826c0e61e8_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfMy0zLTEtMS0zNjUxNw_db603392-4d8c-45cf-a7af-677dfb8ebb68">4,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfNC0xLTEtMS0zNjUxNw_9e258ec0-206a-482e-a95b-f72afcda7837">47,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfNC0zLTEtMS0zNjUxNw_e48eda1c-5f57-4745-b7fc-7b3526bcf787">50,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="i259d35c9b39a480e9902ee2b6e317895"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk5Mw_5d4c2a2c-4b3d-48cc-8195-684df0959985" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5479a522979746c0beefbf88acbfc76c_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfMi0xLTEtMS0zNjUxNw_a4969297-7800-4fe1-8328-fadb484ec221">89,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d33f22f45f044fdb3c35e22eacd0d4d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfMi0zLTEtMS0zNjUxNw_4e8fbcf1-c5e2-4bcf-90d5-b07720f6e78f">104,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2efe54ca2e4f2dbc51a62ceca74009_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfMy0xLTEtMS0zNjUxNw_e1c8de7b-7fca-4037-ad14-04f6911a902b">16,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f9fe04c4724f8d8703c8915a244329_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfMy0zLTEtMS0zNjUxNw_48ece896-66fd-4aaa-873c-1c4a279f897b">15,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia728a540cb63450d8fe3503583cad26d_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNC0xLTEtMS0zNjUxNw_4665504c-8529-405a-b604-9eede6108842">110,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie641fbd2f6974546af07155f94734fbc_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNC0zLTEtMS0zNjUxNw_fc8201a2-017f-427e-8c42-ee41b6b87b37">131,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98381a37664e48548eeae68619c1ae03_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNS0xLTEtMS0zNjUxNw_73762045-6cbf-439d-b3ca-d5c2d67399de">6,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9c16e0b053f4d47b09be402979af494_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNS0zLTEtMS0zNjUxNw_4ca1a4f5-e525-485a-ac9c-5fa3662386b6">7,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNi0xLTEtMS0zNjUxNw_cdcd97a3-8838-4bb0-b9d4-6a46934fd5d5">223,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNi0zLTEtMS0zNjUxNw_fa0078c4-a304-40d8-be53-ec507de0b8f9">258,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMjEzMA_4255a8f1-cac1-4685-9518-20a915d498a6" continuedAt="i482b03dca83a4113a9db43abe017e129" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i482b03dca83a4113a9db43abe017e129"><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was <ix:nonFraction unitRef="number" contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMTQ0_2693437b-a716-4e64-b2bd-988a3d8b670c">92.7</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMTUx_9c97d899-4b4a-47a0-a9b7-d148f2c0535c">40.2</ix:nonFraction> percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. For the nine months ended September&#160;30, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was <ix:nonFraction unitRef="number" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMzQ3_f29d5720-640c-442f-8911-67d532888e3f">117.0</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMzU0_bf75c359-938b-459b-8b04-f1da9265f607">34.0</ix:nonFraction> percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three and nine months ended September&#160;30, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three and nine months ended September&#160;30, 2021, was primarily attributed to an increase in tax liability associated with transfer pricing adjustments, non-deductible executive compensation, and net unfavorable foreign tax related items, partially offset by favorable deductions for stock compensation.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate for the three and nine months ended September&#160;30, 2022 compared to September&#160;30, 2021 is primarily caused by recording a valuation allowance in the current period against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal income tax returns for 2018 through 2021 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2016 through 2021.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, we have accrued $<ix:nonFraction unitRef="usd" contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfODc5NjA5MzAyOTIzNg_11743d24-1f02-418e-9c38-1cfe7bf81521">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfODc5NjA5MzAyOTIzMg_557b309a-33f9-4757-a89e-ae81188e6e7e">0</ix:nonFraction>, respectively, related to unrecognized tax positions.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.</span></div></ix:continuation><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjY2OQ_298e2828-9323-41fc-97bc-a56797ee4ec4" continuedAt="i2e7a543facc6446db642944f47a0f3d5" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i2e7a543facc6446db642944f47a0f3d5" continuedAt="ieba9ceaefc7f4972a48a4b89c79f6255"><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;<ix:nonFraction unitRef="claim" contextRef="if876afffb2454b8f9813b911a0c89bd2_I20220930" decimals="INF" name="natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfODc2_24199a46-c3ca-4420-bc5c-04f5314b0d08">one</ix:nonFraction> or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="ieba9ceaefc7f4972a48a4b89c79f6255" continuedAt="i4068e46dc2b34b34b98381f39d26b7c1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Income Tax Contingencies</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are recorded for probable losses at management&#8217;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of September&#160;30, 2022 and December&#160;31, 2021, accrued liabilities were $<ix:nonFraction unitRef="usd" contextRef="i388c52769b8c403aae9816b6a35b9616_I20220930" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMTcyMw_23b45f82-6c35-446c-8586-abff695c8b04">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if0c2c500c91547a2b8ce14a47ea99029_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMTczMA_af07b6b4-c45e-4a53-b653-a94f1069b021">0.2</ix:nonFraction> million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $<ix:nonFraction unitRef="usd" contextRef="i2a40bfae9b044ad7af9bf711c7647199_I20220930" decimals="INF" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjAzNw_fc3d22fc-f820-4930-8e63-c593cf30ab7e">0</ix:nonFraction> to approximately $<ix:nonFraction unitRef="usd" contextRef="if95aa0b7acd74228b82c668e2ce7b986_I20220930" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjA1Nw_8521b5f6-699b-4bbc-aabe-495d9efa87de">2.7</ix:nonFraction> million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Litigation</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4068e46dc2b34b34b98381f39d26b7c1">We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of September&#160;30, 2022 and December&#160;31, 2021, accrued liabilities were $<ix:nonFraction unitRef="usd" contextRef="i9d6179a221754815aa24768673e73000_I20220930" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjIzNQ_e147094b-31ea-406b-8ece-5c64bdacbfa5">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i712f9d7d51b845a1b2668f6d2775c79d_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfNTQ5NzU1ODE2NjA2_bb85ede1-cee0-4f10-86f1-88e38d9aca31">0.5</ix:nonFraction> million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, <ix:nonFraction unitRef="usd" contextRef="i54a4cd2649ad43e1af381be20efb83db_D20220101-20220930" decimals="INF" name="us-gaap:LossContingencyLossInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjUzMQ_6c199524-680c-4452-9eba-74cac89f30c7">no</ix:nonFraction> provision for losses has been provided.&#160;We believe future payments related to these matters could range from $<ix:nonFraction unitRef="usd" contextRef="i5da800ec6cf0494cbcc64545e0f23b44_I20220930" decimals="INF" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjY0Mw_be9fad74-bbbe-4f85-a7be-97d81e6c759e">0</ix:nonFraction> to approximately $<ix:nonFraction unitRef="usd" contextRef="i3b0e83c4abf344a5b8794db175c95e39_I20220930" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjY2Mw_d3625709-d26b-43f8-82db-e49fff722e9d">0.3</ix:nonFraction> million.</ix:continuation> </span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfNjg4_9936ca16-8aee-4ed0-b873-747a7f11f70c" continuedAt="ia7b228f6b286422ca712907577b854cb" escape="true">Related Party Transactions</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia7b228f6b286422ca712907577b854cb">During the three and nine months ended September&#160;30, 2022 and 2021, our joint venture in China ("NSP China"), owned <ix:nonFraction unitRef="number" contextRef="ib64da197a61a4a098d6c97001abfa251_I20210930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTIx_faf07038-b6ef-498a-93ae-e55196cb5a24"><ix:nonFraction unitRef="number" contextRef="i5c616686bc27495f86f33cccfd0ba207_I20220930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTIx_ffaa953d-2a49-45ac-9a99-d006cfdec801">80</ix:nonFraction></ix:nonFraction> percent by us and <ix:nonFraction unitRef="number" contextRef="i2f558ae5860a4d0aaca0786b80ce2b37_I20220930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTM0_3f910e20-089f-4a7d-bcd9-a8983af06c26"><ix:nonFraction unitRef="number" contextRef="i5ebaa3f43bee42c18c5ed0c1bf61f4b4_I20210930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTM0_e353edfd-bd2f-451a-96b4-970dd9d47443">20</ix:nonFraction></ix:nonFraction> percent by a wholly owned subsidiary of Fosun Pharma, did <ix:nonFraction unitRef="usd" contextRef="i6ee5eda554ad4659907fd5cb08273632_D20210101-20210930" decimals="INF" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTg3_07707738-f11d-49f1-9911-65fab1ba62f9"><ix:nonFraction unitRef="usd" contextRef="ia764c839880b4c7e9899c96c4ea22bfb_D20210701-20210930" decimals="INF" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTg3_8e18fbe5-1449-4735-bce5-8aef92d80aa3"><ix:nonFraction unitRef="usd" contextRef="ief5236b078ac4a6daebf4680b5be165b_D20220101-20220930" decimals="INF" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTg3_f4e604c8-ec9f-4d1e-af1b-c96907a74efe"><ix:nonFraction unitRef="usd" contextRef="i455120a077da4df088d0bd54ec5106fa_D20220701-20220930" decimals="INF" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTg3_fce438ed-4f3c-4db4-ac0d-cb9700fb2449">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t borrow any amounts from the Company or our joint venture partner. As of September&#160;30, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from the Company were $<ix:nonFraction unitRef="usd" contextRef="i3e093e27ec0a4b8ba600829b8e48847e_I20220930" decimals="-5" name="us-gaap:NotesReceivableRelatedPartiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMzMx_a19f9977-b8fb-423d-b53e-91a122c5ae84">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iad3dfe96a539486182ac2875e73b964a_I20211231" decimals="-5" name="us-gaap:NotesReceivableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMzM4_b5fa9041-792d-4803-b264-372372fa1cf5">1.2</ix:nonFraction> million, respectively. As of September&#160;30, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from our joint venture partner were $<ix:nonFraction unitRef="usd" contextRef="i0b4a4f5139a945ab966207cbdb52726a_I20220930" decimals="-5" name="us-gaap:NotesReceivableRelatedPartiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfNDQ0_60c0ad15-23b0-4e3a-ba0c-244b874661ba">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idd095404eb1749d5b8208d23f0b59607_I20211231" decimals="-5" name="us-gaap:NotesReceivableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfNDUx_2f102159-0bd0-4b3d-b277-af6739515f74">0.3</ix:nonFraction> million, respectively. These notes were payable in less than one year and bore interest of <ix:nonFraction unitRef="number" contextRef="i4a632e9166b44345976a990799025881_D20220101-20220930" decimals="INF" name="us-gaap:RelatedPartyTransactionRate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfNTM3_7d3050ed-f88c-43db-b4e7-56e2ff622453">3.0</ix:nonFraction> percent. The notes between NSP China and the Company are eliminated in consolidation. In March 2022, the outstanding principal and interest amounts were repaid.</ix:continuation> </span></div><div><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RleHRyZWdpb246MzliZjQ1NzNmZWFhNGYxMjhkNjNmYWVjMDQ5ZjUwZTlfMjE2Mw_c3da3a42-5daa-4055-861d-f9e6d9c0b117" continuedAt="i56dd103e5e474946b05e05f4eb12042e" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i56dd103e5e474946b05e05f4eb12042e" continuedAt="icde70d575b5e4a87a97a3644631c9030"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RleHRyZWdpb246MzliZjQ1NzNmZWFhNGYxMjhkNjNmYWVjMDQ5ZjUwZTlfMjE3MQ_bad4a0a3-0b74-4c49-9382-e6fdea89e5ab" continuedAt="i3ed0caf859a849259969a53743881f87" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of September&#160;30, 2022 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4162cfa26b14df99488a4f76a09b41f_I20220930" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMi0xLTEtMS0zNjUxNw_48d71150-a1b2-4351-a383-e0c04567ff39">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f3880d0019417fb3e190f74f5f8a25_I20220930" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMi0zLTEtMS0zNjUxNw_efe901bc-d557-4555-8c7d-18af3bb9087e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id147596397c04e229b6d434f653bc101_I20220930" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMi01LTEtMS0zNjUxNw_03f99c8b-fe4d-4251-b5a3-6bb1564d375e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e406e3dd789497cb667823793e51f2d_I20220930" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMi03LTEtMS0zNjUxNw_fc0f7820-1057-4759-8cb0-0ed1431ce96b">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4162cfa26b14df99488a4f76a09b41f_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMy0xLTEtMS0zNjUxNw_c10865d2-8e9f-4fb4-890b-5fc566f3294c">692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f3880d0019417fb3e190f74f5f8a25_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMy0zLTEtMS0zNjUxNw_3dbfb948-e7e6-409c-8970-19da05b031a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id147596397c04e229b6d434f653bc101_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMy01LTEtMS0zNjUxNw_c8345a60-bde7-47b3-92d6-cb5474cd1414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e406e3dd789497cb667823793e51f2d_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMy03LTEtMS0zNjUxNw_65317a70-7e4d-4747-ac0e-2eee3a9ee687">692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="icde70d575b5e4a87a97a3644631c9030"><ix:continuation id="i3ed0caf859a849259969a53743881f87"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b5f131172d44dbab10213532398fcf_I20211231" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNC0xLTEtMS0zNjUxNw_9fbf8831-43e1-4ed7-a4f1-057c403c2982">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id750b81e065841b08fc01573faa37105_I20211231" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNC0zLTEtMS0zNjUxNw_bb3aa427-1d07-4d74-9071-53e52e0648e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4b170f280e46a2b3047bb6edd5bf27_I20211231" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNC01LTEtMS0zNjUxNw_2f2b30a5-43d3-4eb0-bb96-b66f686d28de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id976048dc79248cdb7a4f9d5569849ac_I20211231" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNC03LTEtMS0zNjUxNw_7f4bcaf2-70b1-413c-a50b-1dfdaba59ab4">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b5f131172d44dbab10213532398fcf_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNS0xLTEtMS0zNjUxNw_ed6444b6-af40-4191-9a0c-1463932da167">964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id750b81e065841b08fc01573faa37105_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNS0zLTEtMS0zNjUxNw_0d710ba2-0e60-49c6-8a37-fd2789f83652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4b170f280e46a2b3047bb6edd5bf27_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNS01LTEtMS0zNjUxNw_c9a9085a-2e01-4611-b954-4a3e6d8bf9b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id976048dc79248cdb7a4f9d5569849ac_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNS03LTEtMS0zNjUxNw_7524a1fd-550b-42af-bcf6-756d0a1f17b6">964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment securities - trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022 and for the year ended December&#160;31, 2021, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the nine months ended September&#160;30, 2022 and 2021, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfNDA1MQ_926318ba-8085-44ac-96ca-345a3a187a3e" continuedAt="i78b8937f0238484ea28ff901b74be7c0" escape="true">Revenue Recognition</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i78b8937f0238484ea28ff901b74be7c0" continuedAt="i6bbf477478284fb2a9832c20b52553ca"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Sales taxes and value-added taxes in the United States and foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Amounts received for unshipped merchandise are recorded as deferred revenue. Amounts for membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within <ix:nonNumeric contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" name="natr:RevenuefromContractwithCustomerRefundPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfMTQxMg_7c4f445a-04cf-4a87-9137-8335c699f70b">ninety days</ix:nonNumeric> of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our U.S. operations extend short-term credit associated with product promotions. In addition, for certain of our international operations, we offer credit terms consistent with industry standards within the country of operation. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are grouped into <ix:nonFraction unitRef="product_category" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="INF" name="natr:NumberofPrincipalCategoriesofProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfMzEwMw_b236daf1-5f5f-4966-b36e-0349e0c450a7">six</ix:nonFraction> principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have <ix:nonFraction unitRef="segment" contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfMzIyNA_14f19675-a26c-4b22-b0fe-330b1d8efff2">four</ix:nonFraction> business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy WorldWide&#174; brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><ix:continuation id="i6bbf477478284fb2a9832c20b52553ca"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expense volume incentives when incurred because the amortization period would have been one year or less.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our contracts with customers have a duration of less than <ix:nonNumeric contextRef="i12e083e1f3414241b1bb88a79fea2b88_D20220101-20220930" name="natr:ContractWithCustomerContractTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfMzk3Nw_b1731306-aa85-48b9-a8ee-1b329e2abce2">one year</ix:nonNumeric>. The value of any unsatisfied performance obligations is insignificant.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included in this report, as well as the consolidated financial statements, the notes thereto, and management&#8217;s discussion and analysis included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021, and our other reports filed since the date of such Form&#160;10-K.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who resell our products to consumers.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent consultants market and sell our products to customers and sponsor other independent consultants who also market our products to customers. Because a significant amount of revenue is generated through the sales of our independent consultants, our revenue can be impacted by the number and productivity of our independent consultants. We seek to motivate and provide incentives to our independent consultants by offering high quality products, product support, training seminars, and financial incentives, among other considerations.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">COVID-19</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In or about December 2019, a novel strain of coronavirus, SARS-CoV-2 &#8220;COVID-19&#8221;, began aggressively spreading throughout the world, including all the primary markets where we conduct business. As COVID-19 has spread throughout the world, it has impacted our markets differently. At various times during the course of the pandemic and throughout our markets, governments have issued orders and restrictions that have limited the ability of our consultants to meet with consumers, put downward pressure on our sales in many of our markets and added substantial uncertainties to our global supply chain. Different variants of COVID-19 continue to arise and spread in various places around the world. We continue to take actions to mitigate the effects COVID-19 may have on our business, such actions may ultimately be insufficient to avoid substantial impact on the consolidated financial statement or material health of the Company. At this time, the duration of any business disruption and related financial impact cannot be reasonably estimated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eastern Europe</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2022, Russian forces launched significant military action against Ukraine. There continues to be sustained conflict and disruption in the region, which is expected to endure for the foreseeable future. Our consultants in our Russia and Other market, a market within our Europe business segment that includes </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Russia, Ukraine, Belarus and other Common Independent States in the region</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, continue to operate their independent businesses, albeit at a reduced level than prior to the start of the conflict. For the nine months ended September&#160;30, 2022, we have recorded a pretax charge of $2.3 million, primarily related to the impairment of inventory, as well as accruals for contractual obligations related to Russian operations. We expect that this will continue to impact our business for the foreseeable future. We will continue monitoring the social, political, regulatory and economic environment in Ukraine and Russia, and will consider further actions as appropriate.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Russia and Other for the three and nine months ended September&#160;30, 2022, were $13.3 million and $38.9 million, respectively, compared to $14.6 million and $42.9 million for the same periods in 2021. Operating income related to Russia and Other for the three and nine months ended September&#160;30, 2022, was $1.0 million and $3.2 million, respectively, prior to the charges noted above, compared to $1.4 million and $4.1 million for the same periods in 2021. As of September&#160;30, 2022, Russia and Other had assets of $5.9 million, net of working capital reserves, which primarily consisted of inventories and accounts receivable. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More broadly, there could be additional negative impacts to our net sales, earnings and cash flows should the situation escalate beyond its current scope, including, among other potential impacts, economic recessions in certain neighboring countries or globally due to inflationary pressures and supply chain cost increases or the geographic proximity of the war relative to the rest of Europe. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inflation</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the inflation rate in the U.S. began to increase significantly. In 2022, the inflation rate increase accelerated and during the nine months ended September&#160;30, 2022, was the highest in 40 years. Europe and other areas in which we do business are also experiencing higher levels of inflation. Our operations have been, and may continue to be, adversely impacted by inflation, primarily from higher costs of raw materials, labor, production, distribution and transportation costs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, we experienced a decrease in our consolidated net sales of 8.9 percent (or 2.3 percent in local currencies) compared to the same period in 2021. Asia net sales decreased approximately 1.1 percent (or increased 11.9 percent in local currencies) compared to the same period in 2021. Europe net sales decreased approximately 11.4 percent (or 6.0 percent in local currencies) compared to the same period in 2021. North America net sales decreased approximately 16.5 percent (or 16.3 percent in local currencies) compared to the same period in 2021. Latin America and Other net sales decreased approximately 14.5 percent (or 13.3 percent in local currencies) compared to the same period in 2021. The strengthening of the U.S. dollar versus the local currencies, primarily in our Asian and European markets, resulted in an approximate 6.6 percent, or $7.6 million, decrease of our net sales during the quarter.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased $0.2 million during the three months ended September&#160;30, 2022, compared to the same period in 2021, and as a percentage of net sales were 28.4 percent and 25.6 percent for the three months ended September&#160;30, 2022 and 2021, respectively. The increase in cost of sales percentage is primarily due to changes in inventory valuation reserves, changes in market mix, heightened inflation, and increases in raw materials, production and transportation costs. For the nine months ended September&#160;30, 2022, we had incremental valuation charges of $5.0 million related to inventory. Of that amount, $1.7 million related to the conflict between Russia and Ukraine, and $3.3 million related to changes in forecasted demand and production issues, among other factors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In absolute terms, selling, general and administrative expenses decreased $2.7 million during the three months ended September&#160;30, 2022, compared to the same period in 2021, and as a percentage of net sales were 35.2 percent and 34.4 percent for the three months ended September&#160;30, 2022 and 2021, respectively. The dollar decrease was primarily related to lower service fees that resulted from a decline in China's net sales, lower expenses relating to declines in Russia and Other's net sales, and lower compensation, partially offset by increases in the expected level of convention and distributor events.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an international business, we have significant sales and costs denominated in currencies other than the U.S. Dollar. We expect foreign markets with functional currencies other than the U.S. Dollar will continue to represent a substantial portion of our overall sales and related operating expenses. Accordingly, changes in foreign currency exchange rates could materially affect sales and costs or the comparability of sales and costs from period to period as a result of translating foreign markets financial statements into our reporting currency.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our unaudited consolidated operating results from continuing operations in U.S. dollars and as a percentage of net sales for the three months ended September&#160;30, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of<br/>net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of<br/>net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,240)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,453)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,736)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,994)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income&#160;taxes</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,389)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,458&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,258)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our unaudited consolidated operating results from continuing operations in U.S. dollars and as a percentage of net sales for the nine months ended September&#160;30, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of<br/>net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of<br/>net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,984)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,686)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,076&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,051)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,037)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income&#160;taxes</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,039&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,837&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,798)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,404&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,938)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International operations have provided, and are expected to continue to provide, a significant portion of our total net sales. As a result, total net sales will continue to be affected by fluctuations in the U.S. dollar against foreign currencies. In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, in addition to comparing the percent change in net sales from one period to another in U.S. dollars, we present net sales excluding the impact of foreign exchange fluctuations. We compare the percentage change in net sales from one period to another period by excluding the effects of foreign currency exchange as shown below. Net sales excluding the impact of foreign exchange fluctuations is not a U.S. GAAP financial measure and removes from net sales in U.S. dollars the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries, by translating the current period net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period. We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. However, net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP. Throughout the last five years, foreign currency exchange rates have fluctuated significantly. See Item 3.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in net sales by operating segment with a reconciliation to net sales excluding the impact of currency fluctuations for the three months ended September&#160;30, 2022 and 2021 (dollar amounts in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Sales&#160;by&#160;Operating&#160;Segment</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact&#160;of<br/>Currency<br/>Exchange</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent<br/>Change<br/>Excluding<br/>Impact&#160;of<br/>Currency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,506&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,643)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in net sales by operating segment with a reconciliation to net sales excluding the impact of currency fluctuations for the nine months ended September&#160;30, 2022 and 2021 (dollar amounts in thousands):&#160;</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:38.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Sales&#160;by&#160;Operating&#160;Segment</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact&#160;of<br/>Currency<br/>Exchange</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent<br/>Change<br/>Excluding<br/>Impact&#160;of<br/>Currency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,515)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,607)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,145&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,482)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net sales for the three and nine months ended September&#160;30, 2022, were $104.5 million and $319.2 million, respectively, compared to $114.7 million and $326.1 million for the same period in 2021, which represents decreases of 8.9 percent and 2.1 percent, respectively. The decrease was primarily related to product sales declines in our Europe, North America, and Latin America and Other operating segments. Excluding the impact of foreign currency exchange rate fluctuations, consolidated net sales for the three and nine months ended September&#160;30, 2022, decreased 2.3 percent and increased 2.6 percent, respectively, from the same periods in 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Asia</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Asia for the three and nine months ended September&#160;30, 2022, were $47.9 million and $141.4 million, respectively, compared to $48.4 million and $127.7 million for the same periods in 2021, or decrease of 1.1 percent and increase of 10.7 percent, respectively. In local currency, net sales for the three and nine months ended September&#160;30, 2022, increased 11.9 percent and 20.5 percent, respectively, compared to the same periods in 2021. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notable activity in the following markets contributed to the results of Asia:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our South Korea market, net sales decreased $1.0 million and $5.3 million, or 6.4 percent and 10.9 percent, for the three and nine months ended September&#160;30, 2022, respectively, compared to the same periods in 2021. In local currency, net sales for the three and nine months ended September&#160;30, 2022, increased 7.7 percent and decreased 0.3 percent, respectively, compared to the same periods in 2021. The increase in local currency for the three months ended September&#160;30, 2022, was primarily the result of product promotions intended to stimulate activity as well as an increase in demand for nutritional supplements. The decrease in local currency for the nine months ended September&#160;30, 2022, was primarily the result of government restrictions in the market intended to slow the spread of COVID-19, which were not lifted until the second quarter.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our Taiwan market, net sales increased $6.1 million and $20.3 million, or 82.9 percent and 136.5 percent, for the three and nine months ended September&#160;30, 2022, compared to the same periods in 2021. In local currencies, net sales for the three </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and nine months ended September&#160;30, 2022, increased 97.4 percent and 147.1 percent, compared to the same periods in 2021. We attribute the growth in net sales primarily to product promotions intended to stimulate activity as well as an increase in demand for nutritional supplements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our Japan market, net sales decreased $0.2 million and increased $3.0 million, or decreased 1.8 percent and increased 11.1 percent, for the three and nine months ended September&#160;30, 2022, respectively, compared to the same periods in 2021. In local currencies, net sales for the three and nine months ended September&#160;30, 2022, increased 22.0 percent and 30.3 percent, respectively, compared to the same periods in 2021. We attribute the growth in net sales primarily to product promotions intended to stimulate activity as well as an increase in demand for nutritional supplements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our China market, net sales decreased $4.3 million and $1.2 million, or 34.5 percent and 3.8 percent, for the three and nine months ended September&#160;30, 2022, respectively, compared to the same periods in 2021. In local currencies, net sales for the three and nine months ended September&#160;30, 2022, decreased 30.8 percent and 2.2 percent, respectively, compared to the same periods in 2021. The decrease in net sales was primarily the result of additional government restrictions in the market intended to slow the spread of COVID-19, which included lockdowns during the third quarter.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Europe</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Europe for the three and nine months ended September&#160;30, 2022, were $19.3 million and $58.2 million, respectively, compared to $21.8 million and $65.5 million for the same periods in 2021, or decreases of 11.4 percent and 11.1 percent, respectively. In local currency, net sales for the three and nine months ended September&#160;30, 2022, decreased 6.0 percent and 7.1 percent, respectively, compared to the same periods in 2021. The functional currency for many of these markets is the U.S. Dollar which reduces the effect from foreign currency fluctuations. Fluctuations in foreign exchange rates had unfavorable impacts on net sales of $1.2 million and $2.6 million for the three and nine months ended September&#160;30, 2022, respectively. Net sales decreased primarily as a result of conflict between Russia and Ukraine which has placed significant financial pressures on the surrounding Western and Eastern Europe markets, and customer sensitivity due to inflationary pressures, among other factors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">North America</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to North America for the three and nine months ended September&#160;30, 2022, were $31.5 million and $101.6 million, respectively, compared to $37.7 million and $112.9 million for the same periods in 2021, or decreases of 16.5 percent and 10.0 percent, respectively. In local currency, net sales for the three and nine months ended September&#160;30, 2022, decreased 16.3 percent and 9.8 percent, respectively, compared to the same periods in 2021. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, net sales decreased $5.9 million and $10.5 million, or 16.8 percent and 10.0 percent, for the three and nine months ended September&#160;30, 2022, respectively, compared to the same periods in 2021. The decrease in sales was due primarily to a reduction in the average order size attributed to customer sensitivity due to inflationary pressures, among other factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Latin America and Other</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Latin America and Other markets for the three and nine months ended September&#160;30, 2022, were $5.8 million and $18.0 million, respectively, compared to $6.8 million and $20.1 million for the same periods in 2021, or decreases of 14.5 percent and 10.3 percent, respectively. In local currency, net sales for the three and nine months ended September&#160;30, 2022, decreased 13.3 percent and 9.5 percent, respectively, compared to the same periods in 2021. Fluctuations in foreign currency had unfavorable impacts on net sales of $0.1 million and $0.2 million for the three and nine months ended September&#160;30, 2022, respectively. The decrease in sales was due primarily to a reduction in the average order size attributed to customer sensitivity due to inflationary pressures, among other factors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further information related to our Asia, Europe, North America, and Latin America and Other business segments is set forth in Note 7 to the Unaudited Condensed Consolidated Financial Statements in Part&#160;1,&#160;Item 1 of this report.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales as a percent of net sales was 28.4 percent and 29.3 percent for the three and nine months ended September&#160;30, 2022, compared to 25.6 percent and 26.0 percent for the same periods in 2021. The increase in cost of sales percentage is primarily due to changes in inventory valuation reserves as a result of the conflict between Russia and Ukraine, as well as reserves for other markets, changes in market mix, persistent inflation, unfavorable exchange rates, and increases in raw materials, production and transportation costs. For the nine months ended September&#160;30, 2022, we had incremental valuation charges of $5.0 million related to inventory. Of that amount, $1.7 million related to the conflict between Russia and Ukraine, and $3.3 million related to changes in forecast demand and production issues, among other factors.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Volume Incentives</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives expense as a percent of net sales was 31.6 percent and 31.1 percent for the three and nine months ended September&#160;30, 2022, respectively, compared to 31.2 percent and 32.3 percent for the same periods in 2021. These payments are designed to provide incentives for reaching certain sales levels. Volume incentives vary slightly, on a percentage basis, by product due to pricing policies and commission plans in place in our various operations. We do not pay volume incentives in China, instead we pay independent service fees which are included in selling, general and administrative expenses. Volume incentives as a percentage of net sales can fluctuate based on promotional activity and mix of sales by market. The increase in volume incentives as a percent of net sales for the three months ended September&#160;30, 2022 is primarily due to change in market mix, reflecting growth in markets where volume incentives as a percentage of net sales are higher than the consolidated average, and the decline in China. The decrease for the nine months ended September&#160;30, 2022 reflects cost savings from the September 2020 launch of our new consultant sales and compensation plan in North America and Latin America and Other.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses represent operating expenses, components of which include labor and benefits, sales events, professional fees, travel and entertainment, marketing, occupancy costs, communications costs, bank fees, depreciation and amortization, independent services fees paid in China, and other miscellaneous operating expenses.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses decreased by $2.7 million and $5.6 million, respectively, to $36.8 million and $114.3 million for the three and nine months ended September&#160;30, 2022, respectively, compared to the same periods in 2021. Selling, general and administrative expenses were 35.2 percent and 35.8 percent of net sales for the three and nine months ended September&#160;30, 2022, compared to 34.4 percent and 33.3 percent for the same periods in 2021. The dollar decrease was primarily related to lower service fees that resulted from a decline in China's net sales, lower expenses relating to declines in Russia and Other's net sales, and lower compensation expense, partially offset by increases in consultant events, promotions and marketing.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Loss, Net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other loss, net, for the three and nine months ended September&#160;30, 2022, were losses of $2.3 million and $3.0 million, respectively, compared to $0.9 million and $2.3 million during the same periods in 2021, respectively. Other loss, net for the three and nine months ended September&#160;30, 2022 primarily consisted of foreign exchange losses as a result of net changes in foreign currencies primarily in Asia, Europe and Latin America.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 92.7 percent and 40.2 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. For the nine months ended September&#160;30, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 117.0 percent and 34.0 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three and nine months ended September&#160;30, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three and nine months ended September&#160;30, 2021, was primarily attributed to an increase in tax liability associated with transfer pricing adjustments, non-</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deductible executive compensation, and net unfavorable foreign tax related items, partially offset by favorable deductions for stock compensation.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate for the three and nine months ended September&#160;30, 2022 compared to September&#160;30, 2021 is primarily caused by recording a valuation allowance in the current period against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal income tax returns for 2018 through 2021 are open to examination for federal tax purposes. We have several foreign tax jurisdictions that have open tax years from 2016 through 2021.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, we have accrued $0.2&#160;million and $0, respectively, related to unrecognized tax positions. </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Categories</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our line of over 700 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. We purchase herbs and other raw materials in bulk and, after quality control testing, we formulate, encapsulate, tablet or concentrate them, label and package them for shipment. Most of our products are manufactured at our facility in Spanish Fork, Utah. Contract manufacturers produce some of our products in accordance with our specifications and standards. We have implemented quality control procedures to verify that our contract manufacturers have complied with our specifications and standards.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 7, Segment Information, for a summary of the U.S. dollar amounts from the sale of general health, immune, cardiovascular, digestive, personal care and weight management products for the three and nine months ended September&#160;30, 2022 and 2021, by business segment.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution and Marketing</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our products primarily through our network of independent consultants, who market our products to customers through direct selling techniques and sponsor other independent consultants who also market our products to customers. We seek to motivate and provide incentives to our independent consultants by offering high quality products and providing independent consultants with product support, training seminars, sales conventions, travel programs and financial incentives.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products sold in the United States are shipped directly from our manufacturing and warehouse facilities located in Spanish Fork, Utah, as well as from our regional warehouses located in Georgia, Ohio and Texas. Many of our international operations maintain warehouse facilities and inventory to supply their independent consultants. However, in foreign markets where we do not maintain warehouse facilities, we have contracted with third-parties to distribute our products and provide support services to our force of independent consultants.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, we generally sell our products on a cash or credit card basis. From time to time, our U.S. operations extend short-term credit associated with product promotions. For certain of our international operations, we use independent distribution centers and offer credit terms that are generally consistent with industry standards within each respective country.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pay sales commissions, or &#8220;volume incentives&#8221; to our independent consultants based upon their own product sales and the product sales of their sales organization. As an exception, in China, we do not pay volume incentives; rather, we pay independent service fees, which are included in selling, general and administrative expenses. These volume incentives are recorded as an expense in the year earned. The amounts of volume incentives that we expensed during the quarters ended September&#160;30, 2022 and 2021, are set forth in the Condensed Consolidated Financial Statements in Item 1 of this report. In addition to the opportunity to receive volume incentives, independent consultants who attain certain levels of monthly product sales are eligible for additional incentive programs including automobile allowances, sales convention privileges and travel awards.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal use of cash is to pay for operating expenses, including volume incentives, inventory and raw material purchases, capital assets and funding of international expansion. As of September&#160;30, 2022, working capital was $78.9 million, compared to $88.0 million as of December&#160;31, 2021. At September&#160;30, 2022, we had $57.0 million in cash, of which $2.9 million was held in the U.S. and $54.1 million was held in foreign markets and may be subject to various withholding taxes and other restrictions related to repatriation before becoming available to be used along with the normal cash flows from operations to fund any unanticipated shortfalls in future cash flows.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net consolidated cash inflows (outflows) are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,866)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022, operating activities used cash of $2.9 million, compared to providing cash of $20.3 million in the same period in 2021. Operating cash flows decreased primarily due to lower gross margins and the timing of payments for accrued liabilities, accrued volume incentives and service fees, accounts payable, deferred revenue, and receipts of accounts receivable. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022, investing activities used $4.7 million, compared to $4.6 million for the same period in 2021, which consisted of capital expenditures related to the purchase of equipment, computer systems and software. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022, financing activities used $15.3 million, compared to $29.5 million in cash for the same period in 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we used cash to repurchase 834,000 shares of our common stock under the share repurchase program for $12.9 million. At September&#160;30, 2022, the remaining balance available for repurchases under the program was $24.6&#160;million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a revolving credit agreement with Bank of America, N.A (the &#8220;Credit Agreement&#8221;), as well as a credit agreement with Banc of America Leasing and Capital, LLC (the "Capital Credit Agreement"). At September&#160;30, 2022, there was no outstanding balance under the Credit Agreement. During the nine months ended September&#160;30, 2022 we made monthly payments of $0.1&#160;million pursuant to the Capital Credit Agreement. As of September&#160;30, 2022, there was $1.5&#160;million outstanding balance under the Capital Credit Agreement, $1.3&#160;million of which was classified as current. Our debt obligations are discussed in greater detail in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Credit Facility and Other Obligations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Consolidated Financial Statements in Item 1, Part 1 of this report.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that cash generated from operations, along with available cash and cash equivalents, will be sufficient to fund our normal operating needs, including capital expenditures, on both a short- and long-term basis.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other things such as a prolonged economic downturn, a decrease in demand for our products, an unfavorable settlement of our unrecognized tax positions or non-income tax contingencies could adversely affect our long-term liquidity.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with U.S. GAAP and form the basis for the following discussion and analysis on critical accounting policies and estimates. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related disclosure of contingent assets and liabilities. On a regular basis, we evaluate our estimates and assumptions. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations. We have discussed the development, selection and disclosure of these estimates with the Board of Directors and our Audit Committee.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our significant accounting policies is provided in Note 1 of the Notes to Consolidated Financial Statements in Item 8 of the Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. We believe the critical accounting policies and estimates described below reflect our more significant estimates and assumptions used in the preparation of the consolidated financial statements. The impact and any associated risks on our business that are related to these policies are also discussed throughout this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; where such policies affect reported and expected financial results.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue recognition practices are discussed in Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue Recognition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Consolidated Financial Statements in Item 1, Part 1 of this report.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are adjusted to lower of cost and net realizable value, using the first-in, first-out method. The components of inventory cost include raw materials, labor and overhead. To estimate any necessary adjustments, various assumptions are made in regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning and market conditions. If future demand and market conditions are less favorable than our assumptions, additional inventory adjustments could be required.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Trip Accrual</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for expenses associated with our direct sales program, which rewards independent consultants with paid attendance for incentive trips, including our conventions and meetings. Expenses associated with incentive trips are accrued over qualification periods as they are earned. We specifically analyze incentive trip accruals based on historical and current sales trends as well as contractual obligations when evaluating the adequacy of the incentive trip accrual. Actual results could generate liabilities more or less than the amounts recorded.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in certain legal proceedings and disputes. When a loss is considered probable in connection with litigation or non-income tax contingencies and when such loss can be reasonably estimated with a range, we record our best estimate within the range related to the contingency. If there is no best estimate, we record the minimum of the range. As additional information becomes available, we assess the potential liability related to the contingency and revise the estimates. Revision in estimates of the potential liabilities could materially affect our results of operations in the period of adjustment. Our contingencies are discussed in further detail in Note 10, &#8220;Commitments and Contingencies&#8221;, to the Notes of our Condensed Consolidated Financial Statements, of Item 1, Part&#160;1 of this report.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes, deferred tax assets and liabilities and contingent reserves reflect management&#8217;s best assessment of estimated future taxes to be paid. We are subject to income taxes in both the United States and numerous foreign jurisdictions. Significant judgments and estimates are required in determining our consolidated provision for income taxes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense. In evaluating our ability to recover our deferred tax assets, management considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, we develop assumptions including the amount of future state, federal and foreign pretax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment about the forecasts of future taxable income, and are consistent with the plans and estimates that we are using to manage the underlying businesses. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are recorded as reserves against net deferred tax assets by us when it is determined that net deferred tax assets are not likely to be realized in the foreseeable future.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Management is not aware of any such changes that would have a material effect on our results of operations, cash flows or financial position.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized.</span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several countries and intend to grow our international operations. Net sales, operating income and net income are affected by fluctuations in currency exchange rates, interest rates and other uncertainties inherent in doing business and selling product in more than one currency. In addition, our operations are exposed to risks associated with changes in social, political and economic conditions inherent in international operations, including changes in the laws and policies that govern international investment in countries where we have operations, as well as, to a lesser extent, changes in U.S. laws and regulations relating to international trade and investment. For further information, see Part II, Item 7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disclosure controls and procedures (as defined in Rule&#160;13a-15(e)&#160;under the Exchange Act) are designed to provide reasonable assurance that the information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules&#160;and forms adopted by the SEC, and that such information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosures. Our management, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September&#160;30, 2022. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September&#160;30, 2022, at the reasonable assurance level.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal controls over financial reporting (as defined in Rule&#160;13a-15(f)&#160;under the Exchange Act) during the quarter ended September&#160;30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II OTHER INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the information set forth in this report, you should carefully consider the risks discussed under the heading &#8220;Risk Factors&#8221; in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021, which could have a material adverse effect on our business or consolidated financial statements, results of operations, and cash flows. Additional risks not currently known, or risks that are currently believed to be not material, may also impair business operations.&#160;There have been no material changes to our risk factors since the filing of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021, except as set forth below.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geopolitical issues, conflicts and other global events could adversely affect our results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because a substantial portion of our business is conducted outside of the United States, our business is subject to global political issues and conflicts. Such political issues and conflicts could have a material adverse effect on our results of operations and financial condition if they escalate in areas in which we do business. In addition, changes in and adverse actions by governments in foreign markets in which we do business could have a material adverse effect on our results of operations and financial condition. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Russia&#8217;s invasion of Ukraine and the continuing war between Russia and Ukraine has negatively impacted our operations in both countries and the region. In fiscal 2021, operations in our Russia and Other market, a market within our Europe business segment that includes Russia, Ukraine, Belarus and other Common Independent States in the region, accounted for 13.8% of net sales. We are unable to estimate future impacts to our business due to the high level of uncertainty as to how the war will evolve, its duration, and its ultimate resolution. Within Ukraine, there is a possibility of loss of life, physical damage and destruction of property, and loss of earning opportunities for many of our independent distributors and dealers. We may not be able to operate in many areas due to damage and safety concerns. Within Russia, we may need to further reduce our operations due to sanctions and counter sanctions, currency or payment controls, and supply chain challenges. Certain suppliers, vendors, independent distributors and customers are all impacted by the war and their ability to successfully maintain their operations could also impact our results of operations or product sales throughout the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing coronavirus pandemic and the responses thereto around the world could adversely impact our business and operating results.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the COVID-19 pandemic, governments around the world have issued orders restricting travel, the number of people who may gather, or for their citizens to shelter-in-place to slow the spread of COVID-19. Such orders, restrictions and recommendations have resulted in widespread closures of businesses not deemed &#8220;essential,&#8221; work stoppages, limitations on the number of people allowed to gather in one location, slowdowns and delays in world-wide supply chains, work-from-home policies, travel restrictions and cancellation of events, among other effects. In particular, travel and logistics restrictions, shelter-in-place orders and other measures, including working remotely, social distancing and other policies implemented in foreign and domestic sites to protect the health and safety of employees, have resulted in, and are expected to continue to result in, transportation disruptions (such as reduced availability of air transport, port closures, and increased border controls or closures), production delays and capacity limitations at our facilities and some of our customers and suppliers, as well as reduced workforce availability or productivity. These and other adverse impacts on our supply chain could limit our ability to obtain required materials in a timely manner, maintain adequate inventory levels, and respond to changes in customer demand, which could adversely affect our business and result of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The duration and extent of COVID-19&#8217;s impact on our business are difficult to assess or predict. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conditions vary significantly by geography, and the continued rise of COVID-19 variants and associated spread have resulted in additional disruptions, government lockdowns, and other restrictive measures. Stay-at-home and quarantine mandates have disrupted or halted our operations in certain parts of China and may continue to impact our business in the near term. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further quarantines, government reactions or shutdowns could disrupt or halt our operations and materially harm our business, financial condition and results of operations. Our manufacturing personnel and other employees could also be affected by COVID-19, potentially reducing their availability, and a widespread outbreak of COVID-19 among our manufacturing or supply-chain employees could disrupt or halt our operations. Further, restrictions on gatherings of individuals may limit the ability of our independent consultants to sell our products. Additionally, the procedures we take to mitigate the effect of COVID-19 on our workforce, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including but not limited to, social distancing and additional sanitizing measures, could reduce the efficiency of our operations, increase our operating costs or prove insufficient to protect our employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">High inflation and other difficult economic conditions could adversely affect our results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumer spending, including spending for our products, is affected by, among other things, prevailing economic conditions, including, among others, unemployment rates, inflation, fuel prices, salaries and wages, the availability of consumer credit, consumer confidence and consumer perception of economic conditions. The rate of inflation recently reached its highest level in the U.S. in over forty years. Europe and other areas in which we do business are also experiencing higher than desired inflation. Inflation may require consumers to reconsider purchases of items they consider nonessential and, as a result, consumers may purchase fewer of our products if they consider our products nonessential. We believe high levels of inflation in the U.S. and other regions in which we do business have resulted, and will continue to result, in increased input costs and lower net sales of our products. We may not be able to pass any inflation-related increases on to customers without adversely affecting net sales. A prolonged period of high inflation, recession, and other unfavorable economic conditions that adversely affect the ability of consumers to pay for our products could have a material adverse effect on our business, financial condition, cash flows, and results of operations.</span></div><div><span><br/></span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchases of our common stock during the fiscal quarter ended September&#160;30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Periods</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs<br/>&#160;(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2022 to July 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2022 to August 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2022 to September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,630&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;On March 10, 2021, we announced a $15.0 million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0 million shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. We purchased 93,000 shares of our common stock during the quarter ended September&#160;30, 2022 under the terms of this Board approved plan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual timing, number, and value of common shares repurchased under our board-approved plan will be determined at our discretion and will depend on a number of factors, including, among others, general market and business conditions, the trading price of common shares, and applicable legal requirements. We have no obligation to repurchase any common shares under the authorization, and the repurchase plan may be suspended, discontinued, or modified at any time for any reason.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFAULTS UPON SENIOR SECURITIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6eb6669461dd48148c47c5e30947a7a4_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBITS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Index to Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Item&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000275053/000027505321000026/amendmenttooperatingagreem.htm">Amendment to Operating Agreement of Nature&#8217;s Sunshine Hong Kong Limited, dated August 13, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/275053/000027505322000020/executiveemploymentagreeme.htm">Employment Agreement between the Company and Jonathan David Lanoy dated September 6, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/275053/000027505322000020/interimcfoletteragreement-.htm">Letter Agreement with Jonathan David Lanoy dated September 6, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="executiveemploymentagreeme.htm">Employment Agreement between the Company and  Daniel Norman dated September 27, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2022930-ex311.htm">Certification of Chief Executive Officer under SEC Rule&#160;13a-14(a)/15d-14(a)&#160;promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2022930-ex312.htm">Certification of Chief Financial Officer under SEC Rule&#160;13a-14(a)/15d-14(a)&#160;promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2022930-ex321.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section&#160;1350 Chief Executive Officer pursuant to 18 U.S.C. Section&#160;1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2022930-ex322.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section&#160;1350 Financial Officer pursuant to 18 U.S.C. Section&#160;1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover page Interactive Data File (the cover page XBRL tags are embedded within iXBRL (Inline Extensible Business Reporting Language) document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Previously filed as Exhibit 99.1 to the Current Report on Form 8-K filed on August 17, 2021 and incorporated by reference herein.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Filed currently herewith.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Previously filed as an exhibit to the Current Report on Form 8-K filed on September 6, 2022 and incorporated by reference herein.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i6eb6669461dd48148c47c5e30947a7a4_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6eb6669461dd48148c47c5e30947a7a4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nature</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">s Sunshine Products, Inc.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Terrence O. Moorehead</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jonathan D. Lanoy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan D. Lanoy, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Interim Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>2
<FILENAME>executiveemploymentagreeme.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iafd847dab3f54d7bb0d0d54f4dc84836_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDED AND RESTATED EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;THIS EMPLOYMENT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">is made on this 27th day of September, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;), by and between Nature&#8217;s Sunshine Products, Inc., a Utah corporation, (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;) and Daniel Norman (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;This Agreement amends and restates in its entirety the Employment Agreement between the Company and Executive dated March 31, 2020.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Positions and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Beginning on or before the Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Date of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;), and continuing until Executive&#8217;s employment with the Company is terminated either by the Company or by Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;), Executive will be employed by the Company as Executive Vice President, President Asia&#47;Pacific reporting directly to the Chief Executive Officer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;) of the Company. In addition, without additional compensation, if lawfully and reasonably requested by the CEO or the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;), Executive will serve in other additional officer positions of the Company and its subsidiaries or as an officer, director, manager or equity owner of any affiliate of the Company or any division or branch of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Place of Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Executive shall perform his services hereunder at the Company&#8217;s current principal office in Lehi, Utah, or in another location designated by the Company that is within 50 miles of Lehi, Utah&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:126%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">that Executive will be required to travel from time to time as reasonably required for business purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Company Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Executive will follow and adhere to all written policies of the Company in force and as may be added, amended or replaced from time to time, which are not inconsistent with this Agreement or applicable law including, without limitation, securities laws compliance (including, without limitation, use or disclosure of material nonpublic information, restrictions on sales of Company stock, and reporting requirements), conflicts of interest, and employee harassment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Compensation and Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive shall receive an annual salary in the amount set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, paid in accordance with the Company&#8217;s payroll practices, as in effect from time to time. Base salary shall be subject to review on at least an annual basis by the CEO. Executive understands that no further compensation will be given for his acting as an officer or shareholder of any Affiliate of the Company or any division or branch of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive shall be eligible to participate in the Company&#8217;s executive bonus program (as modified from time to time) or any successor program (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EBP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The EBP, as currently constituted, provides for additional compensation commensurate with Executive&#8217;s responsibilities based upon company and individual performance measures, with an EBP target as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and a maximum bonus potential payout equal to the greater of (i) 175% of Executive&#8217;s EBP target or (ii) the maximum bonus payout set forth in the EBP as established by the Board for the relevant year. Payment of any bonus under the EBP is in the Company&#8217;s sole discretion and such payments will be made in accordance with Internal Revenue Code Section 409A and the Treasury Regulations thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the terms of the EBP.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Executive will be eligible to participate in retirement&#47;savings, health insurance, term life insurance, long term disability insurance and other employee benefit plans, policies or arrangements maintained by the Company as provided to similarly situated employees and, at the discretion of the Board, in incentive plans, stock option plans and change in control severance plans maintained by the Company for its executives, if any, subject to the terms and conditions of such plans, policies or arrangements.   Benefits may be modified by the Company at any time without notice to Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Indemnification&#59; D&#38;O Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To the fullest extent permitted by the laws of the State of Utah in effect on the date hereof, or as such laws may from time to time hereafter be amended to increase the scope of such permitted indemnification, the Company shall indemnify Executive if Executive becomes a party to or participant in, or is threatened to be made a party to or participant in, any action or proceeding, whether civil, criminal, judicial, legislative, administrative or investigative, including an action by or in the right of Company to procure a judgment in its favor, and including an action by or in the right of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise of any type or kind, domestic or foreign, related to the fact that Executive is or was an officer, director, employee or agent of the Company or any subsidiary of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or is or was serving at the request of the Company as a director, officer, employee, member, manager, trustee or agent of any other corporation, limited liability company, partnership, joint venture, trust or other entity or enterprise, or by reason of any action or inaction by Executive in any such capacity, whether or not serving in such capacity at the time any loss is incurred for which indemnification can be provided under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), against all judgments, fines, amounts paid in settlement and all reasonable expenses and costs, including attorneys' fees, experts&#8217; fees, court costs, transcript costs, travel expenses, and all other costs and expenses incurred in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to defend, be a witness or participate in, any Action, or in connection with any appeal resulting from any Action, including without limitation costs relating to any bond or its equivalent, and expenses incurred by Executive in connection with the interpretation, enforcement or defense of Executive&#8217;s rights under this Agreement, by litigation or otherwise (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), incurred or suffered by or imposed upon Executive in connection with any such Action, or in connection with an appeal therein&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, than no such indemnification shall be required with respect to any settlement or other non-adjudicated disposition of any threatened or pending action or proceeding unless Company has given its prior consent to such settlement or other disposition, which consent shall not be unreasonably withheld, conditioned or delayed. The indemnification requirement of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is intended to be broadly interpreted and to provide for indemnification to the fullest extent permitted by law and is intended to be in addition to any other rights of indemnification available to Executive under the Company&#8217;s articles of incorporation or bylaws or under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Advancement of Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To the fullest extent permitted by the laws of the State of Utah in effect on the date hereof, or as such laws may from time to time hereafter be amended to increase the scope of such permitted advances, the Company shall, upon request, advance to or promptly reimburse Executive for all Expenses reasonably incurred in defending any such Action in advance of the final disposition of such Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that Executive shall cooperate in good faith with any request by Company that common counsel be utilized by the parties to an Action who are similarly situated unless to do so would be inappropriate due to actual or potential differing interests between or among such parties. As a condition of such advancement, Executive must furnish to the Company (a) a written affirmation of his good faith belief that (i) his conduct was in good faith&#59; and (ii) he reasonably believed that his conduct was in, or not opposed to, the Company&#8217;s best interests&#59; and (iii) in the case of any criminal proceeding, he had no reasonable cause to believe his conduct was unlawful, and (b) a written undertaking, executed personally or on his behalf, to repay the advance if Executive is ultimately found not to be entitled to indemnification or, where indemnification is granted, to the extent the expenses so advanced or reimbursed by Company exceed the indemnification to which Executive is entitled. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">D&#38;O Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For the duration of Executive&#8217;s service as an officer of the Company, and thereafter for so long as Executive is subject to any action for which the Company is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">obligated to indemnify Executive under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above, the Company will maintain directors&#8217; and officers&#8217; liability insurance commensurate (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">D&#38;O Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with industry standard terms and amount but shall in all events which shall in all events be no less protective and extensive in scope and amount to that provided by the Company&#8217;s D&#38;O Insurance policies as of the date hereof. The Company&#8217;s obligation to advance Expenses under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be net of amounts for such Expenses received under D&#38;O Insurance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reimbursement of Business Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In accordance with the Company&#8217;s normal policies for expense reimbursement, the Company shall reimburse Executive for all reasonable travel, entertainment and other expenses incurred or paid by Executive in connection with, or related to, the performance of Executive&#8217;s duties, responsibilities or services under this Agreement, upon presentation of documentation, including expense statements, vouchers and&#47;or such other supporting information as the Company may request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive must submit proper documentation for each reimbursable expense eligible for reimbursement under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> within sixty (60) days after the later of (i) Executive&#8217;s incurrence of such expense or (ii) Executive&#8217;s receipt of the invoice for such expense. If such expense qualifies hereunder for reimbursement, then the Company will reimburse Executive for that expense within ten (10) business days after Executive&#8217;s submission of a request that complies with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and in all events each reimbursement must be made no later than the end of the calendar year following the calendar year in which the expense was incurred. The amount of reimbursements in any calendar year shall not affect the expenses eligible for reimbursement in the same or any other calendar year. Executive&#8217;s right to reimbursement may not be liquidated or exchanged for any other benefit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Upon cessation of his employment with the Company, Executive will be entitled only to such compensation and benefits as described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">5.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Termination without Cause or for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. The Company may terminate Executive&#8217;s employment at any time without Cause (as defined below), and Executive may resign at any time with Good Reason (as defined below). If Executive&#8217;s employment by the Company is terminated by the Company without Cause, or if Executive resigns for Good Reason&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">5.1.1.&#160;&#160;&#160;&#160;the Company shall pay all accrued and unpaid base salary through the date of such termination and reimburse all then unreimbursed expenses properly incurred by Executive pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">5.1.2.&#160;&#160;&#160;&#160;provided a Release (as defined below) has been executed and become effective and enforceable in accordance with its terms following expiration of the applicable revocation period and Executive complies with the Restrictive Covenants (as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">), the Company shall pay equal installment payments payable in accordance with the Company's normal payroll practices, but no less frequently than monthly, which are in the aggregate equal to  the severance period set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Schedule A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Severance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;) of Executive&#8217;s base salary for the  year in which the termination occurs. The first such payment will be made on the sixtieth (60th) day following Executive&#8217;s &#8220;separation from service&#8221; (as such term is defined under Code Section 409A) and the remaining payments will be made in accordance with the Company&#8217;s normal payroll schedule for salaried employees&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">5.1.3.&#160;&#160;&#160;&#160;provided a Release has been executed and become effective and enforceable in accordance with its terms following expiration of the applicable revocation period and Executive complies with the Restrictive Covenants (as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">), the Company shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">reimburse Executive for the costs he incurs for continuation of Executive&#8217;s health insurance coverage under COBRA (and for his family members if Executive provided for their coverage during his employment) during the Severance Period and in accord with the Company&#8217;s group health plans applicable to its employees currently in effect. Executive shall, within thirty (30) days after each monthly COBRA payment he pays during the Severance Period for which he is entitled to reimbursement in accordance with the foregoing, submit appropriate evidence of such payment to the Company, and the Company shall reimburse Executive, within ten (10) business days following receipt of such submission. The following provisions shall govern such reimbursement of continuation costs&#58; (i) the amount of the COBRA costs eligible for reimbursement in any one (1) calendar year of coverage will not affect the amount of such costs eligible for reimbursement in any other calendar year for which such reimbursement is to be provided hereunder&#59; (ii) no COBRA costs will be reimbursed after the close of the calendar year following the calendar year in which those costs were incurred&#59; and (iii) Executive&#8217;s right to the reimbursement of such costs cannot be liquidated or exchanged for any other benefit. In the event the Company&#8217;s reimbursement of the reimbursable portion of any COBRA payment hereunder results in Executive&#8217;s recognition of taxable income (whether for federal, state or local income tax purposes), the Company will report such taxable income as taxable W-2 wages and collect the applicable withholding taxes, and Executive will be responsible for the payment of any additional income tax liability resulting from such coverage&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">5.1.4&#160;&#160;&#160;&#160;Executive&#8217;s bonus for the year in which the employment termination occurs, if any, will be pro-rated based upon the percentage of the year in which Executive was employed and paid by the Company. Any bonus paid out under this Section 5.1.4 will be based on Executive&#8217;s target bonus for the corporate or divisional performance as applicable, once such performance is known, and paid at the same time as all other Company bonuses are paid for the applicable year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221; means </font></div><div style="margin-bottom:12pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;padding-left:5.8pt">a material reduction in Executive&#8217;s base salary other than a general reduction in base salary that affects all similarly situated executives in substantially the same proportions&#59;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;padding-left:5.18pt">a material reduction in Executive&#8217;s target bonus percentage, or benefits&#59;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;padding-left:5.8pt">any material breach by the Company of a material provision of this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;padding-left:5.18pt">the Company's failure to obtain an agreement from any successor to the Company to assume and agree to perform this Agreement in a substantially similar manner and extent that the Company would be required to perform if no succession had taken place, except where such assumption occurs by operation of law&#59; or</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;padding-left:5.8pt">or, if within 18 months of a Change in Control as defined in Section 5.6 below there is&#58;</font></div><div style="margin-bottom:12pt;padding-left:126pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;padding-left:12.2pt">a relocation of Executive&#8217;s principal place of employment by more than 50 miles&#59;</font></div><div style="margin-bottom:12pt;padding-left:126pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;padding-left:9.15pt">a material, adverse change in Executive&#8217;s title, authority, duties, or responsibilities (other than temporarily while Executive is physically or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:126pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">mentally incapacitated or as required by applicable law) taking into account the Company&#8217;s size, status as a public company, and capitalization as of the date of this Agreement&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, that in each case Executive must provide the Company with written notice of the events Executive indicates constitutes Good Reason within thirty (30) days after the occurrence of such event.  Failure to give such notice within thirty (30) days of the occurrence shall be deemed a waiver by Executive of his right to terminate for Good Reason with respect to such circumstances.  If Executive provides such notice, in the case of the circumstances described in clauses (d) and (g) above, the Company thereafter will have thirty (30) days to cure such alleged breach.  If a cure period applies and the Company does not cure the alleged breach within the thirty (30) day notice period, Executive must thereafter resign within fifteen (15) days of the expiration of the thirty (30) day notice period in order to resign for Good Reason. If no cure period applies, Executive must thereafter resign within fifteen (15) days of Executive&#8217;s delivery of notice in order to resign for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">5.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Release and Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Notwithstanding any provision of this Agreement, the payments and benefits described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Sections 5.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">5.1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> and any other Section that incorporates such payment requirements are conditioned on (a) Executive&#8217;s execution and delivery in a manner consistent with the requirements of the Older Workers Benefit Protection Act, if applicable, and any applicable state law, to the Company of a release of all claims related to Executive&#8217;s employment by the Company and the termination thereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;), and (b) Executive&#8217;s compliance with the Restrictive Covenants set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> of this Agreement. A breach of the Restrictive Covenants by Executive shall constitute a breach of this Agreement, which shall relieve the Company of any further payment obligation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Sections 5.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">5.1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may terminate Executive&#8217;s employment immediately for Cause. If Executive&#8217;s employment with the Company is terminated by the Company for Cause then the Company&#8217;s obligation to Executive will be limited solely to the payment of accrued and unpaid base salary through the date of such termination and reimbursement of all then unreimbursed expenses properly incurred by Executive pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To terminate Executive&#8217;s employment for Cause, the CEO, in consultation with the Board, must determine in good faith that Cause exists, that Executive has been notified of the basis of such determination, and that after any applicable time to cure such Cause has not done so. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">a)&#160;&#160;&#160;&#160;conviction of, or the entry of a plea of guilty or no contest to, a felony or any crime that materially adversely affects the business, standing or reputation of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">b)&#160;&#160;&#160;&#160;engagement in fraud, embezzlement or other misappropriation of funds, or any act of material dishonesty committed in connection with Executive&#8217;s employment&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">c)&#160;&#160;&#160;&#160;material breach of any material provisions of this Agreement, which breach is not cured within fifteen (15) days after the Company provides written notice to Executive of such material breach&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">d)&#160;&#160;&#160;&#160;willful refusal to perform the lawful and reasonable directives of the CEO or the Board, other than any such failure resulting from Incapacity (as defined below) due to mental or physical illness which failure or refusal is not cured within fifteen (15) days after the Company provides written notice to Executive of such material failure or refusal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation by Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive may resign his employment without Good Reason by giving the Company four weeks&#8217; notice of said resignation&#59; the Company may elect to pay Executive&#8217;s base salary in lieu of notice. If Executive resigns without Good Reason, then the Company&#8217;s obligation to Executive will be limited solely to the payment of accrued and unpaid base salary through the date of such termination and reimbursement of all then unreimbursed expenses properly incurred by Executive pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination upon Death or Incapacity of Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Executive's employment hereunder shall terminate automatically upon Executive's death during the Employment Term, and the Company may terminate Executive's employment on account of Executive's Incapacity (as defined below). In the event of termination of Executive&#8217;s employment by reason of Executive&#8217;s death or Incapacity, the provisions governing termination without Cause in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above shall apply. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Incapacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Executive's inability, due to physical or mental incapacity, to substantially perform his duties and responsibilities under this Agreement for one hundred eighty (180) days out of any three hundred sixty-five (365) day period or one hundred twenty (120) consecutive days&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in the event the Company temporarily replaces Executive, or transfers Executive's duties or responsibilities to another individual on account of Executive's inability to perform such duties due to a mental or physical incapacity which is, or is reasonably expected to become, an Incapacity, then Executive's employment shall not be deemed terminated by the Company and Executive shall not be able to resign with Good Reason as a result thereof. Any question as to the existence of Executive's Incapacity as to which Executive and the Company cannot agree shall be determined in writing by a qualified independent physician mutually acceptable to Executive and the Company. If Executive and the Company cannot agree as to a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third who shall make such determination in writing. The determination of Incapacity made in writing to the Company and Executive shall be final and conclusive for all purposes of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination in Connection with a Change in Control Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Provided the Release under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> has been executed and become effective and enforceable in accordance with its terms following expiration of the applicable revocation period and Executive complies with the Restrictive Covenants set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in the event&#58; (i) Executive&#8217;s employment is terminated for any reason, except for Cause, within eighteen (18) months following the occurrence of a Change in Control Event (as defined below) or in anticipation of a Change in Control Event or (ii) Executive terminates his employment within eighteen (18) months following the occurrence of a Change in Control Event for Good Reason, Executive will be entitled to the amounts set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 5.1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> 5.1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (except that for purposes of Section 5.1.3 the Severance Period shall be the period set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and an amount equal to the change in control multiplier set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> times the sum of (i) Executive&#8217;s target EBP bonus (ii) and Executive&#8217;s annual base salary at the time of termination. All amounts payable to Executive pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be paid in a lump sum payment within fifteen (15) days of any applicable revocation period, except as required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement. For purposes of this Agreement, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Change in Control Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the occurrence of any one of the following events&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6.1.    consummation of a plan approved by the shareholders of the Company of complete dissolution or liquidation of the Company&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6.2.    consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company or any of its subsidiaries that requires the approval of the Company&#8217;s shareholders, whether for such transaction or the issuance of securities in the transaction (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Business Combination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), unless immediately following such Business Combination&#58; (A) more than 50% of the total voting power of (x) the corporation resulting from such Business Combination </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Surviving Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or (y) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership of at least 90% of the voting securities eligible to elect directors of the Surviving Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Parent Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), is represented by Company Voting Securities (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that were outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities among the holders thereof immediately prior to the Business Combination, (B) no person (other than any employee benefit plan (or related trust) sponsored or maintained by the Surviving Corporation or the Parent Corporation) is or becomes the beneficial owner, directly or indirectly, of 50% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (C) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) following the consummation of the Business Combination were Incumbent Directors (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> at the time of the approval by the Board of the execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-Qualifying Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6.3.    consummation of a sale of all or substantially all of the Company&#8217;s business and&#47;or assets to a person or entity which is not a subsidiary&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6.4.    any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)) is or becomes a &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Acquiring Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of the combined voting power of the Company&#8217;s then outstanding securities eligible to vote for the election of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Company Voting Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the event described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not be deemed to be a Change in Control Event by virtue of any of the following acquisitions&#58; (A) by the Company or any subsidiary, (B) by any employee benefit plan (or related trust) sponsored or maintained by the Company or any subsidiary, (C) by any underwriter temporarily holding securities pursuant to an offering of such securities, or (D) pursuant to a Non-Qualifying Transaction, as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6.5.    during any period not longer than two consecutive years, individuals who at the beginning of such period constituted the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Incumbent Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) cease for any reason to constitute at least a majority thereof, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any person becoming a director subsequent to the beginning of such period whose election or nomination for election was approved by a vote of a least a majority of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent Director, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board shall be deemed to be an Incumbent Director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without regard to the circumstances of Executive&#8217;s termination from employment, Executive hereby also covenants that upon termination, if he is listed as an officer, director, partner, secretary or shareholder on any Affiliate, division or branch of the Company, he will sign over any and all rights to stock (except Company stock and stock rights that Executive holds personally) and&#47;or resign as an officer or director of such entity prior to departure from the Company as required by the law applicable to the entity or by that entity&#8217;s procedural requirements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive understands and acknowledges that during the Employment Term, he will have access to and learn about information of any sort (whether merely remembered or embodied in a tangible or intangible form) that is (i) related to the Company or its subsidiaries&#8217; or affiliates&#8217; (including their predecessors) current or potential business and (ii) not generally or publicly known (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Confidential Information includes, without limitation, information, and data obtained by Executive while employed by the Company and its subsidiaries (or any of their predecessors) or while performing services hereunder concerning the business or affairs of the Company or any of its subsidiaries or affiliates&#59; technical information concerning </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company software (including source code and object code), products and services, including product data, specifications, documentation, hardware configuration information, diagrams, flow charts, drawings, test results, formulas, algorithms, processes, inventions, research projects, engineering, and product development&#59; business information, including markets, cost information, profits, sales information, accounting and unpublished financial information, business plans, markets and marketing methods, customer lists (including, but not limited to, customers of the Company on whom Executive called or with whom Executive became acquainted during the term of Executive&#8217;s Employment), and customer information (including pricing, preferences, discounts and contracts), purchasing techniques, supplier lists, supplier information (including pricing, preferences, discounts, and contracts) and advertising and business strategies&#59; information about employees, including their compensation, strengths, weaknesses and skills, recruiting strategies and goals and hiring criteria&#59; and other information not generally known to the public, which has independent economic value to the owner or discloser of the information or which, if misused or disclosed, could reasonably be expected to adversely affect the business of the owner or discloser of the information.  Confidential Information does not, however, include information that (w)&#160;was lawfully in Executive&#8217;s possession prior to disclosure of such information by the Company&#59; (x)&#160;was, or at any time becomes, available in the public domain other than through a violation of this Agreement&#59; (y)&#160;is documented by Executive as having been developed by Executive outside the scope of his rendering services hereunder and independently&#59; or (z)&#160;is furnished to Executive by a third party not under an obligation of confidentiality to the Company.  Executive agrees that he will not directly or indirectly use or divulge, or permit others to use or divulge, any Confidential Information for any reason, except as authorized in writing by the Company.  Executive will be allowed to disclose such information of the Company to the extent that such disclosure is&#58;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;duly approved in writing by the Company&#59; </font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) &#160;&#160;&#160;&#160;necessary for Executive to enforce his rights under this Agreement in connection with a legal proceeding&#59;  </font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) &#160;&#160;&#160;&#160;required by law or by the order of a court or similar judicial or administrative body, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Executive notifies the Company of such required disclosure promptly and reasonably cooperates with the Company in any lawful action to contest or limit the scope of such required disclosure&#59; or</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;to report possible violations of federal law or regulation to any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. &#160;Executive does not need the prior authorization of the Company to make any such reports or disclosures and he is not required to notify the Company that he has made such reports or disclosures.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">Executive&#8217;s obligations under this Agreement are in addition to any obligations he has under state or federal law.  Executive agrees that he will not violate in any way the rights that the Company has with regard to trade secrets or Confidential Information. Executive&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> are indefinite in term.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. In consideration of the compensation and other benefits provided to Executive pursuant to this Agreement, Executive agrees to be bound by the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;). These Restrictive Covenants will apply without regard to whether any termination or cessation of Executive&#8217;s employment is initiated by the Company or Executive, and without regard to the reason for that termination or cessation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">7.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Covenant Not To Compete</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Executive covenants and agrees that, during his employment by the Company and for a period of twelve (12) months following immediately thereafter </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">Executive will not, anywhere within the territory where the Company did business during Executive&#8217;s employment do any of the following, directly or indirectly&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">7.1.1.&#160;&#160;&#160;&#160;own, manage, operate, control, serve as a consultant to, be employed by, participate in, or be connected, in any manner, with the ownership, management, operation or control of any business that distributes its product through a multilevel marketing program or that engages in any activity that competes with any activity in which the Company is then engaged, including sales or distribution of herbs, vitamins or nutritional supplements or any other product which the Company sells or distributes at the time of Executive&#8217;s termination (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Competing Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:158%">Notwithstanding Executive&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:158%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:158%">, Executive will be entitled to own, as a passive investor, up to two percent (2%) of any publicly traded company without violating this provision.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Covenant Not to Solicit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">.  During the Restricted Period, Executive covenants and agrees that he will not do any of the following, directly or indirectly&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.2.1. solicit or attempt to solicit any employee or agent of the Company or any of its affiliates to alter or terminate their employment with the Company or hire or offer to hire any employee or agent of the Company or any of its affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.2.2. solicit or attempt to solicit any distributor or wholesale customer of the Company to alter or discontinue its relationship with the Company&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.2.3. solicit or attempt to persuade any supplier or vendor of the Company to alter or discontinue its relationship with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Acknowledgements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. The Company and Executive agree that (a) the Restrictive Covenants do not impose an undue hardship on Executive and are reasonably necessary to protect the business of the Company and its Affiliates&#59; (b) the nature of Executive&#8217;s responsibilities with the Company under this Agreement require him to have access to Confidential Information which is valuable and confidential to the Company&#59; (c) the scope of the Restrictive Covenants is reasonable in terms of length of time and geographic scope&#59; and (d) adequate consideration supports the Restrictive Covenants, including the provisions of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Property of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Proprietary Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. All right, title and interest in and to Proprietary Information (as defined below) will be and remain the sole and exclusive property of the Company. Executive will not remove from the Company&#8217;s offices or premises any documents, records, notebooks, files, correspondence, reports, memoranda or similar materials of or containing Proprietary Information, or other materials or property of any kind belonging to the Company unless necessary or appropriate in the performance of Executive&#8217;s duties to the Company. If Executive removes such materials or property in the performance of Executive&#8217;s duties, Executive will return such materials or property promptly after the removal has served its purpose. Executive will not make, retain, remove and&#47;or distribute any copies of any such materials or property, or divulge to any third person the nature of and&#47;or contents of such materials or property, except to the extent necessary to perform Executive&#8217;s duties on behalf of the Company. Upon termination of Executive&#8217;s employment with the Company, Executive will leave with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">the Company or promptly return to the Company all originals and copies of such materials or property then in Executive&#8217;s possession, custody, or control.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:111%">&#8220;Proprietary Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:111%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">means any and all proprietary information developed or acquired by the Company that has not been specifically authorized to be disclosed. Such Proprietary Information shall include, but shall not be limited to, the following items and information relating to the following items&#58; (a) all trade secrets (including research and development, know-how, formulas, compositions, manufacturing and production processes and techniques, methodologies, technical data, designs, drawings and specifications) as well as all inventions (whether patentable or unpatentable and whether or not reduced to practice) and all improvements thereto, (b) computer codes and instructions, processing systems and techniques, inputs, and outputs (regardless of the media on which stored or located) and hardware and software configurations, designs, architecture and interfaces, (c) business research, studies, procedures and costs, (d) financial data, (e) distributor network information, the identities of actual and prospective distributors and distribution methods, (f) marketing data, methods, plans and efforts, (g) the identities of actual and prospective suppliers, (h) the terms of contracts and agreements with, the needs and requirements of and the Company&#8217;s course of dealing with, actual or prospective suppliers, (i) personnel information, (j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:111%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">customer and vendor credit information, and (k) information received from third parties subject to obligations of nondisclosure or non-use. Failure by the Company to mark any of the Proprietary Information as confidential or proprietary shall not affect its status as Proprietary Information.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">. Executive agrees that all the Intellectual Property (as defined below) will be considered &#8220;works made for hire&#8221; as that term is defined in Section 101 of the Copyright Act (17 U.S.C. &#167;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:111%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">101) and that all right, title and interest in such Intellectual Property will be the sole and exclusive property of the Company. To the extent that any of the Intellectual Property may not by law be considered a work made for hire, or to the extent that, notwithstanding the foregoing, Executive retains any interest in the Intellectual Property, Executive hereby irrevocably assigns and transfers to the Company any and all right, title, or interest that Executive may now or in the future have in the Intellectual Property under patent, copyright, trade secret, trademark or other law, in perpetuity or for the longest period otherwise permitted by law, without the necessity of further consideration. The Company will be entitled to obtain and hold in its own name all copyrights, patents, trade secrets, trademarks and other similar registrations with respect to such Intellectual Property. Executive further agrees to execute any and all documents and provide any further cooperation or assistance reasonably required by the Company to perfect, maintain or otherwise protect its rights in the Intellectual Property, at no cost to Executive. If the Company is unable after reasonable efforts to secure Executive&#8217;s signature, cooperation or assistance in accordance with the preceding sentence, whether because of Executive&#8217;s incapacity or any other reason whatsoever, Executive hereby designates and appoints the Company or its designee as Executive&#8217;s agent and attorney-in-fact to act on his behalf solely for the purpose of executing and filing documents and doing all other lawfully permitted acts necessary or desirable to perfect, maintain or otherwise protect the Company&#8217;s rights in the Intellectual Property. Executive acknowledges and agrees that such appointment is coupled with an interest and is therefore irrevocable.  Notwithstanding the foregoing, nothing in this Agreement shall be construed to require Executive to assign or license to the Company any right in or to an invention that (a) is created by Executive entirely on Executive&#8217;s own time&#59; and (b) is not an Employment Invention. An &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:111%">Employment Invention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#8221; means any invention or part thereof conceived, developed, reduced to practice, or created by Executive which is (a) conceived, developed, reduced to practice, or created by Executive&#58; (i) within the scope of Executive&#8217;s employment&#59; (ii) on the Company&#8217;s time&#59; or (iii) with the aid, assistance, or use of any of the Company&#8217;s property, equipment, facilities, supplies, resources, or intellectual property&#59; (b) the result of any work, services, or duties performed by Executive for the Company&#59; (c) related to the industry or trade of the Company&#59; or (d) related to the current or demonstrably anticipated business, research, or development of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.3.1. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:126%">Intellectual Property</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:126%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:126%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">means (a) all inventions (whether patentable or unpatentable and whether or not reduced to practice), all improvements thereto, and all patents and patent applications claiming such inventions, (b) all trademarks, service marks, trade dress, logos, trade names, fictitious names, brand names, brand marks and corporate names, together with all translations, adaptations, derivations, and combinations thereof and including all goodwill associated therewith, and all applications, registrations, and renewals in connection therewith, (c) all copyrightable works, all copyrights, and all applications, registrations, and renewals in connection therewith, (d) all mask works and all applications, registrations, and renewals in connection therewith, (e) all trade secrets (including research and development, know-how, formulas, compositions, manufacturing and production processes and techniques, methodologies, technical data, designs, drawings and specifications), (f) all computer software (including data, source and object codes and related documentation), (g) all other proprietary rights and (h) all copies and tangible embodiments thereof (in whatever form or medium) which, in the case of any or all of the foregoing, pertains to an Employment Invention.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Acknowledgements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Executive acknowledges that the nature of Executive's position gives him access to and knowledge of Confidential Information and places him in a position of trust and confidence with the Company. Executive understands and acknowledges that the services he provides to the Company are unique, special or extraordinary.  Executive further understands and acknowledges that the Company's ability to reserve these for the exclusive knowledge and use of the Company is of great competitive importance and commercial value to the Company, and that improper use or disclosure by Executive is likely to result in unfair or unlawful competitive activity.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">Executive further acknowledges that the amount of his compensation reflects, in part, his obligations and the Company's rights under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">of this Agreement&#59; that he has no expectation of any additional compensation, royalties or other payment of any kind not otherwise referenced herein in connection herewith&#59; that he will not be subject to undue hardship by reason of his full compliance with the terms and conditions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">of this Agreement or the Company's enforcement thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Remedies and Enforcement Upon Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event of a breach or threatened breach by Executive of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of this Agreement, Executive hereby consents and agrees that the Company shall be entitled to seek, in addition to other available remedies, a temporary or permanent injunction or other equitable relief against such breach or threatened breach from any court of competent jurisdiction, without the necessity of showing any actual damages or that money damages would not afford an adequate remedy, and without the necessity of posting any bond or other security. The aforementioned equitable relief shall be in addition to, not in lieu of, legal remedies, monetary damages or other available forms of relief</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">10.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Disclosure of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Executive agrees fully and completely to disclose the existence and terms of this Agreement to any future employer or potential employer of Executive and authorizes the Company, at its election, to make such disclosure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">10.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Extension and Termination of Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. If Executive breaches </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> in any respect, the restrictions contained in that section will be extended for a period equal to the period that Executive was in breach. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Other Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Executive represents and warrants to the Company that there are no restrictions, agreements or understandings whatsoever to which Executive is a party that would prevent or make unlawful his execution of this Agreement, that would be inconsistent or in conflict with this Agreement or Executive&#8217;s obligations hereunder, or that would otherwise prevent, limit or impair the performance of Executive&#8217;s duties under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. This Agreement shall be binding upon any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company, and the Company shall require any such successor to expressly assume and agree in writing to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place, or, in the event the Company remains in existence, the Company shall continue to employ Executive under the terms hereof. As used in this Agreement, the term &#8220;Company&#8221; shall mean and include the Company and any successor to its business and&#47;or assets, which assumes or is obligated to perform this Agreement by contract, operation of law or otherwise. This Agreement shall inure to the benefit of and be enforceable by Executive and his personal or legal representatives, executors, estate, trustee, administrators, successors, heirs, distributees, devisees and legatees. The duties of Executive hereunder are personal to Executive and may not be assigned by him. If Executive dies and any amounts become payable under this Agreement, the Company will pay those amounts to his estate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Governing Law and Enforcement&#59; Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. EXCEPT WHERE PREEMPTED BY FEDERAL LAW, THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH FEDERAL LAW AND THE LAWS OF THE STATE OF UTAH, APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT STATE.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">To the fullest extent permitted by applicable law, Executive and the Company agree that any and all disputes, demands, claims, or controversies (&#8220;claims&#8221;) relating to, arising from or regarding Executive&#8217;s employment, including claims by the Company, claims against the Company, and claims against any current or former parent, affiliate, subsidiary, successor or predecessor of the Company, and each of the Company&#8217;s and these entities&#8217; respective officers, directors, agents or employees, shall be resolved by final and binding arbitration before a single arbitrator in Utah County, Utah, which will be the sole and exclusive procedure for the resolution of any disputes. The binding arbitration will be administered by AAA in accordance with AAA Employment Arbitration Rules and Procedures (the &#8220;Rules&#8221;), except as modified herein. The arbitrator must have had both training and experience as an arbitrator of general employment and commercial matters and who is and for at least ten (10) years has been, a state or federal judge, or a partner, shareholder, or member in a law firm in Salt Lake City, Utah (the &#8220;Qualifications&#8221;). If Executive and the Company cannot agree on an arbitrator, then the arbitrator will be selected in accordance with the Rules but will still be required to meet the Qualifications. Reasonable and proportional discovery will be permitted and the arbitrator may decide any issue as to the scope of discovery or any discovery disputes that arise. Unless otherwise agreed by the parties, all depositions shall take place in Salt Lake City, Utah. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">Nothing in this provision shall prevent either Executive or the Company from seeking and obtaining temporary or preliminary injunctive relief in court to prevent irreparable harm to Executive&#8217;s or Company&#8217;s confidential information or trade secrets pending the conclusion of any arbitration. This arbitration agreement does not apply to any claims that have been expressly excluded from arbitration by a governing law not preempted by the Federal Arbitration Act and does not restrict or preclude Executive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">from communicating with, filing an administrative charge or claim with, or providing testimony to any governmental entity about any actual or potential violation of law or obtaining relief through a government agency process. The parties hereto agree that claims shall be resolved on an individual basis only, and not on a class, collective, or representative basis on behalf of other employees to the fullest extent permitted by applicable law (&#8220;Class Waiver&#8221;). Any claim that all or part of the Class Waiver is invalid, unenforceable, or unconscionable may be determined only by a court. In no case may class, collective or representative claims proceed in arbitration on behalf of other employees. Except as to the Class Waiver, the arbitrator may decide any issue as to whether or as to the extent to which any dispute is subject to the dispute resolution provisions in this provision and the arbitrator may award any relief permitted by law. The arbitrator will consider and decide any motion for summary judgment or summary adjudication based on the Federal Rules of Civil Procedure as if being decided by a federal district court. The arbitrator must base the arbitration award on the provisions of this section and applicable law and must render the award in writing, including an explanation of the reasons for the award. Judgment upon the award may be entered by any court having jurisdiction of the matter, and the decision of the arbitrator will be final and binding. There is no right to an appeal. Any award or finding will be confidential. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">The arbitrator&#8217;s fees will be paid by the Company. Unless otherwise agreed, the prevailing party will be entitled to its costs and attorneys' fees incurred in any litigation or dispute relating to the claims. The arbitrator shall apply the applicable substantive law of Utah in deciding the claims at issue, except as otherwise required by law. Claims will be governed by their applicable statute of limitations and failure to demand arbitration within the prescribed time period shall bar the claims as provided by law. This arbitration agreement is enforceable under and governed by the Federal Arbitration Act. In the event that any portion of this arbitration agreement is held to be invalid or unenforceable, any such provision shall be severed, and the remainder of this arbitration agreement will be given full force and effect. Executive acknowledges and agrees that Executive has read this arbitration agreement carefully, is bound by it and are WAIVING ANY RIGHT TO HAVE A TRIAL BEFORE A COURT OR JURY OF ANY AND ALL CLAIMS SUBJECT TO ARBITRATION UNDER THIS ARBITRATION AGREEMENT.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:126%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. The waiver by either party of any right hereunder or of any breach by the other party will not be deemed a waiver of any other right hereunder or of any other breach by the other party. No waiver will be deemed to have occurred unless set forth in writing. No waiver will constitute a continuing waiver unless specifically stated, and any waiver will operate only as to the specific term or condition waived.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law. However, if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability will not affect any other provision, and this Agreement will be reformed, construed and enforced as though the invalid, illegal or unenforceable provision had never been herein contained.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Sections 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%"> of this Agreement will survive termination of this Agreement and&#47;or the cessation of Executive&#8217;s employment by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any notice or communication required or permitted under this Agreement shall be made in writing and shall be sufficient if personally delivered or sent by overnight delivery or by registered or certified mail and addressed, if to Executive, to Executive&#8217;s address set forth </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in the Company&#8217;s records, or if to the Company, to its principal office, to the attention of the CEO. Such notice shall be deemed given when delivered if delivered personally, or, if sent by registered or certified mail, at the earlier of actual receipt or three days after mailing in United States mail, addressed as aforesaid with postage prepaid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement&#58; Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement, the attached exhibits, the Plan, and the RSU Agreement contain the entire agreement and understanding of the parties hereto relating to the subject matter hereof&#59; and merge and supersede all prior and contemporaneous discussions, agreements and understandings of every nature relating to Executive&#8217;s employment or engagement with, or compensation by, the Company and any of its affiliates or subsidiaries or any of their predecessors. This Agreement may not be changed or modified, except by an agreement in writing signed by each of the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. The Company shall have the right to withhold from any amount payable hereunder any Federal, state and local taxes in order for the Company to satisfy any withholding tax obligation it may have under any applicable law or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.10.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. The headings of sections and paragraphs of this Agreement are inserted for convenience only and shall not in any way affect the meaning or construction of any provision of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.11.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Counterparts&#59; Facsimile</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. This Agreement may be executed in multiple counterparts (including by facsimile signature), each of which will be deemed to be an original, but all of which together will constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.12.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Third Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. This Agreement will be binding on, inure to the benefit of and be enforceable by the parties and their respective heirs, personal representatives, successors and assigns. This Agreement does not confer any rights, remedies, obligations or liabilities to any entity or person other than Executive and the Company and Executive&#8217;s and the Company&#8217;s permitted successors and assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">11.13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%;text-decoration:underline">Acknowledgment of Full Understanding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:126%">. EXECUTIVE ACKNOWLEDGES AND AGREES THAT HE HAS FULLY READ, UNDERSTANDS AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. EXECUTIVE ACKNOWLEDGES AND AGREES THAT HE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF HIS CHOICE BEFORE SIGNING THIS AGREEMENT.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;11.14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The parties intend that the provisions of this Agreement comply with or be exempt from Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and all provisions of this Agreement shall be construed in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A.  Notwithstanding the foregoing, nothing in the Agreement shall be interpreted or construed to transfer any liability for any tax (including a tax or penalty due as a result or a failure to comply with Section 409A) from Employee to the Company or to any other individual or entity. A termination of employment shall not be deemed to have occurred for purposes of any provision of the Agreement providing for the payment of any amounts or benefits upon or following a termination for employment unless such termination also constitutes a &#8220;Separation from Service&#8221; within the meaning of Section 409A and, for purposes of any such provision of this Agreement, referees to a &#8220;termination,&#8221; &#8220;termination of employment,&#8221; &#8220;separation from service&#8221; or like terms shall mean Separation from Service. Each installment payment required under this Agreement shall be considered a separate payment for purposes of Section 409A. If, upon separation from service, Executive is a &#8220;specified employee&#8221; within the meaning of  Section 409A, any payment under this Agreement that is subject to Section 409A and would otherwise be paid within six (6) months after Executive&#8217;s separation from service will instead be paid in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the seventh moth following Executive&#8217;s separation from service (to the extent required by Section 409A(a)(2)(B)(i)).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11.15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Protected Activity Not Prohibited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive understands that nothing in this Agreement shall in any way limit or prohibit Executive from engaging in any Protected Activity. For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Protected Activity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Government Agencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Executive understands that in connection with such Protected Activity, Executive is permitted to disclose documents or other information as permitted by law, and without giving notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, Executive agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Confidential Information to any parties other than the Government Agencies. Executive further understands that &#8220;Protected Activity&#8221; does not include the disclosure of any Company attorney-client privileged communications. In addition, pursuant to the Defend Trade Secrets Act of 2016, Executive is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (a) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual&#8217;s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11.16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">280G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Anything in this Agreement to the contrary notwithstanding, in the event that it shall be determined that any payment, distribution, or other action by the Company to or for Executive&#8217;s benefit (whether paid or payable or distributed or distributable pursuant to the terms of the Agreement or otherwise (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Parachute Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), would result in an &#8220;excess parachute payment&#8221; within the meaning of Section 280G(b)(i) of the Code, and the value determined in accordance with Section 280G(d)(4) of the Code of the Parachute Payments, net of all taxes imposed on Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Net After-Tax Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that Executive would receive would be increased if the Parachute Payments were reduced, then the Parachute Payments shall be reduced by an amount (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Reduction Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) so that the Net After-Tax Amount after such reduction is greatest. For purposes of determining the Net After-Tax Amount, Executive shall be deemed to (i) pay federal income taxes at the highest marginal rates of federal income taxation for the calendar year in which the Parachute Payment is to be made, and (ii) pay applicable state and local income taxes at the highest marginal rate of taxation for the calendar year in which the Parachute Payment is to be made, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. Subject to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, all determinations required to be made under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including the Net After-Tax Amount, the Reduction Amount and the Parachute Payments that are to be reduced pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and the assumptions to be utilized in arriving at such determinations, shall be made by an independent public accounting firm selected by Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Accounting Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which shall provide detailed supporting calculations both to the Company and Executive within fifteen (15) business days of the receipt of notice from Executive that there has been a Parachute Payment, or such earlier time as is requested by Executive. The Accounting Firm&#8217;s decision as to which Parachute Payments are to be reduced shall be made (a) only from Parachute Payments that the Accounting Firm determines reasonably may be characterized as &#8220;parachute payments&#8221; under Section 280G of the Code&#59; (b) only from Parachute Payments that are required to be made in cash&#59; (c) only with respect to any amounts that are not payable pursuant to a &#8220;nonqualified deferred compensation plan&#8221; subject to Code Section 409A of the Code, until those payments have been reduced to zero&#59; and (d) in reverse chronological order, to the extent that any Parachute Payments subject to reduction are made over time (e.g., in installments). In no event, however, shall any Parachute Payments be reduced if and to the extent such reduction would cause a violation of Code Section 409A or other applicable law. All fees and expenses of the Accounting Firm shall be borne solely by the Company. Any determination by the Accounting Firm shall be binding upon the Company and Executive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:126%"> &#91;This space left blank intentionally&#59; signature page follows&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NATURE&#8217;S SUNSHINE PRODUCTS, INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_&#47;s&#47; Terrence O. Moorehead</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">President and Chief Executive Officer</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:180pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DANIEL NORMAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Daniel Norman&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:125%">Schedule A</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Amended and Restated Employment Agreement </font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> &#8211; Annual Salary&#58; $350,000</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> &#8211; Bonus Target Percentage&#58; 60%</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Section 5.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> &#8211; Severance Period&#58; Tier 3 (see schedule below)</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> &#8211; Severance Period in a Change of Control for purposes of COBRA coverage&#58; 12 months</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> &#8211; Change in Control Multiplier&#58; Tier 3 (see schedule below) </font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:125%">Tier Schedule</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.483%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Tier</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Bonus Target %</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Severance Period</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Severance Period upon Change in Control</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Change in Control Severance Multiplier</font></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Tier 3</font></td><td colspan="3" style="background-color:#d9d9d9;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">40-60</font></td><td colspan="3" style="background-color:#d9d9d9;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">12 months</font></td><td colspan="3" style="background-color:#d9d9d9;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">12 months</font></td><td colspan="3" style="background-color:#d9d9d9;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1*</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">*In addition to the multiplier set forth above, Executive will be entitled to additional cash compensation in the amount of $175,000 upon a qualifying termination in connection with a Change in Control.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Employee Initials&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">DN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">__&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline"> &#160;&#160;&#160;&#160;9&#47;27&#47;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Company Initials&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">TM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">_&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline"> &#160;&#160;&#160;&#160;9&#47;27&#47;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NATR202209&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> &#47; 18</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>natr2022930-ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i05d99570e9044c93b5a006ea29b14ee0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Terrence O. Moorehead, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> I have reviewed this Quarterly Report on Form&#160;10-Q of Nature&#8217;s Sunshine Products,&#160;Inc. (&#8220;the registrant&#8221;)&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>natr2022930-ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="idf22ded3180b46ea96fed9605481b5ed_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jonathan D. Lanoy, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have reviewed this Quarterly Report on Form&#160;10-Q of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jonathan D. Lanoy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan D. Lanoy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Interim Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>natr2022930-ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id13d878413084952b9e5cbad7321444a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Terrence O. Moorehead, President and Chief Executive Officer of the Company, certify, pursuant to 18.U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>natr2022930-ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1feadc69819e437181ac13d4363ab63f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Jonathan D. Lanoy, Executive Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18.U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jonathan D. Lanoy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan D. Lanoy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Interim Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>natr-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0c0039ed-9423-4265-b7e9-653c93e0671e,g:99a2bdfa-c370-4e73-96ea-a47009d21b4e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:natr="http://naturessunshine.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://naturessunshine.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://naturessunshine.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://naturessunshine.com/role/BasisofPresentation">
        <link:definition>0000009 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://naturessunshine.com/role/Inventories">
        <link:definition>0000010 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTrading" roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTrading">
        <link:definition>0000011 - Disclosure - Investment Securities - Trading</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevolvingCreditFacilityandOtherObligations" roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations">
        <link:definition>0000012 - Disclosure - Revolving Credit Facility and Other Obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://naturessunshine.com/role/NetIncomePerShare">
        <link:definition>0000013 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactions" roleURI="http://naturessunshine.com/role/CapitalTransactions">
        <link:definition>0000014 - Disclosure - Capital Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://naturessunshine.com/role/SegmentInformation">
        <link:definition>0000015 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://naturessunshine.com/role/IncomeTaxes">
        <link:definition>0000016 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://naturessunshine.com/role/CommitmentsandContingencies">
        <link:definition>0000017 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://naturessunshine.com/role/RelatedPartyTransactions">
        <link:definition>0000018 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://naturessunshine.com/role/FairValueMeasurements">
        <link:definition>0000019 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://naturessunshine.com/role/RevenueRecognition">
        <link:definition>0000020 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://naturessunshine.com/role/BasisofPresentationPolicies">
        <link:definition>0000021 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://naturessunshine.com/role/InventoriesTables">
        <link:definition>0000022 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://naturessunshine.com/role/NetIncomePerShareTables">
        <link:definition>0000023 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsTables" roleURI="http://naturessunshine.com/role/CapitalTransactionsTables">
        <link:definition>0000024 - Disclosure - Capital Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://naturessunshine.com/role/SegmentInformationTables">
        <link:definition>0000025 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://naturessunshine.com/role/FairValueMeasurementsTables">
        <link:definition>0000026 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationDetails" roleURI="http://naturessunshine.com/role/BasisofPresentationDetails">
        <link:definition>0000027 - Disclosure - Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://naturessunshine.com/role/InventoriesDetails">
        <link:definition>0000028 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTradingDetails" roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails">
        <link:definition>0000029 - Disclosure - Investment Securities - Trading (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevolvingCreditFacilityandOtherObligationsDetails" roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails">
        <link:definition>0000030 - Disclosure - Revolving Credit Facility and Other Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails" roleURI="http://naturessunshine.com/role/NetIncomePerShareDetails">
        <link:definition>0000031 - Disclosure - Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsNarrativeDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails">
        <link:definition>0000032 - Disclosure - Capital Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsStockOptionActivityDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails">
        <link:definition>0000033 - Disclosure - Capital Transactions - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsRSUActivityDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails">
        <link:definition>0000034 - Disclosure - Capital Transactions - RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://naturessunshine.com/role/SegmentInformationDetails">
        <link:definition>0000035 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://naturessunshine.com/role/IncomeTaxesDetails">
        <link:definition>0000036 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000037 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://naturessunshine.com/role/RelatedPartyTransactionsDetails">
        <link:definition>0000038 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails">
        <link:definition>0000039 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>0000040 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="natr_BankofAmericaCreditAgreementMember" abstract="true" name="BankofAmericaCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" abstract="true" name="PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_LatinAmericaAndOtherSegmentMember" abstract="true" name="LatinAmericaAndOtherSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_IndicativeIndexMember" abstract="true" name="IndicativeIndexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_GeneralHealthProductsMember" abstract="true" name="GeneralHealthProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" abstract="false" name="ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="natr_ChinaJointVentureMember" abstract="true" name="ChinaJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_TimeBasedStockOptionsMember" abstract="true" name="TimeBasedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_AccruedVolumeIncentiveandServiceFees" abstract="false" name="AccruedVolumeIncentiveandServiceFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ContributionMargin" abstract="false" name="ContributionMargin" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ContractWithCustomerContractTerm" abstract="false" name="ContractWithCustomerContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_NonIncomeTaxMember" abstract="true" name="NonIncomeTaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" abstract="false" name="IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" abstract="true" name="DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember" abstract="true" name="TimeBasedRestrictedStockUnitsRSUs3YearVestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" abstract="false" name="IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_NorthAmericaSegmentMember" abstract="true" name="NorthAmericaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ContributionMarginAbstract" abstract="true" name="ContributionMarginAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember" abstract="true" name="AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_AsiaSegmentMember" abstract="true" name="AsiaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_DigestiveProductsMember" abstract="true" name="DigestiveProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="natr_DebtInstrumentNumberOfMonthlyPayments" abstract="false" name="DebtInstrumentNumberOfMonthlyPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_CompanysJointVenturePartnerMember" abstract="true" name="CompanysJointVenturePartnerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" abstract="false" name="MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_A2012IncentivePlanMember" abstract="true" name="A2012IncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_CardiovascularProductsMember" abstract="true" name="CardiovascularProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_DilutiveSecuritiesExcludedfromComputationofEarnings" abstract="false" name="DilutiveSecuritiesExcludedfromComputationofEarnings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_PerformanceBasedRestrictedStockUnitsRSUsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_FosunPharmaMember" abstract="true" name="FosunPharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_NumberofPrincipalCategoriesofProducts" abstract="false" name="NumberofPrincipalCategoriesofProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_LineOfCreditFacilityNumberOfSeparateIncreases" abstract="false" name="LineOfCreditFacilityNumberOfSeparateIncreases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_RestrictionPeriodForIssuanceOfShares" abstract="false" name="RestrictionPeriodForIssuanceOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_EuropeSegmentMember" abstract="true" name="EuropeSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_AccruedSeveranceandRentCostsMember" abstract="true" name="AccruedSeveranceandRentCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_WeightManagementProductsMember" abstract="true" name="WeightManagementProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" abstract="false" name="StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_VolumeIncentives" abstract="false" name="VolumeIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" abstract="true" name="AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember" abstract="true" name="TimeBasedRestrictedStockUnitsRSUs1YearVestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" abstract="true" name="BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" abstract="true" name="ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_NetSalesandOperatingIncomeTargetsMember" abstract="true" name="NetSalesandOperatingIncomeTargetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_RevenuefromContractwithCustomerRefundPeriod" abstract="false" name="RevenuefromContractwithCustomerRefundPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_OperatingLeaseNonCashLeaseExpense" abstract="false" name="OperatingLeaseNonCashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_NaturesSunshineProductsChinaMember" abstract="true" name="NaturesSunshineProductsChinaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_PersonalCareProductsMember" abstract="true" name="PersonalCareProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ImmunityProductsMember" abstract="true" name="ImmunityProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>natr-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0c0039ed-9423-4265-b7e9-653c93e0671e,g:99a2bdfa-c370-4e73-96ea-a47009d21b4e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b35f66d6-53bb-48d0-ac8c-b08e4de17c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_11fc7d2a-e3a9-4bca-a796-5b4d6dc9851e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b35f66d6-53bb-48d0-ac8c-b08e4de17c59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_11fc7d2a-e3a9-4bca-a796-5b4d6dc9851e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ed28e733-e59d-4f17-b4fd-e4fb0d5712e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b35f66d6-53bb-48d0-ac8c-b08e4de17c59" xlink:to="loc_us-gaap_MinorityInterest_ed28e733-e59d-4f17-b4fd-e4fb0d5712e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ea50e94c-d725-41cc-be88-1e47817d44e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b35f66d6-53bb-48d0-ac8c-b08e4de17c59" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ea50e94c-d725-41cc-be88-1e47817d44e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_69f3486a-5aeb-4219-97b4-c0b0098ebb22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b35f66d6-53bb-48d0-ac8c-b08e4de17c59" xlink:to="loc_us-gaap_CommonStockValue_69f3486a-5aeb-4219-97b4-c0b0098ebb22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_aef662d0-7fff-4b46-908a-e388768feea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_18d010fb-24e6-4eb6-b2d9-3670376ff3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aef662d0-7fff-4b46-908a-e388768feea6" xlink:to="loc_us-gaap_AssetsCurrent_18d010fb-24e6-4eb6-b2d9-3670376ff3f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_550219f2-c6e5-4c09-b969-fad489073cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aef662d0-7fff-4b46-908a-e388768feea6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_550219f2-c6e5-4c09-b969-fad489073cc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d19aa60a-caa7-4f89-9366-8d729fe44ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aef662d0-7fff-4b46-908a-e388768feea6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d19aa60a-caa7-4f89-9366-8d729fe44ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_3b09cf93-2ad3-4a86-8c37-8f59a434bcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aef662d0-7fff-4b46-908a-e388768feea6" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_3b09cf93-2ad3-4a86-8c37-8f59a434bcd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_060f8981-6eb0-4989-9b99-6f2b8f5ca8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aef662d0-7fff-4b46-908a-e388768feea6" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_060f8981-6eb0-4989-9b99-6f2b8f5ca8ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8564b3db-e6c3-4c2b-b974-d83f3cf54082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aef662d0-7fff-4b46-908a-e388768feea6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8564b3db-e6c3-4c2b-b974-d83f3cf54082" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d9d3b955-9275-45ca-adb3-db5beaa4aa8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:to="loc_us-gaap_AccountsPayableCurrent_d9d3b955-9275-45ca-adb3-db5beaa4aa8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees_a6770ce8-f343-4b76-8c8e-6b9d4882178a" xlink:href="natr-20220930.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:to="loc_natr_AccruedVolumeIncentiveandServiceFees_a6770ce8-f343-4b76-8c8e-6b9d4882178a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c274984f-b6d9-49df-b520-051f0bda808d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c274984f-b6d9-49df-b520-051f0bda808d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b5943f08-d44d-492b-8191-4c07d6816125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b5943f08-d44d-492b-8191-4c07d6816125" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_b82bb332-6d82-4a85-8be6-404034424c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_b82bb332-6d82-4a85-8be6-404034424c9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_90850aa9-6dce-4582-a100-a2bc272c88f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_90850aa9-6dce-4582-a100-a2bc272c88f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_82160a07-377f-4f95-97fe-4e20d1d86205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_82160a07-377f-4f95-97fe-4e20d1d86205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_48a5655e-ae11-491b-8294-89d4b0e5db1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a24de723-71e9-4c19-bfd9-6f528ab65a5a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_48a5655e-ae11-491b-8294-89d4b0e5db1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_86070ed3-19b1-46a1-95ef-af9ec32853c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_62070fe9-2441-4f9f-96a8-dd91f7211a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_86070ed3-19b1-46a1-95ef-af9ec32853c1" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_62070fe9-2441-4f9f-96a8-dd91f7211a44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_900a9d64-4d5f-4e14-b1f6-7b4d4d85c090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_86070ed3-19b1-46a1-95ef-af9ec32853c1" xlink:to="loc_us-gaap_LiabilitiesCurrent_900a9d64-4d5f-4e14-b1f6-7b4d4d85c090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b2e8c214-b130-4d5c-9f22-aa159244edd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_86070ed3-19b1-46a1-95ef-af9ec32853c1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b2e8c214-b130-4d5c-9f22-aa159244edd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_baaed14e-0ce8-4336-9296-6ca3d669c7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_86070ed3-19b1-46a1-95ef-af9ec32853c1" xlink:to="loc_us-gaap_LongTermNotesPayable_baaed14e-0ce8-4336-9296-6ca3d669c7bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_9f8f7222-799c-4ee8-b3c5-3ad3296d9d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_86070ed3-19b1-46a1-95ef-af9ec32853c1" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_9f8f7222-799c-4ee8-b3c5-3ad3296d9d48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5f645cfe-8e55-4efe-9338-ec677c4e5bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_86070ed3-19b1-46a1-95ef-af9ec32853c1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5f645cfe-8e55-4efe-9338-ec677c4e5bba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ecc44ee8-593e-4b1b-a42b-80b87a26ca0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_86070ed3-19b1-46a1-95ef-af9ec32853c1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ecc44ee8-593e-4b1b-a42b-80b87a26ca0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_23a8878c-99ae-4b34-ab6a-c7963a47638a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2aad5e70-e434-4040-a0a5-41bbc9613098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23a8878c-99ae-4b34-ab6a-c7963a47638a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2aad5e70-e434-4040-a0a5-41bbc9613098" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_358390f7-5fc8-479c-80cd-3a800553f4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23a8878c-99ae-4b34-ab6a-c7963a47638a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_358390f7-5fc8-479c-80cd-3a800553f4a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_328e7c65-966e-43fe-8416-a37f02c2bb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23a8878c-99ae-4b34-ab6a-c7963a47638a" xlink:to="loc_us-gaap_InventoryNet_328e7c65-966e-43fe-8416-a37f02c2bb52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_87d1792d-2f55-4d4d-a229-c4c30b6769ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23a8878c-99ae-4b34-ab6a-c7963a47638a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_87d1792d-2f55-4d4d-a229-c4c30b6769ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_48f35abf-8cca-4a66-8928-6ea9cb2f67a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_328a08de-0e8e-46e2-acb1-3d4d68b27867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_48f35abf-8cca-4a66-8928-6ea9cb2f67a7" xlink:to="loc_us-gaap_Liabilities_328a08de-0e8e-46e2-acb1-3d4d68b27867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44def8a6-36aa-49a0-878d-f1af1ee0286c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_48f35abf-8cca-4a66-8928-6ea9cb2f67a7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44def8a6-36aa-49a0-878d-f1af1ee0286c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_54950fb3-f930-49e3-b33f-cdfec0697e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_dbb8d530-94fd-4d34-b129-3e59db5b6190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_54950fb3-f930-49e3-b33f-cdfec0697e19" xlink:to="loc_us-gaap_GrossProfit_dbb8d530-94fd-4d34-b129-3e59db5b6190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives_d46aeaa6-1c6e-4565-b12e-d640abc9a41d" xlink:href="natr-20220930.xsd#natr_VolumeIncentives"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_54950fb3-f930-49e3-b33f-cdfec0697e19" xlink:to="loc_natr_VolumeIncentives_d46aeaa6-1c6e-4565-b12e-d640abc9a41d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_634f95bd-995a-4163-bb9e-941dec58d034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_54950fb3-f930-49e3-b33f-cdfec0697e19" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_634f95bd-995a-4163-bb9e-941dec58d034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3dcb1d34-df10-41ab-9b74-b9dbd3be0ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_388337ff-74c2-443a-b96c-93e855c18b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3dcb1d34-df10-41ab-9b74-b9dbd3be0ec1" xlink:to="loc_us-gaap_ProfitLoss_388337ff-74c2-443a-b96c-93e855c18b66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4f49b302-e54e-4975-b6a5-3b95fb019419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3dcb1d34-df10-41ab-9b74-b9dbd3be0ec1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4f49b302-e54e-4975-b6a5-3b95fb019419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4e40c778-e8f8-46f3-8e5a-e941a3f83bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a1b39d2-5405-48a4-af9c-8974efa31585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_4e40c778-e8f8-46f3-8e5a-e941a3f83bb1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a1b39d2-5405-48a4-af9c-8974efa31585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0abf370c-27ba-4f30-b168-440054c6e24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_4e40c778-e8f8-46f3-8e5a-e941a3f83bb1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0abf370c-27ba-4f30-b168-440054c6e24b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_adf43be6-b36c-4d38-9cec-0b522085bd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf3b07a7-1954-4e99-8885-ad04f79db3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_adf43be6-b36c-4d38-9cec-0b522085bd6c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf3b07a7-1954-4e99-8885-ad04f79db3ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f05ffc19-07ac-4883-bfd3-e77cab83fdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_adf43be6-b36c-4d38-9cec-0b522085bd6c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f05ffc19-07ac-4883-bfd3-e77cab83fdf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_83370bda-16ca-4c87-ae30-734dc1e32b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f045e61d-ddee-44cb-aa59-c42783019de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_83370bda-16ca-4c87-ae30-734dc1e32b8a" xlink:to="loc_us-gaap_OperatingIncomeLoss_f045e61d-ddee-44cb-aa59-c42783019de3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_92a9e08c-c985-4f73-aa96-a787df49b91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_83370bda-16ca-4c87-ae30-734dc1e32b8a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_92a9e08c-c985-4f73-aa96-a787df49b91a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_140c8229-5db0-4695-97f7-63f1c41fc73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2e16cfe0-4b5a-400d-909b-3b097eae3f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_140c8229-5db0-4695-97f7-63f1c41fc73d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2e16cfe0-4b5a-400d-909b-3b097eae3f35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ea49ce4d-ce19-4ce0-84cb-16d8f5b7ff62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_140c8229-5db0-4695-97f7-63f1c41fc73d" xlink:to="loc_us-gaap_ProfitLoss_ea49ce4d-ce19-4ce0-84cb-16d8f5b7ff62" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c7a8887-dce2-4e44-a771-e929130c1fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e7f408e2-4d27-4a49-b035-37511f092af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c7a8887-dce2-4e44-a771-e929130c1fc3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e7f408e2-4d27-4a49-b035-37511f092af6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4c685dc3-cf9c-408d-8e7a-fa6b4774211c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_ProfitLoss_4c685dc3-cf9c-408d-8e7a-fa6b4774211c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_0af86bba-7862-4d64-aff3-1ac378a8a39e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_0af86bba-7862-4d64-aff3-1ac378a8a39e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_989e0c21-775d-4dea-aa42-2e8cb9286529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_989e0c21-775d-4dea-aa42-2e8cb9286529" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense_285d0622-a430-4584-b13f-d567f10a54ca" xlink:href="natr-20220930.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_natr_OperatingLeaseNonCashLeaseExpense_285d0622-a430-4584-b13f-d567f10a54ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_762e34f9-c95d-4a89-8bdd-b37673f9dec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_ShareBasedCompensation_762e34f9-c95d-4a89-8bdd-b37673f9dec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_30b29b00-397c-4488-9815-4551cf0565e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_30b29b00-397c-4488-9815-4551cf0565e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7af162ff-362c-4dfc-8f26-d05596fbd7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7af162ff-362c-4dfc-8f26-d05596fbd7ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_2d0d2326-98f0-4224-a8a3-aeac865398cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_2d0d2326-98f0-4224-a8a3-aeac865398cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_943c834e-5710-4464-a098-4ad8377305be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_943c834e-5710-4464-a098-4ad8377305be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_f5b8a0c1-fc6f-45a8-baa7-8dc669c47f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_GainLossOnInvestments_f5b8a0c1-fc6f-45a8-baa7-8dc669c47f6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_36d45f1a-3d0a-4a84-97a0-868a70c0d3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_36d45f1a-3d0a-4a84-97a0-868a70c0d3d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6a17232a-d614-4328-867d-e749ab43f49d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6a17232a-d614-4328-867d-e749ab43f49d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ed41c608-1990-4ddc-b574-e210a2a35f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ed41c608-1990-4ddc-b574-e210a2a35f16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9ffa1542-f191-48b5-85a6-606071bfa64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9ffa1542-f191-48b5-85a6-606071bfa64e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_833255e5-a505-4fa4-bff6-fc7f60ebbfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_833255e5-a505-4fa4-bff6-fc7f60ebbfa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_814cf125-5d60-4ce7-848f-9accec81ff21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_814cf125-5d60-4ce7-848f-9accec81ff21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_1c2cd9d3-7a4c-47bf-bb59-112e1638a17e" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_1c2cd9d3-7a4c-47bf-bb59-112e1638a17e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6cc98d21-d15d-49aa-aed5-8e6caa40b9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6cc98d21-d15d-49aa-aed5-8e6caa40b9f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8f372565-59fb-4e06-9a9a-fc987f32f915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8f372565-59fb-4e06-9a9a-fc987f32f915" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_a5250383-774c-43d5-aed4-664aa15ed5eb" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_a5250383-774c-43d5-aed4-664aa15ed5eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_57f0744e-4d00-4df7-b662-bb7cef5b1c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_57f0744e-4d00-4df7-b662-bb7cef5b1c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_6c40bd31-b3fd-4203-bf60-34ea9a08fe42" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_6c40bd31-b3fd-4203-bf60-34ea9a08fe42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_d96236c3-dacd-4ef8-9c0e-cf3b42571fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:calculationArc order="23" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f58724ca-8231-4d7a-be95-41e030db15e0" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_d96236c3-dacd-4ef8-9c0e-cf3b42571fcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a554a1c1-a592-4b04-8508-c0a2cd090020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_cbf54726-81fc-43bd-a34f-b67c70a720ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a554a1c1-a592-4b04-8508-c0a2cd090020" xlink:to="loc_us-gaap_PaymentsOfDividends_cbf54726-81fc-43bd-a34f-b67c70a720ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_c66f4113-c252-47aa-b177-89fe4e7a54c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a554a1c1-a592-4b04-8508-c0a2cd090020" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_c66f4113-c252-47aa-b177-89fe4e7a54c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_b8ae4d02-8984-4db7-8e00-32e67273febc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a554a1c1-a592-4b04-8508-c0a2cd090020" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_b8ae4d02-8984-4db7-8e00-32e67273febc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_400b67b2-af26-4909-87d5-275a019b7d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a554a1c1-a592-4b04-8508-c0a2cd090020" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_400b67b2-af26-4909-87d5-275a019b7d34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_56d90fa0-ba6e-4b2d-93da-cdd39585bf99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a554a1c1-a592-4b04-8508-c0a2cd090020" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_56d90fa0-ba6e-4b2d-93da-cdd39585bf99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d4cd59de-e4e1-4973-9fc9-bf452feb47bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a554a1c1-a592-4b04-8508-c0a2cd090020" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d4cd59de-e4e1-4973-9fc9-bf452feb47bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5297b785-aab2-4cf5-bebf-5d1bf7ae6345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a554a1c1-a592-4b04-8508-c0a2cd090020" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5297b785-aab2-4cf5-bebf-5d1bf7ae6345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c18e88b-61de-4c97-923f-8f8012a5f6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_62ed7381-7d88-46b7-93ae-12ffe29cc87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c18e88b-61de-4c97-923f-8f8012a5f6e4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_62ed7381-7d88-46b7-93ae-12ffe29cc87c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fc10a95e-c8ab-4ee1-a9e6-aa60df57b4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c18e88b-61de-4c97-923f-8f8012a5f6e4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fc10a95e-c8ab-4ee1-a9e6-aa60df57b4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fe4940aa-902b-4a92-b5b5-b52c26f34fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c18e88b-61de-4c97-923f-8f8012a5f6e4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fe4940aa-902b-4a92-b5b5-b52c26f34fb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9724f7a-01a8-4783-bdcf-0a0b43cb43b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c18e88b-61de-4c97-923f-8f8012a5f6e4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9724f7a-01a8-4783-bdcf-0a0b43cb43b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_aea93d3d-37ff-4c10-8836-41f9ce1371c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_880bf591-cfb6-404f-83b1-62028400804b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aea93d3d-37ff-4c10-8836-41f9ce1371c9" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_880bf591-cfb6-404f-83b1-62028400804b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8b098215-4df0-4596-9f11-1eece2a94127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aea93d3d-37ff-4c10-8836-41f9ce1371c9" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8b098215-4df0-4596-9f11-1eece2a94127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2ea59a64-bcae-4b05-ad07-c135f4ee7b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aea93d3d-37ff-4c10-8836-41f9ce1371c9" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2ea59a64-bcae-4b05-ad07-c135f4ee7b1b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#NetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ca53f1a0-543a-412b-b866-f6ccbd285e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_11551897-c80e-41d1-b5ab-c96eae0391d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ca53f1a0-543a-412b-b866-f6ccbd285e92" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_11551897-c80e-41d1-b5ab-c96eae0391d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_586f7357-75c6-4158-8357-36672e91e0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ca53f1a0-543a-412b-b866-f6ccbd285e92" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_586f7357-75c6-4158-8357-36672e91e0eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dccf2808-1eb6-4392-8844-41651d6889d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_c03a4804-42b9-46c5-abf3-a2f524bb3460" xlink:href="natr-20220930.xsd#natr_ContributionMargin"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dccf2808-1eb6-4392-8844-41651d6889d2" xlink:to="loc_natr_ContributionMargin_c03a4804-42b9-46c5-abf3-a2f524bb3460" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_44c6fad3-f3f6-403d-bef1-c5b49b221284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dccf2808-1eb6-4392-8844-41651d6889d2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_44c6fad3-f3f6-403d-bef1-c5b49b221284" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b0473ba0-c6f6-47aa-92e7-8603542fd29c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_7ffe08db-3009-49d6-88c9-3e987519d025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b0473ba0-c6f6-47aa-92e7-8603542fd29c" xlink:to="loc_us-gaap_TradingSecurities_7ffe08db-3009-49d6-88c9-3e987519d025" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>natr-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0c0039ed-9423-4265-b7e9-653c93e0671e,g:99a2bdfa-c370-4e73-96ea-a47009d21b4e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended" id="ia0aae5d8ec3747e0bf708dbfd42bcdf5_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_df160b45-3050-4c67-91c0-1fe521ad417e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_df160b45-3050-4c67-91c0-1fe521ad417e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0666b92e-fa10-46eb-b44c-ddb8e38d5ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_CommonStockSharesIssued_0666b92e-fa10-46eb-b44c-ddb8e38d5ce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b243a1-2edb-4c24-b7a3-cbedff58bf11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b243a1-2edb-4c24-b7a3-cbedff58bf11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_70d46ef0-3a69-4625-a81c-c04abb91ec77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_70d46ef0-3a69-4625-a81c-c04abb91ec77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_ea4f1de2-65d4-4381-9b04-020278e95502" xlink:href="natr-20220930.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_ea4f1de2-65d4-4381-9b04-020278e95502" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_2f1c4347-ae7c-401d-af2b-8b339a15b7c3" xlink:href="natr-20220930.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_2f1c4347-ae7c-401d-af2b-8b339a15b7c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_694b245e-bca8-437f-84bc-bc2c9611e841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_DividendsCommonStockCash_694b245e-bca8-437f-84bc-bc2c9611e841" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_b556204b-eb16-411c-8b21-33fd5f918594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_b556204b-eb16-411c-8b21-33fd5f918594" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e4b31db1-9682-4f75-a8f6-9514363745b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e4b31db1-9682-4f75-a8f6-9514363745b8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_50ceb5d9-766f-4a63-b123-732320b0ac23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_ProfitLoss_50ceb5d9-766f-4a63-b123-732320b0ac23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_832215c8-b483-47da-a4d4-e5ddac98b3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_832215c8-b483-47da-a4d4-e5ddac98b3d3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_569e2192-3ebf-458f-b6d8-ad474bf22d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_721d92de-25c8-4ce5-b0a4-3e75c263c796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7c1ef7ce-99d2-4382-8ced-64cca672f8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_df160b45-3050-4c67-91c0-1fe521ad417e" xlink:to="loc_us-gaap_StatementTable_7c1ef7ce-99d2-4382-8ced-64cca672f8c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_adc8ffb8-01ac-4a03-b276-c6e6153a806f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7c1ef7ce-99d2-4382-8ced-64cca672f8c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_adc8ffb8-01ac-4a03-b276-c6e6153a806f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_adc8ffb8-01ac-4a03-b276-c6e6153a806f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_adc8ffb8-01ac-4a03-b276-c6e6153a806f" xlink:to="loc_us-gaap_EquityComponentDomain_adc8ffb8-01ac-4a03-b276-c6e6153a806f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_adc8ffb8-01ac-4a03-b276-c6e6153a806f" xlink:to="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_851e32cd-5b60-4cd6-b847-bd6449f0a914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:to="loc_us-gaap_CommonStockMember_851e32cd-5b60-4cd6-b847-bd6449f0a914" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e95d9232-4223-4445-a7b0-dd6f4a9c9a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:to="loc_us-gaap_RetainedEarningsMember_e95d9232-4223-4445-a7b0-dd6f4a9c9a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9907cd53-a4b2-4424-8186-d55aa0ddb9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9907cd53-a4b2-4424-8186-d55aa0ddb9fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1115cc4b-b030-41cc-a621-e754c7406d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1115cc4b-b030-41cc-a621-e754c7406d96" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#BasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="extended" id="i941db19d2a044a829ba8bbe696ca69be_BasisofPresentationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_dbb4de11-ea32-42cd-acf3-9e8f35103be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_dbb4de11-ea32-42cd-acf3-9e8f35103be0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c94d6357-f103-4092-9703-9d72b09a1059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_MinorityInterest_c94d6357-f103-4092-9703-9d72b09a1059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_69a05ad7-bc78-4251-ae62-716a7a50a20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_RestructuringCharges_69a05ad7-bc78-4251-ae62-716a7a50a20b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_5d1a7517-36f4-4263-8d93-53716d972ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_RestructuringReserve_5d1a7517-36f4-4263-8d93-53716d972ef6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_03356e41-fa5a-4caf-8129-c81c1c1a4779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_MinorityInterestTable_03356e41-fa5a-4caf-8129-c81c1c1a4779" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_03356e41-fa5a-4caf-8129-c81c1c1a4779" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f4c53fd4-251f-4e65-bedc-6359c281c004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f4c53fd4-251f-4e65-bedc-6359c281c004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedSeveranceandRentCostsMember_648993ea-aafa-4415-92d1-29ff0afdcb9b" xlink:href="natr-20220930.xsd#natr_AccruedSeveranceandRentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f4c53fd4-251f-4e65-bedc-6359c281c004" xlink:to="loc_natr_AccruedSeveranceandRentCostsMember_648993ea-aafa-4415-92d1-29ff0afdcb9b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#RevolvingCreditFacilityandOtherObligationsDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="extended" id="i225c2890e3a041e68a79959e5c45a66e_RevolvingCreditFacilityandOtherObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_08289918-219e-4d49-aa5e-ae8fee4714d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_08289918-219e-4d49-aa5e-ae8fee4714d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_c06fe655-3b45-44fe-ba3c-fd838bcc596d" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_c06fe655-3b45-44fe-ba3c-fd838bcc596d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_d68367fb-6df4-4d63-8528-6fa5043febce" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_d68367fb-6df4-4d63-8528-6fa5043febce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_a142da8e-b289-42a2-81aa-6ebaae6c391b" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_a142da8e-b289-42a2-81aa-6ebaae6c391b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_11fb35c5-a69b-4da2-8389-1f1fb3983083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_11fb35c5-a69b-4da2-8389-1f1fb3983083" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_817f5db3-8afb-4199-bec5-84ab6bbf895c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_817f5db3-8afb-4199-bec5-84ab6bbf895c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_2154a23a-9212-4c14-9a2e-eaf90f76ad1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_2154a23a-9212-4c14-9a2e-eaf90f76ad1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_0b52c657-1731-467c-87db-2c4edfd68255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_LineOfCredit_0b52c657-1731-467c-87db-2c4edfd68255" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments_13a19996-bbbf-4451-b328-ea28b9e9189b" xlink:href="natr-20220930.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_natr_DebtInstrumentNumberOfMonthlyPayments_13a19996-bbbf-4451-b328-ea28b9e9189b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_151cb4aa-2b8f-4065-9deb-6f24b1e6c64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_151cb4aa-2b8f-4065-9deb-6f24b1e6c64b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_472d8775-52de-4329-836e-2e817728a582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_LinesOfCreditCurrent_472d8775-52de-4329-836e-2e817728a582" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f5f0270f-10b2-4750-bc89-262eb6b569d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:to="loc_us-gaap_CreditFacilityAxis_f5f0270f-10b2-4750-bc89-262eb6b569d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f5f0270f-10b2-4750-bc89-262eb6b569d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f5f0270f-10b2-4750-bc89-262eb6b569d2" xlink:to="loc_us-gaap_CreditFacilityDomain_f5f0270f-10b2-4750-bc89-262eb6b569d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_48315054-b442-4942-9bea-a44825b99a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f5f0270f-10b2-4750-bc89-262eb6b569d2" xlink:to="loc_us-gaap_CreditFacilityDomain_48315054-b442-4942-9bea-a44825b99a15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_236d1f85-e032-424e-a6ac-5dc2f622310a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_48315054-b442-4942-9bea-a44825b99a15" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_236d1f85-e032-424e-a6ac-5dc2f622310a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_f754465e-60f3-4122-a395-0c0d954f4372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_48315054-b442-4942-9bea-a44825b99a15" xlink:to="loc_us-gaap_LineOfCreditMember_f754465e-60f3-4122-a395-0c0d954f4372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2f7f949e-edbe-456e-a4fd-3f53e52e8886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:to="loc_us-gaap_VariableRateAxis_2f7f949e-edbe-456e-a4fd-3f53e52e8886" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2f7f949e-edbe-456e-a4fd-3f53e52e8886_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2f7f949e-edbe-456e-a4fd-3f53e52e8886" xlink:to="loc_us-gaap_VariableRateDomain_2f7f949e-edbe-456e-a4fd-3f53e52e8886_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1b8d67df-b1ab-40fd-bb03-5cae1ddda572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2f7f949e-edbe-456e-a4fd-3f53e52e8886" xlink:to="loc_us-gaap_VariableRateDomain_1b8d67df-b1ab-40fd-bb03-5cae1ddda572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_526b74dd-6b82-425b-b131-51ebbea45c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1b8d67df-b1ab-40fd-bb03-5cae1ddda572" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_526b74dd-6b82-425b-b131-51ebbea45c76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember_1a09498a-60d7-4d9e-ae4d-88fc247169f2" xlink:href="natr-20220930.xsd#natr_IndicativeIndexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1b8d67df-b1ab-40fd-bb03-5cae1ddda572" xlink:to="loc_natr_IndicativeIndexMember_1a09498a-60d7-4d9e-ae4d-88fc247169f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ebead361-9c9a-4a6a-9316-4e620bf410e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:to="loc_us-gaap_DebtInstrumentAxis_ebead361-9c9a-4a6a-9316-4e620bf410e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ebead361-9c9a-4a6a-9316-4e620bf410e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ebead361-9c9a-4a6a-9316-4e620bf410e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ebead361-9c9a-4a6a-9316-4e620bf410e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b1d2fd7-8bc2-4b22-b014-a01143bece3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ebead361-9c9a-4a6a-9316-4e620bf410e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b1d2fd7-8bc2-4b22-b014-a01143bece3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember_655c581b-776d-4534-853f-e51a8400ce61" xlink:href="natr-20220930.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b1d2fd7-8bc2-4b22-b014-a01143bece3f" xlink:to="loc_natr_BankofAmericaCreditAgreementMember_655c581b-776d-4534-853f-e51a8400ce61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_aedded02-4269-4c03-befa-36bf40f94252" xlink:href="natr-20220930.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b1d2fd7-8bc2-4b22-b014-a01143bece3f" xlink:to="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_aedded02-4269-4c03-befa-36bf40f94252" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#CapitalTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="extended" id="i9a54463f39954446b256225cc5405038_CapitalTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_0d65cd86-d208-4bb1-8821-d03a30b926fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_0d65cd86-d208-4bb1-8821-d03a30b926fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_4de17ed2-8a00-41c4-9bf7-866612701799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_DividendsCommonStockCash_4de17ed2-8a00-41c4-9bf7-866612701799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f03e302a-3b42-44ff-a4dd-4305bbb7423c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f03e302a-3b42-44ff-a4dd-4305bbb7423c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_58bf64c2-00d8-4099-aa5b-3d4b072be8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_58bf64c2-00d8-4099-aa5b-3d4b072be8a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_19583441-cee0-4e8d-9908-d67193e1a485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_19583441-cee0-4e8d-9908-d67193e1a485" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_ad9007f5-2701-48e0-9b97-f2f0a29624ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_ad9007f5-2701-48e0-9b97-f2f0a29624ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_801b574c-d3ed-4d58-af8a-a1345dd836d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_801b574c-d3ed-4d58-af8a-a1345dd836d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_8a73aea1-2944-47b2-8628-ff82b2ca1654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_8a73aea1-2944-47b2-8628-ff82b2ca1654" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_374ae48b-d8ca-434a-a119-129945657564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_374ae48b-d8ca-434a-a119-129945657564" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_a565c3f9-5ab0-44f4-9766-c6331039b50e" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_a565c3f9-5ab0-44f4-9766-c6331039b50e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_4076c545-3740-421e-a161-d7ac98878ab7" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_4076c545-3740-421e-a161-d7ac98878ab7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_be8e44ff-5d71-4484-878f-7e495ddf114f" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_be8e44ff-5d71-4484-878f-7e495ddf114f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f027077b-9b79-445e-ac82-e5aa5a718e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f027077b-9b79-445e-ac82-e5aa5a718e0a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a8a3012d-f06f-4c67-9339-e122e6d775a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a8a3012d-f06f-4c67-9339-e122e6d775a5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_caad009f-dd83-402b-9ba4-5d4f6fbcd986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_caad009f-dd83-402b-9ba4-5d4f6fbcd986" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a5ec159a-3e3b-473d-8791-89b4dfa139c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a5ec159a-3e3b-473d-8791-89b4dfa139c4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c021aa0-99c0-42be-ae0a-a41205e0036d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c021aa0-99c0-42be-ae0a-a41205e0036d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b859dc09-15b8-4ff3-9436-09cc8616097e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b859dc09-15b8-4ff3-9436-09cc8616097e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9d229650-98dc-402a-8176-85bd5875e0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9d229650-98dc-402a-8176-85bd5875e0b7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_61edc2a9-f80b-4458-8b0c-7109417a6454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_61edc2a9-f80b-4458-8b0c-7109417a6454" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_de9a0eb5-eee7-4807-a314-642ada3403d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_de9a0eb5-eee7-4807-a314-642ada3403d2" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares_397347c1-2160-4a6c-b1dc-ba5d4086e4a9" xlink:href="natr-20220930.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_RestrictionPeriodForIssuanceOfShares_397347c1-2160-4a6c-b1dc-ba5d4086e4a9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_5029a7a7-3c18-4e19-a66e-6dd5041d8b1e" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_5029a7a7-3c18-4e19-a66e-6dd5041d8b1e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d9f8ed4c-b09a-4df4-8641-6d2b122b3836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d9f8ed4c-b09a-4df4-8641-6d2b122b3836" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d732961c-fa73-4144-b2f2-24f875a2c218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d732961c-fa73-4144-b2f2-24f875a2c218" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_20e38cdd-18f8-4a54-afd8-105b2bdb677a" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_20e38cdd-18f8-4a54-afd8-105b2bdb677a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_33af4439-1b54-40f0-8fe8-30ff9ef85eda" xlink:href="natr-20220930.xsd#natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_33af4439-1b54-40f0-8fe8-30ff9ef85eda" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_f386170a-0282-4c74-806a-636361d86412" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_f386170a-0282-4c74-806a-636361d86412" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0cf0171d-4e18-432f-a2ee-99951797a65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0cf0171d-4e18-432f-a2ee-99951797a65c" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5a1709d5-3817-4dd1-924b-b541f4d961e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5a1709d5-3817-4dd1-924b-b541f4d961e5" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_76948f4a-b58c-4280-b05d-0147b2c3f9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_76948f4a-b58c-4280-b05d-0147b2c3f9f7" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5e4b1fc4-99d9-425c-be8c-ad7d27748d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5e4b1fc4-99d9-425c-be8c-ad7d27748d81" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_4a413f46-9bc1-481f-ae8d-8aca24f33762" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_4a413f46-9bc1-481f-ae8d-8aca24f33762" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_us-gaap_AwardTypeAxis_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fd64830-e91e-4724-92a1-98fa7d9f35d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fd64830-e91e-4724-92a1-98fa7d9f35d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e068fcb0-1575-4b07-a05a-1b433f38a36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fd64830-e91e-4724-92a1-98fa7d9f35d7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e068fcb0-1575-4b07-a05a-1b433f38a36a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember_9c46f948-8516-4799-a9c8-8f5017b2a531" xlink:href="natr-20220930.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_e068fcb0-1575-4b07-a05a-1b433f38a36a" xlink:to="loc_natr_TimeBasedStockOptionsMember_9c46f948-8516-4799-a9c8-8f5017b2a531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_b3cd5d47-4dac-4cc4-9188-025629085aeb" xlink:href="natr-20220930.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_e068fcb0-1575-4b07-a05a-1b433f38a36a" xlink:to="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_b3cd5d47-4dac-4cc4-9188-025629085aeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fd64830-e91e-4724-92a1-98fa7d9f35d7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember_319e1fc9-378b-40b5-947b-b89a89a47926" xlink:href="natr-20220930.xsd#natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:to="loc_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember_319e1fc9-378b-40b5-947b-b89a89a47926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember_4102e3e4-7680-4142-8f26-c912f0316cbf" xlink:href="natr-20220930.xsd#natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:to="loc_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember_4102e3e4-7680-4142-8f26-c912f0316cbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_cec01825-4189-47fd-bcc6-12d848850a79" xlink:href="natr-20220930.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:to="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_cec01825-4189-47fd-bcc6-12d848850a79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember_5d825483-5bac-431f-b257-33480da4fceb" xlink:href="natr-20220930.xsd#natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:to="loc_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember_5d825483-5bac-431f-b257-33480da4fceb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_2b580599-e4a5-45ea-9f72-22979b61354e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_srt_TitleOfIndividualAxis_2b580599-e4a5-45ea-9f72-22979b61354e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2b580599-e4a5-45ea-9f72-22979b61354e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_2b580599-e4a5-45ea-9f72-22979b61354e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2b580599-e4a5-45ea-9f72-22979b61354e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c14266be-17fa-4c64-90f5-a5bfa038c4ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_2b580599-e4a5-45ea-9f72-22979b61354e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c14266be-17fa-4c64-90f5-a5bfa038c4ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_ab6e97b4-2420-4cd1-a37b-97d5fa41e48c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c14266be-17fa-4c64-90f5-a5bfa038c4ce" xlink:to="loc_srt_DirectorMember_ab6e97b4-2420-4cd1-a37b-97d5fa41e48c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_9ef695af-54a6-48b2-b7dd-ea453cc698d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_us-gaap_VestingAxis_9ef695af-54a6-48b2-b7dd-ea453cc698d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_9ef695af-54a6-48b2-b7dd-ea453cc698d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_9ef695af-54a6-48b2-b7dd-ea453cc698d3" xlink:to="loc_us-gaap_VestingDomain_9ef695af-54a6-48b2-b7dd-ea453cc698d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_6789ca8f-419f-49c3-8928-c1674b306cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_9ef695af-54a6-48b2-b7dd-ea453cc698d3" xlink:to="loc_us-gaap_VestingDomain_6789ca8f-419f-49c3-8928-c1674b306cf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NetSalesandOperatingIncomeTargetsMember_3b1b564b-61b2-4d80-80f0-15278edaf5b4" xlink:href="natr-20220930.xsd#natr_NetSalesandOperatingIncomeTargetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_6789ca8f-419f-49c3-8928-c1674b306cf7" xlink:to="loc_natr_NetSalesandOperatingIncomeTargetsMember_3b1b564b-61b2-4d80-80f0-15278edaf5b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b03d6c78-8ca0-465f-b348-30be39a7269b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_srt_RangeAxis_b03d6c78-8ca0-465f-b348-30be39a7269b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b03d6c78-8ca0-465f-b348-30be39a7269b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b03d6c78-8ca0-465f-b348-30be39a7269b" xlink:to="loc_srt_RangeMember_b03d6c78-8ca0-465f-b348-30be39a7269b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_788bc526-2e89-4012-a353-55b4e61ecbb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b03d6c78-8ca0-465f-b348-30be39a7269b" xlink:to="loc_srt_RangeMember_788bc526-2e89-4012-a353-55b4e61ecbb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aaa8b0f7-2c3a-4df8-bffc-96924b1f18f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_788bc526-2e89-4012-a353-55b4e61ecbb7" xlink:to="loc_srt_MinimumMember_aaa8b0f7-2c3a-4df8-bffc-96924b1f18f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_11793232-fbd6-4466-b6b5-901fb7d82516" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_788bc526-2e89-4012-a353-55b4e61ecbb7" xlink:to="loc_srt_MaximumMember_11793232-fbd6-4466-b6b5-901fb7d82516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d11a1f75-0efa-4cfd-a862-777e41798c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_us-gaap_PlanNameAxis_d11a1f75-0efa-4cfd-a862-777e41798c33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d11a1f75-0efa-4cfd-a862-777e41798c33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d11a1f75-0efa-4cfd-a862-777e41798c33" xlink:to="loc_us-gaap_PlanNameDomain_d11a1f75-0efa-4cfd-a862-777e41798c33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5ea0c32e-ffc6-4b7b-b842-dbb6967a7001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d11a1f75-0efa-4cfd-a862-777e41798c33" xlink:to="loc_us-gaap_PlanNameDomain_5ea0c32e-ffc6-4b7b-b842-dbb6967a7001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_4ddb42a8-2b56-4268-bd74-8b3885133957" xlink:href="natr-20220930.xsd#natr_A2012IncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5ea0c32e-ffc6-4b7b-b842-dbb6967a7001" xlink:to="loc_natr_A2012IncentivePlanMember_4ddb42a8-2b56-4268-bd74-8b3885133957" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#CapitalTransactionsStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="extended" id="ibdf5885bed114acf83e1fc6d85998c89_CapitalTransactionsStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c629554b-3e29-4793-a49a-5a2dc99d7312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c629554b-3e29-4793-a49a-5a2dc99d7312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b008a3f3-2473-40b8-a5b7-72957285d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b008a3f3-2473-40b8-a5b7-72957285d8cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d8fd1727-ea72-4289-96ba-16852453bb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d8fd1727-ea72-4289-96ba-16852453bb3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a4d9baec-ad65-4e3c-aa3b-c2dd982b2853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a4d9baec-ad65-4e3c-aa3b-c2dd982b2853" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c723ba87-625a-4b47-95bb-149c4dacec64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c0e8d65e-3d72-4569-9e0e-1f2330724755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c0e8d65e-3d72-4569-9e0e-1f2330724755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b0274a6c-af2c-49c3-969d-d58b42dc1757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b0274a6c-af2c-49c3-969d-d58b42dc1757" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_a5aed2a0-5f4e-4330-8377-e71daa48426d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_a5aed2a0-5f4e-4330-8377-e71daa48426d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5dda43c5-88c0-4348-8467-58ec7ab7256c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5dda43c5-88c0-4348-8467-58ec7ab7256c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4245191d-effc-4c87-8d7b-4318d70e15f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_d991e3f3-57ae-4900-873d-c8ee3717be7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_d991e3f3-57ae-4900-873d-c8ee3717be7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a715b580-98cf-40e9-ae68-36dcd43ff6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a715b580-98cf-40e9-ae68-36dcd43ff6f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_ddd3ce33-1c78-4513-97ee-2b41446199fb" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_ddd3ce33-1c78-4513-97ee-2b41446199fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_f432bb29-5ff3-4c30-8f3b-e145d65d45fc" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_f432bb29-5ff3-4c30-8f3b-e145d65d45fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c0792ac4-9cd8-40c3-af00-b61e4d9612d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6991101-9dda-4864-94e9-63cb2d52fda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6991101-9dda-4864-94e9-63cb2d52fda2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6991101-9dda-4864-94e9-63cb2d52fda2" xlink:to="loc_us-gaap_AwardTypeAxis_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d781b2fa-63d0-4ada-bfc1-622d0884f5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d781b2fa-63d0-4ada-bfc1-622d0884f5f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_94e27cd4-3462-4e53-b88f-54be5a23ee7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d781b2fa-63d0-4ada-bfc1-622d0884f5f2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_94e27cd4-3462-4e53-b88f-54be5a23ee7b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#CapitalTransactionsRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="extended" id="i0affdaff78844c42af0b027a94cbd5c0_CapitalTransactionsRSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f150605-8e55-4006-8bdb-f67081b78c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f150605-8e55-4006-8bdb-f67081b78c0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_450add92-6e4d-429b-87c4-28b87baa36ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_450add92-6e4d-429b-87c4-28b87baa36ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1964abc0-73da-4561-9e38-2d51bbdf827e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1964abc0-73da-4561-9e38-2d51bbdf827e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_21913c8e-4720-4673-aa15-39f299a7f537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_21913c8e-4720-4673-aa15-39f299a7f537" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1a9d842e-470a-47d3-81a8-911d9aa638f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1a9d842e-470a-47d3-81a8-911d9aa638f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6f979f67-8c32-4ff3-896b-438c1b2147c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f150605-8e55-4006-8bdb-f67081b78c0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8246c28-ea97-494d-9833-18746ae4ad86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8246c28-ea97-494d-9833-18746ae4ad86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_57083f55-caf0-4a09-9ef0-adc34f67dc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_57083f55-caf0-4a09-9ef0-adc34f67dc39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8e23ab29-4a4d-4dad-bdab-2f7524bc436d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8e23ab29-4a4d-4dad-bdab-2f7524bc436d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8b011e8-f96b-4fe8-bfa7-4660348351cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8b011e8-f96b-4fe8-bfa7-4660348351cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_14b03186-789a-4365-9adb-aa97e423c397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f150605-8e55-4006-8bdb-f67081b78c0a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7ad13cbc-8202-46ca-b3dd-e83de80a6861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:to="loc_us-gaap_PlanNameAxis_7ad13cbc-8202-46ca-b3dd-e83de80a6861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7ad13cbc-8202-46ca-b3dd-e83de80a6861_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7ad13cbc-8202-46ca-b3dd-e83de80a6861" xlink:to="loc_us-gaap_PlanNameDomain_7ad13cbc-8202-46ca-b3dd-e83de80a6861_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_35644de3-8bf0-4d2d-8e6b-15cf4471ac70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7ad13cbc-8202-46ca-b3dd-e83de80a6861" xlink:to="loc_us-gaap_PlanNameDomain_35644de3-8bf0-4d2d-8e6b-15cf4471ac70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_e889826c-1c74-4898-bfdc-46a5f3c29f26" xlink:href="natr-20220930.xsd#natr_A2012IncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_35644de3-8bf0-4d2d-8e6b-15cf4471ac70" xlink:to="loc_natr_A2012IncentivePlanMember_e889826c-1c74-4898-bfdc-46a5f3c29f26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3d423bbf-eda0-4cfb-b217-3a95ef66ac22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:to="loc_us-gaap_AwardTypeAxis_3d423bbf-eda0-4cfb-b217-3a95ef66ac22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d423bbf-eda0-4cfb-b217-3a95ef66ac22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3d423bbf-eda0-4cfb-b217-3a95ef66ac22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d423bbf-eda0-4cfb-b217-3a95ef66ac22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54496f9a-a9fc-45da-9dd9-4ffb2417c0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3d423bbf-eda0-4cfb-b217-3a95ef66ac22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54496f9a-a9fc-45da-9dd9-4ffb2417c0ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6990b7a1-763c-4946-9eee-3025e2811d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54496f9a-a9fc-45da-9dd9-4ffb2417c0ba" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6990b7a1-763c-4946-9eee-3025e2811d0f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended" id="ia6f912bad0334f0394501d04b94e4be5_SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3494807e-9296-4e25-b554-c580ffbebaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_NumberOfReportableSegments_3494807e-9296-4e25-b554-c580ffbebaf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_3ef708d8-46b0-4474-bd7d-b8946ee5cf39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_3ef708d8-46b0-4474-bd7d-b8946ee5cf39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_839a2aa2-969b-4a47-b6bd-573d42fbb1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_3ef708d8-46b0-4474-bd7d-b8946ee5cf39" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_839a2aa2-969b-4a47-b6bd-573d42fbb1b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract_96c60fc3-3247-4359-a2b6-b8e25810d0dc" xlink:href="natr-20220930.xsd#natr_ContributionMarginAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_natr_ContributionMarginAbstract_96c60fc3-3247-4359-a2b6-b8e25810d0dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_99a03223-a2ab-4614-820c-386d04de2d2a" xlink:href="natr-20220930.xsd#natr_ContributionMargin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_natr_ContributionMarginAbstract_96c60fc3-3247-4359-a2b6-b8e25810d0dc" xlink:to="loc_natr_ContributionMargin_99a03223-a2ab-4614-820c-386d04de2d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f0c7b548-4fae-4f34-b17e-bab082fdbd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f0c7b548-4fae-4f34-b17e-bab082fdbd76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1ffdc162-1eea-42e3-b723-def43004ab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_OperatingIncomeLoss_1ffdc162-1eea-42e3-b723-def43004ab9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f7ab5a73-a55d-4ce0-a277-f49d2960ec68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f7ab5a73-a55d-4ce0-a277-f49d2960ec68" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3325fb51-0c64-47a0-b6f4-963f7acf645d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3325fb51-0c64-47a0-b6f4-963f7acf645d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_06a58b4b-f5a5-4978-89a2-075ffa6c5937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_06a58b4b-f5a5-4978-89a2-075ffa6c5937" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6fbe312f-2743-47f0-84e7-8e858c37f085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_Assets_6fbe312f-2743-47f0-84e7-8e858c37f085" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_836bf16f-62ef-4708-9288-cff5ced7e478" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:to="loc_srt_StatementGeographicalAxis_836bf16f-62ef-4708-9288-cff5ced7e478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_836bf16f-62ef-4708-9288-cff5ced7e478_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_836bf16f-62ef-4708-9288-cff5ced7e478" xlink:to="loc_srt_SegmentGeographicalDomain_836bf16f-62ef-4708-9288-cff5ced7e478_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_836bf16f-62ef-4708-9288-cff5ced7e478" xlink:to="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_851e764c-d30b-47e7-8ddd-117c3f89ef25" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_country_CN_851e764c-d30b-47e7-8ddd-117c3f89ef25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f178dd0e-cdbc-4cdf-a732-4ed10a68ffc4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_country_US_f178dd0e-cdbc-4cdf-a732-4ed10a68ffc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR_b028d22e-50b2-4603-90c4-4546aa45690d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_KR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_country_KR_b028d22e-50b2-4603-90c4-4546aa45690d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_02438935-c1d3-478b-ad9a-61e6b569b7d3" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_TW"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_country_TW_02438935-c1d3-478b-ad9a-61e6b569b7d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember_c9b344c8-7d63-4536-986a-99d812b7d91e" xlink:href="natr-20220930.xsd#natr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_natr_OtherCountriesMember_c9b344c8-7d63-4536-986a-99d812b7d91e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_341d5827-d413-460c-a0f5-1a3802264654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_341d5827-d413-460c-a0f5-1a3802264654" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_341d5827-d413-460c-a0f5-1a3802264654_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_341d5827-d413-460c-a0f5-1a3802264654" xlink:to="loc_us-gaap_SegmentDomain_341d5827-d413-460c-a0f5-1a3802264654_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_341d5827-d413-460c-a0f5-1a3802264654" xlink:to="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember_0e638978-5054-46e5-bdd1-7bfb8ab4c561" xlink:href="natr-20220930.xsd#natr_AsiaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:to="loc_natr_AsiaSegmentMember_0e638978-5054-46e5-bdd1-7bfb8ab4c561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember_e4505b1e-ac4e-4100-890f-1ea426c1266b" xlink:href="natr-20220930.xsd#natr_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:to="loc_natr_EuropeSegmentMember_e4505b1e-ac4e-4100-890f-1ea426c1266b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember_41ecd5a0-22fd-4a88-9143-a7143f63cfd3" xlink:href="natr-20220930.xsd#natr_NorthAmericaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:to="loc_natr_NorthAmericaSegmentMember_41ecd5a0-22fd-4a88-9143-a7143f63cfd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember_8123551c-b310-4c19-bf1f-22caa2188d12" xlink:href="natr-20220930.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:to="loc_natr_LatinAmericaAndOtherSegmentMember_8123551c-b310-4c19-bf1f-22caa2188d12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e188bcfc-efab-40b8-8b22-7e6fc0073587" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:to="loc_srt_ProductOrServiceAxis_e188bcfc-efab-40b8-8b22-7e6fc0073587" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e188bcfc-efab-40b8-8b22-7e6fc0073587_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e188bcfc-efab-40b8-8b22-7e6fc0073587" xlink:to="loc_srt_ProductsAndServicesDomain_e188bcfc-efab-40b8-8b22-7e6fc0073587_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e188bcfc-efab-40b8-8b22-7e6fc0073587" xlink:to="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember_fd6226bb-7525-45c1-8919-76c0c3f7028f" xlink:href="natr-20220930.xsd#natr_GeneralHealthProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_GeneralHealthProductsMember_fd6226bb-7525-45c1-8919-76c0c3f7028f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember_77233c91-dbf3-4e1d-bc76-ed158c2ad1e7" xlink:href="natr-20220930.xsd#natr_ImmunityProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_ImmunityProductsMember_77233c91-dbf3-4e1d-bc76-ed158c2ad1e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember_8d759af9-38cf-4ad6-bfaa-0df3a3ac3e43" xlink:href="natr-20220930.xsd#natr_CardiovascularProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_CardiovascularProductsMember_8d759af9-38cf-4ad6-bfaa-0df3a3ac3e43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember_a5ad2f4f-bb4b-4c88-b03d-a89f962e1ff9" xlink:href="natr-20220930.xsd#natr_DigestiveProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_DigestiveProductsMember_a5ad2f4f-bb4b-4c88-b03d-a89f962e1ff9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember_b482396f-4656-43c8-9c64-a88dc96246ba" xlink:href="natr-20220930.xsd#natr_PersonalCareProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_PersonalCareProductsMember_b482396f-4656-43c8-9c64-a88dc96246ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember_087439ec-59e0-4b87-af4a-6a9fff24a4a8" xlink:href="natr-20220930.xsd#natr_WeightManagementProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_WeightManagementProductsMember_087439ec-59e0-4b87-af4a-6a9fff24a4a8" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ic51f56a0d62d4d8baba874fffa74044e_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_45884dd5-3c0f-4681-994b-522decb4546b" xlink:href="natr-20220930.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_45884dd5-3c0f-4681-994b-522decb4546b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e5132fdd-e29a-4746-8ed9-41dec2ea4144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e5132fdd-e29a-4746-8ed9-41dec2ea4144" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_cc5fe58f-c60c-494f-950d-23fe4b829f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_cc5fe58f-c60c-494f-950d-23fe4b829f28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_27d16b60-7925-4e2c-964f-a38aad203b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_27d16b60-7925-4e2c-964f-a38aad203b55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_6748b69d-0198-4264-85d1-ef44640f42d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:to="loc_us-gaap_LitigationStatusAxis_6748b69d-0198-4264-85d1-ef44640f42d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_6748b69d-0198-4264-85d1-ef44640f42d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_6748b69d-0198-4264-85d1-ef44640f42d8" xlink:to="loc_us-gaap_LitigationStatusDomain_6748b69d-0198-4264-85d1-ef44640f42d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d8425e29-7d7e-46b0-a189-14675521ca88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_6748b69d-0198-4264-85d1-ef44640f42d8" xlink:to="loc_us-gaap_LitigationStatusDomain_d8425e29-7d7e-46b0-a189-14675521ca88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_190d08d9-3028-428e-b7f1-67fe66df65b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d8425e29-7d7e-46b0-a189-14675521ca88" xlink:to="loc_us-gaap_PendingLitigationMember_190d08d9-3028-428e-b7f1-67fe66df65b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bc6e12ae-f008-4678-98d0-90df38b5071a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:to="loc_srt_RangeAxis_bc6e12ae-f008-4678-98d0-90df38b5071a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bc6e12ae-f008-4678-98d0-90df38b5071a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bc6e12ae-f008-4678-98d0-90df38b5071a" xlink:to="loc_srt_RangeMember_bc6e12ae-f008-4678-98d0-90df38b5071a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4d631641-4e22-4595-850a-cd3fd6318ac6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bc6e12ae-f008-4678-98d0-90df38b5071a" xlink:to="loc_srt_RangeMember_4d631641-4e22-4595-850a-cd3fd6318ac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a760a7a6-70af-4b23-9791-fb8e8ec2bf68" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4d631641-4e22-4595-850a-cd3fd6318ac6" xlink:to="loc_srt_MinimumMember_a760a7a6-70af-4b23-9791-fb8e8ec2bf68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2900de38-e775-4e5b-b6af-2888bf45c51f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4d631641-4e22-4595-850a-cd3fd6318ac6" xlink:to="loc_srt_MaximumMember_2900de38-e775-4e5b-b6af-2888bf45c51f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0a3c2347-dd69-4ce6-96fd-00630f7ca042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0a3c2347-dd69-4ce6-96fd-00630f7ca042" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0a3c2347-dd69-4ce6-96fd-00630f7ca042_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0a3c2347-dd69-4ce6-96fd-00630f7ca042" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0a3c2347-dd69-4ce6-96fd-00630f7ca042_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9b8defd1-7b2a-4106-a5b0-413ef801727e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0a3c2347-dd69-4ce6-96fd-00630f7ca042" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9b8defd1-7b2a-4106-a5b0-413ef801727e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_06d1505b-508b-4cfa-b76b-48b56afefd24" xlink:href="natr-20220930.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9b8defd1-7b2a-4106-a5b0-413ef801727e" xlink:to="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_06d1505b-508b-4cfa-b76b-48b56afefd24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember_d56ba991-ee74-4a23-ada3-e89354afd89c" xlink:href="natr-20220930.xsd#natr_NonIncomeTaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9b8defd1-7b2a-4106-a5b0-413ef801727e" xlink:to="loc_natr_NonIncomeTaxMember_d56ba991-ee74-4a23-ada3-e89354afd89c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="i39fadc2435ec4ab58cdbbbfc7df8ee80_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_eab256d6-3625-4a15-9013-73a3d78eb3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_eab256d6-3625-4a15-9013-73a3d78eb3b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_72b18c30-ea5e-4760-81e8-ca9ea4500b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_72b18c30-ea5e-4760-81e8-ca9ea4500b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ca5f20fb-4e4f-417d-a836-c6ffb6fe31bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ca5f20fb-4e4f-417d-a836-c6ffb6fe31bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_88986441-93b5-43d1-9549-3637e4e86ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_88986441-93b5-43d1-9549-3637e4e86ec8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_0ba3f56f-04fa-4747-a223-4d0509ce64f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_0ba3f56f-04fa-4747-a223-4d0509ce64f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_68a3dbd4-ec80-4057-bf91-762871b791ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_srt_CounterpartyNameAxis_68a3dbd4-ec80-4057-bf91-762871b791ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_68a3dbd4-ec80-4057-bf91-762871b791ab_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_68a3dbd4-ec80-4057-bf91-762871b791ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_68a3dbd4-ec80-4057-bf91-762871b791ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e087ee0f-5185-4e7d-81b5-bdb92941e928" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_68a3dbd4-ec80-4057-bf91-762871b791ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e087ee0f-5185-4e7d-81b5-bdb92941e928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember_cb92c4ae-14b5-4c3a-bf51-3beff8e011cf" xlink:href="natr-20220930.xsd#natr_ChinaJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e087ee0f-5185-4e7d-81b5-bdb92941e928" xlink:to="loc_natr_ChinaJointVentureMember_cb92c4ae-14b5-4c3a-bf51-3beff8e011cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NaturesSunshineProductsChinaMember_f2767309-bd8c-469c-9797-3d6e0e9b624c" xlink:href="natr-20220930.xsd#natr_NaturesSunshineProductsChinaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e087ee0f-5185-4e7d-81b5-bdb92941e928" xlink:to="loc_natr_NaturesSunshineProductsChinaMember_f2767309-bd8c-469c-9797-3d6e0e9b624c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_9b97141c-001b-49aa-a6b4-3e29b7013c3a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_srt_OwnershipAxis_9b97141c-001b-49aa-a6b4-3e29b7013c3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9b97141c-001b-49aa-a6b4-3e29b7013c3a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_9b97141c-001b-49aa-a6b4-3e29b7013c3a" xlink:to="loc_srt_OwnershipDomain_9b97141c-001b-49aa-a6b4-3e29b7013c3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b467514c-0157-45c9-9bb2-f9e1bcb6aede" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_9b97141c-001b-49aa-a6b4-3e29b7013c3a" xlink:to="loc_srt_OwnershipDomain_b467514c-0157-45c9-9bb2-f9e1bcb6aede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember_33139e28-be52-4f39-874d-4c2db9a8cef8" xlink:href="natr-20220930.xsd#natr_ChinaJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b467514c-0157-45c9-9bb2-f9e1bcb6aede" xlink:to="loc_natr_ChinaJointVentureMember_33139e28-be52-4f39-874d-4c2db9a8cef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b7aa4afd-3e25-42d5-a285-1145d62040ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b7aa4afd-3e25-42d5-a285-1145d62040ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b7aa4afd-3e25-42d5-a285-1145d62040ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b7aa4afd-3e25-42d5-a285-1145d62040ab" xlink:to="loc_us-gaap_RelatedPartyDomain_b7aa4afd-3e25-42d5-a285-1145d62040ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_04508ab4-fb61-4058-aa25-cee4083f3759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b7aa4afd-3e25-42d5-a285-1145d62040ab" xlink:to="loc_us-gaap_RelatedPartyDomain_04508ab4-fb61-4058-aa25-cee4083f3759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_5a917baf-e75a-4271-821c-91948287c272" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_04508ab4-fb61-4058-aa25-cee4083f3759" xlink:to="loc_srt_SubsidiariesMember_5a917baf-e75a-4271-821c-91948287c272" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_03e82cf4-a81c-4c9b-a58f-20f720b8383e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_03e82cf4-a81c-4c9b-a58f-20f720b8383e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_03e82cf4-a81c-4c9b-a58f-20f720b8383e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_03e82cf4-a81c-4c9b-a58f-20f720b8383e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_03e82cf4-a81c-4c9b-a58f-20f720b8383e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c648ef68-d6a1-4983-8749-7e11367a8e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_03e82cf4-a81c-4c9b-a58f-20f720b8383e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c648ef68-d6a1-4983-8749-7e11367a8e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_3639ba76-57d2-4529-906e-1d391339c243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c648ef68-d6a1-4983-8749-7e11367a8e11" xlink:to="loc_us-gaap_NotesReceivableMember_3639ba76-57d2-4529-906e-1d391339c243" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_eed40978-5d5c-4be6-8e7c-34020d9a3022" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_dei_LegalEntityAxis_eed40978-5d5c-4be6-8e7c-34020d9a3022" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_eed40978-5d5c-4be6-8e7c-34020d9a3022_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_eed40978-5d5c-4be6-8e7c-34020d9a3022" xlink:to="loc_dei_EntityDomain_eed40978-5d5c-4be6-8e7c-34020d9a3022_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d2355c10-d84e-4e6d-8254-581027cd91ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_eed40978-5d5c-4be6-8e7c-34020d9a3022" xlink:to="loc_dei_EntityDomain_d2355c10-d84e-4e6d-8254-581027cd91ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FosunPharmaMember_a8986879-ed95-4460-b96c-7a4f795cba7f" xlink:href="natr-20220930.xsd#natr_FosunPharmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d2355c10-d84e-4e6d-8254-581027cd91ba" xlink:to="loc_natr_FosunPharmaMember_a8986879-ed95-4460-b96c-7a4f795cba7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CompanysJointVenturePartnerMember_a8d8481e-5864-46a3-a22f-c77abd89ec89" xlink:href="natr-20220930.xsd#natr_CompanysJointVenturePartnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d2355c10-d84e-4e6d-8254-581027cd91ba" xlink:to="loc_natr_CompanysJointVenturePartnerMember_a8d8481e-5864-46a3-a22f-c77abd89ec89" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="ife59185deb1046498e3337c2e391ff0d_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_def2427f-3ee8-4a9a-9044-07711a5dcdcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_3782ddba-9247-499d-a2ec-9cafbdbec364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_def2427f-3ee8-4a9a-9044-07711a5dcdcc" xlink:to="loc_us-gaap_TradingSecurities_3782ddba-9247-499d-a2ec-9cafbdbec364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_76b965e5-7444-4ac9-bba7-2f51350ec1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_def2427f-3ee8-4a9a-9044-07711a5dcdcc" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_76b965e5-7444-4ac9-bba7-2f51350ec1fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_def2427f-3ee8-4a9a-9044-07711a5dcdcc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ec924c09-1648-4705-a1ef-0ddcd1d610ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ec924c09-1648-4705-a1ef-0ddcd1d610ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ec924c09-1648-4705-a1ef-0ddcd1d610ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ec924c09-1648-4705-a1ef-0ddcd1d610ac" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ec924c09-1648-4705-a1ef-0ddcd1d610ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_27739c71-ae24-4b46-a880-a26ae8e840c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ec924c09-1648-4705-a1ef-0ddcd1d610ac" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_27739c71-ae24-4b46-a880-a26ae8e840c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_75d81480-2290-4bf8-bdaf-0da09492fae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_27739c71-ae24-4b46-a880-a26ae8e840c2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_75d81480-2290-4bf8-bdaf-0da09492fae1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_823ee181-cbd7-4933-8be4-689ac3f2bb69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_823ee181-cbd7-4933-8be4-689ac3f2bb69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_823ee181-cbd7-4933-8be4-689ac3f2bb69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_823ee181-cbd7-4933-8be4-689ac3f2bb69" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_823ee181-cbd7-4933-8be4-689ac3f2bb69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_823ee181-cbd7-4933-8be4-689ac3f2bb69" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_83713873-93e5-41de-b1c9-2bcf8f013b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_83713873-93e5-41de-b1c9-2bcf8f013b53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5d37a468-687d-4690-a7c8-77859f445f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5d37a468-687d-4690-a7c8-77859f445f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f68d8821-9a63-458e-88ff-0d661e0b1581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f68d8821-9a63-458e-88ff-0d661e0b1581" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_054d9bd6-0dbc-4598-98b8-09d14813679c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_054d9bd6-0dbc-4598-98b8-09d14813679c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_054d9bd6-0dbc-4598-98b8-09d14813679c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_054d9bd6-0dbc-4598-98b8-09d14813679c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_054d9bd6-0dbc-4598-98b8-09d14813679c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_fe1953c6-c85c-4963-9024-4ad444791a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_054d9bd6-0dbc-4598-98b8-09d14813679c" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_fe1953c6-c85c-4963-9024-4ad444791a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1509772e-82bc-4b9e-ae6d-764d0c29677a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_fe1953c6-c85c-4963-9024-4ad444791a5b" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1509772e-82bc-4b9e-ae6d-764d0c29677a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_fb0f1600-c045-47a8-ad11-83de06154b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1509772e-82bc-4b9e-ae6d-764d0c29677a" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_fb0f1600-c045-47a8-ad11-83de06154b63" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended" id="i79367f108f8949ebac944dfe237bd8cf_RevenueRecognitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RevenuefromContractwithCustomerRefundPeriod_112d7073-f830-4a02-9249-5dcc916a99d3" xlink:href="natr-20220930.xsd#natr_RevenuefromContractwithCustomerRefundPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_natr_RevenuefromContractwithCustomerRefundPeriod_112d7073-f830-4a02-9249-5dcc916a99d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NumberofPrincipalCategoriesofProducts_4028efc2-22cc-492d-abb4-f121df1c7a9f" xlink:href="natr-20220930.xsd#natr_NumberofPrincipalCategoriesofProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_natr_NumberofPrincipalCategoriesofProducts_4028efc2-22cc-492d-abb4-f121df1c7a9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_cecdf52f-be90-4152-b179-7d6ed542574e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_us-gaap_NumberOfReportableSegments_cecdf52f-be90-4152-b179-7d6ed542574e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContractWithCustomerContractTerm_d0f5dce6-1bec-4533-b8ba-5ec0db26c45a" xlink:href="natr-20220930.xsd#natr_ContractWithCustomerContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_natr_ContractWithCustomerContractTerm_d0f5dce6-1bec-4533-b8ba-5ec0db26c45a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_be182e58-940e-4267-bc2d-884a7eda7742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_be182e58-940e-4267-bc2d-884a7eda7742" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b64c5379-fc07-4b50-bfc1-692b0551f9be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_be182e58-940e-4267-bc2d-884a7eda7742" xlink:to="loc_srt_RangeAxis_b64c5379-fc07-4b50-bfc1-692b0551f9be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b64c5379-fc07-4b50-bfc1-692b0551f9be_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b64c5379-fc07-4b50-bfc1-692b0551f9be" xlink:to="loc_srt_RangeMember_b64c5379-fc07-4b50-bfc1-692b0551f9be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_80693b22-afba-4653-b8e0-31fea9d3d883" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b64c5379-fc07-4b50-bfc1-692b0551f9be" xlink:to="loc_srt_RangeMember_80693b22-afba-4653-b8e0-31fea9d3d883" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_81c81603-f930-4132-9584-5d9c2dc39367" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_80693b22-afba-4653-b8e0-31fea9d3d883" xlink:to="loc_srt_MaximumMember_81c81603-f930-4132-9584-5d9c2dc39367" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>natr-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0c0039ed-9423-4265-b7e9-653c93e0671e,g:99a2bdfa-c370-4e73-96ea-a47009d21b4e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_dbb503f0-e7b4-4cc3-a0f6-4f3ef3567482_terseLabel_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_label_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities Excluded from Computation of Earnings</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_documentation_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:href="natr-20220930.xsd#natr_DilutiveSecuritiesExcludedfromComputationofEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:to="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e1d8492b-ccf2-482e-a6a3-7f2ea7b423ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d2191d50-daf7-4df5-8b48-88a9b434b714_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_75553867-4960-44fa-af85-fde52e398516_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_7a8572da-aa95-4481-af28-5a3705df7542_terseLabel_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value-added tax assessments and other civil litigation</link:label>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_label_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Added Tax Assessments And Other Civil Litigation [Member]</link:label>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_documentation_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to value added tax assessments and other civil litigation in which the entity is involved.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:href="natr-20220930.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:to="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AsiaSegmentMember_c298a046-2145-49ab-8b13-06f101e59ffa_terseLabel_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia</link:label>
    <link:label id="lab_natr_AsiaSegmentMember_label_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Segment [Member]</link:label>
    <link:label id="lab_natr_AsiaSegmentMember_documentation_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember" xlink:href="natr-20220930.xsd#natr_AsiaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AsiaSegmentMember" xlink:to="lab_natr_AsiaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_76d0e271-bf05-4909-9ccf-572779e93bfd_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_850ebf7d-f47d-4e38-bbed-e3c4a2f62713_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_4672e9e2-197b-4dc3-9537-ae79a29855f3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_282d5c21-463f-4839-b907-fc9a328f4321_terseLabel_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Other</link:label>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_label_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America And Other Segment [Member]</link:label>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_documentation_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America And Other Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember" xlink:href="natr-20220930.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LatinAmericaAndOtherSegmentMember" xlink:to="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_423d924a-1365-4207-96e3-6fc6dfe9d064_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_c795e12f-18b1-4e2a-b1da-c3d445d4a316_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities - trading</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PersonalCareProductsMember_f6e8cf4c-af05-40e1-93a1-497cd2708064_terseLabel_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal care</link:label>
    <link:label id="lab_natr_PersonalCareProductsMember_label_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Care Products [Member]</link:label>
    <link:label id="lab_natr_PersonalCareProductsMember_documentation_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to personal care products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember" xlink:href="natr-20220930.xsd#natr_PersonalCareProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PersonalCareProductsMember" xlink:to="lab_natr_PersonalCareProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_2fbcd461-bae2-497b-9a1f-c1c42a4882a2_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NonIncomeTaxMember_a7f8c3d7-31d9-4abe-b1ac-703b64660298_terseLabel_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Income Tax Contingencies</link:label>
    <link:label id="lab_natr_NonIncomeTaxMember_label_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Income Tax [Member]</link:label>
    <link:label id="lab_natr_NonIncomeTaxMember_documentation_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to non-income tax matters, including value-added taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember" xlink:href="natr-20220930.xsd#natr_NonIncomeTaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NonIncomeTaxMember" xlink:to="lab_natr_NonIncomeTaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_a4ef75a1-18cd-4332-a000-a5d6df103a95_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized gains (losses) on investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_72c813cb-d933-47d0-8fe2-f4f4c5de833a_terseLabel_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of monthly payments</link:label>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_label_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Monthly Payments</link:label>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_documentation_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Monthly Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:href="natr-20220930.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:to="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_83ed091f-b738-4e6f-805a-21b0325daeb0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9dc2b92a-409b-464e-88fe-d4cae43665f6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_33cd552c-3894-4d53-a2b8-9c5ba130ab95_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_3d315c0c-c2de-4985-8a98-8b5a1f49e9ef_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of note payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_abff6de8-1cad-4869-8656-a8d425343f39_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for losses</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_25b8db3f-35a0-43ea-837b-a9d538458ca4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_299d4c31-4dfb-4c50-bb36-a75447b88f61_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation loss (net of tax)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_82091e63-f92a-4a2b-978b-13ea73edacca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88160520-da3f-4acf-b78d-315c704c3a6e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_effbe988-a5fd-4a2e-8eae-f9036df46522_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_GeneralHealthProductsMember_c135d6eb-d640-49e1-8ea0-a696d06cd750_terseLabel_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General health</link:label>
    <link:label id="lab_natr_GeneralHealthProductsMember_label_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Health Products [Member]</link:label>
    <link:label id="lab_natr_GeneralHealthProductsMember_documentation_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to general health products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember" xlink:href="natr-20220930.xsd#natr_GeneralHealthProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_GeneralHealthProductsMember" xlink:to="lab_natr_GeneralHealthProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a33b8d2c-76c9-445c-aa56-4f780fe66581_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_00dad196-bc5e-40bc-91b8-ee24ed779515_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_43110d52-f169-4099-afc7-31becff3d27b_terseLabel_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_label_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Non-Cash Lease Expense</link:label>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_documentation_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Non-Cash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense" xlink:href="natr-20220930.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_OperatingLeaseNonCashLeaseExpense" xlink:to="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_6fc79310-a89d-498a-b7b0-95ce1a665d1b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of trading investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Purchase of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_4df7e6c8-10ce-4d54-b18d-8ca5f3cb3769_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4d04fbf2-c56a-4bce-b704-7e5d4d9baa36_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_c1cb64af-f216-4916-a83f-8b552b197be2_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award performance period</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_b59187a7-6da3-413b-8907-6b0c51053cf8_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting installments</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Vesting Installments</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Vesting Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_0144332a-cac0-47d9-8cf6-57bd7a7cc927_terseLabel_en-US" xlink:label="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount for lack of marketability</link:label>
    <link:label id="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_label_en-US" xlink:label="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability</link:label>
    <link:label id="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_documentation_en-US" xlink:label="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:href="natr-20220930.xsd#natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:to="lab_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c6e16be4-0cde-454b-9770-975616def6dd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_25d09b27-6c2a-491a-a497-8d97c3bb5724_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments of related party borrowing</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_79a3dbb1-c078-4979-98dc-870c63ce999d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_a92415fb-6827-4959-ba04-06af03e2eccc_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_6bad8059-fb20-43e6-b100-cd69c3506a90_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, rate</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionRate" xlink:to="lab_us-gaap_RelatedPartyTransactionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_f99c205d-7530-4187-8040-2eae280f7ff2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_f6aa44f1-f2cf-4c61-86c7-1207b0e0fa6f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8355bfa0-7961-4d45-bcbb-3ec47d94a772_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ChinaJointVentureMember_8adc7f87-9748-4941-bc79-41eeda580e68_terseLabel_en-US" xlink:label="lab_natr_ChinaJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China Joint Venture</link:label>
    <link:label id="lab_natr_ChinaJointVentureMember_label_en-US" xlink:label="lab_natr_ChinaJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China Joint Venture [Member]</link:label>
    <link:label id="lab_natr_ChinaJointVentureMember_documentation_en-US" xlink:label="lab_natr_ChinaJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember" xlink:href="natr-20220930.xsd#natr_ChinaJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ChinaJointVentureMember" xlink:to="lab_natr_ChinaJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_44a42ce1-f072-4176-befb-79e3b5d074b5_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_df45128a-7269-4e77-8d7b-a8aee7741645_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of separate increases</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Number Of Separate Increases</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Number Of Separate Increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:to="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_b908b5b1-d064-4226-8f0f-3310f19b4a33_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_fa825403-2dde-4c77-b787-1a4b38e21bfc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation potential compensation expense to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d455ea8f-f968-48d8-a1a6-72613bd4498f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_48b2fe97-5759-479c-bcb8-6a49eadf2e61_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_6d21d1b0-4895-45ea-a484-e14d20cc4e41_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5b33f5d1-46a8-45e9-a3d6-0ccc504eab59_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9d8c5a0d-c0d8-4d2f-b2c8-7e0c40fee846_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 - Quoted Prices in Active Markets for Identical Assets</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_dc5fec23-76a4-4749-a856-394651fe0668_terseLabel_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assets per segment</link:label>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_label_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment1 [Table Text Block]</link:label>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_documentation_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:href="natr-20220930.xsd#natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:to="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_aa8744b5-9f33-4cc0-a64d-70831a95b9c1_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3e321982-bb71-44f6-a505-229cb3faabbd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_c521f70d-255b-463e-a4a1-002a48cc82e2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_32701e55-4e3f-4bf0-b6b6-87140235f471_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ContributionMargin_d602d1c9-7841-473f-bdb2-29124420aa42_terseLabel_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total contribution margin</link:label>
    <link:label id="lab_natr_ContributionMargin_label_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:label id="lab_natr_ContributionMargin_documentation_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin" xlink:href="natr-20220930.xsd#natr_ContributionMargin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ContributionMargin" xlink:to="lab_natr_ContributionMargin" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f785c594-43cb-459d-b593-7f373ead3997_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_93805d30-816b-4b48-b3fe-4bd87b7a566f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_6bcf47e2-4266-4609-910f-5741b8ec6af9_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_36f8e92a-72b5-4ff9-ac4e-e650ae55b0e0_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_5d0bd6e7-af2f-4089-85d0-1e9ce036902f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_505f4019-ec26-4034-b4c6-f8f2bbc60213_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_88cc567c-c44f-4e12-bc2a-69fd649c8c1f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_456745f7-a553-4485-b8f8-6995df70f1ac_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember_155a3299-243c-49ec-92ff-6baa0f01d441_terseLabel_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs), 1-year Vesting</link:label>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember_label_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs), 1-year Vesting [Member]</link:label>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember_documentation_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember" xlink:href="natr-20220930.xsd#natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember" xlink:to="lab_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_18e1d892-2674-4714-a448-57e252e30b67_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00026243-e99a-4896-bc34-c8da047ccb28_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0606f87a-d1cf-4123-bbac-bd1552dfc1ba_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a920284e-2d02-419f-8c94-0b35b4b6527b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_35fafacf-f9c4-4cd0-b16e-ad861df657d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Exercise Price&#160;Per&#160;Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_9c8c4e21-b28d-4e5e-aed6-cc65942e54d9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility and Other Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ea5d75b-cd13-4111-82c6-e18c68314c3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_e4d88cba-2744-4944-ab00-44d500d031ce_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_b4ed1b6a-7476-46d7-bd56-0a15cb820ab6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_cf6501b3-d2fd-4898-aa66-0b68787cafb0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_70fcab6c-ef6d-44da-b3e2-f458dc8bacbf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_53e82be4-44fe-4cdd-ae2a-93f655f32042_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_094b5baa-e21d-4111-a245-3befa5936a76_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0f245c6a-4039-40a1-b6fa-d7417aa52058_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ef1f765f-895f-48d5-a4ee-dcfc18c36121_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_a069a630-0496-4011-b3b0-58e4fde5a5a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_f75298f1-8c91-46e7-8c4f-a012cbcbcd8a_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase in maximum borrowing capacity</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:to="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_89eb5637-74a9-43e4-804b-4b531dc7e5ea_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_94590da5-e75e-4aa9-9159-a44e7354afb1_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, three (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Three</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the three operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c103707a-f4ce-471e-b445-6d644312f61c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_36cee6f3-336b-4d6c-8bea-5a5ee81b7b1e_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_2f080953-29ed-4d28-8e76-9381d27ae6c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_6bcdec5d-1950-4be2-846c-073d8f301f48_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted net income per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_c31ae85c-6776-492b-9455-5369f66b7e1f_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, one (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, One</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the first operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_f9bbe975-3d1f-4005-8ead-7468ea1e6f0d_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, two (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Two</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the second operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_e10a4f96-7733-47dd-80a8-329f8e0a2b68_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_beeeff33-f54a-4717-8161-ad864e22c902_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41b3a44-d8ed-43c6-a96c-7a2da4c4042c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_371355f1-a8bf-499c-92f9-2c227208f72e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_2d082386-ae41-43a8-8898-2a2322e3722e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f1121e2e-522c-4fb9-a84f-36c860ee9c3e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3d635d67-a0e6-4b55-ab8b-8343e9c63e31_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_abd37b38-99fe-4119-a0f6-3f2ccc051898_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6d39e7fd-e41f-486e-a45b-b1f70db67bcf_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_1d04de24-3360-445b-b5d0-c82a91b1df14_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_7ba4801d-1c0e-49e6-80b3-ca48389a9ab4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_EuropeSegmentMember_5f746611-8979-48c3-a2a5-1f38b0e4fac2_terseLabel_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_natr_EuropeSegmentMember_label_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:label id="lab_natr_EuropeSegmentMember_documentation_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember" xlink:href="natr-20220930.xsd#natr_EuropeSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_EuropeSegmentMember" xlink:to="lab_natr_EuropeSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ee1571f5-9ec3-407f-b8c4-bc1ae29f1d32_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation payable</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_34e0b1cc-b258-4d83-b0ca-fc7edaa428e0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_4a5ca66a-06af-4338-87a4-fd61401eafd8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d07b5357-f25d-47b0-90ae-cfbccb558545_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c9032fe6-877c-443f-8179-b68881b050ed_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which the remaining compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_955b7be6-a826-434d-a52c-989ac72dd0c6_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d33e97c7-92eb-45bb-a5c7-1ef5a459fd1c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_060c97c4-166a-4e47-9f35-a09cebc5d35d_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NetSalesandOperatingIncomeTargetsMember_e9893730-2fea-433d-ba69-67080aed0a9f_terseLabel_en-US" xlink:label="lab_natr_NetSalesandOperatingIncomeTargetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales and Operating Income Targets</link:label>
    <link:label id="lab_natr_NetSalesandOperatingIncomeTargetsMember_label_en-US" xlink:label="lab_natr_NetSalesandOperatingIncomeTargetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales and Operating Income Targets [Member]</link:label>
    <link:label id="lab_natr_NetSalesandOperatingIncomeTargetsMember_documentation_en-US" xlink:label="lab_natr_NetSalesandOperatingIncomeTargetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales and Operating Income Targets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NetSalesandOperatingIncomeTargetsMember" xlink:href="natr-20220930.xsd#natr_NetSalesandOperatingIncomeTargetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NetSalesandOperatingIncomeTargetsMember" xlink:to="lab_natr_NetSalesandOperatingIncomeTargetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6307dfde-b0ca-4555-8070-8490a16cefde_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_FosunPharmaMember_8cd336ac-505d-4be1-a75f-6063cfd7d962_terseLabel_en-US" xlink:label="lab_natr_FosunPharmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fosun Pharma Member</link:label>
    <link:label id="lab_natr_FosunPharmaMember_label_en-US" xlink:label="lab_natr_FosunPharmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fosun Pharma [Member]</link:label>
    <link:label id="lab_natr_FosunPharmaMember_documentation_en-US" xlink:label="lab_natr_FosunPharmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fosun Pharma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FosunPharmaMember" xlink:href="natr-20220930.xsd#natr_FosunPharmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_FosunPharmaMember" xlink:to="lab_natr_FosunPharmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_40e684c4-a2d3-440f-b09b-8cbdced29cc6_terseLabel_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum number of claims that the Company's insurance coverage may not be sufficient to cover</link:label>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_label_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Number of Claims Companies Insurance Coverage May Not Cover</link:label>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_documentation_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:href="natr-20220930.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:to="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_7bbcaa46-abba-426b-8968-8959123f71ad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_03ecfd32-2fd5-4ee3-a3b3-21d853db9ae2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e3c12fc3-4ff1-4596-a973-17cff738df84_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f9ccdb1b-3d75-4b84-81cb-40475ebc4dd1_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_b9f7542b-cd78-41ac-96d6-fe7569edd6a8_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_63422168-de6a-413e-8ed9-5ab1a6804063_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_45d88e91-527c-42d5-8c6b-13de2f0618b5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_74d47690-c21a-432d-a811-57fcc6860e37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_83228fdb-8c9a-41d1-b6b0-97a772d2800f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_8fa4018e-eabb-4037-b874-f65f24a59031_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7b562bc-48b2-4d00-8208-be12e9ac7899_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf650e8d-6157-4ce2-b615-69414d1c5745_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_9c3642ca-d7b5-4b00-b8c6-0bc83db5039f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_9fd2660b-f471-4cb8-885d-c5e0e97239aa_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_65548e88-fbe7-4570-aae0-9f7f686af662_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_be787a73-1dbf-4b78-a321-b4a8ad1e67d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_fae54e98-3d56-4dba-9257-26217c887504_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ae98d53e-4726-487c-97cd-16d70bb85ae6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_b89b7f48-0d40-47a7-b642-d603c7427b02_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_69328750-aa78-4389-ace6-4a4a330268d9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes, as a percentage of income before income taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_f21acf5e-c2d3-473c-8c47-b2b07d11cbaa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_c1b855c4-558b-4c39-b510-c22fa0354d35_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NaturesSunshineProductsChinaMember_017252ce-14be-4ac2-9d75-7d60bb823db3_verboseLabel_en-US" xlink:label="lab_natr_NaturesSunshineProductsChinaMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NSP China</link:label>
    <link:label id="lab_natr_NaturesSunshineProductsChinaMember_label_en-US" xlink:label="lab_natr_NaturesSunshineProductsChinaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natures Sunshine Products, China [Member]</link:label>
    <link:label id="lab_natr_NaturesSunshineProductsChinaMember_documentation_en-US" xlink:label="lab_natr_NaturesSunshineProductsChinaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natures Sunshine Products, China [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NaturesSunshineProductsChinaMember" xlink:href="natr-20220930.xsd#natr_NaturesSunshineProductsChinaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NaturesSunshineProductsChinaMember" xlink:to="lab_natr_NaturesSunshineProductsChinaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_7771d7d0-1392-4fc4-9662-766320aeb9f0_terseLabel_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_label_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_documentation_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:href="natr-20220930.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:to="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e074b47f-6530-44a8-ae91-c87d9473c5d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_a3e57409-cf90-4b1d-b4fc-6d14a18ea602_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_4bf0f2df-b6e2-4826-8081-13db01f9362b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of shares authorized under the plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_5458519d-7edc-4ed0-970e-045ab7763a42_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities - Trading</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_a2ef7c12-2baa-4e70-a86d-0677257ba983_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_414efa22-d5fa-4bd5-a818-d50cb6b8298f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_c925d01a-a660-4779-aeaa-0688a862fb9e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_8e07e4f3-c89a-4570-b14d-2a700a191bda_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2fa369f3-22e5-440d-a0a4-7428febe4773_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_db2555e2-e6f8-4c32-b143-1d6af956dc32_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_da343095-98f2-4a9a-a734-7adac00a1323_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a1f3f600-d5ae-4e38-95d3-8723356570fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_407c8b08-c67d-47de-b93c-e63222b2ff6a_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_e022b7ff-aab5-40ee-9083-4a60ae56bb8e_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_528a01e4-429c-4c50-a4b8-e36c893852bb_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_e0249c6c-3ce8-4b31-acb3-68083a16ac73_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_b6f75fab-74d4-410d-843e-fcddcee65bdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Transactions</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cbd71881-70a5-48e0-b062-d0970247e41e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ContractWithCustomerContractTerm_1e6ecd70-50ff-49b7-8b54-ec9285cae3e1_terseLabel_en-US" xlink:label="lab_natr_ContractWithCustomerContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, contract term</link:label>
    <link:label id="lab_natr_ContractWithCustomerContractTerm_label_en-US" xlink:label="lab_natr_ContractWithCustomerContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Contract Term</link:label>
    <link:label id="lab_natr_ContractWithCustomerContractTerm_documentation_en-US" xlink:label="lab_natr_ContractWithCustomerContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Contract Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContractWithCustomerContractTerm" xlink:href="natr-20220930.xsd#natr_ContractWithCustomerContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ContractWithCustomerContractTerm" xlink:to="lab_natr_ContractWithCustomerContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_0c19c152-b1bb-4fa4-b429-6a12f7fe46f0_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_bd2efbcd-5961-48aa-83ca-b42fd2dce30e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of cash dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_51a2076d-b7f6-4288-ad5f-359cbb05aa8b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_d8c4bba2-7b32-4648-9cd6-d055909968e5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d25649d1-874d-4457-bc47-db57082f06f5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_78cedaf7-86de-442e-a47e-2841b3031a5b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_7aec8246-65c8-429e-b5dd-292be0b2e92d_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, common stock, cash</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_f198d2cb-dcfd-46c8-a7e7-a291ff1dcbef_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_47ac2641-b0d6-466d-8ba4-9d24cc6d3bfd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_889541b2-58ee-4491-bc68-b6dcac2471d2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_cd1f5ecc-8864-49b1-8aef-0783e9c39927_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_fa63187a-7668-4c06-81d4-d3ab39a9eb07_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_becff12d-8213-4ead-8bdd-d03010b6de32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4254c8c8-cecd-436e-b3d4-f080a3487043_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b8670c12-9f3f-473c-ab7d-14f5b9580feb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_abe93776-f8f2-4611-afae-e38c196f01a1_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_39ef6354-f23b-4351-b7c7-7067c893cd38_terseLabel_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund period</link:label>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_label_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Refund Period</link:label>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_documentation_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Refund Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:href="natr-20220930.xsd#natr_RevenuefromContractwithCustomerRefundPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:to="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b05b3803-e875-480b-bff8-4418114fcc42_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_260728df-4d6e-4dd7-a069-4f8d6269cd82_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_27d6d01a-9c35-4876-bb7e-cea40283b259_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of trading investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a006dae8-e3c7-4676-a29e-d116874ad47f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_d7aaa755-225b-4775-96c4-7c690199af4d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_891982af-eba2-4a49-83db-c98f5098bf4b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d3e981c8-6f4a-4f84-9294-37297e9d2e73_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $673 and $143, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a27f356e-1964-4fdc-a595-8bcd7db651c1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_5e75b199-a8ad-4ef5-9fa5-06e348d369fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember_01cbf9e9-afd7-4a7e-8b19-04447fa926f2_terseLabel_en-US" xlink:label="lab_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA Performance-Based Restricted Stock Units</link:label>
    <link:label id="lab_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA Performance Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA Performance Based Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember" xlink:href="natr-20220930.xsd#natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember" xlink:to="lab_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_8d9b29f3-d5cd-4728-9a71-0f05be567852_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_0d828425-aeab-44d6-be65-8205bf0f69ed_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_66a85e77-143c-42bf-b5a3-3cf966d39309_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_6359b20a-89fa-4784-a76b-0ba4f6be5db5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ceece4e5-32ca-4eda-8e83-f36722803cc5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f67c4361-cdc3-495b-b326-afd7db555718_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_9e03263f-c0bf-4469-a05e-2ea6a7018ce0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_17428449-8d70-4755-8b7b-9cda84fcb89f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_b05b42b7-66aa-49b1-bc3d-ff71fa94d05d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_2d9817cd-b621-4634-a20c-c725fe91646a_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_e766e852-8fee-4f24-9830-71c4696d23a1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_cd29266e-764c-4f32-8950-1454c099c587_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_7de55832-15eb-460e-8aa4-81d5c863d3e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_1f9f676c-684b-43ce-92bd-223340a88378_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ef788be-0908-4f58-a629-9e2a9e57d74b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_WeightManagementProductsMember_eb74d95d-e487-4930-9202-252abe53ae32_terseLabel_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight management</link:label>
    <link:label id="lab_natr_WeightManagementProductsMember_label_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight Management Products [Member]</link:label>
    <link:label id="lab_natr_WeightManagementProductsMember_documentation_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to weight management products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember" xlink:href="natr-20220930.xsd#natr_WeightManagementProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_WeightManagementProductsMember" xlink:to="lab_natr_WeightManagementProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_2ccbd704-2135-4ee2-aeef-9202d76bd2cb_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_78a052b2-c03e-401b-b98c-73092fa748fe_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_539d18ee-5d36-415d-850d-35cbd8d220e3_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6076bb13-14cf-4db8-a111-5f36de606d53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0833d231-2a04-42d4-bb79-cdd47292ab74_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_e15ace3d-c939-479a-942a-81f915d23c2e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4676567b-0832-4554-b4f1-9a7cc4cad221_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_d66d515a-3a19-4927-9f53-401b7045995c_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f2d03cb6-f47b-4174-b5e6-52761b410fc7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d22f0bdf-4e19-4896-8326-68d364b3b7c5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AccruedSeveranceandRentCostsMember_04665d4c-6dab-443b-8180-82878afc9a58_terseLabel_en-US" xlink:label="lab_natr_AccruedSeveranceandRentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance and Rent Costs</link:label>
    <link:label id="lab_natr_AccruedSeveranceandRentCostsMember_label_en-US" xlink:label="lab_natr_AccruedSeveranceandRentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance and Rent Costs [Member]</link:label>
    <link:label id="lab_natr_AccruedSeveranceandRentCostsMember_documentation_en-US" xlink:label="lab_natr_AccruedSeveranceandRentCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance and Rent Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedSeveranceandRentCostsMember" xlink:href="natr-20220930.xsd#natr_AccruedSeveranceandRentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AccruedSeveranceandRentCostsMember" xlink:to="lab_natr_AccruedSeveranceandRentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_46d245ef-2885-4b21-8da9-828d437ac5c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_cb37f8f0-256d-4efe-a0d4-349ec0144227_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6aa7dbc0-5680-454e-b2a0-77ab1ba347a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_3f858ce0-4d1f-459d-8099-2ab488bab5f9_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_797dbb0c-c438-4e3c-b677-46c1b95cef8c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_2c26ac2a-2ab2-434a-9986-4a739497c923_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_1b06e0f1-162c-435e-8b62-d27a731abcca_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_584be386-1bd7-4b14-bc2e-bdd14a3df0cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic values of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_80693967-29e8-4dab-a401-5cb649c669bb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_a8bdc257-ed42-4c2e-921b-301a4fbd3e2e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_8939c262-e2cd-4989-aeb3-00c201974aff_terseLabel_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of principal categories of products</link:label>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_label_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Principal Categories of Products</link:label>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_documentation_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Principal Categories of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NumberofPrincipalCategoriesofProducts" xlink:href="natr-20220930.xsd#natr_NumberofPrincipalCategoriesofProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NumberofPrincipalCategoriesofProducts" xlink:to="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7bdaa359-4a84-41e8-93bb-b32bfc745cbb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f7655058-7dcd-4cb4-a4ea-ec9ffac4c880_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_d2ff3cef-f662-4a00-aa6d-309f3d6aee9c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ac0bcf7a-e1e9-47c1-87a1-10579fc7c73e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of composition of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_6c038007-aae8-46a9-a1d2-b29ef120d475_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_2dbef26d-259b-4eba-8678-952d2b1513d6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividends (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d10ccdef-acdb-48a2-b43c-83435500e777_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value, 50,000 shares authorized, 19,166 and 19,724 shares issued&#160;and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2e1adc05-9c61-4dc2-b5a6-665e4d8428bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_ed199003-105b-4ca0-a592-f0c66b0f532d_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cf4c17af-656b-4867-a938-959a950c9bea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_a472ecc5-fd83-458a-b39f-99f1e815f585_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability related to unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_A2012IncentivePlanMember_a66ce093-f36b-4443-a56d-abede3baec23_terseLabel_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Stock Incentive Plan</link:label>
    <link:label id="lab_natr_A2012IncentivePlanMember_label_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Incentive Plan [Member]</link:label>
    <link:label id="lab_natr_A2012IncentivePlanMember_documentation_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to 2012 incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember" xlink:href="natr-20220930.xsd#natr_A2012IncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_A2012IncentivePlanMember" xlink:to="lab_natr_A2012IncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_fad8db9c-6163-42eb-b94f-ace9969cd9b4_terseLabel_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction period for issuance of shares</link:label>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_label_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction Period for Issuance of Shares</link:label>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_documentation_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the restriction period before shares will be issued related to a share-based compensation plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares" xlink:href="natr-20220930.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_RestrictionPeriodForIssuanceOfShares" xlink:to="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_229e412b-99ff-4d54-8445-faaeb82a5b66_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22a15197-7873-4a5b-84ae-c715d81271d5_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_10666755-afb2-46e5-9889-8a70cd5fdfa7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bd42aba5-29a9-4c41-94e4-66307398c4f5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3523c599-43a9-4ebc-aaee-e4374bf92209_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b03e1bf3-b860-494c-8efa-c86e34659ae9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_1cb0d254-399a-4ccd-b2af-3d7070d99278_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Liabilities</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_73e03803-0f40-4a78-bc22-88e294c449a4_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued volume incentives and service fees</link:label>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_label_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Volume Incentives and Service Fees</link:label>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:to="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c08f1886-5a35-4223-92c8-d122f6101f0e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e1f847b4-f702-4ca1-89c5-8769765c0d72_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_fcbbf3d5-5583-49b4-a2a2-a7f1c3ea62ae_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_3b83ada9-8acd-49ab-9a21-6ba4e7917157_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_fc5d0cbf-d7fe-4e7e-a235-ecb1f4cb39ea_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum withholding requirements (in shares)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Minimum Withholding Requirements</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_bd438238-98eb-4987-b63a-9ad2311cebde_terseLabel_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_label_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options and Restricted Stock Exercised</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_documentation_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:href="natr-20220930.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:to="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_35b779f5-fae3-43a5-9bfc-4957835c5596_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ca5fbaa0-c75c-4964-b01a-97c673b4fd17_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f2f5541-3de2-4bd0-9e0b-8f8386962bf8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_country_KR_f12547aa-aea0-4aca-8498-c8b0b4e65749_terseLabel_en-US" xlink:label="lab_country_KR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea</link:label>
    <link:label id="lab_country_KR_label_en-US" xlink:label="lab_country_KR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KOREA, REPUBLIC OF</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_KR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_KR" xlink:to="lab_country_KR" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_0690d5ad-2bfd-442d-a70c-8b0fd0526fef_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested subject to restriction period (in shares)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested Subject to Restriction Period, Number</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_86c93057-15ee-438b-b83b-42c16c4ccc84_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_085d8ed4-5eff-41ef-a5b9-e0fe92c9c349_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reportable business segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_324f88d1-dd62-4261-8426-51b5ab20ac2c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_35f28163-3def-4025-b9ac-e59ace866c6e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_f4e06936-2124-41bf-8f75-f226dfb5cb0f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities - trading</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_b08698ab-6afd-4f72-95dd-3c6aa933bc9f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities portfolio</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Restricted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingRestricted" xlink:to="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_027e93db-b13a-469b-848c-77035f33a20c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_af041d6c-fc76-4a1f-b429-a8bb6a0d7961_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_333a98f2-bf5c-44b9-9254-831dc309225c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual commitment fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_bba89acc-eb9d-4faf-ab27-0bece1fbe507_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_e251fcbf-07b7-4c4f-b8da-7d5d85a6b287_terseLabel_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive shares excluded from diluted-per-share amounts:</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_label_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities Excluded from Computation of Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:href="natr-20220930.xsd#natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:to="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4cb74317-97d6-49fe-b0b7-eb3d4a1be6ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1b64449c-7190-40d6-ac1c-4d31aa31d892_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91b35891-99d4-46b5-9417-842e4e13d182_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_cd2f21df-f5ca-4a22-a9ca-a7adfc538b9c_terseLabel_en-US" xlink:label="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from diluted-per-share amounts:</link:label>
    <link:label id="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_label_en-US" xlink:label="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Dilutive Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:href="natr-20220930.xsd#natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:to="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_76ec8d1d-ebb6-4c65-899e-7bbb51ad73f4_terseLabel_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_label_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options and Restricted Stock Exercised</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_documentation_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:href="natr-20220930.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:to="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7a946b2d-5e95-4c21-a102-e014e7a09008_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_da686f17-e645-4b4c-a34d-dda8cd6f4c4c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c04a1ad4-618b-47e2-a6be-4bb7ba8696ff_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_63c5a7f1-74c7-47dc-b4c8-23829cd39357_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b0091b68-7d0f-4d44-ab9a-e41841fd9b2e_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_VolumeIncentives_801c962c-c632-4c8f-9c25-8b2af5c1a9e9_terseLabel_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume incentives</link:label>
    <link:label id="lab_natr_VolumeIncentives_label_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume Incentives</link:label>
    <link:label id="lab_natr_VolumeIncentives_documentation_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives" xlink:href="natr-20220930.xsd#natr_VolumeIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_VolumeIncentives" xlink:to="lab_natr_VolumeIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_cd2644d2-2e4b-401e-8e87-40db5a1af0bb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_98b80cb3-7818-41ab-b96f-283d1eea43fa_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c5f48e88-b001-498e-9d9c-0ae4b302a5b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ade93651-f318-4680-b718-e09ac68d4977_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3bc082b4-a4c6-42c8-b4cd-73c2979ee73f_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3ec0b6ab-1824-48a4-94a0-2a962cd31433_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other loss, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3cb02482-3274-4060-b3ec-52791f42c74a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other loss, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_8c6fac79-203d-47ea-b495-a8f32e1ce6ae_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_e2c77f38-6606-42c2-8b67-4254cf9ee4bc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b60e9fc3-01e3-4ae7-91d0-63ce6849b563_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DigestiveProductsMember_dc411818-376d-4439-a38e-e2c9e16fdaf0_terseLabel_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive</link:label>
    <link:label id="lab_natr_DigestiveProductsMember_label_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Products [Member]</link:label>
    <link:label id="lab_natr_DigestiveProductsMember_documentation_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to digestive products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember" xlink:href="natr-20220930.xsd#natr_DigestiveProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DigestiveProductsMember" xlink:to="lab_natr_DigestiveProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c69146c0-018c-4e6a-a796-37089f807e48_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_683eb61b-28b8-419e-a2be-3d2a55129d71_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d1536d99-a4de-4891-a05d-fa6ca12da58b_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_e9d98f89-2eb1-4ddb-82bd-cab3e321a91e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of revenue generated by each of the Company's product lines</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9c676b40-18ad-4561-83bb-56e844a8b0be_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_d2f10407-b055-4de6-b736-6cc2be363747_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of consolidated net sales revenue by geographical locations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_69eda8e0-9838-457f-b45a-7eac5f28d5ab_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_61470cf4-69a7-43e5-acce-45cb987844b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_d113e78d-064e-4519-95d0-91721b6b91f0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_509f7f21-b6f6-4701-b84a-496929e214c6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cc5bb2a1-b115-420e-b570-eed8c29a6541_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_e156c0ca-8f6c-40c8-b2f7-74626ad8b0cf_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d3d2401a-021b-473c-819e-f5aa3e32c0f0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_f834ca8e-0c8c-4e4a-bb0e-ed4622673fba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_CompanysJointVenturePartnerMember_7fd12aa1-41e7-448a-984e-bc021496b83c_terseLabel_en-US" xlink:label="lab_natr_CompanysJointVenturePartnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Joint Venture Partner</link:label>
    <link:label id="lab_natr_CompanysJointVenturePartnerMember_label_en-US" xlink:label="lab_natr_CompanysJointVenturePartnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Joint Venture Partner [Member]</link:label>
    <link:label id="lab_natr_CompanysJointVenturePartnerMember_documentation_en-US" xlink:label="lab_natr_CompanysJointVenturePartnerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Joint Venture Partner [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CompanysJointVenturePartnerMember" xlink:href="natr-20220930.xsd#natr_CompanysJointVenturePartnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_CompanysJointVenturePartnerMember" xlink:to="lab_natr_CompanysJointVenturePartnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_4741be8e-e156-4fd2-9eed-d359be4b541a_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability related to unrecognized tax benefits</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_label_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Liability Related to Unrecognized Tax Positions</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:to="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_cb8d69e5-8747-4676-91de-762200efda9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_54536c4c-549e-474d-a29d-48fb3fa85e36_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_aece50d4-5dd5-4a86-b4b6-534966073962_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_62387e37-7452-4ebe-8c2c-ad4526f53a05_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the company's hierarchy for assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_5fcfe94d-709b-491a-bf9d-382ffd448174_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in dollars per share)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e7596ab0-2381-46e7-ba04-4c55a88e8acd_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ImmunityProductsMember_067e84ce-ecee-45dc-ae82-8b1b145d398b_terseLabel_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immune</link:label>
    <link:label id="lab_natr_ImmunityProductsMember_label_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunity Products [Member]</link:label>
    <link:label id="lab_natr_ImmunityProductsMember_documentation_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to immunity products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember" xlink:href="natr-20220930.xsd#natr_ImmunityProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ImmunityProductsMember" xlink:to="lab_natr_ImmunityProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b94be8e6-5dec-4860-9b3c-b12e25f68c49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_614d7669-9d4e-40ab-bc37-49ed3d5ef412_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_ccac2268-71ec-42ac-817f-7c13ebe88990_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0203119d-e594-4a71-b4e1-28cf0ad73c37_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d6c26dee-fb56-4649-a572-60be59a47849_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture ownership, noncontrolling party</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_730aa88f-678d-4afa-94e9-b1474a7261b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_d8623908-249e-4cfe-9cb2-2f14504a3531_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments of revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_4f228362-0657-4e09-b605-1a79b3d8a755_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_57abed8f-6f82-49a8-9934-27f7f591f69c_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6a6686df-e91d-4633-9ed4-b2d96caffb63_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss_a411e52f-d960-49fd-8fa4-1d50d385bf75_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, trading, realized gains (losses)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_22f49a91-63d7-4c7d-bb15-f1c57625e980_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_369f8b9f-8e7c-4c33-bcf0-c5c0e0650418_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3df1e06c-d24e-425e-a0d7-e96c8764c7fc_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d6a56af1-2157-4a14-afdd-578ffd4c42a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8b4a5847-1d0e-4f9c-ae49-f54bde9c8ec0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_9c225c8f-8a04-4efd-8650-fbe1ad662afa_terseLabel_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued volume incentives and service fees</link:label>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_label_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Volume Incentive and Service Fees</link:label>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_documentation_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the liability that is related to incentives that are payable, due to volume sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees" xlink:href="natr-20220930.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AccruedVolumeIncentiveandServiceFees" xlink:to="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_69229036-cef2-4129-b604-7e41d2668e31_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_8eaaf5e8-4e4b-47c7-bde8-f76ae28a6179_terseLabel_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital Credit Agreement</link:label>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_label_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital, LLC, Credit Agreement [Member]</link:label>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_documentation_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital, LLC, Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:href="natr-20220930.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:to="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_95bfb0b1-b2e2-4f80-b9cb-ab50688f6a52_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_178892c4-6219-4fb2-9f5c-40b53c9fea0b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_f8412dcf-d3f5-4f27-a47c-9fe055186987_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NorthAmericaSegmentMember_d4cdb2c9-7bdb-40bb-a725-13922e71e1e6_terseLabel_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America</link:label>
    <link:label id="lab_natr_NorthAmericaSegmentMember_label_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment [Member]</link:label>
    <link:label id="lab_natr_NorthAmericaSegmentMember_documentation_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember" xlink:href="natr-20220930.xsd#natr_NorthAmericaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NorthAmericaSegmentMember" xlink:to="lab_natr_NorthAmericaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_c5b8c9b9-7c27-4e96-a3ce-d316e0acc7f6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a78403e2-19cc-403a-825b-d056c545c9f4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b3631d9b-549c-42c6-bd5f-37cee68a09b9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b0034b9a-e482-486b-8e68-10db68e5f63d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_a496ed4b-7d5f-4500-9cdd-3305b15acf67_terseLabel_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance based stock options operating income margins</link:label>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_label_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options Vesting Upon Achieving Operating Income Margins [Member]</link:label>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_documentation_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the performance based stock options, which vest upon achieving operating income margins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:href="natr-20220930.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:to="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_905f4a71-033b-42a8-a8bc-af754af223a3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67616fb9-7fd3-4bb6-897f-f92af3e49d68_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_104c282e-5739-4626-b51c-61b1172ab9b7_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_2a128a16-5cbe-40ad-9b41-81d210481d68_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_5431ae4b-a178-43a2-9e27-6433efac1f26_terseLabel_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement</link:label>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_label_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement [Member]</link:label>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_documentation_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember" xlink:href="natr-20220930.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_BankofAmericaCreditAgreementMember" xlink:to="lab_natr_BankofAmericaCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IndicativeIndexMember_6c26011e-3d60-4a55-8b80-85c730aeb758_terseLabel_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index</link:label>
    <link:label id="lab_natr_IndicativeIndexMember_label_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index [Member]</link:label>
    <link:label id="lab_natr_IndicativeIndexMember_documentation_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember" xlink:href="natr-20220930.xsd#natr_IndicativeIndexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IndicativeIndexMember" xlink:to="lab_natr_IndicativeIndexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_70d6bc1a-1fd0-4407-bafb-0ccffb0bde12_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b150160a-44f4-4e40-a603-b0058fdb23fb_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7b934c2b-13a8-4278-98dd-97a72eadd878_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b4e5c88a-b4b1-44db-9a36-2a67bab6bc17_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_98e5dcc9-6916-44ae-9e3e-6edfed6fe353_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_83580a4d-0b1b-4606-9485-c7cbe4efe4a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of consolidated property, plant and equipment by geographical locations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_03e9b750-4820-4e10-8f9b-00726f71ebb0_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b7371b1f-d59e-4558-9b9e-c154143b5c38_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net sales revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2abf0993-ed0c-44b4-ad8e-d524ce6ba081_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_09735efd-887d-4d81-9acb-2fdc002a2046_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5c462ead-351d-4b81-8b6c-22e63856f88a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_66562611-8f2c-43b7-a98d-42a4487665c5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 - Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_ed477c6e-3f5e-42c1-a573-08d9c024c3a5_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_TW_727b8820-5375-47a3-8b53-f6e1d98d23ee_terseLabel_en-US" xlink:label="lab_country_TW" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan</link:label>
    <link:label id="lab_country_TW_label_en-US" xlink:label="lab_country_TW" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAIWAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_TW"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TW" xlink:to="lab_country_TW" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_a5348bf8-507d-4dec-b178-2c4e545c9b5c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_e92c168b-76ae-41e9-bdaf-dba2ff20e215_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableRelatedPartiesCurrent_984fccd5-12f8-442b-a82e-cf189cfd4995_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, related parties, current</link:label>
    <link:label id="lab_us-gaap_NotesReceivableRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:to="lab_us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_43c61694-5850-468c-91f5-47201213eb59_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_de4bd1f6-2a81-45ec-8489-1a0737121adb_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_74e97406-d9d7-4a6d-87f2-15eddc2559bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_654343ed-ad6a-4941-a466-ac177ea905c5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3824fa56-2b82-403c-a36d-48d80ab70139_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_460dbfc3-e59f-4215-b76d-039e3a589a0a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to tax withholding for net-share settled equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_c4f1bdbe-48f1-49db-8718-14430ef05f1c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_4f70e507-500d-4171-9215-64bdb99b70f6_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange losses</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c20da570-26d3-41b5-8568-b935bb121c95_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4ce3babb-24cc-48c1-8ce2-2cb2922e92f5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3a703822-8d0e-4e63-a540-c34a4765c193_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_41c7c841-c498-46de-b5b7-0294429f92b3_terseLabel_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based stock options</link:label>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_label_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Based Stock Options [Member]</link:label>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_documentation_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the time-based stock options, which vest over differing periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember" xlink:href="natr-20220930.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_TimeBasedStockOptionsMember" xlink:to="lab_natr_TimeBasedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5f8194db-d8e7-4dd6-8535-17f2a555f94f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_5123f3ed-b74a-4e5a-9c98-76df6f2c3cc0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2 - Significant Other Observable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_bb8138f3-104c-4184-8ba4-4ed01a388180_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_8392551e-d6bb-4d2e-aaa6-8b3d1c795c06_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_69bdd538-fcc9-49a0-9215-f3cd49510b08_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bcef9425-6eda-483d-8a57-33753e381e64_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8c67ffe8-c93d-4f72-8631-2f17709b03f9_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_d764f84c-a6ca-40e7-a838-9e9e8b63c50f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture ownership</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4cbff0df-f3eb-41f1-92fd-0915294edb4b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_7d9852ef-ff98-47bb-b48c-32cb3bcec076_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term note payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_2ac308d3-43a6-4dd0-839b-5e11251a15a2_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability related to unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_4b5e2b79-b1e9-4677-addd-68d04d7aa44b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restricted stock unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ContributionMarginAbstract_19a57d50-d02b-41cd-a930-3f0a2b369607_terseLabel_en-US" xlink:label="lab_natr_ContributionMarginAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution margin:</link:label>
    <link:label id="lab_natr_ContributionMarginAbstract_label_en-US" xlink:label="lab_natr_ContributionMarginAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract" xlink:href="natr-20220930.xsd#natr_ContributionMarginAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ContributionMarginAbstract" xlink:to="lab_natr_ContributionMarginAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_f6b25a89-2854-4d2d-9a99-b591a873df4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b1064aa0-0db0-474e-afe3-884ac0f8128f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_4e13360c-fdd8-4e57-ad6b-9a37735dfdaf_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_83209a42-58f0-4e11-8da5-26a368565b39_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_e81f7fb8-9b44-4e6a-95cd-802c76ba7b7a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_6242f581-9d78-4976-b791-14e998ffd55f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, amount</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_903a6566-10ed-4cca-a983-7b8cd3bd9ad9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_84e5ffca-4aa4-4476-acce-08d1821cfa62_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_336d98bb-4146-40ad-a973-4ce697737138_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_a4a378e7-6e5d-4eba-bb24-442487538d5d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_2a3d70b1-1235-4e4f-bf83-a7ec4a64011c_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase in maximum borrowing capacity, per occurrence</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:to="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9c5dc217-2225-4b2c-bd29-2c37cde4a63c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d31ff48b-a885-400d-810d-17ea75b3d444_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized under the plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_42dd3332-9403-43e7-a0db-f4e5763b5dea_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNoParValue_06e71b6d-ed71-4b27-8568-27c364399c51_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockNoParValue_label_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, No Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue" xlink:to="lab_us-gaap_CommonStockNoParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_74540e60-232b-4a53-b109-27b979e9d437_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_OtherCountriesMember_74470c5f-5c1a-48e1-a295-bbd3810fc443_terseLabel_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_natr_OtherCountriesMember_label_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_natr_OtherCountriesMember_documentation_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to all other international countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember" xlink:href="natr-20220930.xsd#natr_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_OtherCountriesMember" xlink:to="lab_natr_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_92a96e09-37c2-4064-93f4-107e5f76a443_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares included in the calculation of diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4be5f4f8-b75e-44b7-ae5d-d7e66d820479_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_307ca8c0-af23-43d4-a027-75be4e38999f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7b75d41b-d2a6-4b14-9b2e-4238c13e41b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant&#160;Date Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_345b2824-7eea-42b8-95de-8672e1c8fd66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_5ab7288d-69a4-44e1-b621-4cb740a80bc3_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_cb5a64fb-1a71-4c30-9366-ca5bbcb0b8e6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7035097f-0603-46e8-86a5-09ad736e7d5c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b29032f0-b2c6-41ad-9b69-9ba993e727d6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_cce63096-e785-4ed2-9a0a-e33cb3062a43_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested stock options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_dac8b34a-ea82-486b-aa45-987d721a4c0a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_5672c88e-4b2c-4a6e-b5e1-f8252d89541c_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, outstanding, current</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_900129eb-0354-4d44-b86e-d30036c4abff_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_db9e7233-87b8-4e47-af35-fc743b90453b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_edfbddab-f1c9-4f12-8946-c273aeaa0241_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d6e4badd-40f6-4efb-bfa0-47835263bad4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_5195bde1-dbcc-409c-b4af-b4a61c4ca57f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_14ad8a0a-f688-419d-9b24-3f562b002de7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember_e2beeddf-6fca-4847-8d3e-460fdb732fb2_terseLabel_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs), 3-year Vesting</link:label>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember_label_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs), 3-year Vesting [Member]</link:label>
    <link:label id="lab_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember_documentation_en-US" xlink:label="lab_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Based Restricted Stock Units (RSUs), 3-year Vesting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember" xlink:href="natr-20220930.xsd#natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember" xlink:to="lab_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0767ef4f-5050-40d8-b5d0-18e5c39128e2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_2e254b0d-14c0-47a0-9c88-01c0d6b36a94_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6d67f490-e516-4751-9fcb-b2eb316d55da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_CardiovascularProductsMember_2ada7e28-f399-4dc7-bd15-346da89f6ae2_terseLabel_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular</link:label>
    <link:label id="lab_natr_CardiovascularProductsMember_label_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular Products [Member]</link:label>
    <link:label id="lab_natr_CardiovascularProductsMember_documentation_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to cardiovascular products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember" xlink:href="natr-20220930.xsd#natr_CardiovascularProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_CardiovascularProductsMember" xlink:to="lab_natr_CardiovascularProductsMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>natr-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0c0039ed-9423-4265-b7e9-653c93e0671e,g:99a2bdfa-c370-4e73-96ea-a47009d21b4e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://naturessunshine.com/role/CoverPage" xlink:type="simple" xlink:href="natr-20220930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3070fd97-a721-4e8b-ad94-049636d05698" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_DocumentType_3070fd97-a721-4e8b-ad94-049636d05698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_28a5fcba-9f7e-47ed-b10b-ff5ab039231f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_DocumentQuarterlyReport_28a5fcba-9f7e-47ed-b10b-ff5ab039231f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e6e5f261-7fa9-4891-81be-6568225cadfc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_DocumentPeriodEndDate_e6e5f261-7fa9-4891-81be-6568225cadfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_dc9f56bc-05f4-4691-adfd-640fc7c3b55f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_DocumentTransitionReport_dc9f56bc-05f4-4691-adfd-640fc7c3b55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1931d9bf-e461-4944-9255-025762f30b10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityFileNumber_1931d9bf-e461-4944-9255-025762f30b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d112cb40-e785-4651-8f5a-c2fcf7023cca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityRegistrantName_d112cb40-e785-4651-8f5a-c2fcf7023cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d5b7c2fd-8321-4747-87f3-d9c2afc5ca94" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d5b7c2fd-8321-4747-87f3-d9c2afc5ca94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2e9febbb-d7c3-40d1-92b3-03ac52a490dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityTaxIdentificationNumber_2e9febbb-d7c3-40d1-92b3-03ac52a490dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5081a56a-bd3a-4bf8-b715-a4bf384ce5bd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityAddressAddressLine1_5081a56a-bd3a-4bf8-b715-a4bf384ce5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_2b38181c-51b2-4be4-819c-3ccd98cdd259" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityAddressAddressLine2_2b38181c-51b2-4be4-819c-3ccd98cdd259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ce88aa62-4e59-40e3-8dae-1c4919bd0802" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityAddressCityOrTown_ce88aa62-4e59-40e3-8dae-1c4919bd0802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f14189fa-2b96-43df-9d40-50044c672a14" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityAddressStateOrProvince_f14189fa-2b96-43df-9d40-50044c672a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f4068812-21e5-49f1-8bee-78a5228561b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityAddressPostalZipCode_f4068812-21e5-49f1-8bee-78a5228561b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3d570b60-b184-41b5-a5eb-4e95c7f3b3f8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_CityAreaCode_3d570b60-b184-41b5-a5eb-4e95c7f3b3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_fd5e7849-49b6-4660-a3eb-e0367f7c09c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_LocalPhoneNumber_fd5e7849-49b6-4660-a3eb-e0367f7c09c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6f34018d-4c7e-477f-9832-29d5011270da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_Security12bTitle_6f34018d-4c7e-477f-9832-29d5011270da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_35496f33-9f21-4c76-8be8-50e6fbf3643d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_TradingSymbol_35496f33-9f21-4c76-8be8-50e6fbf3643d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_af087e6b-d27d-4710-9717-6bfeaa41de55" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_SecurityExchangeName_af087e6b-d27d-4710-9717-6bfeaa41de55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a77ec828-c2aa-4f4f-8707-8af6ad164f87" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityCurrentReportingStatus_a77ec828-c2aa-4f4f-8707-8af6ad164f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_571227ab-edc9-4992-b4cb-11befaef1404" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityInteractiveDataCurrent_571227ab-edc9-4992-b4cb-11befaef1404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ff34c003-09b8-4c07-abc4-47b5df9c86d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityFilerCategory_ff34c003-09b8-4c07-abc4-47b5df9c86d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f1bd4a4c-5c3f-4c84-bc45-51e3c461a1ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntitySmallBusiness_f1bd4a4c-5c3f-4c84-bc45-51e3c461a1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fb61af45-727b-48d9-b1a6-e25bfaf02f5c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityEmergingGrowthCompany_fb61af45-727b-48d9-b1a6-e25bfaf02f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b32fb22a-369e-44f0-b73f-4b3e1f2dab30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityShellCompany_b32fb22a-369e-44f0-b73f-4b3e1f2dab30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_8680324e-d4cd-4c65-b683-1e1cb73e52d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_8680324e-d4cd-4c65-b683-1e1cb73e52d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f70882d7-691c-4c99-a385-66e73457ed89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_EntityCentralIndexKey_f70882d7-691c-4c99-a385-66e73457ed89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4578cf7c-dac0-4277-aba2-e96d2bfc46d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_AmendmentFlag_4578cf7c-dac0-4277-aba2-e96d2bfc46d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_17835233-7f03-4ff2-b2a7-e08e16a8b3ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_CurrentFiscalYearEndDate_17835233-7f03-4ff2-b2a7-e08e16a8b3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_be025578-a915-4255-ba5f-bc10580c705a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_DocumentFiscalYearFocus_be025578-a915-4255-ba5f-bc10580c705a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_a9ccf796-f1f4-45b1-94c5-fdb8cc858b00" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_830a0be6-2ed2-4c3e-bdbc-04e4dab5ff41" xlink:to="loc_dei_DocumentFiscalPeriodFocus_a9ccf796-f1f4-45b1-94c5-fdb8cc858b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_63748b6e-8522-447b-a268-c4e8b359a5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63748b6e-8522-447b-a268-c4e8b359a5e2" xlink:to="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_92b1517e-6073-4f13-86b3-5e413dd335ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_92b1517e-6073-4f13-86b3-5e413dd335ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7a83d4c7-57db-46cc-b1b9-12f56eed2e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92b1517e-6073-4f13-86b3-5e413dd335ef" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7a83d4c7-57db-46cc-b1b9-12f56eed2e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1e7010c3-13b3-4818-a9c2-76c5d1703bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92b1517e-6073-4f13-86b3-5e413dd335ef" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1e7010c3-13b3-4818-a9c2-76c5d1703bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f56972a3-a180-413b-8602-a18898d01bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92b1517e-6073-4f13-86b3-5e413dd335ef" xlink:to="loc_us-gaap_InventoryNet_f56972a3-a180-413b-8602-a18898d01bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_48486fe9-ed46-47a7-8726-54ccdc6fbeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92b1517e-6073-4f13-86b3-5e413dd335ef" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_48486fe9-ed46-47a7-8726-54ccdc6fbeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ecd89780-7fb6-4258-a9c6-670d7c9cd070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92b1517e-6073-4f13-86b3-5e413dd335ef" xlink:to="loc_us-gaap_AssetsCurrent_ecd89780-7fb6-4258-a9c6-670d7c9cd070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8041a9e5-50d9-4e94-95a6-b58586d41fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8041a9e5-50d9-4e94-95a6-b58586d41fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2d93a30a-2583-4747-9d17-86fca037b65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2d93a30a-2583-4747-9d17-86fca037b65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_9f2a7511-b7bf-4241-ab54-173975eefc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_9f2a7511-b7bf-4241-ab54-173975eefc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7a5f9744-170c-4f82-8a8d-c43101d88cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7a5f9744-170c-4f82-8a8d-c43101d88cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f4d8ad13-1bea-4df5-9fcc-155e3007fdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f4d8ad13-1bea-4df5-9fcc-155e3007fdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_29d462b4-4758-48d2-92f1-1fc3187625f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d8fdb2b0-3db7-48f8-8c02-db47d285155c" xlink:to="loc_us-gaap_Assets_29d462b4-4758-48d2-92f1-1fc3187625f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63748b6e-8522-447b-a268-c4e8b359a5e2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_863b0d0e-c4c3-4f19-adfb-1cf6962403d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_us-gaap_AccountsPayableCurrent_863b0d0e-c4c3-4f19-adfb-1cf6962403d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees_b7b3757b-e682-4396-bbd0-1c940dd7a904" xlink:href="natr-20220930.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_natr_AccruedVolumeIncentiveandServiceFees_b7b3757b-e682-4396-bbd0-1c940dd7a904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3c5a3d3a-806f-4d3d-a33a-32496381b36d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3c5a3d3a-806f-4d3d-a33a-32496381b36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d4baae03-4099-4894-a8d4-caf2cd29cbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d4baae03-4099-4894-a8d4-caf2cd29cbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_404e92b8-cd22-41b1-8369-92ac03500aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_404e92b8-cd22-41b1-8369-92ac03500aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_fdf7705d-dcc0-4a36-9ebc-42b91c71768a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_fdf7705d-dcc0-4a36-9ebc-42b91c71768a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_77ca7836-d3ca-4b2d-b600-16c3954856de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_77ca7836-d3ca-4b2d-b600-16c3954856de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9e6b6e45-95ab-4aae-aa36-3aab0e5f4352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9e6b6e45-95ab-4aae-aa36-3aab0e5f4352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c68ff01a-955c-4552-9445-2e2848244553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8ffd011-a9d0-47b4-a154-ab0e701a7324" xlink:to="loc_us-gaap_LiabilitiesCurrent_c68ff01a-955c-4552-9445-2e2848244553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_b159a147-3552-4f2d-8c1a-eef8721042a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_b159a147-3552-4f2d-8c1a-eef8721042a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_609ce88a-f95a-4b73-ae26-beaa9c96c761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_609ce88a-f95a-4b73-ae26-beaa9c96c761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_a6d39ba2-e5bc-4709-9ea6-751699239fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_LongTermNotesPayable_a6d39ba2-e5bc-4709-9ea6-751699239fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_d756a745-dcab-4bd3-9ff8-0386565c3618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_d756a745-dcab-4bd3-9ff8-0386565c3618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ea46d3b0-c4b9-4687-85d1-21470e92c209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ea46d3b0-c4b9-4687-85d1-21470e92c209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_938c3dc6-0c86-4f33-b219-65db672468e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_938c3dc6-0c86-4f33-b219-65db672468e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1d1790b2-9134-4e9c-94c6-af3de5ab0544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_Liabilities_1d1790b2-9134-4e9c-94c6-af3de5ab0544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3f324940-169c-4640-9510-6b287df8a115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3f324940-169c-4640-9510-6b287df8a115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_650beac0-6da0-4890-bd4d-4138235cf4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f324940-169c-4640-9510-6b287df8a115" xlink:to="loc_us-gaap_CommonStockValue_650beac0-6da0-4890-bd4d-4138235cf4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4a3b856e-2fcc-4717-808a-30297c48651f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f324940-169c-4640-9510-6b287df8a115" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4a3b856e-2fcc-4717-808a-30297c48651f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_01f7ed8d-485c-414e-96c4-ada1146ee9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f324940-169c-4640-9510-6b287df8a115" xlink:to="loc_us-gaap_MinorityInterest_01f7ed8d-485c-414e-96c4-ada1146ee9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_970dc3cb-546b-46cb-8fd3-232804264ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f324940-169c-4640-9510-6b287df8a115" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_970dc3cb-546b-46cb-8fd3-232804264ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_121202e0-06b4-4d3b-b791-2ed79b1cfd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3f324940-169c-4640-9510-6b287df8a115" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_121202e0-06b4-4d3b-b791-2ed79b1cfd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1cfa1170-6b90-49cc-ae04-fc43ea61bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5df5188c-9f57-477f-8d89-e8e72ef48293" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_1cfa1170-6b90-49cc-ae04-fc43ea61bdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6f232bc0-6200-4237-8357-5d848f997ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ee939749-20ef-47ae-8cca-cc5884789c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f232bc0-6200-4237-8357-5d848f997ef7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ee939749-20ef-47ae-8cca-cc5884789c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue_2f696c68-a559-4812-ab2c-45220adf43b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f232bc0-6200-4237-8357-5d848f997ef7" xlink:to="loc_us-gaap_CommonStockNoParValue_2f696c68-a559-4812-ab2c-45220adf43b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_dd3c6472-ee81-4e31-9d66-35f7c6e0db07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f232bc0-6200-4237-8357-5d848f997ef7" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_dd3c6472-ee81-4e31-9d66-35f7c6e0db07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cf64eaa1-c5eb-4db0-872e-e567cb5e3648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f232bc0-6200-4237-8357-5d848f997ef7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cf64eaa1-c5eb-4db0-872e-e567cb5e3648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8e3c8adb-c59e-4a91-90c0-12d6e26a46e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f232bc0-6200-4237-8357-5d848f997ef7" xlink:to="loc_us-gaap_CommonStockSharesIssued_8e3c8adb-c59e-4a91-90c0-12d6e26a46e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b9021a4-4183-4d66-bb2f-fec05d4b5ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b9021a4-4183-4d66-bb2f-fec05d4b5ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0b0ed9c9-39bf-4c93-bfed-f0ec1eea1a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0b0ed9c9-39bf-4c93-bfed-f0ec1eea1a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3644dece-dd4f-4417-9b9a-54871d95e912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_GrossProfit_3644dece-dd4f-4417-9b9a-54871d95e912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1b17e810-6929-4781-aee7-689b7832726f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1b17e810-6929-4781-aee7-689b7832726f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives_d4fc8886-7d8d-4331-9a2d-cd7a2f7f3b45" xlink:href="natr-20220930.xsd#natr_VolumeIncentives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b17e810-6929-4781-aee7-689b7832726f" xlink:to="loc_natr_VolumeIncentives_d4fc8886-7d8d-4331-9a2d-cd7a2f7f3b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2ee100f9-ad4e-4f44-bcd0-cd28a36861f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b17e810-6929-4781-aee7-689b7832726f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2ee100f9-ad4e-4f44-bcd0-cd28a36861f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_44907faa-a523-48ba-b998-244d01e7df27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b17e810-6929-4781-aee7-689b7832726f" xlink:to="loc_us-gaap_OperatingIncomeLoss_44907faa-a523-48ba-b998-244d01e7df27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_26c282e2-ccd0-49c2-9f97-ed41cd8645fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b17e810-6929-4781-aee7-689b7832726f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_26c282e2-ccd0-49c2-9f97-ed41cd8645fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32dc62e8-931e-439a-9f67-584f7e8faacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b17e810-6929-4781-aee7-689b7832726f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32dc62e8-931e-439a-9f67-584f7e8faacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_833dcce4-5af5-4b8c-afbf-1f06b2175b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b17e810-6929-4781-aee7-689b7832726f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_833dcce4-5af5-4b8c-afbf-1f06b2175b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f680aade-2099-480a-b8b9-a80f86f39bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_ProfitLoss_f680aade-2099-480a-b8b9-a80f86f39bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5455f4f6-1d50-446b-86db-69d4c12dfc57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5455f4f6-1d50-446b-86db-69d4c12dfc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_998fd392-dc94-451b-8c14-5b5d75d5c04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_NetIncomeLoss_998fd392-dc94-451b-8c14-5b5d75d5c04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8a88f671-0e3e-4125-bd44-f4e0ab1bfc24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8a88f671-0e3e-4125-bd44-f4e0ab1bfc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_238ac7b0-bad4-48e3-a336-5445bb1e9fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a88f671-0e3e-4125-bd44-f4e0ab1bfc24" xlink:to="loc_us-gaap_EarningsPerShareBasic_238ac7b0-bad4-48e3-a336-5445bb1e9fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f38fa476-e34d-43b4-a7e2-7489809f9965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a88f671-0e3e-4125-bd44-f4e0ab1bfc24" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f38fa476-e34d-43b4-a7e2-7489809f9965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36f5e28a-e24b-4ac5-93d6-6645ba080901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36f5e28a-e24b-4ac5-93d6-6645ba080901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49377775-6676-4997-ae00-da78ba3073a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49377775-6676-4997-ae00-da78ba3073a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_00330092-3c52-428b-8966-27503227c5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60c221e1-c946-433b-a5bf-67a944e4c911" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_00330092-3c52-428b-8966-27503227c5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bece8e8b-0a53-44d4-b8f6-8fb0bc1f5c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3fedd3fc-c546-41c2-a7e1-6243866b808e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bece8e8b-0a53-44d4-b8f6-8fb0bc1f5c98" xlink:to="loc_us-gaap_ProfitLoss_3fedd3fc-c546-41c2-a7e1-6243866b808e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_19847287-ab79-43a8-ab3e-b214dbddd8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bece8e8b-0a53-44d4-b8f6-8fb0bc1f5c98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_19847287-ab79-43a8-ab3e-b214dbddd8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5f2fc751-2b20-4b09-9534-3d02c1474fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bece8e8b-0a53-44d4-b8f6-8fb0bc1f5c98" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5f2fc751-2b20-4b09-9534-3d02c1474fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_693a5d90-58f8-4715-ad0e-b575021475ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7c1ef7ce-99d2-4382-8ced-64cca672f8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_693a5d90-58f8-4715-ad0e-b575021475ce" xlink:to="loc_us-gaap_StatementTable_7c1ef7ce-99d2-4382-8ced-64cca672f8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_adc8ffb8-01ac-4a03-b276-c6e6153a806f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7c1ef7ce-99d2-4382-8ced-64cca672f8c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_adc8ffb8-01ac-4a03-b276-c6e6153a806f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_adc8ffb8-01ac-4a03-b276-c6e6153a806f" xlink:to="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_851e32cd-5b60-4cd6-b847-bd6449f0a914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:to="loc_us-gaap_CommonStockMember_851e32cd-5b60-4cd6-b847-bd6449f0a914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e95d9232-4223-4445-a7b0-dd6f4a9c9a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:to="loc_us-gaap_RetainedEarningsMember_e95d9232-4223-4445-a7b0-dd6f4a9c9a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9907cd53-a4b2-4424-8186-d55aa0ddb9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9907cd53-a4b2-4424-8186-d55aa0ddb9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1115cc4b-b030-41cc-a621-e754c7406d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f17b50c-9b5f-41b8-8e5e-c77977627c36" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1115cc4b-b030-41cc-a621-e754c7406d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_df160b45-3050-4c67-91c0-1fe521ad417e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7c1ef7ce-99d2-4382-8ced-64cca672f8c5" xlink:to="loc_us-gaap_StatementLineItems_df160b45-3050-4c67-91c0-1fe521ad417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_df160b45-3050-4c67-91c0-1fe521ad417e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0666b92e-fa10-46eb-b44c-ddb8e38d5ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_CommonStockSharesIssued_0666b92e-fa10-46eb-b44c-ddb8e38d5ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b243a1-2edb-4c24-b7a3-cbedff58bf11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b243a1-2edb-4c24-b7a3-cbedff58bf11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_70d46ef0-3a69-4625-a81c-c04abb91ec77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_70d46ef0-3a69-4625-a81c-c04abb91ec77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_ea4f1de2-65d4-4381-9b04-020278e95502" xlink:href="natr-20220930.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_ea4f1de2-65d4-4381-9b04-020278e95502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_2f1c4347-ae7c-401d-af2b-8b339a15b7c3" xlink:href="natr-20220930.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_2f1c4347-ae7c-401d-af2b-8b339a15b7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_694b245e-bca8-437f-84bc-bc2c9611e841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_DividendsCommonStockCash_694b245e-bca8-437f-84bc-bc2c9611e841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_b556204b-eb16-411c-8b21-33fd5f918594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_b556204b-eb16-411c-8b21-33fd5f918594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e4b31db1-9682-4f75-a8f6-9514363745b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e4b31db1-9682-4f75-a8f6-9514363745b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_50ceb5d9-766f-4a63-b123-732320b0ac23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_ProfitLoss_50ceb5d9-766f-4a63-b123-732320b0ac23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_832215c8-b483-47da-a4d4-e5ddac98b3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_832215c8-b483-47da-a4d4-e5ddac98b3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_569e2192-3ebf-458f-b6d8-ad474bf22d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_CommonStockSharesIssued_569e2192-3ebf-458f-b6d8-ad474bf22d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_721d92de-25c8-4ce5-b0a4-3e75c263c796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_51e8ba98-eea9-47a3-82f2-5e893f4c963a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_721d92de-25c8-4ce5-b0a4-3e75c263c796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7c68d1ed-3df7-4458-9a99-b348ef612f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1d4abe5a-4241-415c-8525-10b2da320de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7c68d1ed-3df7-4458-9a99-b348ef612f09" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1d4abe5a-4241-415c-8525-10b2da320de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="natr-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ccfd5998-e4b8-4f37-accf-87254ca70677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ccfd5998-e4b8-4f37-accf-87254ca70677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c96d4d61-aa00-47f4-9cb3-f429d2736251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ccfd5998-e4b8-4f37-accf-87254ca70677" xlink:to="loc_us-gaap_ProfitLoss_c96d4d61-aa00-47f4-9cb3-f429d2736251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ccfd5998-e4b8-4f37-accf-87254ca70677" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_f350183f-be4d-4405-bc37-94b1fc813939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_f350183f-be4d-4405-bc37-94b1fc813939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_daf33cb7-8d75-47bb-818f-acf836590447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_daf33cb7-8d75-47bb-818f-acf836590447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense_6df4b950-dddd-4a11-9701-18ad45b790d8" xlink:href="natr-20220930.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_natr_OperatingLeaseNonCashLeaseExpense_6df4b950-dddd-4a11-9701-18ad45b790d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_259da7d7-31dc-4cdf-9d57-8ed2286121c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_ShareBasedCompensation_259da7d7-31dc-4cdf-9d57-8ed2286121c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_44358b41-7843-4873-8a17-b36d0e45713d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_44358b41-7843-4873-8a17-b36d0e45713d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4317ab50-fdb4-43e4-aac0-f3b37db4d8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4317ab50-fdb4-43e4-aac0-f3b37db4d8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_38432ced-337e-42d7-bf87-506772482ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_38432ced-337e-42d7-bf87-506772482ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_084d0a02-e376-4369-a333-a8974b68ecb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_084d0a02-e376-4369-a333-a8974b68ecb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_859b01ad-d5d9-4b80-b460-747455f451c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_GainLossOnInvestments_859b01ad-d5d9-4b80-b460-747455f451c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2119965a-0bfe-4e8a-8550-466889350bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a05b09b-e7ef-4717-a199-cf49b16d2e31" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2119965a-0bfe-4e8a-8550-466889350bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ccfd5998-e4b8-4f37-accf-87254ca70677" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f000d610-836d-40ca-9784-c4ec9ecd823d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f000d610-836d-40ca-9784-c4ec9ecd823d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3e2218b5-7114-4273-845c-49b11f59380f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3e2218b5-7114-4273-845c-49b11f59380f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_594ef33f-8942-4550-a160-f20d31044458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_594ef33f-8942-4550-a160-f20d31044458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6929cb04-5c24-4b57-a5e4-42733644fefa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6929cb04-5c24-4b57-a5e4-42733644fefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_00ac3a07-daf5-478d-93ad-ff3932714be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_00ac3a07-daf5-478d-93ad-ff3932714be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_70de24f2-1380-43ea-9a1b-a38865ebaaa4" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_70de24f2-1380-43ea-9a1b-a38865ebaaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_047af9ef-b671-4af9-8c2a-709224c67425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_047af9ef-b671-4af9-8c2a-709224c67425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_457686f7-aa34-4370-a1fc-110a3d76531e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_457686f7-aa34-4370-a1fc-110a3d76531e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_a0feaf2d-94bd-46bc-80d9-6aac1251cc30" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_a0feaf2d-94bd-46bc-80d9-6aac1251cc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_99a69f01-d0de-4659-8d2f-13246c7c7429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_99a69f01-d0de-4659-8d2f-13246c7c7429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_f09fbf9f-6940-4608-9401-9430b8f4b3f5" xlink:href="natr-20220930.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_f09fbf9f-6940-4608-9401-9430b8f4b3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_ba934896-527b-4d62-95df-d92e099734e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cb5ed7f5-a8dc-4b81-8882-bbf8faca0812" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_ba934896-527b-4d62-95df-d92e099734e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95bf78d3-88c9-4dab-94fc-874bd94725d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ccfd5998-e4b8-4f37-accf-87254ca70677" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95bf78d3-88c9-4dab-94fc-874bd94725d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5aebe2d8-1ac0-4294-b10b-18340b0a10f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5aebe2d8-1ac0-4294-b10b-18340b0a10f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5116b949-888b-4b19-941d-c30aef3be1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5aebe2d8-1ac0-4294-b10b-18340b0a10f2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5116b949-888b-4b19-941d-c30aef3be1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a32b9010-485b-41f9-9c4a-9d96746a053c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5aebe2d8-1ac0-4294-b10b-18340b0a10f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a32b9010-485b-41f9-9c4a-9d96746a053c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_e1ef8051-e0e5-476b-b711-d4461065a7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:to="loc_us-gaap_PaymentsOfDividends_e1ef8051-e0e5-476b-b711-d4461065a7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_a933e68c-6a48-4988-abb0-696ee5833e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_a933e68c-6a48-4988-abb0-696ee5833e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c6652236-2663-4cfe-969d-97aa27fb3739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c6652236-2663-4cfe-969d-97aa27fb3739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_32947027-b755-44a1-b176-7572c0586580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_32947027-b755-44a1-b176-7572c0586580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_957691e8-d2b4-4007-a988-ad3da5bb5f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_957691e8-d2b4-4007-a988-ad3da5bb5f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_172257c3-7972-4adb-85cb-48076ee61bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_172257c3-7972-4adb-85cb-48076ee61bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_261ddf86-0727-40d7-9f8f-25e4417df15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_261ddf86-0727-40d7-9f8f-25e4417df15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_36f47f11-a066-4a9d-98fa-95a624ac029e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a80e863-ec7b-405b-8600-3da0e21fb827" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_36f47f11-a066-4a9d-98fa-95a624ac029e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ecb52c2-477e-4c9f-8abd-787138dfe14b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ecb52c2-477e-4c9f-8abd-787138dfe14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6de7f774-2a16-470d-a174-603a7d564207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6de7f774-2a16-470d-a174-603a7d564207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91585b85-6368-4a07-a1ad-03a94f61e498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91585b85-6368-4a07-a1ad-03a94f61e498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e109bc6-ed18-49b8-9b01-534027e3a96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e109bc6-ed18-49b8-9b01-534027e3a96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d5f1e870-24d5-4e72-bf43-24c26621a735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2145aafb-de70-448e-92c0-9c283ba01370" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d5f1e870-24d5-4e72-bf43-24c26621a735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_1484bc02-395e-4227-980d-f6e083d5b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d5f1e870-24d5-4e72-bf43-24c26621a735" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_1484bc02-395e-4227-980d-f6e083d5b88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_df0a391c-0231-4818-8775-fc262b78453e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d5f1e870-24d5-4e72-bf43-24c26621a735" xlink:to="loc_us-gaap_InterestPaidNet_df0a391c-0231-4818-8775-fc262b78453e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentation" xlink:type="simple" xlink:href="natr-20220930.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e1ba1b6-1901-4ec2-80e7-c0ed0089b66c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_b3f204c6-7403-4e25-913a-86662248536e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e1ba1b6-1901-4ec2-80e7-c0ed0089b66c" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_b3f204c6-7403-4e25-913a-86662248536e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/Inventories" xlink:type="simple" xlink:href="natr-20220930.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c34b2ad8-c106-4e87-8635-eb574a420aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_d25f3f2f-9df7-48c4-a028-b0f96ac0505f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c34b2ad8-c106-4e87-8635-eb574a420aa7" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_d25f3f2f-9df7-48c4-a028-b0f96ac0505f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTrading" xlink:type="simple" xlink:href="natr-20220930.xsd#InvestmentSecuritiesTrading"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InvestmentSecuritiesTrading" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_84715910-1701-452d-8dc6-5ca295435f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_479cc639-02bd-494d-b45f-7bfaee759adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_84715910-1701-452d-8dc6-5ca295435f2a" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_479cc639-02bd-494d-b45f-7bfaee759adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations" xlink:type="simple" xlink:href="natr-20220930.xsd#RevolvingCreditFacilityandOtherObligations"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1671bb5c-34f1-4296-bfae-bbf45ead5da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_0dbbb4f3-aaf1-4597-8230-3d17a0e691a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1671bb5c-34f1-4296-bfae-bbf45ead5da9" xlink:to="loc_us-gaap_LongTermDebtTextBlock_0dbbb4f3-aaf1-4597-8230-3d17a0e691a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="natr-20220930.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_69281b7d-021f-4fc8-ad85-d0ce398e7b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a885c57e-6417-45f2-a652-942684d51a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_69281b7d-021f-4fc8-ad85-d0ce398e7b1a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a885c57e-6417-45f2-a652-942684d51a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactions" xlink:type="simple" xlink:href="natr-20220930.xsd#CapitalTransactions"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cee26b6e-ad7f-43db-891f-c75e0bc9dedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_3173b77d-883d-4de0-a29b-892551d7a5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cee26b6e-ad7f-43db-891f-c75e0bc9dedc" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_3173b77d-883d-4de0-a29b-892551d7a5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformation" xlink:type="simple" xlink:href="natr-20220930.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ada83f29-e26e-477c-a1ff-ddc3514706b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_ad71cbab-f731-4511-bc6e-c70c1d27f3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ada83f29-e26e-477c-a1ff-ddc3514706b0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_ad71cbab-f731-4511-bc6e-c70c1d27f3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/IncomeTaxes" xlink:type="simple" xlink:href="natr-20220930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9d1f3e7a-2cea-4d30-a0db-808ea549fc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_97898939-c81e-4a8a-a9ff-c98107dfe3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9d1f3e7a-2cea-4d30-a0db-808ea549fc23" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_97898939-c81e-4a8a-a9ff-c98107dfe3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="natr-20220930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5685c684-6695-4468-814a-6ef195b10eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dfc2e4b7-9745-460c-86a7-407a15cb86d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5685c684-6695-4468-814a-6ef195b10eed" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dfc2e4b7-9745-460c-86a7-407a15cb86d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="natr-20220930.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_705be6ca-a07a-4176-b4fd-5acc9be3c6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_528077cb-0d5a-47b1-9160-9dea3b900069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_705be6ca-a07a-4176-b4fd-5acc9be3c6e1" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_528077cb-0d5a-47b1-9160-9dea3b900069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="natr-20220930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c89dd25d-3f7f-41da-8910-2c5a6ce7df5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_347f2efa-b1f5-4137-b8df-0bb8a22404cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c89dd25d-3f7f-41da-8910-2c5a6ce7df5e" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_347f2efa-b1f5-4137-b8df-0bb8a22404cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevenueRecognition" xlink:type="simple" xlink:href="natr-20220930.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c06cfb34-e80b-426d-821e-8296730f8da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_675d3fb8-db5d-44fe-a055-d3e940a070d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c06cfb34-e80b-426d-821e-8296730f8da3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_675d3fb8-db5d-44fe-a055-d3e940a070d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="natr-20220930.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4ceae7ee-fb9a-47b7-b7e2-5544743afc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_17fdee22-d6c1-4b27-8d39-c240e3e4891a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4ceae7ee-fb9a-47b7-b7e2-5544743afc4a" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_17fdee22-d6c1-4b27-8d39-c240e3e4891a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_02163ab1-43c8-4c71-9b15-bc183a9c0d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4ceae7ee-fb9a-47b7-b7e2-5544743afc4a" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_02163ab1-43c8-4c71-9b15-bc183a9c0d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_fe8f46af-559f-48f3-b93e-c79df1114553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4ceae7ee-fb9a-47b7-b7e2-5544743afc4a" xlink:to="loc_us-gaap_UseOfEstimates_fe8f46af-559f-48f3-b93e-c79df1114553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0d0bb2b6-aea2-4322-90e7-f428c231509f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4ceae7ee-fb9a-47b7-b7e2-5544743afc4a" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0d0bb2b6-aea2-4322-90e7-f428c231509f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesTables" xlink:type="simple" xlink:href="natr-20220930.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_dbc1c9fc-e131-4be5-8998-b55d30b655f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_db36d232-9936-4749-ba48-7ee50e30b0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dbc1c9fc-e131-4be5-8998-b55d30b655f5" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_db36d232-9936-4749-ba48-7ee50e30b0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="natr-20220930.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c0203867-e366-4cbb-849e-975967027eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_31b1a2dc-a7db-4397-aa8f-c6e0c829c8de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c0203867-e366-4cbb-849e-975967027eaf" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_31b1a2dc-a7db-4397-aa8f-c6e0c829c8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsTables" xlink:type="simple" xlink:href="natr-20220930.xsd#CapitalTransactionsTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_733cd5c7-0b2d-4247-a84e-1be8fa605f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_739a0872-de63-4314-b5bb-c2e0203c3817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_733cd5c7-0b2d-4247-a84e-1be8fa605f4e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_739a0872-de63-4314-b5bb-c2e0203c3817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_74bacaa4-8cca-4e6c-8599-76455ec80417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_733cd5c7-0b2d-4247-a84e-1be8fa605f4e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_74bacaa4-8cca-4e6c-8599-76455ec80417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="natr-20220930.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b2969ea1-7956-4159-a851-c2d4367cbb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6fc82a6d-2254-4cc8-a72a-9c0aa49cd35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b2969ea1-7956-4159-a851-c2d4367cbb75" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6fc82a6d-2254-4cc8-a72a-9c0aa49cd35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_d7d7c340-1ff6-45ee-9999-ee51878fded1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b2969ea1-7956-4159-a851-c2d4367cbb75" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_d7d7c340-1ff6-45ee-9999-ee51878fded1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_c8e097ac-4f7e-46fb-b492-57cb3726bc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b2969ea1-7956-4159-a851-c2d4367cbb75" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_c8e097ac-4f7e-46fb-b492-57cb3726bc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_d400d0ee-4861-419c-a7e8-5c7c7ab688d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b2969ea1-7956-4159-a851-c2d4367cbb75" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_d400d0ee-4861-419c-a7e8-5c7c7ab688d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_cede5269-7fdc-4d6f-b699-b8ec178b2979" xlink:href="natr-20220930.xsd#natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b2969ea1-7956-4159-a851-c2d4367cbb75" xlink:to="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_cede5269-7fdc-4d6f-b699-b8ec178b2979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="natr-20220930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7f0c6d62-2ad0-4a4c-997e-3aeb5403c75d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_d2e8baed-3eee-45fe-b0b9-5e71eaee78c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7f0c6d62-2ad0-4a4c-997e-3aeb5403c75d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_d2e8baed-3eee-45fe-b0b9-5e71eaee78c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#BasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_438f9b25-e95f-433f-b193-44b5532d14a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_03356e41-fa5a-4caf-8129-c81c1c1a4779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_438f9b25-e95f-433f-b193-44b5532d14a4" xlink:to="loc_us-gaap_MinorityInterestTable_03356e41-fa5a-4caf-8129-c81c1c1a4779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_03356e41-fa5a-4caf-8129-c81c1c1a4779" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f4c53fd4-251f-4e65-bedc-6359c281c004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_59ae7556-99fd-4248-b77a-0bd3c1bc8c0a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f4c53fd4-251f-4e65-bedc-6359c281c004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedSeveranceandRentCostsMember_648993ea-aafa-4415-92d1-29ff0afdcb9b" xlink:href="natr-20220930.xsd#natr_AccruedSeveranceandRentCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f4c53fd4-251f-4e65-bedc-6359c281c004" xlink:to="loc_natr_AccruedSeveranceandRentCostsMember_648993ea-aafa-4415-92d1-29ff0afdcb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_03356e41-fa5a-4caf-8129-c81c1c1a4779" xlink:to="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_dbb4de11-ea32-42cd-acf3-9e8f35103be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_dbb4de11-ea32-42cd-acf3-9e8f35103be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c94d6357-f103-4092-9703-9d72b09a1059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_MinorityInterest_c94d6357-f103-4092-9703-9d72b09a1059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_69a05ad7-bc78-4251-ae62-716a7a50a20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_RestructuringCharges_69a05ad7-bc78-4251-ae62-716a7a50a20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_5d1a7517-36f4-4263-8d93-53716d972ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbe6cd67-d617-4b34-aa22-c2af65c68856" xlink:to="loc_us-gaap_RestructuringReserve_5d1a7517-36f4-4263-8d93-53716d972ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6edbc2a6-6aa0-4548-9d8f-f1800e00da23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4261863e-fdd4-4fda-9f44-fcc4a1f0bbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6edbc2a6-6aa0-4548-9d8f-f1800e00da23" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4261863e-fdd4-4fda-9f44-fcc4a1f0bbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2dbda23f-e894-4883-ae4e-a7decdec298d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6edbc2a6-6aa0-4548-9d8f-f1800e00da23" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2dbda23f-e894-4883-ae4e-a7decdec298d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bb25b6fd-f3a1-4c03-ab3d-0dfcc5304ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6edbc2a6-6aa0-4548-9d8f-f1800e00da23" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bb25b6fd-f3a1-4c03-ab3d-0dfcc5304ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_35e5118e-2642-4e6d-a33c-454d9d44ce32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6edbc2a6-6aa0-4548-9d8f-f1800e00da23" xlink:to="loc_us-gaap_InventoryNet_35e5118e-2642-4e6d-a33c-454d9d44ce32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#InvestmentSecuritiesTradingDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_20074c9b-2ebb-4843-a435-0d2eccfabee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_0a33a179-a75a-4841-894d-4e37feb420d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_20074c9b-2ebb-4843-a435-0d2eccfabee8" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_0a33a179-a75a-4841-894d-4e37feb420d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss_dc0e95ec-be71-44ee-ab01-b9c4e6dc2c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_20074c9b-2ebb-4843-a435-0d2eccfabee8" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss_dc0e95ec-be71-44ee-ab01-b9c4e6dc2c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#RevolvingCreditFacilityandOtherObligationsDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d974847e-b835-466d-8cac-0f8cc0c1e49d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d974847e-b835-466d-8cac-0f8cc0c1e49d" xlink:to="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f5f0270f-10b2-4750-bc89-262eb6b569d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:to="loc_us-gaap_CreditFacilityAxis_f5f0270f-10b2-4750-bc89-262eb6b569d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_48315054-b442-4942-9bea-a44825b99a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f5f0270f-10b2-4750-bc89-262eb6b569d2" xlink:to="loc_us-gaap_CreditFacilityDomain_48315054-b442-4942-9bea-a44825b99a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_236d1f85-e032-424e-a6ac-5dc2f622310a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_48315054-b442-4942-9bea-a44825b99a15" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_236d1f85-e032-424e-a6ac-5dc2f622310a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_f754465e-60f3-4122-a395-0c0d954f4372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_48315054-b442-4942-9bea-a44825b99a15" xlink:to="loc_us-gaap_LineOfCreditMember_f754465e-60f3-4122-a395-0c0d954f4372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2f7f949e-edbe-456e-a4fd-3f53e52e8886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:to="loc_us-gaap_VariableRateAxis_2f7f949e-edbe-456e-a4fd-3f53e52e8886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1b8d67df-b1ab-40fd-bb03-5cae1ddda572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2f7f949e-edbe-456e-a4fd-3f53e52e8886" xlink:to="loc_us-gaap_VariableRateDomain_1b8d67df-b1ab-40fd-bb03-5cae1ddda572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_526b74dd-6b82-425b-b131-51ebbea45c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1b8d67df-b1ab-40fd-bb03-5cae1ddda572" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_526b74dd-6b82-425b-b131-51ebbea45c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember_1a09498a-60d7-4d9e-ae4d-88fc247169f2" xlink:href="natr-20220930.xsd#natr_IndicativeIndexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1b8d67df-b1ab-40fd-bb03-5cae1ddda572" xlink:to="loc_natr_IndicativeIndexMember_1a09498a-60d7-4d9e-ae4d-88fc247169f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ebead361-9c9a-4a6a-9316-4e620bf410e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:to="loc_us-gaap_DebtInstrumentAxis_ebead361-9c9a-4a6a-9316-4e620bf410e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b1d2fd7-8bc2-4b22-b014-a01143bece3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ebead361-9c9a-4a6a-9316-4e620bf410e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b1d2fd7-8bc2-4b22-b014-a01143bece3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember_655c581b-776d-4534-853f-e51a8400ce61" xlink:href="natr-20220930.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b1d2fd7-8bc2-4b22-b014-a01143bece3f" xlink:to="loc_natr_BankofAmericaCreditAgreementMember_655c581b-776d-4534-853f-e51a8400ce61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_aedded02-4269-4c03-befa-36bf40f94252" xlink:href="natr-20220930.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b1d2fd7-8bc2-4b22-b014-a01143bece3f" xlink:to="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_aedded02-4269-4c03-befa-36bf40f94252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_613365b2-8601-41e1-b8f1-df88d3405619" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_08289918-219e-4d49-aa5e-ae8fee4714d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_08289918-219e-4d49-aa5e-ae8fee4714d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_c06fe655-3b45-44fe-ba3c-fd838bcc596d" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_c06fe655-3b45-44fe-ba3c-fd838bcc596d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_d68367fb-6df4-4d63-8528-6fa5043febce" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_d68367fb-6df4-4d63-8528-6fa5043febce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_a142da8e-b289-42a2-81aa-6ebaae6c391b" xlink:href="natr-20220930.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_a142da8e-b289-42a2-81aa-6ebaae6c391b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_11fb35c5-a69b-4da2-8389-1f1fb3983083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_11fb35c5-a69b-4da2-8389-1f1fb3983083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_817f5db3-8afb-4199-bec5-84ab6bbf895c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_817f5db3-8afb-4199-bec5-84ab6bbf895c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_2154a23a-9212-4c14-9a2e-eaf90f76ad1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_2154a23a-9212-4c14-9a2e-eaf90f76ad1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_0b52c657-1731-467c-87db-2c4edfd68255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_LineOfCredit_0b52c657-1731-467c-87db-2c4edfd68255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments_13a19996-bbbf-4451-b328-ea28b9e9189b" xlink:href="natr-20220930.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_natr_DebtInstrumentNumberOfMonthlyPayments_13a19996-bbbf-4451-b328-ea28b9e9189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_151cb4aa-2b8f-4065-9deb-6f24b1e6c64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_151cb4aa-2b8f-4065-9deb-6f24b1e6c64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_472d8775-52de-4329-836e-2e817728a582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6df7cd27-a452-4e01-bc89-404c22af4f6d" xlink:to="loc_us-gaap_LinesOfCreditCurrent_472d8775-52de-4329-836e-2e817728a582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#NetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cf1ddfa7-8b4c-485f-b622-69b56109b4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f74442dd-8665-424a-b74d-288a5e06202f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cf1ddfa7-8b4c-485f-b622-69b56109b4af" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f74442dd-8665-424a-b74d-288a5e06202f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3a6fb635-beb8-44b9-887d-a12ea929e688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cf1ddfa7-8b4c-485f-b622-69b56109b4af" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3a6fb635-beb8-44b9-887d-a12ea929e688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e605ddd4-ebe9-4b9c-8558-1fbdc4ade3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cf1ddfa7-8b4c-485f-b622-69b56109b4af" xlink:to="loc_us-gaap_EarningsPerShareBasic_e605ddd4-ebe9-4b9c-8558-1fbdc4ade3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39a970d9-3f70-4ab3-88be-16afc503c348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cf1ddfa7-8b4c-485f-b622-69b56109b4af" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39a970d9-3f70-4ab3-88be-16afc503c348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7afd0ba0-c47a-42d8-a746-67e7797210f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39a970d9-3f70-4ab3-88be-16afc503c348" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7afd0ba0-c47a-42d8-a746-67e7797210f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e563e313-81f7-439f-b68f-68e6f6ee1db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39a970d9-3f70-4ab3-88be-16afc503c348" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e563e313-81f7-439f-b68f-68e6f6ee1db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5e850806-ee1e-4fb4-827d-b6f55c852b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39a970d9-3f70-4ab3-88be-16afc503c348" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5e850806-ee1e-4fb4-827d-b6f55c852b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3cacb878-80d3-45e2-8684-c2fd2ea38f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cf1ddfa7-8b4c-485f-b622-69b56109b4af" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3cacb878-80d3-45e2-8684-c2fd2ea38f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_d7b1e5ad-47ba-4131-ac5b-c5605d35f135" xlink:href="natr-20220930.xsd#natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cf1ddfa7-8b4c-485f-b622-69b56109b4af" xlink:to="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_d7b1e5ad-47ba-4131-ac5b-c5605d35f135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_917e6ade-1a14-4ef0-b4c8-1e3293855f6a" xlink:href="natr-20220930.xsd#natr_DilutiveSecuritiesExcludedfromComputationofEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_d7b1e5ad-47ba-4131-ac5b-c5605d35f135" xlink:to="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_917e6ade-1a14-4ef0-b4c8-1e3293855f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_b5f10dca-90e5-44f7-9436-cf8184a11d72" xlink:href="natr-20220930.xsd#natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cf1ddfa7-8b4c-485f-b622-69b56109b4af" xlink:to="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_b5f10dca-90e5-44f7-9436-cf8184a11d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2d1a3dc6-d98e-447e-b8d6-7ab9b21f4375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_b5f10dca-90e5-44f7-9436-cf8184a11d72" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2d1a3dc6-d98e-447e-b8d6-7ab9b21f4375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_12e0c584-2c4a-45a7-b9fd-88dffc95b4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_b5f10dca-90e5-44f7-9436-cf8184a11d72" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_12e0c584-2c4a-45a7-b9fd-88dffc95b4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#CapitalTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2243ea4f-039d-4166-a9e5-cf3d1cf3e42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2243ea4f-039d-4166-a9e5-cf3d1cf3e42c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_us-gaap_AwardTypeAxis_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fd64830-e91e-4724-92a1-98fa7d9f35d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_be6f6ef1-ef5b-498e-87e4-bb5aeb59cbd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fd64830-e91e-4724-92a1-98fa7d9f35d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e068fcb0-1575-4b07-a05a-1b433f38a36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fd64830-e91e-4724-92a1-98fa7d9f35d7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e068fcb0-1575-4b07-a05a-1b433f38a36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember_9c46f948-8516-4799-a9c8-8f5017b2a531" xlink:href="natr-20220930.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_e068fcb0-1575-4b07-a05a-1b433f38a36a" xlink:to="loc_natr_TimeBasedStockOptionsMember_9c46f948-8516-4799-a9c8-8f5017b2a531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_b3cd5d47-4dac-4cc4-9188-025629085aeb" xlink:href="natr-20220930.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_e068fcb0-1575-4b07-a05a-1b433f38a36a" xlink:to="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_b3cd5d47-4dac-4cc4-9188-025629085aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fd64830-e91e-4724-92a1-98fa7d9f35d7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember_319e1fc9-378b-40b5-947b-b89a89a47926" xlink:href="natr-20220930.xsd#natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:to="loc_natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember_319e1fc9-378b-40b5-947b-b89a89a47926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember_4102e3e4-7680-4142-8f26-c912f0316cbf" xlink:href="natr-20220930.xsd#natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:to="loc_natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember_4102e3e4-7680-4142-8f26-c912f0316cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_cec01825-4189-47fd-bcc6-12d848850a79" xlink:href="natr-20220930.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:to="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_cec01825-4189-47fd-bcc6-12d848850a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember_5d825483-5bac-431f-b257-33480da4fceb" xlink:href="natr-20220930.xsd#natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2092b1d0-8417-4d57-bce0-e02c85aaa047" xlink:to="loc_natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember_5d825483-5bac-431f-b257-33480da4fceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_2b580599-e4a5-45ea-9f72-22979b61354e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_srt_TitleOfIndividualAxis_2b580599-e4a5-45ea-9f72-22979b61354e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c14266be-17fa-4c64-90f5-a5bfa038c4ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_2b580599-e4a5-45ea-9f72-22979b61354e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c14266be-17fa-4c64-90f5-a5bfa038c4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_ab6e97b4-2420-4cd1-a37b-97d5fa41e48c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c14266be-17fa-4c64-90f5-a5bfa038c4ce" xlink:to="loc_srt_DirectorMember_ab6e97b4-2420-4cd1-a37b-97d5fa41e48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_9ef695af-54a6-48b2-b7dd-ea453cc698d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_us-gaap_VestingAxis_9ef695af-54a6-48b2-b7dd-ea453cc698d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_6789ca8f-419f-49c3-8928-c1674b306cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_9ef695af-54a6-48b2-b7dd-ea453cc698d3" xlink:to="loc_us-gaap_VestingDomain_6789ca8f-419f-49c3-8928-c1674b306cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NetSalesandOperatingIncomeTargetsMember_3b1b564b-61b2-4d80-80f0-15278edaf5b4" xlink:href="natr-20220930.xsd#natr_NetSalesandOperatingIncomeTargetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_6789ca8f-419f-49c3-8928-c1674b306cf7" xlink:to="loc_natr_NetSalesandOperatingIncomeTargetsMember_3b1b564b-61b2-4d80-80f0-15278edaf5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b03d6c78-8ca0-465f-b348-30be39a7269b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_srt_RangeAxis_b03d6c78-8ca0-465f-b348-30be39a7269b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_788bc526-2e89-4012-a353-55b4e61ecbb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b03d6c78-8ca0-465f-b348-30be39a7269b" xlink:to="loc_srt_RangeMember_788bc526-2e89-4012-a353-55b4e61ecbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aaa8b0f7-2c3a-4df8-bffc-96924b1f18f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_788bc526-2e89-4012-a353-55b4e61ecbb7" xlink:to="loc_srt_MinimumMember_aaa8b0f7-2c3a-4df8-bffc-96924b1f18f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_11793232-fbd6-4466-b6b5-901fb7d82516" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_788bc526-2e89-4012-a353-55b4e61ecbb7" xlink:to="loc_srt_MaximumMember_11793232-fbd6-4466-b6b5-901fb7d82516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d11a1f75-0efa-4cfd-a862-777e41798c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_us-gaap_PlanNameAxis_d11a1f75-0efa-4cfd-a862-777e41798c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5ea0c32e-ffc6-4b7b-b842-dbb6967a7001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d11a1f75-0efa-4cfd-a862-777e41798c33" xlink:to="loc_us-gaap_PlanNameDomain_5ea0c32e-ffc6-4b7b-b842-dbb6967a7001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_4ddb42a8-2b56-4268-bd74-8b3885133957" xlink:href="natr-20220930.xsd#natr_A2012IncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5ea0c32e-ffc6-4b7b-b842-dbb6967a7001" xlink:to="loc_natr_A2012IncentivePlanMember_4ddb42a8-2b56-4268-bd74-8b3885133957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09afef04-60cb-41a3-ae36-04ed8b9fbd00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_0d65cd86-d208-4bb1-8821-d03a30b926fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_0d65cd86-d208-4bb1-8821-d03a30b926fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_4de17ed2-8a00-41c4-9bf7-866612701799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_DividendsCommonStockCash_4de17ed2-8a00-41c4-9bf7-866612701799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f03e302a-3b42-44ff-a4dd-4305bbb7423c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f03e302a-3b42-44ff-a4dd-4305bbb7423c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_58bf64c2-00d8-4099-aa5b-3d4b072be8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_58bf64c2-00d8-4099-aa5b-3d4b072be8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_19583441-cee0-4e8d-9908-d67193e1a485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_19583441-cee0-4e8d-9908-d67193e1a485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_ad9007f5-2701-48e0-9b97-f2f0a29624ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_ad9007f5-2701-48e0-9b97-f2f0a29624ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_801b574c-d3ed-4d58-af8a-a1345dd836d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_801b574c-d3ed-4d58-af8a-a1345dd836d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_8a73aea1-2944-47b2-8628-ff82b2ca1654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_8a73aea1-2944-47b2-8628-ff82b2ca1654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_374ae48b-d8ca-434a-a119-129945657564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_374ae48b-d8ca-434a-a119-129945657564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_a565c3f9-5ab0-44f4-9766-c6331039b50e" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_a565c3f9-5ab0-44f4-9766-c6331039b50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_4076c545-3740-421e-a161-d7ac98878ab7" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_4076c545-3740-421e-a161-d7ac98878ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_be8e44ff-5d71-4484-878f-7e495ddf114f" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_be8e44ff-5d71-4484-878f-7e495ddf114f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f027077b-9b79-445e-ac82-e5aa5a718e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f027077b-9b79-445e-ac82-e5aa5a718e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a8a3012d-f06f-4c67-9339-e122e6d775a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a8a3012d-f06f-4c67-9339-e122e6d775a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_caad009f-dd83-402b-9ba4-5d4f6fbcd986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_caad009f-dd83-402b-9ba4-5d4f6fbcd986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a5ec159a-3e3b-473d-8791-89b4dfa139c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a5ec159a-3e3b-473d-8791-89b4dfa139c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c021aa0-99c0-42be-ae0a-a41205e0036d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c021aa0-99c0-42be-ae0a-a41205e0036d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b859dc09-15b8-4ff3-9436-09cc8616097e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b859dc09-15b8-4ff3-9436-09cc8616097e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9d229650-98dc-402a-8176-85bd5875e0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9d229650-98dc-402a-8176-85bd5875e0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_61edc2a9-f80b-4458-8b0c-7109417a6454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_61edc2a9-f80b-4458-8b0c-7109417a6454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_de9a0eb5-eee7-4807-a314-642ada3403d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_de9a0eb5-eee7-4807-a314-642ada3403d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares_397347c1-2160-4a6c-b1dc-ba5d4086e4a9" xlink:href="natr-20220930.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_RestrictionPeriodForIssuanceOfShares_397347c1-2160-4a6c-b1dc-ba5d4086e4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_5029a7a7-3c18-4e19-a66e-6dd5041d8b1e" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_5029a7a7-3c18-4e19-a66e-6dd5041d8b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d9f8ed4c-b09a-4df4-8641-6d2b122b3836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d9f8ed4c-b09a-4df4-8641-6d2b122b3836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d732961c-fa73-4144-b2f2-24f875a2c218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d732961c-fa73-4144-b2f2-24f875a2c218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_20e38cdd-18f8-4a54-afd8-105b2bdb677a" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_20e38cdd-18f8-4a54-afd8-105b2bdb677a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_33af4439-1b54-40f0-8fe8-30ff9ef85eda" xlink:href="natr-20220930.xsd#natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability_33af4439-1b54-40f0-8fe8-30ff9ef85eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_f386170a-0282-4c74-806a-636361d86412" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_f386170a-0282-4c74-806a-636361d86412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0cf0171d-4e18-432f-a2ee-99951797a65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0cf0171d-4e18-432f-a2ee-99951797a65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5a1709d5-3817-4dd1-924b-b541f4d961e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5a1709d5-3817-4dd1-924b-b541f4d961e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_76948f4a-b58c-4280-b05d-0147b2c3f9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_76948f4a-b58c-4280-b05d-0147b2c3f9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5e4b1fc4-99d9-425c-be8c-ad7d27748d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5e4b1fc4-99d9-425c-be8c-ad7d27748d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_4a413f46-9bc1-481f-ae8d-8aca24f33762" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c044a03-584b-4b16-9948-3a246db7236a" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_4a413f46-9bc1-481f-ae8d-8aca24f33762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#CapitalTransactionsStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a5436ad9-6e52-4dec-b33c-8e3101c33678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6991101-9dda-4864-94e9-63cb2d52fda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a5436ad9-6e52-4dec-b33c-8e3101c33678" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6991101-9dda-4864-94e9-63cb2d52fda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6991101-9dda-4864-94e9-63cb2d52fda2" xlink:to="loc_us-gaap_AwardTypeAxis_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d781b2fa-63d0-4ada-bfc1-622d0884f5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_66f1f6e9-b53d-4efe-8ee9-7df4f9660b6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d781b2fa-63d0-4ada-bfc1-622d0884f5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_94e27cd4-3462-4e53-b88f-54be5a23ee7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d781b2fa-63d0-4ada-bfc1-622d0884f5f2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_94e27cd4-3462-4e53-b88f-54be5a23ee7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6991101-9dda-4864-94e9-63cb2d52fda2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c629554b-3e29-4793-a49a-5a2dc99d7312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c629554b-3e29-4793-a49a-5a2dc99d7312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b008a3f3-2473-40b8-a5b7-72957285d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b008a3f3-2473-40b8-a5b7-72957285d8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d8fd1727-ea72-4289-96ba-16852453bb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d8fd1727-ea72-4289-96ba-16852453bb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a4d9baec-ad65-4e3c-aa3b-c2dd982b2853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a4d9baec-ad65-4e3c-aa3b-c2dd982b2853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c723ba87-625a-4b47-95bb-149c4dacec64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_935d5a23-a726-4f7d-90f2-ff30941996be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c723ba87-625a-4b47-95bb-149c4dacec64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c0e8d65e-3d72-4569-9e0e-1f2330724755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c0e8d65e-3d72-4569-9e0e-1f2330724755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b0274a6c-af2c-49c3-969d-d58b42dc1757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b0274a6c-af2c-49c3-969d-d58b42dc1757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_a5aed2a0-5f4e-4330-8377-e71daa48426d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_a5aed2a0-5f4e-4330-8377-e71daa48426d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5dda43c5-88c0-4348-8467-58ec7ab7256c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5dda43c5-88c0-4348-8467-58ec7ab7256c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4245191d-effc-4c87-8d7b-4318d70e15f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ced6b449-b408-4e2b-a10a-f6b5927a74cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4245191d-effc-4c87-8d7b-4318d70e15f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38b43245-ba7d-49b3-8c42-c5694cf6aa1c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_d991e3f3-57ae-4900-873d-c8ee3717be7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_d991e3f3-57ae-4900-873d-c8ee3717be7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a715b580-98cf-40e9-ae68-36dcd43ff6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a715b580-98cf-40e9-ae68-36dcd43ff6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_ddd3ce33-1c78-4513-97ee-2b41446199fb" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_ddd3ce33-1c78-4513-97ee-2b41446199fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_f432bb29-5ff3-4c30-8f3b-e145d65d45fc" xlink:href="natr-20220930.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_f432bb29-5ff3-4c30-8f3b-e145d65d45fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c0792ac4-9cd8-40c3-af00-b61e4d9612d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49e83852-cd40-4566-99fb-14d7a73562fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c0792ac4-9cd8-40c3-af00-b61e4d9612d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#CapitalTransactionsRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_846032b6-5cae-44a1-9e02-3ab030371c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_846032b6-5cae-44a1-9e02-3ab030371c88" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7ad13cbc-8202-46ca-b3dd-e83de80a6861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:to="loc_us-gaap_PlanNameAxis_7ad13cbc-8202-46ca-b3dd-e83de80a6861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_35644de3-8bf0-4d2d-8e6b-15cf4471ac70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7ad13cbc-8202-46ca-b3dd-e83de80a6861" xlink:to="loc_us-gaap_PlanNameDomain_35644de3-8bf0-4d2d-8e6b-15cf4471ac70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_e889826c-1c74-4898-bfdc-46a5f3c29f26" xlink:href="natr-20220930.xsd#natr_A2012IncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_35644de3-8bf0-4d2d-8e6b-15cf4471ac70" xlink:to="loc_natr_A2012IncentivePlanMember_e889826c-1c74-4898-bfdc-46a5f3c29f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3d423bbf-eda0-4cfb-b217-3a95ef66ac22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:to="loc_us-gaap_AwardTypeAxis_3d423bbf-eda0-4cfb-b217-3a95ef66ac22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54496f9a-a9fc-45da-9dd9-4ffb2417c0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3d423bbf-eda0-4cfb-b217-3a95ef66ac22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54496f9a-a9fc-45da-9dd9-4ffb2417c0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6990b7a1-763c-4946-9eee-3025e2811d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54496f9a-a9fc-45da-9dd9-4ffb2417c0ba" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6990b7a1-763c-4946-9eee-3025e2811d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f150605-8e55-4006-8bdb-f67081b78c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71edaf23-240d-4611-81d4-7c4bce955db3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f150605-8e55-4006-8bdb-f67081b78c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f150605-8e55-4006-8bdb-f67081b78c0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_450add92-6e4d-429b-87c4-28b87baa36ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_450add92-6e4d-429b-87c4-28b87baa36ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1964abc0-73da-4561-9e38-2d51bbdf827e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1964abc0-73da-4561-9e38-2d51bbdf827e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_21913c8e-4720-4673-aa15-39f299a7f537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_21913c8e-4720-4673-aa15-39f299a7f537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1a9d842e-470a-47d3-81a8-911d9aa638f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1a9d842e-470a-47d3-81a8-911d9aa638f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6f979f67-8c32-4ff3-896b-438c1b2147c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0a6626e6-cad0-4cc1-8ff7-5212fffb37bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6f979f67-8c32-4ff3-896b-438c1b2147c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1f150605-8e55-4006-8bdb-f67081b78c0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8246c28-ea97-494d-9833-18746ae4ad86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8246c28-ea97-494d-9833-18746ae4ad86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_57083f55-caf0-4a09-9ef0-adc34f67dc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_57083f55-caf0-4a09-9ef0-adc34f67dc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8e23ab29-4a4d-4dad-bdab-2f7524bc436d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8e23ab29-4a4d-4dad-bdab-2f7524bc436d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8b011e8-f96b-4fe8-bfa7-4660348351cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8b011e8-f96b-4fe8-bfa7-4660348351cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_14b03186-789a-4365-9adb-aa97e423c397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fa0a1369-1573-4983-91e6-3b215c4633a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_14b03186-789a-4365-9adb-aa97e423c397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_40ba29b4-4b5e-40e1-b2d1-618502408747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_40ba29b4-4b5e-40e1-b2d1-618502408747" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_836bf16f-62ef-4708-9288-cff5ced7e478" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:to="loc_srt_StatementGeographicalAxis_836bf16f-62ef-4708-9288-cff5ced7e478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_836bf16f-62ef-4708-9288-cff5ced7e478" xlink:to="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_851e764c-d30b-47e7-8ddd-117c3f89ef25" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_country_CN_851e764c-d30b-47e7-8ddd-117c3f89ef25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f178dd0e-cdbc-4cdf-a732-4ed10a68ffc4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_country_US_f178dd0e-cdbc-4cdf-a732-4ed10a68ffc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR_b028d22e-50b2-4603-90c4-4546aa45690d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_KR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_country_KR_b028d22e-50b2-4603-90c4-4546aa45690d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_02438935-c1d3-478b-ad9a-61e6b569b7d3" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_TW"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_country_TW_02438935-c1d3-478b-ad9a-61e6b569b7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember_c9b344c8-7d63-4536-986a-99d812b7d91e" xlink:href="natr-20220930.xsd#natr_OtherCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce298c09-50d4-4a11-bb1f-d7d62f5594f9" xlink:to="loc_natr_OtherCountriesMember_c9b344c8-7d63-4536-986a-99d812b7d91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_341d5827-d413-460c-a0f5-1a3802264654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_341d5827-d413-460c-a0f5-1a3802264654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_341d5827-d413-460c-a0f5-1a3802264654" xlink:to="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember_0e638978-5054-46e5-bdd1-7bfb8ab4c561" xlink:href="natr-20220930.xsd#natr_AsiaSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:to="loc_natr_AsiaSegmentMember_0e638978-5054-46e5-bdd1-7bfb8ab4c561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember_e4505b1e-ac4e-4100-890f-1ea426c1266b" xlink:href="natr-20220930.xsd#natr_EuropeSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:to="loc_natr_EuropeSegmentMember_e4505b1e-ac4e-4100-890f-1ea426c1266b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember_41ecd5a0-22fd-4a88-9143-a7143f63cfd3" xlink:href="natr-20220930.xsd#natr_NorthAmericaSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:to="loc_natr_NorthAmericaSegmentMember_41ecd5a0-22fd-4a88-9143-a7143f63cfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember_8123551c-b310-4c19-bf1f-22caa2188d12" xlink:href="natr-20220930.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_507c5a74-721c-49c0-bf83-5ac703fe7e87" xlink:to="loc_natr_LatinAmericaAndOtherSegmentMember_8123551c-b310-4c19-bf1f-22caa2188d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e188bcfc-efab-40b8-8b22-7e6fc0073587" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:to="loc_srt_ProductOrServiceAxis_e188bcfc-efab-40b8-8b22-7e6fc0073587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e188bcfc-efab-40b8-8b22-7e6fc0073587" xlink:to="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember_fd6226bb-7525-45c1-8919-76c0c3f7028f" xlink:href="natr-20220930.xsd#natr_GeneralHealthProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_GeneralHealthProductsMember_fd6226bb-7525-45c1-8919-76c0c3f7028f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember_77233c91-dbf3-4e1d-bc76-ed158c2ad1e7" xlink:href="natr-20220930.xsd#natr_ImmunityProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_ImmunityProductsMember_77233c91-dbf3-4e1d-bc76-ed158c2ad1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember_8d759af9-38cf-4ad6-bfaa-0df3a3ac3e43" xlink:href="natr-20220930.xsd#natr_CardiovascularProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_CardiovascularProductsMember_8d759af9-38cf-4ad6-bfaa-0df3a3ac3e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember_a5ad2f4f-bb4b-4c88-b03d-a89f962e1ff9" xlink:href="natr-20220930.xsd#natr_DigestiveProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_DigestiveProductsMember_a5ad2f4f-bb4b-4c88-b03d-a89f962e1ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember_b482396f-4656-43c8-9c64-a88dc96246ba" xlink:href="natr-20220930.xsd#natr_PersonalCareProductsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_PersonalCareProductsMember_b482396f-4656-43c8-9c64-a88dc96246ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember_087439ec-59e0-4b87-af4a-6a9fff24a4a8" xlink:href="natr-20220930.xsd#natr_WeightManagementProductsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6aa53656-7a5e-461c-8895-2d6549980278" xlink:to="loc_natr_WeightManagementProductsMember_087439ec-59e0-4b87-af4a-6a9fff24a4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6b0fd02b-2fef-4329-a473-cc5d40bd07a2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3494807e-9296-4e25-b554-c580ffbebaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_NumberOfReportableSegments_3494807e-9296-4e25-b554-c580ffbebaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_3ef708d8-46b0-4474-bd7d-b8946ee5cf39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_3ef708d8-46b0-4474-bd7d-b8946ee5cf39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_839a2aa2-969b-4a47-b6bd-573d42fbb1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_3ef708d8-46b0-4474-bd7d-b8946ee5cf39" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_839a2aa2-969b-4a47-b6bd-573d42fbb1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract_96c60fc3-3247-4359-a2b6-b8e25810d0dc" xlink:href="natr-20220930.xsd#natr_ContributionMarginAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_natr_ContributionMarginAbstract_96c60fc3-3247-4359-a2b6-b8e25810d0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_99a03223-a2ab-4614-820c-386d04de2d2a" xlink:href="natr-20220930.xsd#natr_ContributionMargin"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_ContributionMarginAbstract_96c60fc3-3247-4359-a2b6-b8e25810d0dc" xlink:to="loc_natr_ContributionMargin_99a03223-a2ab-4614-820c-386d04de2d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f0c7b548-4fae-4f34-b17e-bab082fdbd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f0c7b548-4fae-4f34-b17e-bab082fdbd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1ffdc162-1eea-42e3-b723-def43004ab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_OperatingIncomeLoss_1ffdc162-1eea-42e3-b723-def43004ab9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f7ab5a73-a55d-4ce0-a277-f49d2960ec68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f7ab5a73-a55d-4ce0-a277-f49d2960ec68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3325fb51-0c64-47a0-b6f4-963f7acf645d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3325fb51-0c64-47a0-b6f4-963f7acf645d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_06a58b4b-f5a5-4978-89a2-075ffa6c5937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_06a58b4b-f5a5-4978-89a2-075ffa6c5937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6fbe312f-2743-47f0-84e7-8e858c37f085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_38b646b0-49e2-4534-aa9a-a39a1d520c34" xlink:to="loc_us-gaap_Assets_6fbe312f-2743-47f0-84e7-8e858c37f085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f1d7bc88-4cd5-48cb-9d1e-ba4a9f44bdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6dc189f3-cf56-4eea-8f3e-050341b30f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f1d7bc88-4cd5-48cb-9d1e-ba4a9f44bdd7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6dc189f3-cf56-4eea-8f3e-050341b30f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_5904218a-3170-465d-95c6-21e1008f1714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f1d7bc88-4cd5-48cb-9d1e-ba4a9f44bdd7" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_5904218a-3170-465d-95c6-21e1008f1714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5ccd45a9-abf9-4d70-9940-6f81b9f41174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5ccd45a9-abf9-4d70-9940-6f81b9f41174" xlink:to="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_6748b69d-0198-4264-85d1-ef44640f42d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:to="loc_us-gaap_LitigationStatusAxis_6748b69d-0198-4264-85d1-ef44640f42d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d8425e29-7d7e-46b0-a189-14675521ca88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_6748b69d-0198-4264-85d1-ef44640f42d8" xlink:to="loc_us-gaap_LitigationStatusDomain_d8425e29-7d7e-46b0-a189-14675521ca88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_190d08d9-3028-428e-b7f1-67fe66df65b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d8425e29-7d7e-46b0-a189-14675521ca88" xlink:to="loc_us-gaap_PendingLitigationMember_190d08d9-3028-428e-b7f1-67fe66df65b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bc6e12ae-f008-4678-98d0-90df38b5071a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:to="loc_srt_RangeAxis_bc6e12ae-f008-4678-98d0-90df38b5071a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4d631641-4e22-4595-850a-cd3fd6318ac6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bc6e12ae-f008-4678-98d0-90df38b5071a" xlink:to="loc_srt_RangeMember_4d631641-4e22-4595-850a-cd3fd6318ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a760a7a6-70af-4b23-9791-fb8e8ec2bf68" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4d631641-4e22-4595-850a-cd3fd6318ac6" xlink:to="loc_srt_MinimumMember_a760a7a6-70af-4b23-9791-fb8e8ec2bf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2900de38-e775-4e5b-b6af-2888bf45c51f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4d631641-4e22-4595-850a-cd3fd6318ac6" xlink:to="loc_srt_MaximumMember_2900de38-e775-4e5b-b6af-2888bf45c51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0a3c2347-dd69-4ce6-96fd-00630f7ca042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0a3c2347-dd69-4ce6-96fd-00630f7ca042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9b8defd1-7b2a-4106-a5b0-413ef801727e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0a3c2347-dd69-4ce6-96fd-00630f7ca042" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9b8defd1-7b2a-4106-a5b0-413ef801727e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_06d1505b-508b-4cfa-b76b-48b56afefd24" xlink:href="natr-20220930.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9b8defd1-7b2a-4106-a5b0-413ef801727e" xlink:to="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_06d1505b-508b-4cfa-b76b-48b56afefd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember_d56ba991-ee74-4a23-ada3-e89354afd89c" xlink:href="natr-20220930.xsd#natr_NonIncomeTaxMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9b8defd1-7b2a-4106-a5b0-413ef801727e" xlink:to="loc_natr_NonIncomeTaxMember_d56ba991-ee74-4a23-ada3-e89354afd89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20e7c6ba-23c8-4216-ac40-191a2cce67ac" xlink:to="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_45884dd5-3c0f-4681-994b-522decb4546b" xlink:href="natr-20220930.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_45884dd5-3c0f-4681-994b-522decb4546b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e5132fdd-e29a-4746-8ed9-41dec2ea4144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e5132fdd-e29a-4746-8ed9-41dec2ea4144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_cc5fe58f-c60c-494f-950d-23fe4b829f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_cc5fe58f-c60c-494f-950d-23fe4b829f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_27d16b60-7925-4e2c-964f-a38aad203b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d67827-ab5d-4570-863c-497a5b055ea5" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_27d16b60-7925-4e2c-964f-a38aad203b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a25762aa-9819-44d5-a2fa-cdc8701dc2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a25762aa-9819-44d5-a2fa-cdc8701dc2c1" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_68a3dbd4-ec80-4057-bf91-762871b791ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_srt_CounterpartyNameAxis_68a3dbd4-ec80-4057-bf91-762871b791ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e087ee0f-5185-4e7d-81b5-bdb92941e928" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_68a3dbd4-ec80-4057-bf91-762871b791ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e087ee0f-5185-4e7d-81b5-bdb92941e928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember_cb92c4ae-14b5-4c3a-bf51-3beff8e011cf" xlink:href="natr-20220930.xsd#natr_ChinaJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e087ee0f-5185-4e7d-81b5-bdb92941e928" xlink:to="loc_natr_ChinaJointVentureMember_cb92c4ae-14b5-4c3a-bf51-3beff8e011cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NaturesSunshineProductsChinaMember_f2767309-bd8c-469c-9797-3d6e0e9b624c" xlink:href="natr-20220930.xsd#natr_NaturesSunshineProductsChinaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e087ee0f-5185-4e7d-81b5-bdb92941e928" xlink:to="loc_natr_NaturesSunshineProductsChinaMember_f2767309-bd8c-469c-9797-3d6e0e9b624c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_9b97141c-001b-49aa-a6b4-3e29b7013c3a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_srt_OwnershipAxis_9b97141c-001b-49aa-a6b4-3e29b7013c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b467514c-0157-45c9-9bb2-f9e1bcb6aede" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_9b97141c-001b-49aa-a6b4-3e29b7013c3a" xlink:to="loc_srt_OwnershipDomain_b467514c-0157-45c9-9bb2-f9e1bcb6aede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ChinaJointVentureMember_33139e28-be52-4f39-874d-4c2db9a8cef8" xlink:href="natr-20220930.xsd#natr_ChinaJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b467514c-0157-45c9-9bb2-f9e1bcb6aede" xlink:to="loc_natr_ChinaJointVentureMember_33139e28-be52-4f39-874d-4c2db9a8cef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b7aa4afd-3e25-42d5-a285-1145d62040ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b7aa4afd-3e25-42d5-a285-1145d62040ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_04508ab4-fb61-4058-aa25-cee4083f3759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b7aa4afd-3e25-42d5-a285-1145d62040ab" xlink:to="loc_us-gaap_RelatedPartyDomain_04508ab4-fb61-4058-aa25-cee4083f3759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_5a917baf-e75a-4271-821c-91948287c272" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_04508ab4-fb61-4058-aa25-cee4083f3759" xlink:to="loc_srt_SubsidiariesMember_5a917baf-e75a-4271-821c-91948287c272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_03e82cf4-a81c-4c9b-a58f-20f720b8383e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_03e82cf4-a81c-4c9b-a58f-20f720b8383e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c648ef68-d6a1-4983-8749-7e11367a8e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_03e82cf4-a81c-4c9b-a58f-20f720b8383e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c648ef68-d6a1-4983-8749-7e11367a8e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_3639ba76-57d2-4529-906e-1d391339c243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c648ef68-d6a1-4983-8749-7e11367a8e11" xlink:to="loc_us-gaap_NotesReceivableMember_3639ba76-57d2-4529-906e-1d391339c243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_eed40978-5d5c-4be6-8e7c-34020d9a3022" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_dei_LegalEntityAxis_eed40978-5d5c-4be6-8e7c-34020d9a3022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d2355c10-d84e-4e6d-8254-581027cd91ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_eed40978-5d5c-4be6-8e7c-34020d9a3022" xlink:to="loc_dei_EntityDomain_d2355c10-d84e-4e6d-8254-581027cd91ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FosunPharmaMember_a8986879-ed95-4460-b96c-7a4f795cba7f" xlink:href="natr-20220930.xsd#natr_FosunPharmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d2355c10-d84e-4e6d-8254-581027cd91ba" xlink:to="loc_natr_FosunPharmaMember_a8986879-ed95-4460-b96c-7a4f795cba7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CompanysJointVenturePartnerMember_a8d8481e-5864-46a3-a22f-c77abd89ec89" xlink:href="natr-20220930.xsd#natr_CompanysJointVenturePartnerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d2355c10-d84e-4e6d-8254-581027cd91ba" xlink:to="loc_natr_CompanysJointVenturePartnerMember_a8d8481e-5864-46a3-a22f-c77abd89ec89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9d49bfc5-1af0-4c71-aea9-9504949ce065" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_eab256d6-3625-4a15-9013-73a3d78eb3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_eab256d6-3625-4a15-9013-73a3d78eb3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_72b18c30-ea5e-4760-81e8-ca9ea4500b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_72b18c30-ea5e-4760-81e8-ca9ea4500b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ca5f20fb-4e4f-417d-a836-c6ffb6fe31bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ca5f20fb-4e4f-417d-a836-c6ffb6fe31bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_88986441-93b5-43d1-9549-3637e4e86ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_88986441-93b5-43d1-9549-3637e4e86ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_0ba3f56f-04fa-4747-a223-4d0509ce64f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9d762154-7c5d-4712-a134-e0203b5bb987" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_0ba3f56f-04fa-4747-a223-4d0509ce64f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_76030820-9f65-4e6d-bfa9-669fb02aee7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_76030820-9f65-4e6d-bfa9-669fb02aee7a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ec924c09-1648-4705-a1ef-0ddcd1d610ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ec924c09-1648-4705-a1ef-0ddcd1d610ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_27739c71-ae24-4b46-a880-a26ae8e840c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ec924c09-1648-4705-a1ef-0ddcd1d610ac" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_27739c71-ae24-4b46-a880-a26ae8e840c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_75d81480-2290-4bf8-bdaf-0da09492fae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_27739c71-ae24-4b46-a880-a26ae8e840c2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_75d81480-2290-4bf8-bdaf-0da09492fae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_823ee181-cbd7-4933-8be4-689ac3f2bb69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_823ee181-cbd7-4933-8be4-689ac3f2bb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_823ee181-cbd7-4933-8be4-689ac3f2bb69" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_83713873-93e5-41de-b1c9-2bcf8f013b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_83713873-93e5-41de-b1c9-2bcf8f013b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5d37a468-687d-4690-a7c8-77859f445f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5d37a468-687d-4690-a7c8-77859f445f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f68d8821-9a63-458e-88ff-0d661e0b1581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_743c1d06-e89d-40f3-9e5e-d3d21884474a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f68d8821-9a63-458e-88ff-0d661e0b1581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_054d9bd6-0dbc-4598-98b8-09d14813679c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_054d9bd6-0dbc-4598-98b8-09d14813679c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_fe1953c6-c85c-4963-9024-4ad444791a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_054d9bd6-0dbc-4598-98b8-09d14813679c" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_fe1953c6-c85c-4963-9024-4ad444791a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1509772e-82bc-4b9e-ae6d-764d0c29677a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_fe1953c6-c85c-4963-9024-4ad444791a5b" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1509772e-82bc-4b9e-ae6d-764d0c29677a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_fb0f1600-c045-47a8-ad11-83de06154b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1509772e-82bc-4b9e-ae6d-764d0c29677a" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_fb0f1600-c045-47a8-ad11-83de06154b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_def2427f-3ee8-4a9a-9044-07711a5dcdcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_894cf0cc-cf99-4411-873f-680d8f5b25b9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_def2427f-3ee8-4a9a-9044-07711a5dcdcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_3782ddba-9247-499d-a2ec-9cafbdbec364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_def2427f-3ee8-4a9a-9044-07711a5dcdcc" xlink:to="loc_us-gaap_TradingSecurities_3782ddba-9247-499d-a2ec-9cafbdbec364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_76b965e5-7444-4ac9-bba7-2f51350ec1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_def2427f-3ee8-4a9a-9044-07711a5dcdcc" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_76b965e5-7444-4ac9-bba7-2f51350ec1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="natr-20220930.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_342ced07-8d98-49fa-98ff-90876f3120ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_be182e58-940e-4267-bc2d-884a7eda7742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_342ced07-8d98-49fa-98ff-90876f3120ab" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_be182e58-940e-4267-bc2d-884a7eda7742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b64c5379-fc07-4b50-bfc1-692b0551f9be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_be182e58-940e-4267-bc2d-884a7eda7742" xlink:to="loc_srt_RangeAxis_b64c5379-fc07-4b50-bfc1-692b0551f9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_80693b22-afba-4653-b8e0-31fea9d3d883" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b64c5379-fc07-4b50-bfc1-692b0551f9be" xlink:to="loc_srt_RangeMember_80693b22-afba-4653-b8e0-31fea9d3d883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_81c81603-f930-4132-9584-5d9c2dc39367" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_80693b22-afba-4653-b8e0-31fea9d3d883" xlink:to="loc_srt_MaximumMember_81c81603-f930-4132-9584-5d9c2dc39367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_be182e58-940e-4267-bc2d-884a7eda7742" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RevenuefromContractwithCustomerRefundPeriod_112d7073-f830-4a02-9249-5dcc916a99d3" xlink:href="natr-20220930.xsd#natr_RevenuefromContractwithCustomerRefundPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_natr_RevenuefromContractwithCustomerRefundPeriod_112d7073-f830-4a02-9249-5dcc916a99d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NumberofPrincipalCategoriesofProducts_4028efc2-22cc-492d-abb4-f121df1c7a9f" xlink:href="natr-20220930.xsd#natr_NumberofPrincipalCategoriesofProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_natr_NumberofPrincipalCategoriesofProducts_4028efc2-22cc-492d-abb4-f121df1c7a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_cecdf52f-be90-4152-b179-7d6ed542574e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_us-gaap_NumberOfReportableSegments_cecdf52f-be90-4152-b179-7d6ed542574e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContractWithCustomerContractTerm_d0f5dce6-1bec-4533-b8ba-5ec0db26c45a" xlink:href="natr-20220930.xsd#natr_ContractWithCustomerContractTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f70b765c-61af-4c27-b630-4d54844210cb" xlink:to="loc_natr_ContractWithCustomerContractTerm_d0f5dce6-1bec-4533-b8ba-5ec0db26c45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>natr-20220930_g1.jpg
<DESCRIPTION>NATR LOGO
<TEXT>
begin 644 natr-20220930_g1.jpg
M_]C_X1((17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    A    <@$R  (    4
M    DX=I  0    !    J    -0 "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C @*$UA8VEN=&]S:"D ,C R,#HP,3HR-2 P.#HQ,CHP,P
M  .@ 0 #     0 !  "@ @ $     0  !+"@ P $     0   5@
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   0S@        !(     0   $@
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M_OMG&+E&<JCI6* .T?TBYW7\KIF+TJZSJM9MPG;:[6!I?H]S6!VT?N.]^_\
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M+C  .$))300E       0                     #A"24T$.@      Y0
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M;G,    7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M     $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG
M='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M     0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N
M(&1O=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&
M(U)L=                $)L9"!5;G1&(U)L=                %)S;'15
M;G1&(U!X;$!2            "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU
M;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M   08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N
M9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H
M=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0
M $@    !  $ 2     $  3A"24T$)@      #@             _@   .$))
M300-       $    6CA"24T$&0      !    !XX0DE- _,       D
M      $ .$))32<0       *  $          3A"24T#]0      2  O9F8
M 0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M     0 U     0 M    !@       3A"24T#^       <   ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H   X0DE-!         (  3A"24T$ @      !      X0DE-
M!#        (! 3A"24T$+0      !@ !     CA"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -)    !@
M           !6   !+     * %4 ;@!T &D = !L &4 9  M #0    !
M                      $             !+    %8
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   %8     %)G:'1L;VYG
M   $L     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   !6     !29VAT;&]N9P  !+     #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!0       0    #.$))300,     !#J     0   *     N
M   !X   5D   !#. !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1"  N * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
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ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
M/P#U1SFM:7.(:UHDDZ  +DG]9ZW]9,BS&^K[AA]-I=LNZF\2YWBW':?Y/O\
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ML]OZ1$ZEU?"Z8[%;E.(.9<W'JB-'._/?N+?T3?SW_P M8'^+8$="N!Y&4_\
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M62]@SO1<_>&^W<UY9_-S^Z%>Z#]8<;K73W7U17DTB,B@F2Q\:?UJK(_1/_\
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M &\ <    !0 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  R #
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M1E0     245#('-21T(               $  /;6  $     TRU(4" @
M                                                           1
M8W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0
M   4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9
M E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M
M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,
M9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I
M(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-2
M1T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M
M     %A96B        #S40 !     1;,6%E:(                     !8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N
M8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                9&5S8P
M   N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S
M4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO
M=7(@<W!A8V4@+2!S4D="                             &1E<V,
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@
M245#-C$Y-C8M,BXQ                                  !V:65W
M   3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4
M %<?YVUE87,          0                        */     G-I9R
M    0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P [
M $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D
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M&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[
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M],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X
M#D%D;V)E &1      ?_; (0  @(" @(" @(" @," @(#! ," @,$!00$! 0$
M!08%!04%!04&!@<'" <'!@D)"@H)"0P,# P,# P,# P,# P,# $# P,%! 4)
M!@8)#0H)"@T/#@X.#@\/# P,# P/#PP,# P,# \,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,_\  $0@!6 2P P$1  (1 0,1 ?_=  0 EO_$ :(    '
M 0$! 0$           0% P(& 0 '" D*"P$  @(# 0$! 0$          0 "
M P0%!@<("0H+$  " 0,# @0"!@<#! (& G,! @,1!  %(1(Q05$&$V$B<8$4
M,I&A!Q6Q0B/!4M'A,Q9B\"1R@O$E0S13DJ*R8W/"-40GDZ.S-A=49'3#TN((
M)H,)"A@9A)1%1J2T5M-5*!KRX_/$U.3T976%E:6UQ=7E]69VAI:FML;6YO8W
M1U=G=X>7I[?'U^?W.$A8:'B(F*BXR-CH^"DY25EI>8F9J;G)V>GY*CI*6FIZ
MBIJJNLK:ZOH1  (" 0(#!04$!08$" ,#;0$  A$#!"$2,4$%41-A(@9Q@9$R
MH;'P%,'1X2-"%5)B<O$S)#1#@A:24R6B8[+"!W/2->)$@Q=4DP@)"A@9)C9%
M&B=D=%4W\J.SPR@IT^/SA)2DM,34Y/1E=865I;7%U>7U1E9F=H:6IK;&UN;V
M1U=G=X>7I[?'U^?W.$A8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*
MFJJZRMKJ^O_:  P# 0 "$0,1 #\ ^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*O*//OYY?E+^60D3SKY[TO2+R,5;25D-S?>W^B6XDFH?$I3+889SY!
MU.O[<T6A_O\ +&)[N<O]*+/V/CKSG_S\:\BZ<9H/(WD?5O,TJ55+[4IH]-MR
M>S*JBYE8>S*A^694-!(_4:>.UO\ P1]-#;!BE/S)$1_OC]SYC\S_ //P+\\]
M9:1="BT'RA :B)K.R-U.!_E/>O,A/RC ]LR8Z'&.=EYC5?\ !![1R_W?!C'D
M+/\ LK'V/#-;_P"<EOS\\P%SJ'YL>8HA)]M+"[;3E->W&R$(I[4RX:?&/X0Z
M+/[3=IYOJSS^!X?]S3S34/.WG/5F+:KYNUK4F;[375_<3$_,O(<L$(CD'6Y-
M;J,GUY)'WR)_2QR2664\I9&E;KR<ECO\\DXQ)/-4ANKFW(,%Q+ 5Z&-V6GW$
M8TD3(Y%E.G?F'Y_TAD;2?//F#2VC^PUIJ=U 5^1CD6F1..)Y@.5C[1U./Z,L
MQ[I$?I>H:'_SE1_SD)Y>9&L?S5UJYX?LZF\>I@CW%ZD]<JEIL9_A=I@]JNU,
M/TYY'^M4O]T"]W\K_P#/PW\XM):./S)HOE_S9;"GJ2&"2QNF^4D#F(?\BCE,
MM! \K#OM+_P0]?C_ +V,)CW&)^S;_8OJ'R7_ ,_$?RLUDQ0>=/+>L^2KEZ<[
MF+CJEFGB3)$(I_N@.8T]!,<C;U&B_P"")H\NV:$L9_TT?LH_[%]B^2/S4_+G
M\R+<7'D?SGI7F/X.<EI:SK]:C7QEMGXS1_[-!F)/%*'U"GL=#VKI-:+P9(S\
M@=_B.8^(9_D'8.Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*O_T/OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL54Y98H(I
M)YY%AAA4O-,Y"JJJ*EF)V  ZDXH) %GD^*_S;_YSG_*?\OC<Z7Y49OS)\QPD
MH8M-D$>FQ.-OWE\597_YXJX[$C,S%HISW.P>*[7]NM%H[CB_>S\OI^,O^)M^
M;7YF?\Y?_G=^9;7-M+YF;RCH4]5&A>7N5DA0[<9+@,;B2HV8-)Q/\HS88]+C
MATL^;YMVG[8=HZZP9\$3_##T_,_4?G7D^869G9G=B[N2SNQJ23U).9#RY-M8
MJ[%78J[%78J[%78J[%78J[%5>UN[JQN8;RRN9;.[MG$EO=0.T<D;CHR.I!!'
MB#B1;*$Y0(,31'4/KW\L?^<WOSI\@-;6>MZDGYB:#%17L-<):["#KZ=^H];E
M[R^H!_+F+DT<)\MB]?V7[<=H:.A.7BP[I<_A+G\^)^EGY1_\YB?D_P#FL]MI
MCZFWDKS3<<470-<9(EED.W&VNP?2EJ=@"5<]DS79=).&_,/I?9'MCH>T*CQ>
M',_PRVOW2Y'[#Y/JS,9ZMV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5__1^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OG'\\/^
M<G_RW_(^WDL]5NSK_G!X^=EY-T]U-Q\0JC7,FZVZ';=OB(W5&S(PZ:67EL.]
MYOMSVHTG90J9XLG2 Y_'^:/?OW OQW_.7_G)S\TOSJGFMM<U8Z-Y6+5MO)^E
MLT-F%!^$SFO.X8;;R$@'=57IFUQ:>&/ES[WQWMGVGUG:A(R2X8?S([1^/\[X
M_ !\\Y>\\[%78J[%7H/E3\I_S-\\^FWE'R%KNOP2_9OK2QF:V%?YK@J(E^EL
MA++"/,@.PTG9.LU?]SBG(=X!KY\GT)H'_."7_.0^M!&O="TORPC[AM5U. FA
M[E;/ZTP^1%<HEK<8ZV]#I_83M3+]48P_K2'^]XGJVF_\^WOS"E53J_YA^7;%
MS]M;.&[NP/D9$MZ_=E1[0CT!=MC_ .!OJC]>: ]P)_XEE47_ #[3O"!Z_P"<
M<,9[A-!9_P!>H+D?Y0_H_;^QRA_P-)==0/\ 2?\ 'E*?_GVIJ2JQMOS@MIG_
M &5ET-XP?F5OGI]V/\H#^;]J)?\  TGTU _TG_'BP_5?^?<7YH0*6T;SSY8U
M(C]B[^N6A/RX03BOS.3&OAU!</+_ ,#C6#Z,L#[^(?H+R'S#_P X2?\ .16@
M"22+R=;^8;>*I:XTG4+66M/Y8I9(IF^A,MCK,9ZTZ?4>Q':N'EC$A_1D#]A(
M/V/GCS-Y#\[>2Y?1\W>4=9\LR%N*?I.RGM0Q_P AI44-[$'+XSC+D;>>U.@U
M&E-9L<H?U@1][%,DXCL5=BKL5?6WY(_\YB_F=^4;6FD:C<OYY\E0\4/E_4I6
M,]M&.UG=D,\=!T1@R4Z*.N8N;20R;\B]=V)[8ZSLZH2/B8_YI.X_JRYCW;CR
M?L-^47YZ?EW^=>D'4?)>L![ZV0-JWER[XQ:A9D[?O8:FJUV#H60].5:C-5EP
MRQG=]A[([=TO:D.+#+<<XG:4?>/TBP]@RIW#L5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK_ /_2^_F*NQ5V*NQ5V*NQ5V*NQ5V*
MJ4\\-M#-<W,R6]O;HTD\\C!$1$%69F-   *DG%$I"(L[ /RX_P"<D/\ G.DQ
MOJ'DG\D+M6*\K?5/S# Y"O1TTU2*'P]9O^>8^S)FRT^BZS^3Y;[2>W57@T)\
MCD_XC_BOET+\M[R\N]0NKF_O[J:^OKR1IKN\N':6661S5G=W)9F)-22:G-D!
M3Y;.<IR,I$DGF3S*'Q8NQ5FGDC\N?//YD:H-'\C>5[_S+? KZRVD1,4(;8-/
M,W&*)3_,[*/?(3R1@+D:<W0]G:G73X,$#,^73WGD/B_0;\M/^?=&IW2VVH?F
MOYP32XVHTGES0 )KBAWXR7DR^FA'0A(W'@V8.37C^$?-]"[,_P"!S.52U>3A
M_HPW/^F.WR!][[L\B?\ .,_Y(?ETL3^7_P O]-GU"*A&LZJGZ1N^8_;62Z]3
MTS_QC"CVS"GJ,D^9>ZT'LSV=HO[O%$GOEZC\Y77PI[J % 50%5115&P &4N^
M;Q5V*NQ5V*NQ5V*J%S:VU[;RVMY;Q7=K.I2>VF19(W4]0RL""/GB#3&41(5(
M6"^:_/W_ #B#^0OG\337'DR+RQJ<H--6\N,-.<$]6]!%-LQ)W):(G,B&JR0Z
MW[WFM?[']FZRR<?!+OAZ?L^GYA\%?F=_S[U\_P#EY+G4?RVURV\]6$=771KH
M+8:DJ]>*%V,$M!U/-">RYG8]=$_4*>"[3_X'NIPW+32&0=Q],O\ B3\Q[GP;
MY@\M^8/*>J7&B>9]%O?+^KVI_P!(TW4('MYE!Z'A( :&FQ&Q[9FQD)"QN\%J
M--ET\S#+$QD.A%%)<+2[%4[\N>9=?\H:S8^8?+&KW6A:WILGJ66I6<ACE0]Q
M4=01LRFH(V((P2B)"BWZ;4Y=-D&3%(QD.1#]A?\ G&K_ )S5T;\Q7L/)7YG/
M;>7?/$O&#3=;%(M/U5^BJ:[03M_+]AS]BA(3-5J-&8;QW#[#[->VN/6U@U50
MR\@>49_\3+RY'IW/OS,%[]V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*O_T_OYBKL5=BKL5=BKL5=BKL52W6-8TOR_I=_K>MZA!I6D
M:5 ]SJ.HW+B.*&*,59W8[  80"30:\V:&&!G,B,8BR3R ?BC_P Y0_\ .76L
M_F[=7GDWR1/<:)^6<#E)FWBN=9*'^\N.A2&HJD7?[4F]%3;Z;2C'N>?W/B?M
M1[79.T2<. F.$?.?F?Z/='XGN'B/,QXAV*IIHFAZSYDU2RT/R_I=UK6L:C((
MK'3+*)IIY7/940$G;<^ P&0 LMN#!DSS$,<3*1Y "R7Z=?DA_P ^_%*V7F+\
M[KT@GC+'Y"TV6E._&]O(S]Z0G_GIU&:[-KND/F^G=A_\#[EDUQ_S ?\ =2_1
M'_3/TO\ +7E7RWY-TFWT'RIH=EY>T>U_N=.L(4@C!Z%B$ Y,:;L:D]SFOE(R
M-DV^F:;2XM- 8\41&(Z 4G^1<AV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*L"\_P#Y
M8>0OS1TDZ-Y[\L67F"T 86TTR<;BW+=6M[A.,L1]T85[Y.&24#<33@=H=EZ;
M7PX,\!(?:/<>8^#\J?SS_P"<#/-?D]+SS%^5%Q<>=O+T7*6;RY*H_2]LG7]V
M$ 6Z _R0K]@C;G-GAUHEM+8_8^4]N^P6;37DTA.2'\W^,>[^=\*/D7Y]30RV
M\LL$\3P3P.T<T,BE71U-&5E-"""*$',Y\^((-'FIXH=BK]./^<4O^<SIM-?3
M?RU_.'5#-IC<+;RUYYNGJ]L=E2WOY&^U'V64FJ='JOQ)KM3I+]4/D^G>RGMF
M85IM9+T\HS/3REY=TNG7;<?6-65U5T8,C %6!J"#T(.:Q]9!MO%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J^1OSK_YS%_+[\E?-I\DZAHNK>8]=M[>
M*YU1-/$*0VPG4/%&SS.I+LA#4"T (WKL,K#I)9!?(/(]M^V.E[+S^!*,IR !
M-50OES/.MWI7Y(?G[Y'_ #WT.[U3RK)-8ZEI<@CUGRW?<%O+;E7TY"$9@T<E
M/A=32M0:$$97FP2Q&B[+L/M_3]K8S+%8,><3S'[#WO;\I=X[%78J[%78J[%7
M8J[%7S_J7_.5'_./FDW]WIM[^:.DK=V,K0W*PK<3H'0T8"6&)T:A[JQ&7C39
M#O3S^3VJ[+QR,99XV/>?M I!?]#<?\XY_P#ETM._Y$7G_5##^5R]S#_1=V5_
MJ\?D?U/0?(7YR?EA^9\]]:>0_.=AYCO--C$M[90%XYTC)"^IZ4JHY6I + 4!
M('?*YXIP^H4[#0=LZ/7DC3Y!,CF!S^1>F96[-V*NQ5V*NQ5V*NQ5V*NQ5X?^
M>?Y]^3OR$T'3=8\T0W>I7>MW#VVC:)8",W$YB4-+(3(Z*J1AEY&O5E !KEV'
M!+*:#H^W>W\'9&.,\H),C0 YGOY]!^D)7^0__.2'DG\_K;6_\.6=]HNK>7FB
M.HZ-J(C]4PS<A'-$T3N'2JE3T*GJ-U).?3RQ5?5J[!]I-/VP)>&#&4>8-<CU
M%='T)E#T+L5=BKL5=BKL5=BKY^U'_G*C_G'S2KZ[TV\_-+21=V4K0W"PK<3H
M'0T8++#$Z-0]U8C+QILAZ//Y/:KLO'(QEGC8]Y^T"D'_ -#<?\XY_P#ETM._
MY$7G_5##^5R]S#_1=V5_J\?D?U._Z&X_YQS_ /+I:=_R(O/^J&/Y7+W+_HN[
M*_U>/R/ZG?\ 0W'_ #CG_P"72T[_ )$7G_5#'\KE[E_T7=E?ZO'Y']3O^AN/
M^<<__+I:=_R(O/\ JAC^5R]R_P"B[LK_ %>/R/ZG?]#<?\XY_P#ETM._Y$7G
M_5#'\KE[E_T7=E?ZO'Y']3O^AN/^<<__ "Z6G?\ (B\_ZH8_E<O<O^B[LK_5
MX_(_J=_T-Q_SCG_Y=+3O^1%Y_P!4,?RN7N7_ $7=E?ZO'Y']3O\ H;C_ )QS
M_P#+I:=_R(O/^J&/Y7+W+_HN[*_U>/R/ZG?]#<?\XY_^72T[_D1>?]4,?RN7
MN7_1=V5_J\?D?U/1O(7YO?EI^:!OT\A><+#S)-I@5K^VMRZ31*YHKF*54?B3
MMRI2NU<KGBE#ZA3L=!VOI-??Y?()USKG\CN]'RMV3L5=BK"?//YC^1ORTTV#
M5O/?F:R\M6%W+Z%I+=,>4TE*E8XT#.Y W/%30=<G#'*9J(MP==VEIM# 3SS$
M =A?7W#F\H_Z&X_YQS_\NEIW_(B\_P"J&6_E<O<ZK_1=V5_J\?D?U.'_ #EO
M_P XYD@?\K2TW?Q@O!_S(Q_*Y>Y?]%W97^KQ^1_4]\TC5]+U_3+'6M$U"WU;
M2-3A6XT_4K61989HG%5='4D$'*""#1=_AS0S0$X$2B18(Y%,<#8[%78J[%78
MJ\Z\^_FU^6_Y7K8-Y]\WV/EIM4Y_H^"X+-+,(Z<V6*)7<JM0"U* ]\LABE/Z
M1;KM?VOI-!7YC((<7*^9^ W>;_\ 0W'_ #CG_P"72T[_ )$7G_5#+/RN7N=;
M_HN[*_U>/R/ZE\7_ #EG_P XZS2QQ)^:>EAY6"J7BNHU!)I\3O"%4>Y-,'Y7
M)_-2/:WLHFO'C]OZGT);W%O>6\%W:3QW5K=1K-;7,+!XY(W 971E)#*P-01L
M1E#T$9"0!!L%6Q9.Q5V*M$@ DF@&Y)Q5\^WO_.5G_./.GWES8W/YIZ2;BTD:
M*;T5N)X^2FAXRQ1.C#W5B,O&FR'^%YZ?M7V7"1B<\;'O/V@4A?\ H;C_ )QS
M_P#+I:=_R(O/^J&'\KE[F/\ HN[*_P!7C\C^IW_0W'_..?\ Y=+3O^1%Y_U0
MQ_*Y>Y?]%W97^KQ^1_4[_H;C_G'/_P NEIW_ "(O/^J&/Y7+W+_HN[*_U>/R
M/ZG?]#<?\XY_^72T[_D1>?\ 5#'\KE[E_P!%W97^KQ^1_4[_ *&X_P"<<_\
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M+/\ H;C_ )QS_P#+I:=_R(O/^J&'\KE[D?Z+NRO]7C\C^IW_ $-Q_P XY_\
METM._P"1%Y_U0Q_*Y>Y?]%W97^KQ^1_4[_H;C_G'/_RZ6G?\B+S_ *H8_E<O
M<O\ HN[*_P!7C\C^IW_0W'_..?\ Y=+3O^1%Y_U0Q_*Y>Y?]%W97^KQ^1_4[
M_H;C_G'/_P NEIW_ "(O/^J&/Y7+W+_HN[*_U>/R/ZG?]#<?\XY_^72T[_D1
M>?\ 5#'\KE[E_P!%W97^KQ^1_4[_ *&X_P"<<_\ RZ6G?\B+S_JAC^5R]R_Z
M+NRO]7C\C^I='_SEK_SCI(Z1K^:>F!G8*I:*[5:G;=F@  ]R<?RN7^:H]K>R
MC_EX_(_J?05G>6FH6EK?V%U%>V-]$EQ97D#K)%+%(H9)(W4D,K*000:$9CD4
M]#"<9Q$HFP=P1R(1.+)V*NQ5V*NQ5@/GG\TOR[_+6U6[\]><-,\MK(I>"WNI
M@;F51U,5LG*:2G^0AR<,<I_2+=?KNU=+H1>?)&'O.Y]PYGX!\J:__P _!_R-
MTJ62'2;+S+YG*U].YM+&*"!OINYX9!_R+S*CH<AYT'E=1_P0NSL9J G/W  ?
M[(@_8PX?\_(/R[YD-^7OF,1]G$MH6_X'U /QR7\GR[PX7_)R-+?]U/[/ULRT
M3_GX/^1>IND6IV7F;RX3]N>\L89HE^FTN)W(_P!AD3H<@[BYN#_@A=G9#4A.
M'O (_P!B2?L?2/D?\\_RB_,=HH?)OY@:1J][-0Q:49OJUZU?"TN1%,?^ S'G
MAG#F'I-#V[H=;MARQD>ZZE_I31^QZOE3MG8J_P#_U/OYBKL5=BKL5=BKL5=B
MJ%OKZSTRRN]2U&ZBL=/L(7N+Z]G<1Q0PQ*6>1W8@*JJ"23T&$"V&3)''$RD:
M %DGH'X<_P#.5W_.4>H?G/K$OE7RI<36'Y8Z//\ Z-%O&^K3QG:ZN%V(C!WB
MC/3[;#E0)N--IAC%GF^'>U?M3+M/)X6(D88G_3G^<?+^:/B=^7C/,MXQV*O:
MOR4_(;SW^>>O_HORM9_5M(LW7]/>:;I6%G9(V_Q$?WDA'V8UW/>BU84YL\<0
MLNZ[$[!U/:V7@Q"HCZI'Z8_K/</T;OW!_)7_ )Q]_+[\C=(%IY8L/KFO7403
M6O-MXJM?71V)4-TBBJ-HTVZ<N3?$=/FSRRG?D^X]B>SVE[*A6(7(\Y'ZC^H>
M0^T[O<<I=X[%78J[%6"^<?S._+S\OHC+YU\Z:/Y:/'G';7MU''<2#_BN"IE?
M_8J<G#'*?(6X.L[3TNC%Y\D8>\B_@.9?+?FC_G/[\B-#:2+1CKOG&5:A)=.L
M?0@)'B]\]NX'N$.9,=#D/.@\MJO;_LW%M#CR>X4/]EP_<\2U?_GY3&&9-!_*
M1G3]BYO]8"GZ8HK1O^)Y<.S^^7V.CS?\$H?Y/3_.7Z!']+"I_P#GY#^8+$_5
MOR\\O1+^R)9KN0_>'3)_R?'O+A2_X)&JZ88?,JUK_P _(_/*,#>_EOH5PG=8
M;JYA/ONWJ?JP'L^/>4Q_X).I_BPP/Q(_6] T3_GY/HLK(GF/\JKVQ3_=D^FZ
MI'=$^XCFM[?[N>0/9YZ2=A@_X)6,_P!Y@(]T@?L(C][WORG_ ,YR_P#./GF=
MHHKOS!?^4+F6@2#7+&2-:^!FM3<Q+\V<#*):/)'I;O\ 2>W/9>?8S.,_TA^F
M/$/M?4/E[S5Y9\VV(U/RMYATWS)IYH/KNF745U$">Q:)F /L<QY1,=B*>HT^
MJPZF/%BG&8[XD'[D^R+D.Q5V*NQ5\F?\Y!_\XE^2/SKM[O6].2+RG^8@0FW\
MQP1TAO&4?#'?Q+_> ]/4'QKM]I1P.5@U4L>W,/)>T/LEI^U 9Q]&;^<.1_K#
MK[^8\^3\3OS#_+CSC^5GF6[\J>=M'ETC5;;XHB?BAN822%GMY1\,D;4V([[&
MC @;?'DC,6'Q/M'LW/H,QQ9X\,A\B.\'J&#Y-P78J_3+_G#7_G+!]&FTO\H?
MS,U(MHTS+:^2?,UR^]FY/&.QN7;_ '4QVB8GX#\!^"G#7ZO2WZX_%],]C/:S
MPC'1ZF7IY0D>G]$^7<>G+ER^M6:M];=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BK\%/^<WO_ %I7S[_Q@T?_ +I=KF[T?]T/C][X)[<?\:V7W1_W$7A'
MY<?F-YJ_*KS;IGG/R??FRU73FI)&U6@N8&(]2WN$!'..0#<=1LRD, 1=DQB8
MHNA[-[1S=GYXYL)J0^1'4'O!_&[]_/R._.WRK^>?DZ#S+Y?D%IJ5KPA\R^7)
M'#3Z?=$5XMTY1O0F.0"C#P8,JZ3-A.*5%]_[#[;P]K8!EQ[2'U1ZQ/ZNX]??
M8>S92[IV*NQ5V*NQ5V*L=\X.\7E+S1)&Q22/2+YD=30@B!R"#[9*',.-K#6"
M9'\T_<_F%SHGYA=BK[2_YP&=U_YR#L55BJR:%J:R &G(<$:A\=P#F)K?[OXO
M:^P)_P!=!_4D_<K-,^Y.Q5V*NQ5V*NQ5V*NQ5V*OP)_YS _-C_E:?YR:T;"Y
M]?RSY-Y:#Y?XFL;_ %=S]9N%IL?5FY48=4">&;O2XN"'F7P'VP[6_E#7RX3<
M,?IC\.9^)^RF*?\ .-'YJM^4'YO>6?,UQ.8= O9/T3YJ%:*=/O&57D;Q]%PD
MWOPID]1B\2!'5Q?9GM7^3==#*3Z#Z9?U3^K:7P?T/JRNJNC!T< JP-00>A!S
M0OT0#:[%78J[%78J[%6.><69/*/FET8HZ:1?,CJ:$$6[D$$9*',.-K#6"?\
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MM>6\C12QL.C(Z$,I]P<2+90G*!$HD@CJ'VQ^37_.<_YF>09[32_/DTOYC>5
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M'_./ODQ(63R1'YHOH@.6H>8I&U O3^:W?C;?=$,PYZO)+K7N>WT7L;V9I?\
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M_P#^39R[3_WD?>Z3VE_XS-1_4/W/YT<WS\YNQ5^C_P#S[=_Y3[\Q?_ ?M_\
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M4=U?QMU8[%(B* ;O4_"NMU6K_AA\WU7V2]C14=5K(^<8'_=2'W1^?<_48
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M9FF?<W8J[%78J[%78JP+\T?/VF_EA^7_ )J\]ZKQ:W\NV+SPV['CZ]RU([:
M'QEE94^G)XX&<A$=7 [4U\-!I9YY\H"_>>@^)H/YM==UK4O,FM:OYAUFY:\U
M;7+R>_U*Z;K)/<.9)&^EF.=!$ "@_-F?///DEDF;E(DD^9W*586I]N?\X)?E
M5_CK\VQYOU&V]70/RVC346+"J/J4I9;%/FA5YJCH47QS#UN7AA74O;^PG97Y
MO7>-(>C%O_G'Z?EO+X)9_P YO_E3_P J[_.&[U_3[;T?+OYC+)K-D5%$2^Y
M7\0]_482^PD [8='EXX5U#5[<=D_DM><D1Z,OJ'];^(?/?\ SGQMF6\:B]/O
M[S2K^RU/3KA[/4-.GCNK&[C-'BFA8/&ZGL58 C$B]F>/)+'(2B:(-@^8?T@?
MDO\ F19_FS^6?E/SU:E$GU>S5=7M4Z07\!]*ZBIU $JGC7JI![YS^;'X<S%^
MD.Q>TH]HZ3'G'.0W\I#:0^?V/4<K=H[%78J[%78J[%78JP7\T/\ R6GYB?\
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M^)=_T.C_ ,XS_P#ES4_[A.K_ /9%C^4R]WW+_HT[(_U;_8S_ .)=_P!#H_\
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M[%7R7_SFS-YL3_G'_P QVOE33[C4#J5Y9VWF$VJ,\L.F<S)-)Q0$\2\:(_\
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MS$UW]W\7M?8#_C3']27Z'[CYIGW)V*NQ5V*NQ5V*NQ5^2_\ S\H_Y2+\J?\
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M4HZK5CU#>,#T_I2\^X=.N^P^G&:Y].=BKL5=BKL5>(_\Y)_^2$_-O_P&;_\
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MLI_.8N_["[S_ $$]K_ZC_LX?\4[_ *$I_P"<FO\ RVG_ '.=&_[+L?SF+O\
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MNK]"?^A#/^<>?^K/K/\ W%)LP?SN1]"_T!=E_P V7^F+O^A#/^<>?^K/K/\
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MXAEPR$HGK^@]Q\BRO(N6[%78J[%78J[%78J[%78J[%78J[%78J[%78J_&?\
MY^*^6AIWYK^5O,L482+S+Y=2*9J?;N+">1':O_&*6(?1FVT$K@1W%\9_X(NF
MX-;#*/XX?;$G]!#\^\SGSYEGD+7CY5\\^3/,X?A_AW7-/U(MX"UN8Y3^"Y&<
M>*)'>'+T&H_+ZG'E_F2B?D07].&<Z_3CL5=BKL5=BKL5=BKL5=BKL5=BKL5?
M@I_SF]_ZTKY]_P",&C_]TNUS=Z/^Z'Q^]\$]N/\ C6R^Z/\ N(OD[,EY-%6/
M^]MG_P 9X_\ B0Q++']0][^I+.;?J5V*NQ5YY^:/Y8^5?S=\G:EY,\W6?KV%
MZ.=I>( +BSN5!$5S;N0>+I7Y$55JJ2,LQY#CE8==VIV7A[1P'#F%@\CUB>A'
MF/V<G\_?YQ_E!YJ_)7SG>^4?,\/-16;1-:C4BWU"T)(2>(FM/!EK56J#V)WF
M+*,D;#\_=L]CYNR]0<.4>X])#O'Z1T+RK+'5.Q5V*NQ5]H?\X$?^M":;_P!L
M/4_^3:YB:W^[^+VGL#_QJ#^K)^YF:9]S=BKL5=BJ!U/4K'1M-U#6-4N4LM-T
MJVEO-0O)#1(H($,DDC'P55).$"S089<L<4#.1J,023W <W\WGYP_F-??FO\
MF3YK\]WO-$UN]8Z9:N=[>RB BM8=MJI$JAJ=6J>^;_%C\.(B_-W;':,NT-7D
MSR_B.P[HC:(^7VO-,L=8[%78JB+6[N[*59[*ZEM)U^S-"[1N/DRD'$BV49R@
M;B:+U?RW_P Y ?G9Y2:,Z%^:'F*WCBIZ=I<7LEY;BG_+O=&6+_A<JE@QRY@.
MVTWM!VAI_P"[SS'D22/E*P^FO*7_ #\"_,FUMI-)_,7RSHOY@Z+>1/;ZC1/T
M==S12J4D5FB#P$%2=O1%?',>6ACSB:>FTG_!!U<1P:F$<L3L?X21UY>G_8OA
M;5VTM]5U)]$BN(=&>ZF;28;HJ9TMBY,2RE206"T!(ZG,P76[PN8P,Y<%\-FK
MYUTM+\+6S_\ *SS_ *C^5WY@^5?/>F<GG\O7R3W%LIIZ]LU8[F G_BV)F3VK
M7(9("<3$]78=E=H3T&JQYX\XGYCJ/B+#^DK1-8T[S%H^E:_H]RMYI.MV<-]I
MMVGV98+A!)&X^:L#G/D$&B_26#-#-CCD@;C( @^1W"9X&UV*NQ5V*NQ5@OYH
M?^2T_,3_ ,!C5_\ J"ER>/ZA[W![4_Q3-_4E_N2_F=SH7YF=BK[5_P"<!/\
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M??1?S^_F-^7?FG\K/-VJ>3/-]@;+5M,?X9%J8;F!B?3N+=R!SCD J#\P0&!
MWF/()BP_/_:79V;L_/+#F%2'R(Z$>1_&[!\FX+L5=BK[0_YP(_\ 6A--_P"V
M'J?_ ";7,36_W?Q>T]@?^-0?U9/W,S3/N;L5=BKL5?!'_.??YL?X0_+:S_+S
M2[GT];_,20K?A#\<6DVK*TU:;CUI.$8_F7U!F;H<7%+B/1X'V_[6_+:0:>)]
M67G_ %!S^9H>ZWXM9MWQ9V*NQ5V*NQ5V*NQ5V*NQ5V*OV6_Y]^_FO_B?\O\
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MT/Z.6(M*UZ;D$,94<"@@VH.^8NJU!Q50YO7^R?LYB[8EE&24HB'#RK?BOO\
M<^WXO^?<OY- #U_-WG.0]REUIR?KT]LP_P _/N'X^+W _P"!SH.N3)\X_P#$
MK9_^?<OY.L#]6\W^<HCV,ESI\@_"P3'\_/N")?\  XT'3)D^<?\ B6*:E_S[
M9\JRJWZ'_-'5;%C]DWFG078'S$<MO7)#M ]0XF3_ (&N$_1GD/?$'],7E>O?
M\^X/S"M0[>6OS T#6>.ZIJ$-SI[,/;TUNQ7YGZ<MCVA'J"ZO/_P-]5'^ZRPE
M[P8_=Q/ ?-7_ #AU_P Y#>5!)++Y GUVTCK2ZT.>'4"U/Y8(G,_WQY?'5XY=
M7G]7['=J:?<XC(?T2)?8/5]CYTU71M7T*\DT[7-*O-&U"'^]L;Z"2WF7_6CE
M56'W9>"#R><RX9XI<,XF)[B*/VI=A:W8J[%4WT'S!KOE?5;37/+>KWFA:Q8M
MSM-3L9G@FC/>CH0:'H1T(ZX)1$A1;L&HR:>8GCD8R'(@T7Z6_D=_S\!N(39^
M7?SNM/K,)*Q1>?-.A D7MRO;2, ,/%X0#_Q6>N:_-H>L/D^E]A_\$ BL>N%_
MTP/]U$??'Y/U"T+7M$\SZ39:[Y=U6UUO1M1C$MCJ=E*LT,JGNKH2-CL1U!V.
M^:V43$T7U#!J,>> R8Y"43R(W";8&YV*J4\$-S#-;7,*7%O<(T<\$BAT='%&
M5E-000:$'%$HB0H[@OR2_P"<K/\ G#)_+::E^9/Y0Z<\WE].=SYD\E0 L]BO
MVGN+)14M".K1]8^JU39-IIM7?IGS[WR/VK]C/ XM3HQZ.<H#^'SC_1[QTZ;<
MOFKFP?-78J]1_*#\W/-?Y,><K'S?Y6N*M'2'6-(D8BWO[0D%[>8#QI56I56H
MPRO+B&2-%VG8_:^;LS4#-B/O'20[C^-G] _Y6_F=Y6_-WR;IGG3RG=>M8WR\
M+NS<CU[.Z0#U;:=03Q="?D11EJI!S1Y,9QRHOT%V7VIA[1T\<^$['F.L3U!\
MQ^WD]$RMV+L5=BKL5>-_FI^?GY6_DY:L_G3S+##JAC]2U\M6=+G4IP15>-NI
MJ@;L\A5/\K+<6">3D'3=J]OZ/LP?OY^KI$;R/P_2:'F_,7\U_P#G/_\ ,7S4
M;G3/RWL(OR^T5ZH-3;A=ZK*O2OJ.OI0U'9%+#M)FQQ:&,=Y;OF':W_! U6HN
M.F'A1[^<_P!0^ OS?"FLZWK/F+4;C5]?U:\UO5;MN5UJ5_/)<3R'Q:21F8_2
M<S0 !0>%S9\F:9GDD92/4FS\REF%J=BKL5=BKL597HGD+SSYFXGRWY,UWS '
M^P=-TZYNZ_+T8VR)G&/,@.7@T&IS_P!WCE+W1)^X/3M,_P"<7O\ G(+5@#:_
ME/KT7+I]<A6R^_ZTT5,K.IQC^(.SQ>R_:>3E@G\1P_[JF96/_.$__.2EZ\8?
M\ODL(G8 SW6JZ8JJ#W94NG>@]ER!UF(=?O<W'[$]K2_R5>^4?^*M^V_Y8>5+
MKR+^77D?R;?74=[>^5]#L=-O+J$$1R2VT"QN4J >/(&E16G7-/DEQ2)[R^V]
MEZ0Z32XL,C9A$ GS 9UD'/=BKL5=BKL5=BKL5=BKL5=BKL5?@I_SF]_ZTKY]
M_P",&C_]TNUS=Z/^Z'Q^]\$]N/\ C6R^Z/\ N(OD[,EY-%6/^]MG_P 9X_\
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M\EI^8G_@,:O_ -04N3Q_4/>X/:G^*9OZDO\ <E_,[G0OS,[%7VK_ ,X"?^M
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M&$C&0HC8H?%B]%_*;\QM6_*?\P?+7GO2"SRZ)=!KVS#<1=6<GP7-NW;]Y&2
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M$G8&-D?'B%_)+/\ HFE/_P"7FC_\)\_]Y+#_ "A_1^W]C5_R;0_\I/\ L/\
MC[V3\DO^<%O+'Y5^<M/\[Z_YPE\\:GH;^OH-D+!;"U@N *+/(IGN&D9.J;J
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MD9/PJ\B7T2N0.I"+7P&;$=H?T?M?,<G_  - 9'AU%#I<+/SXA]P0O_1-*?\
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M "A_1^W]B_\ )M#_ ,I/^P_X^[_HFE/_ .7FC_\ "?/_ 'DL?Y0_H_;^Q?\
MDVA_Y2?]A_Q]W_1-*?\ \O-'_P"$^?\ O)8_RA_1^W]B_P#)M#_RD_[#_C[O
M^B:4_P#Y>:/_ ,)\_P#>2Q_E#^C]O[%_Y-H?^4G_ &'_ !]W_1-*?_R\T?\
MX3Y_[R6/\H?T?M_8O_)M#_RD_P"P_P"/KX_^?:3^HGK?G*#$&'J!/+]&*]P"
M=1(!^C'^4/Z/V_L2/^!IOOJ/]A_Q]^DOD7R?I?Y?^3O+?DK16EDTSRS80V%I
M-.0TL@B6ADD( ')VJQH *G8 9KYS,Y$GJ^DZ'1PT>"&"'TP  OFRO(N6[%78
MJ\._YR _)#3?S[\C0^3K_7)_+LUAJ46JZ9JT,*W CN(HI8:20L\?-"DS;!U-
M:&NU#=@S'%*^;H_:#L.':^F&&4C B0D#5[@$;C:Q1/4/AW_HFE/_ .7FC_\
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M.JV<6H:9J<$EKJ%A.H>*:&52CQNIV(9201A!(-AAEQ1RP,)BXD40>H+\"O\
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MECY"7,P]_?'[1YC9^Q%C?6>IV=KJ.G7<-_87T27%E>V[K)%-%(H9)(W4D,K
M@@@T.:HBGV&$XY(B42"#N".1"*P,W8J^*O\ G,'_ )QKA_-[RT_G'RI9*/S)
M\L6S&"., -JMG'5FM'\9%W,)\:H=F!7,TNH\,T>1>*]L/9H=I8?&Q#]] ?Z>
M/\WW_P WY==OATZ/&[QR(T<D;%9(V%"I&Q!!Z$9N'PTBMBMQ5]:?\XA_GR_Y
M-?F'%I^M793R'YSDBLO,:NW[NTFKQM[X#MZ9:DGBA)W*KF+JL'B1VYAZWV0[
M>_DS5<,S^ZR4)>1Z2^'7R]P?O.K!@&4AE855AN"#W&:5]Z;Q5!ZCI]EJVGWV
ME:E:QWNG:E;RVM_9RCE'+#,I22-QW#*2#A!HV&&3'')$PD+!%$=X/-^5.G?\
M^ZM:/YD7 U7S59)^5<5V\]M);/(=7EM>7*.V9'B$2/3X6DYD?M!23Q&R.O'#
ML/5]CY5C_P"!UD_-GCR#P+O:^,CNY4#WF_.NC]0_*_E;R]Y*T'3?+'E72;?1
M-"TF(0V.G6R\44=2234LS&I9F)9C4DDG-=*1D;/-]0TNEQ:7&,6*(C&/(#\?
M;U3_ "+D.Q5+M6U?2M TV]UG6]1MM(TG3HC-?ZE>2K#!#&O5GD<A5'S.$ DT
M&O-FAA@9S(C$<R=@'Y>_GO\ \Y^R,U[Y9_(^'TT!:*X\_P!]%5F[$V%K*-O:
M28?*,;-FQPZ'K/Y/EW;WM^=\6A_TY'^YB?OE\NK\RM:US6?,FJ7FM>8-5N]:
MU?4',E[J=[,\\\K'N\CDD_?FQ  %!\RSY\F>9GDD92/,DV4KPM3L5=BK-/)_
MY<^??/\ <FU\E>4-6\S2*P262PM9)8HB?]^S >G&/=V R$\D8<S3FZ/LW4ZP
MU@QRG[@2/B>0^+ZU\G_\^_/SLUX13^9+K1/)%LU#+#=W)O+L ^$5F)(C\C*,
MQIZ[&.5EZW1_\#[M#-OE,<8\SQ'Y1L?[)])>6_\ GV_Y%M5C;S;^8>N:W(*%
MTTNWM].0GP_?"\:GTCZ,QY=H2Z /2Z;_ (&^FC_?9I2_J@1^_B>TZ/\ \X._
M\XXZ4J?6/)]WKDJ=)M0U2]J3XE;>6%#_ ,#E)UF4]7=8?8;LK'SQF7OE+]!
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MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O\
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M/^B[LK_5X_(_J>O^2O/OD[\Q=&_Q!Y(\PVGF32!,UO)>6C$^G,@!:.1&"LC
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M_P!4,O\ RN7N='_HN[*_U>/R/ZER?\Y:_P#..DCI&OYIZ8&<A06ANU6I\6:
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MV-WKEI;VQMF>)S'(\2R7*2,BD&A*@GL.F9D=#,B]GAM3[?Z##FEBX9GA-&0
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MS+^7GGQE)5E\NZH58;$$6DM"#D\?U#WN%VE_BN7^I+[B_F6SH7YE=BK]>?\
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MZ4#AU&RYH]3A\.7D>3] ^RW;@[5T@E+^\AM/W])?YWWV.CZ4S'>E=BK\WO\
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M,\Q_\_'OS$N[I&\J>0] T2Q5P6BU.2YU&9U!Z>I$]FHKW^#,J.@CU)>2U/\
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MGRG>1^0Z >08+DW 1FG:;J.KWMMIFDV%SJFI7CB.ST^TB>>>5ST6..,,S'V
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M;[,;6?W1^'WO5>Q/_&OA_P __<2?OKFD??78J[%78J_G:_YR?_\ 6@?S8_\
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MFKS[_P 9]'_[JEKF5H_[T?'[GD_;C_C)R^^/^[B_!7-T^".Q5_0]_P XM?\
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MT,[A7<^+?\$+L_P=;'.!MECO_6CL?LX7P-F:\"GWE7S#>^4O,_EWS3IQI?\
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MZEYCECJW8J[%7V=_S@O^7,_G/\[-.\Q7%H\FA?E_;R:M=7)0F(WC PV<1:E
M_-S*H_XK.8FMR<..NI>S]A>S3JNT!D(].(<1[KY1'OO?X/W.S3/NCL5?*7_.
M:7G,>3O^<??-T<<WHW_FU[?R]8;TY?7'Y7*_3;1RYDZ2'%D'EN\I[:ZW\MV9
MDH[SJ ^//_8@OP0S=O@;L5?MU_S[_P#*C:%^1CZ]-%QG\Z:Y>7\4A%";>VX6
M4:_(/!(1\\T^NE>2NX/M_P#P/])X/9WB'GDD3\!Z?O!?<68;W#L5=BKL5=BK
ML5=BKL5?S3_F]93:;^;'YFV%PI6:S\UZS$X/?C>S"OO7KG0XC<![@_-/;$##
M6YHGIDE_NB\[R;KGW1_S@%Y]TSRI^<-]Y=U:=+6+SYI9T_39W(53?P2K-!&2
M=AZBB15\6XJ-SF'KH&4+'1[KV U\-/KSCF:\6-#^L#8'QW^-/VTS3OMKL5=B
MKL5=BKL5=BKL58KYZ_Y0CSC_ -L/4?\ J&DR4/J'O<77?XOD_JR^XOYC<Z)^
M8G8J_6W_ )]L_P#*+?FE_P!M73O^3$V:OM#F'UO_ (&O]SG_ *T?N+]+\U[Z
M8[%78J[%6%?F3_Y+KS]_X#FJ_P#4)+D\?U#WN%VE_BN7^I+[B_F8SH7YE=BK
M]=_^?;G_ "A/YE?]MRT_ZACFK[0^H>Y]>_X&W^+YOZP^Y^DN:]])=BKL5?)'
M_.<?_K-OG7_F+TC_ +J-OF5H_P"]#R/MS_QDY/?'_=!^#6;I\&=BKL5370]<
MU?RUK&G:_H&HSZ3K.D3I<Z;J-NW"6&6,U5E/ZP=B-CM@E$2%%MP9YX,@R8R8
MRB;!'0OW:_YQ?_YR7TC\]/+WZ-U5H-+_ #'T.!3KVD*>*748HOUVU4]48D<U
MZQL:'X2I.EU.G.([<GW?V7]IH=K8N&=#-$>H=_\ 2CY=XZ'X/JW,9ZMV*NQ5
M^.7_ #\=_P#)I>1O_ 57_J.N<VV@^@^]\<_X(_\ CF+_ (7_ +XOSPS.?.WK
MO_./_P#Y//\ *#_P,=%_ZC8LJS_W<O<7;^S_ /QHZ?\ X9#_ '0?T?YH'Z0=
MBKL5?G1_S\@LII/RX\@:BJDP6GF1[:5NP>XLY72OT0MF?V>?4?<^<_\ !(@3
MI,4N@G7S!_4_'K-J^/.Q5_2)^1OGW3/S)_*GR3YJTRX24W.F6]OJL*D$P7UM
M&L5U"PZ@K(II7JM&Z$9H,T#"9#](]AZ^&NT6/+$\X@'RD-B/G]CUC*G;.Q5V
M*NQ5V*NQ5V*NQ5\7?\Y[_P#K/>H_]MS3/^3C9EZ+^\^#Q?M]_P 99_K1?AIF
MY?#'8J_HN_YQL_\ )"?E)_X#-A_R;&:'4?WDO>_1GLU_QF:?^H/N>W92[MV*
MNQ5V*NQ5^%/_ #G=_P"M%>8/^V5I7_4,N;G1?W8?"?;S_C5G_5C]SXYS+>.?
M4_\ SA3_ .M-?EI_V^?^Z+?9C:S^Z/P^]ZKV)_XU\/\ G_[B3]]<TC[Z[%78
MJ[%7\[7_ #D__P"M _FQ_P"!!<?J7-]IO[N/N?G;VH_XT\_]<O",N="^Y?\
MGWQ_Y/F\_P# 5U#_ )/VN8>N_N_B]S_P/?\ C2/_  N7WQ?MOFG?;G8J[%78
MJ_F'\Y?\I?YK_P"VQ??]1#YT4/I#\PZW^_R?UC]Y8WDG&=BKL5?I3_SAQ_SE
MG_AR33?RE_,W4_\ G7I66V\F^9[E_P#>!B:)9W+M_N@G:-S_ '9^$_NZ<-?J
M]+?JCSZOI7L;[6^ 8Z352]'*$C_#_1/]'N/3ERY?7/-6^NNQ5V*ODW_G-[_U
MFKS[_P 9]'_[JEKF5H_[T?'[GD_;C_C)R^^/^[B_!7-T^".Q5_0]_P XM?\
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MTP/"G4_YIVE^WWBWO&4.^=BKL5=BKL5=BKL5?%W_ #GO_P"L]ZC_ -MS3/\
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M*'?NQ5V*OS__ .?C/_DF?*7_ (&EI_W3M0S.T'UGW?J?/_\ @C?XAC_X:/\
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M_P 4/MY][TW_ )S>_P#6:O/O_&?1_P#NJ6N5Z/\ O1\?N=I[<?\ &3E]\?\
M=Q?@KFZ?!'8J_H>_YQ:_]9[_ "H_[8<?_)Q\T6I_O)>]^B/9;_C+P?U7OV4.
M_=BKL5?G_P#\_&?_ "3/E+_P-+3_ +IVH9G:#ZS[OU/G_P#P1O\ $,?_  T?
M[F3\8\VSXP[%78J[%78J[%78J_IG_+;_ ,EUY!_\!S2O^H2+.>R?4?>_379O
M^*XOZD?N#__7^_F*NQ5V*NQ5V*J4\$%U!-:W4,=S;7,;17%O*H=)$<<65E:H
M((-"#BB41($$6"_(_P#YRC_YPJN_+SZC^8/Y.Z=)?>7SRN-=\D0 O/8_M/+9
M+NTD/<QCXD_9Y)LFTTVLOTSY][Y'[4^Q4L-ZC1BX<Y0'./G'O'ES'3;E\V,V
M#YJ[%6U9D971BKJ058&A!'0@XJ#3[L_)#_G.CSY^7RVF@?F''-^8/E2$+'%>
M22 :O:1C;X)WVN !^S*>7_%@ IF%FT49[QV/V/=]A^W6IT=8]1>7'W_QCX_Q
M?'YOU<_++\Z?RU_-[3Q?>1O,]MJ4Z('O-%D/HZA;>/K6KT< ';D 4/[+'-;D
MPRQGU!]7[,[:TG:4>+!,$]1RD/?'G\>7F]3RIVKL5?&W_.>.F+?_ /..^N73
M+4Z+J^EWJ'P+W M:_=.1F7HC60/&^WF+C[+D?YLHG[>']+\+,W+X4[%7]"W_
M #BA?MJ7_.._Y5W#FICTEK4'VM+B:W'X1YHM2*R2?H;V3R<?9> _T:^1(_0^
MALH>A=BK^<'_ )R!LQ8?GE^;MNHXK_B[6)54= )KN24#_ALW^ WCC[@_-_M!
M#@[1U _VR7VDEY#EKJ'8J^K_ /G#?\I5_-+\XM+FU*V]?RQY'"Z[K@=:QRR1
M.!:6[5V/J348J>J(XS&U>7@AYEZSV-[)_/Z^)D+AC]4OA](^)^P%^]N:1][=
MBJ1^9O,>C^4/+VL^:-?NUL=%T"SEOM2NFWXQ0J6:@_:8THH&Y- -\E&)D:#1
MJ=3CTV*67(:C$$D^0?SG_G'^:6M?G%^8.N^>=99HQ?R^EH^G%N2V5A$2+>W7
MM\*FK$?:<LW?-]BQC'$1#\Y]L]J9.TM5+//KR'\V/0?K\[+R_+'5I[Y7\LZW
MYR\PZ1Y6\MV$FIZYKMREIIMC'U>1SU).RJHJS,=E4$G88)2$19Y-^ETV34Y8
MXL8N4C0#^@/_ )Q[_(?R_P#D1Y+AT:R$5_YGU18Y_-WF(+\5U< ;1QD@$0Q5
M(C7YL?B8YH\^<Y97T?H'V>[!Q=DZ?@CO,[REWG_B1T^?,O?,H=^[%78J[%78
MJD/FCS+HWDWR[K7FKS#>+8:+H%I+>ZE=-^S'$M2%'[3-T51N20!N<E&)D:#C
MZK4X]-BEER&HQ%E_.5^;OYE:M^;GYA>8_/>K\HGU>X(TZP+<EM+*+X+:W7M\
M" 5('Q-5NIS?8L8QQ$0_.7:_:<^T=5///^([#NCT'P'V[O-LL=:]-_)W\MM1
M_-O\Q_*_D33^<:ZQ= ZI>H*_5K&+]Y=3FNU5C4\:]6XKWRO+D&.)D[/L;LV?
M:.KA@C_$=SW1',_+[7]'^DZ5I^A:5INB:3:I9:7I%K#9:;9Q[)%! @CC1?95
M4#- 22;+](8<4<4(P@*C$  =P'),,#8[%78J[%78J[%78J[%78J[%78JX@$$
M$5!ZC%7RW^:7_.'WY*_F?]9OGT#_  ?YBN*L=>T#C:EI#ORFMN)@DJ=V/ .?
MYQF3CU4X=;'F\MVK[']GZ^Y<'AS/\4-OF/I/ROS?F3^<G_.%GYJ_E9'>:SI$
M0_,#RE:@R2:MI<3"[@C&Y:YL:NZ@#<M&74#=BN;'%JX3V.Q?,>V?8K6]G@SA
M^]QCK'F/?'G\K'>^/<RGCW8JFVA:[J_EC6=,\PZ!J$VE:UH]PEUINHV[<9(I
M8S56!_6#L1L=L$HB0HMN#/DP9(Y,9,91-@CH7]"__./7YPV?YV_EEH_F]%CM
M]:A)T_S5I\?V8-0@5?4XC<A)%99$W-%8 FH.:+/B\.=/T-[/=L1[4TD<W*7*
M0[I#G\#S'D7M^4N\=BK%?/7_ "A'G'_MAZC_ -0TF2A]0][BZ[_%\G]67W%_
M,;G1/S$[%7ZV_P#/MG_E%OS2_P"VKIW_ "8FS5]H<P^M_P# U_N<_P#6C]Q?
MI?FO?3'8J[%78JPK\R?_ "77G[_P'-5_ZA)<GC^H>]PNTO\ %<O]27W%_,QG
M0OS*[%7Z[_\ /MS_ )0G\RO^VY:?]0QS5]H?4/<^O?\  V_Q?-_6'W/TES7O
MI+L5=BKY(_YSC_\ 6;?.O_,7I'_=1M\RM'_>AY'VY_XR<GOC_N@_!K-T^#.Q
M5_1=_P XV?\ DA/RD_\  9L/^38S0ZC^\E[WZ,]FO^,S3_U!]SV[*7=O!/\
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M]1_[;FF?\G&S+T7]Y\'B_;[_ (RS_6B_#3-R^&.Q5_1=_P XV?\ DA/RD_\
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M*OZ'O^<6O_6>_P J/^V''_R<?-%J?[R7O?HCV6_XR\']5[]E#OW8J[%7Y_\
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M!$DAL)$GE*)(:(\[PQR) K=C*RBF_3+88)S%@;.GUW;^AT.48L^41D>FY^=
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MVVDL[)J?1,X_XQ^^;+0X?XS\'RS_ ((/;G+0XSW&?^]C_OC_ )K\P-(UC5=
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MY]Q>0+B75O/7YG74!6TM+5/+FCS,-I)IG2ZN^/O&L<0_V>:[7SV$?B^G_P#
MX[/)GEU1&P' />:,OE4?F_6#-8^L.Q5V*OSL_P"<_?R6G\T^5M._-G0+0SZO
MY*A-KYFBC6KRZ2[%UFVW/U:1B3_D.S'9<S]#FX3PGJ^=>W_8IU&$:O&+EC%2
M_J=_^:?L)/1^.V;5\==BKW;\E/\ G(G\Q?R,U"63RO>I?:!?2"35O*=_RDLI
MVH 9%"D-%)04YH16@Y!@*93FP1RC?F[[L3VBU79,OW1N!YQ/TG]1\Q\;?I3Y
M1_Y^'?E)JUM$/-N@Z[Y0U&@^L+'&FHV@/^1-$R2GZ81FOGH)CD07TK2?\$30
MY!^^C*!_TP^8W_V+*M5_YSX_YQ]T^W::SO\ 7-<E JMI9:8Z.33I6Z:!/^&R
M T60]SE9?;[LN N)E+R$?^*I\6_G1_SGEYX\^65YY=_+W3F_+[0;M6BNM4$W
MJZM/&=B%E4*MN&!W].K>$G;,S#HHQWEN7B^VO;W4:N)QZ<>% \S=S/Q_A^&_
MF^""22234G<DYFO NQ5](_\ .+7Y+W'YS_FEI>GW5JTGE#RX\>J><;@C]V;>
M-JQVI/3E<N.%*UX\V'V<Q]3F\.'F>3TGLMV*>T]9&)'[N'JG[OYO^<=O=9Z/
MZ"E4* J@*JBBJ-@ .PS1OT&WBKL5=BKY(_YSC_\ 6;?.O_,7I'_=1M\RM'_>
MAY'VY_XR<GOC_N@_!K-T^#.Q5_1=_P XV?\ DA/RD_\  9L/^38S0ZC^\E[W
MZ,]FO^,S3_U!]SV[*7=NQ5V*NQ5^>_\ SF+_ ,XJ+Y_M+S\T/R[TX#SS81<_
M,6AVZT.KP1K_ 'D:CK<QJ.G611Q^T%!SM)J>#TRY?<^>^V/LI^<B=5IQ^]'U
M ?QCO'](?:/.GXV,K(S(ZE64D,I%"".H(S;/C1%-8J]=_P"<?_\ R>?Y0?\
M@8Z+_P!1L659_P"[E[B[?V?_ .-'3_\ #(?[H/Z/\T#](.Q5V*L)_,?SYHGY
M8^2?,7GGS!)QTWR_:-.800'GE-$AMXZ_MRR,J+[G?;)XX&<A$=7![2U^/0:>
M>?)RB+]YZ#WD[/YP_//G+6_S"\W>8/.GF*?ZQK'F*\>[NV%>*<MDBC!K1(T
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MK_UGO\J/^V''_P G'S1:G^\E[WZ(]EO^,O!_5>_90[]V*NQ5^?\ _P _&?\
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ML:A)J?F'RU; FXNXA$4CFB0;R&"K'@-R&J 2M,S-%DC"6_5XCVZ[-U6LT<?
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MJ]^RAW[L5=BK\_\ _GXS_P"29\I?^!I:?]T[4,SM!]9]WZGS_P#X(W^(8_\
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MPQ^41?VV^5<R7E7TA_SB-Y<7S/\ \Y$?EI:2Q\X--OY=7F-*A3IMO+=Q$_\
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M0Y1'TCW_ ,[W<O>_1I555"J JJ**HV  [#,!]';Q5V*NQ5\B?\YPZ%J^O?\
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M\L<__(MOZ8VOAR[BF.D>6O,&O:G8:-HVC7FHZIJ<Z6]A8P0N\DDDAHJJ /'
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M(?RZ\]+>6$]OH5QKT5SHM[(I6.XF:W$=UZ9/V@@BC!(VKMVS5Z^N(=]/KG_
MX&0:7+Q B)F"#WFJE7R#]%<P'T5V*OS=_P"<Y?\ G'WS]^96O^3?.OY?>7G\
MR7-II[Z-KMG;R1)/&B3-/;2!9&3DM9I 2#MM7;-AH\\8 B1I\V]N?9[4Z[+C
MSZ>'&0.&0%7SL<_>7REY;_YP-_YR"UTQG4M*TCRC$]"9-5U&)R%\>%B+HU]C
M3Z,R9:W&/-Y33>P7:F7ZHQA_6D/][Q/I/R?_ ,^W=(B,4_GW\R+J^&QETW0K
M1+8#V%S<F8D'_C",QY]H'^$/2Z/_ (&T!OJ,Q/E$5]IO_<OKOR)_SBW^17Y>
MM#<:+Y!L;_4H:%=7UFNI7',='7ZR72-O>-5S%GJ<D^9>OT'LMV=HZ,,0,N^7
MJ/V[#X /H!555"J JJ**HV  [#*'H&\5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
9L5=BKL5=BKL5=BKL5=BKL5=BKL5=BK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426251296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 21, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0327982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2901 Bluegrass Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lehi<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">341-7900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NATR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,166,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000275053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426393936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 56,984<span></span>
</td>
<td class="nump">$ 86,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $673 and $143, respectively</a></td>
<td class="nump">9,977<span></span>
</td>
<td class="nump">8,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">67,603<span></span>
</td>
<td class="nump">60,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">8,237<span></span>
</td>
<td class="nump">8,760<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">142,801<span></span>
</td>
<td class="nump">164,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">47,354<span></span>
</td>
<td class="nump">50,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">16,541<span></span>
</td>
<td class="nump">18,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRestricted', window );">Investment securities - trading</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax assets</a></td>
<td class="nump">7,011<span></span>
</td>
<td class="nump">13,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">9,109<span></span>
</td>
<td class="nump">10,447<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">223,508<span></span>
</td>
<td class="nump">258,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,475<span></span>
</td>
<td class="nump">9,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_AccruedVolumeIncentiveandServiceFees', window );">Accrued volume incentives and service fees</a></td>
<td class="nump">21,177<span></span>
</td>
<td class="nump">23,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">24,856<span></span>
</td>
<td class="nump">31,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">1,460<span></span>
</td>
<td class="nump">3,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Related party notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">2,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">4,065<span></span>
</td>
<td class="nump">4,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of note payable</a></td>
<td class="nump">1,272<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">63,887<span></span>
</td>
<td class="nump">76,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Liability related to unrecognized tax benefits</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of operating lease liabilities</a></td>
<td class="nump">14,474<span></span>
</td>
<td class="nump">15,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Long-term note payable</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation payable</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">1,218<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">1,054<span></span>
</td>
<td class="nump">1,177<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">81,754<span></span>
</td>
<td class="nump">97,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value, 50,000 shares authorized, 19,166 and 19,724 shares issued&#160;and outstanding, respectively</a></td>
<td class="nump">121,242<span></span>
</td>
<td class="nump">133,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">32,681<span></span>
</td>
<td class="nump">35,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">4,012<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(16,181)<span></span>
</td>
<td class="num">(10,205)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">141,754<span></span>
</td>
<td class="nump">161,404<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 223,508<span></span>
</td>
<td class="nump">$ 258,874<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_AccruedVolumeIncentiveandServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the liability that is related to incentives that are payable, due to volume sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_AccruedVolumeIncentiveandServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284425989744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common stock, no par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">19,166,000<span></span>
</td>
<td class="nump">19,724,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">19,166,000<span></span>
</td>
<td class="nump">19,724,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426814224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 104,506<span></span>
</td>
<td class="nump">$ 114,746<span></span>
</td>
<td class="nump">$ 319,161<span></span>
</td>
<td class="nump">$ 326,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">29,632<span></span>
</td>
<td class="nump">29,419<span></span>
</td>
<td class="nump">93,563<span></span>
</td>
<td class="nump">84,861<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">74,874<span></span>
</td>
<td class="nump">85,327<span></span>
</td>
<td class="nump">225,598<span></span>
</td>
<td class="nump">241,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_VolumeIncentives', window );">Volume incentives</a></td>
<td class="nump">33,070<span></span>
</td>
<td class="nump">35,793<span></span>
</td>
<td class="nump">99,241<span></span>
</td>
<td class="nump">105,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">36,792<span></span>
</td>
<td class="nump">39,528<span></span>
</td>
<td class="nump">114,281<span></span>
</td>
<td class="nump">108,666<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">5,012<span></span>
</td>
<td class="nump">10,006<span></span>
</td>
<td class="nump">12,076<span></span>
</td>
<td class="nump">27,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other loss, net</a></td>
<td class="num">(2,281)<span></span>
</td>
<td class="num">(886)<span></span>
</td>
<td class="num">(3,037)<span></span>
</td>
<td class="num">(2,290)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">2,731<span></span>
</td>
<td class="nump">9,120<span></span>
</td>
<td class="nump">9,039<span></span>
</td>
<td class="nump">24,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">3,662<span></span>
</td>
<td class="nump">10,573<span></span>
</td>
<td class="nump">8,433<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">5,458<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
<td class="nump">16,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">810<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to common shareholders</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 4,858<span></span>
</td>
<td class="num">$ (2,344)<span></span>
</td>
<td class="nump">$ 15,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic and diluted net income per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="nump">$ 0.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic common shares outstanding (in shares)</a></td>
<td class="nump">19,198<span></span>
</td>
<td class="nump">19,894<span></span>
</td>
<td class="nump">19,384<span></span>
</td>
<td class="nump">19,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted common shares outstanding (in shares)</a></td>
<td class="nump">19,482<span></span>
</td>
<td class="nump">20,375<span></span>
</td>
<td class="nump">19,384<span></span>
</td>
<td class="nump">20,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_VolumeIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_VolumeIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284425943184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 5,458<span></span>
</td>
<td class="num">$ (1,534)<span></span>
</td>
<td class="nump">$ 16,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation loss (net of tax)</a></td>
<td class="num">(2,544)<span></span>
</td>
<td class="num">(925)<span></span>
</td>
<td class="num">(5,976)<span></span>
</td>
<td class="num">(1,091)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="num">$ (2,344)<span></span>
</td>
<td class="nump">$ 4,533<span></span>
</td>
<td class="num">$ (7,510)<span></span>
</td>
<td class="nump">$ 15,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284422825280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 157,234<span></span>
</td>
<td class="nump">$ 139,311<span></span>
</td>
<td class="nump">$ 26,030<span></span>
</td>
<td class="nump">$ 1,848<span></span>
</td>
<td class="num">$ (9,955)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">$ 1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">(914)<span></span>
</td>
<td class="num">$ (914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(19,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">4,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">141,498<span></span>
</td>
<td class="nump">$ 139,402<span></span>
</td>
<td class="nump">10,188<span></span>
</td>
<td class="nump">1,984<span></span>
</td>
<td class="num">(10,076)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 157,234<span></span>
</td>
<td class="nump">$ 139,311<span></span>
</td>
<td class="nump">26,030<span></span>
</td>
<td class="nump">1,848<span></span>
</td>
<td class="num">(9,955)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">$ (6,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">16,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">147,630<span></span>
</td>
<td class="nump">$ 134,252<span></span>
</td>
<td class="nump">21,586<span></span>
</td>
<td class="nump">2,838<span></span>
</td>
<td class="num">(11,046)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">141,498<span></span>
</td>
<td class="nump">$ 139,402<span></span>
</td>
<td class="nump">10,188<span></span>
</td>
<td class="nump">1,984<span></span>
</td>
<td class="num">(10,076)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">1,066<span></span>
</td>
<td class="nump">$ 1,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">(660)<span></span>
</td>
<td class="num">$ (660)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,500)<span></span>
</td>
<td class="num">$ (1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">6,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,540<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">147,153<span></span>
</td>
<td class="nump">$ 138,308<span></span>
</td>
<td class="nump">16,728<span></span>
</td>
<td class="nump">2,238<span></span>
</td>
<td class="num">(10,121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">$ 886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">(442)<span></span>
</td>
<td class="num">$ (442)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(4,500)<span></span>
</td>
<td class="num">$ (4,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">5,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,858<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(925)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(925)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 147,630<span></span>
</td>
<td class="nump">$ 134,252<span></span>
</td>
<td class="nump">21,586<span></span>
</td>
<td class="nump">2,838<span></span>
</td>
<td class="num">(11,046)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">19,724<span></span>
</td>
<td class="nump">19,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 161,404<span></span>
</td>
<td class="nump">$ 133,382<span></span>
</td>
<td class="nump">35,025<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
<td class="num">(10,205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">$ 801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">(795)<span></span>
</td>
<td class="num">$ (795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(7,971)<span></span>
</td>
<td class="num">$ (7,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(2,686)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,950)<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(975)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 149,778<span></span>
</td>
<td class="nump">$ 125,417<span></span>
</td>
<td class="nump">32,075<span></span>
</td>
<td class="nump">3,466<span></span>
</td>
<td class="num">(11,180)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">19,724<span></span>
</td>
<td class="nump">19,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 161,404<span></span>
</td>
<td class="nump">$ 133,382<span></span>
</td>
<td class="nump">35,025<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
<td class="num">(10,205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="num">(834)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">$ (12,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (1,534)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">19,166<span></span>
</td>
<td class="nump">19,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 141,754<span></span>
</td>
<td class="nump">$ 121,242<span></span>
</td>
<td class="nump">32,681<span></span>
</td>
<td class="nump">4,012<span></span>
</td>
<td class="num">(16,181)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">149,778<span></span>
</td>
<td class="nump">$ 125,417<span></span>
</td>
<td class="nump">32,075<span></span>
</td>
<td class="nump">3,466<span></span>
</td>
<td class="num">(11,180)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">$ 540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">(334)<span></span>
</td>
<td class="num">$ (334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(2,457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,457)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">144,479<span></span>
</td>
<td class="nump">$ 121,623<span></span>
</td>
<td class="nump">32,591<span></span>
</td>
<td class="nump">3,902<span></span>
</td>
<td class="num">(13,637)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">593<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(974)<span></span>
</td>
<td class="num">$ (974)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">$ (2,544)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,544)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">19,166<span></span>
</td>
<td class="nump">19,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 141,754<span></span>
</td>
<td class="nump">$ 121,242<span></span>
</td>
<td class="nump">$ 32,681<span></span>
</td>
<td class="nump">$ 4,012<span></span>
</td>
<td class="num">$ (16,181)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284428555680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividend (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284422689984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (1,534)<span></span>
</td>
<td class="nump">$ 16,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">1,017<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">8,112<span></span>
</td>
<td class="nump">8,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_OperatingLeaseNonCashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">3,859<span></span>
</td>
<td class="nump">4,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">1,934<span></span>
</td>
<td class="nump">2,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on sale of property, plant and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">5,967<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities', window );">Purchase of trading investment securities</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Proceeds from sale of trading investment securities</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized gains (losses) on investments</a></td>
<td class="nump">195<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign exchange losses</a></td>
<td class="nump">2,938<span></span>
</td>
<td class="nump">2,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(3,233)<span></span>
</td>
<td class="num">(2,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(10,809)<span></span>
</td>
<td class="num">(10,771)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(1,787)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">368<span></span>
</td>
<td class="num">(267)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(1,626)<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees', window );">Accrued volume incentives and service fees</a></td>
<td class="num">(253)<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(5,172)<span></span>
</td>
<td class="num">(1,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(2,040)<span></span>
</td>
<td class="num">(551)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(3,692)<span></span>
</td>
<td class="num">(4,170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">1,201<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions', window );">Liability related to unrecognized tax benefits</a></td>
<td class="nump">213<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Deferred compensation payable</a></td>
<td class="num">(271)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(2,866)<span></span>
</td>
<td class="nump">20,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(4,730)<span></span>
</td>
<td class="num">(4,626)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,730)<span></span>
</td>
<td class="num">(4,626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of cash dividends</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Principal payments of long-term debt</a></td>
<td class="num">(931)<span></span>
</td>
<td class="num">(1,001)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">31,538<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Principal payments of revolving credit facility</a></td>
<td class="num">(31,538)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Principal payments of related party borrowing</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments related to tax withholding for net-share settled equity awards</a></td>
<td class="num">(1,129)<span></span>
</td>
<td class="num">(2,016)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(12,945)<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(15,305)<span></span>
</td>
<td class="num">(29,475)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rates on cash and cash equivalents</a></td>
<td class="num">(6,299)<span></span>
</td>
<td class="num">(2,714)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(29,200)<span></span>
</td>
<td class="num">(16,534)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the beginning of the period</a></td>
<td class="nump">86,184<span></span>
</td>
<td class="nump">92,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the end of the period</a></td>
<td class="nump">56,984<span></span>
</td>
<td class="nump">75,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">3,386<span></span>
</td>
<td class="nump">4,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 195<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_OperatingLeaseNonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Non-Cash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_OperatingLeaseNonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284431252976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $0.1 million and $0.8 million for the three and nine months ended September&#160;30, 2022, respectively. Net income attributable to the noncontrolling interests was $0.6 million and $1.0 million for the three and nine months ended September&#160;30, 2021, respectively. As of September&#160;30, 2022 and December&#160;31, 2021, noncontrolling interests were $4.0 million and $3.2 million, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Related Accruals and Expenses</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded $0.1 million and $0.4 million of restructuring related expenses during the three and nine months ended September&#160;30, 2022, respectively. We recorded $0 and $48,000 of restructuring related expenses during the three and nine months ended September&#160;30, 2021, respectively. Accrued severance and restructuring related costs were $0 and $0.2 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the </span></div>potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284432280768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,603&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284432223360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities - Trading<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investment Securities - Trading</a></td>
<td class="text">Investment Securities - Trading<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trading securities portfolio totaled $0.7 million at September&#160;30, 2022, and $1.0 million at December&#160;31, 2021, and generated losses of $25,000 and $4,000 for the three months ended September&#160;30, 2022 and 2021, respectively, and losses of $0.2 million and gains of $0.1 million for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284432223360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revolving Credit Facility and Other Obligations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Revolving Credit Facility and Other Obligations</a></td>
<td class="text">Revolving Credit Facility and Other Obligations<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$25.0 million (the &#8220;Credit Agreement&#8221;).&#160;On June 23, 2022 the credit agreement was amended to extend the term to mature on July 1, 2027 and allows for additional borrowings of $25.0&#160;million or up to three separate increases of no less than $5.0&#160;million each, subject to the lender's due diligence. The amendment to the credit agreement also modified the calculation of interest. Interest under the amended Credit Agreement is the greater of BSBY Daily Floating Rate or the Index Floor, plus&#160;1.50 percent&#160;(4.62 percent as of September&#160;30, 2022), and an annual commitment fee of&#160;0.25 percent&#160;on the unused portion of the commitment. At September&#160;30, 2022 and December 31, 2021, there was no outstanding balance under the Credit Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of September&#160;30, 2022, we were in compliance with the debt covenants set forth in the Credit Agreement.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $6.0&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $3.7&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of 3.00 percent and are required to settle our borrowings under the Capital Credit Agreement in 36 monthly payments of $0.1&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of September&#160;30, 2022, there was $1.5&#160;million outstanding balance under the Capital Credit Agreement, of which $1.3&#160;million was classified as current.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284431199408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">Net Income Per Share<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per common share (&#8220;Basic EPS&#8221;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#8220;Diluted EPS&#8221;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three and nine months ended September&#160;30, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,344)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the nine months ended September 30, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the nine months ended September 30, 2022 include 576 restricted stock units.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted- average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284422802432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Capital Transactions</a></td>
<td class="text">Capital Transactions<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a special non-recurring cash dividend of $1.00 per common share in an aggregate amount of $19.9&#160;million that was paid on April 5, 2021, to shareholders of record on March 29, 2021. In accordance with the provisions of our 2012 Stock Incentive Plan (the "2012 Incentive Plan"), as a result of the special dividend we are required to make the participant's original grant whole by preventing either dilution or enlargement of the benefits or potential benefits intended by the original grant. The 2012 Incentive Plan provides our Compensation Committee with the discretion to meet this requirement. See further discussion in the Share-Based Compensation section of this Note.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a $15.0&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0&#160;million in common shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the nine months ended September&#160;30, 2022 and 2021, we repurchased 834,000 and 350,000 shares of our common stock for $12.9&#160;million and $6.0&#160;million, respectively. At September&#160;30, 2022, the remaining balance available for repurchases under the program was $24.6&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#8217;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500,000 shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by 1,500,000 shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by 2,000,000 shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to 48 months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no share-based compensation expense for the three- and nine-month periods ended September&#160;30, 2022 and 2021. As of September&#160;30, 2022 and December&#160;31, 2021, there was no unrecognized share-based compensation expense related to the grants described above.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the aggregate intrinsic value of outstanding and exercisable stock options to purchase 143,000 shares of common stock was $0. At December&#160;31, 2021, the aggregate intrinsic value of outstanding and exercisable options to purchase 172,000 shares of common stock was $1.1 million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine-month periods ended September&#160;30, 2022 and 2021, we issued 29,000 and 53,000 shares of common stock upon the exercise of stock options at an average exercise price of $9.17 and $12.00 per share, respectively. The aggregate intrinsic value of options exercised during the nine-month periods ended September&#160;30, 2022 and 2021, was $0.3 million and $0.4 million, respectively. For the nine-month periods ended September&#160;30, 2022 and 2021, the Company recognized $0.1 million and $0.2 million of tax benefits from the exercise of stock options, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, we did not have any unvested stock options outstanding.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding restricted stock units (&#8220;RSUs&#8221;), include time-based RSUs, which vest over differing periods of time ranging from 12 months to up to 36 months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating adjusted EBITDA growth, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until two years after vesting. At September&#160;30, 2022 and December&#160;31, 2021, there were 81,000 and 88,000 vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine-month period ended September&#160;30, 2022, we granted 796,000 RSUs under the 2012 Incentive Plan to the Board of Directors, executive officers and other employees, which were comprised of time-based RSUs, and share-priced and adjusted EBITDA performance-based RSUs. The time-based RSUs were issued with a weighted-average grant date fair value of $11.44 per share and vest in 12 monthly installments over a one year period from the grant date or in annual installments over a three-year period from the grant date. The share-priced performance-based RSUs were issued with a weighted-average grant date fair value of $6.01 per share and vest upon achieving share-priced targets over a three-year period from the grant date. The adjusted EBITDA performance-based RSUs were issued with a weighted-average grant date fair value of $11.00 per share and vest upon achieving adjusted EBITDA targets over a four-year period from the grant date.</span></div><div style="padding-left:36pt;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for share-priced performance RSUs, RSUs are valued at market value on the date of grant, which is the grant date share price discounted for expected dividend payments during the vesting period. For RSUs with post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. Using assumptions previously determined for the application of the option pricing model at the valuation date, the Finnerty Model discount for lack of marketability is approximately 12.9 percent for a common share.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-price performance-based RSUs were estimated using the Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved. Our assumptions include a performance period of three years, expected volatility of 50.1 percent, and a risk-free rate of 3.3 percent.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to time-based RSUs for the three-month periods ended September&#160;30, 2022 and 2021, was approximately $0.3 million and $0.6 million, respectively. Share-based compensation expense related to time-based RSUs for the nine-month periods ended September&#160;30, 2022 and 2021, was approximately $1.2 million and $1.6 million, respectively. As of September&#160;30, 2022 and December&#160;31, 2021, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $3.1 million and $1.6 million, respectively. The remaining compensation expense is expected to be recognized over the weighted average period of approximately 0.8 years.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to performance-based RSUs for the three-month periods ended September&#160;30, 2022 and 2021, was $0.2 million and $0.3 million, respectively. Share-based compensation expense related to performance-based RSUs for the nine-month periods ended September&#160;30, 2022 and 2021, was $0.7 million and $1.2 million, respectively.&#160;Should we attain all of the metrics related to performance-based RSU grants, we would recognize up to $1.8 million of potential share-based compensation expense. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was 80,000 and 150,000 shares for the nine-month periods ended September&#160;30, 2022 and 2021, respectively. Although shares withheld are not issued, they are </span></div>treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427616528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. The geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy WorldWide&#174; brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:55.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,076&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,037)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,039&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Service fees in China totaled $2.5 million and $11.3 million for the three and nine-month periods ended September&#160;30, 2022, respectively, compared to $5.2 million and $11.7 million for the three and nine-month periods ended September&#160;30, 2021. These service fees are included in selling, general and administrative expenses. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September&#160;30, 2022 and 2021, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:55.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,506&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,708&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,328&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,813&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,204&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,504&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,738&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,097&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,506&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,145&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,508&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427576816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 92.7 percent and 40.2 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. For the nine months ended September&#160;30, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 117.0 percent and 34.0 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three and nine months ended September&#160;30, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three and nine months ended September&#160;30, 2021, was primarily attributed to an increase in tax liability associated with transfer pricing adjustments, non-deductible executive compensation, and net unfavorable foreign tax related items, partially offset by favorable deductions for stock compensation.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate for the three and nine months ended September&#160;30, 2022 compared to September&#160;30, 2021 is primarily caused by recording a valuation allowance in the current period against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal income tax returns for 2018 through 2021 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2016 through 2021.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, we have accrued $0.2&#160;million and $0, respectively, related to unrecognized tax positions.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427563296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;one or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Income Tax Contingencies</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are recorded for probable losses at management&#8217;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of September&#160;30, 2022 and December&#160;31, 2021, accrued liabilities were $0.2 million and $0.2 million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $0 to approximately $2.7 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Litigation</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of September&#160;30, 2022 and December&#160;31, 2021, accrued liabilities were $0.6 million and $0.5 million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, no provision for losses has been provided.&#160;We believe future payments related to these matters could range from $0 to approximately $0.3 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427628448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party TransactionsDuring the three and nine months ended September&#160;30, 2022 and 2021, our joint venture in China ("NSP China"), owned 80 percent by us and 20 percent by a wholly owned subsidiary of Fosun Pharma, did not borrow any amounts from the Company or our joint venture partner. As of September&#160;30, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from the Company were $0 and $1.2 million, respectively. As of September&#160;30, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from our joint venture partner were $0 and $0.3 million, respectively. These notes were payable in less than one year and bore interest of 3.0 percent. The notes between NSP China and the Company are eliminated in consolidation. In March 2022, the outstanding principal and interest amounts were repaid.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427580240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of September&#160;30, 2022 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment securities - trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022 and for the year ended December&#160;31, 2021, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the nine months ended September&#160;30, 2022 and 2021, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427476240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Sales taxes and value-added taxes in the United States and foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Amounts received for unshipped merchandise are recorded as deferred revenue. Amounts for membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within ninety days of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our U.S. operations extend short-term credit associated with product promotions. In addition, for certain of our international operations, we offer credit terms consistent with industry standards within the country of operation. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are grouped into six principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have four business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy WorldWide&#174; brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expense volume incentives when incurred because the amortization period would have been one year or less.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our contracts with customers have a duration of less than one year. The value of any unsatisfied performance obligations is insignificant.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426900784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.</span></div>The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the </span></div>potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427598640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of composition of inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,603&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427628448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three and nine months ended September&#160;30, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,344)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the nine months ended September 30, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the nine months ended September 30, 2022 include 576 restricted stock units.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427560640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of restricted stock unit activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426222672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of reportable business segment information</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:55.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,076&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,037)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,039&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div>(2)&#160;&#160;&#160;&#160;Service fees in China totaled $2.5 million and $11.3 million for the three and nine-month periods ended September&#160;30, 2022, respectively, compared to $5.2 million and $11.7 million for the three and nine-month periods ended September&#160;30, 2021. These service fees are included in selling, general and administrative expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Schedule of consolidated net sales revenue by geographical locations</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September&#160;30, 2022 and 2021, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:55.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,506&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of revenue generated by each of the Company's product lines</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,708&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,328&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,813&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,204&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,504&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,738&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,097&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,506&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,145&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Schedule of consolidated property, plant and equipment by geographical locations</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock', window );">Schedule of assets per segment</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,508&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Segment Reporting Information, by Segment1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284427570656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of the company's hierarchy for assets measured at fair value on a recurring basis</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of September&#160;30, 2022 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426353104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Increase (decrease) in noncontrolling interest</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">4,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=natr_AccruedSeveranceandRentCostsMember', window );">Accrued Severance and Rent Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=natr_AccruedSeveranceandRentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=natr_AccruedSeveranceandRentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284429328544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 26,394<span></span>
</td>
<td class="nump">$ 22,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">1,880<span></span>
</td>
<td class="nump">1,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">39,329<span></span>
</td>
<td class="nump">36,612<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 67,603<span></span>
</td>
<td class="nump">$ 60,852<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284429303120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities - Trading (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRestricted', window );">Trading securities portfolio</a></td>
<td class="nump">$ 692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRealizedGainLoss', window );">Debt securities, trading, realized gains (losses)</a></td>
<td class="num">$ (25)<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284422169808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revolving Credit Facility and Other Obligations (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 23, 2022 </div>
<div>USD ($) </div>
<div>borrowing</div>
</th>
<th class="th">
<div>Nov. 19, 2020 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 11, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Bank of America Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings', window );">Potential increase in maximum borrowing capacity</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_LineOfCreditFacilityNumberOfSeparateIncreases', window );">Number of separate increases | borrowing</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence', window );">Potential increase in maximum borrowing capacity, per occurrence</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Annual commitment fee</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | LIBOR | Bank of America Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.62%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Banc of America Leasing and Capital Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_DebtInstrumentNumberOfMonthlyPayments', window );">Number of monthly payments | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit, outstanding, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Indicative Index | Banc of America Leasing and Capital Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DebtInstrumentNumberOfMonthlyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Monthly Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DebtInstrumentNumberOfMonthlyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityNumberOfSeparateIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Number Of Separate Increases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityNumberOfSeparateIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=natr_BankofAmericaCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=natr_BankofAmericaCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=natr_IndicativeIndexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=natr_IndicativeIndexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426534496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to common shareholders</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 4,858<span></span>
</td>
<td class="num">$ (2,344)<span></span>
</td>
<td class="nump">$ 15,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">19,198<span></span>
</td>
<td class="nump">19,894<span></span>
</td>
<td class="nump">19,384<span></span>
</td>
<td class="nump">19,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Diluted shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average shares outstanding (in shares)</a></td>
<td class="nump">19,198<span></span>
</td>
<td class="nump">19,894<span></span>
</td>
<td class="nump">19,384<span></span>
</td>
<td class="nump">19,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock-based awards (in shares)</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average shares outstanding (in shares)</a></td>
<td class="nump">19,482<span></span>
</td>
<td class="nump">20,375<span></span>
</td>
<td class="nump">19,384<span></span>
</td>
<td class="nump">20,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="nump">$ 0.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract', window );"><strong>Dilutive shares excluded from diluted-per-share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_DilutiveSecuritiesExcludedfromComputationofEarnings', window );">Stock options (in shares)</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">460<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract', window );"><strong>Anti-dilutive shares excluded from diluted-per-share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options (in shares)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive shares included in the calculation of diluted earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DilutiveSecuritiesExcludedfromComputationofEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DilutiveSecuritiesExcludedfromComputationofEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284418307488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 05, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 05, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>vestingInstallment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 08, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 10, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Common stock, dividends (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends, common stock, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,858,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">834,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 974,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">$ 7,971,000<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,900,000<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember', window );">2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized under the plan (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional number of shares authorized under the plan (in shares) | shares</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="nump">53,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.17<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic values of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefit from the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember', window );">Time-based stock options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne', window );">Operating income margin, one (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo', window );">Operating income margin, two (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree', window );">Operating income margin, three (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested stock options outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability', window );">Discount for lack of marketability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which the remaining compensation cost is expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements', window );">Minimum withholding requirements (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">796,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Minimum | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Director | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_RestrictionPeriodForIssuanceOfShares', window );">Restriction period for issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber', window );">Nonvested subject to restriction period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember', window );">Time-Based Restricted Stock Units (RSUs), 1-year Vesting | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments', window );">Number of vesting installments | vestingInstallment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember', window );">Time-Based Restricted Stock Units (RSUs), 3-year Vesting | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember', window );">Performance-Based Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember', window );">Performance-Based Restricted Stock Units (RSUs) | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember', window );">Performance-Based Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share based compensation potential compensation expense to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember', window );">Performance-Based Restricted Stock Units (RSUs) | Net Sales and Operating Income Targets | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember', window );">Adjusted EBITDA Performance-Based Restricted Stock Units | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_RestrictionPeriodForIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the restriction period before shares will be issued related to a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_RestrictionPeriodForIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Vesting Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the first operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the three operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the second operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=natr_NetSalesandOperatingIncomeTargetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=natr_NetSalesandOperatingIncomeTargetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284425570080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - Stock Option Activity (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at the beginning of the period (in shares)</a></td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or canceled (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(29,000)<span></span>
</td>
<td class="num">(53,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at the end of the period (in shares)</a></td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted&#160;Average Exercise Price&#160;Per&#160;Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 12.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or canceled (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">9.17<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at the end of the period (in dollars per share)</a></td>
<td class="nump">12.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted&#160;Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">5.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue', window );">Forfeited or canceled (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue', window );">Exercised (in dollars per share)</a></td>
<td class="nump">3.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 5.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426321072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - RSU Activity (Details) - 2012 Stock Incentive Plan - RSUs<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted Stock Units outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">830,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">796,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(271,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Issued (in shares) | shares</a></td>
<td class="num">(329,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted Stock Units outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">1,026,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant&#160;Date Fair&#160;Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted Stock Units outstanding, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">10.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">9.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Issued (in dollars per share) | $ / shares</a></td>
<td class="nump">7.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted Stock Units outstanding, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284417861088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of business segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">$ 104,506<span></span>
</td>
<td class="nump">$ 114,746<span></span>
</td>
<td class="nump">$ 319,161<span></span>
</td>
<td class="nump">$ 326,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">41,804<span></span>
</td>
<td class="nump">49,534<span></span>
</td>
<td class="nump">126,357<span></span>
</td>
<td class="nump">135,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">36,792<span></span>
</td>
<td class="nump">39,528<span></span>
</td>
<td class="nump">114,281<span></span>
</td>
<td class="nump">108,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">5,012<span></span>
</td>
<td class="nump">10,006<span></span>
</td>
<td class="nump">12,076<span></span>
</td>
<td class="nump">27,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other loss, net</a></td>
<td class="num">(2,281)<span></span>
</td>
<td class="num">(886)<span></span>
</td>
<td class="num">(3,037)<span></span>
</td>
<td class="num">(2,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">2,731<span></span>
</td>
<td class="nump">9,120<span></span>
</td>
<td class="nump">9,039<span></span>
</td>
<td class="nump">24,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">47,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">223,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">47,878<span></span>
</td>
<td class="nump">48,417<span></span>
</td>
<td class="nump">141,370<span></span>
</td>
<td class="nump">127,708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">21,268<span></span>
</td>
<td class="nump">21,421<span></span>
</td>
<td class="nump">64,639<span></span>
</td>
<td class="nump">55,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">89,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">14,705<span></span>
</td>
<td class="nump">13,150<span></span>
</td>
<td class="nump">40,010<span></span>
</td>
<td class="nump">37,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">654<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="nump">2,779<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">14,626<span></span>
</td>
<td class="nump">13,018<span></span>
</td>
<td class="nump">41,498<span></span>
</td>
<td class="nump">35,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">8,599<span></span>
</td>
<td class="nump">10,427<span></span>
</td>
<td class="nump">28,625<span></span>
</td>
<td class="nump">25,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">2,758<span></span>
</td>
<td class="nump">4,201<span></span>
</td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">12,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">6,536<span></span>
</td>
<td class="nump">7,158<span></span>
</td>
<td class="nump">21,074<span></span>
</td>
<td class="nump">17,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">19,328<span></span>
</td>
<td class="nump">21,813<span></span>
</td>
<td class="nump">58,204<span></span>
</td>
<td class="nump">65,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">7,189<span></span>
</td>
<td class="nump">6,959<span></span>
</td>
<td class="nump">18,157<span></span>
</td>
<td class="nump">20,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">16,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">8,638<span></span>
</td>
<td class="nump">9,308<span></span>
</td>
<td class="nump">25,162<span></span>
</td>
<td class="nump">28,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,899<span></span>
</td>
<td class="nump">2,285<span></span>
</td>
<td class="nump">5,973<span></span>
</td>
<td class="nump">6,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">2,385<span></span>
</td>
<td class="nump">2,774<span></span>
</td>
<td class="nump">7,168<span></span>
</td>
<td class="nump">8,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">4,849<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">14,921<span></span>
</td>
<td class="nump">16,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">3,529<span></span>
</td>
<td class="nump">3,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="nump">1,451<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">31,504<span></span>
</td>
<td class="nump">37,738<span></span>
</td>
<td class="nump">101,567<span></span>
</td>
<td class="nump">112,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">10,839<span></span>
</td>
<td class="nump">17,193<span></span>
</td>
<td class="nump">35,858<span></span>
</td>
<td class="nump">48,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">110,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">14,241<span></span>
</td>
<td class="nump">16,573<span></span>
</td>
<td class="nump">44,509<span></span>
</td>
<td class="nump">49,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">3,546<span></span>
</td>
<td class="nump">5,056<span></span>
</td>
<td class="nump">12,479<span></span>
</td>
<td class="nump">14,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">3,427<span></span>
</td>
<td class="nump">4,171<span></span>
</td>
<td class="nump">11,162<span></span>
</td>
<td class="nump">12,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">8,096<span></span>
</td>
<td class="nump">9,079<span></span>
</td>
<td class="nump">25,734<span></span>
</td>
<td class="nump">28,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,397<span></span>
</td>
<td class="nump">1,978<span></span>
</td>
<td class="nump">4,961<span></span>
</td>
<td class="nump">5,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">881<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
<td class="nump">3,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">5,796<span></span>
</td>
<td class="nump">6,778<span></span>
</td>
<td class="nump">18,020<span></span>
</td>
<td class="nump">20,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">2,508<span></span>
</td>
<td class="nump">3,961<span></span>
</td>
<td class="nump">7,703<span></span>
</td>
<td class="nump">11,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,597<span></span>
</td>
<td class="nump">1,959<span></span>
</td>
<td class="nump">5,012<span></span>
</td>
<td class="nump">5,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">806<span></span>
</td>
<td class="nump">2,225<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">438<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">2,569<span></span>
</td>
<td class="nump">2,941<span></span>
</td>
<td class="nump">7,961<span></span>
</td>
<td class="nump">8,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">1,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">522<span></span>
</td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">29,077<span></span>
</td>
<td class="nump">34,960<span></span>
</td>
<td class="nump">93,789<span></span>
</td>
<td class="nump">104,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">43,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_KR', window );">South Korea</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">14,967<span></span>
</td>
<td class="nump">15,985<span></span>
</td>
<td class="nump">43,085<span></span>
</td>
<td class="nump">48,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_TW', window );">Taiwan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">13,465<span></span>
</td>
<td class="nump">7,361<span></span>
</td>
<td class="nump">35,148<span></span>
</td>
<td class="nump">14,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=natr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">46,997<span></span>
</td>
<td class="nump">$ 56,440<span></span>
</td>
<td class="nump">147,139<span></span>
</td>
<td class="nump">$ 158,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">$ 3,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,262<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ContributionMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ContributionMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ContributionMarginAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ContributionMarginAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_GeneralHealthProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_GeneralHealthProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_ImmunityProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_ImmunityProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_CardiovascularProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_CardiovascularProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_DigestiveProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_DigestiveProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_PersonalCareProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_PersonalCareProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_WeightManagementProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_WeightManagementProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_KR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_KR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_TW">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_TW</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=natr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=natr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284431333936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Provision (benefit) for income taxes, as a percentage of income before income taxes</a></td>
<td class="nump">92.70%<span></span>
</td>
<td class="nump">40.20%<span></span>
</td>
<td class="nump">117.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Liability related to unrecognized tax benefits</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284425867296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember', window );">Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover', window );">Minimum number of claims that the Company's insurance coverage may not be sufficient to cover | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Provision for losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember', window );">Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liabilities</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liabilities</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284422774160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=natr_ChinaJointVentureMember', window );">China Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Joint venture ownership</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=natr_ChinaJointVentureMember', window );">China Joint Venture | Fosun Pharma Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Joint venture ownership, noncontrolling party</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=natr_ChinaJointVentureMember', window );">China Joint Venture | Subsidiaries | Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember', window );">NSP China | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedPartiesCurrent', window );">Notes receivable, related parties, current</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember', window );">NSP China | Subsidiaries | Company's Joint Venture Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedPartiesCurrent', window );">Notes receivable, related parties, current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember', window );">NSP China | Subsidiaries | Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party transaction, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=natr_ChinaJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=natr_ChinaJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=natr_FosunPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=natr_FosunPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=natr_ChinaJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=natr_ChinaJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=natr_NaturesSunshineProductsChinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=natr_CompanysJointVenturePartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=natr_CompanysJointVenturePartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284426831456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Recurring basis - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 - Quoted Prices in Active Markets for Identical Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 - Significant Other Observable Inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 - Significant Unobservable Inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140284428747040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>segment </div>
<div>product_category</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_RevenuefromContractwithCustomerRefundPeriod', window );">Refund period</a></td>
<td class="text">90 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_NumberofPrincipalCategoriesofProducts', window );">Number of principal categories of products | product_category</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of business segments | segment</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContractWithCustomerContractTerm', window );">Contract with customer, contract term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ContractWithCustomerContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Contract Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ContractWithCustomerContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_NumberofPrincipalCategoriesofProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Principal Categories of Products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_NumberofPrincipalCategoriesofProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_RevenuefromContractwithCustomerRefundPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Refund Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_RevenuefromContractwithCustomerRefundPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>natr-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:natr="http://naturessunshine.com/20220930"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="natr-20220930.xsd" xlink:type="simple"/>
    <context id="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7ce7aad2623047ba8addd0803daa97b8_I20221021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-10-21</instant>
        </period>
    </context>
    <context id="id5fbf276129e47918eed3c1199ae0b7f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if49e9f1a5ba44e46b40fa8219c379488_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5e5b7f325a374195a547054c530354da_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21726f161d9144c981677c9a99d24247_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35a03d0e2e0f4675968fee999d70cd9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03abfe1166e94acca8a49677b13b5cf0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1933b6d048a44bf8cfbb6b1cd3cd3d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2f1bb76039d144b9aa58a21c14728060_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3f4d3acbe9b44659a91f7fd1c3d496a6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i15218d9f24de436b834e94ec6b7a0b0a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9297f3eeb3c94b419740d6866d8f7fa3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia8d091b18a034cff89766812998da336_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i69e160aafda54f33bc08d1b8e1e4a739_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i806380af81994042ab6c34e36fc9e4e4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iff8fc16447ae46a9b23c72b39b9594ee_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i94264228c295486ba38b41b36c269fb7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iba67555887c94157b7a8aa02815a129c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i150dc190a6c548f8964429c219799683_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1faefa48e67d4f9bbfe8e3424767234d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id1d99554b99d48c89c6d05c03b41c591_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie041b2243726491bbcd617dcdbd9ee67_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia23da71b505a4aed8729342c64157a41_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if6b247ac9dad4b0d9c915a260843ac3a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8a3f5bcc65a84d81b343742fa3687210_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5d93b30a1dd64266b09ca1dbe8a45ce9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i266bc0c70d8240a68e7030d4a3572f2a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i67def2bf001441ce8b5360fb751d05c8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i896cdfbdeb6844b7919d0c99a82986ba_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6f5368041dc04d7a876079103b591a82_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i22bf72498d14409e8704c249bbf5dff4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4633088b44c14861af62ac14bfa848b0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i82edb931ed8744efb0bb55d80302158e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if3eefe80682a456688d647d706338b94_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i584cc6cef84645d9aced1d159fb33e8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifcdea242da894c9096e6edc3b69c848c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45b62ba4a6054191ab5a2cfa2177eb37_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i567421871cb84ff3947a1c4f0439f49e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b678cf1500d473b98980c984f33d848_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if699539c6d8d44db865d338e2352f43f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id292b6800f4b4953a4a8fc8f19b5c00f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia6c47cc5bdab45b9a83e045e422ae9d1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia2daecb1c459472faf935c58f3d99556_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1ed2af8ce51a451dad2b3584762627b2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i05f25ce1bda74c48805771205ffcbbf8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i261b16c64967417fb69e183d714d9071_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie5a44095252141c78d08c366bb1f2bce_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic8a7eaf75c524a39958b86619197e5f9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf26778247cf45e487700b6f55866416_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3478de1ed17e4979a47bd4d3d1f5d7d0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8bd19a9c61024bdcbe7a41dbec049830_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7dd64c1df3f04a6ea9ed4b040fb9c417_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7debe8761cc44795a69514ea9d87827b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ide03d0a470604be19addddae37f14109_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if56b974fe0214d9691e4d03c981d7efb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i428520a8a69e426a8fe5926e9ce42e43_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie441a8e4124a4d1b8054036ab19f5a25_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib6b8c3d3276a40a8b5cf97b7662f1789_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id81a97f8651b47b3a684dd5ff1e10415_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9d49ac7e33054ec294ea97a34ce760b0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibb9057781307454eaa3ab969709f5839_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibaca5bb1e0ec4e8fac38bd64a9792a66_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i742edf6aff37488aa80e713e9a672a7a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2f10af2594854b9fb57ee7ef9b152993_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib41f685a036d4f58a4e05731f4478dfc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie1a51afc7549405b92c990bdb852d8cb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">natr:AccruedSeveranceandRentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i004662f9de7b4fdfbabc81b8850a070f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">natr:AccruedSeveranceandRentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia06b2ea113604f608cfe139f6473b4f8_I20170711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-07-11</instant>
        </period>
    </context>
    <context id="ia088a5fe1c0d4659856719b55cc649b5_I20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-23</instant>
        </period>
    </context>
    <context id="i22efa19eb0344c72ad687994862269e2_D20220623-20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="iddc8134658ca4954b354f15805380b94_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8f0cbc126bdd4b63949c4345575e09e6_D20220623-20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="if06d201ef25c4642849a07427e18a4e2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3c79105659ed47199844f29f16ee8732_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e03c2f550744858bfdef123a1e103dc_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="i42bf1f4955d14fd785dd3122c680d83b_I20201119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-19</instant>
        </period>
    </context>
    <context id="i03715efd129a44a1865caa1ea43fa333_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">natr:IndicativeIndexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8562a44c05df4b34a7f6a8878e388882_D20201119-20201119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-19</startDate>
            <endDate>2020-11-19</endDate>
        </period>
    </context>
    <context id="id7b42e335b02463ea1d3019cd2f3474b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i98e5bb1cef6c4becb6ebf74bc1b7e3eb_D20210405-20210405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2021-04-05</startDate>
            <endDate>2021-04-05</endDate>
        </period>
    </context>
    <context id="iee350a313d8f4cd4b7964c9818ca55c8_I20210310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-03-10</instant>
        </period>
    </context>
    <context id="i38f58e1adc7e4bd4adbdfed111f9df0b_I20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="i6c0ddf3d82324bcb905a643d93542091_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="ibae0afd2c25447bc920e0df4c8c9b207_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="if9593f0319dc4fe48d712b42fc7be268_D20210505-20210505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-05</startDate>
            <endDate>2021-05-05</endDate>
        </period>
    </context>
    <context id="icb44a2c98f1740dbb00c82b0e332d00e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i50cfb2216c6e4898a183ccf77630d5ae_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieb5874cb29674dc6a3388b35641bbd9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1121eb8e41764e2f885ce89e9efd6fca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i070b06d98cf645ae85a6b3eff5f58702_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic3925d99f6de43c5afbf93f61d4d675d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie46e49fee8fd42a2aab87f77ac2f490e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23b536a276514486b763bbc7d3034568_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9ef0509b465a4ac38cc9efafd19b9daf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2dc49deb25cc408796443b55a640d385_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic20e20adf95940ca8fd836f859de3b03_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifa9bd7370039495491ec25c69d400f48_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic152af38654942a3a96dcd69544a74da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0055094229274cb5af4f7333a237c4ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1ae4407db5044cd68a2c86c97449360f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie9f3b5b7f4ad40a29dec40525ebba7de_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedRestrictedStockUnitsRSUs1YearVestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9901ca354f7443948673dbff989dd14d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedRestrictedStockUnitsRSUs3YearVestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i05187ed32f1a4459918c007aceb10282_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1a19d8970b2543048df69222e0305ed8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">natr:NetSalesandOperatingIncomeTargetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i04dd1d0e30dd4749869d484b28d4c2f3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if1aa6de8d3384bec8195c0705cf1e5ee_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i10c14c6b81e84c7b8f58f51625726416_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i761305687fcc410da48c9004616a56eb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iabe8b4b0a68d4a079325eda61ea70e86_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8dff8e40d0d240aa9a88877fdfd05209_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i523fb664c6924406a1e7680eb6501b9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic317fd5637e24133b38464894a02a48a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id8b227faac114cf89d93aacc27030ee3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa5248e41f6f4304969ef1dca24c02cb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if495bbb4e2364ea1b89e3ce85fd3847d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7532a655100648398d64a5c418cefbd7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5d187ffc6a1e4ec4a033a6d10d3b0da6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic6759b4d6bdc4c09915380281d2e0a8d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaffce26a8c8b429fb3267aa0f04b6886_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5d3acc32b97542e5a94dd4a3bb1b4cd7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6de094914c5f46db86d9dc44c155ea51_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie9597cde95214777a01076967abb5bfd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i01f17fd5fec04cceb20a25018feb023a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7ee2afc6d0574fa68adf6928f3f7ca2e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i35fb57db9af244869c886dfc1addaba9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if7f268d552ed4fd791df8fd022fc4127_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9ca94f66cae0472e950944808843bf52_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia0c54aef4fc24df184a67d7a6e8a4686_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id8bbc89738474e36a998144b3ab76005_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if64ed51372db4414b6b3e91b38ec9b38_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i989dadafa5b04aa6983e589a0e3400b1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i66f83106d3c64004a59b18515c555b70_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icefc13a45af1427495b1821d0c2f7f72_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia9d15fce936b4a1393ca7b8ca3173e02_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id9789e91bbdb4bb3981bfa676460e65f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iad4ac3adcab842aa92dac9e2832e0d49_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5c2ceb81578b43c2a003d38ceeea837f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2f7fca25b7e64744a88843d142be5e47_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i43ce284ec08d45a8b2f4eaf1d21af325_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f7edfa74c3a4facaef4c6ce7195e3a1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7890d7b2c60340b3922736cdbf24446a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iac3dd237480d4bb2a35fab25b753dc3b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c0a4dbff9664147803b502780897f38_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3b416cf57d384a54804362b64dbbf5ea_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7ecb353578384ec8a536a7a833c0fc5c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i14a40364c7f64f5b80d862226b34ff6a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic001fa920873448dbc6ef54932a229ce_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9960683c96654f1ebd545850683426af_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7057434687ff46f199ae8cac13391907_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i746ecd7e625c4144b3062ca451baff75_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i34383a427ad9404f8336487647135d64_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i031ea41430044721be426b9e153f6d4e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieb7cc106017f4bf790288d1410c6604f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if7aa79c6bd1146a299f812340a1c9843_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice4ea04852d949b7b25b5dff1ff385c0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3b447bb6325c4a93813bee7f6470e956_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a38b38d33164e7f8b12740fd234f511_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6afa9b57d0c8439a97666baea62606a5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1422bc583463406ab563aaeac2967f11_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i271947650c0641aa8199e5d38ec3dc01_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia86d933ddea04f8fb10973d2824e48fa_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6f271afb02914124b483854f23bca344_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iae9278b469d041fc8fff0e48fbaf4ca2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8e611910bb3b4d8ab7ed214bddf977b3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6db6b432f4df49c1b4c2fca343cba1bf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if69d793ea3634ef3bc0a0ae9b4bcb442_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2d5784c20ae64613902d57eaa1241f9a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idecec013f09941a7ae837474c48050ec_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if691899efd02473bbc07a3634d9602b9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1a1a086a005d481397a9ec0c504d08f3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i07a9c9b9a5d64082b24c3ce6b7f77d2a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if666c3e591d34e419fe5cea9d63c76d0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id82dd7fc19f2499ab5018e7a7327d0f2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie3fc9b884d79481ba64714a98c37701b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i455e487fd71d4e1f9f70e1f7708b649d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib2febb6991fd410a9e2bb3ad36bfa7b0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i766f81ea59e3447c8731e8067d14378c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i93b388a0ba69473fb479c83bba1002bc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic0d2a86b74014923a32749b21e57e32b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id811e29bb810469fb1c0ff8a40d5baca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i110b96df81934c4a895b7332653dfdfa_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idb2292964ed74f2c93618691aed0bf17_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1e9fedb6d37e44a48ae4c2c1a283eced_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if8027c00bfbb440189c17c3cef6fd9b0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i92940ae0daed421bbc0a168e8b5e7afd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ida2f5eb698ef4d4497ce138f3923d2a9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie8871c124bfc4ab59b69f58aa8ac2306_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if8f1af7974d3467f8810ee1a2c00cef0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i229bd20fdbd341b1a80e3c4e77eccf82_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i705c1e9af35d4a6e8814be31f200cad7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i91e4ef35e1824ccd882bf7fff758fffa_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2403109edfcf49318ed206f1f7e61b38_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0b7f893932fe4cdfa20944e08ccd08b2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i15464f06de2947f184afb9420f0a1d8f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5d33ddcece9a4459a1d275467de416cc_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f841c8711ef4ed49fbf8d826bc99285_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2489b6c3524e4e7b9c1a4e326997805c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic089f06dc3df44b08a41d0888be18ae8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i422653a3b8d4475789d80957e8caed9d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia31f4302be1d4bfba2a29bd5573f373f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5e4d19f07f584072a8e2b404743234e4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9e8031c49d064ec995642d0179e0484b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i16eb866672624d548d5ec50e5c190e14_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idc90dbbf82d04aea8f8e7d67a1c1b202_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i601e923be0e041b98944eb6ce61046a8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i88024d56c5604272b98bf435e9880a43_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9795542b5d774f05aa511f90de376487_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1e26d0a6ff7f45ada98e9349e001bbcb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib25551ab7ec84b1bb4cba21a91fe3ed1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i16954cbf01f143ceb864705c2fa0aa79_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c51dace4af44a7ca2837c323c420d65_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i81d52a6ed02545c9901d63a06dde0c2d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i46f7036575f84653b7c99e0bfb760ad9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id685627d492845129ed93f47b2600c71_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if8828b4bb2ca4a78bc626f16aaba9fb6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iccd76854b160450aaf7d25c1de52f345_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i973e94e3c4404183a5aafd47340dac63_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i326578d04941458389bc907b4ad873c0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9e200f708ff842429882977de66a40cb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic6450b3e52c24654b5a6cc4658015a1b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5664bf6fe1c74422abdd683652227653_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f174cab779147c29b714f2811393f87_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9d25faa8b14c4291be6d757f80e48839_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i328dfba4c23f4457928a6cdb96fc8f77_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iee902b6bcd8140a6bcd5753dea705623_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia0380da3a0fc43dabab9b5d91973518b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7763e9ad44b443bf8f1343ad714748ad_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i09258a1dafea4f46913ce7064e9df669_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if881a438f54d41fdbca0d3ae23ae6f96_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib8ceb2715c3147c3a1acd033f373b6f7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5641230f75e947e3b420ea68cb7362a5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3d3e4239b05749efb73231210fcd5b18_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ff533dd32af4803adfde1b7642cb050_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i22b7264ca2e0467e95df7299dce5077d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i54595879e3a144e9984de9671b792908_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1f54d1d04d5442bfbd655e919fea5146_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i66719a00cb6a489eba77f2f4f2fad567_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia834fba69cf84a55bcbbac80c88e2afe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9c1f33dd8d78416888f9868e6b210ee4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic071da5568ec49dba654382b69827d3a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia26db1a48ab045ff967ff61767510615_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i40a63ab18aa54729a20e2ec4a9991db1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i37724458b90a4f009836dd15510c28d2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i18896a1ab1614d4fbd39660918fa2ea5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i82fb728c64d94cd9a7821fd5b723bcbc_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3712db2c199b49b3b7c8d62c7dea3e2c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5143d898f89c4757b88ba36166facb40_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if34568f0ea034fd888a5237c3a1cb09b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5a28ef0b4677478f8f5027325b718a83_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5b008c611ecb4419800960c8e592d0ad_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ba0114f77e84101866720c25f0493b7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i27b314b15d654ad785f11accf7d8aded_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0a4aaaf217b48c082080afab03641e6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icebd38c2c3754ea4936025826c0e61e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5479a522979746c0beefbf88acbfc76c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2d33f22f45f044fdb3c35e22eacd0d4d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief2efe54ca2e4f2dbc51a62ceca74009_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i62f9fe04c4724f8d8703c8915a244329_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia728a540cb63450d8fe3503583cad26d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie641fbd2f6974546af07155f94734fbc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98381a37664e48548eeae68619c1ae03_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia9c16e0b053f4d47b09be402979af494_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if876afffb2454b8f9813b911a0c89bd2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i388c52769b8c403aae9816b6a35b9616_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if0c2c500c91547a2b8ce14a47ea99029_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a40bfae9b044ad7af9bf711c7647199_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if95aa0b7acd74228b82c668e2ce7b986_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9d6179a221754815aa24768673e73000_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i712f9d7d51b845a1b2668f6d2775c79d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54a4cd2649ad43e1af381be20efb83db_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5da800ec6cf0494cbcc64545e0f23b44_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3b0e83c4abf344a5b8794db175c95e39_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib64da197a61a4a098d6c97001abfa251_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5c616686bc27495f86f33cccfd0ba207_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2f558ae5860a4d0aaca0786b80ce2b37_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:FosunPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5ebaa3f43bee42c18c5ed0c1bf61f4b4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:FosunPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6ee5eda554ad4659907fd5cb08273632_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia764c839880b4c7e9899c96c4ea22bfb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ief5236b078ac4a6daebf4680b5be165b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i455120a077da4df088d0bd54ec5106fa_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:ChinaJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3e093e27ec0a4b8ba600829b8e48847e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iad3dfe96a539486182ac2875e73b964a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b4a4f5139a945ab966207cbdb52726a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:CompanysJointVenturePartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idd095404eb1749d5b8208d23f0b59607_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">natr:CompanysJointVenturePartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a632e9166b44345976a990799025881_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">natr:NaturesSunshineProductsChinaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic4162cfa26b14df99488a4f76a09b41f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i01f3880d0019417fb3e190f74f5f8a25_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id147596397c04e229b6d434f653bc101_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1e406e3dd789497cb667823793e51f2d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i33b5f131172d44dbab10213532398fcf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id750b81e065841b08fc01573faa37105_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f4b170f280e46a2b3047bb6edd5bf27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id976048dc79248cdb7a4f9d5569849ac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12e083e1f3414241b1bb88a79fea2b88_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="borrowing">
        <measure>natr:borrowing</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="payment">
        <measure>natr:payment</measure>
    </unit>
    <unit id="vestinginstallment">
        <measure>natr:vestingInstallment</measure>
    </unit>
    <unit id="segment">
        <measure>natr:segment</measure>
    </unit>
    <unit id="claim">
        <measure>natr:claim</measure>
    </unit>
    <unit id="product_category">
        <measure>natr:product_category</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGFibGU6NWNiYWRmN2U0NTBmNDYyZTlhNmEzMGI4MTFlZGFjZjAvdGFibGVyYW5nZTo1Y2JhZGY3ZTQ1MGY0NjJlOWE2YTMwYjgxMWVkYWNmMF8xLTEtMS0xLTM2NTE3_e9a8870e-8ec2-4bf5-9ef6-9f1b1323dec9">0000275053</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGFibGU6NWNiYWRmN2U0NTBmNDYyZTlhNmEzMGI4MTFlZGFjZjAvdGFibGVyYW5nZTo1Y2JhZGY3ZTQ1MGY0NjJlOWE2YTMwYjgxMWVkYWNmMF80LTEtMS0xLTM2NTE3_9aa127dd-2d10-4f87-9b8b-f445af84c8b1">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGFibGU6NWNiYWRmN2U0NTBmNDYyZTlhNmEzMGI4MTFlZGFjZjAvdGFibGVyYW5nZTo1Y2JhZGY3ZTQ1MGY0NjJlOWE2YTMwYjgxMWVkYWNmMF8xMi0xLTEtMS0zNjUxNw_51eba60f-6d4e-481c-83af-d43cae2ca344">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGFibGU6NWNiYWRmN2U0NTBmNDYyZTlhNmEzMGI4MTFlZGFjZjAvdGFibGVyYW5nZTo1Y2JhZGY3ZTQ1MGY0NjJlOWE2YTMwYjgxMWVkYWNmMF8xMy0xLTEtMS0zNjUxNw_3d6b8603-e162-463f-8b59-ce09404db84b">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80L2ZyYWc6MjJhMjJlZWFiYTk2NDI1Mzg1YjNiMDhlZmU4NWM2ODYvdGV4dHJlZ2lvbjoyMmEyMmVlYWJhOTY0MjUzODViM2IwOGVmZTg1YzY4Nl8xOQ_fae11ef0-c77e-4e52-8562-a01051bb92c6">--12-31</dei:CurrentFiscalYearEndDate>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod
      contextRef="i5d187ffc6a1e4ec4a033a6d10d3b0da6_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81NS9mcmFnOjgwMmMxN2JlMWM2ZTRjODg5ZDY5OTk4Njg5YWQ0ZTFlL3RhYmxlOjc4OGIxNGE1ZTM3NDRmNjZhMDBiM2Y5YTIxMGNhNzVhL3RhYmxlcmFuZ2U6Nzg4YjE0YTVlMzc0NGY2NmEwMGIzZjlhMjEwY2E3NWFfMS0xLTEtMS0zNjUxNw_111bfa51-7ab7-4b9f-ae65-55d536936b65">P1Y</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod
      contextRef="ic6759b4d6bdc4c09915380281d2e0a8d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81NS9mcmFnOjgwMmMxN2JlMWM2ZTRjODg5ZDY5OTk4Njg5YWQ0ZTFlL3RhYmxlOjc4OGIxNGE1ZTM3NDRmNjZhMDBiM2Y5YTIxMGNhNzVhL3RhYmxlcmFuZ2U6Nzg4YjE0YTVlMzc0NGY2NmEwMGIzZjlhMjEwY2E3NWFfMS0yLTEtMS0zNjUxNw_21ece1ac-a5b7-41bd-8aa7-9b678bd3299e">P1Y3M</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <dei:DocumentType
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8xNTM_f06e7715-7726-4cb5-97dd-5ec2d327506a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8xNzA_1e9acc28-99bb-4c3a-8539-2458afcfb48c">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8yOTc_a7c59df4-16df-4afc-8c8e-0c76b3012d1d">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8zMDg_6e9d0c08-a8de-47d7-8752-7295c5bf21d3">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF80OTI_90f0573f-fa9c-4e5b-93fb-5eac4f605076">001-34483</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF80OTg_071d9d9d-d83a-4cd0-b8ef-05311f92a97b">NATURE&#x2019;S SUNSHINE PRODUCTS,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6MTNiZmU4ODE0NjEzNGZlZThhNjRhYmY4MzM3MTU3NGMvdGFibGVyYW5nZToxM2JmZTg4MTQ2MTM0ZmVlOGE2NGFiZjgzMzcxNTc0Y18wLTAtMS0xLTM2NTE3_97b3e6b4-c5db-416a-8fb2-0918b4ebc8ae">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6MTNiZmU4ODE0NjEzNGZlZThhNjRhYmY4MzM3MTU3NGMvdGFibGVyYW5nZToxM2JmZTg4MTQ2MTM0ZmVlOGE2NGFiZjgzMzcxNTc0Y18wLTItMS0xLTM2NTE3_8e1344ad-35eb-4c76-9c51-819c6b36a035">87-0327982</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81NjA_7919d302-98a9-41ce-a33c-c063921715cd">2901 Bluegrass Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81NjQ_e9d9c280-82fb-4bf8-bfd2-4b871345c566">Suite&#160;100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81Njc_e28579b1-3c97-4569-a8fb-d4d5335fccff">Lehi</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81NzE_3d226bfb-8a8f-47c0-ab2e-d8d212c3b888">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF81NzQ_263302da-ac47-4e7a-85a6-ce2d9813ec03">84043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF82MzQ_c1047269-3c6e-4169-942f-20e370112e2b">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF82Mzg_cb616819-9338-425b-8fe0-08640a859f8b">341-7900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6N2VhZjQwZmMyMTBkNGQ3ODk3NTEzZTY5YjI0MGJhNjcvdGFibGVyYW5nZTo3ZWFmNDBmYzIxMGQ0ZDc4OTc1MTNlNjliMjQwYmE2N18xLTAtMS0xLTM2NTE3_94e479bb-0eb7-4fe1-8df3-ae1fa08bb36c">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6N2VhZjQwZmMyMTBkNGQ3ODk3NTEzZTY5YjI0MGJhNjcvdGFibGVyYW5nZTo3ZWFmNDBmYzIxMGQ0ZDc4OTc1MTNlNjliMjQwYmE2N18xLTEtMS0xLTM2NTE3_f83255e0-7c96-44fe-952f-9580e09dae47">NATR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6N2VhZjQwZmMyMTBkNGQ3ODk3NTEzZTY5YjI0MGJhNjcvdGFibGVyYW5nZTo3ZWFmNDBmYzIxMGQ0ZDc4OTc1MTNlNjliMjQwYmE2N18xLTItMS0xLTM2NTE3L3RleHRyZWdpb246NWYyYTYzZjQxOWQ1NGNlMWIyMWFmOWU3Y2VkYWMwN2ZfNA_49158ce3-cb17-4860-aee4-34167340e683">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8xMTMy_0587c7cb-fc4f-46ea-a32a-d0542134e007">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8xNDU4_a36c7d3e-7a2a-4075-9f4e-1d2b06bdfb0e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6YzUxMDM1NjZjZTBhNGRmNjkzMmFhNDYzNDkxM2JiNmIvdGFibGVyYW5nZTpjNTEwMzU2NmNlMGE0ZGY2OTMyYWE0NjM0OTEzYmI2Yl8wLTItMS0xLTM2NTE3L3RleHRyZWdpb246YmExNGIzOTQ5NGRlNDVkZGE0NWE5NzBhYWYxZTU3MTNfNQ_27b4de87-1090-4eb0-9547-54afd223a109">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6YzUxMDM1NjZjZTBhNGRmNjkzMmFhNDYzNDkxM2JiNmIvdGFibGVyYW5nZTpjNTEwMzU2NmNlMGE0ZGY2OTMyYWE0NjM0OTEzYmI2Yl8yLTItMS0xLTM2NTE3L3RleHRyZWdpb246MWRjZDVhZjhjYTY1NGQwZjljZDk0M2UxNzhiZTlmZjZfMzE_fb2edd05-1a6b-4c3b-b8e6-d81b12c4977f">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGFibGU6YzUxMDM1NjZjZTBhNGRmNjkzMmFhNDYzNDkxM2JiNmIvdGFibGVyYW5nZTpjNTEwMzU2NmNlMGE0ZGY2OTMyYWE0NjM0OTEzYmI2Yl80LTItMS0xLTM2NTE3L3RleHRyZWdpb246NjNmOGI0YWU2MDg4NGE2YmI3ZjYwMzc5ZWM2NzVjYjJfMzA_01bfb5db-f229-448a-8294-eeb4b10928f1">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8yMjk5_fa03dda2-9f27-4cf3-b235-0b3015ce1878">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i7ce7aad2623047ba8addd0803daa97b8_I20221021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xL2ZyYWc6NTBmYWU3YzRkNDViNDQyYjllNzc5MzVjY2RkNGEwMzQvdGV4dHJlZ2lvbjo1MGZhZTdjNGQ0NWI0NDJiOWU3NzkzNWNjZGQ0YTAzNF8yMjg4_a654e9a2-3336-4f4a-a929-6d4728651585"
      unitRef="shares">19166635</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMy0xLTEtMS0zNjUxNw_1ecf74f0-d288-416c-9b0c-aaea6aff78ef"
      unitRef="usd">56984000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMy0zLTEtMS0zNjUxNw_f4311b01-5085-4f97-8790-ac5c61887a37"
      unitRef="usd">86184000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNC0wLTEtMS0zNjUxNy90ZXh0cmVnaW9uOjRlNDdhYTgwYmYwNDQ5N2NhMGIzOGQ3YmIyZWY3Njg3XzY3_245edf1e-e625-4e27-b929-792ac081067a"
      unitRef="usd">673000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNC0wLTEtMS0zNjUxNy90ZXh0cmVnaW9uOjRlNDdhYTgwYmYwNDQ5N2NhMGIzOGQ3YmIyZWY3Njg3Xzc0_ebe9d7f3-9a3d-4f93-95f2-588db4937a57"
      unitRef="usd">143000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNC0xLTEtMS0zNjUxNw_d13ea105-3dde-4011-bf17-739861091f6a"
      unitRef="usd">9977000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNC0zLTEtMS0zNjUxNw_f0475a0c-165f-4fa5-95c0-4de350d4b2f5"
      unitRef="usd">8871000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNy0xLTEtMS0zNjUxNw_b0c59645-1db6-49a1-9c8b-860238ee97e8"
      unitRef="usd">67603000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNy0zLTEtMS0zNjUxNw_ee31bb8d-78ba-4f1a-b715-c037c89a409f"
      unitRef="usd">60852000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfOC0xLTEtMS0zNjUxNw_37ce70a5-88d5-4a78-9f24-b47ef22eac3d"
      unitRef="usd">8237000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfOC0zLTEtMS0zNjUxNw_61f74bfe-01ce-4a46-8821-4ea12e230568"
      unitRef="usd">8760000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfOS0xLTEtMS0zNjUxNw_fce10190-ae01-4a04-a5a6-1d6717c5a917"
      unitRef="usd">142801000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfOS0zLTEtMS0zNjUxNw_acc58918-dbe9-4982-9dc2-323647382e75"
      unitRef="usd">164667000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTEtMS0xLTEtMzY1MTc_edc2f259-6032-46f9-953b-349b7ccbf02e"
      unitRef="usd">47354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTEtMy0xLTEtMzY1MTc_e33e411b-057b-422e-a4ca-88d071637df6"
      unitRef="usd">50857000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTItMS0xLTEtMzY1MTc_1a84483d-896a-4557-98f9-f4957f507ca0"
      unitRef="usd">16541000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTItMy0xLTEtMzY1MTc_7508e0eb-a0f4-4816-9cc9-2df830541229"
      unitRef="usd">18349000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTMtMS0xLTEtMzY1MTc_1cc64f85-6025-4228-881f-0ef78e94e72f"
      unitRef="usd">692000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTMtMy0xLTEtMzY1MTc_48ad19ef-4a97-4e47-93ab-23ad0dc33d58"
      unitRef="usd">964000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTUtMS0xLTEtMzY1MTc_8fd0be89-e773-4e81-a558-e16bc38ad575"
      unitRef="usd">7011000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTUtMy0xLTEtMzY1MTc_8c3710a0-7b62-463c-81ab-80b27636b919"
      unitRef="usd">13590000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTYtMS0xLTEtMzY1MTc_4d4a4eab-3238-4959-9a57-e5dfe33f1728"
      unitRef="usd">9109000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTYtMy0xLTEtMzY1MTc_9bee82af-5fa4-4c27-9a9e-a03d5343b043"
      unitRef="usd">10447000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTctMS0xLTEtMzY1MTc_ac7cab8f-7aa2-4995-8af0-090c85a25875"
      unitRef="usd">223508000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMTctMy0xLTEtMzY1MTc_794875dc-6248-4f36-bbab-3f5ab426eba4"
      unitRef="usd">258874000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjEtMS0xLTEtMzY1MTc_454a93b5-af91-44e7-bd46-e2356513fd31"
      unitRef="usd">7475000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjEtMy0xLTEtMzY1MTc_c814d1d4-364b-4c25-a790-79d12168e69a"
      unitRef="usd">9702000</us-gaap:AccountsPayableCurrent>
    <natr:AccruedVolumeIncentiveandServiceFees
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjItMS0xLTEtMzY1MTc_df404c05-189f-499e-a354-ff19d9ffa1f6"
      unitRef="usd">21177000</natr:AccruedVolumeIncentiveandServiceFees>
    <natr:AccruedVolumeIncentiveandServiceFees
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjItMy0xLTEtMzY1MTc_8c2d3f30-28df-4aab-80af-1ae4fddac76a"
      unitRef="usd">23131000</natr:AccruedVolumeIncentiveandServiceFees>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjMtMS0xLTEtMzY1MTc_e10a066a-ec8f-4a3a-99ec-4a7657517b19"
      unitRef="usd">24856000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjMtMy0xLTEtMzY1MTc_1d65b5c8-c256-4b21-9753-1841fa99e96c"
      unitRef="usd">31600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjQtMS0xLTEtMzY1MTc_725b14c1-4c03-4039-8bf7-1bbe552f44c6"
      unitRef="usd">1460000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjQtMy0xLTEtMzY1MTc_e66cb509-00d5-4e9e-b14a-d73d9d34cde3"
      unitRef="usd">3694000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjYtMS0xLTEtMzY1MTc_1a0f47b7-7d6b-4f46-9dfd-350b82ee99eb"
      unitRef="usd">0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjYtMy0xLTEtMzY1MTc_1a76289d-43fa-4f6b-97f7-2fe4421da3bb"
      unitRef="usd">302000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjctMS0xLTEtMzY1MTc_330c7a54-0858-4098-a164-8b2d78cf47ee"
      unitRef="usd">3582000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjctMy0xLTEtMzY1MTc_3140cba4-7ca7-4f50-8089-2c37f6ce1a6f"
      unitRef="usd">2647000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjgtMS0xLTEtMzY1MTc_d6230b6e-2b6d-4cc7-979a-1f7c7a88da1e"
      unitRef="usd">4065000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjgtMy0xLTEtMzY1MTc_df4e50d1-9214-452f-96a5-2c8c9de43e65"
      unitRef="usd">4350000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjktMS0xLTEtMzY1MTc_ff9004cb-3dc2-4d87-b759-19029b049ed1"
      unitRef="usd">1272000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMjktMy0xLTEtMzY1MTc_6b43777c-7710-4fd4-bc69-17a7bd9e837f"
      unitRef="usd">1244000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzAtMS0xLTEtMzY1MTc_70a06065-d5fe-4e01-95bf-c7501bddade1"
      unitRef="usd">63887000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzAtMy0xLTEtMzY1MTc_7d002d1d-4d02-4d16-bb54-891696f5e748"
      unitRef="usd">76670000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzItMS0xLTEtMzY1MTc_cb1d44be-8f53-439c-8882-0816e45059d9"
      unitRef="usd">213000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzItMy0xLTEtMzY1MTc_b510eb83-c448-4304-a8db-79b8e3d0a8ca"
      unitRef="usd">0</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzMtMS0xLTEtMzY1MTc_5d0fde10-4940-4d89-bde1-0b44081d5e2f"
      unitRef="usd">14474000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzMtMy0xLTEtMzY1MTc_08903563-fe3e-47ce-826f-69bd295956d7"
      unitRef="usd">15919000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzUtMS0xLTEtMzY1MTc_9ecaf703-07fa-46e8-9bd6-ffb01d731012"
      unitRef="usd">216000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzUtMy0xLTEtMzY1MTc_70ca4754-4878-43cf-a577-472f86ac631b"
      unitRef="usd">1174000</us-gaap:LongTermNotesPayable>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzYtMS0xLTEtMzY1MTc_f352b476-679b-4e07-9ffa-f32633b0f7b4"
      unitRef="usd">692000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzYtMy0xLTEtMzY1MTc_a05809e2-d599-40c4-9fb2-22bd4f7c876d"
      unitRef="usd">964000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzctMS0xLTEtMzY1MTc_02a47504-dc72-4bf0-a652-928d68026c1d"
      unitRef="usd">1218000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzctMy0xLTEtMzY1MTc_19423a4e-2862-4fb9-a9c4-cddc72ec0c89"
      unitRef="usd">1566000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzgtMS0xLTEtMzY1MTc_966feadf-3b43-44a9-b4e9-58715b250714"
      unitRef="usd">1054000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzgtMy0xLTEtMzY1MTc_30b0704d-b93c-4b8b-b756-6e163f6aca08"
      unitRef="usd">1177000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzktMS0xLTEtMzY1MTc_3f1c52d4-2acf-4732-8273-128c979632e2"
      unitRef="usd">81754000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfMzktMy0xLTEtMzY1MTc_87b25be5-4932-4785-98f7-ec9f8526783d"
      unitRef="usd">97470000</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl8xOA_14a70fa6-950c-473d-9528-e6716dd70db7"
      unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl8xOA_5990384f-0117-401d-8692-0d8ba9cab7b6"
      unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl8zMg_dd33b74c-3f68-444a-b58d-e613c9623f4e"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl8zMg_fd3f6ef4-ac2d-4696-92bf-2c94331f4873"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl81NA_dbc94ac7-2b13-4b9b-9b8a-de0166ea207f"
      unitRef="shares">19166000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl81NA_fbd6ec15-864b-426f-81b2-fed8182afcda"
      unitRef="shares">19166000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl82MQ_3c397812-b8ca-462e-a035-5e99739089b1"
      unitRef="shares">19724000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMC0xLTEtMzY1MTcvdGV4dHJlZ2lvbjo0NWUxODgxMzYwYjc0ZTJkYWEyN2FiZTkzNjIwZDgzYl82MQ_b6a768a4-8943-44b3-b964-baa8198eaea8"
      unitRef="shares">19724000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMS0xLTEtMzY1MTc_344a61c5-491d-4857-807f-0062f27e6dc1"
      unitRef="usd">121242000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDQtMy0xLTEtMzY1MTc_eb081d18-9b4f-46d9-9964-107229d7dc40"
      unitRef="usd">133382000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDUtMS0xLTEtMzY1MTc_d054a1c3-3e78-4324-ba9d-12ac475122c1"
      unitRef="usd">32681000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDUtMy0xLTEtMzY1MTc_e8ae22ff-7b9c-470d-a16c-36d44f7966f6"
      unitRef="usd">35025000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:MinorityInterest
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDYtMS0xLTEtMzY1MTc_49379e42-8253-424a-8e76-ed7eb708b107"
      unitRef="usd">4012000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDYtMy0xLTEtMzY1MTc_0bdf4174-24be-40d2-b75b-444d55bc6cb4"
      unitRef="usd">3202000</us-gaap:MinorityInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDctMS0xLTEtMzY1MTc_a628b169-6071-4eea-b3d9-fb66f8339b98"
      unitRef="usd">-16181000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDctMy0xLTEtMzY1MTc_0863c1fb-c3d1-41d5-9c68-f1cf85b9060b"
      unitRef="usd">-10205000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDgtMS0xLTEtMzY1MTc_ce972365-9b78-4846-9088-cc8e5d2e4c9f"
      unitRef="usd">141754000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDgtMy0xLTEtMzY1MTc_cd746cd0-f4b1-4c23-9bd6-f066b1531999"
      unitRef="usd">161404000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDktMS0xLTEtMzY1MTc_878888d9-ab55-4ff3-b127-1b65a1b7b58b"
      unitRef="usd">223508000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8xOS9mcmFnOmU4NjY1NDAwNmYyNzRiZDQ5NmJmYWJlNWYxMGU1YmZkL3RhYmxlOjFhNGRiYjAyYmY2NTQyOTNiMjEzMTkzMjNkZWMzZTllL3RhYmxlcmFuZ2U6MWE0ZGJiMDJiZjY1NDI5M2IyMTMxOTMyM2RlYzNlOWVfNDktMy0xLTEtMzY1MTc_b3b63515-abc3-46bd-94fe-449003e60e42"
      unitRef="usd">258874000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMi0xLTEtMS0zNjUxNw_9c406a20-9335-4157-b64c-2877dad8d66d"
      unitRef="usd">104506000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMi0zLTEtMS0zNjUxNw_78f2e7bb-171f-4dc6-ab38-5b99b9926a05"
      unitRef="usd">114746000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMy0xLTEtMS0zNjUxNw_f9565993-eb61-4e39-9921-cf201c5e18c1"
      unitRef="usd">29632000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMy0zLTEtMS0zNjUxNw_f1021a89-319a-4d32-b99a-19ecb07aaf23"
      unitRef="usd">29419000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfNC0xLTEtMS0zNjUxNw_e1846a10-6ca8-46ec-bb44-0c1dd09bdbe8"
      unitRef="usd">74874000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfNC0zLTEtMS0zNjUxNw_01223cb1-e953-4029-a8c0-6934c1b092e0"
      unitRef="usd">85327000</us-gaap:GrossProfit>
    <natr:VolumeIncentives
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfNy0xLTEtMS0zNjUxNw_73403400-8e51-4301-b2ae-277aadc65544"
      unitRef="usd">33070000</natr:VolumeIncentives>
    <natr:VolumeIncentives
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfNy0zLTEtMS0zNjUxNw_439642d5-b1f8-4b51-b68e-bfb4efbb9221"
      unitRef="usd">35793000</natr:VolumeIncentives>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfOC0xLTEtMS0zNjUxNw_383fbebf-435c-4f22-8e1f-c20106c870de"
      unitRef="usd">36792000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfOC0zLTEtMS0zNjUxNw_51542882-5a83-4bab-b48c-b0c99c9a7187"
      unitRef="usd">39528000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfOS0xLTEtMS0zNjUxNw_8ac114ab-de6c-4fdb-9d57-26d152553996"
      unitRef="usd">5012000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfOS0zLTEtMS0zNjUxNw_0dbf3dc7-01f7-4bd4-9900-d8e933c66394"
      unitRef="usd">10006000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTAtMS0xLTEtMzY1MTc_a1886982-fe50-4df1-9e3f-3b5988a57c9b"
      unitRef="usd">-2281000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTAtMy0xLTEtMzY1MTc_ba972f92-425a-45dc-9e3c-8a883324f1b2"
      unitRef="usd">-886000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTEtMS0xLTEtMzY1MTc_3a4f098e-62a9-4faf-aade-43853e9ccd62"
      unitRef="usd">2731000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTEtMy0xLTEtMzY1MTc_43dfe894-866f-4b2e-a6bc-b2b28e22f893"
      unitRef="usd">9120000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTItMS0xLTEtMzY1MTc_14f551bd-1172-4fd9-95a4-6628450058a7"
      unitRef="usd">2531000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTItMy0xLTEtMzY1MTc_e16d3f61-c746-469e-a05e-eb9c0d191f51"
      unitRef="usd">3662000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTMtMS0xLTEtMzY1MTc_21e5dd39-d8f2-4a74-8b13-570865358216"
      unitRef="usd">200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTMtMy0xLTEtMzY1MTc_fcc08471-e0a4-42d4-9cba-a8afd556df39"
      unitRef="usd">5458000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTQtMS0xLTEtMzY1MTc_9c5acbcf-2983-4aa9-af2c-325a046c0627"
      unitRef="usd">110000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTQtMy0xLTEtMzY1MTc_f771647a-6cfc-4bdf-8b39-0f4a7c93e69f"
      unitRef="usd">600000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTUtMS0xLTEtMzY1MTc_9c337eec-2db1-421b-9922-94a3ceff4f0a"
      unitRef="usd">90000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMTUtMy0xLTEtMzY1MTc_c2a9e832-0da7-4ed2-b97f-daa97996b3e1"
      unitRef="usd">4858000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjItMS0xLTEtMzY1MTc_9b65d910-f30f-4d02-8e1f-520678e5ac37"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjItMy0xLTEtMzY1MTc_99737db6-3611-4049-a355-4f0ab51b0af1"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjctMS0xLTEtMzY1MTc_1dcee3ad-a0a3-47c8-a3fe-a636a77b21c9"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjctMy0xLTEtMzY1MTc_7dbcafc3-2225-4113-bbc0-773dad226131"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjktMS0xLTEtMzY1MTc_7cb4f59b-7354-4cef-a535-3847e62c5489"
      unitRef="shares">19198000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMjktMy0xLTEtMzY1MTc_e740a5b6-2156-4982-b27f-3888691395d4"
      unitRef="shares">19894000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMzAtMS0xLTEtMzY1MTc_742e25a3-7c71-4b27-a9e8-ed0f07d287ce"
      unitRef="shares">19482000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOmExYzg5Nzg2MDA2YjQ1ZjU5ZDQ4MzFhYTJkMTA0MTFlL3RhYmxlcmFuZ2U6YTFjODk3ODYwMDZiNDVmNTlkNDgzMWFhMmQxMDQxMWVfMzAtMy0xLTEtMzY1MTc_8d7b70b5-4415-495f-8a62-dfe6ae047027"
      unitRef="shares">20375000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMi0xLTEtMS0zNjUxNw_1ac77a74-01be-4e61-a5e5-fb707700d54f"
      unitRef="usd">319161000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMi0zLTEtMS0zNjUxNw_691a66db-0eb7-4b20-8e57-ad86419558d0"
      unitRef="usd">326145000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMy0xLTEtMS0zNjUxNw_14596211-300e-48a4-b2b9-82b61ae8c352"
      unitRef="usd">93563000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMy0zLTEtMS0zNjUxNw_6a44c743-8abe-446c-adcf-ff90c40396ed"
      unitRef="usd">84861000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfNC0xLTEtMS0zNjUxNw_f8fa11fd-d304-42a5-ab35-34465709802e"
      unitRef="usd">225598000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfNC0zLTEtMS0zNjUxNw_745dc519-9137-42d9-adb1-11be1718b203"
      unitRef="usd">241284000</us-gaap:GrossProfit>
    <natr:VolumeIncentives
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfNy0xLTEtMS0zNjUxNw_6fdffe02-937d-4af6-8862-80904fce36a0"
      unitRef="usd">99241000</natr:VolumeIncentives>
    <natr:VolumeIncentives
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfNy0zLTEtMS0zNjUxNw_56bb4c12-a1aa-4345-86cf-a20349e484ea"
      unitRef="usd">105491000</natr:VolumeIncentives>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfOC0xLTEtMS0zNjUxNw_bd1aa2f8-6f74-4002-b017-58911d779a1a"
      unitRef="usd">114281000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfOC0zLTEtMS0zNjUxNw_30b90d3e-2620-40ab-8e35-65fc59390914"
      unitRef="usd">108666000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfOS0xLTEtMS0zNjUxNw_2c94366c-a4d3-41f9-94e7-a12373c3c85e"
      unitRef="usd">12076000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfOS0zLTEtMS0zNjUxNw_6da18141-ca54-4677-ab54-536af4b29a7e"
      unitRef="usd">27127000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTAtMS0xLTEtMzY1MTc_e30ec685-eaed-4512-96eb-bd67b329373a"
      unitRef="usd">-3037000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTAtMy0xLTEtMzY1MTc_30424319-afbd-4376-871b-c429ea82f3ac"
      unitRef="usd">-2290000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTEtMS0xLTEtMzY1MTc_d198fe20-323b-416e-bef3-e23a200ccc28"
      unitRef="usd">9039000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTEtMy0xLTEtMzY1MTc_276fb3ac-7ef1-4ab1-9ac6-96216089d86c"
      unitRef="usd">24837000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTItMS0xLTEtMzY1MTc_4e6b0999-7e82-4cf5-8ffc-5827d189bda1"
      unitRef="usd">10573000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTItMy0xLTEtMzY1MTc_3ac43123-a93c-43d9-a723-a8c103b7e805"
      unitRef="usd">8433000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTMtMS0xLTEtMzY1MTc_c36b6571-36f3-4287-a89b-0576d7002a1e"
      unitRef="usd">-1534000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTMtMy0xLTEtMzY1MTc_46aaf8a9-583e-4711-a704-764abf6f7636"
      unitRef="usd">16404000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTQtMS0xLTEtMzY1MTc_52825766-3325-41d6-b189-e49127f808de"
      unitRef="usd">810000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTQtMy0xLTEtMzY1MTc_c3f5a3f9-99b3-463c-b50f-2e49c366a0eb"
      unitRef="usd">990000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTUtMS0xLTEtMzY1MTc_8b36631b-6389-41c3-95fb-8c034155cb01"
      unitRef="usd">-2344000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMTUtMy0xLTEtMzY1MTc_30da4c72-bf59-4e85-bda7-d30de15b166e"
      unitRef="usd">15414000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjItMS0xLTEtMzY1MTc_955a5c54-1ace-4007-8404-e40f35c7d273"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjItMy0xLTEtMzY1MTc_ce2d6496-9334-4ff8-a7f3-b08ee01eea2b"
      unitRef="usdPerShare">0.77</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjctMS0xLTEtMzY1MTc_1161f2ba-9fed-42b1-9334-7ee6f36a76e1"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjctMy0xLTEtMzY1MTc_0d4def3f-6199-41c0-8639-0061cb219b27"
      unitRef="usdPerShare">0.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjktMS0xLTEtMzY1MTc_c3137284-cf6f-42e4-8bbf-88fad27f23d7"
      unitRef="shares">19384000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMjktMy0xLTEtMzY1MTc_6e3f997f-39c9-4c68-b8a7-7a55c3d0dc18"
      unitRef="shares">19896000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMzAtMS0xLTEtMzY1MTc_805f8bd5-dcb1-44a3-82fb-2eaa5ee78b80"
      unitRef="shares">19384000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMzAtMy0xLTEtMzY1MTc_2b1b169e-acc1-4b09-ac07-963e68582baa"
      unitRef="shares">20292000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMzItMS0xLTEtMzY1MTc_5a39b8c6-158c-440b-833e-cc6cd16893c8"
      unitRef="usdPerShare">0</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yMi9mcmFnOmYxNTgzNWRhYzA3NzQxMzc4Mjg4MzI1MWE4MzBiZjZmL3RhYmxlOjJhNjUzMjk0YzE5NDQyNTQ4YjY4NzljMTAzYjNlOWQ2L3RhYmxlcmFuZ2U6MmE2NTMyOTRjMTk0NDI1NDhiNjg3OWMxMDNiM2U5ZDZfMzItMy0xLTEtMzY1MTc_3096c59d-a257-463c-aec4-059e7e6b8afa"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfMi0xLTEtMS0zNjUxNw_c9b95d24-1e8b-49bc-8244-56924b6c5535"
      unitRef="usd">200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfMi0zLTEtMS0zNjUxNw_b5f5cdc3-f95c-4244-9ae4-a87dba41436c"
      unitRef="usd">5458000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfMy0xLTEtMS0zNjUxNw_31c45d46-93a8-4755-a83d-f5956f6b2d97"
      unitRef="usd">-2544000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfMy0zLTEtMS0zNjUxNw_6e2c972b-8358-4cb5-8812-f640bc6d0528"
      unitRef="usd">-925000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfNy0xLTEtMS0zNjUxNw_243d2418-813c-446a-ab29-8191f1c45cb7"
      unitRef="usd">-2344000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOmMxZmQ3ODVlZGZjMzRhNTBhMmU1OTA5ZDAxNGVhZDhkL3RhYmxlcmFuZ2U6YzFmZDc4NWVkZmMzNGE1MGEyZTU5MDlkMDE0ZWFkOGRfNy0zLTEtMS0zNjUxNw_a9160e8b-4ffe-4de4-ba68-ef9e05316c51"
      unitRef="usd">4533000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfMi0xLTEtMS0zNjUxNw_bdea92fe-c4a4-4edd-b36d-4316abce412b"
      unitRef="usd">-1534000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfMi0zLTEtMS0zNjUxNw_2127a808-d7d3-475f-9628-89536637919c"
      unitRef="usd">16404000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfMy0xLTEtMS0zNjUxNw_1508b644-db3f-4d34-86a9-5bbed1442f25"
      unitRef="usd">-5976000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfMy0zLTEtMS0zNjUxNw_504f7274-fce4-42f2-bf03-f961910adcb5"
      unitRef="usd">-1091000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfNi0xLTEtMS0zNjUxNw_e5a5b853-2b6e-485f-b1fb-5bd86c082b55"
      unitRef="usd">-7510000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yNS9mcmFnOmE1ZWNlNDk5YjBiMjRlYTI4MjgyNmUyYTJmMzA1Y2VlL3RhYmxlOjczYzQ2MDdhYmY3MDRiOWVhMzhkMmQ1MDE1N2NkMTA0L3RhYmxlcmFuZ2U6NzNjNDYwN2FiZjcwNGI5ZWEzOGQyZDUwMTU3Y2QxMDRfNi0zLTEtMS0zNjUxNw_bbd4abcd-05c2-4e3a-92d0-2a7c088740e7"
      unitRef="usd">15313000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="i21726f161d9144c981677c9a99d24247_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi0xLTEtMS0zNjUxNw_34bd8a52-e611-4b81-b65c-334d6d24965f"
      unitRef="shares">19724000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21726f161d9144c981677c9a99d24247_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi0zLTEtMS0zNjUxNw_663ddbf8-932a-4bfb-8f9d-5653aaa1e5e5"
      unitRef="usd">133382000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i35a03d0e2e0f4675968fee999d70cd9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi01LTEtMS0zNjUxNw_7949e3a1-827d-4409-98a5-6c2efaaecb77"
      unitRef="usd">35025000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03abfe1166e94acca8a49677b13b5cf0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi03LTEtMS0zNjUxNw_18daea20-5182-4319-9451-958e4a7b6c15"
      unitRef="usd">3202000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1933b6d048a44bf8cfbb6b1cd3cd3d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi05LTEtMS0zNjUxNw_e60ab6bc-dae2-48a5-96ab-0eb4f83cf47b"
      unitRef="usd">-10205000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMi0xMS0xLTEtMzY1MTc_4d0f9c48-b6ee-4d9a-afae-ec19db829aa2"
      unitRef="usd">161404000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMy0zLTEtMS0zNjUxNw_cf2069d1-1c0b-4832-9d32-7158833a115c"
      unitRef="usd">801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMy0xMS0xLTEtMzY1MTc_b83b59d4-0e06-46df-8394-4898ff3e24ec"
      unitRef="usd">801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNC0xLTEtMS0zNjUxNw_72507661-c7c6-475e-a68d-f61946bcd923"
      unitRef="shares">218000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNC0zLTEtMS0zNjUxNw_ebe0d779-3b9c-47a3-8801-dd70a66f8ef0"
      unitRef="usd">-795000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNC0xMS0xLTEtMzY1MTc_250b03ae-6acf-4ac5-b2ff-70c5522fe94c"
      unitRef="usd">-795000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNS0xLTEtMS0zNjUxNw_62387724-456c-4a84-a98a-978b49156c1a"
      unitRef="shares">451000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i7a461b1277dc43a2839c935a35b35ebc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNS0zLTEtMS0zNjUxNw_9a48b589-5044-46f7-a69a-b0d9d5edbd85"
      unitRef="usd">7971000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNS0xMS0xLTEtMzY1MTc_0fe55510-090b-4109-9da4-ce1804bf95d5"
      unitRef="usd">7971000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProfitLoss
      contextRef="i2f1bb76039d144b9aa58a21c14728060_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNi01LTEtMS0zNjUxNw_9e779b02-448a-47e9-ab56-f4cbce099866"
      unitRef="usd">-2950000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3f4d3acbe9b44659a91f7fd1c3d496a6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNi03LTEtMS0zNjUxNw_443d9ae4-78aa-4b44-9f29-cd1b6a1e99fd"
      unitRef="usd">264000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNi0xMS0xLTEtMzY1MTc_4d8fc23f-2652-473b-8012-ee9864a14272"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i15218d9f24de436b834e94ec6b7a0b0a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNy05LTEtMS0zNjUxNw_dbd86020-3781-4a52-b4fd-31bab9f44715"
      unitRef="usd">-975000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i45f7f3e4b3064fd384ac81edd895884a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfNy0xMS0xLTEtMzY1MTc_78c99d8d-e72e-494c-a70d-34c0f461f0a0"
      unitRef="usd">-975000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9297f3eeb3c94b419740d6866d8f7fa3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC0xLTEtMS0zNjUxNw_8d792d24-d538-4078-989e-4d791cd0c9b7"
      unitRef="shares">19491000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9297f3eeb3c94b419740d6866d8f7fa3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC0zLTEtMS0zNjUxNw_c2cb1aab-0a44-4654-b2fb-e6bc71afdfae"
      unitRef="usd">125417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8d091b18a034cff89766812998da336_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC01LTEtMS0zNjUxNw_94cec152-8cc8-4c5a-b26c-4c8fbf2a1855"
      unitRef="usd">32075000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69e160aafda54f33bc08d1b8e1e4a739_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC03LTEtMS0zNjUxNw_efcf21fb-77a4-498b-84ec-90d514e13538"
      unitRef="usd">3466000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i806380af81994042ab6c34e36fc9e4e4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC05LTEtMS0zNjUxNw_9d81779c-36aa-4c56-acbd-59651a44e7ad"
      unitRef="usd">-11180000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff8fc16447ae46a9b23c72b39b9594ee_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOC0xMS0xLTEtMzY1MTc_2ce595a1-126c-46de-b340-e93fa98ae6bc"
      unitRef="usd">149778000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOS0zLTEtMS0zNjUxNw_da989593-709e-4a84-ad96-5ab58099655b"
      unitRef="usd">540000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfOS0xMS0xLTEtMzY1MTc_a675ca73-f5b8-4e7b-9e3d-3b626ae74eb0"
      unitRef="usd">540000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTAtMS0xLTEtMzY1MTc_ae7ae831-d328-4511-bbc1-b3f7ad24ce6c"
      unitRef="shares">58000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTAtMy0xLTEtMzY1MTc_ae7eee58-7632-40e3-9773-e3f412d59cbc"
      unitRef="usd">-334000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTAtMTEtMS0xLTM2NTE3_f1e389a6-99f4-4905-b391-8657806929b3"
      unitRef="usd">-334000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTEtMS0xLTEtMzY1MTc_5d187266-5ad8-45df-9b01-f37d45a199db"
      unitRef="shares">290000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i94264228c295486ba38b41b36c269fb7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTEtMy0xLTEtMzY1MTc_1b413150-978b-4906-a29f-273b1ec9dfe6"
      unitRef="usd">4000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTEtMTEtMS0xLTM2NTE3_2b3209c5-4bec-454e-9761-d75a6aa96976"
      unitRef="usd">4000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProfitLoss
      contextRef="i150dc190a6c548f8964429c219799683_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTItNS0xLTEtMzY1MTc_269ae304-f73b-4967-9b87-54e0bb36f767"
      unitRef="usd">516000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1faefa48e67d4f9bbfe8e3424767234d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTItNy0xLTEtMzY1MTc_2c23fcba-9212-46ef-9351-fb9d530ce8e3"
      unitRef="usd">436000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTItMTEtMS0xLTM2NTE3_909ef5be-fbba-49c1-9723-824a76dbbf0a"
      unitRef="usd">952000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id1d99554b99d48c89c6d05c03b41c591_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTMtOS0xLTEtMzY1MTc_2ff74b53-a9ff-44d3-aac7-5bd527284390"
      unitRef="usd">-2457000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iba67555887c94157b7a8aa02815a129c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTMtMTEtMS0xLTM2NTE3_d1b27b4b-aeea-41a0-9418-4aaed273237c"
      unitRef="usd">-2457000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie041b2243726491bbcd617dcdbd9ee67_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtMS0xLTEtMzY1MTc_de85293a-7272-43db-bf05-a8499f6dfd46"
      unitRef="shares">19259000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie041b2243726491bbcd617dcdbd9ee67_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtMy0xLTEtMzY1MTc_4bca9850-f5a5-4846-98e2-02ca43e896eb"
      unitRef="usd">121623000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia23da71b505a4aed8729342c64157a41_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtNS0xLTEtMzY1MTc_af9da5e5-f1c3-4e8c-9c8a-f3b608414531"
      unitRef="usd">32591000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6b247ac9dad4b0d9c915a260843ac3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtNy0xLTEtMzY1MTc_b6d194a1-5b44-47f8-9e4a-33d79ed36891"
      unitRef="usd">3902000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8a3f5bcc65a84d81b343742fa3687210_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtOS0xLTEtMzY1MTc_67e842c7-fb58-400d-ba53-65fbc0c6abe3"
      unitRef="usd">-13637000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5d93b30a1dd64266b09ca1dbe8a45ce9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTQtMTEtMS0xLTM2NTE3_f4b4815b-e21f-4dd6-954d-fc46d48aa4f9"
      unitRef="usd">144479000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i266bc0c70d8240a68e7030d4a3572f2a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTUtMy0xLTEtMzY1MTc_46d2494c-55d0-47d1-9974-3a73fcdef790"
      unitRef="usd">593000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTUtMTEtMS0xLTM2NTE3_644b4b23-7a4a-4635-a00d-81c634fe1d93"
      unitRef="usd">593000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i266bc0c70d8240a68e7030d4a3572f2a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTctMS0xLTEtMzY1MTc_53ac6b2a-7448-4b72-9b7d-a254c587b9da"
      unitRef="shares">93000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i266bc0c70d8240a68e7030d4a3572f2a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTctMy0xLTEtMzY1MTc_a556516f-58a4-4733-be22-4bc67d68ad90"
      unitRef="usd">974000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTctMTEtMS0xLTM2NTE3_c4580475-680c-45f4-8ce8-dd3cfd5f07e4"
      unitRef="usd">974000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProfitLoss
      contextRef="i67def2bf001441ce8b5360fb751d05c8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTgtNS0xLTEtMzY1MTc_48b76b8f-7923-42eb-b6f7-b06101a99484"
      unitRef="usd">90000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i896cdfbdeb6844b7919d0c99a82986ba_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTgtNy0xLTEtMzY1MTc_998db57c-57a0-4dce-a1bc-a4f8a507bc30"
      unitRef="usd">110000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTgtMTEtMS0xLTM2NTE3_a87d1561-3705-466f-a703-98eb1003ff6d"
      unitRef="usd">200000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f5368041dc04d7a876079103b591a82_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTktOS0xLTEtMzY1MTc_84837d5c-cdbe-4fea-a290-949ff3f3c8c8"
      unitRef="usd">-2544000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMTktMTEtMS0xLTM2NTE3_3bfb0a7c-74c1-4e5b-9acb-f083b5d0e5a9"
      unitRef="usd">-2544000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i22bf72498d14409e8704c249bbf5dff4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtMS0xLTEtMzY1MTc_afe64c02-d38b-4b18-bae0-b53192ad7ee0"
      unitRef="shares">19166000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22bf72498d14409e8704c249bbf5dff4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtMy0xLTEtMzY1MTc_3dc65279-dbca-46d3-b3cd-cea8d7c2b4b5"
      unitRef="usd">121242000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4633088b44c14861af62ac14bfa848b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtNS0xLTEtMzY1MTc_f5d061e6-10f0-401d-8a32-1226f755bdca"
      unitRef="usd">32681000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i82edb931ed8744efb0bb55d80302158e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtNy0xLTEtMzY1MTc_d68506d4-7bee-4366-afef-df9e9cd42881"
      unitRef="usd">4012000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3eefe80682a456688d647d706338b94_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtOS0xLTEtMzY1MTc_21f262e7-57dc-40fd-b953-4b7650e9502c"
      unitRef="usd">-16181000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmNkYTNiNzFmYWZlNTQ3NTRiZjY3ZTVhMWNmOWRjY2JlL3RhYmxlcmFuZ2U6Y2RhM2I3MWZhZmU1NDc1NGJmNjdlNWExY2Y5ZGNjYmVfMjAtMTEtMS0xLTM2NTE3_c5caa964-70fb-4f7e-b7df-2295ada906c9"
      unitRef="usd">141754000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="i584cc6cef84645d9aced1d159fb33e8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi0xLTEtMS0zNjUxNw_32471aa6-4abc-4590-b4fe-828bd9a05b87"
      unitRef="shares">19697000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i584cc6cef84645d9aced1d159fb33e8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi0zLTEtMS0zNjUxNw_ad3e4fe3-b2df-4acd-b7a5-b9dedc96abd0"
      unitRef="usd">139311000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcdea242da894c9096e6edc3b69c848c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi01LTEtMS0zNjUxNw_e481c68f-2eaa-4ce2-bcd0-e8504e3333bc"
      unitRef="usd">26030000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45b62ba4a6054191ab5a2cfa2177eb37_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi03LTEtMS0zNjUxNw_37855efd-3f2c-45c7-9e45-969e0a89e8b0"
      unitRef="usd">1848000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i567421871cb84ff3947a1c4f0439f49e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi05LTEtMS0zNjUxNw_ad6cdf37-9b48-4bc7-8c66-be1230171cdf"
      unitRef="usd">-9955000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b678cf1500d473b98980c984f33d848_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMi0xMS0xLTEtMzY1MTc_df302ac3-7c6a-4702-9fc8-2a59e453d053"
      unitRef="usd">157234000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="if699539c6d8d44db865d338e2352f43f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMy0zLTEtMS0zNjUxNw_6629a2e9-b8db-4691-ac1b-9565b5e3fda7"
      unitRef="usd">1005000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMy0xMS0xLTEtMzY1MTc_e36d0c88-b8a9-4d9b-9ea7-2f96a7c8608a"
      unitRef="usd">1005000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="if699539c6d8d44db865d338e2352f43f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNC0xLTEtMS0zNjUxNw_d0badf26-2803-423c-8c79-0fa5d0b291fe"
      unitRef="shares">218000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="if699539c6d8d44db865d338e2352f43f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNC0zLTEtMS0zNjUxNw_0a69693b-9b1f-429d-80a2-470f1654dbd9"
      unitRef="usd">-914000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNC0xMS0xLTEtMzY1MTc_747150a0-ce67-479e-884b-11e105c2b5b3"
      unitRef="usd">-914000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNS0wLTEtMS0zNjUxNy90ZXh0cmVnaW9uOmFmMTQ4ZTBjMDg0YzQzYjVhOGIwMzE3NTlhODExNzkxXzIw_f205440a-3d54-4be4-b7ee-b9229e731d66"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="id292b6800f4b4953a4a8fc8f19b5c00f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNS01LTEtMS0zNjUxNw_f7a838dc-f8c5-4b07-a1b2-d82bec43443e"
      unitRef="usd">19858000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNS0xMS0xLTEtMzY1MTc_5221f776-a9e6-4685-9444-53f7f5e2058e"
      unitRef="usd">19858000</us-gaap:DividendsCommonStockCash>
    <us-gaap:ProfitLoss
      contextRef="id292b6800f4b4953a4a8fc8f19b5c00f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNi01LTEtMS0zNjUxNw_6da3f4e7-2074-436a-805f-a2d7f3bd5d9c"
      unitRef="usd">4016000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia6c47cc5bdab45b9a83e045e422ae9d1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNi03LTEtMS0zNjUxNw_b4dddf77-f7a3-432d-80cf-f1583de3fef0"
      unitRef="usd">136000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNi0xMS0xLTEtMzY1MTc_44462da1-2991-45cf-8077-1da20b4bd1a0"
      unitRef="usd">4152000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia2daecb1c459472faf935c58f3d99556_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNy05LTEtMS0zNjUxNw_56bc86fb-24d7-4e40-8e21-b3d50e7c0928"
      unitRef="usd">-121000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfNy0xMS0xLTEtMzY1MTc_d6ce59e3-a044-421f-8c52-a40ce669da55"
      unitRef="usd">-121000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1ed2af8ce51a451dad2b3584762627b2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC0xLTEtMS0zNjUxNw_6d11c887-98f1-4d7d-adc5-52993588afde"
      unitRef="shares">19915000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ed2af8ce51a451dad2b3584762627b2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC0zLTEtMS0zNjUxNw_c49b9079-ecbd-4549-ae02-3db3940edfd6"
      unitRef="usd">139402000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05f25ce1bda74c48805771205ffcbbf8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC01LTEtMS0zNjUxNw_6b58437e-459d-4f1c-9376-49485c8ca8b6"
      unitRef="usd">10188000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i261b16c64967417fb69e183d714d9071_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC03LTEtMS0zNjUxNw_0f7d1944-7ddd-4923-9aa1-aaccb507221c"
      unitRef="usd">1984000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie5a44095252141c78d08c366bb1f2bce_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC05LTEtMS0zNjUxNw_59f8c228-7d86-484d-b3be-08b81e2f2d02"
      unitRef="usd">-10076000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8a7eaf75c524a39958b86619197e5f9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOC0xMS0xLTEtMzY1MTc_ffc37db1-cfed-4cf9-9409-d0cfe2b164b9"
      unitRef="usd">141498000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOS0zLTEtMS0zNjUxNw_265d32e2-24f0-4e6d-a7c0-ee4dac473f46"
      unitRef="usd">1066000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfOS0xMS0xLTEtMzY1MTc_246c9fef-5c84-41d9-bf5a-fc560bdc2d92"
      unitRef="usd">1066000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTAtMS0xLTEtMzY1MTc_cef7426d-4cc5-4a66-9793-3303a03a4608"
      unitRef="shares">152000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTAtMy0xLTEtMzY1MTc_df08601b-1a85-49de-bb8b-e51b01422b06"
      unitRef="usd">-660000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTAtMTEtMS0xLTM2NTE3_cb80b62a-096d-4baf-bbb7-0bf7b6c7a023"
      unitRef="usd">-660000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTEtMS0xLTEtMzY1MTc_7790bbab-2deb-4d83-95e6-04d93145020a"
      unitRef="shares">77000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i2b580f802b58474b94e96b97924cc7a1_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTEtMy0xLTEtMzY1MTc_8824e273-dc13-4944-a390-05cfab300196"
      unitRef="usd">1500000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTEtMTEtMS0xLTM2NTE3_7a3b6889-fc16-48f8-a094-62c64bb2cf30"
      unitRef="usd">1500000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProfitLoss
      contextRef="i3478de1ed17e4979a47bd4d3d1f5d7d0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTItNS0xLTEtMzY1MTc_363170af-a29f-401d-92e6-2c0b39284a3f"
      unitRef="usd">6540000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8bd19a9c61024bdcbe7a41dbec049830_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTItNy0xLTEtMzY1MTc_dab8679e-e6ac-4831-bc1b-4e4b1bf2d9f9"
      unitRef="usd">254000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTItMTEtMS0xLTM2NTE3_d040186b-8fee-434c-828f-9085c33e2b14"
      unitRef="usd">6794000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7dd64c1df3f04a6ea9ed4b040fb9c417_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTMtOS0xLTEtMzY1MTc_d2d530ee-b53c-40b1-a24f-ba56d5278c5e"
      unitRef="usd">-45000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icf26778247cf45e487700b6f55866416_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTMtMTEtMS0xLTM2NTE3_074c8085-7cf8-4a65-a0af-f987092a3f3d"
      unitRef="usd">-45000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7debe8761cc44795a69514ea9d87827b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtMS0xLTEtMzY1MTc_6ce6fc60-ca68-42c7-a478-44a077dee894"
      unitRef="shares">19990000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7debe8761cc44795a69514ea9d87827b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtMy0xLTEtMzY1MTc_57dd08b7-d1c9-482f-9cba-0de8be851491"
      unitRef="usd">138308000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide03d0a470604be19addddae37f14109_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtNS0xLTEtMzY1MTc_be7c284a-c4c6-4db4-a117-6183687c273f"
      unitRef="usd">16728000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if56b974fe0214d9691e4d03c981d7efb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtNy0xLTEtMzY1MTc_c68b449f-7264-4512-877f-3207c3e8e673"
      unitRef="usd">2238000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i428520a8a69e426a8fe5926e9ce42e43_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtOS0xLTEtMzY1MTc_be863e88-7c08-4dc1-bab1-aab487756977"
      unitRef="usd">-10121000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie441a8e4124a4d1b8054036ab19f5a25_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTQtMTEtMS0xLTM2NTE3_9d5be73f-98ce-474f-b9cd-836692ff0a29"
      unitRef="usd">147153000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTUtMy0xLTEtMzY1MTc_fb6cdabc-a28c-4d10-b1e5-8eedaa470eb1"
      unitRef="usd">886000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTUtMTEtMS0xLTM2NTE3_69a9b2e7-dd3b-4d97-8d12-43460e734ed0"
      unitRef="usd">886000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTYtMS0xLTEtMzY1MTc_4630d978-de5f-44bc-bb98-7e5b94334643"
      unitRef="shares">58000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTYtMy0xLTEtMzY1MTc_ca42cceb-e433-4029-8d85-a1a1568be37a"
      unitRef="usd">-442000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTYtMTEtMS0xLTM2NTE3_1924239f-33ec-45e2-9b28-c9a821f3e813"
      unitRef="usd">-442000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctMS0xLTEtMzY2Nzg_dbb0327c-8b3b-4035-9e87-bd5cb9ace0b4"
      unitRef="shares">273000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i49a20f20391f4fa592b1926397a800dd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctMy0xLTEtMzY2Nzg_016cd111-1b70-4090-aa21-01661bab0553"
      unitRef="usd">4500000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctMTEtMS0xLTM2Njc4_8b6bcad5-a5a3-4351-9cb6-625f52238512"
      unitRef="usd">4500000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProfitLoss
      contextRef="ib6b8c3d3276a40a8b5cf97b7662f1789_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctNS0xLTEtMzY1MTc_00013dae-12b3-413f-8e66-ce33f6a6a211"
      unitRef="usd">4858000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id81a97f8651b47b3a684dd5ff1e10415_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctNy0xLTEtMzY1MTc_4ae89cb8-d4c4-4d6e-b1a0-3a1d3d21f494"
      unitRef="usd">600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTctMTEtMS0xLTM2NTE3_223802ba-b31a-45bc-8bce-28581c88ae7f"
      unitRef="usd">5458000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9d49ac7e33054ec294ea97a34ce760b0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTgtOS0xLTEtMzY1MTc_83e6da3a-ca30-4be6-9bce-50d31f65e6f5"
      unitRef="usd">-925000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTgtMTEtMS0xLTM2NTE3_fc2ad587-185d-422f-b34e-686dfc94b16e"
      unitRef="usd">-925000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibb9057781307454eaa3ab969709f5839_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktMS0xLTEtMzY1MTc_550fbc29-8e4f-4571-822e-44b7a78c2c44"
      unitRef="shares">19775000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb9057781307454eaa3ab969709f5839_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktMy0xLTEtMzY1MTc_0f9f7bb7-c7ea-40a2-9fe3-e9029a239dc8"
      unitRef="usd">134252000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibaca5bb1e0ec4e8fac38bd64a9792a66_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktNS0xLTEtMzY1MTc_7bb1855f-cf42-4c1a-9745-874162b29da8"
      unitRef="usd">21586000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i742edf6aff37488aa80e713e9a672a7a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktNy0xLTEtMzY1MTc_5702ec19-f89a-4204-a5a3-788757de7bf9"
      unitRef="usd">2838000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f10af2594854b9fb57ee7ef9b152993_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktOS0xLTEtMzY1MTc_8f9fedd9-0363-4e95-99b5-8d6a22a1db75"
      unitRef="usd">-11046000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib41f685a036d4f58a4e05731f4478dfc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8yOC9mcmFnOmVlNWFkNjUxZmE4YTQ3YjFhMzFkZDQ1ZTczZTE1YzkxL3RhYmxlOmI4ZWZiYjVhOGQ0ZjQyOWJiNThlZTRhZGI4ZGFhYWJiL3RhYmxlcmFuZ2U6YjhlZmJiNWE4ZDRmNDI5YmI1OGVlNGFkYjhkYWFhYmJfMTktMTEtMS0xLTM2NTE3_0b250a23-3db8-4d28-b925-fcf71b4c76ad"
      unitRef="usd">147630000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMy0xLTEtMS0zNjUxNw_bc4b8208-e03c-4161-9399-9b7918a78ed7"
      unitRef="usd">-1534000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMy0zLTEtMS0zNjUxNw_a6b95476-a132-4a80-a1cc-703574d22754"
      unitRef="usd">16404000</us-gaap:ProfitLoss>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNS0xLTEtMS0zNjUxNw_f21aee53-1610-4f8c-9346-7971229790f5"
      unitRef="usd">1017000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNS0zLTEtMS0zNjUxNw_412d458a-dd2c-42ea-b3c7-791e15edc2b0"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNi0xLTEtMS0zNjUxNw_b8858f82-d9aa-403b-bf1b-5b1216a6f6d4"
      unitRef="usd">8112000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNi0zLTEtMS0zNjUxNw_2dbaa5a7-6807-49d0-9eb0-65956e70f46b"
      unitRef="usd">8276000</us-gaap:DepreciationDepletionAndAmortization>
    <natr:OperatingLeaseNonCashLeaseExpense
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNy0xLTEtMS0zNjUxNw_17515ad3-70d6-4fad-a123-0739661e30e5"
      unitRef="usd">3859000</natr:OperatingLeaseNonCashLeaseExpense>
    <natr:OperatingLeaseNonCashLeaseExpense
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNy0zLTEtMS0zNjUxNw_a7287b7c-2162-4007-8ef5-4321f6027028"
      unitRef="usd">4043000</natr:OperatingLeaseNonCashLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfOC0xLTEtMS0zNjUxNw_1faa1f80-f6c7-44da-b134-85bb0335505b"
      unitRef="usd">1934000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfOC0zLTEtMS0zNjUxNw_86284def-73b9-4d9f-a828-433d3439e08a"
      unitRef="usd">2957000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfOS0xLTEtMS0zNjUxNw_40e370c3-fcb4-41a9-a40b-b9a93ecf48ed"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfOS0zLTEtMS0zNjUxNw_8f0b4838-d89b-4724-b7de-019bd7bc0494"
      unitRef="usd">-24000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTAtMS0xLTEtMzY1MTc_7ab7bcb8-6439-40ac-895e-3d383391ede0"
      unitRef="usd">5967000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTAtMy0xLTEtMzY1MTc_22baa91a-11fd-4ac9-ad41-2f75623949a5"
      unitRef="usd">2891000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTEtMS0xLTEtMzY1MTc_43d50fda-270b-4c56-9a17-85e85d12c9f1"
      unitRef="usd">26000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTEtMy0xLTEtMzY1MTc_86a4d177-04ae-4031-92f1-df142dd77623"
      unitRef="usd">30000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTItMS0xLTEtMzY1MTc_5989182f-68b3-4ed9-88f4-09bf64343b30"
      unitRef="usd">102000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTItMy0xLTEtMzY1MTc_07e556ec-c32f-4613-aed4-564832491c1b"
      unitRef="usd">175000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:GainLossOnInvestments
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTMtMS0xLTEtMzY1MTc_385d181d-c0f7-4937-9e6f-648a904413e4"
      unitRef="usd">-195000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTMtMy0xLTEtMzY1MTc_0a952e5c-6673-4eb0-9207-5cb18555d5ad"
      unitRef="usd">62000</us-gaap:GainLossOnInvestments>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTQtMS0xLTEtMzY1MTc_d2bf3559-3153-4129-9587-d11885c80d07"
      unitRef="usd">-2938000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTQtMy0xLTEtMzY1MTc_5c106efe-07d4-4441-a8ad-a16e53a100cf"
      unitRef="usd">-2483000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTYtMS0xLTEtMzY1MTc_59d1a6a1-7b1e-4fc5-9cce-4630c6b7ab11"
      unitRef="usd">3233000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTYtMy0xLTEtMzY1MTc_cd84b293-9a90-4453-a583-d9ef90447e87"
      unitRef="usd">2054000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTctMS0xLTEtMzY1MTc_eeeb3b3e-a744-4da3-8daf-6b73361d46b8"
      unitRef="usd">10809000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTctMy0xLTEtMzY1MTc_649ca882-a4b0-43a2-982f-863cfafe4594"
      unitRef="usd">10771000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTgtMS0xLTEtMzY1MTc_a5111ca7-ddb0-474b-a1b3-1af529b3c8a2"
      unitRef="usd">116000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTgtMy0xLTEtMzY1MTc_3f59e729-24a4-4b82-be86-585b0f92ab95"
      unitRef="usd">1787000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTktMS0xLTEtMzY1MTc_65dea15c-88c5-4ae1-aa24-2a2543a3f60f"
      unitRef="usd">-368000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMTktMy0xLTEtMzY1MTc_208cb40e-ae0b-4ff7-bd05-1860788e3aac"
      unitRef="usd">267000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjAtMS0xLTEtMzY1MTc_7f805026-4732-4cac-bcc0-e8a704bef43e"
      unitRef="usd">-1626000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjAtMy0xLTEtMzY1MTc_c896f6b1-7870-404d-985a-c3db8367c0aa"
      unitRef="usd">421000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjEtMS0xLTEtMzY1MTc_7990caec-d587-45f1-a887-2882caa8cde2"
      unitRef="usd">-253000</natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees>
    <natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjEtMy0xLTEtMzY1MTc_c1dd33da-b552-494b-b9a9-fdae40885716"
      unitRef="usd">2750000</natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjItMS0xLTEtMzY1MTc_fce8e8fa-e518-4a36-b063-e2772d2580e4"
      unitRef="usd">-5172000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjItMy0xLTEtMzY1MTc_e19c2db5-1a49-4925-abc1-aa15d97afff3"
      unitRef="usd">-1646000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjMtMS0xLTEtMzY1MTc_1a232888-6f4c-484f-9d9f-e2b948bf98f0"
      unitRef="usd">-2040000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjMtMy0xLTEtMzY1MTc_2c13c5cf-fb06-421d-b372-e781ed6acec2"
      unitRef="usd">-551000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <natr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjQtMS0xLTEtMzY1MTc_879a1457-1dcf-4124-b19b-c08150dbed79"
      unitRef="usd">-3692000</natr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <natr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjQtMy0xLTEtMzY1MTc_af5ae95f-0c2b-41df-bb48-f9c20f05423f"
      unitRef="usd">-4170000</natr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjUtMS0xLTEtMzY1MTc_f7caf1fb-5d69-4d00-a518-4ab303cfc1d2"
      unitRef="usd">1201000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjUtMy0xLTEtMzY1MTc_0974f7e4-ce39-4115-9449-f1ecf55ce33e"
      unitRef="usd">1316000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjYtMS0xLTEtMzY1MTc_ef4efc89-f3da-4963-98c2-0db7bae1253a"
      unitRef="usd">213000</natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions>
    <natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjYtMy0xLTEtMzY1MTc_5fdb9260-e562-4eb3-9cca-3f417c878308"
      unitRef="usd">-87000</natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjctMS0xLTEtMzY1MTc_d53dcb2c-533d-43a6-9674-246a32c76fd9"
      unitRef="usd">-271000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjctMy0xLTEtMzY1MTc_27667aeb-ef5f-4504-b840-55a01284766d"
      unitRef="usd">-34000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjgtMS0xLTEtMzY1MTc_e4b4e9de-738b-4b52-b16d-d9858d6f366d"
      unitRef="usd">-2866000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMjgtMy0xLTEtMzY1MTc_809ef553-ff6b-42ff-930d-15ff9a27aae0"
      unitRef="usd">20281000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzAtMS0xLTEtMzY1MTc_322a0251-8b39-48c3-9505-dbc753c2b623"
      unitRef="usd">4730000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzAtMy0xLTEtMzY1MTc_cd55c673-315d-4690-80db-ee332ea9de91"
      unitRef="usd">4626000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzQtMS0xLTEtMzY1MTc_c35afdd3-4c61-4fe7-913e-1aba1135eda7"
      unitRef="usd">-4730000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzQtMy0xLTEtMzY1MTc_b9c3b2c7-ce26-4606-846d-3c9d02e2a09c"
      unitRef="usd">-4626000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividends
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzYtMS0xLTEtMzY1MTc_f85924d7-6a5e-457e-b3e0-2789d0e0dd96"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzYtMy0xLTEtMzY1MTc_eac7a639-be71-4dd9-9284-8a0fb628750f"
      unitRef="usd">19858000</us-gaap:PaymentsOfDividends>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzctMS0xLTEtMzY1MTc_d7872be3-62ad-42c1-a4bc-a89763057d13"
      unitRef="usd">931000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzctMy0xLTEtMzY1MTc_25b43b3d-dae4-4647-b5f7-6da0ce2a78ea"
      unitRef="usd">1001000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzgtMS0xLTEtMzY1MTc_1429f523-8ebd-4c0e-a5b9-1c9b7b58c494"
      unitRef="usd">31538000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzgtMy0xLTEtMzY1MTc_736c9bc0-cc67-4550-b02a-01c47589bd25"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzktMS0xLTEtMzY1MTc_90ea5edd-7423-45c5-a312-45bcb4107a2f"
      unitRef="usd">31538000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfMzktMy0xLTEtMzY1MTc_553ef585-f0c9-4ecf-a3c8-4ab8e09f06d6"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDEtMS0xLTEtMzY1MTc_0fc5e0e9-8f0d-4b3e-9a76-4cbdd90a9f26"
      unitRef="usd">300000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDEtMy0xLTEtMzY1MTc_e92d79ce-5c10-4706-b20e-76b94a6e00d1"
      unitRef="usd">600000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDMtMS0xLTEtMzY1MTc_90226264-3bc3-4b9c-a6ae-e1891d4f439e"
      unitRef="usd">1129000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDMtMy0xLTEtMzY1MTc_0ff8ef8b-58a3-4483-972d-b6e56c6208ee"
      unitRef="usd">2016000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDUtMS0xLTEtMzY1MTc_c6ebc6d1-6927-4253-9362-a6806a461ee8"
      unitRef="usd">12945000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDUtMy0xLTEtMzY1MTc_92da41e4-64e7-408b-9880-8bf9b427321c"
      unitRef="usd">6000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDYtMS0xLTEtMzY1MTc_5c0dec08-883d-4417-85a2-5318be9f2d7f"
      unitRef="usd">-15305000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDYtMy0xLTEtMzY1MTc_b8eaaad2-81d0-4984-9636-32132cf6e2f6"
      unitRef="usd">-29475000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDctMS0xLTEtMzY1MTc_8680fefa-c625-4e4b-b51e-e801c9116b1c"
      unitRef="usd">-6299000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDctMy0xLTEtMzY1MTc_70ddba2a-263a-4425-9518-824d402c8b55"
      unitRef="usd">-2714000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDgtMS0xLTEtMzY1MTc_4b7bb4b5-6576-4117-b7e0-dd6ba17293de"
      unitRef="usd">-29200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDgtMy0xLTEtMzY1MTc_42153839-4c74-4dde-95ed-aefe96542ee6"
      unitRef="usd">-16534000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDktMS0xLTEtMzY1MTc_0e30f1da-b137-4f37-8e11-9d24b09df9cd"
      unitRef="usd">86184000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8b678cf1500d473b98980c984f33d848_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNDktMy0xLTEtMzY1MTc_f2c889ca-d624-4592-9c33-e307ca880c9e"
      unitRef="usd">92069000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTAtMS0xLTEtMzY1MTc_5794878e-8469-46a2-a891-eb3011fd3056"
      unitRef="usd">56984000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib41f685a036d4f58a4e05731f4478dfc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTAtMy0xLTEtMzY1MTc_e31a81db-6857-4a3a-ad19-2c91c6e86bb4"
      unitRef="usd">75535000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTItMS0xLTEtMzY1MTc_d7af7009-9862-431e-a47c-4face9925e47"
      unitRef="usd">3386000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTItMy0xLTEtMzY1MTc_239d5196-7693-4a37-a035-9ae60d820c2a"
      unitRef="usd">4431000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTMtMS0xLTEtMzY1MTc_8e0e0e7e-f038-4625-9b3a-548651313c60"
      unitRef="usd">195000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zMS9mcmFnOmVlNGZjZmQ3NTUyMDQyMjY5N2Y1NmRmNjE1Zjk5NTI4L3RhYmxlOjI0MjdlZGQwOTY1YjQxZWJhZDc5MGM5MmNmNWFiNDU5L3RhYmxlcmFuZ2U6MjQyN2VkZDA5NjViNDFlYmFkNzkwYzkyY2Y1YWI0NTlfNTMtMy0xLTEtMzY1MTc_ffd1f8db-f521-49f5-813b-146deb7d34dc"
      unitRef="usd">156000</us-gaap:InterestPaidNet>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY2NA_ed3c6df8-987f-4c18-bb03-dad03edbe8f0">Basis of Presentation&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY4NQ_8546777e-e136-48ad-bed6-bb7ef06dc632">Basis of Presentation&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $0.1 million and $0.8 million for the three and nine months ended September&#160;30, 2022, respectively. Net income attributable to the noncontrolling interests was $0.6 million and $1.0 million for the three and nine months ended September&#160;30, 2021, respectively. As of September&#160;30, 2022 and December&#160;31, 2021, noncontrolling interests were $4.0 million and $3.2 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Related Accruals and Expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded $0.1 million and $0.4 million of restructuring related expenses during the three and nine months ended September&#160;30, 2022, respectively. We recorded $0 and $48,000 of restructuring related expenses during the three and nine months ended September&#160;30, 2021, respectively. Accrued severance and restructuring related costs were $0 and $0.2 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the &lt;/span&gt;&lt;/div&gt;potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY3NQ_9fde5306-c04e-4680-bdf2-7ae29bff65ac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY3OA_8fb3a1f5-fde5-4886-842d-d7c90db2230f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.</us-gaap:UseOfEstimates>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzEyMQ_9ec5f04e-c374-4cab-9214-3036254bbe66"
      unitRef="usd">100000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzEyOA_d3bb259f-453c-49e9-a285-af58b76c11a4"
      unitRef="usd">800000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzI0Mw_4698ec08-af7a-4e5e-bb30-92e6e6c562dd"
      unitRef="usd">600000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzI1MA_37bd79c0-0bba-405d-90cc-354490ae7c9b"
      unitRef="usd">1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterest
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzM1Mg_e1102072-fb62-4e6b-89a3-9ad250cd8bdf"
      unitRef="usd">4000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzM1OQ_097bfc4a-59f2-4a87-9d9b-2772fe99e4f8"
      unitRef="usd">3200000</us-gaap:MinorityInterest>
    <us-gaap:RestructuringCharges
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzQzNg_19aaeff9-ce05-484a-8091-d23a21ca6848"
      unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzQ0Mw_38b36b3d-1afc-429c-91a2-910d530a1291"
      unitRef="usd">400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzUzNw_b91f7869-d195-48da-925b-8809e21817ac"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzU0NA_63c8a78f-bbf6-4e43-8b85-40540259f2d2"
      unitRef="usd">48000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="ie1a51afc7549405b92c990bdb852d8cb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzY4MQ_b9f3e13f-b18b-4402-b7f6-37a6ee1e9e65"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i004662f9de7b4fdfbabc81b8850a070f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfMzY4OA_03be44ce-cbb9-4ee5-8e32-7438da026621"
      unitRef="usd">200000</us-gaap:RestructuringReserve>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF8zNy9mcmFnOjAwMjVkMGE4MDA3NjQ0NThhMmU1ZWI2YmY0MjNkM2QzL3RleHRyZWdpb246MDAyNWQwYTgwMDc2NDQ1OGEyZTVlYjZiZjQyM2QzZDNfNDY3NA_80e46036-557c-4c41-a5c6-e255bae27a76">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the &lt;/span&gt;&lt;/div&gt;potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are elective and subject to meeting certain criteria that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This could affect balances of right of use assets, lease liabilities, and notes payables. The amendments in this update are effective as of March 12, 2020 through December 21, 2022. The adoption of this ASU is not expected to have a significant impact on our Consolidated Financial Statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RleHRyZWdpb246MzEwNzQyMWQ5NzVmNDQ1Mzk3OGE0OTQ2Yzc4ZjNkNDdfMTA2_077d7238-f218-408b-bcf3-c6212f9c2419">Inventories&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The composition of inventories is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RleHRyZWdpb246MzEwNzQyMWQ5NzVmNDQ1Mzk3OGE0OTQ2Yzc4ZjNkNDdfMTA5_44816d38-fe51-406a-a56f-bedf183166dd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The composition of inventories is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMS0xLTEtMS0zNjUxNw_8983a366-1ad5-4869-a104-f660c46e133a"
      unitRef="usd">26394000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMS0zLTEtMS0zNjUxNw_4df00991-65b0-404e-ae76-0f56852a2f9f"
      unitRef="usd">22494000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMi0xLTEtMS0zNjUxNw_07a9e971-4d10-47b7-a67e-be1275b868c9"
      unitRef="usd">1880000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMi0zLTEtMS0zNjUxNw_78ecf4ff-7919-4080-bbf4-33df014e0f6c"
      unitRef="usd">1746000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMy0xLTEtMS0zNjUxNw_df123aae-2390-4f40-87ee-5ec6ac8b3397"
      unitRef="usd">39329000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfMy0zLTEtMS0zNjUxNw_ae062c29-8af1-4bbf-87a6-6e3c96f79103"
      unitRef="usd">36612000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfNC0xLTEtMS0zNjUxNw_791d22d2-c957-4e3b-bdd0-236cad3dc952"
      unitRef="usd">67603000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80MC9mcmFnOjMxMDc0MjFkOTc1ZjQ0NTM5NzhhNDk0NmM3OGYzZDQ3L3RhYmxlOmU1NGQ2ZDY0MzM5YzQ0NmM4NjUzMDA3OTZlMjg0ZjY3L3RhYmxlcmFuZ2U6ZTU0ZDZkNjQzMzljNDQ2Yzg2NTMwMDc5NmUyODRmNjdfNC0zLTEtMS0zNjUxNw_8c217180-a23b-4972-84bc-bfbd05dfa57e"
      unitRef="usd">60852000</us-gaap:InventoryNet>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMjg5_ab6c4efe-b58a-4a53-94e2-4de2166e2d31">Investment Securities - Trading&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our trading securities portfolio totaled $0.7 million at September&#160;30, 2022, and $1.0 million at December&#160;31, 2021, and generated losses of $25,000 and $4,000 for the three months ended September&#160;30, 2022 and 2021, respectively, and losses of $0.2 million and gains of $0.1 million for the nine months ended September&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfODQ_46ef5c0a-5a08-42ee-9a14-6017f5feb19e"
      unitRef="usd">700000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfOTg_865282f6-9741-4007-befb-5640a42ad405"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRealizedGainLoss
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMTMy_31c5307c-f939-40ad-a86c-f3a141f3f630"
      unitRef="usd">-25000</us-gaap:DebtSecuritiesTradingRealizedGainLoss>
    <us-gaap:DebtSecuritiesTradingRealizedGainLoss
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMTQ4_dc21528e-6fac-4f80-87ac-e5aa8eadb545"
      unitRef="usd">4000</us-gaap:DebtSecuritiesTradingRealizedGainLoss>
    <us-gaap:DebtSecuritiesTradingRealizedGainLoss
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMjE3_eded4f1f-3bc5-4c43-8e65-bc8d46401177"
      unitRef="usd">200000</us-gaap:DebtSecuritiesTradingRealizedGainLoss>
    <us-gaap:DebtSecuritiesTradingRealizedGainLoss
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80My9mcmFnOjJlMmY5MzEzZjI2NDQ2MjdhYzAwZDczZTllMWNlNjA4L3RleHRyZWdpb246MmUyZjkzMTNmMjY0NDYyN2FjMDBkNzNlOWUxY2U2MDhfMjMz_b339401e-838d-4bc9-a457-efa628e18cd3"
      unitRef="usd">100000</us-gaap:DebtSecuritiesTradingRealizedGainLoss>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMjA1OQ_2d12ce02-92dd-4603-a22d-9f51cb9421b7">Revolving Credit Facility and Other Obligations&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$25.0 million (the &#x201c;Credit Agreement&#x201d;).&#160;On June 23, 2022 the credit agreement was amended to extend the term to mature on July 1, 2027 and allows for additional borrowings of $25.0&#160;million or up to three separate increases of no less than $5.0&#160;million each, subject to the lender's due diligence. The amendment to the credit agreement also modified the calculation of interest. Interest under the amended Credit Agreement is the greater of BSBY Daily Floating Rate or the Index Floor, plus&#160;1.50 percent&#160;(4.62 percent as of September&#160;30, 2022), and an annual commitment fee of&#160;0.25 percent&#160;on the unused portion of the commitment. At September&#160;30, 2022 and December 31, 2021, there was no outstanding balance under the Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of September&#160;30, 2022, we were in compliance with the debt covenants set forth in the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $6.0&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $3.7&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of 3.00 percent and are required to settle our borrowings under the Capital Credit Agreement in 36 monthly payments of $0.1&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of September&#160;30, 2022, there was $1.5&#160;million outstanding balance under the Capital Credit Agreement, of which $1.3&#160;million was classified as current.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia06b2ea113604f608cfe139f6473b4f8_I20170711"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTc1_c770afe6-09f9-427a-b17d-d250bdabbb63"
      unitRef="usd">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings
      contextRef="ia088a5fe1c0d4659856719b55cc649b5_I20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMzM5_8e50ea72-6693-4ef7-b00f-48ce49b1112c"
      unitRef="usd">25000000</natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings>
    <natr:LineOfCreditFacilityNumberOfSeparateIncreases
      contextRef="ia088a5fe1c0d4659856719b55cc649b5_I20220623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMzUx_430cb35a-02a2-4620-a980-59fa94d54b4c"
      unitRef="borrowing">3</natr:LineOfCreditFacilityNumberOfSeparateIncreases>
    <natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence
      contextRef="ia088a5fe1c0d4659856719b55cc649b5_I20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMzg5_915cfe3c-c018-42db-b7d4-257892a4c44a"
      unitRef="usd">5000000</natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i22efa19eb0344c72ad687994862269e2_D20220623-20220623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNTkx_e278cbfa-882e-4775-93ee-01486ced341f"
      unitRef="number">0.015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iddc8134658ca4954b354f15805380b94_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNTk1_f88e303b-a401-4d7d-a8b2-7ca890cd749c"
      unitRef="number">0.0462</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i8f0cbc126bdd4b63949c4345575e09e6_D20220623-20220623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNjQx_7544bfe0-a398-4709-9a9e-d9082048b0b0"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCredit
      contextRef="if06d201ef25c4642849a07427e18a4e2_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNzI0_98402646-851c-435a-af6a-8095e5425e09"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3c79105659ed47199844f29f16ee8732_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfNzI0_9988d23f-b4a7-4f20-8771-280f2b4043d1"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0e03c2f550744858bfdef123a1e103dc_I20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTUxNA_b61b8ee5-3f4d-49fd-b6c6-28a6d9bf6e14"
      unitRef="usd">6000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i42bf1f4955d14fd785dd3122c680d83b_I20201119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTYzMA_292675d3-e829-4c3e-9415-399bfa0fb929"
      unitRef="usd">3700000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i03715efd129a44a1865caa1ea43fa333_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTcyMg_94fd01d1-26f2-4510-aa57-c833f4c93dbc"
      unitRef="number">0.0300</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <natr:DebtInstrumentNumberOfMonthlyPayments
      contextRef="i8562a44c05df4b34a7f6a8878e388882_D20201119-20201119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTgxMw_51287cec-e618-4c58-8067-12ceb0c578c6"
      unitRef="payment">36</natr:DebtInstrumentNumberOfMonthlyPayments>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i8562a44c05df4b34a7f6a8878e388882_D20201119-20201119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTgzNw_98ca1474-96f2-4bf1-983a-b5c2a84abaf9"
      unitRef="usd">100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LineOfCredit
      contextRef="id7b42e335b02463ea1d3019cd2f3474b_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMTk2MA_3e9a71b3-80c1-426f-9a3b-d5ad689d75d6"
      unitRef="usd">1500000</us-gaap:LineOfCredit>
    <us-gaap:LinesOfCreditCurrent
      contextRef="id7b42e335b02463ea1d3019cd2f3474b_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80Ni9mcmFnOjFmNTBkNDcxYzM0MzQ5OTM4NTVhYjE3NGVmMjU5NzlmL3RleHRyZWdpb246MWY1MGQ0NzFjMzQzNDk5Mzg1NWFiMTc0ZWYyNTk3OWZfMjAyOA_a33e5d39-622b-4b08-8f46-8a173a22a619"
      unitRef="usd">1300000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RleHRyZWdpb246MzFjZWQxNTlhMzdlNDEyYWFmNDk5NmE0OTNjOWU0MzlfMTc1Mw_bb0357f2-5295-4249-b11d-575c189fcab7">Net Income Per Share&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per common share (&#x201c;Basic EPS&#x201d;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#x201c;Diluted EPS&#x201d;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three and nine months ended September&#160;30, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Anti-dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;As a result of the net loss for the nine months ended September 30, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the nine months ended September 30, 2022 include 576 restricted stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted- average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RleHRyZWdpb246MzFjZWQxNTlhMzdlNDEyYWFmNDk5NmE0OTNjOWU0MzlfMTc1MA_55213184-5d80-4bf0-9ef6-013425ae3ec7">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three and nine months ended September&#160;30, 2022 and 2021 (dollar and share amounts in thousands, except for per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Anti-dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;As a result of the net loss for the nine months ended September 30, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the nine months ended September 30, 2022 include 576 restricted stock units.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNS0xLTEtMS0zNjUxNw_f2468410-1e8b-4926-8694-39bbb4d79f76"
      unitRef="usd">90000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNS0zLTEtMS0zNjUxNw_6838423a-468c-4031-8e2f-346b606f280d"
      unitRef="usd">4858000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNS01LTEtMS0zNjUxNw_7a22b530-1985-4711-8c26-8028cefbaa36"
      unitRef="usd">-2344000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNS03LTEtMS0zNjUxNw_ad75da6a-006f-4b08-bdf8-bfb3c2400df0"
      unitRef="usd">15414000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNy0xLTEtMS0zNjUxNw_12470454-975a-41e1-ae21-4e67c1a24061"
      unitRef="shares">19198000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNy0zLTEtMS0zNjUxNw_020fbc0b-481c-4e18-a461-ed8132a994eb"
      unitRef="shares">19894000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNy01LTEtMS0zNjUxNw_80494e38-8056-44c9-aa99-c613233547b1"
      unitRef="shares">19384000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfNy03LTEtMS0zNjUxNw_fd7dabac-e43d-47c8-b0e4-9723ca1fb2cd"
      unitRef="shares">19896000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTItMS0xLTEtMzY1MTc_ec98db73-6a1f-4d8a-b8f4-bb65f48d549b"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTItMy0xLTEtMzY1MTc_8bd44c64-4559-402e-9d09-570e8a975892"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTItNS0xLTEtMzY1MTc_fcb403c1-7fb0-4922-ba88-fd943336fa42"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTItNy0xLTEtMzY1MTc_098d9357-cdd0-464d-95c5-0dc7e30c371a"
      unitRef="usdPerShare">0.77</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTUtMS0xLTEtMzY1MTc_746027d7-e9c5-4ae5-b81f-2cd937757f13"
      unitRef="shares">19198000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTUtMy0xLTEtMzY1MTc_57d0576b-e2fd-4458-9ed6-f4653407b18c"
      unitRef="shares">19894000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTUtNS0xLTEtMzY1MTc_ae26c545-ff9b-414e-a26e-e25151853cf4"
      unitRef="shares">19384000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTUtNy0xLTEtMzY1MTc_17645fbe-b8d0-4f74-9eb1-f206b8948d3a"
      unitRef="shares">19896000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTYtMS0xLTEtMzY1MTc_033b2a50-2411-4ece-a6d9-6489a91f2c0e"
      unitRef="shares">284000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTYtMy0xLTEtMzY1MTc_e843b2a7-b4ea-450b-936b-177e3d63204c"
      unitRef="shares">481000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTYtNS0xLTEtMzY1MTc_2bfb1939-59b9-46a6-88dd-9b455934c3c0"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTYtNy0xLTEtMzY1MTc_d410fee4-2d39-478e-ac4f-bd7dd44fe1e3"
      unitRef="shares">396000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTctMS0xLTEtMzY1MTc_ac3463aa-af97-47ca-ac22-dc6f504b7bd4"
      unitRef="shares">19482000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTctMy0xLTEtMzY1MTc_6f71a90b-fd77-4d54-a40e-1977c79a1898"
      unitRef="shares">20375000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTctNS0xLTEtMzY1MTc_df9562c0-76a1-48ac-b107-720cc416ebda"
      unitRef="shares">19384000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMTctNy0xLTEtMzY1MTc_f6695051-3f7d-45cc-9922-0342eeac4c13"
      unitRef="shares">20292000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjItMS0xLTEtMzY1MTc_73ae1342-56b2-406c-92bd-46d673f8d519"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjItMy0xLTEtMzY1MTc_e6dc4099-1528-4ffc-b215-68099a48cbaf"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjItNS0xLTEtMzY1MTc_e88cbf55-8ac7-4e57-af8a-85873a7810b3"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjItNy0xLTEtMzY1MTc_5a583b40-04ce-436a-8256-379e6cd139eb"
      unitRef="usdPerShare">0.76</us-gaap:EarningsPerShareDiluted>
    <natr:DilutiveSecuritiesExcludedfromComputationofEarnings
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjUtMS0xLTEtMzY1MTc_8234dbd6-b88f-4f67-9866-1534f0cd031a"
      unitRef="shares">576000</natr:DilutiveSecuritiesExcludedfromComputationofEarnings>
    <natr:DilutiveSecuritiesExcludedfromComputationofEarnings
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjUtMy0xLTEtMzY1MTc_a70ff575-fb57-4dda-afda-48536f1eb510"
      unitRef="shares">460000</natr:DilutiveSecuritiesExcludedfromComputationofEarnings>
    <natr:DilutiveSecuritiesExcludedfromComputationofEarnings
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjUtNS0xLTEtMzY1MTc_bfbf2f75-ec44-4eb9-a616-92c6ad754051"
      unitRef="shares">0</natr:DilutiveSecuritiesExcludedfromComputationofEarnings>
    <natr:DilutiveSecuritiesExcludedfromComputationofEarnings
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjUtNy0xLTEtMzY1MTc_249fcc63-3846-492e-a4a7-6074a2d3f017"
      unitRef="shares">460000</natr:DilutiveSecuritiesExcludedfromComputationofEarnings>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjgtMS0xLTEtMzY1MTc_7e3e8e00-a9e5-438e-9fd4-d754e06b7f93"
      unitRef="shares">25000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjgtMy0xLTEtMzY1MTc_d77f7e69-e720-438b-91f6-273158d47a3e"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjgtNS0xLTEtMzY1MTc_f4aaea34-2686-4c81-bf72-f2f7749b4cc9"
      unitRef="shares">576000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RhYmxlOjRiMjgzOTUxMjg5OTRjOTc5MzU3NTE4MTQ3ZmVmNDZmL3RhYmxlcmFuZ2U6NGIyODM5NTEyODk5NGM5NzkzNTc1MTgxNDdmZWY0NmZfMjgtNy0xLTEtMzY1MTc_f993d554-482b-4805-bbeb-fab894033f97"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RleHRyZWdpb246MzFjZWQxNTlhMzdlNDEyYWFmNDk5NmE0OTNjOWU0MzlfOTA4_51bf0d64-a141-467d-8673-50027aab9203"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF80OS9mcmFnOjMxY2VkMTU5YTM3ZTQxMmFhZjQ5OTZhNDkzYzllNDM5L3RleHRyZWdpb246MzFjZWQxNTlhMzdlNDEyYWFmNDk5NmE0OTNjOWU0MzlfMTEyNA_3dfa16ee-a24f-4a45-9964-017c279acf81"
      unitRef="shares">576000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYzMQ_6f4ef5ba-e9f5-4512-8304-366890f78587">Capital Transactions&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27.35pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2021, we announced a special non-recurring cash dividend of $1.00 per common share in an aggregate amount of $19.9&#160;million that was paid on April 5, 2021, to shareholders of record on March 29, 2021. In accordance with the provisions of our 2012 Stock Incentive Plan (the "2012 Incentive Plan"), as a result of the special dividend we are required to make the participant's original grant whole by preventing either dilution or enlargement of the benefits or potential benefits intended by the original grant. The 2012 Incentive Plan provides our Compensation Committee with the discretion to meet this requirement. See further discussion in the Share-Based Compensation section of this Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27.35pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27.35pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2021, we announced a $15.0&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0&#160;million in common shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the nine months ended September&#160;30, 2022 and 2021, we repurchased 834,000 and 350,000 shares of our common stock for $12.9&#160;million and $6.0&#160;million, respectively. At September&#160;30, 2022, the remaining balance available for repurchases under the program was $24.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#x2019;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500,000 shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by 1,500,000 shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by 2,000,000 shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to 48 months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no share-based compensation expense for the three- and nine-month periods ended September&#160;30, 2022 and 2021. As of September&#160;30, 2022 and December&#160;31, 2021, there was no unrecognized share-based compensation expense related to the grants described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the aggregate intrinsic value of outstanding and exercisable stock options to purchase 143,000 shares of common stock was $0. At December&#160;31, 2021, the aggregate intrinsic value of outstanding and exercisable options to purchase 172,000 shares of common stock was $1.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine-month periods ended September&#160;30, 2022 and 2021, we issued 29,000 and 53,000 shares of common stock upon the exercise of stock options at an average exercise price of $9.17 and $12.00 per share, respectively. The aggregate intrinsic value of options exercised during the nine-month periods ended September&#160;30, 2022 and 2021, was $0.3 million and $0.4 million, respectively. For the nine-month periods ended September&#160;30, 2022 and 2021, the Company recognized $0.1 million and $0.2 million of tax benefits from the exercise of stock options, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, we did not have any unvested stock options outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our outstanding restricted stock units (&#x201c;RSUs&#x201d;), include time-based RSUs, which vest over differing periods of time ranging from 12 months to up to 36 months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating adjusted EBITDA growth, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until two years after vesting. At September&#160;30, 2022 and December&#160;31, 2021, there were 81,000 and 88,000 vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock unit activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine-month period ended September&#160;30, 2022, we granted 796,000 RSUs under the 2012 Incentive Plan to the Board of Directors, executive officers and other employees, which were comprised of time-based RSUs, and share-priced and adjusted EBITDA performance-based RSUs. The time-based RSUs were issued with a weighted-average grant date fair value of $11.44 per share and vest in 12 monthly installments over a one year period from the grant date or in annual installments over a three-year period from the grant date. The share-priced performance-based RSUs were issued with a weighted-average grant date fair value of $6.01 per share and vest upon achieving share-priced targets over a three-year period from the grant date. The adjusted EBITDA performance-based RSUs were issued with a weighted-average grant date fair value of $11.00 per share and vest upon achieving adjusted EBITDA targets over a four-year period from the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except for share-priced performance RSUs, RSUs are valued at market value on the date of grant, which is the grant date share price discounted for expected dividend payments during the vesting period. For RSUs with post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. Using assumptions previously determined for the application of the option pricing model at the valuation date, the Finnerty Model discount for lack of marketability is approximately 12.9 percent for a common share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-price performance-based RSUs were estimated using the Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved. Our assumptions include a performance period of three years, expected volatility of 50.1 percent, and a risk-free rate of 3.3 percent.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to time-based RSUs for the three-month periods ended September&#160;30, 2022 and 2021, was approximately $0.3 million and $0.6 million, respectively. Share-based compensation expense related to time-based RSUs for the nine-month periods ended September&#160;30, 2022 and 2021, was approximately $1.2 million and $1.6 million, respectively. As of September&#160;30, 2022 and December&#160;31, 2021, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $3.1 million and $1.6 million, respectively. The remaining compensation expense is expected to be recognized over the weighted average period of approximately 0.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to performance-based RSUs for the three-month periods ended September&#160;30, 2022 and 2021, was $0.2 million and $0.3 million, respectively. Share-based compensation expense related to performance-based RSUs for the nine-month periods ended September&#160;30, 2022 and 2021, was $0.7 million and $1.2 million, respectively.&#160;Should we attain all of the metrics related to performance-based RSU grants, we would recognize up to $1.8 million of potential share-based compensation expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was 80,000 and 150,000 shares for the nine-month periods ended September&#160;30, 2022 and 2021, respectively. Although shares withheld are not issued, they are &lt;/span&gt;&lt;/div&gt;treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i98e5bb1cef6c4becb6ebf74bc1b7e3eb_D20210405-20210405"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTE2_92745478-7f6a-46d6-8104-bfdb3b03052b"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i98e5bb1cef6c4becb6ebf74bc1b7e3eb_D20210405-20210405"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTYy_b85317f8-6d35-43de-a323-85a360a9c8c1"
      unitRef="usd">19900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iee350a313d8f4cd4b7964c9818ca55c8_I20210310"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTEzNA_0f667d06-a155-40fe-a5e8-1e1194b2e24e"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i38f58e1adc7e4bd4adbdfed111f9df0b_I20220308"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTI4Ng_bcee1eb0-5976-4a94-923d-738bce1fedca"
      unitRef="usd">30000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTQ3OA_2b5d04b0-e2ad-4809-a1e9-5ac91684ef26"
      unitRef="shares">834000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTQ4NQ_a53cfecd-7286-4e01-a73b-984b5271786b"
      unitRef="shares">350000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTUxOQ_76241e93-0ec2-4c6f-ad6a-cb5859e81216"
      unitRef="usd">12900000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTUyNg_551ad0ec-4114-4299-9986-47edfbdecdb2"
      unitRef="usd">6000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTYyMQ_4addcf23-1126-476a-a3ea-53962ae8f6d9"
      unitRef="usd">24600000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i6c0ddf3d82324bcb905a643d93542091_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMjMyOQ_f921035c-ba58-40a1-9b54-e698a22b9f8b"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ibae0afd2c25447bc920e0df4c8c9b207_D20150101-20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMjU5NA_ae9a30af-f364-482e-b57b-5e7c5e6ca40e"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="if9593f0319dc4fe48d712b42fc7be268_D20210505-20210505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMjgwMQ_f92c1fda-999a-4089-a68f-1512ba8bd9b4"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="icb44a2c98f1740dbb00c82b0e332d00e_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzIzMQ_2faa2895-57dd-4457-acb8-77d119c145c3">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne
      contextRef="i50cfb2216c6e4898a183ccf77630d5ae_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzM2OA_7c30c9ab-d084-4139-8a57-08690035a25c"
      unitRef="number">0.06</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo
      contextRef="i50cfb2216c6e4898a183ccf77630d5ae_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzM3Mg_744a66e5-8614-4caa-a546-247d77503b17"
      unitRef="number">0.08</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree
      contextRef="i50cfb2216c6e4898a183ccf77630d5ae_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzM3OQ_cc73fa8a-2b92-4daf-9ddd-53d1ed517bf8"
      unitRef="number">0.10</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYyNw_f015f99e-61b6-44dc-94c0-a9ea9097ea77">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMS0xLTEtMS0zNjUxNw_31768f75-7a53-401f-a622-db7eb95243ef"
      unitRef="shares">172000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMS0zLTEtMS0zNjUxNw_ae2a8b8e-8d2b-454f-aac6-b439ab763944"
      unitRef="usdPerShare">12.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMS01LTEtMS0zNjUxNw_e54f9d3a-94ea-4c80-b748-ed16b506eb46"
      unitRef="usdPerShare">5.05</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMi0xLTEtMS0zNjUxNw_56fa26a7-5531-4201-a5e5-d50fae574a97"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMi0zLTEtMS0zNjUxNw_ec8c76c3-797e-418f-94ab-eb1b5c36e4c9"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMi01LTEtMS0zNjUxNw_bffd1d09-753e-438f-904d-6a75ec14e0a0"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMy0xLTEtMS0zNjUxNw_1d82dce3-d748-4dba-87a2-b94cfe30f2b8"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMy0zLTEtMS0zNjUxNw_3584e75c-8b42-4a01-8e2b-8671de54fd7b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfMy01LTEtMS0zNjUxNw_426de929-36a3-475e-acc0-a92106b3e9ba"
      unitRef="usdPerShare">0</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNC0xLTEtMS0zNjUxNw_50b0cecf-cf6e-4968-86b3-7a60401f772b"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNC0zLTEtMS0zNjUxNw_005bf32c-5b10-4465-a96a-2daf041769ca"
      unitRef="usdPerShare">9.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNC01LTEtMS0zNjUxNw_dc3a568d-a4ea-4a87-b7e3-a528ce009e37"
      unitRef="usdPerShare">3.92</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNS0xLTEtMS0zNjUxNw_66796395-6b61-4218-ba42-204ff17aef11"
      unitRef="shares">143000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNS0zLTEtMS0zNjUxNw_d2e7cc80-f574-491a-bc9a-addcad7a5ae7"
      unitRef="usdPerShare">12.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjIxZDFiMzJiMzY3MTQ1YjM4ODdkYjI5YThlN2M4MTVhL3RhYmxlcmFuZ2U6MjFkMWIzMmIzNjcxNDViMzg4N2RiMjlhOGU3YzgxNWFfNS01LTEtMS0zNjUxNw_32c78f3b-1482-4c34-ad4f-1e3676ffd4c7"
      unitRef="usdPerShare">5.28</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i070b06d98cf645ae85a6b3eff5f58702_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzYwNw_0dcfb16e-1308-49f7-9d5b-839531b4456a"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzYwNw_1625cd4b-e613-4d8c-b709-7fc924f35f55"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzYwNw_3b1b3d13-6682-440d-b195-a4998fc46730"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic3925d99f6de43c5afbf93f61d4d675d_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzYwNw_402b13c9-3fd8-4d0a-97af-76e2a87d72ac"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzcyMw_252a5c86-1cf1-469a-9961-8e317ebe9af4"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzcyMw_ba1205bb-d68b-494b-a816-d6a2232107b6"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzkwNg_7393720b-0d6f-4d8a-9281-6b8ad03f0aec"
      unitRef="shares">143000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i1121eb8e41764e2f885ce89e9efd6fca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMzkzNg_f1d89fed-041a-44b0-8861-b2ce058024ab"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDAyOA_e9a74818-8cf6-401b-a7a3-916461755496"
      unitRef="shares">172000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ieb5874cb29674dc6a3388b35641bbd9b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDA1OA_16cff105-a00c-4e76-a56f-8c9d0c561f66"
      unitRef="usd">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDExNQ_36c2cdc2-4a96-461d-85ae-6f546f513683"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDEyMg_74764809-4179-40ab-ab93-d9e303a492ee"
      unitRef="shares">53000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDIxNQ_7a7474e2-07cb-448d-8a9c-25d8705d9645"
      unitRef="usdPerShare">9.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDIyMg_64beba90-48a7-45f4-8245-8d166d86bc59"
      unitRef="usdPerShare">12.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDM1MA_118078ad-0350-4805-b4da-29d0b8460ad1"
      unitRef="usd">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDM1Nw_8ce8f226-2017-42c2-b66b-235c90de6434"
      unitRef="usd">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDQ0MA_7693342e-a91a-4e15-bd30-3592258a54ae"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i3ef58f79a23a4fd4902acc6146f97709_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDQ0Nw_106a1b6e-5b0c-4c45-8a81-010c8b6e6542"
      unitRef="usd">200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="ie46e49fee8fd42a2aab87f77ac2f490e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDU0MQ_2d94655b-0821-4b37-9844-309ab2465f9f"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i23b536a276514486b763bbc7d3034568_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDU0MQ_da3704bf-af65-451c-8cf6-f35ce92eedc9"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9ef0509b465a4ac38cc9efafd19b9daf_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDc2NA_de51bbb4-a0a9-41b8-9fab-76079cc6b3eb">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2dc49deb25cc408796443b55a640d385_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNDc3Ng_aa71af41-2103-408d-9d84-af4a907f29e1">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <natr:RestrictionPeriodForIssuanceOfShares
      contextRef="ic20e20adf95940ca8fd836f859de3b03_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTA4MQ_9eece792-fdf4-47e4-a244-d6119646e86f">P2Y</natr:RestrictionPeriodForIssuanceOfShares>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber
      contextRef="ifa9bd7370039495491ec25c69d400f48_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTEyNA_39213b8b-7dd8-46f7-838d-8ad71a5b6aa4"
      unitRef="shares">81000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber
      contextRef="ic152af38654942a3a96dcd69544a74da_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTEzMQ_fcc7b3c4-e57d-4cf3-b998-271c26589a37"
      unitRef="shares">88000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYyMQ_1703b996-1aa9-4d34-8cb5-a0d581141fa8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock unit activity for the nine-month period ended September&#160;30, 2022, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0055094229274cb5af4f7333a237c4ea_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMS0xLTEtMS0zNjUxNw_9a27d020-da9f-4a61-b82b-48d1394c402d"
      unitRef="shares">830000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0055094229274cb5af4f7333a237c4ea_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMS0zLTEtMS0zNjUxNw_34cdd2e0-a398-4ee3-9ca0-4ec3cecfc509"
      unitRef="usdPerShare">9.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMi0xLTEtMS0zNjUxNw_599d95f4-dc42-4419-af85-b40cc3add8fa"
      unitRef="shares">796000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMi0zLTEtMS0zNjUxNw_2f559de8-2d97-45e4-ab27-ca3ea8c24054"
      unitRef="usdPerShare">10.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMy0xLTEtMS0zNjUxNw_cd3f8d10-fc5b-4973-8587-fcc4ad3e003e"
      unitRef="shares">271000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfMy0zLTEtMS0zNjUxNw_975b69d0-2e12-4d51-ab8c-f7f86f05d932"
      unitRef="usdPerShare">9.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfNC0xLTEtMS0zNjUxNw_80e89d32-f80c-46e6-a376-d4128a40b668"
      unitRef="shares">329000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfNC0zLTEtMS0zNjUxNw_c6c6904f-7ccb-4848-b7ca-72c67e4f16dc"
      unitRef="usdPerShare">7.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1ae4407db5044cd68a2c86c97449360f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfNS0xLTEtMS0zNjUxNw_a9d230c1-ebca-4078-9a83-fb985862a379"
      unitRef="shares">1026000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1ae4407db5044cd68a2c86c97449360f_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RhYmxlOjUyZjliMGYzMmFiOTRjZmFhY2Y2NDU0MDAxMTM2NzI0L3RhYmxlcmFuZ2U6NTJmOWIwZjMyYWI5NGNmYWFjZjY0NTQwMDExMzY3MjRfNS0zLTEtMS0zNjUxNw_2ae83093-56ab-4a94-ad8a-d91558fbcf39"
      unitRef="usdPerShare">11.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i91a2ab72afe447f6bd57ea5e8874ca80_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTQyMQ_510b9a2f-4444-41cd-af96-6adcf96edca5"
      unitRef="shares">796000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie9f3b5b7f4ad40a29dec40525ebba7de_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTY5Mw_3ead21c4-35cd-4206-ae20-1cf87751c18d"
      unitRef="usdPerShare">11.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments
      contextRef="ie9f3b5b7f4ad40a29dec40525ebba7de_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTA5OTUxMTY0Njc2Mw_41362700-fae0-47f9-aac8-f75f8267f5df"
      unitRef="vestinginstallment">12</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie9f3b5b7f4ad40a29dec40525ebba7de_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTA5OTUxMTY0Njc2Ng_4377272a-b579-483c-828d-c35a6495c234">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9901ca354f7443948673dbff989dd14d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYyOQ_81b70dc4-d80f-4f05-a4dc-a833a8016b91">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i05187ed32f1a4459918c007aceb10282_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNTg4Mg_48327aab-e0c7-4728-a5a0-0b370af7516a"
      unitRef="usdPerShare">6.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1a19d8970b2543048df69222e0305ed8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODYyNA_87162f05-7836-4063-a795-0ba507aa1ca9">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i04dd1d0e30dd4749869d484b28d4c2f3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTA5OTUxMTY0Njc4MQ_a98ac090-23e2-4b73-955a-239845f58063"
      unitRef="usdPerShare">11.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i04dd1d0e30dd4749869d484b28d4c2f3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfMTA5OTUxMTY0Njc5OQ_c402568c-8da2-4ed5-93a1-2c3e95d94ce1">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <natr:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability
      contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNjYzNQ_5d7b16d7-5e9c-4ea1-bd92-586103d05eaf"
      unitRef="number">0.129</natr:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod
      contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNjkzMw_4416b93f-04db-4bc2-86aa-a25066ab96c0">P3Y</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="if1aa6de8d3384bec8195c0705cf1e5ee_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNjk2MA_67d0fa2c-5634-4d3b-96f6-df5131d6cf48"
      unitRef="number">0.501</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if1aa6de8d3384bec8195c0705cf1e5ee_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNjk4OA_6a3e08b4-83bb-4136-8023-45ea23557fc6"
      unitRef="number">0.033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i10c14c6b81e84c7b8f58f51625726416_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzExNg_a60abcde-8502-47ff-ab83-87c7d855b55d"
      unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i761305687fcc410da48c9004616a56eb_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzEyMw_4af53477-d180-4ed1-8931-87341b778dbd"
      unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzI2MQ_1764938f-37ad-4d30-b52d-f5ea781d6881"
      unitRef="usd">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iabe8b4b0a68d4a079325eda61ea70e86_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzI2OA_4b28cf0f-7588-4fad-8ce0-31efd8e6d32c"
      unitRef="usd">1600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i8dff8e40d0d240aa9a88877fdfd05209_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzQ0MA_68f0124c-3fe1-4f18-bfa7-2c37444fc617"
      unitRef="usd">3100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i523fb664c6924406a1e7680eb6501b9a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzQ0Nw_7394c437-7ced-49cc-b7ac-f19ea1b08207"
      unitRef="usd">1600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzU3OQ_64c410e7-8711-4706-9d03-96608d48a9b6">P0Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic317fd5637e24133b38464894a02a48a_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzcwMQ_3e02505a-3d1b-4242-9754-9051ba40898f"
      unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id8b227faac114cf89d93aacc27030ee3_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzcwOA_ee16b53f-ace7-4218-91aa-a6af5db70da8"
      unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaa5248e41f6f4304969ef1dca24c02cb_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzgzOQ_d7def513-e1a0-47e4-8bae-11b0ac07c9f9"
      unitRef="usd">700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if495bbb4e2364ea1b89e3ce85fd3847d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzg0Ng_189cc84a-5427-458d-b3a9-edebd7fbaa4f"
      unitRef="usd">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i7532a655100648398d64a5c418cefbd7_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfNzk4Mg_191e574d-e65a-4b47-8575-ecc696e2cf1e"
      unitRef="usd">1800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements
      contextRef="i70a0441a83334ed497f02da612fa9d1c_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODI0NQ_216364ee-9ba7-4ea6-869f-1edb65648b9e"
      unitRef="shares">80000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements
      contextRef="iabe8b4b0a68d4a079325eda61ea70e86_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81Mi9mcmFnOmU0ZDFjNDE3MTU3YTQxMWFhZGJiNDk3N2EwZmY0NTAwL3RleHRyZWdpb246ZTRkMWM0MTcxNTdhNDExYWFkYmI0OTc3YTBmZjQ1MDBfODI1Mg_1bb51b27-83b2-4669-98f6-5521d4cb3334"
      unitRef="shares">150000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk4Nw_4d6235db-3b1c-4d15-8e25-d8ddf38f7b93">Segment Information&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. The geographic segments operate under the Nature&#x2019;s Sunshine Products and Synergy WorldWide&#xae; brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reportable business segment information is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin (1):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other loss, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Service fees in China totaled $2.5 million and $11.3 million for the three and nine-month periods ended September&#160;30, 2022, respectively, compared to $5.2 million and $11.7 million for the three and nine-month periods ended September&#160;30, 2021. These service fees are included in selling, general and administrative expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September&#160;30, 2022 and 2021, as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets per segment is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMzk_48244272-4d4d-421b-b64a-c5e523f7c32a"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk4MA_c9b22425-465d-41ae-91cb-dd528ea20ba0">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reportable business segment information is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin (1):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other loss, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.&lt;/span&gt;&lt;/div&gt;(2)&#160;&#160;&#160;&#160;Service fees in China totaled $2.5 million and $11.3 million for the three and nine-month periods ended September&#160;30, 2022, respectively, compared to $5.2 million and $11.7 million for the three and nine-month periods ended September&#160;30, 2021. These service fees are included in selling, general and administrative expenses.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaffce26a8c8b429fb3267aa0f04b6886_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMy0xLTEtMS0zNjUxNw_e3bd4992-09ae-45d3-9a94-801cf8e2fff9"
      unitRef="usd">47878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d3acc32b97542e5a94dd4a3bb1b4cd7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMy0zLTEtMS0zNjUxNw_26c0aff6-9065-47c9-bb87-41be793795bf"
      unitRef="usd">48417000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6de094914c5f46db86d9dc44c155ea51_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMy01LTEtMS0zNjUxNw_05c66962-8936-438b-a1ce-d2b3524778a1"
      unitRef="usd">141370000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9597cde95214777a01076967abb5bfd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMy03LTEtMS0zNjUxNw_f9491e91-03c9-4e5a-ad5f-d51648f8da1a"
      unitRef="usd">127708000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01f17fd5fec04cceb20a25018feb023a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNC0xLTEtMS0zNjUxNw_bf1aca6c-3ed2-4c47-8bc7-7d55cad3a504"
      unitRef="usd">19328000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ee2afc6d0574fa68adf6928f3f7ca2e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNC0zLTEtMS0zNjUxNw_8bfb9688-da74-4b64-b079-0044a48bd00b"
      unitRef="usd">21813000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35fb57db9af244869c886dfc1addaba9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNC01LTEtMS0zNjUxNw_222be6bb-5edd-4219-a994-6ba056128a40"
      unitRef="usd">58204000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7f268d552ed4fd791df8fd022fc4127_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNC03LTEtMS0zNjUxNw_2140c635-9df4-4250-aa91-af95144a948d"
      unitRef="usd">65468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ca94f66cae0472e950944808843bf52_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNS0xLTEtMS0zNjUxNw_8ce5f869-01c9-4b89-8fc1-22ccb1545b02"
      unitRef="usd">31504000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0c54aef4fc24df184a67d7a6e8a4686_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNS0zLTEtMS0zNjUxNw_c6ebac35-2730-4a2d-968c-6799d77ee502"
      unitRef="usd">37738000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8bbc89738474e36a998144b3ab76005_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNS01LTEtMS0zNjUxNw_d017a763-73fb-41f7-bc2b-4b1a70d31537"
      unitRef="usd">101567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if64ed51372db4414b6b3e91b38ec9b38_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNS03LTEtMS0zNjUxNw_8c2cc130-e89a-4b06-b1c6-7486db4805e4"
      unitRef="usd">112872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i989dadafa5b04aa6983e589a0e3400b1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNi0xLTEtMS0zNjUxNw_d27d0a93-e6a9-4396-87e7-6cd8cb722ee5"
      unitRef="usd">5796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66f83106d3c64004a59b18515c555b70_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNi0zLTEtMS0zNjUxNw_e33d6755-0385-4b93-bb59-1bb522e20a4e"
      unitRef="usd">6778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icefc13a45af1427495b1821d0c2f7f72_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNi01LTEtMS0zNjUxNw_3394beba-d9a5-48df-a0ec-87a0cbac42c3"
      unitRef="usd">18020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9d15fce936b4a1393ca7b8ca3173e02_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNi03LTEtMS0zNjUxNw_f4d6b90c-f471-4b69-a8e7-abf419216d16"
      unitRef="usd">20097000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNy0xLTEtMS0zNjUxNw_f84f6b68-fa85-4bc8-82a4-5af0d64ccf1c"
      unitRef="usd">104506000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNy0zLTEtMS0zNjUxNw_a1d08674-5e5b-469f-aa03-b98600f1b40e"
      unitRef="usd">114746000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNy01LTEtMS0zNjUxNw_742516e2-d89d-44f2-b128-ae4fb81f1aeb"
      unitRef="usd">319161000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfNy03LTEtMS0zNjUxNw_79c3d2cc-63d8-4b53-8a03-d6a582d03cab"
      unitRef="usd">326145000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <natr:ContributionMargin
      contextRef="iaffce26a8c8b429fb3267aa0f04b6886_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTAtMS0xLTEtMzY1MTc_f18e3aea-3155-4fb4-9df9-b48d01e62b9c"
      unitRef="usd">21268000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i5d3acc32b97542e5a94dd4a3bb1b4cd7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTAtMy0xLTEtMzY1MTc_9c42d82f-f7e8-4e03-b9e0-01d693dbcac4"
      unitRef="usd">21421000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i6de094914c5f46db86d9dc44c155ea51_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTAtNS0xLTEtMzY1MTc_d2a194b2-9d01-4f2b-b95d-d30aba299dc8"
      unitRef="usd">64639000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="ie9597cde95214777a01076967abb5bfd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTAtNy0xLTEtMzY1MTc_6aa5be9e-7f03-4f8d-b3aa-ade123d49a74"
      unitRef="usd">55203000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i01f17fd5fec04cceb20a25018feb023a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTEtMS0xLTEtMzY1MTc_4353ecf3-0244-4e7d-b03e-3ddd2faf9880"
      unitRef="usd">7189000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i7ee2afc6d0574fa68adf6928f3f7ca2e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTEtMy0xLTEtMzY1MTc_cc9015ed-ee78-45e8-9e3e-b77eeb1504e9"
      unitRef="usd">6959000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i35fb57db9af244869c886dfc1addaba9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTEtNS0xLTEtMzY1MTc_0b24af82-97e6-4936-891d-7350946b86a4"
      unitRef="usd">18157000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="if7f268d552ed4fd791df8fd022fc4127_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTEtNy0xLTEtMzY1MTc_09718ff3-2282-4408-a154-21b0267700ff"
      unitRef="usd">20343000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i9ca94f66cae0472e950944808843bf52_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTItMS0xLTEtMzY1MTc_a8a06f5e-2929-41ce-a29c-65e0cbe3479d"
      unitRef="usd">10839000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="ia0c54aef4fc24df184a67d7a6e8a4686_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTItMy0xLTEtMzY1MTc_de886a14-0efd-408e-a204-c9e609f813ec"
      unitRef="usd">17193000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="id8bbc89738474e36a998144b3ab76005_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTItNS0xLTEtMzY1MTc_c33f5764-aa0c-4dbd-9371-18eb059e19a0"
      unitRef="usd">35858000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="if64ed51372db4414b6b3e91b38ec9b38_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTItNy0xLTEtMzY1MTc_e1ac049a-9f58-4aaa-a691-7a428f6f0571"
      unitRef="usd">48892000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i989dadafa5b04aa6983e589a0e3400b1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTMtMS0xLTEtMzY1MTc_8449cae3-d620-4537-9924-47e3bfeb295e"
      unitRef="usd">2508000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i66f83106d3c64004a59b18515c555b70_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTMtMy0xLTEtMzY1MTc_895cfda9-5d31-423f-88d6-42dea828e7ff"
      unitRef="usd">3961000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="icefc13a45af1427495b1821d0c2f7f72_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTMtNS0xLTEtMzY1MTc_ebbc1429-8bee-4cc7-bb8b-82b0b845bb8c"
      unitRef="usd">7703000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="ia9d15fce936b4a1393ca7b8ca3173e02_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTMtNy0xLTEtMzY1MTc_d6fb93ad-d841-40bf-b641-96885a43d9a3"
      unitRef="usd">11355000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTQtMS0xLTEtMzY1MTc_4d432713-d416-48f1-8ccc-da2b1cb0e87d"
      unitRef="usd">41804000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTQtMy0xLTEtMzY1MTc_d3e81e6b-8494-48a2-8141-a7c9ab0b4372"
      unitRef="usd">49534000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTQtNS0xLTEtMzY1MTc_35fe2fd8-1926-4456-977a-723a15e9fec0"
      unitRef="usd">126357000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTQtNy0xLTEtMzY1MTc_ba698cdd-90e1-45f1-9dde-086ab5fa765c"
      unitRef="usd">135793000</natr:ContributionMargin>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTYtMS0xLTEtMzY1MTc_a101e584-f248-4fa1-8be5-5e01594760ec"
      unitRef="usd">36792000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTYtMy0xLTEtMzY1MTc_757c77b1-122d-4ff5-9dcc-39016fc2222e"
      unitRef="usd">39528000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTYtNS0xLTEtMzY1MTc_417b1cd1-df1a-41f4-96c8-200adec8f8b1"
      unitRef="usd">114281000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTYtNy0xLTEtMzY1MTc_2b642fb1-78ca-442c-873c-c7100b1e0398"
      unitRef="usd">108666000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTctMS0xLTEtMzY1MTc_273bf534-7060-4baf-a386-78793ae187ee"
      unitRef="usd">5012000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTctMy0xLTEtMzY1MTc_022b3109-9dc0-4a3d-a65f-a5f230bf0b82"
      unitRef="usd">10006000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTctNS0xLTEtMzY1MTc_dff2c70e-f40f-45c6-a054-bbe14cdbacca"
      unitRef="usd">12076000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTctNy0xLTEtMzY1MTc_34c8f528-df70-400a-b2fc-43d814e55a1e"
      unitRef="usd">27127000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTktMS0xLTEtMzY1MTc_65588d1c-3d51-4b61-8843-94a58cb8df52"
      unitRef="usd">-2281000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTktMy0xLTEtMzY1MTc_4e92920c-08c1-4f9a-b87a-240919cb3200"
      unitRef="usd">-886000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTktNS0xLTEtMzY1MTc_7d929894-8fad-4392-b33d-71232a17be79"
      unitRef="usd">-3037000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMTktNy0xLTEtMzY1MTc_a2421a40-c19e-4c8f-80ae-3c5b0f5f3f6b"
      unitRef="usd">-2290000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMjAtMS0xLTEtMzY1MTc_74d26927-fd4a-48a4-bd1b-6cda78a5a4bb"
      unitRef="usd">2731000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMjAtMy0xLTEtMzY1MTc_a7eb8410-d357-48a7-a20a-01eed4dfc40f"
      unitRef="usd">9120000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMjAtNS0xLTEtMzY1MTc_245c116c-584f-4628-b069-03fe6214ea3c"
      unitRef="usd">9039000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjkwNjU1YWIwODNhMjQ5ZWM4YmUwMGU4OTYzMzllYzNkL3RhYmxlcmFuZ2U6OTA2NTVhYjA4M2EyNDllYzhiZTAwZTg5NjMzOWVjM2RfMjAtNy0xLTEtMzY1MTc_2664c2d4-9b07-484a-9f65-0901a6d26a70"
      unitRef="usd">24837000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id9789e91bbdb4bb3981bfa676460e65f_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTE3NQ_d2817c61-bc52-4dc6-9787-58494add2474"
      unitRef="usd">2500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iad4ac3adcab842aa92dac9e2832e0d49_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTE4Mg_f302bf72-42c8-4e79-a36b-0d7ca34a85cb"
      unitRef="usd">11300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5c2ceb81578b43c2a003d38ceeea837f_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTI0Ng_4f8af7dc-c2c7-486c-bb21-a48580938b15"
      unitRef="usd">5200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2f7fca25b7e64744a88843d142be5e47_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTI1Mw_4bffb37b-99ec-41cd-bc9a-fee393d1a0ee"
      unitRef="usd">11700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk4OQ_d09233c2-fcc6-40e7-9cd8-2b0497e0b9d7">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September&#160;30, 2022 and 2021, as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43ce284ec08d45a8b2f4eaf1d21af325_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfMy0xLTEtMS0zNjUxNw_8203899e-28d4-4bc5-aa6a-082704cb59e5"
      unitRef="usd">29077000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f7edfa74c3a4facaef4c6ce7195e3a1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfMy0zLTEtMS0zNjUxNw_cbc1f28d-ac0e-4555-a068-5a461999424b"
      unitRef="usd">34960000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7890d7b2c60340b3922736cdbf24446a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfMy01LTEtMS0zNjUxNw_76e5a462-cdf1-46b5-9dbb-ca6d11908317"
      unitRef="usd">93789000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac3dd237480d4bb2a35fab25b753dc3b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfMy03LTEtMS0zNjUxNw_0081cf38-1661-42a7-9a0d-3ed355ab3a11"
      unitRef="usd">104258000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c0a4dbff9664147803b502780897f38_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNC0xLTEtMS0zNjUxNw_1545420b-a9ba-4f74-9eaa-58f12e6e6ecc"
      unitRef="usd">14967000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b416cf57d384a54804362b64dbbf5ea_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNC0zLTEtMS0zNjUxNw_9702c009-2e91-49f8-ae34-9cc5e81ed8f2"
      unitRef="usd">15985000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ecb353578384ec8a536a7a833c0fc5c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNC01LTEtMS0zNjUxNw_d8d3b01a-67df-4b39-a0c5-fdf593e98e9f"
      unitRef="usd">43085000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14a40364c7f64f5b80d862226b34ff6a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNC03LTEtMS0zNjUxNw_abba4f0a-466a-405d-a433-93906cf6ea2d"
      unitRef="usd">48340000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic001fa920873448dbc6ef54932a229ce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNS0xLTEtMS0zNjUxNw_8ec36ef1-5689-4bed-b7c6-a782c07ff747"
      unitRef="usd">13465000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9960683c96654f1ebd545850683426af_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNS0zLTEtMS0zNjUxNw_003a6bd7-5848-467a-b352-fffd18b7cb5c"
      unitRef="usd">7361000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7057434687ff46f199ae8cac13391907_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNS01LTEtMS0zNjUxNw_0afa5b85-498b-4cfd-8bf5-3f476394d493"
      unitRef="usd">35148000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i746ecd7e625c4144b3062ca451baff75_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNS03LTEtMS0zNjUxNw_7f3b373f-c063-4934-ac45-bbef0f86f5be"
      unitRef="usd">14860000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34383a427ad9404f8336487647135d64_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNi0xLTEtMS0zNjUxNw_724dbfbd-a0a1-4357-bae2-9ae79fc825e3"
      unitRef="usd">46997000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i031ea41430044721be426b9e153f6d4e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNi0zLTEtMS0zNjUxNw_69d66972-f5ea-41ec-9506-ca71253b5a3b"
      unitRef="usd">56440000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb7cc106017f4bf790288d1410c6604f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNi01LTEtMS0zNjUxNw_407920a1-a4d5-4275-acf1-dc79f3363845"
      unitRef="usd">147139000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7aa79c6bd1146a299f812340a1c9843_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNi03LTEtMS0zNjUxNw_fbc8ce2a-c903-4a41-9a22-dd70e143e4ea"
      unitRef="usd">158687000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNy0xLTEtMS0zNjUxNw_d86abe5f-f75b-4fa6-8655-6149a09aa579"
      unitRef="usd">104506000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNy0zLTEtMS0zNjUxNw_42fd839d-dcf6-4d4c-b419-7e759f3166d4"
      unitRef="usd">114746000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNy01LTEtMS0zNjUxNw_1f55796f-97b2-4ca9-8da6-cf61c3676a33"
      unitRef="usd">319161000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQxNWU3ZjIwYTY5ODQ4NzRhODIxZDU0ZTczOGFiOGUyL3RhYmxlcmFuZ2U6NDE1ZTdmMjBhNjk4NDg3NGE4MjFkNTRlNzM4YWI4ZTJfNy03LTEtMS0zNjUxNw_09ea6b49-aa5a-43dd-a3d4-5602f117c7ce"
      unitRef="usd">326145000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk5Ng_cb461b7b-0ecd-4ae0-a2e4-cb5c49f7114f">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice4ea04852d949b7b25b5dff1ff385c0_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMy0xLTEtMS0zNjUxNw_de810dd6-e6c3-4228-bc7c-5957c3829827"
      unitRef="usd">14705000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b447bb6325c4a93813bee7f6470e956_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMy0zLTEtMS0zNjUxNw_41ff2f10-199c-4a24-8076-6bcdf8c3ccdc"
      unitRef="usd">13150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a38b38d33164e7f8b12740fd234f511_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMy01LTEtMS0zNjUxNw_92f8e684-cd45-4e41-b4e9-8732cbfc787e"
      unitRef="usd">40010000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6afa9b57d0c8439a97666baea62606a5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMy03LTEtMS0zNjUxNw_e74f1a0e-e3d2-4b9c-bedc-95946b0bb23c"
      unitRef="usd">37140000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1422bc583463406ab563aaeac2967f11_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNC0xLTEtMS0zNjUxNw_cf7971b0-7887-44d4-a078-83bec79f3564"
      unitRef="usd">654000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i271947650c0641aa8199e5d38ec3dc01_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNC0zLTEtMS0zNjUxNw_e5eb58c0-81f2-4d54-910b-5d6411bf79ae"
      unitRef="usd">463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia86d933ddea04f8fb10973d2824e48fa_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNC01LTEtMS0zNjUxNw_c3a3a386-abd3-4101-bbc5-4103f435be82"
      unitRef="usd">2779000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f271afb02914124b483854f23bca344_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNC03LTEtMS0zNjUxNw_7cb774fe-a24e-4f1a-ad9b-185250974341"
      unitRef="usd">1048000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae9278b469d041fc8fff0e48fbaf4ca2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNS0xLTEtMS0zNjUxNw_abffd892-d443-4c6f-9e59-dd88d24966bb"
      unitRef="usd">14626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e611910bb3b4d8ab7ed214bddf977b3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNS0zLTEtMS0zNjUxNw_e06bd56a-d314-465e-9039-e44042f142f4"
      unitRef="usd">13018000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6db6b432f4df49c1b4c2fca343cba1bf_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNS01LTEtMS0zNjUxNw_11ab8712-5226-4f4b-8181-b4ae7f56543c"
      unitRef="usd">41498000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if69d793ea3634ef3bc0a0ae9b4bcb442_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNS03LTEtMS0zNjUxNw_ae63295e-fe51-4438-a825-d7ccdca3fd03"
      unitRef="usd">35181000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d5784c20ae64613902d57eaa1241f9a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNi0xLTEtMS0zNjUxNw_eb71ed0f-ae70-4164-a7f3-3c94b89a6e45"
      unitRef="usd">8599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idecec013f09941a7ae837474c48050ec_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNi0zLTEtMS0zNjUxNw_d4c91fa7-72f7-4f85-af82-4925922a6f3f"
      unitRef="usd">10427000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if691899efd02473bbc07a3634d9602b9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNi01LTEtMS0zNjUxNw_b1eebd94-ed3b-46b4-bec1-54befb568ec7"
      unitRef="usd">28625000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a1a086a005d481397a9ec0c504d08f3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNi03LTEtMS0zNjUxNw_6f8809dc-70bc-4624-8df4-54d1a74c81e8"
      unitRef="usd">25045000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07a9c9b9a5d64082b24c3ce6b7f77d2a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNy0xLTEtMS0zNjUxNw_be436b56-1f2e-46ef-9387-aeca1e663589"
      unitRef="usd">2758000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if666c3e591d34e419fe5cea9d63c76d0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNy0zLTEtMS0zNjUxNw_543faba4-ed11-49fc-b190-afaace81faeb"
      unitRef="usd">4201000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id82dd7fc19f2499ab5018e7a7327d0f2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNy01LTEtMS0zNjUxNw_8f94825b-7661-4b85-8267-a9391ee0fd13"
      unitRef="usd">7384000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3fc9b884d79481ba64714a98c37701b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfNy03LTEtMS0zNjUxNw_16c82f35-e447-4f55-893a-4b699f21d8be"
      unitRef="usd">12015000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i455e487fd71d4e1f9f70e1f7708b649d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOC0xLTEtMS0zNjUxNw_837aa635-4ec8-4175-9450-9b718c403933"
      unitRef="usd">6536000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2febb6991fd410a9e2bb3ad36bfa7b0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOC0zLTEtMS0zNjUxNw_7b7efe01-d90e-4146-840e-5ae9de1a2e76"
      unitRef="usd">7158000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766f81ea59e3447c8731e8067d14378c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOC01LTEtMS0zNjUxNw_5151b92e-687d-4505-ab33-54ef86f49c66"
      unitRef="usd">21074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93b388a0ba69473fb479c83bba1002bc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOC03LTEtMS0zNjUxNw_cfdbe453-c957-40a9-9eba-95a406b7c447"
      unitRef="usd">17279000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaffce26a8c8b429fb3267aa0f04b6886_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOS0xLTEtMS0zNjUxNw_83871208-c723-479b-9c01-0f917ae44387"
      unitRef="usd">47878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d3acc32b97542e5a94dd4a3bb1b4cd7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOS0zLTEtMS0zNjUxNw_86175285-571e-466c-9a95-3449024d7acf"
      unitRef="usd">48417000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6de094914c5f46db86d9dc44c155ea51_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOS01LTEtMS0zNjUxNw_202150f0-0de8-4b5f-9446-a7b83a244853"
      unitRef="usd">141370000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9597cde95214777a01076967abb5bfd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfOS03LTEtMS0zNjUxNw_d2504bab-7594-4832-8d97-d3fea46b7e08"
      unitRef="usd">127708000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0d2a86b74014923a32749b21e57e32b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTEtMS0xLTEtMzY1MTc_f9c6aa7a-8d34-400b-8912-57f18e144fb4"
      unitRef="usd">8638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id811e29bb810469fb1c0ff8a40d5baca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTEtMy0xLTEtMzY1MTc_e33652db-ce33-46d5-b9e1-c3d5b5bfb34d"
      unitRef="usd">9308000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i110b96df81934c4a895b7332653dfdfa_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTEtNS0xLTEtMzY1MTc_0b29e964-ae2a-4084-a327-a18e84b60296"
      unitRef="usd">25162000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb2292964ed74f2c93618691aed0bf17_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTEtNy0xLTEtMzY1MTc_113cdf42-12d7-4aa9-ac58-d691f7ab62f9"
      unitRef="usd">28447000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e9fedb6d37e44a48ae4c2c1a283eced_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTItMS0xLTEtMzY1MTc_033ed2a2-8627-43bf-846b-a7f190cfe517"
      unitRef="usd">1899000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8027c00bfbb440189c17c3cef6fd9b0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTItMy0xLTEtMzY1MTc_328cfd2b-4b18-43be-92c5-f1385533b9fc"
      unitRef="usd">2285000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92940ae0daed421bbc0a168e8b5e7afd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTItNS0xLTEtMzY1MTc_530e2dd4-cb3c-4820-87af-54dc04a02f56"
      unitRef="usd">5973000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida2f5eb698ef4d4497ce138f3923d2a9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTItNy0xLTEtMzY1MTc_cec3966f-66f7-4c57-b502-8f71ffd5f9a0"
      unitRef="usd">6119000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8871c124bfc4ab59b69f58aa8ac2306_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTMtMS0xLTEtMzY1MTc_80ccc27b-da65-41f8-810c-25c5861c7949"
      unitRef="usd">2385000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8f1af7974d3467f8810ee1a2c00cef0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTMtMy0xLTEtMzY1MTc_d4f44aba-e114-4981-8a04-be8f8379f0ee"
      unitRef="usd">2774000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i229bd20fdbd341b1a80e3c4e77eccf82_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTMtNS0xLTEtMzY1MTc_46d113a8-def2-4676-97cb-db1cac7d601a"
      unitRef="usd">7168000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i705c1e9af35d4a6e8814be31f200cad7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTMtNy0xLTEtMzY1MTc_7ffa3689-cb54-4442-a59d-185f8f7a760e"
      unitRef="usd">8602000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91e4ef35e1824ccd882bf7fff758fffa_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTQtMS0xLTEtMzY1MTc_461e42c5-048e-4dc0-9004-0c6f2c957dc7"
      unitRef="usd">4849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2403109edfcf49318ed206f1f7e61b38_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTQtMy0xLTEtMzY1MTc_842fbe7f-42c3-47f7-83be-8a94c3945e04"
      unitRef="usd">5700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b7f893932fe4cdfa20944e08ccd08b2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTQtNS0xLTEtMzY1MTc_170a0517-ae01-4c69-9e93-1f5ed9ab5282"
      unitRef="usd">14921000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15464f06de2947f184afb9420f0a1d8f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTQtNy0xLTEtMzY1MTc_7a2977eb-1620-4ab6-9fa5-3730087a7b2f"
      unitRef="usd">16807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d33ddcece9a4459a1d275467de416cc_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTUtMS0xLTEtMzY1MTc_8f9f4397-d40f-4fe4-ba36-d57e4bd0ccd8"
      unitRef="usd">1087000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f841c8711ef4ed49fbf8d826bc99285_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTUtMy0xLTEtMzY1MTc_2df61b20-9251-432a-9871-d1563fd787ca"
      unitRef="usd">1167000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2489b6c3524e4e7b9c1a4e326997805c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTUtNS0xLTEtMzY1MTc_49cddcca-1e91-4869-bd64-9b482186cec7"
      unitRef="usd">3529000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic089f06dc3df44b08a41d0888be18ae8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTUtNy0xLTEtMzY1MTc_225b9da3-189b-4813-978c-84b4f009fff8"
      unitRef="usd">3592000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i422653a3b8d4475789d80957e8caed9d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTYtMS0xLTEtMzY1MTc_320664a4-e9f1-41e1-a9af-65378e27bcf1"
      unitRef="usd">470000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia31f4302be1d4bfba2a29bd5573f373f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTYtMy0xLTEtMzY1MTc_411f1864-c4a9-4a49-acec-2db7d91c6586"
      unitRef="usd">579000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e4d19f07f584072a8e2b404743234e4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTYtNS0xLTEtMzY1MTc_ba35effa-e78b-44d2-8e48-a24ae0c8fbae"
      unitRef="usd">1451000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e8031c49d064ec995642d0179e0484b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTYtNy0xLTEtMzY1MTc_5017d0af-89a0-4a76-a7f9-413115fe6145"
      unitRef="usd">1901000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01f17fd5fec04cceb20a25018feb023a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTctMS0xLTEtMzY1MTc_23bd185e-987e-49d1-8895-58256e5dc70a"
      unitRef="usd">19328000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ee2afc6d0574fa68adf6928f3f7ca2e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTctMy0xLTEtMzY1MTc_598e6d2c-9afc-4cb6-8d7e-2c3026c89847"
      unitRef="usd">21813000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35fb57db9af244869c886dfc1addaba9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTctNS0xLTEtMzY1MTc_6cc40417-f62f-4a34-9892-5896c45f5cc9"
      unitRef="usd">58204000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7f268d552ed4fd791df8fd022fc4127_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTctNy0xLTEtMzY1MTc_c88ce5b0-f75e-4790-ae5c-b6f3f505f45f"
      unitRef="usd">65468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16eb866672624d548d5ec50e5c190e14_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTktMS0xLTEtMzY1MTc_949e06e2-abd9-4dac-bfcc-5639607b16fd"
      unitRef="usd">14241000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc90dbbf82d04aea8f8e7d67a1c1b202_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTktMy0xLTEtMzY1MTc_679eb7ce-511e-44d1-bb58-e5072789ad53"
      unitRef="usd">16573000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i601e923be0e041b98944eb6ce61046a8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTktNS0xLTEtMzY1MTc_457d2830-ba5c-49eb-9065-114415439307"
      unitRef="usd">44509000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88024d56c5604272b98bf435e9880a43_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMTktNy0xLTEtMzY1MTc_54db5350-a551-4416-8ff4-8f455c38bee0"
      unitRef="usd">49192000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9795542b5d774f05aa511f90de376487_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjAtMS0xLTEtMzY1MTc_9ca71e4b-1183-429a-8f3f-54418e55382f"
      unitRef="usd">3546000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e26d0a6ff7f45ada98e9349e001bbcb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjAtMy0xLTEtMzY1MTc_bbda2f79-49eb-4175-bcde-a83283ff95cf"
      unitRef="usd">5056000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib25551ab7ec84b1bb4cba21a91fe3ed1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjAtNS0xLTEtMzY1MTc_9079f2a7-b344-4fb6-a0da-7f12e3c3948c"
      unitRef="usd">12479000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16954cbf01f143ceb864705c2fa0aa79_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjAtNy0xLTEtMzY1MTc_fc36561f-1e87-4a7b-9a88-3a22873419cc"
      unitRef="usd">14031000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c51dace4af44a7ca2837c323c420d65_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjEtMS0xLTEtMzY1MTc_ba9f165e-89bb-4bdb-bd57-1efa56ad9cce"
      unitRef="usd">3427000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81d52a6ed02545c9901d63a06dde0c2d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjEtMy0xLTEtMzY1MTc_ca94f61f-f6f3-4104-ad4c-253d0e9ac209"
      unitRef="usd">4171000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46f7036575f84653b7c99e0bfb760ad9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjEtNS0xLTEtMzY1MTc_a534bc96-3834-4396-ac3f-9c3330289d3a"
      unitRef="usd">11162000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id685627d492845129ed93f47b2600c71_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjEtNy0xLTEtMzY1MTc_acaa39f0-96e2-49ed-a3d1-88e4bd3bff55"
      unitRef="usd">12406000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8828b4bb2ca4a78bc626f16aaba9fb6_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjItMS0xLTEtMzY1MTc_2b6bb986-d60e-41e7-b008-23f84c015810"
      unitRef="usd">8096000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccd76854b160450aaf7d25c1de52f345_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjItMy0xLTEtMzY1MTc_a74973ab-3f63-446b-8a1a-8f7f8e898e0e"
      unitRef="usd">9079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i973e94e3c4404183a5aafd47340dac63_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjItNS0xLTEtMzY1MTc_cee14714-80e9-4e31-a842-d6dbb62ad089"
      unitRef="usd">25734000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i326578d04941458389bc907b4ad873c0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjItNy0xLTEtMzY1MTc_26458404-e308-48e0-bc00-afc2f8f454a5"
      unitRef="usd">28558000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e200f708ff842429882977de66a40cb_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjMtMS0xLTEtMzY1MTc_3483d100-f59f-4452-bba8-de9954498cdb"
      unitRef="usd">1397000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6450b3e52c24654b5a6cc4658015a1b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjMtMy0xLTEtMzY1MTc_9bda2067-0031-476e-b3ef-53c8c28551d9"
      unitRef="usd">1978000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5664bf6fe1c74422abdd683652227653_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjMtNS0xLTEtMzY1MTc_76c569bf-b530-4b62-9a50-f141ef6cb24f"
      unitRef="usd">4961000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f174cab779147c29b714f2811393f87_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjMtNy0xLTEtMzY1MTc_e70a741e-e501-4924-9e1a-ea413ebe5d4e"
      unitRef="usd">5631000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d25faa8b14c4291be6d757f80e48839_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjQtMS0xLTEtMzY1MTc_b1054874-e5b9-4b84-86e5-e4f507a2e0f3"
      unitRef="usd">797000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i328dfba4c23f4457928a6cdb96fc8f77_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjQtMy0xLTEtMzY1MTc_16918aa0-7df4-4c99-b0f3-fea768d50e01"
      unitRef="usd">881000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee902b6bcd8140a6bcd5753dea705623_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjQtNS0xLTEtMzY1MTc_25955dfe-e0b1-4ef3-9b9f-e181253385f6"
      unitRef="usd">2722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0380da3a0fc43dabab9b5d91973518b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjQtNy0xLTEtMzY1MTc_df015fab-f854-4b80-8427-55e7a46cff1e"
      unitRef="usd">3054000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ca94f66cae0472e950944808843bf52_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjUtMS0xLTEtMzY1MTc_2ccd9dd7-a1ff-435b-b3bf-0f28928a8c87"
      unitRef="usd">31504000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0c54aef4fc24df184a67d7a6e8a4686_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjUtMy0xLTEtMzY1MTc_9307e60a-5da6-4629-8b7d-a60612d48dae"
      unitRef="usd">37738000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8bbc89738474e36a998144b3ab76005_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjUtNS0xLTEtMzY1MTc_32ae4280-7a54-431b-beb7-1c942242baab"
      unitRef="usd">101567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if64ed51372db4414b6b3e91b38ec9b38_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjUtNy0xLTEtMzY1MTc_34d08d4e-e5a7-49af-916f-4c525945f1a6"
      unitRef="usd">112872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7763e9ad44b443bf8f1343ad714748ad_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjctMS0xLTEtMzY1MTc_3f667ccf-1040-44d2-b3c1-4dfd3bbb6253"
      unitRef="usd">1597000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09258a1dafea4f46913ce7064e9df669_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjctMy0xLTEtMzY1MTc_3b353c0f-cce4-4fbe-8fb1-ca014c0b0b5f"
      unitRef="usd">1959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if881a438f54d41fdbca0d3ae23ae6f96_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjctNS0xLTEtMzY1MTc_d0c23d6d-a590-454c-95d4-93351bb52a86"
      unitRef="usd">5012000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8ceb2715c3147c3a1acd033f373b6f7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjctNy0xLTEtMzY1MTc_8672bcef-ca4b-4512-ab0f-79e1e293b0f6"
      unitRef="usd">5807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5641230f75e947e3b420ea68cb7362a5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjgtMS0xLTEtMzY1MTc_c06f5e9d-ccda-4444-9563-50c85cc1eb57"
      unitRef="usd">709000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d3e4239b05749efb73231210fcd5b18_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjgtMy0xLTEtMzY1MTc_5bab8022-9f5b-4a95-bb1c-d8f24e2a611a"
      unitRef="usd">806000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ff533dd32af4803adfde1b7642cb050_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjgtNS0xLTEtMzY1MTc_25ed87da-8a90-466b-8ab9-85a752f2db45"
      unitRef="usd">2225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22b7264ca2e0467e95df7299dce5077d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjgtNy0xLTEtMzY1MTc_a7019506-f4fa-4ca2-b3a9-008d42511d3c"
      unitRef="usd">2314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54595879e3a144e9984de9671b792908_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjktMS0xLTEtMzY1MTc_ff76d294-47b1-4c16-bc1e-2976a64a3267"
      unitRef="usd">438000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f54d1d04d5442bfbd655e919fea5146_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjktMy0xLTEtMzY1MTc_1d1f5834-ab12-4ba8-9cd6-0392c2951b6c"
      unitRef="usd">448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66719a00cb6a489eba77f2f4f2fad567_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjktNS0xLTEtMzY1MTc_3f17d745-9a66-4d19-9ab2-ea012ce7260b"
      unitRef="usd">1250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia834fba69cf84a55bcbbac80c88e2afe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMjktNy0xLTEtMzY1MTc_9d5070ae-ebdb-4f7e-aa98-bd3b477847c5"
      unitRef="usd">1351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c1f33dd8d78416888f9868e6b210ee4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzAtMS0xLTEtMzY1MTc_9c557331-94ba-466e-a45b-4a48dd1aa87e"
      unitRef="usd">2569000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic071da5568ec49dba654382b69827d3a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzAtMy0xLTEtMzY1MTc_b943eea7-a4ea-42b0-ba34-ed500b25c3a9"
      unitRef="usd">2941000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia26db1a48ab045ff967ff61767510615_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzAtNS0xLTEtMzY1MTc_fa94dae8-7f10-4a78-a9a1-a8757e5eaf07"
      unitRef="usd">7961000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40a63ab18aa54729a20e2ec4a9991db1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzAtNy0xLTEtMzY1MTc_df870aff-1198-41c3-bf15-d0ac351fc3d7"
      unitRef="usd">8813000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37724458b90a4f009836dd15510c28d2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzEtMS0xLTEtMzY1MTc_30ca2e7a-7fe7-4af8-8dd5-b8520f413809"
      unitRef="usd">329000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18896a1ab1614d4fbd39660918fa2ea5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzEtMy0xLTEtMzY1MTc_2dadf52e-a1f7-4fe3-b174-b3d944bf8699"
      unitRef="usd">406000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82fb728c64d94cd9a7821fd5b723bcbc_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzEtNS0xLTEtMzY1MTc_5ddb88cd-e4cf-4603-84f0-eb84f7802d7d"
      unitRef="usd">1050000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3712db2c199b49b3b7c8d62c7dea3e2c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzEtNy0xLTEtMzY1MTc_92503570-36b2-430e-bb37-7eba3e77351e"
      unitRef="usd">1149000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5143d898f89c4757b88ba36166facb40_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzItMS0xLTEtMzY1MTc_e0b98662-5689-4d3d-ad3d-f22eb7df789c"
      unitRef="usd">154000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if34568f0ea034fd888a5237c3a1cb09b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzItMy0xLTEtMzY1MTc_ee387540-9288-409d-a237-a1f641b1365b"
      unitRef="usd">218000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a28ef0b4677478f8f5027325b718a83_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzItNS0xLTEtMzY1MTc_be01481b-2919-4e25-b6d5-57702f2a3e48"
      unitRef="usd">522000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b008c611ecb4419800960c8e592d0ad_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzItNy0xLTEtMzY1MTc_7cc671c0-e9f4-47e1-80da-cfbb6fb143f0"
      unitRef="usd">663000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i989dadafa5b04aa6983e589a0e3400b1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzMtMS0xLTEtMzY1MTc_8e3f8508-6b2b-4188-95a1-36e6997267ae"
      unitRef="usd">5796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66f83106d3c64004a59b18515c555b70_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzMtMy0xLTEtMzY1MTc_935ef977-71fd-47f0-84dc-430476dd6ca5"
      unitRef="usd">6778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icefc13a45af1427495b1821d0c2f7f72_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzMtNS0xLTEtMzY1MTc_66c1c196-842d-41f6-bd0c-149065362587"
      unitRef="usd">18020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9d15fce936b4a1393ca7b8ca3173e02_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzMtNy0xLTEtMzY1MTc_bb4c5db7-2f12-4f0b-860e-b481d24cbb5e"
      unitRef="usd">20097000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzQtMS0xLTEtMzY1MTc_5d107929-542f-432d-b69b-88b2ac0537d3"
      unitRef="usd">104506000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzQtMy0xLTEtMzY1MTc_2a2ebc40-e418-4363-b60d-e994439e2898"
      unitRef="usd">114746000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzQtNS0xLTEtMzY1MTc_d6517a73-ce39-4cd8-816f-3589ae201022"
      unitRef="usd">319161000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjQ0OTJlNDAxMTg2ZDQ0YzA5NTU5YzQzOTM2ZjVjMzZkL3RhYmxlcmFuZ2U6NDQ5MmU0MDExODZkNDRjMDk1NTljNDM5MzZmNWMzNmRfMzQtNy0xLTEtMzY1MTc_2b70f284-6fb5-491c-8f42-d0fc479a06be"
      unitRef="usd">326145000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk4Mg_a73bc511-3ad4-4f18-8bfb-62dc899bac12">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5ba0114f77e84101866720c25f0493b7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfMi0xLTEtMS0zNjUxNw_59250543-7409-422f-8859-05eb703f63a2"
      unitRef="usd">43886000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i27b314b15d654ad785f11accf7d8aded_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfMi0zLTEtMS0zNjUxNw_40dfb142-4edc-4264-97db-6ca277f8bc3e"
      unitRef="usd">46595000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie0a4aaaf217b48c082080afab03641e6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfMy0xLTEtMS0zNjUxNw_9f297dbd-3171-4d8b-8420-3b90ce6d0bcb"
      unitRef="usd">3468000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icebd38c2c3754ea4936025826c0e61e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfMy0zLTEtMS0zNjUxNw_db603392-4d8c-45cf-a7af-677dfb8ebb68"
      unitRef="usd">4262000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfNC0xLTEtMS0zNjUxNw_9e258ec0-206a-482e-a95b-f72afcda7837"
      unitRef="usd">47354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjllYWVkZjdlNTkwODQ2ZmFhZTdhZmFiMjY1NTMwY2ZlL3RhYmxlcmFuZ2U6OWVhZWRmN2U1OTA4NDZmYWFlN2FmYWIyNjU1MzBjZmVfNC0zLTEtMS0zNjUxNw_e48eda1c-5f57-4745-b7fc-7b3526bcf787"
      unitRef="usd">50857000</us-gaap:PropertyPlantAndEquipmentNet>
    <natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RleHRyZWdpb246NWUxNzNmMTQ0NWFkNDI1ZGI3ZjZiZjg1OWQ5ZmNmM2VfMTk5Mw_5d4c2a2c-4b3d-48cc-8195-684df0959985">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets per segment is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock>
    <us-gaap:Assets
      contextRef="i5479a522979746c0beefbf88acbfc76c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfMi0xLTEtMS0zNjUxNw_a4969297-7800-4fe1-8328-fadb484ec221"
      unitRef="usd">89570000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2d33f22f45f044fdb3c35e22eacd0d4d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfMi0zLTEtMS0zNjUxNw_4e8fbcf1-c5e2-4bcf-90d5-b07720f6e78f"
      unitRef="usd">104659000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ief2efe54ca2e4f2dbc51a62ceca74009_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfMy0xLTEtMS0zNjUxNw_e1c8de7b-7fca-4037-ad14-04f6911a902b"
      unitRef="usd">16872000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i62f9fe04c4724f8d8703c8915a244329_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfMy0zLTEtMS0zNjUxNw_48ece896-66fd-4aaa-873c-1c4a279f897b"
      unitRef="usd">15486000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia728a540cb63450d8fe3503583cad26d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNC0xLTEtMS0zNjUxNw_4665504c-8529-405a-b604-9eede6108842"
      unitRef="usd">110087000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie641fbd2f6974546af07155f94734fbc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNC0zLTEtMS0zNjUxNw_fc8201a2-017f-427e-8c42-ee41b6b87b37"
      unitRef="usd">131207000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i98381a37664e48548eeae68619c1ae03_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNS0xLTEtMS0zNjUxNw_73762045-6cbf-439d-b3ca-d5c2d67399de"
      unitRef="usd">6979000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia9c16e0b053f4d47b09be402979af494_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNS0zLTEtMS0zNjUxNw_4ca1a4f5-e525-485a-ac9c-5fa3662386b6"
      unitRef="usd">7522000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNi0xLTEtMS0zNjUxNw_cdcd97a3-8838-4bb0-b9d4-6a46934fd5d5"
      unitRef="usd">223508000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF81OC9mcmFnOjVlMTczZjE0NDVhZDQyNWRiN2Y2YmY4NTlkOWZjZjNlL3RhYmxlOjhlYjQ1NjZiYWY5MDRlMDU4MTU2NWQxNWIzODk3NjU5L3RhYmxlcmFuZ2U6OGViNDU2NmJhZjkwNGUwNTgxNTY1ZDE1YjM4OTc2NTlfNi0zLTEtMS0zNjUxNw_fa0078c4-a304-40d8-be53-ec507de0b8f9"
      unitRef="usd">258874000</us-gaap:Assets>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMjEzMA_4255a8f1-cac1-4685-9518-20a915d498a6">Income Taxes&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 92.7 percent and 40.2 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. For the nine months ended September&#160;30, 2022 and 2021, our provision for income taxes, as a percentage of income before income taxes was 117.0 percent and 34.0 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate and the U.S. federal statutory tax rate for the three and nine months ended September&#160;30, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets for which we do not expect to receive a benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate and the U.S. federal statutory tax rate for the three and nine months ended September&#160;30, 2021, was primarily attributed to an increase in tax liability associated with transfer pricing adjustments, non-deductible executive compensation, and net unfavorable foreign tax related items, partially offset by favorable deductions for stock compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate for the three and nine months ended September&#160;30, 2022 compared to September&#160;30, 2021 is primarily caused by recording a valuation allowance in the current period against deferred tax assets for which we do not expect to receive a benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our U.S. federal income tax returns for 2018 through 2021 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2016 through 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, we have accrued $0.2&#160;million and $0, respectively, related to unrecognized tax positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMTQ0_2693437b-a716-4e64-b2bd-988a3d8b670c"
      unitRef="number">0.927</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5bae74f5e8e34ab091e422ebc47b02c8_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMTUx_9c97d899-4b4a-47a0-a9b7-d148f2c0535c"
      unitRef="number">0.402</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMzQ3_f29d5720-640c-442f-8911-67d532888e3f"
      unitRef="number">1.17</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5e5b7f325a374195a547054c530354da_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfMzU0_bf75c359-938b-459b-8b04-f1da9265f607"
      unitRef="number">0.34</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id5fbf276129e47918eed3c1199ae0b7f_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfODc5NjA5MzAyOTIzNg_11743d24-1f02-418e-9c38-1cfe7bf81521"
      unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if49e9f1a5ba44e46b40fa8219c379488_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82MS9mcmFnOmU0YmE1ZTQ2OGU5YjRhNmViNDNlZmE4NWMwN2M4NTI3L3RleHRyZWdpb246ZTRiYTVlNDY4ZTliNGE2ZWI0M2VmYTg1YzA3Yzg1MjdfODc5NjA5MzAyOTIzMg_557b309a-33f9-4757-a89e-ae81188e6e7e"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjY2OQ_298e2828-9323-41fc-97bc-a56797ee4ec4">Commitments and Contingencies&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;one or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-Income Tax Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are recorded for probable losses at management&#x2019;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of September&#160;30, 2022 and December&#160;31, 2021, accrued liabilities were $0.2 million and $0.2 million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $0 to approximately $2.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of September&#160;30, 2022 and December&#160;31, 2021, accrued liabilities were $0.6 million and $0.5 million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, no provision for losses has been provided.&#160;We believe future payments related to these matters could range from $0 to approximately $0.3 million.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover
      contextRef="if876afffb2454b8f9813b911a0c89bd2_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfODc2_24199a46-c3ca-4420-bc5c-04f5314b0d08"
      unitRef="claim">1</natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i388c52769b8c403aae9816b6a35b9616_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMTcyMw_23b45f82-6c35-446c-8586-abff695c8b04"
      unitRef="usd">200000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="if0c2c500c91547a2b8ce14a47ea99029_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMTczMA_af07b6b4-c45e-4a53-b653-a94f1069b021"
      unitRef="usd">200000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i2a40bfae9b044ad7af9bf711c7647199_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjAzNw_fc3d22fc-f820-4930-8e63-c593cf30ab7e"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="if95aa0b7acd74228b82c668e2ce7b986_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjA1Nw_8521b5f6-699b-4bbc-aabe-495d9efa87de"
      unitRef="usd">2700000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i9d6179a221754815aa24768673e73000_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjIzNQ_e147094b-31ea-406b-8ece-5c64bdacbfa5"
      unitRef="usd">600000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i712f9d7d51b845a1b2668f6d2775c79d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfNTQ5NzU1ODE2NjA2_bb85ede1-cee0-4f10-86f1-88e38d9aca31"
      unitRef="usd">500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i54a4cd2649ad43e1af381be20efb83db_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjUzMQ_6c199524-680c-4452-9eba-74cac89f30c7"
      unitRef="usd">0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i5da800ec6cf0494cbcc64545e0f23b44_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjY0Mw_be9fad74-bbbe-4f85-a7be-97d81e6c759e"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i3b0e83c4abf344a5b8794db175c95e39_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82NC9mcmFnOjY1OGVkYWU2MjBkZDQ3YzBiMDlmNDdmYjVhZmY0YTgzL3RleHRyZWdpb246NjU4ZWRhZTYyMGRkNDdjMGIwOWY0N2ZiNWFmZjRhODNfMjY2Mw_d3625709-d26b-43f8-82db-e49fff722e9d"
      unitRef="usd">300000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfNjg4_9936ca16-8aee-4ed0-b873-747a7f11f70c">Related Party TransactionsDuring the three and nine months ended September&#160;30, 2022 and 2021, our joint venture in China ("NSP China"), owned 80 percent by us and 20 percent by a wholly owned subsidiary of Fosun Pharma, did not borrow any amounts from the Company or our joint venture partner. As of September&#160;30, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from the Company were $0 and $1.2 million, respectively. As of September&#160;30, 2022 and December&#160;31, 2021 outstanding borrowings by NSP China from our joint venture partner were $0 and $0.3 million, respectively. These notes were payable in less than one year and bore interest of 3.0 percent. The notes between NSP China and the Company are eliminated in consolidation. In March 2022, the outstanding principal and interest amounts were repaid.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ib64da197a61a4a098d6c97001abfa251_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTIx_faf07038-b6ef-498a-93ae-e55196cb5a24"
      unitRef="number">0.80</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i5c616686bc27495f86f33cccfd0ba207_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTIx_ffaa953d-2a49-45ac-9a99-d006cfdec801"
      unitRef="number">0.80</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i2f558ae5860a4d0aaca0786b80ce2b37_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTM0_3f910e20-089f-4a7d-bcd9-a8983af06c26"
      unitRef="number">0.20</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i5ebaa3f43bee42c18c5ed0c1bf61f4b4_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTM0_e353edfd-bd2f-451a-96b4-970dd9d47443"
      unitRef="number">0.20</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i6ee5eda554ad4659907fd5cb08273632_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTg3_07707738-f11d-49f1-9911-65fab1ba62f9"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="ia764c839880b4c7e9899c96c4ea22bfb_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTg3_8e18fbe5-1449-4735-bce5-8aef92d80aa3"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="ief5236b078ac4a6daebf4680b5be165b_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTg3_f4e604c8-ec9f-4d1e-af1b-c96907a74efe"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i455120a077da4df088d0bd54ec5106fa_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMTg3_fce438ed-4f3c-4db4-ac0d-cb9700fb2449"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:NotesReceivableRelatedPartiesCurrent
      contextRef="i3e093e27ec0a4b8ba600829b8e48847e_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMzMx_a19f9977-b8fb-423d-b53e-91a122c5ae84"
      unitRef="usd">0</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent
      contextRef="iad3dfe96a539486182ac2875e73b964a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfMzM4_b5fa9041-792d-4803-b264-372372fa1cf5"
      unitRef="usd">1200000</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent
      contextRef="i0b4a4f5139a945ab966207cbdb52726a_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfNDQ0_60c0ad15-23b0-4e3a-ba0c-244b874661ba"
      unitRef="usd">0</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent
      contextRef="idd095404eb1749d5b8208d23f0b59607_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfNDUx_2f102159-0bd0-4b3d-b277-af6739515f74"
      unitRef="usd">300000</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="i4a632e9166b44345976a990799025881_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF82Ny9mcmFnOjY1NTI1OTVjZTA1MDRkNDk4NzNjZTc0NjA3ZjVmMGFjL3RleHRyZWdpb246NjU1MjU5NWNlMDUwNGQ0OTg3M2NlNzQ2MDdmNWYwYWNfNTM3_7d3050ed-f88c-43db-b4e7-56e2ff622453"
      unitRef="number">0.03</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RleHRyZWdpb246MzliZjQ1NzNmZWFhNGYxMjhkNjNmYWVjMDQ5ZjUwZTlfMjE2Mw_c3da3a42-5daa-4055-861d-f9e6d9c0b117">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs that are not corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of September&#160;30, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment securities - trading&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September&#160;30, 2022 and for the year ended December&#160;31, 2021, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the nine months ended September&#160;30, 2022 and 2021, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RleHRyZWdpb246MzliZjQ1NzNmZWFhNGYxMjhkNjNmYWVjMDQ5ZjUwZTlfMjE3MQ_bad4a0a3-0b74-4c49-9382-e6fdea89e5ab">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of September&#160;30, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:TradingSecurities
      contextRef="ic4162cfa26b14df99488a4f76a09b41f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMi0xLTEtMS0zNjUxNw_48d71150-a1b2-4351-a383-e0c04567ff39"
      unitRef="usd">692000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i01f3880d0019417fb3e190f74f5f8a25_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMi0zLTEtMS0zNjUxNw_efe901bc-d557-4555-8c7d-18af3bb9087e"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="id147596397c04e229b6d434f653bc101_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMi01LTEtMS0zNjUxNw_03f99c8b-fe4d-4251-b5a3-6bb1564d375e"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i1e406e3dd789497cb667823793e51f2d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMi03LTEtMS0zNjUxNw_fc0f7820-1057-4759-8cb0-0ed1431ce96b"
      unitRef="usd">692000</us-gaap:TradingSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic4162cfa26b14df99488a4f76a09b41f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMy0xLTEtMS0zNjUxNw_c10865d2-8e9f-4fb4-890b-5fc566f3294c"
      unitRef="usd">692000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i01f3880d0019417fb3e190f74f5f8a25_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMy0zLTEtMS0zNjUxNw_3dbfb948-e7e6-409c-8970-19da05b031a8"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id147596397c04e229b6d434f653bc101_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMy01LTEtMS0zNjUxNw_c8345a60-bde7-47b3-92d6-cb5474cd1414"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1e406e3dd789497cb667823793e51f2d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjU4ZWU4NjI4NGI3YjRhYjNiMWZjY2NlNDIwOWMzNTFmL3RhYmxlcmFuZ2U6NThlZTg2Mjg0YjdiNGFiM2IxZmNjY2U0MjA5YzM1MWZfMy03LTEtMS0zNjUxNw_65317a70-7e4d-4747-ac0e-2eee3a9ee687"
      unitRef="usd">692000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:TradingSecurities
      contextRef="i33b5f131172d44dbab10213532398fcf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNC0xLTEtMS0zNjUxNw_9fbf8831-43e1-4ed7-a4f1-057c403c2982"
      unitRef="usd">964000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="id750b81e065841b08fc01573faa37105_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNC0zLTEtMS0zNjUxNw_bb3aa427-1d07-4d74-9071-53e52e0648e7"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i5f4b170f280e46a2b3047bb6edd5bf27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNC01LTEtMS0zNjUxNw_2f2b30a5-43d3-4eb0-bb96-b66f686d28de"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="id976048dc79248cdb7a4f9d5569849ac_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNC03LTEtMS0zNjUxNw_7f4bcaf2-70b1-413c-a50b-1dfdaba59ab4"
      unitRef="usd">964000</us-gaap:TradingSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i33b5f131172d44dbab10213532398fcf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNS0xLTEtMS0zNjUxNw_ed6444b6-af40-4191-9a0c-1463932da167"
      unitRef="usd">964000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id750b81e065841b08fc01573faa37105_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNS0zLTEtMS0zNjUxNw_0d710ba2-0e60-49c6-8a37-fd2789f83652"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5f4b170f280e46a2b3047bb6edd5bf27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNS01LTEtMS0zNjUxNw_c9a9085a-2e01-4611-b954-4a3e6d8bf9b5"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id976048dc79248cdb7a4f9d5569849ac_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83MC9mcmFnOjM5YmY0NTczZmVhYTRmMTI4ZDYzZmFlYzA0OWY1MGU5L3RhYmxlOjA4ZTBjZjk0ZDc5NjRhMjlhMGYyNzc3ZTBkYmJmYWEwL3RhYmxlcmFuZ2U6MDhlMGNmOTRkNzk2NGEyOWEwZjI3NzdlMGRiYmZhYTBfNS03LTEtMS0zNjUxNw_7524a1fd-550b-42af-bcf6-756d0a1f17b6"
      unitRef="usd">964000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfNDA1MQ_926318ba-8085-44ac-96ca-345a3a187a3e">Revenue Recognition&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Sales taxes and value-added taxes in the United States and foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Amounts received for unshipped merchandise are recorded as deferred revenue. Amounts for membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within ninety days of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, our U.S. operations extend short-term credit associated with product promotions. In addition, for certain of our international operations, we offer credit terms consistent with industry standards within the country of operation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products are grouped into six principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have four business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#x2019;s Sunshine Products and Synergy WorldWide&#xae; brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Practical Expedients and Exemptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally expense volume incentives when incurred because the amortization period would have been one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of our contracts with customers have a duration of less than one year. The value of any unsatisfied performance obligations is insignificant.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <natr:RevenuefromContractwithCustomerRefundPeriod
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfMTQxMg_7c4f445a-04cf-4a87-9137-8335c699f70b">P90D</natr:RevenuefromContractwithCustomerRefundPeriod>
    <natr:NumberofPrincipalCategoriesofProducts
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfMzEwMw_b236daf1-5f5f-4966-b36e-0349e0c450a7"
      unitRef="product_category">6</natr:NumberofPrincipalCategoriesofProducts>
    <us-gaap:NumberOfReportableSegments
      contextRef="i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfMzIyNA_14f19675-a26c-4b22-b0fe-330b1d8efff2"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <natr:ContractWithCustomerContractTerm
      contextRef="i12e083e1f3414241b1bb88a79fea2b88_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlYjY2Njk0NjFkZDQ4MTQ4YzQ3YzVlMzA5NDdhN2E0L3NlYzo2ZWI2NjY5NDYxZGQ0ODE0OGM0N2M1ZTMwOTQ3YTdhNF83My9mcmFnOjZiYzhlM2I4OWFkZDRkM2ViOTg0N2M4NWZjYTVmYzI1L3RleHRyZWdpb246NmJjOGUzYjg5YWRkNGQzZWI5ODQ3Yzg1ZmNhNWZjMjVfMzk3Nw_b1731306-aa85-48b9-a8ee-1b329e2abce2">P1Y</natr:ContractWithCustomerContractTerm>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>54
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MJ %/9$?&V8WDF_34=<&EY&%ZN6;48T*_H+Y?<BX/-_H'\H/[P7]02P,$%
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M4=2':\Y O#& WU<"VIS=B?DZMO\:.OL/4$L#!!0    ( '&)8U4AR_&/]P(
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M1FBYXX)MZF"X@TV25=_1:RU$)P#RZ -('4#D *LGP*P#S+>.8-4!UEM'L.N
MDOJXXEX*%T0BFDYR]H+R @W9BH-2_3(:]$JRHE#F(H=?$X@3T]G#?1#>S\,
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M_P9/V]AP%,P?NKY9;P^6/5@OZ^?_RT_;@=@[@$0'#J#; ^BI!T3; R+S@/3
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MPJAA@[,=7QN %D/"#1/L(!(9,0*I5]K8DE"EX:%S=)\SNKF6T:VLC&Z;+8?
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MF0ZLSQ8DN"3K3,[9=H1U/Q\U7\PR8;ZPK7,="^*UD"ROP:J"G!;52.YJ'?8
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ML60+@,[<CTG8O2B=L"Y":&':$KZC>*^SGD, :^<BM@*Y5[^VFGRRNA=D UM
M/C<JJD&'3C@P_ULL.F@QA[:EQ8SQ32XIPJ>Q'-I5T*5&=2GH7!J3'-M57G^<
M\]5+&V3V(]6-,AH]A8$@8,5^7DW$^Q1"UVB;21'5BN(EC.,>VQ>F'79$28D&
MX++\!>65UE_041TXK8@/*"X&82A:[VD-JGTK37@Y9B6Z5!0=JPJ4-88+CH\4
M:ZFID ^IG8K[B:1C+]]07M<KY?O^,\[9X-GJ6'F5V,J"18YJ:GQ$4-J505#E
MEP,B>#]^S%-> !*(@=5AODJ4Q4\4LZXRDDP.%"5L9QS1*%A&%Y(&FBXOAB6B
M6%8(\Z<&#*9V)MPKZ0DJ>?([B$U0YPDJ(P13_9$PALJUIB1=-!GF9/JEM<6.
MBTGO?Q?$:5JQP8KYT2O8D N"!5/XEM8B^*AUT'T4T- QPO>/3,2AAQ8B!K>!
M'?<6"58S-7U@6B;BZ_/D<^KT$4$R.62V"'L%0Y&HY4?$HE=)ILH BF]RK"H9
MA5RO$:H<4;*.&+;N&0#[50QC8;1<:8,.J?#@U9VR;99(L4;00LI9KPS#+W4H
MC O49I-E5%@$*PGDO0<R$W^'86Y+T/>+G\-%9!M;+M.4BP4G1:EA$TK.NSK+
M//1!K!S6TBX%1W;GN"-)01L]Z5?)-<X^J.#&!=U3]F 9I)H+>F/U&F5#9N^:
MU@Z,MI1N-G;-ZT$^'&H=H.L]LT)PV$6>[^>0$IW",]MF>7O^[N/$N3XT0) 2
MK*#@0^+>1^*P 9.)B/+3DT$ME&>R=517B)D]VC^$W7?2M.I(EE0UM-8G2J&[
MC#)J0V/8_@MN%3BDTW"][^>=2XAE&?B*QTGF9X,KH>2(LY<0NX:3GYR E(X.
M1$Z0NBC^!/)S;3BH&L*4[*$YTGFB8'B&2-0-.RKEX"#*2>8!1TQ+>[O#E"C#
M=D44=4C:<E*)"GW+>6PT7(WHS$0/!)2Z%U==+E0F905GNEH73+@ZF_IW9\G'
MWAE#NM^335 :'K[0_8NBDI8F:S0QF<N@ZPU6Q2X]9,1@O6JC7&%BBC0)/2$.
M1[^:3>:X<^)-+BXLG/8+P^U0U.D>^%0?''=11B:;>]CY-+34!IZ MX69@//J
M$-]\,OLR?/.'^)9/C 0L\%%C&3\#&'_%5R=[ !GQ\631+3Q4?:W2U-ORP'.=
M&6*9!Q\^_C:3/=V#,!NA$ZER,&PG_0*L\0>".^KI&H<HT_J7Q_805()R<CJ>
MS6;_1Q2/(T@.4W2QNT,_Z"IQ6'OA=J&:=;Y;[)SY!Y/A83R)P?E"DEO/E4?E
M8TC*?00L^J/T146G9XGEWRUO+H4&W5'D;VY1_1-^>S0[&4-@[ICB&NCID3CV
MQ0=,[(4X/3E]^5J\DP6Q_S[WB;?<1T.Z+ U)H'FJ[W-IQ@):XD80-Z$ 0=YA
MXH:()M_1-ZU.0U":N^E:0?[,$RPIUC47M9+Y#CSTT6.Z]QT+%]\-?ZWC<<#&
M]$FK7^T_""[3=[#=]O0U$8[<X-J(=K7&T=GDS]^,A$]?Z-)#= U_%5NYB!L]
M_ZPPNBI/&_">[G[= RGH/Y->_ Y02P,$%     @ <8EC54V6#IV( @  B04
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MCGKDTH=!>@BVC2_C$QN@W7$XQ[<4.S' ^M3:L'Z0#39?9^?_ 5!+ P04
M" !QB6-5]0J%)% %  #,#@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6RU5]MNVS@0_17"710)X/@BRZES!9)>L'UH$31[>5@L%K0TMHA*I$M2<?OW
M>X;4Q6Z3--UB\Q"3XLR9,S.<(7F^-?:C*XB\^%R5VET,"N\WI^.QRPJJI!N9
M#6FLK(RMI,?4KL=N8TGF0:DJQ\ED<CRNI-*#R_/P[<9>GIO:ETK3C16NKBII
MOUQ3:;87@^F@_?!!K0O/'\:7YQNYIEOROV]N+&;C#B57%6FGC!:65A>#J^GI
M=<KR0> /15NW,Q;LR=*8CSQYFU\,)DR(2LH\(TC\W-%+*DL& HU/#>:@,\F*
MN^,6_4WP';XLI:.7IOQ3Y;ZX&"P&(J>5K$O_P6Q_I<:?.>-EIG3AO]A&V=ED
M(++:>5,URF!0*1U_Y><F#CL*BX<4DD8A";RCH<#RE?3R\MR:K; L#30>!%>#
M-L@IS4FY]1:K"GK^\CWR_E9GIB)Q0U;<%M+2^=@#F=?'68-R'5&2!U!.Q#NC
M?>'$:YU3OJ\_!J..5M+2NDX>!;RES4C,)D.13)+D$;Q9Y^8LX,T>P'LMK59Z
M[7HGQ5]72^<M=L7?]_D;X=+[X;A23MU&9G0Q0"DXLG<TN'S^;'H\.7N$;-J1
M31]#?W).?AQ%7$NG,J&QI.+2!DL85"@0%R0.GC];),GD+$J^OKD-\^G9X5 H
MQZ*;VE,NEE]$KNY4CJ#NPN&S+TAL0S% 3-Z116T+75=+6#*K/6-.H$TX+W6
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M;77MEBA\O%_3!CQ?:=V./TC!],GZZM]02P,$%     @ <8EC5:>U3>(C!0
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MVM0GXCX)5#E0NR$WE5I(4_&/Y4S8WHG.V6L5YPYC+U2"#0P[$](+*3IR)9F
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M1P+=I+0M/FL>]X0*"(&<'PME*K52591:;X5U>$\SY7+IL'2@,0]B1#FT$,^
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MY-6+D7#Y0IY?@NW2);BP 5?J]-C@-PPY#L#WM45M]2^\P.Y7T>)O4$L#!!0
M   ( '&)8U6]FH7R.@,  /0'   9    >&PO=V]R:W-H965T<R]S:&5E=#$X
M+GAM;+U546_3,!#^*Z<P(9"J)$VW,49;J=N8V,-0M0UX0#PXR;4Q<^Q@.\OZ
M[SD[:<A$5VD\\-#&]MWW^;L[^SQME+XW!:*%QU)(,PL*:ZO3*#)9@24SH:I0
MDF6E=,DL3?4Z,I5&EGM0*:(DCH^CDG$9S*=^;:GG4U5;P24N-9BZ+)G>G*%0
MS2P8!]N%&[XNK%N(YM.*K?$6[9=JJ6D6]2PY+U$:KB1H7,V"Q?CT[-#Y>X>O
M'!LS&(.+)%7JWDVN\ED0.T$H,+..@='G <]1"$=$,GYUG$&_I0,.QUOV2Q\[
MQ9(R@^=*?..Y+6;!20 YKE@M[(UJ/F$7SY'CRY0P_A^:UG="SEEMK"H[,"DH
MN6R_[+'+PP!P$C\#2#I XG6W&WF5%\RR^52K!K3S)C8W\*%Z-(GCTA7EUFJR
M<L+9^0T*9C&')=-V W>:2<-\OLPTLL3OO**LXSIKN9)GN-[#M9*V,/!1YI@_
MQ4>DJQ>7;,6=)7L);[$*81*/((F39 _?I ]VXODF+PX6OB]28S7-?NR*NZ4]
MW$WK[LVIJ5B&LX NAD']@,'\]:OQ<?QAC^C#7O3A/O875NA?N2YJS>4:;('T
MTXC 9 Z2X%"V-4574Z"*6"Q3U&UXV]IX;QJ,1Z!J#3\5EQ8>4-I:(W )YP67
M#-X$GV^7[3AX2YZ-),:3&"K4&?E"NH':=%3#109-H838= A3IX;GG%H(J!5<
M*E-+6!:,KN@(<DZJ%:&4=FEFDM"EJJ4UL-*J]/&=J[)R!J5WB*TH,Q)U" OC
MV/?%>X'9T#3VIC%Q6F/)[M+9RJ"1<7'TT?^MI4':^R#VO ?C,*&K+@35942-
MSU3H6Y?8_ ]5SZ;DJ<8XG#RG\:Z@.^"J@*;%5&S#4N$/@D!C*' F0='1VB#3
MGHX4.;,E;V-=A).P/P&>L*-+T3:(<J#9H8>)9$2$@E.G] >=MLSH="O!<^;.
M>0A7$JZ9S@J?L9''#G-3T37(>,6$9^XE;0^1CT=CQ7@>[KK;T: 3EZC7_KTQ
MI('0;5/N5_LG;=%V\C_N[7M(*M><.I/ %4'C\-U1 +I]8]J)597OZZFR]$KX
M84'/,FKG0/:5HIQU$[=!_]#/?P-02P,$%     @ <8EC5:&(RU!X!0    \
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M"!OO6_'%FRK<<1+C<6,*CSFNJ&19 -^7!HW9O+"![M*[^!M02P,$%     @
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MU!=_#F7< 0X/ [I9F9B&%3@+:!@,ZF<,\L^?!EG\[0C=84]W> P]7]#LE:U
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MFI3_+.A? 6IG0/LKI>SCQ 7H_F?,_P!02P,$%     @ <8EC59N$;O/W!P
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M8<)7P0RNC!FLG._1'1ZQP%/GW"@-MZ28#SP5(:;8#2@7F<;9TC6NA0C:JUB
MS$K*/&)EYCZCR@1 =RQ/F +&4%!!'/Q)($HK8(OE:9JRG]>.%B%URV;N:P>_
M)$*2J0E!+GF2I0R1@>@8+*I\"#RZYUB2J!-V;&V*?\43E9W$IWER @Z,\F8.
M8>_8NO5W9:P]N-WNU16?H>010,J4P!5^E4F\)L 9SS4 S]B_7OLCM^\-!\ <
M $^@Y/\26!6EY]R'CA[WCPC,.U]MH!QT1-H"SK#%\\T!&C(C#9E7TQ!IY:MR
M471(X"]JM>[.-1L@]P ?^V5;K%>(J0K SR-[A'V\='#7_=3Z0^MK& Q#%^5=
MN=C$< 0!M0_3UBT)/<1&6+M8Z3DHR;%?FI)TO>F@,H+@!GW)BOT-_NU#_E-1
MWA>$=KUNRP .24@$P<C@])KBX&6S*2YHCR[2'8EK8,5W-;$<B2G] IZ(9(<Z
MUKEZAF#<%K,XGTB/_Y^)=0<1"EG$;D;$JC1R/@:SXIFE:"8>DV",QZ@)FH7D
M-CRWAFFD$%TLR"?9HBD4.-> /!1QG@'E65IF(;Q/2 WF FV:E&NL$N!X02P%
MRDYM-NQ+_'DT,NC1R*%'(XL>B.UTC.WT*TIL'\0]2Q%$"&=7S%?TDMQ\A2 I
MFH<_!:*&Q6;>,1*W-[8/[KH_MD</[5? ;]K=;:DB!ZRYC80_H^[Z?Q8]L2S]
M96#OE2LJ[$B%&-7!T$"A E'@:'"PH $JJX!GW]?U!O)3@]J0*B+-#&[F">+A
MJF@7I;\KPGQ#&D-6*E.2E A+]43G-H8.B/]=N70A5@G+39X3TVMPNT2T2,,D
MZ!_!<(W$]PT10H&<Q4Y4Z% RJ88IJV-=$(;]&KMTD&R#$T=L<E+4K)0*JHDE
M-\DTE4L)18?68V@\MFW'DZ;C&2K02ME8$51"5^@G4DD#R-'9%A-43)A"Y<B@
M@.69@B)"Y$]QD5#>1. TZ8BV /(3^0@3Y)7.J3=)DIB;<)=(48ZS)Y# -.26
M@(P,Q=W(G/Y199\CHF&EB8[2!L)X#A!?WUOM"Q.I*6^AEH&="!/*;N(7- P"
M*@R00!]D.MQI8AG7I()&715/05'1_YJ+3%!O0O#2?!#&XU!)T*P1M>7D@@Q]
M"1Q@X.2GL*B<8,G)T['G,7"@V -+AGD6X0AG("\0J(CJ;VLDGT,$3T3>BPW=
MT=#1T)7\.,"3 3(+&Q$S%/9<"?T4& TE-)$M6#LAT\SC[$%CEU+(Y9J2@DRU
MT9N[@"A$!D&)>(DR!*+K.1@"QDMDJ@$4*5+[Y=[XO\#FV<CFV;=U*FM*U;9[
MX&Q=%=">7.%^WY3K:,M7=2T'-?C:KF6W7?%-]?"\9QE[D\5KFI/#EKZ^T=CM
M5]ZY^7"#;N7ZT!;/VPMT"&BV:8#TS\V0 BHR!Y@!N=N?*PYJWG?O\32H$'G(
M#!QL<,0X$#1V#!K[ZJ I BIJ()"W9^!](7!0WOX0Z$U\+OX;BO@!SUQ&^>/1
MV>+\U)^3D8 IB&5[3DXC.Z&#TW#,DP,C':.H3D">!/>\1&%HX$"L&:?\WS$.
M=4ZJ>(*DT@>"0>':YZ7IHT]6D+Z,'^9"GQC]UZOQZ?CM[[+_Y/5E>O_A\*=X
M8J+#T2V6)F\RG"S:_F-<?]/Y=?P -O-=Y^LX!/4N7$L3\/[6^VY[0QN,7T0O
M_@U02P,$%     @ <8EC59VI!63F @  ]P<  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C8N>&ULS55M3]LP$/XKIS QD!A)T])!:2M1&!K2D#K*V(=I']SD
MTE@X=F8[+?S[G9V0P53*T*1I7_QZ]]QSYSO?<*7TK<D1+=P50II1D%M;#L+0
M)#D6S.RK$B7=9$H7S-)6+T)3:F2I5RI$&$=1/RP8E\%XZ,^F>CQ4E15<XE2#
MJ8J"Z?L)"K4:!9W@X>"*+W+K#L+QL&0+G*']4DXU[<(6)>4%2L.5!(W9*#CI
M#"8])^\%;CBNS*,U.$_F2MVZS44Z"B)'" 4FUB$PFI9XBD(X(*+QH\$,6I-.
M\?'Z ?W<^TZ^S)G!4R6^\M3FH^ P@!0S5@E[I58?L?'GP.$E2A@_PJJ1C0)(
M*F-5T2@3@X++>F9W31S^1"%N%&+/NS;D69XQR\9#K5:@G32AN85WU6L3.2[=
MH\RLIEM.>G9\SKB&&R8JA$MDIM)($;<&=J[97*#9'8:6K#C9,&D0)S5B_ SB
M$5PJ:7,#'V2*Z5/]D-BU%.,'BI-X(^ ,RWWH1GL01W&\ :_;NMSU>-V773[C
M)A'*>6W@V\G<6$U9\GV=SS5D;SVDJYR!*5F"HX!*PZ!>8C#>WNKTH^,-A'LM
MX=XF]/&,*C&M!(+*P.8(B2I*)N_?&L@Y:J:3_!ZH/($9@_1T1?V.*3 +F?-U
MZ7UU)4!EE%1:<[EPJ<S-.D\W<EGOZ361RI2@ G?(UF4.^%N72:K2O_%T)S77
MO=>0W2,E%P+*!XO%''6;%+"3DG5&J(6JG$TN*5"J,DRF9G< GW") CK-'#=S
M%SY7RI+IJ>8))<",+R3/>,*D?;*^5I8)N)!+--85!QC'BUM..N^ 4B9U%-]
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M?)::>!OP@T K=]K(.%ER_F0Z-^74"XP@H% HPX#U;PLSH-00:1F_>TYO6-(
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MO2L>N78^B04D%I)8!&'"E_OB^<M]\8O3I3RI"K_2U?7VQ&GKB8?G4-(1NT8
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MWO1IV:OJRG#I?:)$BWC5FE1HFP&J::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ
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M.-TRR5WCK_N,O\_;9 G\UU]PW_N=K=#BV33E;GK-;O2.OA,9"6'BJ"TK@._
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M$]3S%6/R<*,7*(\2I_\"4$L#!!0    ( '&)8U7',A4R5@,  '0+   9
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M0ILBS367IBP&:1>8^;D0^J%C-Z@+[?0O4$L#!!0    ( '&)8U6^O@&].1,
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MI6DHS:!HPW#:K)&E%X@ #)2.'8**I"DH34-I!D4;!M7FL2R83DW1 @ZDX1=
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M2G=F0ORH +[/@?$%X!%ZU%!KB3ZR&.)ZO*^3+#/%ATSOL17P"38WJ!/\AG"
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M7 .)09@&^OZ2<W4X,1V4?TI,_P-02P,$%     @ <HEC53^C(>78!   5"4
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M[@N#.:J".7I!CEQLES):141$5.KF9Z[TYST-:;0CR[AU]6AT<^XL@H3YD+
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
M" !RB6-5%%30X8T#  #R&@  #P   'AL+W=O<FMB;V]K+GAM;,6976_:,!1
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MDO5=Z]5??SEOUZ1697/T9]WOB?DG4$L! A0#%     @ <8EC50=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !QB6-5.#J+-.T    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !QB6-5F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( '&)
M8U6%,P:P] 4  ,0?   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !QB6-5X432+_$&   9'0  &
M        @($V#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ <8EC52'+\8_W @  -@@  !@              ("!714  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( '&)8U6O)'I"( 8  ,,;   8
M              " @8H8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " !QB6-5P7CZ2S4#  #Q"0  &               @('@'@  >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ <8EC5:1+6AC'#0
MQXH  !@              ("!2R(  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( '&)8U4>?%G3M0(   4'   8              " @4@P
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !QB6-5_Z:;
M$L,(  !T)@  &               @($S,P  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ <8EC54U4XOSF!P  ,A4  !@
M ("!+#P  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( '&)
M8U5-E@Z=B (  (D%   9              " @4A$  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ <8EC5>R7#->1 @  / 8  !D
M         ("!!T<  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " !QB6-57A87=Y,%  "I#0  &0              @('/20  >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( '&)8U7U"H4D4 4  ,P.
M   9              " @9E/  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ <8EC5:]T+S=Y#0  /2L  !D              ("!(%4
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !QB6-5B# T
MTE@)  "^%@  &0              @('08@  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( '&)8U6GM4WB(P4  , -   9
M  " @5]L  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M<8EC5>97%V"2!0  (0T  !D              ("!N7$  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " !QB6-5O9J%\CH#  #T!P  &0
M            @(&"=P  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( '&)8U6AB,M0> 4    /   9              " @?-Z  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ <8EC51:>LK"Q!P
M;A(  !D              ("!HH   'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " !QB6-5PET9(U(&  !@$   &0              @(&*
MB   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( '&)8U5L
M>0-.F (  *$%   9              " @1./  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ <8EC5:ZP&ED&!   K H  !D
M     ("!XI$  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '&)8U66 :M:AP(  ,T&   9              "
M@9:H  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ <8EC
M518.P:GY @  90H  !D              ("!5*L  'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " !QB6-58UJT104&  #E,P  &0
M        @(&$K@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( '&)8U7P1W)XS00  !T7   9              " @<"T  !X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ <8EC5>='X(^<&   G+ !
M !D              ("!Q+D  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " !QB6-52Q3GV \$  !6%   &0              @(&7T@
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( '&)8U7',A4R
M5@,  '0+   9              " @=W6  !X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ <8EC5;Z^ ;TY$P  DM4  !D
M ("!:MH  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !Q
MB6-5L90!7PT#  !["@  &0              @(':[0  >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( '*)8U4;4K2]4 0  * 8   9
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M;',O+G)E;'-02P$"% ,4    " !RB6-5%%30X8T#  #R&@  #P
M    @ &U!0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ <HEC53QA]1J-
M 0  3Q@  !H              ( !;PD! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ <HEC59C$(26B 0  IA@  !,
M ( !- L! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #  ,  '#0  !PT!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>306</ContextCount>
  <ElementCount>244</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>54</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Investment Securities - Trading</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InvestmentSecuritiesTrading</Role>
      <ShortName>Investment Securities - Trading</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Revolving Credit Facility and Other Obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations</Role>
      <ShortName>Revolving Credit Facility and Other Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Capital Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactions</Role>
      <ShortName>Capital Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/Inventories</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/NetIncomePerShare</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Capital Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsTables</Role>
      <ShortName>Capital Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/CapitalTransactions</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/SegmentInformation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentationDetails</Role>
      <ShortName>Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/BasisofPresentationPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/InventoriesTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Investment Securities - Trading (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails</Role>
      <ShortName>Investment Securities - Trading (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/InvestmentSecuritiesTrading</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Revolving Credit Facility and Other Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails</Role>
      <ShortName>Revolving Credit Facility and Other Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/NetIncomePerShareTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Capital Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails</Role>
      <ShortName>Capital Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Capital Transactions - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails</Role>
      <ShortName>Capital Transactions - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Capital Transactions - RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails</Role>
      <ShortName>Capital Transactions - RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/SegmentInformationTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/CommitmentsandContingencies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/RelatedPartyTransactions</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="natr-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod -  natr-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="natr-20220930.htm">natr-20220930.htm</File>
    <File>executiveemploymentagreeme.htm</File>
    <File>natr-20220930.xsd</File>
    <File>natr-20220930_cal.xml</File>
    <File>natr-20220930_def.xml</File>
    <File>natr-20220930_lab.xml</File>
    <File>natr-20220930_pre.xml</File>
    <File>natr2022930-ex311.htm</File>
    <File>natr2022930-ex312.htm</File>
    <File>natr2022930-ex321.htm</File>
    <File>natr2022930-ex322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>natr-20220930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="743">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "natr-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "contextCount": 306,
   "dts": {
    "calculationLink": {
     "local": [
      "natr-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "natr-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "natr-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "natr-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "natr-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "natr-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 403,
   "entityCount": 1,
   "hidden": {
    "http://naturessunshine.com/20220930": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 7
   },
   "keyCustom": 30,
   "keyStandard": 214,
   "memberCustom": 29,
   "memberStandard": 24,
   "nsprefix": "natr",
   "nsuri": "http://naturessunshine.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://naturessunshine.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Inventories",
     "role": "http://naturessunshine.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Investment Securities - Trading",
     "role": "http://naturessunshine.com/role/InvestmentSecuritiesTrading",
     "shortName": "Investment Securities - Trading",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Revolving Credit Facility and Other Obligations",
     "role": "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations",
     "shortName": "Revolving Credit Facility and Other Obligations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Net Income Per Share",
     "role": "http://naturessunshine.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Capital Transactions",
     "role": "http://naturessunshine.com/role/CapitalTransactions",
     "shortName": "Capital Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Segment Information",
     "role": "http://naturessunshine.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Income Taxes",
     "role": "http://naturessunshine.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Commitments and Contingencies",
     "role": "http://naturessunshine.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Related Party Transactions",
     "role": "http://naturessunshine.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Fair Value Measurements",
     "role": "http://naturessunshine.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "id5fbf276129e47918eed3c1199ae0b7f_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "id5fbf276129e47918eed3c1199ae0b7f_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Revenue Recognition",
     "role": "http://naturessunshine.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Basis of Presentation (Policies)",
     "role": "http://naturessunshine.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Inventories (Tables)",
     "role": "http://naturessunshine.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Net Income Per Share (Tables)",
     "role": "http://naturessunshine.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Capital Transactions (Tables)",
     "role": "http://naturessunshine.com/role/CapitalTransactionsTables",
     "shortName": "Capital Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Segment Information (Tables)",
     "role": "http://naturessunshine.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://naturessunshine.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Basis of Presentation (Details)",
     "role": "http://naturessunshine.com/role/BasisofPresentationDetails",
     "shortName": "Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "id5fbf276129e47918eed3c1199ae0b7f_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Inventories (Details)",
     "role": "http://naturessunshine.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "id5fbf276129e47918eed3c1199ae0b7f_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "id5fbf276129e47918eed3c1199ae0b7f_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesTradingRestricted",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Investment Securities - Trading (Details)",
     "role": "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails",
     "shortName": "Investment Securities - Trading (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesTradingRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "id5fbf276129e47918eed3c1199ae0b7f_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "id5fbf276129e47918eed3c1199ae0b7f_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "ia06b2ea113604f608cfe139f6473b4f8_I20170711",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Revolving Credit Facility and Other Obligations (Details)",
     "role": "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails",
     "shortName": "Revolving Credit Facility and Other Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "ia06b2ea113604f608cfe139f6473b4f8_I20170711",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Net Income Per Share (Details)",
     "role": "http://naturessunshine.com/role/NetIncomePerShareDetails",
     "shortName": "Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i98e5bb1cef6c4becb6ebf74bc1b7e3eb_D20210405-20210405",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Capital Transactions - Narrative (Details)",
     "role": "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
     "shortName": "Capital Transactions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i98e5bb1cef6c4becb6ebf74bc1b7e3eb_D20210405-20210405",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "ieb5874cb29674dc6a3388b35641bbd9b_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Capital Transactions - Stock Option Activity (Details)",
     "role": "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails",
     "shortName": "Capital Transactions - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i439d7e472e2e473f8e97ec3eae492da9_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i0055094229274cb5af4f7333a237c4ea_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Capital Transactions - RSU Activity (Details)",
     "role": "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
     "shortName": "Capital Transactions - RSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i0055094229274cb5af4f7333a237c4ea_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Segment Information (Details)",
     "role": "http://naturessunshine.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "natr:ContributionMargin",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Income Taxes (Details)",
     "role": "http://naturessunshine.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "if876afffb2454b8f9813b911a0c89bd2_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "if876afffb2454b8f9813b911a0c89bd2_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestOwnershipPercentageByParent",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i5c616686bc27495f86f33cccfd0ba207_I20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Related Party Transactions (Details)",
     "role": "http://naturessunshine.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
       "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
       "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i455120a077da4df088d0bd54ec5106fa_D20220701-20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i1e406e3dd789497cb667823793e51f2d_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://naturessunshine.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i1e406e3dd789497cb667823793e51f2d_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "natr:RevenuefromContractwithCustomerRefundPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Revenue Recognition - Narrative (Details)",
     "role": "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "natr:RevenuefromContractwithCustomerRefundPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i685be554ba7a470e93d5c850d5b5cb09_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i584cc6cef84645d9aced1d159fb33e8f_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (PARENTHETICAL)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i41234bbe82a44e79a33c617bddbc42c9_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Basis of Presentation",
     "role": "http://naturessunshine.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20220930.htm",
      "contextRef": "i7fb953f2e5f840aaaa28e396d495256c_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 54,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "CHINA"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_KR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KOREA, REPUBLIC OF",
        "terseLabel": "South Korea"
       }
      }
     },
     "localname": "KR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_TW": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TAIWAN",
        "terseLabel": "Taiwan"
       }
      }
     },
     "localname": "TW",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "natr_A2012IncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to 2012 incentive plan.",
        "label": "2012 Incentive Plan [Member]",
        "terseLabel": "2012 Stock Incentive Plan"
       }
      }
     },
     "localname": "A2012IncentivePlanMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_AccruedSeveranceandRentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Severance and Rent Costs [Member]",
        "label": "Accrued Severance and Rent Costs [Member]",
        "terseLabel": "Accrued Severance and Rent Costs"
       }
      }
     },
     "localname": "AccruedSeveranceandRentCostsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_AccruedVolumeIncentiveandServiceFees": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the liability that is related to incentives that are payable, due to volume sales.",
        "label": "Accrued Volume Incentive and Service Fees",
        "terseLabel": "Accrued volume incentives and service fees"
       }
      }
     },
     "localname": "AccruedVolumeIncentiveandServiceFees",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted EBITDA Performance Based Restricted Stock Units",
        "label": "Adjusted EBITDA Performance Based Restricted Stock Units [Member]",
        "terseLabel": "Adjusted EBITDA Performance-Based Restricted Stock Units"
       }
      }
     },
     "localname": "AdjustedEBITDAPerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Dilutive Earnings Per Share [Abstract]",
        "terseLabel": "Anti-dilutive shares excluded from diluted-per-share amounts:"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_AsiaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Segment [Member]",
        "label": "Asia Segment [Member]",
        "terseLabel": "Asia"
       }
      }
     },
     "localname": "AsiaSegmentMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Banc of America Leasing and Capital, LLC, Credit Agreement",
        "label": "Banc of America Leasing and Capital, LLC, Credit Agreement [Member]",
        "terseLabel": "Banc of America Leasing and Capital Credit Agreement"
       }
      }
     },
     "localname": "BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_BankofAmericaCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank of America Credit Agreement [Member]",
        "label": "Bank of America Credit Agreement [Member]",
        "terseLabel": "Bank of America Credit Agreement"
       }
      }
     },
     "localname": "BankofAmericaCreditAgreementMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_CardiovascularProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to cardiovascular products of the entity.",
        "label": "Cardiovascular Products [Member]",
        "terseLabel": "Cardiovascular"
       }
      }
     },
     "localname": "CardiovascularProductsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ChinaJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Joint Venture",
        "label": "China Joint Venture [Member]",
        "terseLabel": "China Joint Venture"
       }
      }
     },
     "localname": "ChinaJointVentureMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_CompanysJointVenturePartnerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company's Joint Venture Partner [Member]",
        "label": "Company's Joint Venture Partner [Member]",
        "terseLabel": "Company's Joint Venture Partner"
       }
      }
     },
     "localname": "CompanysJointVenturePartnerMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ContractWithCustomerContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Contract Term",
        "label": "Contract With Customer, Contract Term",
        "terseLabel": "Contract with customer, contract term"
       }
      }
     },
     "localname": "ContractWithCustomerContractTerm",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_ContributionMargin": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.",
        "label": "Contribution Margin",
        "terseLabel": "Total contribution margin"
       }
      }
     },
     "localname": "ContributionMargin",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_ContributionMarginAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution Margin [Abstract]",
        "terseLabel": "Contribution margin:"
       }
      }
     },
     "localname": "ContributionMarginAbstract",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_DebtInstrumentNumberOfMonthlyPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number of Monthly Payments",
        "label": "Debt Instrument, Number of Monthly Payments",
        "terseLabel": "Number of monthly payments"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfMonthlyPayments",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_DigestiveProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to digestive products of the entity.",
        "label": "Digestive Products [Member]",
        "terseLabel": "Digestive"
       }
      }
     },
     "localname": "DigestiveProductsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities Excluded from Computation of Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive shares excluded from diluted-per-share amounts:"
       }
      }
     },
     "localname": "DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_DilutiveSecuritiesExcludedfromComputationofEarnings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.",
        "label": "Dilutive Securities Excluded from Computation of Earnings",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "DilutiveSecuritiesExcludedfromComputationofEarnings",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_EuropeSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Europe Segment [Member]",
        "label": "Europe Segment [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeSegmentMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_FosunPharmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fosun Pharma",
        "label": "Fosun Pharma [Member]",
        "terseLabel": "Fosun Pharma Member"
       }
      }
     },
     "localname": "FosunPharmaMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_GeneralHealthProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to general health products of the entity.",
        "label": "General Health Products [Member]",
        "terseLabel": "General health"
       }
      }
     },
     "localname": "GeneralHealthProductsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ImmunityProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to immunity products of the entity.",
        "label": "Immunity Products [Member]",
        "terseLabel": "Immune"
       }
      }
     },
     "localname": "ImmunityProductsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.",
        "label": "Increase (Decrease) in Liability Related to Unrecognized Tax Positions",
        "terseLabel": "Liability related to unrecognized tax benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease, Liabilities",
        "label": "Increase (Decrease) In Operating Lease, Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.",
        "label": "Increase (Decrease) in Accrued Volume Incentives and Service Fees",
        "terseLabel": "Accrued volume incentives and service fees"
       }
      }
     },
     "localname": "IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IndicativeIndexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicative Index",
        "label": "Indicative Index [Member]",
        "terseLabel": "Indicative Index"
       }
      }
     },
     "localname": "IndicativeIndexMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_LatinAmericaAndOtherSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America And Other Segment [Member]",
        "label": "Latin America And Other Segment [Member]",
        "terseLabel": "Latin America and Other"
       }
      }
     },
     "localname": "LatinAmericaAndOtherSegmentMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings",
        "terseLabel": "Potential increase in maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence",
        "terseLabel": "Potential increase in maximum borrowing capacity, per occurrence"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_LineOfCreditFacilityNumberOfSeparateIncreases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Number Of Separate Increases",
        "label": "Line Of Credit Facility, Number Of Separate Increases",
        "terseLabel": "Number of separate increases"
       }
      }
     },
     "localname": "LineOfCreditFacilityNumberOfSeparateIncreases",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.",
        "label": "Minimum Number of Claims Companies Insurance Coverage May Not Cover",
        "terseLabel": "Minimum number of claims that the Company's insurance coverage may not be sufficient to cover"
       }
      }
     },
     "localname": "MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_NaturesSunshineProductsChinaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Natures Sunshine Products, China [Member]",
        "label": "Natures Sunshine Products, China [Member]",
        "verboseLabel": "NSP China"
       }
      }
     },
     "localname": "NaturesSunshineProductsChinaMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NetSalesandOperatingIncomeTargetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Sales and Operating Income Targets [Member]",
        "label": "Net Sales and Operating Income Targets [Member]",
        "terseLabel": "Net Sales and Operating Income Targets"
       }
      }
     },
     "localname": "NetSalesandOperatingIncomeTargetsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NonIncomeTaxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to non-income tax matters, including value-added taxes.",
        "label": "Non Income Tax [Member]",
        "terseLabel": "Non-Income Tax Contingencies"
       }
      }
     },
     "localname": "NonIncomeTaxMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NorthAmericaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Segment [Member]",
        "label": "North America Segment [Member]",
        "terseLabel": "North America"
       }
      }
     },
     "localname": "NorthAmericaSegmentMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NumberofPrincipalCategoriesofProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Principal Categories of Products",
        "label": "Number of Principal Categories of Products",
        "terseLabel": "Number of principal categories of products"
       }
      }
     },
     "localname": "NumberofPrincipalCategoriesofProducts",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_OperatingLeaseNonCashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Non-Cash Lease Expense",
        "label": "Operating Lease, Non-Cash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseNonCashLeaseExpense",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to all other international countries.",
        "label": "Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PerformanceBasedRestrictedStockUnitsRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-Based Restricted Stock Units (RSUs) [Member]",
        "label": "Performance-Based Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Performance-Based Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsRSUsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the performance based stock options, which vest upon achieving operating income margins.",
        "label": "Performance Based Stock Options Vesting Upon Achieving Operating Income Margins [Member]",
        "terseLabel": "Performance based stock options operating income margins"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PersonalCareProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to personal care products of the entity.",
        "label": "Personal Care Products [Member]",
        "terseLabel": "Personal care"
       }
      }
     },
     "localname": "PersonalCareProductsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_RestrictionPeriodForIssuanceOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the restriction period before shares will be issued related to a share-based compensation plan.",
        "label": "Restriction Period for Issuance of Shares",
        "terseLabel": "Restriction period for issuance of shares"
       }
      }
     },
     "localname": "RestrictionPeriodForIssuanceOfShares",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_RevenuefromContractwithCustomerRefundPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Refund Period",
        "label": "Revenue from Contract with Customer, Refund Period",
        "terseLabel": "Refund period"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerRefundPeriod",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Segment Reporting Information, by Segment1",
        "label": "Schedule of Segment Reporting Information, by Segment1 [Table Text Block]",
        "terseLabel": "Schedule of assets per segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegment1TableTextBlock",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period",
        "terseLabel": "Award performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Minimum Withholding Requirements",
        "terseLabel": "Minimum withholding requirements (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested Subject to Restriction Period, Number",
        "terseLabel": "Nonvested subject to restriction period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Vesting Installments",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Vesting Installments",
        "terseLabel": "Number of vesting installments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the first operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, One",
        "terseLabel": "Operating income margin, one (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the three operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Three",
        "terseLabel": "Operating income margin, three (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the second operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Two",
        "terseLabel": "Operating income margin, two (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited or canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "natr_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Lack of Marketability",
        "terseLabel": "Discount for lack of marketability"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsDiscountforLackofMarketability",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.",
        "label": "Stock Issued During Period, Shares, Stock Options and Restricted Stock Exercised",
        "terseLabel": "Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.",
        "label": "Stock Issued During Period, Value, Stock Options and Restricted Stock Exercised",
        "terseLabel": "Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_TimeBasedRestrictedStockUnitsRSUs1YearVestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-Based Restricted Stock Units (RSUs) [Member]",
        "label": "Time-Based Restricted Stock Units (RSUs), 1-year Vesting [Member]",
        "terseLabel": "Time-Based Restricted Stock Units (RSUs), 1-year Vesting"
       }
      }
     },
     "localname": "TimeBasedRestrictedStockUnitsRSUs1YearVestingMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_TimeBasedRestrictedStockUnitsRSUs3YearVestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-Based Restricted Stock Units (RSUs), 3-year Vesting",
        "label": "Time-Based Restricted Stock Units (RSUs), 3-year Vesting [Member]",
        "terseLabel": "Time-Based Restricted Stock Units (RSUs), 3-year Vesting"
       }
      }
     },
     "localname": "TimeBasedRestrictedStockUnitsRSUs3YearVestingMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_TimeBasedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the time-based stock options, which vest over differing periods.",
        "label": "Time Based Stock Options [Member]",
        "terseLabel": "Time-based stock options"
       }
      }
     },
     "localname": "TimeBasedStockOptionsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to value added tax assessments and other civil litigation in which the entity is involved.",
        "label": "Value Added Tax Assessments And Other Civil Litigation [Member]",
        "terseLabel": "Value-added tax assessments and other civil litigation"
       }
      }
     },
     "localname": "ValueAddedTaxAssessmentsAndOtherCivilLitigationMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_VolumeIncentives": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.",
        "label": "Volume Incentives",
        "terseLabel": "Volume incentives"
       }
      }
     },
     "localname": "VolumeIncentives",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_WeightManagementProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to weight management products of the entity.",
        "label": "Weight Management Products [Member]",
        "terseLabel": "Weight management"
       }
      }
     },
     "localname": "WeightManagementProductsMember",
     "nsuri": "http://naturessunshine.com/20220930",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r43",
      "r45",
      "r98",
      "r99",
      "r243",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r220",
      "r222",
      "r223",
      "r224",
      "r242",
      "r263",
      "r304",
      "r305",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r489",
      "r492",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r220",
      "r222",
      "r223",
      "r224",
      "r242",
      "r263",
      "r304",
      "r305",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r489",
      "r492",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r174",
      "r222",
      "r223",
      "r283",
      "r286",
      "r443",
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r174",
      "r222",
      "r223",
      "r283",
      "r286",
      "r443",
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r204",
      "r220",
      "r222",
      "r223",
      "r224",
      "r242",
      "r263",
      "r294",
      "r304",
      "r305",
      "r334",
      "r335",
      "r336",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r489",
      "r492",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r204",
      "r220",
      "r222",
      "r223",
      "r224",
      "r242",
      "r263",
      "r294",
      "r304",
      "r305",
      "r334",
      "r335",
      "r336",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r489",
      "r492",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r44",
      "r45",
      "r98",
      "r99",
      "r243",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r283",
      "r287",
      "r491",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r283",
      "r287",
      "r491",
      "r500",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r302",
      "r421",
      "r422",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r180",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r33",
      "r430"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r181",
      "r182"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowance for doubtful accounts of $673 and $143, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r15",
      "r460",
      "r476"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r48",
      "r49",
      "r50",
      "r477",
      "r497",
      "r498"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r47",
      "r50",
      "r56",
      "r57",
      "r58",
      "r102",
      "r103",
      "r104",
      "r377",
      "r418",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r23",
      "r183",
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r12",
      "r93",
      "r156",
      "r163",
      "r170",
      "r186",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r371",
      "r379",
      "r398",
      "r428",
      "r430",
      "r458",
      "r475"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r31",
      "r93",
      "r186",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r371",
      "r379",
      "r398",
      "r428",
      "r430"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://naturessunshine.com/role/FairValueMeasurementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r10",
      "r88"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r80",
      "r88",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at the end of the period",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r80",
      "r403"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r225",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Common stock, dividends (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)",
        "verboseLabel": "Cash dividend (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYPARENTHETICAL",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r102",
      "r103",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value",
        "terseLabel": "Common stock, no par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18",
      "r430"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, no par value, 50,000 shares authorized, 19,166 and 19,724 shares issued\u00a0and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r53",
      "r55",
      "r63",
      "r370",
      "r383",
      "r468",
      "r484"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r91",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r272",
      "r273",
      "r284"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r70",
      "r443"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r15",
      "r16",
      "r92",
      "r100",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r260",
      "r261",
      "r414",
      "r459",
      "r461",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Margin on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r38",
      "r257",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r39",
      "r92",
      "r100",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r260",
      "r261",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r39",
      "r92",
      "r100",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r259",
      "r260",
      "r261",
      "r266",
      "r267",
      "r268",
      "r269",
      "r412",
      "r413",
      "r414",
      "r415",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesTradingRealizedGainLoss": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Trading, Realized Gain (Loss)",
        "terseLabel": "Debt securities, trading, realized gains (losses)"
       }
      }
     },
     "localname": "DebtSecuritiesTradingRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesTradingRestricted": {
     "auth_ref": [
      "r440",
      "r501",
      "r502"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Trading, Restricted",
        "terseLabel": "Investment securities - trading",
        "verboseLabel": "Trading securities portfolio"
       }
      }
     },
     "localname": "DebtSecuritiesTradingRestricted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation payable"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r86",
      "r94",
      "r355",
      "r360",
      "r361",
      "r362"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r86",
      "r151"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r283",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends",
        "terseLabel": "Dividends, common stock, cash"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Basic and diluted net income per common share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r64",
      "r107",
      "r108",
      "r109",
      "r110",
      "r111",
      "r116",
      "r119",
      "r125",
      "r126",
      "r127",
      "r131",
      "r132",
      "r386",
      "r387",
      "r469",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings (loss) per share attributable to common shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r64",
      "r107",
      "r108",
      "r109",
      "r110",
      "r111",
      "r119",
      "r125",
      "r126",
      "r127",
      "r131",
      "r132",
      "r386",
      "r387",
      "r469",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Provision (benefit) for income taxes, as a percentage of income before income taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period over which the remaining compensation cost is expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Share based compensation potential compensation expense to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefit from the exercise of stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r56",
      "r57",
      "r58",
      "r102",
      "r103",
      "r104",
      "r106",
      "r112",
      "r114",
      "r134",
      "r187",
      "r265",
      "r270",
      "r342",
      "r343",
      "r344",
      "r356",
      "r357",
      "r385",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r418",
      "r493",
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r248",
      "r258",
      "r259",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r388",
      "r389",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of the company's hierarchy for assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r248",
      "r258",
      "r259",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r389",
      "r431",
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r248",
      "r258",
      "r259",
      "r388",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r248",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r248",
      "r295",
      "r296",
      "r301",
      "r303",
      "r389",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 - Quoted Prices in Active Markets for Identical Assets"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r248",
      "r258",
      "r259",
      "r295",
      "r296",
      "r301",
      "r303",
      "r389",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 - Significant Other Observable Inputs"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r248",
      "r258",
      "r259",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r389",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 - Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r248",
      "r258",
      "r259",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r431",
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r392",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r87",
      "r401",
      "r402"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedLabel": "Foreign exchange losses"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r72",
      "r86",
      "r184"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedLabel": "Realized and unrealized gains (losses) on investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on sale of property, plant and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r68",
      "r93",
      "r156",
      "r162",
      "r166",
      "r169",
      "r172",
      "r186",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r398"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r156",
      "r162",
      "r166",
      "r169",
      "r172",
      "r456",
      "r465",
      "r470",
      "r486"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before provision for income taxes",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r95",
      "r351",
      "r353",
      "r354",
      "r358",
      "r363",
      "r365",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r113",
      "r114",
      "r154",
      "r349",
      "r359",
      "r364",
      "r487"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r85",
      "r442"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 23.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "terseLabel": "Deferred compensation payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Shareholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r127",
      "r308"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Stock-based awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r78",
      "r82",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r24",
      "r190"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r30",
      "r430"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r26",
      "r190"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r25",
      "r190"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r185",
      "r457",
      "r471",
      "r499",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investment Securities - Trading"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InvestmentSecuritiesTrading"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r35",
      "r93",
      "r164",
      "r186",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r372",
      "r379",
      "r380",
      "r398",
      "r428",
      "r429"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r22",
      "r93",
      "r186",
      "r398",
      "r430",
      "r463",
      "r480"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r37",
      "r93",
      "r186",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r372",
      "r379",
      "r380",
      "r398",
      "r428",
      "r429",
      "r430"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Liability related to unrecognized tax benefits"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r16",
      "r461",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "verboseLabel": "Long-term line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Annual commitment fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r13",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Line of credit, outstanding, current"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of note payable"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Revolving Credit Facility and Other Obligations"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Long-term note payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r220",
      "r222",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Provision for losses"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r42",
      "r93",
      "r186",
      "r228",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r398",
      "r462",
      "r479"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Joint venture ownership, noncontrolling party"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Joint venture ownership"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Increase (decrease) in noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r42",
      "r69",
      "r369",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r80",
      "r84",
      "r87"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r51",
      "r54",
      "r58",
      "r61",
      "r87",
      "r93",
      "r105",
      "r107",
      "r108",
      "r109",
      "r110",
      "r113",
      "r114",
      "r123",
      "r156",
      "r162",
      "r166",
      "r169",
      "r172",
      "r186",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r387",
      "r398",
      "r466",
      "r482"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r51",
      "r54",
      "r58",
      "r113",
      "r114",
      "r375",
      "r382"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r110",
      "r116",
      "r117",
      "r124",
      "r127",
      "r156",
      "r162",
      "r166",
      "r169",
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income (loss) attributable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r270",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r32",
      "r97",
      "r423"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "terseLabel": "Related party notes payable"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Notes Receivable"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r19",
      "r97",
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).",
        "label": "Notes Receivable, Related Parties, Current",
        "terseLabel": "Notes receivable, related parties, current"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r156",
      "r162",
      "r166",
      "r169",
      "r172"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Long-term portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r101",
      "r115",
      "r142",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r46",
      "r48",
      "r399",
      "r400",
      "r404"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation loss (net of tax)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r52",
      "r55",
      "r56",
      "r57",
      "r59",
      "r62",
      "r265",
      "r405",
      "r410",
      "r411",
      "r467",
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other loss, net",
        "verboseLabel": "Other loss, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Payments for Purchase of Securities, Operating Activities",
        "negatedLabel": "Purchase of trading investment securities"
       }
      }
     },
     "localname": "PaymentsForPurchaseOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Payments of cash dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Payments related to tax withholding for net-share settled equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r75",
      "r92"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Proceeds from Sale of Securities, Operating Activities",
        "terseLabel": "Proceeds from sale of trading investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r51",
      "r54",
      "r58",
      "r79",
      "r93",
      "r105",
      "r113",
      "r114",
      "r156",
      "r162",
      "r166",
      "r169",
      "r172",
      "r186",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r370",
      "r374",
      "r376",
      "r382",
      "r383",
      "r387",
      "r398",
      "r470"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r202",
      "r430",
      "r472",
      "r481"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "verboseLabel": "Total property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r65",
      "r189"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r302",
      "r421",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r421",
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Related party transaction, amount"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r302",
      "r421",
      "r422",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.",
        "label": "Related Party Transaction, Rate",
        "terseLabel": "Related party transaction, rate"
       }
      }
     },
     "localname": "RelatedPartyTransactionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r302",
      "r421",
      "r425",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r419",
      "r420",
      "r422",
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r77",
      "r92"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Principal payments of revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-Term Debt",
        "negatedTerseLabel": "Principal payments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedTerseLabel": "Principal payments of related party borrowing"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r86",
      "r205",
      "r209",
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r206",
      "r207",
      "r211",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r207",
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r270",
      "r430",
      "r478",
      "r496",
      "r498"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r102",
      "r103",
      "r104",
      "r106",
      "r112",
      "r114",
      "r187",
      "r342",
      "r343",
      "r344",
      "r356",
      "r357",
      "r385",
      "r493",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r147",
      "r148",
      "r161",
      "r167",
      "r168",
      "r174",
      "r175",
      "r178",
      "r282",
      "r283",
      "r443"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total net sales revenue",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r285",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "terseLabel": "Schedule of consolidated property, plant and equipment by geographical locations"
       }
      }
     },
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of revenue generated by each of the Company's product lines"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r27",
      "r28",
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of composition of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r423",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r67",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Schedule of consolidated net sales revenue by geographical locations"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r156",
      "r159",
      "r165",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r156",
      "r159",
      "r165",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of reportable business segment information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of restricted stock unit activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r312",
      "r327",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r143",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r178",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r208",
      "r213",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r143",
      "r145",
      "r146",
      "r156",
      "r160",
      "r166",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]",
        "terseLabel": "Net sales:"
       }
      }
     },
     "localname": "SegmentReportingInformationRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Restricted Stock Units outstanding, ending balance (in shares)",
        "periodStartLabel": "Restricted Stock Units outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Restricted Stock Units outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Restricted Stock Units outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant\u00a0Date Fair\u00a0Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Issued (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional number of shares authorized under the plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized under the plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r329"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic values of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited or canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited or canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value (in dollars per share)",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding at the end of the period (in shares)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at the end of the period (in dollars per share)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted\u00a0Average Exercise Price\u00a0Per\u00a0Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Unvested stock options outstanding (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at the beginning of the period (in dollars per share)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant Date Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r271",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "Capital Transactions"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r143",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r178",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r208",
      "r213",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r41",
      "r56",
      "r57",
      "r58",
      "r102",
      "r103",
      "r104",
      "r106",
      "r112",
      "r114",
      "r134",
      "r187",
      "r265",
      "r270",
      "r342",
      "r343",
      "r344",
      "r356",
      "r357",
      "r385",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r418",
      "r493",
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r134",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r18",
      "r265",
      "r270",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r17",
      "r18",
      "r265",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r17",
      "r18",
      "r265",
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r57",
      "r93",
      "r102",
      "r103",
      "r104",
      "r106",
      "r112",
      "r186",
      "r187",
      "r270",
      "r342",
      "r343",
      "r344",
      "r356",
      "r357",
      "r368",
      "r369",
      "r381",
      "r385",
      "r398",
      "r405",
      "r406",
      "r411",
      "r418",
      "r494",
      "r495"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r6",
      "r14",
      "r464"
     ],
     "calculation": {
      "http://naturessunshine.com/role/FairValueMeasurementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Investment securities - trading"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r206",
      "r207",
      "r211",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r346",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Liability related to unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Potentially dilutive shares included in the calculation of diluted earnings per share"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r118",
      "r127"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted common shares outstanding (in shares)",
        "totalLabel": "Diluted weighted-average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Diluted shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r116",
      "r127"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Basic weighted-average shares outstanding (in shares)",
        "terseLabel": "Weighted average basic common shares outstanding (in shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME",
      "http://naturessunshine.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r515": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r516": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r517": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r518": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r519": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r520": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r521": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000275053-22-000023-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000275053-22-000023-xbrl.zip
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M_OO?XN0J2N+_^BY1L_CETQ>QFCR9/7L:OYA,]N/]^-G3V=-X^O+IRR?/_W4
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M5+6 )T)74#+"G<_V(Q@%33O,M?N7/SW[_L>O[7"C%G](*M@(TSN,[*K(K^
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MKNGZ%VJNK*T:TGG284W1'DQ*\@D3P0Y"K^8TNE)I;<U7PI*QL5Q.T[QTN*3
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M.Z.\6 F#H'!.UW9O2MP(7Y 7G#'A$02#UE*PXN*<?D:'I]GWS)+I=C*9.T&
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MV30#VM!HFB)G"L8 @C-(\I 9Y8T2J3&LLWM#9Y9&20%05JR[6+-XXI&]FNX
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MKM"E)3^3S4ITP7.#K\4^ZZ)BT.M2)1R_4S%5E4$[%)[C8]5&W<@UN<'S:CV
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MM^R?;^!@>7K; CA\!J-R@;RZ=:JC\=TW_[?T#MW8^3'SA)!^=*ZY]*.?\^/
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M;&JQVHWIJHWINA)=?6:\_BZZ^NS4[^R4.L'S4M+K^VWG![^]7\IX$$E*Y9D
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MUK@Z?NYVVUP%&R\RQC,ZP:R1 #;ZH%-6X*1 (5Q(J^/GNJ]7R\\YIYFV,I!
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MDOZOOQZZ;S2J1!.I!)&32S-966!&H$W" P,#4I0,#?771/>-1M6L(DN621[
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MZ-PO&_;%D>_ 0!@O.7BNHE: T5B5.<<0LHD68XI3##@7DC<87,6 M[EH2[X
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M#%!K"E"!*J\"TLQH2CWEAL*@)4;*$J&HE 5 (80)R@!5+8"ZG0*H0 E"!B+
MH&2 !B6 % H";9GE2$JAB=C:D;R.*@50SVTR/1:9P@LZ^4(*NVOMR!W>\]9'
MY3&IS&#'CRI$I#)O15!42K%VW:$9A&$K)2Z,/A(O^=\78"2[DV&]Z?;VQH.:
M/,;QW5.,C<6LVW/H=N,U_/*-;M\H>/[_+J%M_]W1']3PZ.-Q*\W!V>G%ESB.
M+XTT;MRX/'Q[<'OT-CYK^^#F_,,9:7R\(/_O]HS\@RGS+B //,<1&3P6P"BL
M@%!86R@1Y$)O[7!!9F"A,%[F65UE;2=Y=:W&ZK+P'V^\<B(0H#1Q:=^)O[&
M 9/2&:J(T"SN.XC.KJYZRIN\FB0!_:#9 IYO2WB0A*XT4RL-N&?4J.$'=YJ4
M"5II:C9M03I$O$:0 >*<!Q0B!$Q  @BB)$=0H< C#*NZ$F)1?O8P1UJJ ?E4
M)^?&ZW%I6V36X^?1XQE#"U+!-+0 <1;BAJ=9W/ L!-1YPJ"C!@<6#:VZ%*A"
M>OP#.VL2CA('Z[^O^L]UY;H->-T.-PXZ*7R_F\+E'ST5^Q[8/]5SN-)@7Q9I
MFTSV3<3X#.ZE@?NLF]] RQ2G#"!G.*!*(Z"L-$!RB$F4GA)>)ENYSN&L0;/R
M;OZLN&6SM*RX2U+<:5;F/4'&2 >$-#JR,J2!$8@!"XFP4FD*58B*"^N2X0HI
M;DGN[U4A#>]Z_DHWBTQYW^G[>]FE/\4A-L)@+(M#C.=^?S3UNQU7-)<?Q4=F
MN[%DA#J:]?]$'/("1FM12L< U4("%3 %A@H?,/;:$I?L1DRR_V>-U;DL9I'5
M^7G5>9IP<!0$-<$#B*R/ZDQY5&R, /4:88\)9%PF=18<5DB=RW12(%5QMG':
M':1*8M\$+"_BJWARZ/KZH59IIT\9GY:"3R<S="-8CR!* 4 >1E32D +-- ?(
M<8&$95JAXEP6UR5<V%']$[D=J^+GV&"E+^VH*BO]DI1^FI1H:YF,Z R<\0I0
M)3%0SF) ,.%4$(F]8%'I.:USOK"5\5Q*/^8L4Z5P4LVMK1=-PJGD/=8KI_,Q
M+]*H]MBH8?JHN%;*KBF*!Q>!D_E$:OG>I)$,WB4)1.MS?S+_V=%=9ISW"-Y'
MW.[V#!V>VG]\!/2 F0(<$@PH#PHH1@P@5!EAK0D0^ZT=*NJ$52G0.Q]1592=
M94U^-DV^F=)D0CQ%R #(A $48P\TM3HYB*% G @7^-8.2V=699&U"IU959IB
M'(U:V:7N7$6)RV):0#> 5'!X 4_21KBXR^(8=T+X,\G@. WF*+SO^\*>S-!4
M'C0=S) ,I"6EDC@@%=> ,B: DI%IQ$V'B<"@L!HF0[+.:)6B'/-I545)1E;E
MYU/E*98A&)0>>@,T#!10B3A0UBJ 79 $1OW%6$55EO5H0%1(E3?!D9&BP_J#
M=M$(9]10(C7R $7Y]?@,V8NQ;(:QY\W@Y&[F3T?3?NQ3EV([\"YCSUS8<SA+
M(ZSE-$@&.$RIIQC+:-R@ *!/!3,4]0*GJ#Q5I9"\[*BH*(?(REJRLDX1!2JU
M0\H'0+42($HJ<GZB#<!$.^@L(8[)K1W%J^157/\LH15TGNREEAR]HD.)32V9
M4K.R[#-Y+D8SFON#8NI/]?7H\#W[<DL%S_<S3$<&!XV7"G@A2 1/B8!F3 */
MN+$D(BM+)^^B#E'VEZRQ&I?'=;(:/XL:3W$@&>6$H(9 &)X.5XD%$D4.)*&)
MX$RX4:GW!2)UIM8PK+?2K**(;R\ABG>] :BTLY>OV02-;L?FV+VRL>=LAD)0
M1S7U$6P()A)0Q110F@G@F0N>D( $3O97'<&%_;3975)=#2[MR"5K\-(U>(H]
M*..]Q#H %C0%U&(1-5AYH"%QC%!B("61/< ZI6L8T+%*24$/TX@?/?!BN0"5
MFXJGUT">^_G7!HW+37S*\%L>_-H9 J6ML-K( (36T7A3B@&I P1002N9QDPF
M'PS&T7J#LB3KK3(I3S]PT61HR]"VU/2N#&VE0MMT$$\4B&#. HYIM T#X<"8
M9"H&I@W%W$<91FACJ>S@PN=SSP5MI21V+:<U&8F/E&JMM_S,$R_R#2\TRO4Z
M='RXT=^?36V:K5$$54H(.[G4/7_9;<6YZH][ ==2:L/@YE'GX?HWX,HMRUZH
M95E%5.?[+?U:7U7HY_KZ_?C95T'D+X#I*SYC&U;%[JY=RY6^286W%SGQ6U-S
M:CTMIK)[,+P;K9]<&:-L"^KC;-HT950K8AC002$0#5X!C*,<>$P89X@$%^W<
M'5&G@E7H8/^9O#\9D:KT;"_832(CTA(1:<JG8R6B#CD*"*<FG19&;$H=^X1R
M"",N/5=%0Q@!%TZ/J%ZHT0IQO=[0N]KG;FO8]BFB.>I%\_/8R1!O^KF96O/Y
MW 5A>;2IHP>]5V-!_%W(X6 BABB$DY$,WD019+PJ#Z]F<\)=H)!:R "2*J3C
M-0\T812$@)13(6B4RE5@5$>+=[#* 4K55>=%.4=6YY=1YYE09^Q((!!@Z5+.
M5Q'EK - VM/@G+8B]:/#I(Y(6?5!JQ:LM$+\XYYO-B=1/8-_)DWZO2.E;!"5
MCDBSV>(^95YPKH&W,B$2T2"2#)MZ)7 F&!(F)5]@6I>,5\@BRDE4%2,868V?
M5XVGB 5RG!EF);"8<4 -1D )1J+90%'04:,5MUL[!-4Y7,,<JE4A%G=)VCW_
MV7>&,X=8V=XIFU6\CC=-7_>A.;A\/>S'9_>]"3;=9&0J'9G^FB$8 C.#J$6
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M(67>A%)*J4!H#GVI$ML8I3N/SKLS[,P!.X<S' (CSYPC"C@9(H?0(II"!A'
M!)2<$28QXJDP\,J8/]F3LM+<X[YJ9[I1HMY/T8U@+914(.!AM!@H3K$LUFB@
MI0Z.,>X"42F:C;*2VS56WO&Q(ERDIN]UQ$[=O#K?N _C52/_8?:"/!\OB=+Y
MZ@E^6L?R#&-SP-A?,_1%6::ML0%@E7((M%9 !VP!P4Q#RBWD6*3ZM O3E^P
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M-9>J@FQPK5.39ZC*)':P7++R+5D</?$,7WQ:7.?:(N!S$9VQA3L#A!D#2\/
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MDC,A(5=8&5(A1K-)L0RY_]_/]?];SA%Y[O]7'@[MSSA.F$-28)[.OUURG+@
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M&0\K\-1SM?33)#!C+6=:4B>1(=%\ICCHJ!X"(_@X(.:6?BN#C--GF5QX&:T
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M$FR@C@G-E:22*D>KJKEWB,"5/H0/C$^[DX4H9"#$:ZV0T8D@H!@!V> %$M0
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ML)XKEKBLVO3(>Q]_++9>(+F(J8BIB*F(:2$(CD]4*J4I5S[E4@Q:*8R=3$*
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M[6#1JNXO/@]I=CNHBB.VH^W'1OQQDL\<E*C'PQ.0CAWT7N^.(K9_Y^D'86R
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M-0D.@9S!J;7,(AN(0=0;XF74TCF^LJ;$JF"3"68+"HDO(H:W]^'MV[^W=K9
MJ'\W-K?W-O[>W?OP?JNQ^Z9QT8"PL=U\L_M^9WU_>[?Y:QT'AS-S160,A!*Z
MIZX=GT^'O'F'2,J,OK1B*)5/>F(!R'+)DU;'=X]CKH82^ZNY $I=$"Z=3NE!
M>._"!XLW&3-SJV=*G^9^RGB[TJO]K%9O0=>:L>QMSI$<;4_I?&23PM@@HR5%
MG)&(+%<>\61]-(:*R-7*&EME>K):P],5#'TDC[  TV(]W%.>E"[ ],# --[$
MB9D@B)%(2<.RUZ80..D"&1LE#IIB3VUN"<^G-&5;V$K&SZXTRS@I',1>[/]:
M9\B7L;'Z (2IGO,+4"JX,P/N3%:JTQ'#_ZF($F8:\7P&QSAFD>!:"L((\Q+G
MWK3W#A65_(<%-M,'H _%3.]EIN/9"RF0I(-#25""N$D":<(<(ER&Z%1@//A<
M5N#>7LN\4Q?^-;"N'>%G:'U;^S?\,[KUE6OYF+7E\>L1T2FAKD4=YEZ,#>N!
MD\.]SW(:9Z>;#R /NMF00^SD:BWP6Q5ZKVKW#NNVV#:,%%ZHRAZ]NO$QA_?B
MM"9A)]U^*VO/ZZH2<.M;_.-[*PR.1L!RY8NUR%_CRZ]8!X,X'=S\E4694H*O
M3\?5?_-P*Z"2T4DI#9<D!*X)UYXK+R+#ABNK+#]@?&7TI:/>Z!%.[&%$KA?M
M5V03/.%KV_YNS_HK_[HV$<>M#AJ;^/$YNW%F4GJPF:G-'-"]VZOJA[X&>(B]
M_"D8DUV8L32.>GGM^J_;1:16UO8S"N68[49>]JJ#:G9MFO@74$^;Z_L?WF]5
M;6S4'WN-O0_-O?_9;FXUWK[?W?RPL;^W6D/8=G/C56.]N0D?^'-O>W-[_?WV
MUM["XUIS=W]KK[&_V]C8;6YN-?>V-O-O>[M_;V^N[\,?;[:;Z\V-[?6_&WO[
M\$+>'5N(AZJN^+HU@+OY.SSF;Q\Z]C2T )A_7X31_]**>$<\5"M7OO303Z"F
MSS;YO7Z(R7^'I+AY>@R7]G-P5J_SWC]MO]7?3>NP4I]V!K!.OX4%V9_5_^[#
MG?YL5T4&GY0$-\^&)/C+^O>=+_]\W?EKB^]LKK/FEW= 0(^.=HX_D'R]3\>?
M@/ VO^[0=^= :-OQ?]Z???X83ASE$CY_UOSX[ONG_</O.YN>-C??D=V_MLX^
M[_\#8__<^@R$-W_O\V8SE\&AS?6#G'PG0]+(:)40]T0CYS!#P0;,8G!1)US[
M):W.:0SK.=)HO")*Z@!.2>0V16U2I(2 LT)BPL2M-")X%B?9>GJG\<+G>2CQ
M[O8.;:=U7BU%&Q=L"_X8ROTM^#Q@NO5+I_W<!:Z_"2/LM4[R2^N=,*89K=A_
MP5K!F^\.M.!2*95KXS.)N+8!N1@DJ(:*N8.;EXR.:P4&1R<D)IUVD:=(M%5>
M4TJ5L=%RYL>UHI).7OVORF?D*0UU96WR[ZL ".\-QU!]N1;5[>.X/FZ*@P.D
M=-PHSID@F@8KN9*)B9BDDRLWW.=6*YA<1UK9*1B\9K(*>2S2,C)EE%0]V2@_
M@EO5@_\'0Q^<]L!;.HJV/:BST;_'=CM;<&/H=C5.>JUCVX-!-&+G$"A^52 S
M)Z7#,$X3.-RG^5+PS;ZMV6;G=-"KO"*X<'[])/;ZU1\^W_2DUPVG'MRRQL4H
M/@SL$=RN=S+DNU7OE4;WM)?O/>I)U[:^NKH;(DP>Q=_QJ+5:?7VU'@&,??B]
M^B:-T.I%/X"Q9Y_QM ]>&PRF^BR\8*LA]W-8N[YVELQ)K,13^96G[8'-"?G?
MC[JY-&B=BC^Z-/QQ##?\EBMB]1K9QN#F^<6A?]K/)C7N??YK3-6718<?=H6Y
MMJJ\>-K 8($P*43!L$0>\XBXU!BYD"A2-E+C4I+"3@#^TU'/8>O(;$NUMWDI
MS3M!X8(I^^(!]O[16"#L=.19S1():QS9;_E0=.P BL43 -\*R_.%>P$^'6O@
M/8R="(L"@":\$T_RU>P%@1M!<I;U<!WXT*D&LC>HJ@/^MO+7^OK;E=\O-PM;
MQU=&T^K4&^H9YJOE)M\Q7Z75Z8,:5^';*L+W!CY6"X=@]*[Z['J.N[;CZ-6L
M:^_CX6F[OMH>^M]7C?7J66"<[;/5?-FS1NCFJ&'.96N?!IC%O$*DX1VO#R5U
MNX,ZP-C+I['R[+BS1GZ:ZEGR[+?C($X/,C:RB'Y-*J.A#89"/AVV7LU_;PP7
MX3R^%KS</W7]5FC!>ASAGNOM=CW%H[7ZXNO5"M<#C;/#&<TK;6RWCF$ @UKL
M_JJ9OFILU\+LGK0Z>4+@_J"UL-SG,:Y>C.V>"I@7#IM5#@9NPQ=8D.O7?\M?
M;?4'PZ/ZG2R7-HC!G_9Z=15NWSNU[?[OJ]5-6B%FZ72B!R)@>V>5?&PCV59>
M^B_9;KY6I@,WJ%\URWM9PX]=[-5JQ?!J(R]3JT.5Z%6//CCJQ9KD=+)M'L-C
M' T/Y?7S.;VL_M.O4WTI;Q_5&@*# U)1W;@+W[>U<."O++V1M=07KD2657?T
MF)F" 12U?!6<'FG(]"N" 3D0^(^3Z"MA#)_C+-I>'F^>TTVX[)7QDGJ\-T?+
M"V#/!MC %V<QC?Y1][0=LM1ZT8X,],MIQU\RXBS!VR]4F?Y1'.V5'(&I@#8,
M0::Z<#:)]0XPT#;@)Y#N02[I>@UO_[\)C8%O3E48,H7@7O4G;Q?-VK]=[U^3
MCN<#TLT/N?W%%J#-<5ZQ7B#!W%T_T,DQ2Y) F6@BKK5$FM. @O(&''9*&4[C
MGKS$PI*8F_P1Q@EFF@@OI2/,\A@8M8M#2#_4;:0N9#P!%S>KWD)BR9"O72QJ
M=R$5$[RN8C)#:M._LKKGQ>+8?H7E8C1=%8;8/GBP)\/EY,@.&K8N"%TO.ADV
M,C$\OJ K\/DXZ*\VVBWK6NVJJ/HJ?/!;!/VIKYB7(T##?KVVCOJMAE;?M[O]
M'$6HGRRS@#RL^H+59Z]=LZ:=_>E$K![ZQ)YQ9H:#TXI3U,NEK] VM."9@!_T
MNL?#:UZ?@\%1%UZK/Q5A(D??JXBT;>0/]O+]X[!6=F>,;HSVAX<//&6EOAT^
METE5IT?R;L6-2L5SD;56 G:317_I;UP*I-7):UEG,/([QFSB^LQ/X==71-OO
M=^%36?LN0DT!J'VOHL?#ZUW1N:N]@:?'B/)-X!7@9?V:+$]<[O(PS8V*[6.O
M8L?=O&B#WG;0U2_!I[_9]FE$-N35.+]V82R^-;*J=CS,D;:K;U3</J>VY*&L
M7IOGRRG)M+BNF56%C2M"W6YWO]M*ZZM9 OT]J0 @3P*8]: +S#L/::C)C7^
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M Z:K@;^C0)FEQ%NIN5YTO[4(?0:A9]^ :<>D8P$1F\!+I<8C0RR%?\#R&+9
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M,;?SY0EQRP4R!N@<$^6I,M8G3:8K^1DD^]VFSY39*YS@>?][.S?E0?4M0!^
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M0J.0EZM[;QY5V%&^8_YVI>>.\N]FL]:8@IQ'4S)$[[Q5:*?E7Z/HH:S&^C+
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MT#76/276'>P=:T4DS0BG-,L]@B5#5AD!9&,%,+\%264>A'7SV9)/ '<<A&W
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M,9V4,ZS4 H%(P:+/2I,R&*S3Q(//)D:T5B6N-5/4"5 /+=]J *';\RSLN@/
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M(CE.T2"K07&W+G%B*)&!R%P_:AN;!_L5US2J@>$=NM;NAJ*%9=&SKZAH]9#
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M==[Z7KP5HBP^Z>RD 9E,U-H;ETNJ&@ <7CE/M?/6C^4MM<!;WE&C*"URJ4J
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M?EW7C,MZ:E>:K9"B]B&!BT6"JCGP(\NF1Q)6R*A[V,M*L=7YKIR8:BTA:E$
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MC?4&[&V[OY7_Y$L/.!_YV8W_9'AXR_Y1VJ'3T;\>U2U=*,GE&_?<_ #=FCW
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M7<J+=<;UQ=;T(5MX[73KY*-FV\?)S9YX2$XVBS./O7#-P67$YCR;A\/YV%6
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MN>QM_ :6KDF2@LF J1H M"GX""6Q ,O1DKFHTUBW=&\V4I/GOQBG+8LNT2P
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MF,9J\;5KMHU?I&.HFKM2IFIHF<_"ZT0Y$I,DSJ^$S"LRR>/UAS1EX$0L!6]
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M*C!3)5U+5J0*H#R=]02RVF=%JYL5M13[=*,^8RG>.(F9ASC.I,8B0QJJL@P
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M/?=F ='#!K -8(?68*-E:9Z?9 HKYJ NC S<T<C1NU2-S@IQOCC;=;3)F82
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MJM-7/DA4 ]U,KLSQK$R9I =JI=4-X=;M"%\H[<,7A@$;!Z$H 4QCM-S5G:8
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M'TXO_S".SCX8QT=?3B^//AE?3R[.OWT]/KEH$J.W-@B!60<SX..YF,Q%.F]
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M%I\6'8G*KRPT3</GU4DP%WTNTMJP]5&@'Z*,R@O0"']"V00S*JWM,EE-],W
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M,461OW*W!-$LSR0/%AXP/&01IEH\[KJ(RHR1%V!>'J2E.ORJ=PD78JQY73!
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M871R+3(P,C(P.3,P+GAS9.U=6W?B.!)^[U_AY65[SUG"+9U,<CH]AP#IL(<
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M=E]V$K-CRSAM1.4#LNPH%I+C4%23G<I8""ECH7Q!=&140%HBPIH^HA1:M3R
MH31H4K)"&87(< DX])$_B'-U,K(M]7FPX+^;<&<)!N@H%";@2LD,Y21BR!1U
M*&XEBE_+![&N?AY'3T<E- )/2F2Z) :LA:.G8O,7SDADYRP>0\I3NK1& 7D)
M'!(X)!0("4N92#QH4$@*$@X+'&#7Y&!2BK(=0"@D9W'G" Z)Q)*1I&QE.)A0
M2*HB<Z[9>4J$D9*4]L!"(1D*GSYX1;"5 DS&UGF:HPU%"K6^5G:_#>->[WP_
MAG\]QOL^E>"4?[CBCUMD/EO3IH$I49&;!&K.*!:E'K QP;2DH FS*=BGFY)-
M'5P2W\#A^7RYI$ETG6]T^)+B*UW7"Q"QM+'XLH7F4.^T*G.@&F([_.H[M9S%
M3<DM3FQLE!3W0QB;SW9=:Y:!B-F%9QQH^\V<4 ^'F K_T53Q+0)%!H)"]@,S
MODH^+7B .">8I\(&T#S$[[I>SP.B,V*R9%T<MXX\:*W'F^>1V_12CIY#GJR*
M%()YZ)](G FNP'-:8%A_198 K 4X3;SH[7I;9(C6_%;S!5%M0YU'VL#$055,
MD<XVNCAN)2=4&X"H/&R3ZZUK:D05%A5^X57R6(@IG ?^OV,35*S?8Z3;\R&U
M-$>U)9,\420/?>)?7-0<'0^FWH1[Q/R;9<+,;$)H&'+NPYK8@A[CE7VK@[6*
M'\2O0SVA8FR_EC3V##R0P71W*^4!K8CA&+<6I=8+WVA!"WABK\$H4W#X\!VU
MC*:FB=48Z9MB+%95QZU$KCGW^X&V_VB"=+X"W914T8*4^G3O&)8)_A%=G]9T
MB@7QSJ)3#"W0!K3%VZMC[2?FGS'%6G,),VR&OP.4W88(:>/1G\+$OJ(QIS7%
MHL$IB&B!6XW^91'3_@'WP0U.ME^QQ?-@N\;$"+M.R?U)%,E#GYJJ"G5K/RS=
M,6 %Y"LL+(7(U$:8+HF*[S".MR7IA/-J(WCZ27PK%U!='R:VHU%%L[#W]OV"
M/OPD]KSE,!N<=^K?&V-J)/<R4?#H(]:]XPNEZ%P?2OGIXN2I%U4R#S/.7U3;
MV/U_%Z)H-!'KL)=R&UM/)G53!/^!*[0:6DRLO?$S\76@KQC*&IZ<;B2WB>YP
MB[(]R]-9J;JC88U[)'PQ==S4P6#:0=3D+HE_>J'IZ2EN=!P%^D33 >"YYYIA
M07K$7$:UO77FR20VWX=DC=\QHEYPGW*AR@*5Q^D$@7WDJL12KFD'X^5U$O4A
M$)I[R8Y4V9$$@3P0'EZ+97,]2>*]IW!3^Q-66JQU;KOC=G,_1Q<U&9/).QPO
M#]P>'"GU'=Z)P=0S4%WN4.JZ]QKIL<.RQ,I.-* @(L(S3$^IP\Y?CHCY05GB
M$\I,Y$7'<V1Z<0MX5/QX+0P>9_(G!I_0\L<3/!V*'KJJ.;[*C]FV#/%(EAG/
MV\W2S'A&TMGAB()YF*-M,N/C?HG3921CB^>A+Z_-S'16F*J$O6=R*$L3\I$2
M:N.)O9W)OC%]@$5ZKJ^]'L9;[932[VZ&.9O(7+-@,HL?I3 QE:3 Y()YF#H/
MQ.0Y8Y^ EHZ(P=RV0S %#$$+P.T0'^&'X?B UGW+%E>QU+X&\C1&/3W=S7JU
M5M\$!T-P["7&/;9\'LAM@7TAUA(Q?CZ IC/TR3)YZ%5\S#_=C?FM3<P?;X8.
MP3I5L)'6]4@3#O!8/]M! AE*'JB_LYAC#D%/!DKN7$3!/+3?M8G\I5)BJF2!
M]!:L[#/Q*B*_Z<ZUV,&:4OK=U\RHO4E_-1CA!8+*L9^?R;;#F8#RWBO',3=D
MO1449NA !;M$L?B#;V^P$QQ=<5YW?H2G.DGPN2?K;9&@S[WQI9N,.8;K@/,3
M?OPOLH%-["'UV9H^(/H,+7&S[\E^_UNU(1?'<D(!^9U%N] 'SCC,3+&(Q:HK
MG?#[[T]U'/ZWN%+%]Y%%\[#8> GO$>9^-N@7F;#&F^!I,VGV,85D'GKHQLH/
MR$3N7$OGX<JD\M SX8+QB8&UML-ST.YL<2=(\!!"T]QWW#:9A'B;=13P]_:"
M3Y>$]%9!OG\^MW3^Q8%'##*;[QF^>594UJ#WIF)_3RU61>&">=UN$Q2TQ)]H
M!?<ZV:!$E\V#&6F"FK7T6^1^-)QU%_[HU;SW=IYT&[UVO!WY**@\C)U;F&4#
M_Z6+'D0-T#Y8$+Q7FGN]5M97. Y"RX,F7#==T\1Y&W#7,6/"\/KO'+3(DN@]
M&//NMTN2%7$@6![TT,?V".GBR,3>6R5C\<?F)68RM7@>^NJ]X^5F =VS<R^!
M\W2/>.J8FNLW)00[&3#>/^8YVBLDXSE,XM._J>)5DXN@.,:E%I/]1.YZ-NS<
M'G/=L,H7!=RWS!9B<_&[L^*C(WX@I9#,JW?9=]]7'7GOJ_H1J#@V+S&B*23S
M8#\/GN7BG\#>A,3&'KV>][?#X4/ NR/=/Q),,AQ_3,3(ZRPYWDKQ8KW!<L0K
MR<5B!$.9\;Q^"YJ=+B66))$':](U# ?BI76ZWL25?M.>B+?BF3K'!OKVZ;]0
M2P,$%     @ <HEC5829GOQW&   %>(  !4   !N871R+3(P,C(P.3,P7V-A
M;"YX;6SE75ES6S>R?L^OT/5]O1UC7U*33"FVG+C*MER2D\P;"TM#8H4B/8>4
M;,VOOPUJL1;*HD@<B?94)8[$T.=\0'_H#8W&/_[Y^6BT=8+==#@9__R,_\B>
M;>$X3?)P?/#SLS\^O +W[)^__/##/_X'X%^_[KW9>CE)QT<XGFV]Z##,,&]]
M&LX.M_[*./U[JW23HZV_)MW?PY, \,O\+[V8?#SMA@>'LRW!A+CY?[N?6&),
M>LS@E9"@A-$0+7HP6B8OD1G+\?\.?O(^B)A+@"0M X56@C<8("C+F,^"1X7S
MAXZ&X[]_JG_$,,4M&MQX.O_UYV>'L]G'GYX___3ITX^?8S?Z<=(=/!?T\N<7
MWWYV_O7/M[[_2<Z_S;WWS^?_]_*KT^&B+])C^?-_O7VSGP[Q*,!P/)V%<:HO
MF Y_FLX_?#-)83:?\WMQ;=WYC?H;7'P-ZD? !4C^X^=I?O;+#UM;9]/134:X
MAV6K_O>/O=>7KQR'V7&'T^GQ>'HX'../:7+TO'[G^8O==R]WWNWOO*0?]G??
MO'ZY_6'GY:_;;[;?O=C9_WUGY\,^#67^Z-GI1_SYV71X]'&$%Y\==EA^?D8/
M[Z#*G'G)*J#_7>*IS[^ 3F&4CD?S.7I#OY\_N\)KCQ\_SW"<\6S.+@",)NG:
MET958I/NXF^.0L31_-/!\10.0O@XV)]-TM^'DU&FY;3S[^/A[/3U.(V.ZUIZ
M/^GJ2+9GLVX8CV<ACO##Y-V$5MIX1I#IB0>OQS.DT<P&4>IB3#:@98R@7&80
MDDL0F4.5D=ND_?6YKO,QI0F9LZ.$:9Q3Y!S6\RJ$YSB:32\^F8ME+I*VR,_$
MM_K\;2?2+57FF'=GA]B]F!Q][/ 0Q]/A"1*@R1&^F4RG[W"V6SZ$SP/.2[)9
M!$ 9/*B82!]83_,6538Y>:<Y-IZH!T*\/B-7*+W=I:U)1]--.O?9UB>L&O)<
M_9[A#5VZQO7;B__\&\^GQT='\V?"<(9'%W^_ZN(G9^=L\G@"/B,93<JZ+'P[
M'$^Z^>R<CQBS<&1P)*#V&53A%J(J&5"5R+*V7*!M3+.;&);AD?COX=%:(FI&
ME#V<!3([>2=T8QK9] J[7V(9IB'A"IJA5PFR%1H43S0^= XX*NNXS4JA:DR=
M^U$M0R;YWT.FQF)L1B]2CD>3\7R"_@RC8QP87Z1R)H .2(,4W(.W44%BD7Q@
MAS$*T9A,-S$L0QWUWT.=M434C"C;TRG.IH. - Y!\&TIA8RE,N"9J[;3.6M<
M00RFM3<T?W,;_"^.NX[BR@$G"7!6(@B%AB*]:""*[$$:RZ0UI<C2VON]!F"3
M7+85)'O+Y5IY<IOQ\WTW^8C=[/3]*(QGV^-<%^O'FD,@/V^@-:-54@0D@Z1:
M$_,0O?%00E;.,RM3:FTAOX9GDQRM!M)O-O7-R+!+>&CPXX,W&*:X5Z=QM_PQ
MQ?E@!YG[$ P+D$*PY,<YTI_2&'!D>'U!I4)LO?B_"FB37*4&=&@W^<WX\!+C
M;!_3,;GS0YQ^Z$*UWWMDF+MA(@]L("/SJ7@)(F0)*CC"DZ0%5[0/2E),F%UC
M1MP#:9-\H :<:"F AJPH2!8KG^4$/H3/9P.M6HL91LQT' Q&!LI7ED;OP101
M"5,*#E-S0MR%9ADNZ&^)"TVFO9VQJ$FB<PSDO9\[,4X;%66.@"81(Y.(9+>L
M@NQDD:EHQ5SK.&@AD&6$;[X=X:\_V<WD_F88XG T5T@7GFL0%(Q9(<%R](2#
M(JM8<N6?%BY$HX,.C85^&T6#!/?D>#R;O@^G-2:]&%OV64:O-7AAR1'3-<V9
MHX0<=<005 @NML]C+T"R2;'/FAQ8D'I>=^K7IG?=$JM NF/,?TY&QT<UYTTH
MAB<8QGD?NY-APE>(M(Z-M2RA@R(5K;IHJ]%U""9Z\LV=X-;=8/OM[;:EW[9)
M,4\CJ?<ST^TR-F?(%@PV"4NV516(AH:H?*:?M&# -"\LYN"8R^U5P6(PFQ3\
MM-<&#030,-4[GG4AS?X:S@Y?'$]GY'QU%]A.+Y!%[94LS$%6*A,RLL2.>UX#
M=YN-XX8+W3S]>S^N30J'&K.DN5B:$>;=9(87IFP/YWL5[T,W'_<H3*?#,L1\
M"=")&*448+(3-8#3X&+-_C'%I%)")=_:<WH O$V*H!K3IR\AM39#E]'>EV%3
MT*!9"#3.G)#<(L(4.&,01"0%*9*CD*\?,W0;S":%6?V8H34%T%-N]I:F(V?(
ML, L2&LIN"R>O&9;"!T*EGEV1K#6I/@ZHF688;]-9C041;NH?#(^^(#=4<T8
M;H_SB_!Q. NC.<#=.!H>S*?I<O3*!6VT1@C(R1IZ3G91> 6._.K(4.?(6P>U
M#P*X#'G<MTF>_@351X9GX RS#+,$[B,!,(&#UU@@%(])"J=EXOVE=EJ-Y/35
MI/N#@LRN5I.0+G\_F0[G\WPEF4;+TK)"\A1*\;IL"W@3R'7,GA<K. ^J]6;G
M ^!M:/;G0?RXM11ZDDZ?J4[/6/#9*%!9DW)'KB#R8L!&E55V.C'/^EL/#U"/
M3Y 4:D*&%>>Z;S_K"A6C0)?$'(QD%5L"7P3Y@(%K3_3$G)MO<=P':D/306LQ
MHJTDFGM:5R/(00P!,U<(\W2EDM* %]Z 24%F8WRRL?3D4%W%L:'YGO44P[KS
MW7SCNU;&XWAZ?OSEPON_3!M<(:@OCHP3,=)ZGTB#$=8HDP89LB2XN::Q>]H/
M7QKDAB9YUN),OY+JKY+BROCG16#%*)TH='2H-8&BG[R4#C 9:Y-"'6/K[. ]
MD#8TW].$+"VDT+:ZXBJ0+U3%E-2<H-I+!$41( 15,]LL.AL$J4#6FA5WH]G0
M-,]ZCD>;N6]<0W[A%0L9G+..7!T?*@2I($03(%EO9%#6R)O;SWW68*^PGQ:F
MA_/$Q_2P5KR>A!$]=+H]>Q&Z[I2\O;-B?1%"UF@9H*(!UDP[T-36\QTQ)F_(
MW_.M+>=2P#8I#E^=%[<VTYK+I.4^R+PV9 \3$C!R_D@G7XQ9:B<]*Q9T2>0&
M6C+=CJ5,5MLQIK4L*LB>BG,6X=FDN+P=.9I)H!DG7H]/Z-V3[K2:9UE/%R:C
MP1M#0Y/54"MN($A;F$@B1MTZ'+_Z_DV*O-O)?.49;G@P!3^&8=[Y7!UX).5T
MI03R<J?%9FZ]R"!*]<RRRA"$\)!4DBP::WQH76Z\!*Q-"L+;,:*U//I(TA*J
MVP</!\H5J4,LX%(*H$(]->&% X/!IRB*L:'U$?'[,+7<H:'5&9C+" P="=6@
M@)#(YY4T_<9%89WI<7B;Y \U9<)7\M,/FO)F/&]TI%:IC,4% ]($F@,?&)!*
MR%!X*!R1"6=:Z\P^&IALS*9'>Z8]@:!OD/0?SV_.\1OZO77/HOT/].?;G7<?
M]G=?O7[W8O?MSG4X:S0N6O#H/KL7W3>21BV,+C=$OG1C&6CE-2M10O%U"\2C
MA"AE@90+)F:\1=[;H<PO,-;5;;]U])#WW:0,9X,<H\N:!N-KDQ"59=W>(2="
MUO8A44?#F^^P7GG])MFS=>5]4[&L.LMMSE;<*/6?#K(R 0,I*)YJ6*%K=SDN
M$+)1+,3D@^+YOM6_\,D/M!3P30AQ_3ELYXG@W-+\AF,:VH@,X'8^&HZ'TUD=
MZ F>AP@#(VOM6\P4;6@R0-S0**-'8AS/F+3+3+8NJ%D.V0-#]F^#'ST*IUUE
M/,ZNC%)F\IFKXLF%TRAYB."C)3U$"BC+B R;EY9= ]"@=09ITK.A.">E+06L
M2@*4DJ%V:Z X6Z+3.G$73>OV+E_>ODDF:W4)+^B.L<KL]L/5Y1SNHGR43 !J
M1;K86]+%)FBH9QA+9)R65FM7[,$@-\HTMB-+O\)JV6SG@M,*%4O6.D!7'"A3
M9-U>#H#TXB"+DS&V5GYW:8Q5\N\7<_V*A%I/8@W'QS2[Y[9L,I[^BF72X96S
M$SN?R0 1P8;CT)V^)EI,[Q),X%'Z+$ KID&YH.J>;:+PV2HL07+M6A]DZ'$X
MFZ2;5V3?[:V!S1!^P]VD<Z#GOM&OY#K5$(D<Z"(M2R!L)!>ID"L6N:'I4HQI
M1?ZV4*T/2=P!9:.T=E,:K3?KS2AP-3(.N2A9C_=%23X&1<8.?,($+&H*/!WY
MS,T3I'?F'QX^DCT\P?$Q7BS-FR=D=SZ?9Q+KQ@W]DVLG7YKPR&RPP+U6H-![
M<,YI")FI8LG\2FQ=O+H"S$U2I:ORY79[TWZEU? 0_'2V6WZ;3/(\X7W6HV&Z
M/QGE06&ZE'H$BD#1^,E7KX>A)*"U*40G2RZM:S#N1K-1FK(52QI-?F.#V8\'
M4".]VLH!N*D;)\E9"$@VP$J5$T<I8O/JMD=S_]ID_ M3&@W/D#-2Y*)2A!!T
MW607UDF*7#*V7F_W9OR?5AMO"A_O/,"RHO3:%A/3 "?7 5WD KT('IE+4)OV
MD\ME)6'R!H)U-M<XV?->"HKO1+1)6[T;2ZYV,GWRW=\7NV_?[^W\3M]Y_>?.
MV0;JF]W]=O?8+/.NQ]H?7FJLC3:,%USA<7%]QTHE!9S"/5<+NG2N?2;-66<#
M"T86GE2]#T2V;H#5> A--.D"3*]( PP/QF>%<.GT0Q?&4W+F*ZIQGO]VQJ??
MPG \SU%VPRG!>GG<5?S8#2?Y\F(5@:0."M($Q[HUPU@&SWR$VNS5(BF((INW
M\NA_6)OD,#SENEBHQS>(47TDNS$H"G94AH2\]LL@)*YZ/MQD5W2TI9C6)=H/
MVQY[+&=BDXBWHGR>WEG8WO_]U9O=OWIR#RZ?_F@.P>+Q-'(!ZE&-,#TD89\,
MZ6F_GOXQK2<=:WW_M'J-VZ123LZJ6FVRP3GR07-" 0J5(F_1<D O/)<L$9U:
M!Y;+HUM;&X73>K7"],-D._W[>-CAG;<O#- 6Q5R=@BPL*%H;$)G4(*WFO##R
MK$OSS?RET3W0C/:^@=L'N6YIJGYDU[)48-$T7(;_5Z:A:&>%HF#/"<D)I T0
MT=<C=,@DRY%K;%W<N#RZEMO;R3B=DX14M^]()!D<TF!+,%%9JP3G[4_F;&A!
M3!_<^(HQ?\C4MW3V3H;UFF)R6U].CN.L'(\NS@T.6"C.Q!C .E-7IJF[ND4"
M#TE:%UR0OO55H%_#LTD.X>/1HXUX&K:^($<X#>=S1#^/\#RRV3ZJ[N]_YI\/
MO//(DN!@K:Y%RO5.Z: $U+8_T0MGM&A=4;4,KDTZ\OE(!&HNKC8UY==;1%&0
M5.=B_O-%'E20+F2F]H12M916NWFSJ )9&ULX"YHF9*DB\WM?M4G'/GMF10]S
MWZXX_3!T^"NAN-;\9V"-P%KR#,E7;@;GP<6<(4IKK"P^8_/@9C&236JW]$C*
MHX%(VE7ZG*?+=L?[882[Y5HH\26.D"P*'QD#Z2TY4<HY\([72T@T3X5IT]Y/
M7P[9 QLP/4G\UYH_/<BLOQ9>-\K9;"C<B%) &E'K/DH"5X2!S+3VIL1LL?66
MR3V0-JECTZ-Y+^V$U"YD.L]JD$O^_KA+A[4!=/ERV=^B.1"992$)F'>%#*H0
MY*F3>PX!0R+O2GJ76A?J/1SE WMW?Q<:JF=9M@S3$V*>ES*<Z=*O@_1*)B<5
M@K;U3(:JH2'SCHQU=M):R73L(7)_",1EV.:_+VW6IQ![\+/.LL'SY4'#CBZP
MQ*$D4\@P!P>QWF?K<JI-6Y4M[6NK%P%9*D/(OC,EM;Y(FK'C[LWM"Y!_C#L,
MH^%_ZB6W)BM=> "96>VE06&DM[6;A7'!LL2RS*V/2CT$WU)<>NHMF=9<ZDV
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M5B-Y"$:OH.,>!OGJ.&.!S5JB0Y0<PUB/  438*A1$*5TCL3H;8Z5[7\;GH?
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MF#C.H&4C([*(LRIZ4.CZ92$T=4&3>VCD3;KH5K3Q)MK<61?=9(PU3(52YT.
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MAG LO3.]<NW3[[/1ZJBLCZ(*%^[8\_,I!OG3Z446W3Q776!,;YB&*"@O$T,
M1[($ZKA!FRFA9/6TS=L /?08MKY5^K@?-<=R<>FE!9B^+C9=!;*?&TD5#;4Z
M5;&#EGM)1;D*2A(=I-,"-*,EU3\0\-EPD.4N*,]))U.]%DK_)K_C,L^N++Z)
M<JM?<YX.W0+-8I4B2:&GH0VN>1+7/)4D^!@I:)^]<5X$N5S'8MW]YN5'[^U
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M]=I2UZHMYAT'D:O>O?\:3KU9>UQ1Z[63/]*7\TDX<=-T=#Q)#;N6(5ZDC+8
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M$WH&= >W=O[;@3^EK3+%+7#T>_FW4X)MGEY(#XPA%N.)Q8#9S4,6X P:8^R
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M0 E0 [2 DX A8 )8 K8 '' !W $OP >X#%P%@H!0X![P (@#\$ *D 9D 7E
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M@7#8@!91O[LE_9C-V8^!2B\3%&8.NCZI.OK?J:+[)\=+GOO][0GX:;A:-1Z
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M@0EU82YS7%CUJ9. %7* 5?:EZ6P?"X?V^#PG%1ZBFINW[[E_O-[30Q$1!?U
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M>$-GJ-N@WTF(<@)&-X0]1040^AY"(%NN*NT;J$V?^,^N;D>V0R6JX)%/AN/
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M4I&Q^=C:">-MP_T,&7[J-G]6D2%";V!/$UGE^&C2UT9DMR9KVH[,C[+CZ/C
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M7^< ) AE!9  *=!ISE(((FRCFZR.0$0'3$+DH./8![G$IZOKYN\\$+OMF]G
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M.YV_M&,YT-GD%R4B\[360V/%3NU:_\K^D<CTF+!1_G)8C^7B^F[,1)+_FE6
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M5:L_P)K92I&Q*?T('[&H(TIMI%K\:Z6/RYL\D44CH!^6\:%!3^ #7"#'909
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MOUE>61]=%*_:'E+DK[6JMA!TB7SW=?C9#+=5$F%/]$M3'PQZN8^@%(92IK]
M0#S1DP&8)1=*!Y2"10G"=((\,$I/C!2(E) +S_%EZL5OTP4AFYV/A](A^_E
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M4M@ZXWU46KW]';13^%]F^@L#<!VNOD*+A)*<@-1L!H#Y!T1C'$F+[FJ* 27
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M(=Z2H6Z*:A34UT;!4S'!?-JL9662U0V&&\VP=='?4$3@K$N'*'FG! >KCYV
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M;Z7\D=&R JQE!YCM\H."ZJ8RX<!DIB.893I'E27+#E"Z6?)H%JB '9KR^%N
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M7,'A*&]=L_+S85^L[^8XQXZR-F%&JW5#C=5<V"=$^Z% 43FX0C4^Y#/9P7#
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MW7$0OV&7H1%W+B=.V/M!A!H;Y-OOTKP9#O7\+K='U2Q3BK'+ITS2<L);:LL
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MA+K$C$EB:($XMIL:<V;7-43C-T/X8Y6Q1NI<;0<[F@?%U:_?4I?M[K+YL#9
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M_9,!P @<9VE4R/-Y7IWVEKX,3X#PZ)?H-BT@!(?W(K8?VUE(^413&S=_,0"
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M>ME6 C..:U GT(/V(,'!"#*F,F)>L/Z5/YC,S!DNSZ^!O@\,3?8 RJZHY#[
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MR7K%O,XIQM$5>;:_+%GLS?N8FN/G^?L>?W'*]%=Y&@>K<:&^6VEX>)[905Z
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M*[^5Q%[;S&7]'&IW5#DXK4ON\6<()JADP+%U'%F3H\-9<J^3+YM4/8@ %J(
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M\TUT(-:4 HF#IF$PF!0@PRIT.!!?^K;_:W1[/MFN[:S<=_O1O,L71@_I*+)
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M6_H85B2'S@,XF!IYHE,M@'2J+$ENF-C\ >'CW5E9?@[G+-W"<Y<@>+)JMLB
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MR81F(?Y;//3_5A-[,/:_ %!+ P04    " !RB6-5TK!WA77!  #6^0< %0
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MI#_&#M8(G?@&QS7FNMD33U[G&5?K8KW!]E6MAA,FBO9V8XQH0 F!PG-YG:-
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M>%QF+T)\%?ESPL1^#54DJXGB1*U&42V/-_]^D17EEZS\NRAO!,ON4GWCKB9
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M7T6A-WF;-2=R(H:I@R$+(PY1Q 6DL<_4JM_W/(]Z4H964_)6ZW.;&1OE>IX
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M*(RZ;FNRDJ@[ZF\60]W]8]\4X*5.HKTF>?FR48NK^K)X1 B)@@!Z7D ABJ(
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M,JFG=85%JO0473)1WG3?KADH>_I4)#M3J7LW/EU>]:GV;R59G]S8H*>0Q;J
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M+U?83YQ4]?A^XO3CW3-O?,R7)J:X.+'XJ'^VG$0L3&6H(A"ED&LJ2"3 +(5
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M@+CV/NC&HR,T^QN.KLUTS/>T4]O\[3,U^];*,U= I6(N%5"IWF8@&H: TE2
M."0J%BF5DKBE?3K=U]B6(2-JT)#U)BBE[5@UJ UE.\;RA%W/[-0=-O?L4.<!
M\94DJJ6G87-%G5?Y(&64Q2N7EC*HDVZ^W94)CO:2WU,>,JXR;29%TN38Y1'
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MK3[Z/OH9SL?>(RH[/O(^V^WH6]K52[_RQ;_?QJ!4T4:(LPS%409()E* B)*
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MB]5D9E*ZRKZS5KA+;S7Y23GYFSKTQP$;$:^0JJ+#Z/=LS/<THC^,45_J'S0
M",KR2"L-P3;YQ?:CT=],B<,(S/ON@W=M,[^#Y#^&N=]]2+R9_1>(<$'!N<_S
MV;QTB33%+DW-X _EU>LDECQD*64@PJ8(%:8($$1# *GQ8Q!QA.*X0TWQDQV.
MS^.I9)1I85(Z.S:=0Y>S$"(,00PSC6Z8ZMV41APD,".1TM9"AJRN,/QC.UR!
MOWZ0M5MY_>'5\V)90M64=%.1O1+VM!74K0#@651\5@(\W=GP)0'/*GZT-N#Y
MMSK2\^*1SJHB,7>:_N?37)2%B,O(EF9@U[NJ;/A[N>2+O%@N3)F9W=@74P%K
M$[6%>:HHSX@>EEB8*!.J=R<D 12K&,J(RY2ZU17M4]JQT9>'X+I^1]>2 \<R
M9GU3:$//(AADJ^E-<'0L]8\K?8.&PF6IK8W*0:US\&<O@8"##(\O+N]5UF&7
M@B%@/UA)!NFTVT)D"F>88&[=4IE-XG:]>IHO\G]+,9':4,U4C$&:AL4A%P28
MI9G^6X*X(E(BYA1LW=+7V!:!4M0RJ\I-G?^(;L3M?DS5AK<=L7M"L6=:K@#\
M5@)8Y:?:2NJ/2"W@\$2#;3T-2F(6*N]3D,TK'4_=^9,4:^.D\[5TXOYB*G<\
M+.AL27EQM/'N;><W15$]EH:2*!Z#,)(Q0%1F@$0B!&FLC5.,"$O2V,D+IHL4
M8R.=6HFR+%_I$5](&S05N3&GI[N_[E3TL-O 61Y]]ST<?1]B]S42[N?0ER#I
MZT2YDPS#G@U? M/!*>]%C76J4?1H<C&^RB^+N5CSU;)R^1<<19'Q@HZS5._C
M44P C;$$VC C,DJ5H"ITJ#MTM).QD>!&3*?B0,?Q:R<K7ZCTS$4;"8-:Q/.!
M$0Z?F'W4F0>H!@H^^[J--\MG:KYX+F\@33 HS8N"&*MY(#:XOM2X5E43_,:0
MG8'M3 VCX^\.69>H5?J]6D/MSW8T,$VB,?/1&#=P<P*K]\/F]FTAG^1LJ7NK
M?KK)")^2"*4\U*8EY@#)U"2#)ZGFT! 3A<-,(JM$A!W['QN?;L0OJJDVY:ZO
M&BP2@GL9&$O3L3^X^S8:?2#M;B!VP\N7:>C8^[!&83=H#LS!CLUT]-OE?+$V
M;@"FS0?Z72YK-] 4QY*E$0,0,Q,81R2@D$D0"TB3)()$9)&3C^ZIGL9&8=7L
M61D1@Q?Z9LQM1W_;DZ#:D9(7J'JFGTK&FFL**?OPECT'A2_/V)/]#.L%>T[=
M X_7LR^XA]#^1K_GS^OGVF2/DC@51.\%D9  F>II-$P$4#3E-(*")M@JK/Z@
MY;'-^THX^TC779S:I_9%VO<\E2NY/ ; G]3V@KC3W?8&BRH]JD8S9O3X Y>>
M;I=AIG_D0B_WFRWE5_DJ9VMI*JI\^*ZGQ(Q.[];+E9[YB^6[MWH;I.V%;W+Q
MFO/F+;XD@F"%"8"210 )P0"&3 !.62QC&%$2.?EH]";IV%BA>3:[*+4*'N7,
M..G((@V,I/RIWLH;.XW.WO[7LM[D!U-SO=KUI-SW1^!ZFG[%H>V9\BHERMHU
MM1K!1@\SKIOC+^.I4>M2G;CWDZVY=^"]']#[EO-*A_@]P7WZH+^O#COO =?/
MZ^*"H?!"/++;-+%PGZ7>DFH3<T)XFJ4,A2#"5 "4I!' ,6,@225&B&(6,J>U
MQ+'_L:T0#?&#>>%ARW=.8XQKLO/^T6E K'>5?<'<_UYS@W#IPWSTO.LG(_[/
M1?I+LR!K';SN0[N YV]WZM3[T'O6+M <V<EV:N9R/Y+3M'N[6BUR9DJ4/LP_
MSA<R?YR5-4ARJ2GY%SE_7-"7IYS?+B1M5 V!*@I1F $6)HFVM64*6!:G(.4<
M,AFG<8:<HMM[E'5L7-JTMOG&=U%/>U,:L$C+N#'"M8GVN%%*&V_%'';/@-?G
MA^!J;U]U>/N^KMCQ<6FWOK>ZFIO32MM@HZX9^JW"@=%X(+N\MP'JP77&MZ17
M<[#I"?(V-YR^NNSH-%V6!-@K!'"[NJ.+Q5L^>RP2O$Q2(@7%,@0$QUA;Y9D"
M#"449)+R1$$L$NJ4_M2JU[&M'W=^*K38(6Y'[]YQ[)FH-Q >UCZAJZ"6NLR"
MY=&OV@4E7Q[65GT.ZVOM L.!U[73R]VX2!OBFMF6\KTL__QD0DR*BVB3*K&F
MR5]SRHK,4I,T0EG(%0(IH1E L4P Y5QJ?N*,X PCQ%(75G+L?VS\]%XJN5AH
MNZ:R8MUHR15\.X+J$=*>J:J6//BIEOUGDYRC%K^H&;XQ*V^"C0K^:*LC=IX(
MS+7W0:FL(S3[I-:UF8Y'H<NE7&V\-404Q3+# H0I,I05$4 2H2VL*(,12QF)
MC$.TJ65C>=#9;-V)FC9]]#>9RIH\=05O6HCJ>&RY Y[EH6172/H^<BSDZL.A
MY9C"OHX)=]H>]A#PF%H'1WQ''^ILB-0>+U]H+DR)IR0D*E,P BQ5*=!VA_X;
M1A0@DA)()(P0=[4U]KH8FSE1F.@O6K8B;V'><%PK<J&4=]9J/1..,_D(N-:V
MQ 60]6\N;%S5 B.>YTI9IY7WM][O=S#TDGY"P2.K]JDG+\BVR,ZGPF+[J;"J
MA%>?Y[-7N5Q)\8?,'Y_TG[>O<D$?Y2^Z@=5[NI+;3+D;SWZ>, :I)I$H2@""
MH00LR4(@I< <$IHFR,D!=G@5QD97M>!_^X\H#?^K$C\HY ^, HW\VAVR,0[[
M=5B>[8]ZS/L^\K\\-^,F^^(&B)N@AB)H_8#ZB7ZXVG#ZS-8XK +#)VV\R@ =
MS=UX'4FZK;"_Y;/YHL@:J9<"W7.9%W)_^SV149+RD%. 5<H!"DTJ8J@RD*$4
MIE1@%G*GDO)VW8YM)=N>/(GFR=-,?Z7F=&(^G9HS\KS2R6TQLQP(NP7(/[P]
M+QJ?=R&LY;ZI4NX&1\[\_/&[&UJ>.-FRTT%YU V(?>YS?-N-KX3,)Z7_Y+=G
M.IW6&:PF(A80A1$%(8R8WOW''& 3M*822HV+.P_MLA><:']L#%2*&!0R;C+,
MV1'-*03;&<4#+CU3AQLDUN1P1O$C++"4_.^/\]?_K=\L"4#_93OO3[4WR 0_
MHTP]D\\]ULW$V)@L[]Y^TPRP7I2&D$E+=_L]7TX4CA&G6 )M59A8>D0!8WK;
M+84V+F":Q8HY)3(^T]_8IG1#QBJ5Y)]&3,<X^7,@V]D-'J'K>=8[H^9L%5AB
MX<D<.-?;H': I>K[!H#M:QV2%U4A5LO_,]?6]3]TJ[IQDQ9I)A=5(&:F1 0I
MC0"*9 80PA00C"1@7%L&B*0,QU9Y).VZ&QN);$/0"I&#2N:@$MHAA\]YI-NI
MQ#]^/3/)&>BZY$$ZCZ%#1B2O6 Z4&^EB3-VR'UE#U)H'Z7PKPV5$LM9H)S>2
M_5L=*/C0)6/C?E'EJ7N8_SY;2#Y_G)F4GP_T^Y?Y,B^.M28H0Q&3)JM<E*0
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MI+$_#5%ON>N/='GEA/6G03B?I;[E7?=\5]^,ZU>^>HL@>\A7^LL/81A'$1%
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MZCX%G'N\XYY2/IKFOA8)^_2*^#Y?\NG<!%IO,PLDF7Y5F(VBPA @0C$@)$8
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M/_-<SQU3AV>M][[S6G WEG+!WHZJ>D*T9[XZD6WO)MB('VSE-W9BJ8$_PNH
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MH?.N^(=GS7N_[V:!_3I?+DWD0*[G]HSG4L_MSW2U7IBH_,V/RX-/SA*:(L5
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M1QL._6)&*OVBW3/E*/$=K;%2FZ\^*M\K#[Q\_L%[=L);>]'+NL8=Q(YXR\&
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M?3//B]7GJYM5^#?'RUOYQWQ^5TGS<D@X9TR 6% E]8P2D+*0 Q3[@I$DA()
M8ZEG!P/&1B3*A>K+9$.$7GOA:3>\]\J1#T=>")ZX*AA2>F,AD>S23<TL- 3X
M/7.3*^XN&M4N'6 A8=US1PRD<-WY0+!3M6X!8J/HM<MSA]/$;N'UEF1VF^>X
MK4JKK]O5]>*8_OLM7_+I<O'(E\735+Y5Q?%<Z[T\:LEE/XD3+I  D1_Y\K.3
MI8!$S =!RB,:9@%,.9S-^9U24C=;IYHW;C30LG*@;9K0WSB;R@=]D5VU4N=^
M'BN[CW2=V$+70N&U[79+6HL.,5OB=@SR,--*;;12Y*_,]J;/(&O+RXHS)P=1
MMEX'VP/6T;K8HN%!U\GV@.RNFQV>X$9GO^4K?'>W5 P@9]E+4=4U/,_G_*S@
M#ZL9Y#!"1-7#1E3M!V$?9%1^=/L!]5E,PAAG5N6Q#S4XMG7RMKV*N^KBG?\H
MFSUMM&5T[2#H9D35)90]TU-+%*TIR12:CHCH8'.#TH^I\[ND8WQ?6\VYDZH&
MQI0OZVV#G$I2JP3ZM9K1-?]1?))>?9W%+$X$RGS HR"6#!0%(!.4  (Y"8.8
M11&SRVQQLV-LQ+2I0[;DZM7([_/GX:4JD,SEY]-2#10]\3,^7SSD<_U_>8'V
MU3N97JD5P\&K*T34]:Z*<W:=;K@#W7]7]KV3O-&+M0]J([C<.CZJNDGU2-T%
MI6"<IYSQM#>]:,<YX=FY4IR=%6^D"^<$U7X5.+?'.411)WC)\L5WO%)EBI9R
M@<F^T:*N9 8QPPF'*1!AE@'$: (("R(0HICA-!,QYN;ATJ:6QD:KV[9:!-L:
MX30(:W8%4L^$M6VF5]OI$IYL1,PB#MD5<F];4D]]WN%<#7TU(]-MF!]KF*NI
MG6LANJXJZYD V!AL;'S <%%%$S^VPH=&-^RCUDWPY1KYZ\=W]6_D#W7L_>.[
M_P!02P,$%     @ <HEC54NA9C(=:0  9:X$ !4   !N871R+3(P,C(P.3,P
M7W!R92YX;6SLO5F76TF.)OA>OR(FYG608?M2IZKZ>&C)U!F%I)84F5WSPF,+
M3&('1:I)ND*J7S\PTO>53MKU:U)E+I++G7XO#/@,!L"P_-O_^/II]M,77*ZF
MB_F__\S_PG[^">=ID:?S#__^\^_OGX/[^7_\Q[_\R[_]7P#_Z]>W+W]ZNDC'
MGW"^_NG)$L,:\T]_3M<??_I'QM4?/Y7EXM-/_U@L_YA^"0#_L?FE)XO/WY;3
M#Q_7/PDFQ-6?+O^5)<:DQPQ>"0E*& W1H@>C9?(2F;$<_Y\/_^I]$#&7 $E:
M!@JM!&\P0%"6,9\%CPHW#YU-YW_\:_TCAA7^1(N;KS;__/>?/Z[7G__UEU_^
M_///OWR-R]E?%LL/OPAZ^2^GG_[YY.-?KWW^3[GY-/?>_[+YZ=E'5].;/DB/
MY;_\K]]>ODL?\5. Z7RU#O-47[":_NMJ\\V7BQ36&Y[?2]=/MWZB_@M./P;U
M6\ %2/Z7KZO\\W_\RT\_;=FQ7,SP+9:?ZM^_OWUQ]LIY6!\O<;4ZGJ\^3N?X
ME[3X]$O]S"]/%H2(-^%#I7CSA/6WS_CO/Z^FGS[/SK[W<8GEWW^F9RRABI9Y
MR>I[_^_S7_[EG(3/]!Y"S6;)+^D;)\^H;]N;'/RZQGG&[4I/7S1;I$L?FE4^
M+Y:GOSD+$6>;[TXR3B>;)Q_%U7H9TGKB) LLH@&!68!*$B'FF( I5#E$78KB
MEU=?*5\1Z1NQK##]Y</BRR_TX%\J1^H7&]9LV'+M=5OV[$?WZ2Y\3Y^=2&99
MR=Y"L(+3WG 10O:*R/9&FLRT\>X@LB^^[3+5%\5ZM$P_+989EZ1&3E\7ENF2
MB*]#^.03OWP.2WH0I(_363[][:I/6LAJO6C N:U8B-R??Z)5%UPN,;_<2N76
MQ6U6MB;EBIM/MI#X_SP.2WKB[-M;_+Q8KB?"!5U2#."+15"6-&GD+$(I.D32
MK$+RTD3X5UZ\$PY$_S@XA)^=0.(-+J>+_&R>G]*!/$&#N@C#P9;@03G/P?&(
M=* :)X1.(9?4!!"77KL3'&3_<-B?EYV X?TRS%?3RO@30.?DBS:5!;HH4(;6
M0&1G,(J59).,6K=1$%??O!,D5/^0.(BC(Z/BV7P]77][/IWAJ^-/$9<3[B7/
M/A9 1;!67BGP0FM@0ELCBF2D[ Y"P]4W[H0"W2\*#N)@%])_BQ^FE0GS]:OP
M"2>9<Y&B8H#6:4*O)IU&9QLD45*Q3,B40@,$7'[K3B@PO:/@ $YV@807Y-@O
M285M&/^.^(]/%L?S]?+;DT6FY>AHB?0,3E9CV"H+SA8)V2<12J+3SJL&P+B3
MB)UP8GO'23L^=P&;]^'KBTSLFY;I-F9QH@D%^H(Q1LATZ(%BF9,FC!*8#$F+
MH#S+AUF:=[Y^)ZBXWJ'2@K==@.0HYQJ[.?GKY72.?**9XT&;0 R1 50L#J+E
M&@)]*9U*J&-N ) ;7KT3.'SOX#B4IYT"0TP(R8X[GD#S2&R)J,BO\@GHQ,S>
MI9R%]H, 0^P6OF+?'S(>QM2>D/&$OGR]?+_X<SY)Z%P(AJA'3?XV0PDN!P2>
ME.<^9N:8:(>+\Q?OAHJ.HYHM&-H3)C9&T^OEF^7BRW2><%*XXLZ7 ")Z TKF
M CZ3Y:T94RH9*P)O89O>_/;=T-%QK+,9:WN"R)O%:AUF_]_T\\:H+HH9Y[@
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MF1>)-H!(&.CL($\WL'I:,8=!*U^2:#U5_0YRFN7*W01A;YUW7GI(CM,6"2Y
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M01#H*NFC(2RM&Q2A'R)E D%LR.BE))Z(!8U>BHI92L-\-'0@-+709NQX3>Z
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MQ.J28?3851;JV,!872[,OZ[=V)LFOTO6;@9(<*.-H X%8C% T2Z6JAI#1-)
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M40IRIX>*-_/ O1C\-:3<P;/BQW-@U2MB0(T2@SC:8E0JA:L5FS(T4DBN)4U
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M]SPJ$D*?D28L9>>WIG',T*W2YI:9NPNH,LNDM0"/\(Y0(?>G=B'1/J=D![T
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MA[L\Q*T>_**K.OKOR]R7;B?_ U!+ P04    " !RB6-5F  RD4P(  !'-P
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M@;0.HZ_S%Z+#703$P0-.L=QQ+[CA7BU26END/,4R_L(MX@.1D$W8M=+C%,0
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M=&T7@&YC) 4AFUNM.#$(;M$K4&9-<.=&3*&'SD#RODREFQ M7S4L.2*/4@_
MX$-NB2YDYIZHW)03R@N3HP.P/HV(8VV$-\#GZ -0F!VDZ >P!7)R,"12*!>P
MCHY(YIXA;-'^C&B/7Q/:7Q[S9R.>%CX:$B @23 9EB/<RG9%4CLC^VM$]W"Z
M.L_U$,>.&)EMR*;[NG#W6[ ._^ S::!20?)PH8SUIT4([[4@K 3:XQ%* VQ1
M^EPH%:\)I2\:D\/67X80U;;+Y-.WK,3I(R(QD6L=QX4AH"PPV15:,VT=7J=G
MSJC+QJCHC_#(*CQH6M$E0<1CC+PC71H>(PY]69XJ]JJ8V;4;K!IR.Z/]%%V]
MAP#A:8=?CY(23%@JKR$M:_1WY*M_>8E^2*^P406Z[K9 ]W(%.O\<6DR]374>
M'"E6+R)^'B<)LX_($I:2\YEI'!-TIXV=$7-_ 55FF70.X#M,I*^1^E.[D&B?
M5[*#?@$#OR5B@7^I3#!U9O!'(=%\[[@*%?M2_NZVYK:MN6T";C^DF'AB(BP1
MEE03ICIS+ %Q5-+I6>UK#/R:^'%(1#U#]BFT?Y ]?4;U*'269:I0I5\13[G
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M :/)_"R<3GXH3#>0]-QCF+^$Q>C\Q6@V75CSWU]-W\-H'.I6WW7]1P3GWW.
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M+FAT;5!+ 0(4 Q0    ( '*)8U7_=,'IZ]X! $ID%P 1              "
M 5U;  !N871R+3(P,C(P.3,P+FAT;5!+ 0(4 Q0    ( '*)8U5VG1']I0T
M *"+   1              "  7<Z @!N871R+3(P,C(P.3,P+GAS9%!+ 0(4
M Q0    ( '*)8U6$F9[\=Q@  !7B   5              "  4M( @!N871R
M+3(P,C(P.3,P7V-A;"YX;6Q02P$"% ,4    " !RB6-55&ACD4D[   NC0(
M%0              @ 'U8 ( ;F%T<BTR,#(R,#DS,%]D968N>&UL4$L! A0#
M%     @ <HEC517UF;J)< $ 7,H! !0              ( !<9P" &YA='(M
M,C R,C Y,S!?9S$N:G!G4$L! A0#%     @ <HEC5=*P=X5UP0  UOD' !4
M             ( !+ T$ &YA='(M,C R,C Y,S!?;&%B+GAM;%!+ 0(4 Q0
M   ( '*)8U5+H68R'6D  &6N!  5              "  =3.! !N871R+3(P
M,C(P.3,P7W!R92YX;6Q02P$"% ,4    " !RB6-5YYL_VDD(  !$-P  %0
M            @ $D. 4 ;F%T<C(P,C(Y,S M97@S,3$N:'1M4$L! A0#%
M  @ <HEC59@ ,I%,"   1S<  !4              ( !H$ % &YA='(R,#(R
M.3,P+65X,S$R+FAT;5!+ 0(4 Q0    ( '*)8U4LX5H^_00  *D8   5
M          "  1])!0!N871R,C R,CDS,"UE>#,R,2YH=&U02P$"% ,4
M" !RB6-5X]I4/1D%  #(&   %0              @ %/3@4 ;F%T<C(P,C(Y
B,S M97@S,C(N:'1M4$L%!@     ,  P ) ,  )M3!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
